1	S	NN	PERCENT	s	nn	2	SENT_1	[p1l21t108r44b145],
2	%	NN	PERCENT	%	_	0	SENT_1	[p1l51t108r134b145],
3	+	CC	O	+	_	0	SENT_1	[p1l51t108r134b145],
4	E	NN	O	e	conj_+	2	SENT_1	[p1l143t108r163b145],
5	A	DT	O	a	quantmod	6	SENT_1	[p1l306t108r334b145],
6	pҘ	JJ	PERCENT	pҙ	num	7	SENT_1	[p1l343t108r399b145],
7	%	NN	PERCENT	%	dep	2	SENT_1	[p1l343t108r399b145],
8	+	CC	O	+	_	0	SENT_1	[p1l343t108r399b145],
9	nature	NN	O	nature	nn	11	SENT_1	[p1l1797t124r1888b145],
10	publishing	NN	O	publishing	nn	11	SENT_1	[p1l1897t121r2046b152],
11	group	NN	O	group	conj_+	7	SENT_1	[p1l2055t128r2139b152],

1	Novel	JJ	O	novel	amod	3	SENT_2	[p1l27t261r262b337],
2	Immunomodulatory	JJ	O	immunomodulatory	amod	3	SENT_2	[p1l295t261r1168b358],
3	Approaches	NNS	O	approach	nsubj	4	SENT_2	[p1l1189t261r1702b356],
4	forthe	VBP	O	forthe	_	0	SENT_2	[p1l1725t260r2002b337],
5	Management	NN	O	management	dobj	4	SENT_2	[p1l25t377r600b469],
6	of	IN	O	of	_	0	SENT_2	[p1l623t372r711b449],
7	Multiple	JJ	O	multiple	amod	8	SENT_2	[p1l730t373r1081b468],
8	Sclerosis	NN	O	sclerosis	prep_of	5	SENT_2	[p1l1107t373r1470b449],

1	OH	NN	O	oh	nn	2	SENT_3	[p1l21t523r94b557],
2	Kantarcil	NN	O	kantarcil	_	0	SENT_3	[p1l106t516r310b563],
3	,	,	O	,	_	0	SENT_3	[p1l106t516r310b563],
4	I	PRP	O	I	appos	2	SENT_3	[p1l322t524r337b557],
5	Pirkol	NN	O	pirkol	nn	8	SENT_3	[p1l349t516r476b557],
6	and	CC	O	and	_	0	SENT_3	[p1l489t521r565b557],
7	M	NN	O	m	conj_and	5	SENT_3	[p1l575t524r617b557],
8	Rodriguezz	NN	O	rodriguezz	dep	2	SENT_3	[p1l629t516r859b569],

1	We	PRP	O	we	nsubj	2	SENT_4	[p1l20t643r74b672],
2	provide	VBP	O	provide	_	0	SENT_4	[p1l84t641r219b679],
3	a	DT	O	a	det	5	SENT_4	[p1l227t650r245b672],
4	focused	JJ	O	focused	amod	5	SENT_4	[p1l254t641r392b672],
5	review	NN	O	review	dobj	2	SENT_4	[p1l403t642r520b672],
6	of	IN	O	of	_	0	SENT_4	[p1l528t641r565b672],
7	novel	JJ	O	novel	amod	9	SENT_4	[p1l572t641r666b672],
8	immunomodulatory	JJ	O	immunomodulatory	amod	9	SENT_4	[p1l678t641r1037b680],
9	approaches	NNS	O	approach	prep_of	5	SENT_4	[p1l1045t641r1251b680],
10	for	IN	O	for	_	0	SENT_4	[p1l1259t641r1309b672],
11	the	DT	O	the	det	12	SENT_4	[p1l1317t641r1374b672],
12	treatment	NN	O	treatment	prep_for	2	SENT_4	[p1l1383t645r1561b672],
13	of	IN	O	of	_	0	SENT_4	[p1l1570t641r1606b672],
14	multiple	JJ	O	multiple	amod	15	SENT_4	[p1l1614t641r1760b680],
15	sclerosis	NN	O	sclerosis	prep_of	12	SENT_4	[p1l1769t641r1926b676],
16	,	,	O	,	_	0	SENT_4	[p1l1769t641r1926b676],
17	the	DT	O	the	det	19	SENT_4	[p1l1934t641r1992b672],
18	most	RBS	O	most	advmod	19	SENT_4	[p1l2002t645r2089b672],
19	common	JJ	O	common	appos	15	SENT_4	[p1l20t703r175b725],
20	acquired	VBN	O	acquire	partmod	19	SENT_4	[p1l186t694r339b733],
21	inflammatory	JJ	O	inflammatory	amod	23	SENT_4	[p1l350t694r591b734],
22	demyelinating	VBG	O	demyelinate	amod	23	SENT_4	[p1l599t694r854b734],
23	disease	NN	O	disease	dobj	20	SENT_4	[p1l864t694r994b725],
24	of	IN	O	of	_	0	SENT_4	[p1l1003t694r1040b725],
25	humans	NNS	O	human	prep_of	23	SENT_4	[p1l1047t694r1197b725],
26	.	.	O	.	_	0	SENT_4	[p1l1047t694r1197b725],

1	The	DT	O	the	det	2	SENT_5	[p1l1205t694r1270b725],
2	requirement	NN	O	requirement	nsubjpass	8	SENT_5	[p1l1280t695r1500b733],
3	for	IN	O	for	_	0	SENT_5	[p1l1508t694r1558b725],
4	such	JJ	O	such	amod	6	SENT_5	[p1l1566t694r1645b725],
5	a	DT	O	a	det	6	SENT_5	[p1l1656t703r1673b725],
6	review	NN	O	review	prep_for	2	SENT_5	[p1l1684t695r1801b725],
7	was	VBD	O	be	auxpass	8	SENT_5	[p1l1808t703r1876b725],
8	stimulated	VBN	O	stimulate	_	0	SENT_5	[p1l1885t694r2073b725],
9	by	IN	O	by	_	0	SENT_5	[p1l2084t694r2126b734],
10	the	DT	O	the	det	12	SENT_5	[p1l20t749r78b779],
11	emerging	VBG	O	emerge	amod	12	SENT_5	[p1l86t750r256b788],
12	application	NN	O	application	agent	8	SENT_5	[p1l266t749r464b787],
13	of	IN	O	of	_	0	SENT_5	[p1l474t748r511b779],
14	novel	JJ	O	novel	amod	16	SENT_5	[p1l518t749r613b779],
15	oral	JJ	O	oral	amod	16	SENT_5	[p1l623t749r688b779],
16	medications	NNS	O	medication	prep_of	12	SENT_5	[p1l700t749r915b779],
17	and	CC	O	and	_	0	SENT_5	[p1l924t749r990b779],
18	the	DT	O	the	det	19	SENT_5	[p1l999t749r1057b779],
19	need	NN	O	need	conj_and	12	SENT_5	[p1l1067t749r1152b779],
20	for	IN	O	for	_	0	SENT_5	[p1l1162t748r1212b779],
21	the	DT	O	the	det	23	SENT_5	[p1l1219t749r1277b779],
22	practicing	VBG	O	practice	amod	23	SENT_5	[p1l1287t749r1462b788],
23	physician	NN	O	physician	prep_for	19	SENT_5	[p1l1473t749r1637b788],
24	to	TO	O	to	aux	25	SENT_5	[p1l1647t753r1682b779],
25	place	VB	O	place	infmod	23	SENT_5	[p1l1693t749r1784b787],
26	these	DT	O	these	dobj	25	SENT_5	[p1l1792t749r1889b779],
27	within	IN	O	within	_	0	SENT_5	[p1l1897t749r2008b779],
28	the	DT	O	the	det	30	SENT_5	[p1l2017t749r2075b779],
29	treatment	NN	O	treatment	nn	30	SENT_5	[p1l20t807r198b834],
30	paradigm	NN	O	paradigm	prep_within	25	SENT_5	[p1l208t803r387b842],
31	.	.	O	.	_	0	SENT_5	[p1l208t803r387b842],

1	We	PRP	O	we	nsubj	2	SENT_6	[p1l394t805r448b834],
2	provide	VBP	O	provide	_	0	SENT_6	[p1l458t803r593b841],
3	a	DT	O	a	det	5	SENT_6	[p1l602t812r620b834],
4	conceptual	JJ	O	conceptual	amod	5	SENT_6	[p1l630t803r824b841],
5	diagram	NN	O	diagram	dobj	2	SENT_6	[p1l834t803r980b842],
6	of	IN	O	of	_	0	SENT_6	[p1l990t803r1027b834],
7	our	PRP$	O	we	poss	9	SENT_6	[p1l1033t812r1093b834],
8	current	JJ	DATE	current	amod	9	SENT_6	[p1l1101t807r1229b834],
9	view	NN	O	view	prep_of	5	SENT_6	[p1l1237t804r1320b834],
10	of	IN	O	of	_	0	SENT_6	[p1l1328t803r1365b834],
11	the	DT	O	the	det	12	SENT_6	[p1l1371t803r1428b834],
12	pathogenesis	NN	O	pathogenesis	prep_of	9	SENT_6	[p1l1439t803r1676b842],
13	of	IN	O	of	_	0	SENT_6	[p1l1685t803r1722b834],
14	demyelination	NN	O	demyelination	prep_of	12	SENT_6	[p1l1728t803r1983b842],
15	and	CC	O	and	_	0	SENT_6	[p1l1993t803r2058b834],
16	remyelination	NN	O	remyelination	prep_of	12	SENT_6	[p1l22t857r265b896],
17	in	IN	O	in	_	0	SENT_6	[p1l277t858r306b887],
18	this	DT	O	this	det	19	SENT_6	[p1l316t857r380b887],
19	disorder	NN	O	disorder	prep_in	2	SENT_6	[p1l389t857r543b887],
20	.	.	O	.	_	0	SENT_6	[p1l389t857r543b887],

1	In	IN	O	in	_	0	SENT_7	[p1l553t858r583b887],
2	addition	NN	O	addition	prep_in	5	SENT_7	[p1l593t857r752b892],
3	,	,	O	,	_	0	SENT_7	[p1l593t857r752b892],
4	we	PRP	O	we	nsubj	5	SENT_7	[p1l760t866r810b887],
5	include	VBP	O	include	_	0	SENT_7	[p1l820t857r949b887],
6	a	DT	O	a	det	8	SENT_7	[p1l958t866r975b887],
7	working	VBG	O	work	amod	8	SENT_7	[p1l985t857r1129b896],
8	template	NN	O	template	dobj	5	SENT_7	[p1l1139t857r1299b895],
9	on	IN	O	on	_	0	SENT_7	[p1l1308t866r1351b887],
10	how	WRB	O	how	advmod	12	SENT_7	[p1l1363t857r1437b887],
11	to	TO	O	to	aux	12	SENT_7	[p1l1445t861r1481b887],
12	use	VB	O	use	prepc_on	5	SENT_7	[p1l1491t866r1550b887],
13	a	DT	O	a	det	14	SENT_7	[p1l1558t866r1576b887],
14	tier	NN	O	tier	dobj	12	SENT_7	[p1l1585t858r1645b887],
15	1	CD	NUMBER	1	dep	14	SENT_7	[p1l1656t859r1667b887],
16	and	CC	O	and	_	0	SENT_7	[p1l1682t857r1748b887],
17	tier	NN	O	tier	nn	19	SENT_7	[p1l1757t858r1817b887],
18	2	CD	NUMBER	2	num	19	SENT_7	[p1l1826t859r1844b887],
19	approach	NN	O	approach	dobj	12	SENT_7	[p1l1854t857r2020b895],
20	to	TO	O	to	_	0	SENT_7	[p1l2030t861r2066b887],
21	medications	NNS	O	medication	prep_to	19	SENT_7	[p1l21t911r237b941],
22	as	IN	O	as	mark	25	SENT_7	[p1l246t919r282b941],
23	the	DT	O	the	det	24	SENT_7	[p1l290t911r348b941],
24	disease	NN	O	disease	nsubj	25	SENT_7	[p1l357t911r487b941],
25	worsens	VBZ	O	worsen	advcl	12	SENT_7	[p1l495t919r641b941],
26	in	IN	O	in	_	0	SENT_7	[p1l651t911r681b941],
27	the	DT	O	the	det	28	SENT_7	[p1l690t911r748b941],
28	individual	NN	O	individual	prep_in	25	SENT_7	[p1l758t911r943b941],
29	.	.	O	.	_	0	SENT_7	[p1l758t911r943b941],

1	We	PRP	O	we	nsubj	2	SENT_8	[p1l950t912r1004b941],
2	emphasize	VBP	O	emphasize	_	0	SENT_8	[p1l1013t911r1203b949],
3	the	DT	O	the	det	4	SENT_8	[p1l1211t911r1269b941],
4	approach	NN	O	approach	dobj	2	SENT_8	[p1l1278t911r1444b949],
5	of	IN	O	of	_	0	SENT_8	[p1l1455t910r1491b941],
6	treatment	NN	O	treatment	prep_of	4	SENT_8	[p1l1497t915r1675b941],
7	based	VBN	O	base	_	0	SENT_8	[p1l1685t911r1788b941],
8	on	IN	O	on	prepc_based_on	2	SENT_8	[p1l1798t919r1841b941],
9	"	``	O	"	punct	11	SENT_8	[p1l1848t911r2114b941],
10	individualized	JJ	O	individualized	amod	11	SENT_8	[p1l1848t911r2114b941],
11	medicine	NN	O	medicine	pobj	2	SENT_8	[p1l21t964r345b999],
12	,	,	O	,	_	0	SENT_8	[p1l21t964r345b999],
13	”	CD	NUMBER	”	appos	11	SENT_8	[p1l21t964r345b999],
14	tailored	VBN	O	tailor	partmod	13	SENT_8	[p1l21t964r345b999],
15	to	TO	O	to	_	0	SENT_8	[p1l355t968r390b995],
16	the	DT	O	the	det	18	SENT_8	[p1l399t964r457b995],
17	specific	JJ	O	specific	amod	18	SENT_8	[p1l466t964r597b1002],
18	needs	NNS	O	need	prep_to	14	SENT_8	[p1l607t964r711b995],
19	of	IN	O	of	_	0	SENT_8	[p1l720t964r756b995],
20	each	DT	O	each	det	21	SENT_8	[p1l763t964r844b995],
21	patient	NN	O	patient	prep_of	18	SENT_8	[p1l855t965r990b1002],
22	.	.	O	.	_	0	SENT_8	[p1l855t965r990b1002],

1	In	IN	O	in	_	0	SENT_9	[p1l1000t966r1030b994],
2	the	DT	DATE	the	det	3	SENT_9	[p1l1040t964r1098b995],
3	future	NN	DATE	future	prep_in	6	SENT_9	[p1l1106t964r1223b999],
4	,	,	O	,	_	0	SENT_9	[p1l1106t964r1223b999],
5	we	PRP	O	we	nsubj	6	SENT_9	[p1l1232t973r1282b995],
6	envision	VBP	O	envision	_	0	SENT_9	[p1l1291t965r1437b995],
7	new	JJ	O	new	amod	8	SENT_9	[p1l1449t973r1522b995],
8	drugs	NNS	O	drug	nsubj	10	SENT_9	[p1l1530t964r1631b1003],
9	to	TO	O	to	aux	10	SENT_9	[p1l1639t968r1675b995],
10	enhance	VB	O	enhance	xcomp	6	SENT_9	[p1l1684t964r1834b995],
11	remyelination	NN	O	remyelination	dobj	10	SENT_9	[p1l1844t964r2088b1003],
12	and	CC	O	and	_	0	SENT_9	[p1l20t1017r86b1048],
13	protect	VB	O	protect	conj_and	10	SENT_9	[p1l97t1022r224b1056],
14	neurons	NNS	O	neuron	dobj	13	SENT_9	[p1l234t1026r377b1048],
15	and	CC	O	and	_	0	SENT_9	[p1l386t1017r452b1048],
16	axons	NNS	O	axon	conj_and	14	SENT_9	[p1l462t1026r564b1048],
17	from	IN	O	from	_	0	SENT_9	[p1l572t1017r655b1048],
18	death	NN	O	death	prep_from	13	SENT_9	[p1l666t1017r766b1048],
19	in	IN	O	in	mark	22	SENT_9	[p1l777t1018r807b1048],
20	order	NN	O	order	dep	22	SENT_9	[p1l817t1017r913b1048],
21	to	TO	O	to	aux	22	SENT_9	[p1l920t1022r956b1048],
22	promote	VB	O	promote	purpcl	13	SENT_9	[p1l967t1022r1119b1056],
23	central	JJ	O	central	amod	26	SENT_9	[p1l1128t1017r1247b1048],
24	nervous	JJ	O	nervous	amod	26	SENT_9	[p1l1259t1026r1400b1048],
25	system	NN	O	system	nn	26	SENT_9	[p1l1409t1022r1530b1057],
26	regeneration	NN	O	regeneration	dobj	22	SENT_9	[p1l1542t1018r1769b1057],
27	and	CC	O	and	_	0	SENT_9	[p1l1779t1017r1845b1048],
28	repair	NN	O	repair	dobj	22	SENT_9	[p1l1856t1018r1966b1056],
29	.	.	O	.	_	0	SENT_9	[p1l1856t1018r1966b1056],

1	Multiple	JJ	O	multiple	amod	5	SENT_10	[p1l7t1213r295b1296],
2	sclerosis	NN	O	sclerosis	nn	5	SENT_10	[p1l316t1213r597b1276],
3	(	CD	NUMBER	(	num	5	SENT_10	[p1l621t1214r786b1289],
4	MS	NN	O	m	nn	5	SENT_10	[p1l621t1214r786b1289],
5	)	NN	O	)	nsubj	11	SENT_10	[p1l621t1214r786b1289],
6	is	VBZ	O	be	cop	11	SENT_10	[p1l811t1219r860b1276],
7	the	DT	O	the	det	11	SENT_10	[p1l880t1213r986b1276],
8	most	RBS	O	most	advmod	9	SENT_10	[p1l1006t1225r1175b1276],
9	common	JJ	O	common	amod	11	SENT_10	[p1l1194t1236r1499b1276],
10	demyelinating	NN	O	demyelinating	nn	11	SENT_10	[p1l1520t1213r2005b1297],
11	disease	NN	O	disease	_	0	SENT_10	[p1l2024t1213r2147b1276, p1l8t1339r149b1379],
12	of	IN	O	of	_	0	SENT_10	[p1l172t1316r247b1379],
13	the	DT	O	the	det	16	SENT_10	[p1l259t1316r366b1379],
14	central	JJ	O	central	amod	16	SENT_10	[p1l390t1316r626b1379],
15	nervous	JJ	O	nervous	amod	16	SENT_10	[p1l649t1339r925b1379],
16	system	NN	O	system	prep_of	11	SENT_10	[p1l949t1328r1201b1400],
17	,	,	O	,	_	0	SENT_10	[p1l949t1328r1201b1400],
18	commonly	RB	O	commonly	advmod	19	SENT_10	[p1l1226t1316r1601b1400],
19	affecting	VBG	O	affect	partmod	11	SENT_10	[p1l1621t1316r1918b1400],
20	young	JJ	O	young	amod	21	SENT_10	[p1l1936t1339r2154b1400],
21	people	NNS	O	people	dobj	19	SENT_10	[p1l6t1419r237b1502],
22	in	IN	O	in	_	0	SENT_10	[p1l261t1425r328b1481],
23	their	PRP$	O	they	poss	26	SENT_10	[p1l351t1419r517b1482],
24	most	RBS	O	most	advmod	25	SENT_10	[p1l538t1431r711b1482],
25	productive	JJ	O	productive	amod	26	SENT_10	[p1l732t1419r1109b1502],
26	years	NNS	DURATION	year	prep_in	19	SENT_10	[p1l1130t1442r1326b1503],
27	.	.	O	.	_	0	SENT_10	[p1l1130t1442r1326b1503],

1	It	PRP	O	it	nsubj	6	SENT_11	[p1l1353t1424r1403b1482],
2	is	VBZ	O	be	cop	6	SENT_11	[p1l1425t1425r1476b1482],
3	the	DT	O	the	det	6	SENT_11	[p1l1499t1419r1607b1482],
4	second	JJ	ORDINAL	second	amod	6	SENT_11	[p1l1632t1419r1874b1482],
5	leading	VBG	O	lead	amod	6	SENT_11	[p1l1895t1419r2152b1503],
6	cause	NN	O	cause	_	0	SENT_11	[p1l8t1544r197b1585],
7	of	IN	O	of	_	0	SENT_11	[p1l221t1521r297b1585],
8	disability	NN	O	disability	prep_of	6	SENT_11	[p1l311t1521r635b1606],
9	after	IN	O	after	mark	14	SENT_11	[p1l656t1521r812b1585],
10	trauma	NN	O	trauma	nsubj	14	SENT_11	[p1l834t1533r1088b1585],
11	among	IN	O	among	_	0	SENT_11	[p1l1112t1544r1352b1606],
12	young	JJ	O	young	amod	13	SENT_11	[p1l1372t1544r1593b1606],
13	adults	NNS	O	adult	prep_among	10	SENT_11	[p1l1616t1513r1872b1585],
14	}	VBP	O	}	advcl	6	SENT_11	[p1l1616t1513r1872b1585],
15	MS	NN	O	m	nsubj	19	SENT_11	[p1l1900t1525r2016b1585],
16	is	VBZ	O	be	cop	19	SENT_11	[p1l2041t1528r2092b1585],
17	a	DT	O	a	det	19	SENT_11	[p1l2117t1544r2152b1585],
18	heterogeneous	JJ	O	heterogeneous	amod	19	SENT_11	[p1l6t1625r491b1709],
19	disease	NN	O	disease	ccomp	14	SENT_11	[p1l512t1625r746b1688],
20	from	IN	O	from	_	0	SENT_11	[p1l765t1625r929b1688],
21	the	DT	O	the	det	22	SENT_11	[p1l947t1625r1051b1688],
22	standpoint	NN	O	standpoint	prep_from	19	SENT_11	[p1l1071t1625r1429b1708],
23	of	IN	O	of	_	0	SENT_11	[p1l1448t1625r1521b1688],
24	clinical	JJ	O	clinical	amod	25	SENT_11	[p1l1531t1625r1769b1688],
25	symptoms	NNS	O	symptom	prep_of	22	SENT_11	[p1l1788t1637r2148b1709],
26	,	,	O	,	_	0	SENT_11	[p1l1788t1637r2148b1709],
27	response	NN	O	response	nn	29	SENT_11	[p1l8t1750r306b1811],
28	to	TO	O	to	dep	29	SENT_11	[p1l326t1740r392b1791],
29	treatment	NN	O	treatment	conj_and	25	SENT_11	[p1l412t1740r764b1800],
30	,	,	O	,	_	0	SENT_11	[p1l412t1740r764b1800],
31	and	CC	O	and	_	0	SENT_11	[p1l787t1728r913b1791],
32	radiological	JJ	O	radiological	amod	33	SENT_11	[p1l932t1728r1337b1812],
33	features	NNS	O	feature	conj_and	25	SENT_11	[p1l1357t1728r1639b1800],
34	,	,	O	,	_	0	SENT_11	[p1l1357t1728r1639b1800],
35	and	CC	O	and	cc	19	SENT_11	[p1l1662t1728r1788b1791],
36	even	RB	O	even	advmod	19	SENT_11	[p1l1808t1751r1964b1791],
37	from	IN	O	from	dep	19	SENT_11	[p1l1984t1728r2151b1791],
38	the	DT	O	the	det	39	SENT_11	[p1l7t1831r114b1894],
39	standpoint	NN	O	standpoint	pobj	37	SENT_11	[p1l138t1831r509b1914],
40	of	IN	O	of	_	0	SENT_11	[p1l532t1831r606b1894],
41	neuropathology	NN	O	neuropathology	prep_of	39	SENT_11	[p1l619t1831r1181b1915],
42	.	.	O	.	_	0	SENT_11	[p1l619t1831r1181b1915],

1	Neuropathologically	RB	MISC	neuropathologically	advmod	2	SENT_12	[p1l1206t1831r1920b1915],
2	different	JJ	O	different	amod	3	SENT_12	[p1l1940t1831r2148b1894, p1l8t1946r114b1997],
3	phases	NNS	O	phase	npadvmod	7	SENT_12	[p1l133t1934r359b2017],
4	of	IN	O	of	_	0	SENT_12	[p1l382t1934r456b1997],
5	MS	NN	O	m	prep_of	7	SENT_12	[p1l467t1938r580b1997],
6	are	VBP	O	be	auxpass	7	SENT_12	[p1l604t1957r704b1997],
7	characterized	VBN	O	characterize	_	0	SENT_12	[p1l726t1934r1188b1997],
8	by	IN	O	by	_	0	SENT_12	[p1l1206t1934r1291b2018],
9	interplay	NN	O	interplay	agent	7	SENT_12	[p1l1308t1934r1617b2018],
10	between	IN	O	between	_	0	SENT_12	[p1l1632t1934r1919b1997],
11	different	JJ	O	different	amod	12	SENT_12	[p1l1941t1934r2148b1997, p1l8t2049r115b2100],
12	levels	NNS	O	level	prep_between	9	SENT_12	[p1l135t2037r323b2100],
13	of	IN	O	of	_	0	SENT_12	[p1l347t2037r421b2100],
14	inﬂammation	NN	O	inﬂammation	nn	16	SENT_12	[p1l435t2037r1473b2121],
15	—	NN	O	—	nn	16	SENT_12	[p1l435t2037r1473b2121],
16	demyelination	NN	O	demyelination	prep_of	12	SENT_12	[p1l435t2037r1473b2121],
17	,	,	O	,	_	0	SENT_12	[p1l435t2037r1473b2121],
18	remyelination	NN	O	remyelination	prep_of	12	SENT_12	[p1l1498t2037r1998b2121],
19	,	,	O	,	_	0	SENT_12	[p1l1498t2037r1998b2121],
20	and	CC	O	and	_	0	SENT_12	[p1l2024t2037r2151b2100],
21	axonal	JJ	O	axonal	amod	22	SENT_12	[p1l8t2140r232b2203],
22	loss	NN	O	loss	prep_of	12	SENT_12	[p1l251t2140r376b2203],
23	(	CD	NUMBER	(	num	26	SENT_12	[p1l401t2141r659b2223],
24	Figure	NN	O	figure	nn	26	SENT_12	[p1l401t2141r659b2223],
25	1	CD	NUMBER	1	num	26	SENT_12	[p1l683t2141r764b2217],
26	)	NN	O	)	nsubjpass	7	SENT_12	[p1l683t2141r764b2217],
27	.	.	O	.	_	0	SENT_12	[p1l683t2141r764b2217],

1	Initially	RB	O	initially	advmod	6	SENT_13	[p1l788t2140r1064b2224],
2	,	,	O	,	_	0	SENT_13	[p1l788t2140r1064b2224],
3	a	DT	O	a	det	5	SENT_13	[p1l1087t2163r1121b2203],
4	T-cell	NN	O	t-cell	nn	5	SENT_13	[p1l1140t2140r1699b2203],
5	—	NN	O	—	nsubj	6	SENT_13	[p1l1140t2140r1699b2203],
6	mediated	VBD	O	mediate	_	0	SENT_13	[p1l1140t2140r1699b2203],
7	autoimmunity	NN	O	autoimmunity	dobj	6	SENT_13	[p1l1719t2146r2148b2203, p1l8t2249r99b2327],
8	with	IN	O	with	_	0	SENT_13	[p1l118t2243r277b2306],
9	the	DT	O	the	det	11	SENT_13	[p1l301t2243r410b2306],
10	classic	JJ	O	classic	amod	11	SENT_13	[p1l436t2243r659b2306],
11	paradigm	NN	O	paradigm	prep_with	6	SENT_13	[p1l683t2243r1026b2327],
12	of	IN	O	of	_	0	SENT_13	[p1l1052t2243r1128b2306],
13	a	DT	O	a	det	14	SENT_13	[p1l1143t2266r1179b2306],
14	shift	NN	O	shift	prep_of	11	SENT_13	[p1l1204t2243r1356b2306],
15	toward	IN	O	toward	_	0	SENT_13	[p1l1379t2243r1628b2306],
16	TH1	NN	O	th1	prep_toward	14	SENT_13	[p1l1651t2246r1842b2309],
17	/	:	O	/	punct	21	SENT_13	[p1l1651t2246r1842b2309],
18	17	CD	NUMBER	17	number	19	SENT_13	[p1l1855t2250r1929b2306],
19	(	CD	NUMBER	(	num	20	SENT_13	[p1l1958t2243r2151b2320],
20	“	NN	O	“	npadvmod	21	SENT_13	[p1l1958t2243r2151b2320],
21	bad	JJ	O	bad	dep	14	SENT_13	[p1l1958t2243r2151b2320],
22	for	IN	O	for	_	0	SENT_13	[p1l7t2346r108b2409],
23	MS	NN	O	m	prep_for	21	SENT_13	[p1l130t2346r308b2423],
24	”	CD	NUMBER	”	number	25	SENT_13	[p1l130t2346r308b2423],
25	)	CD	NUMBER	)	nsubj	39	SENT_13	[p1l130t2346r308b2423],
26	vs.	IN	O	vs.	_	0	SENT_13	[p1l334t2369r424b2409],
27	Th2	NN	O	th2	prep_vs.	25	SENT_13	[p1l451t2346r583b2408],
28	(	CD	NUMBER	(	num	27	SENT_13	[p1l612t2346r846b2430],
29	“	RB	O	“	advmod	30	SENT_13	[p1l612t2346r846b2430],
30	good	JJ	O	good	amod	27	SENT_13	[p1l612t2346r846b2430],
31	for	IN	O	for	_	0	SENT_13	[p1l868t2346r969b2409],
32	MS	NN	O	m	nn	34	SENT_13	[p1l991t2346r1169b2423],
33	”	CD	NUMBER	”	num	34	SENT_13	[p1l991t2346r1169b2423],
34	)	NN	O	)	prep_for	27	SENT_13	[p1l991t2346r1169b2423],
35	may	MD	O	may	aux	39	SENT_13	[p1l1197t2369r1348b2430],
36	be	VB	O	be	cop	39	SENT_13	[p1l1366t2346r1447b2409],
37	the	DT	O	the	det	39	SENT_13	[p1l1470t2346r1580b2409],
38	inducing	VBG	O	induce	amod	39	SENT_13	[p1l1605t2346r1919b2430],
39	event	NN	O	event	rcmod	23	SENT_13	[p1l1942t2358r2146b2409],
40	.	.	O	.	_	0	SENT_13	[p1l1942t2358r2146b2409],

1	However	RB	O	however	advmod	7	SENT_14	[p1l8t2454r324b2521],
2	,	,	O	,	_	0	SENT_14	[p1l8t2454r324b2521],
3	this	DT	O	this	det	5	SENT_14	[p1l344t2449r467b2512],
4	early	JJ	O	early	amod	5	SENT_14	[p1l489t2449r653b2533],
5	paradigm	NN	O	paradigm	nsubj	17	SENT_14	[p1l668t2449r996b2533],
6	mainly	RB	O	mainly	advmod	7	SENT_14	[p1l1015t2449r1253b2533],
7	derives	VBZ	O	derive	_	0	SENT_14	[p1l1270t2449r1507b2512],
8	from	IN	O	from	_	0	SENT_14	[p1l1528t2449r1694b2512],
9	animals	NNS	O	animal	prep_from	7	SENT_14	[p1l1715t2449r1977b2512],
10	used	VBN	O	use	partmod	9	SENT_14	[p1l1997t2449r2154b2512],
11	in	IN	O	in	_	0	SENT_14	[p1l8t2558r74b2614],
12	MS	NN	O	m	nn	14	SENT_14	[p1l93t2556r206b2615],
13	drug	NN	O	drug	nn	14	SENT_14	[p1l229t2552r390b2636],
14	development	NN	O	development	prep_in	10	SENT_14	[p1l409t2552r851b2635],
15	and	CC	O	and	_	0	SENT_14	[p1l871t2552r996b2615],
16	is	VBZ	O	be	cop	17	SENT_14	[p1l1015t2558r1065b2615],
17	unlikely	JJ	O	unlikely	conj_and	7	SENT_14	[p1l1086t2552r1363b2636],
18	to	TO	O	to	aux	21	SENT_14	[p1l1379t2564r1444b2615],
19	be	VB	O	be	cop	21	SENT_14	[p1l1463t2552r1543b2615],
20	universally	RB	O	universally	advmod	21	SENT_14	[p1l1563t2552r1938b2636],
21	applicable	JJ	O	applicable	xcomp	17	SENT_14	[p1l1955t2552r2148b2635, p1l8t2655r176b2718],
22	to	TO	O	to	_	0	SENT_14	[p1l194t2667r259b2718],
23	MS.	NNP	O	MS.	nn	24	SENT_14	[p1l280t2659r408b2718],
24	Pathology	NNP	O	Pathology	prep_to	21	SENT_14	[p1l432t2655r771b2739],
25	studies	NNS	O	study	nsubj	55	SENT_14	[p1l787t2655r1017b2718],
26	have	VBP	O	have	aux	27	SENT_14	[p1l1036t2655r1188b2718],
27	suggested	VBN	O	suggest	rcmod	24	SENT_14	[p1l1209t2655r1533b2739],
28	that	IN	O	that	complm	33	SENT_14	[p1l1551t2655r1681b2718],
29	MS	NN	O	m	nsubj	33	SENT_14	[p1l1700t2659r1811b2718],
30	is	VBZ	O	be	cop	33	SENT_14	[p1l1832t2661r1881b2718],
31	a	DT	O	a	det	33	SENT_14	[p1l1902t2678r1936b2718],
32	heterogeneous	JJ	O	heterogeneous	amod	33	SENT_14	[p1l1953t2655r2148b2718, p1l8t2781r323b2842],
33	disease	NN	O	disease	ccomp	27	SENT_14	[p1l344t2758r598b2830],
34	,	,	O	,	_	0	SENT_14	[p1l344t2758r598b2830],
35	with	IN	O	with	_	0	SENT_14	[p1l617t2758r768b2821],
36	four	CD	NUMBER	four	num	37	SENT_14	[p1l787t2758r928b2821],
37	patterns	NNS	O	pattern	prep_with	33	SENT_14	[p1l946t2770r1219b2841],
38	of	IN	O	of	_	0	SENT_14	[p1l1240t2758r1313b2821],
39	new	JJ	O	new	amod	41	SENT_14	[p1l1323t2781r1463b2821],
40	lesion	NN	O	lesion	nn	41	SENT_14	[p1l1479t2758r1677b2821],
41	development	NN	O	development	prep_of	37	SENT_14	[p1l1698t2758r2151b2841],
42	,	,	O	,	_	0	SENT_14	[p1l1698t2758r2151b2841],
43	which	WDT	O	which	nsubj	49	SENT_14	[p1l6t2861r220b2924],
44	is	VBZ	O	be	cop	45	SENT_14	[p1l243t2867r294b2924],
45	heterogeneous	JJ	O	heterogeneous	rcmod	41	SENT_14	[p1l317t2861r826b2945],
46	among	IN	O	among	_	0	SENT_14	[p1l851t2884r1091b2945],
47	individuals	NNS	O	individual	prep_among	45	SENT_14	[p1l1112t2861r1501b2924],
48	but	CC	O	but	_	0	SENT_14	[p1l1523t2861r1639b2924],
49	homogeneous	JJ	O	homogeneous	rcmod	41	SENT_14	[p1l1660t2861r2151b2945],
50	within	IN	O	within	_	0	SENT_14	[p1l6t2964r238b3027],
51	any	DT	O	any	det	53	SENT_14	[p1l264t2987r390b3048],
52	given	VBN	O	give	amod	53	SENT_14	[p1l412t2970r603b3048],
53	individual	NN	O	individual	prep_within	45	SENT_14	[p1l628t2964r993b3027],
54	and	CC	O	and	_	0	SENT_14	[p1l1019t2964r1150b3027],
55	persists	VBZ	O	persist	rcmod	24	SENT_14	[p1l1173t2970r1440b3047],
56	over	IN	O	over	_	0	SENT_14	[p1l1467t2987r1620b3027],
57	time	NN	O	time	prep_over	55	SENT_14	[p1l1643t2970r1821b3027],
58	.	.	O	.	_	0	SENT_14	[p1l1643t2970r1821b3027],

1	The	DT	O	the	det	3	SENT_15	[p1l1850t2964r1979b3027],
2	four	CD	NUMBER	four	num	3	SENT_15	[p1l2005t2964r2154b3027],
3	patterns	NNS	O	pattern	nsubj	4	SENT_15	[p1l6t3079r289b3150],
4	include	VBP	O	include	_	0	SENT_15	[p1l313t3067r568b3130],
5	T-cell	NN	O	t-cell	dobj	4	SENT_15	[p1l591t3067r1161b3130],
6	—	CD	NUMBER	—	num	8	SENT_15	[p1l591t3067r1161b3130],
7	mediated	JJ	O	mediated	amod	8	SENT_15	[p1l591t3067r1161b3130],
8	mechanisms	NNS	O	mechanism	dep	5	SENT_15	[p1l1183t3067r1636b3139],
9	,	,	O	,	_	0	SENT_15	[p1l1183t3067r1636b3139],
10	antibody	NN	O	antibody	nn	11	SENT_15	[p1l1661t3067r1997b3151],
11	—	NN	O	—	conj_and	5	SENT_15	[p1l1661t3067r1997b3151],
12	and	CC	O	and	_	0	SENT_15	[p1l2024t3067r2152b3130],
13	complement-mediated	JJ	O	complement-mediated	amod	14	SENT_15	[p1l8t3170r771b3253],
14	demyelination	NN	O	demyelination	conj_and	5	SENT_15	[p1l789t3170r1286b3254],
15	,	,	O	,	_	0	SENT_15	[p1l789t3170r1286b3254],
16	distal	JJ	O	distal	amod	19	SENT_15	[p1l1308t3170r1487b3233],
17	oligodendrogliopa	NN	O	oligodendrogliopa	nn	19	SENT_15	[p1l1506t3170r2150b3254],
18	—	NN	O	—	nn	19	SENT_15	[p1l1506t3170r2150b3254],
19	thy	NN	O	thy	conj_and	5	SENT_15	[p1l7t3273r117b3358],
20	and	CC	O	and	_	0	SENT_15	[p1l134t3273r260b3337],
21	apoptosis	NN	O	apoptosis	conj_and	19	SENT_15	[p1l280t3280r617b3357],
22	,	,	O	,	_	0	SENT_15	[p1l280t3280r617b3357],
23	and	CC	O	and	_	0	SENT_15	[p1l639t3273r764b3337],
24	primary	JJ	O	primary	amod	26	SENT_15	[p1l782t3280r1063b3358],
25	oligodendrocyte	NN	O	oligodendrocyte	nn	26	SENT_15	[p1l1080t3273r1635b3358],
26	degeneration	NN	O	degeneration	dobj	4	SENT_15	[p1l1657t3265r2150b3358],
27	?	.	O	?	_	0	SENT_15	[p1l1657t3265r2150b3358],

1	The	DT	O	the	det	3	SENT_16	[p1l81t3377r204b3440],
2	clinical	JJ	O	clinical	amod	3	SENT_16	[p1l223t3377r457b3440],
3	spectrum	NN	O	spectrum	nsubj	17	SENT_16	[p1l476t3389r788b3460],
4	of	IN	O	of	_	0	SENT_16	[p1l807t3377r879b3440],
5	MS	NN	O	m	nn	7	SENT_16	[p1l887t3381r998b3440],
6	likely	JJ	O	likely	amod	7	SENT_16	[p1l1016t3377r1195b3461],
7	reﬂects	NNS	O	reﬂects	prep_of	3	SENT_16	[p1l1210t3377r1442b3440],
8	this	DT	O	this	det	10	SENT_16	[p1l1460t3377r1579b3440],
9	pathological	JJ	O	pathological	amod	10	SENT_16	[p1l1597t3377r2004b3461],
10	heterogeneity	NN	O	heterogeneity	dep	7	SENT_16	[p1l2020t3377r2149b3440, p1l8t3486r358b3564],
11	,	,	O	,	_	0	SENT_16	[p1l2020t3377r2149b3440, p1l8t3486r358b3564],
12	in	IN	O	in	_	0	SENT_16	[p1l378t3486r442b3542],
13	addition	NN	O	addition	_	0	SENT_16	[p1l461t3480r735b3543],
14	to	TO	O	to	_	0	SENT_16	[p1l752t3492r816b3543],
15	other	JJ	O	other	amod	16	SENT_16	[p1l836t3480r1009b3543],
16	factors	NNS	O	factor	conj_in	7	SENT_16	[p1l1026t3480r1244b3543],
17	(	VBP	O	(	_	0	SENT_16	[p1l1266t3480r1441b3556],
18	such	JJ	O	such	_	0	SENT_16	[p1l1266t3480r1441b3556],
19	as	IN	O	as	_	0	SENT_16	[p1l1459t3503r1521b3543],
20	lesion	NN	O	lesion	nn	21	SENT_16	[p1l1538t3480r1731b3543],
21	location	NN	O	location	prep_such_as	17	SENT_16	[p1l1747t3480r2012b3543],
22	and	CC	O	and	_	0	SENT_16	[p1l2031t3480r2153b3543],
23	genetic	JJ	O	genetic	amod	24	SENT_16	[p1l7t3589r246b3667],
24	predisposition	NN	O	predisposition	conj_and	21	SENT_16	[p1l264t3583r749b3666],
25	to	TO	O	to	_	0	SENT_16	[p1l767t3595r832b3646],
26	more	RBR	O	more	prep_to	17	SENT_16	[p1l853t3606r1028b3646],
27	vs.	CC	O	vs.	prep	26	SENT_16	[p1l1045t3606r1131b3646],
28	less	RBR	O	less	advmod	29	SENT_16	[p1l1153t3583r1269b3646],
29	efﬁcient	JJ	O	efﬁcient	amod	30	SENT_16	[p1l1289t3583r1556b3646],
30	repair	NN	O	repair	dep	27	SENT_16	[p1l1575t3583r1798b3666],
31	)	CD	NUMBER	)	dobj	17	SENT_16	[p1l1575t3583r1798b3666],
32	leading	VBG	O	lead	partmod	31	SENT_16	[p1l1820t3583r2068b3667],
33	to	TO	O	to	_	0	SENT_16	[p1l2085t3595r2150b3646],
34	heterogeneous	JJ	O	heterogeneous	amod	35	SENT_16	[p1l7t3686r489b3770],
35	outcomes	NNS	O	outcome	prep_to	32	SENT_16	[p1l508t3698r843b3749],
36	.	.	O	.	_	0	SENT_16	[p1l508t3698r843b3749],

1	MS	NN	O	m	nsubj	3	SENT_17	[p1l864t3690r975b3749],
2	typically	RB	O	typically	advmod	3	SENT_17	[p1l994t3686r1277b3770],
3	extends	VBZ	O	extend	_	0	SENT_17	[p1l1292t3686r1544b3749],
4	from	IN	O	from	_	0	SENT_17	[p1l1562t3686r1726b3749],
5	an	DT	O	a	det	6	SENT_17	[p1l1745t3709r1824b3749],
6	asymptomatic	JJ	O	asymptomatic	prep_from	3	SENT_17	[p1l1843t3698r2149b3770, p2l7t22r194b79],

1	phase	NN	O	phase	_	0	SENT_18	[p2l211t16r419b99],
2	,	,	O	,	_	0	SENT_18	[p2l211t16r419b99],
3	starting	VBG	O	start	appos	1	SENT_18	[p2l440t22r696b100],
4	at	IN	O	at	_	0	SENT_18	[p2l714t28r772b79],
5	an	DT	O	a	det	7	SENT_18	[p2l790t39r869b79],
6	unknown	JJ	O	unknown	amod	7	SENT_18	[p2l888t16r1212b79],
7	age	NN	O	age	prep_at	3	SENT_18	[p2l1231t39r1339b100],
8	with	IN	O	with	_	0	SENT_18	[p2l1356t16r1506b79],
9	an	DT	O	a	det	11	SENT_18	[p2l1526t39r1604b79],
10	unknown	JJ	O	unknown	amod	11	SENT_18	[p2l1623t16r1947b79],
11	duration	NN	O	duration	prep_with	7	SENT_18	[p2l1966t16r2146b79, p2l7t125r162b191],
12	,	,	O	,	_	0	SENT_18	[p2l1966t16r2146b79, p2l7t125r162b191],
13	to	TO	O	to	_	0	SENT_18	[p2l184t131r251b182],
14	clinically	RB	O	clinically	advmod	15	SENT_18	[p2l274t119r583b203],
15	symptomatic	JJ	O	symptomatic	amod	16	SENT_18	[p2l602t125r1046b203],
16	phases	NNS	O	phase	prep_to	1	SENT_18	[p2l1066t119r1293b202],
17	(	CD	NUMBER	(	num	18	SENT_18	[p2l1318t120r1578b202],
18	Figure	NN	O	figure	dep	16	SENT_18	[p2l1318t120r1578b202],
19	2	CD	NUMBER	2	num	20	SENT_18	[p2l1598t120r1683b195],
20	)	NN	O	)	dep	18	SENT_18	[p2l1598t120r1683b195],
21	.	.	O	.	_	0	SENT_18	[p2l1598t120r1683b195],

1	These	DT	O	these	det	2	SENT_19	[p2l1708t119r1903b182],
2	phases	NNS	O	phase	nsubjpass	4	SENT_19	[p2l1924t119r2151b202],
3	are	VBP	O	be	auxpass	4	SENT_19	[p2l10t245r108b285],
4	known	VBN	O	know	_	0	SENT_19	[p2l125t222r357b285],
5	as	IN	O	as	_	0	SENT_19	[p2l377t245r440b285],
6	radiologically	RB	O	radiologically	advmod	7	SENT_19	[p2l459t222r915b306],
7	isolated	VBN	O	isolate	amod	8	SENT_19	[p2l930t222r1185b285],
8	syndrome	NN	O	syndrome	prep_as	4	SENT_19	[p2l1204t222r1553b306],
9	,	,	O	,	_	0	SENT_19	[p2l1204t222r1553b306],
10	clinically	RB	O	clinically	advmod	11	SENT_19	[p2l1573t222r1873b306],
11	isolated	VBN	O	isolate	amod	12	SENT_19	[p2l1888t222r2143b285],
12	syndrome	NN	O	syndrome	appos	8	SENT_19	[p2l10t325r346b409],
13	(	CD	NUMBER	(	num	15	SENT_19	[p2l371t326r565b401],
14	CIS	NN	ORGANIZATION	ci	nn	15	SENT_19	[p2l371t326r565b401],
15	)	NN	O	)	nsubjpass	4	SENT_19	[p2l371t326r565b401],
16	,	,	O	,	_	0	SENT_19	[p2l371t326r565b401],
17	single-attack	JJ	O	single-attack	amod	18	SENT_19	[p2l589t325r1016b409],
18	MS	NN	O	m	appos	15	SENT_19	[p2l1033t329r1146b388],
19	(	CD	NUMBER	(	num	20	SENT_19	[p2l1172t325r1457b402],
20	SAMS	NNP	O	SAMS	dep	18	SENT_19	[p2l1172t325r1457b402],
21	)	CD	NUMBER	)	num	20	SENT_19	[p2l1172t325r1457b402],
22	,	,	O	,	_	0	SENT_19	[p2l1172t325r1457b402],
23	relapsing	VBG	O	relapse	partmod	4	SENT_19	[p2l1480t325r2146b409],
24	—	CD	NUMBER	—	dobj	23	SENT_19	[p2l1480t325r2146b409],
25	remitting	VBG	O	remit	xcomp	23	SENT_19	[p2l1480t325r2146b409],
26	MS	NN	O	m	nn	29	SENT_19	[p2l9t432r121b491],
27	(	CD	NUMBER	(	num	29	SENT_19	[p2l147t428r438b505],
28	RRMS	NN	O	rrm	nn	29	SENT_19	[p2l147t428r438b505],
29	)	NN	O	)	dobj	25	SENT_19	[p2l147t428r438b505],
30	,	,	O	,	_	0	SENT_19	[p2l147t428r438b505],
31	single-attack	JJ	O	single-attack	amod	33	SENT_19	[p2l462t428r889b512],
32	progressive	JJ	O	progressive	amod	33	SENT_19	[p2l905t434r1284b512],
33	MS	NN	O	m	appos	29	SENT_19	[p2l1305t432r1418b491],
34	(	CD	NUMBER	(	num	36	SENT_19	[p2l1443t428r1776b505],
35	SAPMS	NN	O	sapm	nn	36	SENT_19	[p2l1443t428r1776b505],
36	)	NN	O	)	dep	33	SENT_19	[p2l1443t428r1776b505],
37	,	,	O	,	_	0	SENT_19	[p2l1443t428r1776b505],
38	secondary	JJ	O	secondary	amod	40	SENT_19	[p2l1799t428r2145b512],
39	progressive	JJ	O	progressive	amod	40	SENT_19	[p2l8t537r386b615],
40	MS	NN	O	m	dobj	25	SENT_19	[p2l405t535r517b594],
41	(	CD	NUMBER	(	num	43	SENT_19	[p2l542t532r814b607],
42	SPMS	NN	O	spm	nn	43	SENT_19	[p2l542t532r814b607],
43	)	NN	O	)	dep	40	SENT_19	[p2l542t532r814b607],
44	,	,	O	,	_	0	SENT_19	[p2l542t532r814b607],
45	and	CC	O	and	_	0	SENT_19	[p2l836t531r960b594],
46	primary	JJ	O	primary	amod	48	SENT_19	[p2l978t537r1255b615],
47	progressive	JJ	O	progressive	amod	48	SENT_19	[p2l1271t537r1648b615],
48	MS	NN	O	m	dobj	25	SENT_19	[p2l1668t535r1780b594],
49	(	CD	NUMBER	(	num	50	SENT_19	[p2l1805t532r2084b608],
50	PPMS	NNP	O	PPMS	dep	48	SENT_19	[p2l1805t532r2084b608],
51	)	CD	NUMBER	)	num	50	SENT_19	[p2l1805t532r2084b608],
52	.	.	O	.	_	0	SENT_19	[p2l1805t532r2084b608],

1	Currently	RB	DATE	currently	advmod	7	SENT_20	[p2l84t634r442b718],
2	,	,	O	,	_	0	SENT_20	[p2l84t634r442b718],
3	no	DT	O	no	det	5	SENT_20	[p2l470t657r559b697],
4	clinical	JJ	O	clinical	amod	5	SENT_20	[p2l586t634r843b697],
5	trials	NNS	O	trial	nsubj	7	SENT_20	[p2l867t634r1047b697],
6	have	VBP	O	have	aux	7	SENT_20	[p2l1073t634r1234b697],
7	attempted	VBN	O	attempt	_	0	SENT_20	[p2l1261t634r1618b717],
8	to	TO	O	to	aux	9	SENT_20	[p2l1643t646r1711b697],
9	prevent	VB	O	prevent	xcomp	7	SENT_20	[p2l1737t646r2007b717],
10	the	DT	O	the	det	11	SENT_20	[p2l2031t634r2142b697],
11	onset	NN	O	onset	dobj	9	SENT_20	[p2l10t749r193b800],
12	of	IN	O	of	_	0	SENT_20	[p2l215t737r289b800],
13	symptomatic	JJ	O	symptomatic	amod	14	SENT_20	[p2l303t743r749b821],
14	MS	NN	O	m	prep_of	11	SENT_20	[p2l771t741r885b800],
15	in	IN	O	in	_	0	SENT_20	[p2l909t743r976b799],
16	otherwise	RB	O	otherwise	advmod	17	SENT_20	[p2l1000t737r1336b800],
17	asymptomatic	JJ	O	asymptomatic	amod	18	SENT_20	[p2l1360t743r1843b821],
18	individuals	NNS	O	individual	prep_in	9	SENT_20	[p2l1866t737r2139b800, p2l9t840r164b903],
19	.	.	O	.	_	0	SENT_20	[p2l1866t737r2139b800, p2l9t840r164b903],

1	Speciﬂcally	RB	O	speciﬂcally	advmod	4	SENT_21	[p2l192t840r597b924],
2	,	,	O	,	_	0	SENT_21	[p2l192t840r597b924],
3	there	EX	O	there	expl	4	SENT_21	[p2l621t840r799b903],
4	is	VBZ	O	be	_	0	SENT_21	[p2l824t846r875b903],
5	no	DT	O	no	det	6	SENT_21	[p2l899t863r987b903],
6	evidence	NN	O	evidence	nsubj	4	SENT_21	[p2l1012t840r1319b903],
7	to	TO	O	to	aux	8	SENT_21	[p2l1341t852r1409b903],
8	suggest	VB	O	suggest	infmod	6	SENT_21	[p2l1434t852r1690b924],
9	that	IN	O	that	complm	16	SENT_21	[p2l1711t840r1848b903],
10	treating	VBG	O	treat	csubj	18	SENT_21	[p2l1870t846r2144b924],
11	patients	NNS	O	patient	dobj	10	SENT_21	[p2l8t949r269b1026],
12	with	IN	O	with	_	0	SENT_21	[p2l287t943r435b1006],
13	radiologically	RB	O	radiologically	advmod	14	SENT_21	[p2l455t943r911b1027],
14	isolated	VBN	O	isolate	amod	15	SENT_21	[p2l927t943r1182b1006],
15	syndrome	NN	O	syndrome	prep_with	10	SENT_21	[p2l1201t943r1532b1027],
16	prevents	VBZ	O	prevent	ccomp	8	SENT_21	[p2l1550t955r1831b1026],
17	or	CC	O	or	_	0	SENT_21	[p2l1851t966r1921b1006],
18	delays	VBZ	O	delay	ccomp	8	SENT_21	[p2l1940t943r2141b1027],
19	progression	NN	O	progression	dobj	16	SENT_21	[p2l8t1053r407b1131],
20	to	TO	O	to	_	0	SENT_21	[p2l427t1059r492b1110],
21	a	DT	O	a	det	23	SENT_21	[p2l515t1070r549b1110],
22	symptomatic	JJ	O	symptomatic	amod	23	SENT_21	[p2l569t1053r1010b1131],
23	phase	NN	O	phase	prep_to	16	SENT_21	[p2l1028t1047r1238b1130],
24	.	.	O	.	_	0	SENT_21	[p2l1028t1047r1238b1130],

1	However	RB	O	however	advmod	5	SENT_22	[p2l1262t1052r1580b1119],
2	,	,	O	,	_	0	SENT_22	[p2l1262t1052r1580b1119],
3	we	PRP	O	we	nsubj	5	SENT_22	[p2l1599t1070r1692b1110],
4	can	MD	O	can	aux	5	SENT_22	[p2l1713t1070r1830b1110],
5	presume	VB	O	presume	_	0	SENT_22	[p2l1849t1069r2141b1130],
6	that	IN	O	that	complm	14	SENT_22	[p2l8t1150r139b1213],
7	future	JJ	DATE	future	amod	8	SENT_22	[p2l157t1150r358b1213],
8	trials	NNS	O	trial	nsubjpass	14	SENT_22	[p2l377t1150r543b1213],
9	in	IN	O	in	_	0	SENT_22	[p2l563t1156r628b1212],
10	this	DT	O	this	det	11	SENT_22	[p2l647t1150r768b1213],
11	area	NN	O	area	prep_in	8	SENT_22	[p2l789t1173r926b1213],
12	would	MD	O	would	aux	14	SENT_22	[p2l942t1150r1152b1213],
13	be	VB	O	be	auxpass	14	SENT_22	[p2l1168t1150r1246b1213],
14	designed	VBN	O	design	ccomp	5	SENT_22	[p2l1266t1150r1563b1234],
15	similarly	RB	O	similarly	advmod	14	SENT_22	[p2l1583t1150r1875b1234],
16	to	TO	O	to	_	0	SENT_22	[p2l1890t1162r1954b1213],
17	trials	NNS	O	trial	prep_to	14	SENT_22	[p2l1974t1150r2141b1213],
18	designed	VBN	O	design	partmod	17	SENT_22	[p2l10t1253r314b1337],
19	for	IN	O	for	_	0	SENT_22	[p2l334t1253r431b1316],
20	the	DT	O	the	det	23	SENT_22	[p2l450t1253r557b1316],
21	ﬁrst	NN	O	ﬁrst	nn	23	SENT_22	[p2l577t1253r710b1316],
22	clinical	JJ	O	clinical	amod	23	SENT_22	[p2l731t1253r976b1316],
23	attack	NN	O	attack	prep_for	18	SENT_22	[p2l997t1253r1201b1316],
24	of	IN	O	of	_	0	SENT_22	[p2l1219t1253r1293b1316],
25	MS-CIS	NN	O	ms-ci	prep_of	23	SENT_22	[p2l1304t1257r1593b1316],
26	.	.	O	.	_	0	SENT_22	[p2l1304t1257r1593b1316],

1	The	DT	O	the	det	3	SENT_23	[p2l1618t1253r1743b1316],
2	only	JJ	O	only	amod	3	SENT_23	[p2l1765t1253r1915b1337],
3	difference	NN	O	difference	nsubj	7	SENT_23	[p2l1933t1253r2139b1316, p2l10t1379r164b1419],
4	would	MD	O	would	aux	7	SENT_23	[p2l185t1356r403b1419],
5	be	VB	O	be	cop	7	SENT_23	[p2l423t1356r503b1419],
6	the	DT	O	the	det	7	SENT_23	[p2l525t1356r633b1419],
7	outcome	NN	O	outcome	_	0	SENT_23	[p2l657t1368r974b1428],
8	,	,	O	,	_	0	SENT_23	[p2l657t1368r974b1428],
9	that	WDT	O	that	nsubj	12	SENT_23	[p2l999t1356r1134b1419],
10	is	VBZ	O	be	cop	12	SENT_23	[p2l1156t1362r1226b1428],
11	,	,	O	,	_	0	SENT_23	[p2l1156t1362r1226b1428],
12	prevention	NN	O	prevention	rcmod	7	SENT_23	[p2l1250t1362r1626b1439],
13	or	CC	O	or	_	0	SENT_23	[p2l1650t1379r1723b1419],
14	delay	NN	O	delay	conj_or	12	SENT_23	[p2l1745t1356r1927b1440],
15	of	IN	O	of	_	0	SENT_23	[p2l1947t1356r2022b1419],
16	the	DT	O	the	det	19	SENT_23	[p2l2034t1356r2142b1419],
17	ﬁrst	NN	O	ﬁrst	nn	19	SENT_23	[p2l9t1458r138b1522],
18	clinical	JJ	O	clinical	amod	19	SENT_23	[p2l157t1458r395b1522],
19	attack	NN	O	attack	prep_of	12	SENT_23	[p2l415t1458r614b1522],
20	of	IN	O	of	_	0	SENT_23	[p2l631t1458r703b1522],
21	MS	NN	O	m	prep_of	19	SENT_23	[p2l713t1462r823b1522],
22	rather	RB	O	rather	_	0	SENT_23	[p2l844t1458r1045b1522],
23	than	IN	O	than	_	0	SENT_23	[p2l1063t1458r1214b1522],
24	the	DT	O	the	det	27	SENT_23	[p2l1232t1458r1336b1522],
25	second	JJ	ORDINAL	second	amod	27	SENT_23	[p2l1357t1458r1588b1522],
26	clinical	JJ	O	clinical	amod	27	SENT_23	[p2l1607t1458r1845b1522],
27	event	NN	O	event	conj_negcc	7	SENT_23	[p2l1865t1470r2058b1530],
28	,	,	O	,	_	0	SENT_23	[p2l1865t1470r2058b1530],
29	as	RB	O	as	advmod	32	SENT_23	[p2l2080t1481r2143b1522],
30	was	VBD	O	be	cop	32	SENT_23	[p2l8t1584r131b1624],
31	the	DT	O	the	det	32	SENT_23	[p2l151t1561r255b1624],
32	case	NN	O	case	dep	27	SENT_23	[p2l276t1584r412b1624],
33	in	IN	O	in	_	0	SENT_23	[p2l432t1567r498b1623],
34	CIS	NN	ORGANIZATION	ci	nn	35	SENT_23	[p2l519t1565r638b1624],
35	trials	NNS	O	trial	prep_in	32	SENT_23	[p2l658t1561r843b1624],
36	.	.	O	.	_	0	SENT_23	[p2l658t1561r843b1624],

1	This	DT	O	this	det	2	SENT_24	[p2l865t1561r1006b1624],
2	review	NN	O	review	nsubj	4	SENT_24	[p2l1027t1567r1250b1624],
3	will	MD	O	will	aux	4	SENT_24	[p2l1265t1561r1388b1624],
4	focus	VB	O	focus	_	0	SENT_24	[p2l1407t1561r1584b1624],
5	on	IN	O	on	_	0	SENT_24	[p2l1605t1584r1689b1624],
6	available	JJ	O	available	amod	10	SENT_24	[p2l1710t1561r1998b1624],
7	and	CC	O	and	_	0	SENT_24	[p2l2019t1561r2143b1624],
8	upcoming	JJ	O	upcoming	amod	10	SENT_24	[p2l9t1670r354b1748],
9	treatment	NN	O	treatment	nn	10	SENT_24	[p2l371t1676r702b1727],
10	modalities	NNS	O	modality	prep_on	4	SENT_24	[p2l720t1664r1073b1727],
11	for	IN	O	for	_	0	SENT_24	[p2l1093t1664r1189b1727],
12	three	CD	NUMBER	three	num	14	SENT_24	[p2l1207t1664r1379b1727],
13	clinical	JJ	O	clinical	amod	14	SENT_24	[p2l1400t1664r1641b1727],
14	phenomena	NNS	O	phenomenon	prep_for	10	SENT_24	[p2l1659t1664r2061b1747],
15	of	IN	O	of	_	0	SENT_24	[p2l2081t1664r2153b1727],
16	MS	NN	O	m	prep_of	14	SENT_24	[p2l9t1771r140b1830],
17	:	:	O	:	_	0	SENT_24	[p2l9t1771r140b1830],
18	relapses	NNS	O	relapse	dep	10	SENT_24	[p2l165t1767r450b1850],
19	,	,	O	,	_	0	SENT_24	[p2l165t1767r450b1850],
20	pseudorelapses	NNS	O	pseudorelaps	conj_and	18	SENT_24	[p2l472t1767r1009b1850],
21	,	,	O	,	_	0	SENT_24	[p2l472t1767r1009b1850],
22	and	CC	O	and	_	0	SENT_24	[p2l1032t1767r1158b1830],
23	progressive	JJ	O	progressive	amod	25	SENT_24	[p2l1178t1773r1564b1851],
24	disease	NN	O	disease	nn	25	SENT_24	[p2l1587t1767r1827b1830],
25	course	NN	O	course	dep	10	SENT_24	[p2l1849t1790r2087b1830],
26	.	.	O	.	_	0	SENT_24	[p2l1849t1790r2087b1830],

1	Over	IN	O	over	_	0	SENT_25	[p2l84t1874r254b1933],
2	the	DT	DURATION	the	det	5	SENT_25	[p2l272t1870r378b1933],
3	past	JJ	DURATION	past	amod	5	SENT_25	[p2l398t1882r537b1953],
4	few	JJ	DURATION	few	amod	5	SENT_25	[p2l556t1870r677b1933],
5	decades	NNS	DURATION	decade	prep_over	22	SENT_25	[p2l695t1870r980b1942],
6	,	,	O	,	_	0	SENT_25	[p2l695t1870r980b1942],
7	a	DT	O	a	det	8	SENT_25	[p2l1003t1893r1037b1933],
8	number	NN	O	number	nsubj	22	SENT_25	[p2l1057t1870r1328b1933],
9	of	IN	O	of	_	0	SENT_25	[p2l1348t1870r1422b1933],
10	treatment	NN	O	treatment	nn	11	SENT_25	[p2l1432t1882r1767b1933],
11	modalities	NNS	O	modality	prep_of	8	SENT_25	[p2l1786t1870r2143b1933],
12	targeting	VBG	O	target	partmod	11	SENT_25	[p2l8t1979r324b2057],
13	several	JJ	O	several	amod	15	SENT_25	[p2l347t1973r587b2036],
14	biological	JJ	O	biological	amod	15	SENT_25	[p2l608t1973r952b2057],
15	pathways	NNS	O	pathway	dobj	12	SENT_25	[p2l974t1973r1298b2057],
16	presumably	RB	O	presumably	advmod	17	SENT_25	[p2l1321t1973r1733b2057],
17	involved	VBN	O	involve	partmod	15	SENT_25	[p2l1754t1973r2053b2036],
18	in	IN	O	in	_	0	SENT_25	[p2l2075t1979r2143b2035],
19	MS	NN	O	m	prep_in	17	SENT_25	[p2l9t2080r121b2139],
20	have	VBP	O	have	aux	22	SENT_25	[p2l141t2076r294b2139],
21	become	VBN	O	become	cop	22	SENT_25	[p2l313t2076r576b2139],
22	available	JJ	O	available	_	0	SENT_25	[p2l597t2076r886b2139],
23	for	IN	O	for	_	0	SENT_25	[p2l907t2076r1002b2139],
24	preventing	VBG	O	prevent	prepc_for	22	SENT_25	[p2l1020t2082r1386b2160],
25	relapses	NNS	O	relapse	dobj	24	SENT_25	[p2l1404t2076r1668b2159],
26	or	CC	O	or	_	0	SENT_25	[p2l1689t2099r1759b2139],
27	shortening	VBG	O	shorten	prepc_for	22	SENT_25	[p2l1780t2076r2145b2160],
28	a	DT	O	a	det	34	SENT_25	[p2l10t2202r45b2242],
29	relapse	NN	O	relapse	nn	34	SENT_25	[p2l69t2179r313b2262],
30	course	NN	O	course	nn	34	SENT_25	[p2l339t2202r568b2242],
31	(	CD	NUMBER	(	num	34	SENT_25	[p2l597t2180r865b2262],
32	Figure	NN	O	figure	nn	34	SENT_25	[p2l597t2180r865b2262],
33	1	CD	NUMBER	1	num	34	SENT_25	[p2l894t2179r977b2256],
34	)	NN	O	)	dobj	27	SENT_25	[p2l894t2179r977b2256],
35	.	.	O	.	_	0	SENT_25	[p2l894t2179r977b2256],

1	Several	JJ	O	several	nsubjpass	7	SENT_26	[p2l1006t2179r1258b2242],
2	of	IN	O	of	_	0	SENT_26	[p2l1283t2179r1359b2242],
3	these	DT	O	these	det	5	SENT_26	[p2l1373t2179r1554b2242],
4	presumed	JJ	O	presumed	amod	5	SENT_26	[p2l1578t2179r1929b2262],
5	pathways	NNS	O	pathway	prep_of	1	SENT_26	[p2l1952t2179r2139b2262, p2l8t2305r172b2366],
6	are	VBP	O	be	auxpass	7	SENT_26	[p2l195t2305r294b2345],
7	based	VBN	O	base	_	0	SENT_26	[p2l314t2282r510b2345],
8	on	IN	O	on	_	0	SENT_26	[p2l531t2305r618b2345],
9	animal	NN	O	animal	nn	10	SENT_26	[p2l639t2282r874b2345],
10	models	NNS	O	model	prep_on	7	SENT_26	[p2l894t2282r1141b2345],
11	of	IN	O	of	_	0	SENT_26	[p2l1164t2282r1237b2345],
12	demyelination	NN	O	demyelination	prep_of	10	SENT_26	[p2l1250t2282r1740b2366],
13	rather	RB	O	rather	_	0	SENT_26	[p2l1762t2282r1969b2345],
14	than	IN	O	than	_	0	SENT_26	[p2l1988t2282r2143b2345],
15	actual	JJ	O	actual	amod	16	SENT_26	[p2l10t2385r220b2448],
16	proof	NN	O	proof	prep_on	7	SENT_26	[p2l242t2385r444b2468],
17	of	IN	O	of	_	0	SENT_26	[p2l459t2385r535b2448],
18	eﬂicacy	NN	O	eﬂicacy	prep_of	16	SENT_26	[p2l550t2385r815b2469],
19	in	IN	O	in	_	0	SENT_26	[p2l836t2391r904b2447],
20	MS.	NNP	O	MS.	prep_in	18	SENT_26	[p2l928t2389r1063b2448],
21	Some	DT	O	some	dobj	7	SENT_26	[p2l1091t2389r1284b2448],
22	of	IN	O	of	_	0	SENT_26	[p2l1309t2385r1385b2448],
23	the	DT	O	the	det	27	SENT_26	[p2l1398t2385r1507b2448],
24	immunomodula	NN	O	immunomodulum	nn	27	SENT_26	[p2l1533t2385r2139b2448],
25	—	CD	NUMBER	—	num	27	SENT_26	[p2l1533t2385r2139b2448],
26	tory	JJ	O	tory	amod	27	SENT_26	[p2l8t2494r893b2572],
27	—	NN	O	—	prep_of	21	SENT_26	[p2l8t2494r893b2572],
28	immunosuppressive	JJ	O	immunosuppressive	amod	30	SENT_26	[p2l8t2494r893b2572],
29	treatment	NN	O	treatment	nn	30	SENT_26	[p2l915t2500r1252b2551],
30	modalities	NNS	O	modality	nsubj	35	SENT_26	[p2l1274t2488r1634b2551],
31	in	IN	O	in	_	0	SENT_26	[p2l1657t2494r1724b2550],
32	MS	NN	O	m	prep_in	30	SENT_26	[p2l1747t2492r1861b2551],
33	are	VBP	O	be	cop	35	SENT_26	[p2l1885t2511r1986b2551],
34	also	RB	O	also	advmod	35	SENT_26	[p2l2010t2488r2141b2551],
35	carryovers	NNS	O	carryover	rcmod	27	SENT_26	[p2l10t2614r372b2675],
36	from	IN	O	from	_	0	SENT_26	[p2l396t2591r566b2654],
37	other	JJ	O	other	amod	39	SENT_26	[p2l589t2591r773b2654],
38	autoimmune	JJ	O	autoimmune	amod	39	SENT_26	[p2l796t2597r1240b2654],
39	disorders	NNS	O	disorder	prep_from	35	SENT_26	[p2l1264t2591r1584b2654],
40	on	IN	O	on	_	0	SENT_26	[p2l1609t2614r1696b2654],
41	the	DT	O	the	det	42	SENT_26	[p2l1718t2591r1826b2654],
42	assumption	NN	O	assumption	prep_on	39	SENT_26	[p2l1850t2613r2140b2674, p2l8t2700r147b2757],
43	that	IN	O	that	complm	50	SENT_26	[p2l169t2694r304b2757],
44	the	DT	O	the	det	45	SENT_26	[p2l324t2694r431b2757],
45	majority	NN	O	majority	nsubjpass	50	SENT_26	[p2l454t2700r750b2778],
46	of	IN	O	of	_	0	SENT_26	[p2l770t2694r844b2757],
47	MS	NN	O	m	nn	48	SENT_26	[p2l857t2698r971b2757],
48	pathology	NN	O	pathology	prep_of	45	SENT_26	[p2l994t2694r1344b2778],
49	is	VBZ	O	be	auxpass	50	SENT_26	[p2l1363t2700r1414b2757],
50	mediated	VBN	O	mediate	ccomp	35	SENT_26	[p2l1437t2694r1758b2757],
51	via	IN	O	via	_	0	SENT_26	[p2l1777t2700r1880b2757],
52	similar	JJ	O	similar	amod	54	SENT_26	[p2l1903t2694r2142b2757],
53	autoimmune	JJ	O	autoimmune	amod	54	SENT_26	[p2l10t2803r459b2860],
54	mechanisms	NNS	O	mechanism	prep_via	50	SENT_26	[p2l483t2797r938b2860],
55	.	.	O	.	_	0	SENT_26	[p2l483t2797r938b2860],

1	Although	IN	O	although	mark	6	SENT_27	[p2l964t2797r1300b2881],
2	the	DT	O	the	det	4	SENT_27	[p2l1322t2797r1432b2860],
3	latter	JJ	O	latter	amod	4	SENT_27	[p2l1454t2797r1636b2860],
4	assumption	NN	O	assumption	nsubj	6	SENT_27	[p2l1660t2803r2065b2880],
5	is	VBZ	O	be	cop	6	SENT_27	[p2l2089t2803r2141b2860],
6	debatable	JJ	O	debatable	_	0	SENT_27	[p2l10t2900r350b2972],
7	,	,	O	,	_	0	SENT_27	[p2l10t2900r350b2972],
8	and	CC	O	and	_	0	SENT_27	[p2l373t2900r498b2963],
9	the	DT	O	the	det	11	SENT_27	[p2l516t2900r622b2963],
10	treatment	NN	O	treatment	nn	11	SENT_27	[p2l641t2912r975b2963],
11	modalities	NNS	O	modality	nsubj	12	SENT_27	[p2l994t2900r1350b2963],
12	do	VBP	O	do	conj_and	6	SENT_27	[p2l1371t2900r1454b2963],
13	not	RB	O	not	neg	15	SENT_27	[p2l1476t2912r1589b2963],
14	primarily	RB	O	primarily	advmod	15	SENT_27	[p2l1608t2900r1931b2984],
15	target	NN	O	target	dobj	12	SENT_27	[p2l1947t2912r2142b2984],

1	‘	NNP	O	‘	nn	2	SENT_28	[p2l21t3066r190b3098],
2	Department	NNP	ORGANIZATION	Department	_	0	SENT_28	[p2l21t3066r190b3098],
3	of	IN	ORGANIZATION	of	_	0	SENT_28	[p2l197t3069r224b3092],
4	Neurology	NNP	ORGANIZATION	Neurology	prep_of	2	SENT_28	[p2l230t3069r370b3099],
5	,	,	O	,	_	0	SENT_28	[p2l230t3069r370b3099],
6	Mayo	NNP	ORGANIZATION	Mayo	nn	13	SENT_28	[p2l377t3070r446b3099],
7	Clinic	NNP	ORGANIZATION	Clinic	nn	13	SENT_28	[p2l454t3069r529b3096],
8	,	,	O	,	_	0	SENT_28	[p2l454t3069r529b3096],
9	Rochester	NNP	LOCATION	Rochester	appos	13	SENT_28	[p2l538t3069r669b3096],
10	,	,	O	,	_	0	SENT_28	[p2l538t3069r669b3096],
11	Minnesota	NNP	LOCATION	Minnesota	appos	13	SENT_28	[p2l677t3070r819b3096],
12	,	,	O	,	_	0	SENT_28	[p2l677t3070r819b3096],
13	USA	NNP	LOCATION	USA	appos	4	SENT_28	[p2l827t3070r885b3092],
14	.	.	O	.	_	0	SENT_28	[p2l827t3070r885b3092],

1	2Department	NN	O	2department	_	0	SENT_29	[p2l892t3065r1063b3098],
2	of	IN	O	of	_	0	SENT_29	[p2l1070t3069r1097b3092],
3	Immunology	NNP	O	Immunology	prep_of	1	SENT_29	[p2l1103t3069r1273b3099],
4	,	,	O	,	_	0	SENT_29	[p2l1103t3069r1273b3099],
5	Mayo	NNP	ORGANIZATION	Mayo	nn	12	SENT_29	[p2l1281t3070r1350b3099],
6	Clinic	NNP	ORGANIZATION	Clinic	nn	12	SENT_29	[p2l1357t3069r1433b3096],
7	,	,	O	,	_	0	SENT_29	[p2l1357t3069r1433b3096],
8	Rochester	NNP	LOCATION	Rochester	appos	12	SENT_29	[p2l1442t3069r1573b3096],
9	,	,	O	,	_	0	SENT_29	[p2l1442t3069r1573b3096],
10	Minnesota	NNP	LOCATION	Minnesota	appos	12	SENT_29	[p2l1581t3070r1723b3096],
11	,	,	O	,	_	0	SENT_29	[p2l1581t3070r1723b3096],
12	USA	NNP	LOCATION	USA	appos	3	SENT_29	[p2l1731t3070r1789b3092],
13	.	.	O	.	_	0	SENT_29	[p2l1731t3070r1789b3092],

1	Correspondence	NN	O	correspondence	_	0	SENT_30	[p2l1796t3069r2016b3098],
2	:	:	O	:	_	0	SENT_30	[p2l1796t3069r2016b3098],
3	M	NN	O	m	dep	1	SENT_30	[p2l21t3108r42b3130],
4	Rodriguez	NNP	PERSON	Rodriguez	dep	3	SENT_30	[p2l52t3107r182b3137],
5	(	CD	NUMBER	(	num	4	SENT_30	[p2l190t3107r572b3137],
6	rodrigue2.moses@mayo.edu	NN	O	rodrigue2.moses@mayo.edu	dep	3	SENT_30	[p2l190t3107r572b3137],
7	)	CD	NUMBER	)	num	6	SENT_30	[p2l190t3107r572b3137],
8	Received	VBN	O	receive	dep	3	SENT_30	[p2l21t3148r130b3171],
9	9	CD	DATE	9	num	10	SENT_30	[p2l139t3150r152b3171],
10	August	NNP	DATE	August	dobj	8	SENT_30	[p2l159t3149r247b3177],
11	201	CD	NUMBER	201	num	10	SENT_30	[p2l254t3150r293b3171],
12	3	CD	NUMBER	3	dep	10	SENT_30	[p2l300t3150r319b3175],
13	;	:	O	;	_	0	SENT_30	[p2l300t3150r319b3175],
14	accepted	VBN	O	accept	dep	8	SENT_30	[p2l326t3148r439b3177],
15	13	CD	DATE	13	num	16	SENT_30	[p2l450t3150r475b3171],
16	September	NNP	DATE	September	dobj	14	SENT_30	[p2l484t3148r621b3177],
17	201	CD	NUMBER	201	num	16	SENT_30	[p2l628t3150r666b3171],
18	3	CD	NUMBER	3	dep	16	SENT_30	[p2l674t3150r692b3174],
19	;	:	O	;	_	0	SENT_30	[p2l674t3150r692b3174],
20	advance	NN	O	advance	dep	16	SENT_30	[p2l700t3148r803b3171],
21	online	NN	O	online	prep	20	SENT_30	[p2l811t3148r887b3171],
22	publication	NN	O	publication	dep	21	SENT_30	[p2l896t3148r1033b3177],
23	20	CD	DATE	20	num	22	SENT_30	[p2l1042t3150r1070b3171],
24	November	NNP	DATE	November	tmod	14	SENT_30	[p2l1079t3148r1209b3171],
25	201	CD	NUMBER	201	num	24	SENT_30	[p2l1216t3150r1255b3171],
26	3	CD	NUMBER	3	dobj	8	SENT_30	[p2l1262t3150r1280b3171],
27	.	.	O	.	_	0	SENT_30	[p2l1262t3150r1280b3171],

1	doi	FW	O	doi	nn	2	SENT_31	[p2l1288t3148r1342b3171],
2	:1	FW	O	:1	dep	7	SENT_31	[p2l1288t3148r1342b3171],
3	0.1	CD	NUMBER	0.1	num	4	SENT_31	[p2l1349t3150r1377b3171],
4	038/c	NN	O	038/c	dep	2	SENT_31	[p2l1385t3148r1533b3177],
5	|	CD	NUMBER	|	num	6	SENT_31	[p2l1385t3148r1533b3177],
6	pt	NN	O	pt	dep	7	SENT_31	[p2l1385t3148r1533b3177],
7	.201	CD	NUMBER	.201	dep	13	SENT_31	[p2l1385t3148r1533b3177],
8	3.1	CD	NUMBER	3.1	number	9	SENT_31	[p2l1540t3150r1569b3171],
9	96	CD	NUMBER	96	dep	7	SENT_31	[p2l1576t3150r1604b3171],
10	32	CD	NUMBER	32	num	11	SENT_31	[p2l20t3191r50b3212],
11	VOLUME	NN	O	volume	dep	9	SENT_31	[p2l1367t3191r1475b3212],
12	95	CD	NUMBER	95	num	13	SENT_31	[p2l1483t3191r1510b3212],
13	NUMBER	NN	O	number	dep	19	SENT_31	[p2l1520t3191r1628b3212],
14	1	CD	NUMBER	1	number	15	SENT_31	[p2l1638t3192r1645b3212],
15	|	CD	NUMBER	|	dep	13	SENT_31	[p2l1659t3189r1661b3219],
16	JANUARY	NNP	DATE	JANUARY	dep	15	SENT_31	[p2l1670t3191r1788b3212],
17	2014	CD	DATE	2014	num	16	SENT_31	[p2l1796t3191r1854b3212],
18	|	CD	NUMBER	|	num	19	SENT_31	[p2l1863t3189r1865b3219],
19	www.nature.com/cpt	NN	O	www.nature.com/cpt	_	0	SENT_31	[p2l1874t3191r2139b3217],

1	STATE	NN	O	state	nn	2	SENT_32	[p2l1757t3334r1898b3372],
2	ART	NN	O	art	_	0	SENT_32	[p2l2041t3334r2135b3371],

1	IGFI	NNP	O	IGFI	nn	2	SENT_33	[p3l1484t351r1534b384],
2	OG	NNP	O	OG	_	0	SENT_33	[p3l1399t409r1446b436],

1	precursor	NN	O	precursor	nn	2	SENT_34	[p3l1303t443r1447b470],
2	CNTF	NN	MISC	cntf	_	0	SENT_34	[p3l1647t435r1718b460],

1	o	NN	O	o	_	0	SENT_35	[p3l1419t507r1440b531],
2	I	CD	NUMBER	i	num	3	SENT_35	[p3l1658t495r1668b552],
3	N	NN	O	n	dep	1	SENT_35	[p3l1399t507r1418b531],

1	PIANTE	NN	O	piante	nn	4	SENT_36	[p3l614t593r699b615],
2	S	NN	O	s	nn	4	SENT_36	[p3l705t593r718b613],
3	Mli-L	NN	O	mli-l	nn	4	SENT_36	[p3l639t627r693b647],
4	1a	NN	O	1a	_	0	SENT_36	[p3l701t627r730b647],
5	7	CD	NUMBER	7	dep	4	SENT_36	[p3l1667t655r1669b657],

1	ivhcroglia	NN	O	ivhcroglium	nn	2	SENT_37	[p3l698t655r834b687],
2	‘	NN	O	‘	_	0	SENT_37	[p3l1190t683r1191b687],
3	,	,	O	,	_	0	SENT_37	[p3l1351t678r1360b683],
4	7	CD	NUMBER	7	number	5	SENT_37	[p3l1549t690r1554b691],
5	»	CD	NUMBER	»	appos	2	SENT_37	[p3l1650t667r1652b669],
6	Asti	NNP	O	Asti	nn	7	SENT_37	[p3l1729t655r1782b679],
7	otzyte	NN	O	otzyte	dep	2	SENT_37	[p3l1789t657r1869b685],

1	Central	NNP	O	Central	nn	2	SENT_38	[p3l90t747r230b782],
2	R	NNP	O	R	poss	4	SENT_38	[p3l310t735r414b787],
3	'	POS	O	'	_	0	SENT_38	[p3l310t735r414b787],
4	l.	NN	O	l.	_	0	SENT_38	[p3l310t735r414b787],
5	l	NN	O	l	dep	4	SENT_38	[p3l310t735r414b787],
6	‘	NN	O	‘	dep	5	SENT_38	[p3l310t735r414b787],
7	.	.	O	.	_	0	SENT_38	[p3l310t735r414b787],

1	.	.	O	.	_	0	SENT_39	[p3l310t735r414b787],

1	lEil	NN	O	leil	nsubj	5	SENT_40	[p3l310t735r414b787],
2	nervous	JJ	O	nervous	amod	4	SENT_40	[p3l92t805r250b831],
3	system	NN	O	system	nn	4	SENT_40	[p3l92t847r226b888],
4	Activation	NN	O	activation	dep	1	SENT_40	[p3l1465t1327r1602b1352],
5	induced	VBD	O	induce	_	0	SENT_40	[p3l1465t1359r1574b1384],

1	Illustrated	NNP	O	Illustrated	_	0	SENT_41	[p3l2117t1642r2139b1764],
2	by	IN	O	by	dep	1	SENT_41	[p3l2117t1602r2145b1631],
3	Zina	NNP	PERSON	Zina	nn	4	SENT_41	[p3l2117t1538r2139b1594],
4	Deretsky	NNP	PERSON	Deretsky	pobj	2	SENT_41	[p3l2117t1411r2145b1527],
5	,	,	O	,	_	0	SENT_41	[p3l2117t1411r2145b1527],
6	Dr.	NNP	O	Dr.	nn	7	SENT_41	[p3l2117t1366r2139b1399],
7	Katarci	NNP	PERSON	Katarci	conj_and	4	SENT_41	[p3l2117t1260r2143b1355],
8	,	,	O	,	_	0	SENT_41	[p3l2117t1260r2143b1355],
9	Dr.	NNP	O	Dr.	nn	10	SENT_41	[p3l2117t1215r2139b1248],
10	Pirko	NNP	PERSON	Pirko	pobj	2	SENT_41	[p3l2117t1135r2143b1204],
11	,	,	O	,	_	0	SENT_41	[p3l2117t1135r2143b1204],
12	and	CC	O	and	_	0	SENT_41	[p3l2117t1078r2139b1124],
13	Dr.	NNP	O	Dr.	nn	14	SENT_41	[p3l2117t1033r2139b1066],
14	Rodriguez	NNP	PERSON	Rodriguez	pobj	2	SENT_41	[p3l2117t891r2145b1022],

1	Figure	NNP	O	Figure	_	0	SENT_42	[p3l17t1818r107b1848],
2	1	CD	NUMBER	1	num	5	SENT_42	[p3l116t1819r126b1841],
3	Model	NNP	O	Model	nn	5	SENT_42	[p3l155t1817r237b1842],
4	ofthe	NN	O	ofthe	nn	5	SENT_42	[p3l246t1817r322b1842],
5	immunopathogenesis	NN	O	immunopathogenesis	dep	1	SENT_42	[p3l330t1817r623b1848],
6	of	IN	O	of	_	0	SENT_42	[p3l631t1817r659b1842],
7	MS	NN	O	m	prep_of	5	SENT_42	[p3l665t1818r704b1842],
8	(	CD	NUMBER	(	num	7	SENT_42	[p3l713t1818r738b1845],
9	it	PRP	O	it	nsubj	12	SENT_42	[p3l713t1818r738b1845],
10	is	VBZ	O	be	cop	12	SENT_42	[p3l746t1818r763b1842],
11	not	RB	O	not	neg	12	SENT_42	[p3l772t1821r816b1842],
12	possible	JJ	O	possible	rcmod	1	SENT_42	[p3l824t1817r933b1848],
13	to	TO	O	to	aux	14	SENT_42	[p3l940t1821r967b1842],
14	show	VB	O	show	xcomp	12	SENT_42	[p3l975t1817r1045b1842],
15	the	DT	O	the	det	17	SENT_42	[p3l1052t1817r1095b1842],
16	time	NN	O	time	nn	17	SENT_42	[p3l1102t1818r1162b1842],
17	axis	NN	O	axis	dobj	14	SENT_42	[p3l1170t1818r1219b1842],
18	or	CC	O	or	_	0	SENT_42	[p3l1227t1824r1254b1842],
19	provide	VB	O	provide	conj_or	14	SENT_42	[p3l1262t1817r1362b1848],
20	deﬁnite	JJ	O	deﬁnite	amod	21	SENT_42	[p3l1370t1817r1471b1842],
21	prooffor	NN	O	prooffor	iobj	19	SENT_42	[p3l1480t1817r1594b1848],
22	the	DT	O	the	det	25	SENT_42	[p3l1601t1817r1644b1842],
23	time	NN	O	time	nn	25	SENT_42	[p3l1651t1818r1711b1842],
24	sequence	NN	O	sequence	nn	25	SENT_42	[p3l1719t1824r1846b1848],
25	ofevents	NNS	O	ofevent	dobj	19	SENT_42	[p3l1854t1817r1974b1842],
26	in	IN	O	in	_	0	SENT_42	[p3l1982t1818r2004b1841],
27	this	DT	O	this	det	29	SENT_42	[p3l2012t1817r2060b1842],
28	paradigm	NN	O	paradigm	nn	29	SENT_42	[p3l17t1858r207b1889],
29	)	NN	O	)	prep_in	25	SENT_42	[p3l17t1858r207b1889],
30	.	.	O	.	_	0	SENT_42	[p3l17t1858r207b1889],

1	We	PRP	O	we	nsubj	2	SENT_43	[p3l17t1858r207b1889],
2	show	VBP	O	show	_	0	SENT_43	[p3l215t1858r286b1882],
3	the	DT	O	the	det	4	SENT_43	[p3l292t1858r336b1882],
4	interaction	NN	O	interaction	dobj	2	SENT_43	[p3l344t1859r487b1882],
5	between	IN	O	between	_	0	SENT_43	[p3l497t1858r612b1882],
6	the	DT	O	the	det	7	SENT_43	[p3l620t1858r663b1882],
7	cellular	JJ	O	cellular	prep_between	4	SENT_43	[p3l671t1858r766b1882],
8	and	CC	O	and	_	0	SENT_43	[p3l774t1858r822b1882],
9	the	DT	O	the	det	13	SENT_43	[p3l831t1858r874b1882],
10	humoral	JJ	O	humoral	amod	13	SENT_43	[p3l883t1858r992b1882],
11	immune	JJ	O	immune	amod	13	SENT_43	[p3l1002t1859r1113b1882],
12	system	NN	O	system	nn	13	SENT_43	[p3l1121t1862r1212b1889],
13	components	NNS	O	component	dobj	2	SENT_43	[p3l1221t1862r1395b1888],
14	,	,	O	,	_	0	SENT_43	[p3l1221t1862r1395b1888],
15	the	DT	O	the	det	16	SENT_43	[p3l1402t1858r1445b1882],
16	neurons	NNS	O	neuron	conj_and	4	SENT_43	[p3l1454t1865r1568b1886],
17	,	,	O	,	_	0	SENT_43	[p3l1454t1865r1568b1886],
18	astrocytes	NNS	O	astrocyte	conj_and	4	SENT_43	[p3l1576t1862r1716b1889],
19	,	,	O	,	_	0	SENT_43	[p3l1576t1862r1716b1889],
20	myelin	JJ	O	myelin	conj_and	4	SENT_43	[p3l1725t1858r1819b1889],
21	,	,	O	,	_	0	SENT_43	[p3l1725t1858r1819b1889],
22	and	CC	O	and	_	0	SENT_43	[p3l1827t1858r1875b1882],
23	medications	NNS	O	medication	conj_and	4	SENT_43	[p3l1885t1858r2053b1882],
24	.	.	O	.	_	0	SENT_43	[p3l1885t1858r2053b1882],

1	Blue	NNP	O	Blue	nn	2	SENT_44	[p3l2063t1858r2118b1882],
2	arrows	NNS	O	arrow	nsubj	3	SENT_44	[p3l16t1906r104b1923],
3	indicate	VBP	O	indicate	_	0	SENT_44	[p3l113t1899r218b1923],
4	a	DT	O	a	det	7	SENT_44	[p3l225t1906r238b1923],
5	favorable	JJ	O	favorable	amod	7	SENT_44	[p3l246t1899r370b1923],
6	immune	JJ	O	immune	amod	7	SENT_44	[p3l379t1900r489b1923],
7	effect	NN	O	effect	dobj	3	SENT_44	[p3l497t1899r578b1923],
8	.	.	O	.	_	0	SENT_44	[p3l497t1899r578b1923],

1	Red	NNP	O	Red	nn	2	SENT_45	[p3l587t1899r634b1923],
2	arrows	NNS	O	arrow	nsubj	3	SENT_45	[p3l643t1906r731b1923],
3	indicate	VBP	O	indicate	_	0	SENT_45	[p3l740t1899r845b1923],
4	a	DT	O	a	det	7	SENT_45	[p3l853t1906r866b1923],
5	detrimental	JJ	O	detrimental	amod	6	SENT_45	[p3l874t1899r1029b1923],
6	immune	JJ	O	immune	amod	7	SENT_45	[p3l1038t1900r1149b1923],
7	effect	NN	O	effect	dobj	3	SENT_45	[p3l1157t1899r1237b1923],
8	.	.	O	.	_	0	SENT_45	[p3l1157t1899r1237b1923],

1	Green	NNP	O	Green	nn	2	SENT_46	[p3l1245t1900r1323b1923],
2	arrows	NNS	O	arrow	nsubj	6	SENT_46	[p3l1332t1906r1420b1923],
3	leading	VBG	O	lead	partmod	2	SENT_46	[p3l1429t1899r1526b1930],
4	from	IN	O	from	_	0	SENT_46	[p3l1534t1899r1596b1923],
5	medications	NNS	O	medication	prep_from	3	SENT_46	[p3l1606t1899r1768b1923],
6	indicate	VBP	O	indicate	_	0	SENT_46	[p3l1777t1899r1881b1923],
7	a	DT	O	a	det	9	SENT_46	[p3l1889t1906r1902b1923],
8	stimulatory	JJ	O	stimulatory	amod	9	SENT_46	[p3l1911t1899r2062b1930],
9	effect	NN	O	effect	dobj	6	SENT_46	[p3l16t1940r91b1965],
10	by	IN	O	by	_	0	SENT_46	[p3l99t1940r130b1971],
11	the	DT	O	the	det	12	SENT_46	[p3l137t1940r180b1965],
12	medication	NN	O	medication	prep_by	6	SENT_46	[p3l189t1940r345b1965],
13	.	.	O	.	_	0	SENT_46	[p3l189t1940r345b1965],

1	A	DT	O	a	_	0	SENT_47	[p3l352t1941r371b1964],
2	truncated	VBN	O	truncate	csubj	9	SENT_47	[p3l378t1940r507b1965],
3	green	JJ	O	green	amod	4	SENT_47	[p3l516t1947r591b1971],
4	line	NN	O	line	dobj	2	SENT_47	[p3l601t1940r647b1965],
5	leading	VBG	O	lead	amod	4	SENT_47	[p3l656t1940r752b1971],
6	from	IN	O	from	_	0	SENT_47	[p3l760t1940r823b1965],
7	the	DT	O	the	det	8	SENT_47	[p3l831t1940r874b1965],
8	medication	NN	O	medication	prep_from	4	SENT_47	[p3l883t1940r1031b1965],
9	indicates	VBZ	O	indicate	dep	1	SENT_47	[p3l1041t1940r1158b1965],
10	an	DT	O	a	det	12	SENT_47	[p3l1166t1947r1197b1965],
11	inhibitory	JJ	O	inhibitory	amod	12	SENT_47	[p3l1206t1940r1335b1971],
12	effect	NN	O	effect	dobj	9	SENT_47	[p3l1343t1940r1423b1965],
13	.	.	O	.	_	0	SENT_47	[p3l1343t1940r1423b1965],

1	A	DT	O	a	det	3	SENT_48	[p3l1431t1941r1449b1964],
2	black	JJ	O	black	amod	3	SENT_48	[p3l1458t1940r1527b1965],
3	line	NN	O	line	nsubj	4	SENT_48	[p3l1535t1940r1581b1965],
4	indicates	VBZ	O	indicate	_	0	SENT_48	[p3l1589t1940r1707b1965],
5	migration	NN	O	migration	dobj	4	SENT_48	[p3l1716t1941r1843b1971],
6	of	IN	O	of	_	0	SENT_48	[p3l1852t1940r1880b1965],
7	a	DT	O	a	det	10	SENT_48	[p3l1885t1947r1898b1965],
8	ce	NN	O	ce	nn	10	SENT_48	[p3l1907t1940r2011b1965],
9	|	NN	O	|	nn	10	SENT_48	[p3l1907t1940r2011b1965],
10	|	NN	O	|	prep_of	5	SENT_48	[p3l1907t1940r2011b1965],
11	.	.	O	.	_	0	SENT_48	[p3l1907t1940r2011b1965],

1	The	DT	O	the	det	2	SENT_49	[p3l1907t1940r2011b1965],
2	effector	NN	O	effector	nn	3	SENT_49	[p3l16t1981r119b2005],
3	line	NN	O	line	nsubj	4	SENT_49	[p3l127t1981r173b2005],
4	dashed	VBN	O	dash	_	0	SENT_49	[p3l181t1981r277b2005],
5	with	IN	O	with	_	0	SENT_49	[p3l285t1981r342b2005],
6	a	DT	O	a	det	7	SENT_49	[p3l351t1981r527b2005],
7	”	NN	O	”	prep_with	4	SENT_49	[p3l351t1981r527b2005],
8	?	.	O	?	_	0	SENT_49	[p3l351t1981r527b2005],
9	"	''	O	"	punct	4	SENT_49	[p3l351t1981r527b2005],

1	indicates	VBZ	O	indicate	_	0	SENT_50	[p3l351t1981r527b2005],
2	an	DT	O	a	det	8	SENT_50	[p3l535t1988r566b2005],
3	unclear	JJ	O	unclear	amod	8	SENT_50	[p3l576t1981r673b2005],
4	or	CC	O	or	_	0	SENT_50	[p3l680t1988r707b2005],
5	unproven	JJ	O	unproven	amod	8	SENT_50	[p3l715t1988r842b2011],
6	but	CC	O	but	_	0	SENT_50	[p3l852t1981r896b2005],
7	intriguing	JJ	O	intriguing	conj_but	3	SENT_50	[p3l905t1983r1034b2012],
8	action	NN	O	action	dobj	1	SENT_50	[p3l1043t1981r1186b2005],
9	.	.	O	.	_	0	SENT_50	[p3l1043t1981r1186b2005],

1	The	DT	O	the	det	2	SENT_51	[p3l1043t1981r1186b2005],
2	balance	NN	O	balance	nsubjpass	13	SENT_51	[p3l1195t1981r1297b2005],
3	between	IN	O	between	_	0	SENT_51	[p3l1306t1981r1421b2005],
4	inflammation	NN	O	inflammation	nn	5	SENT_51	[p3l1430t1981r1607b2005],
5	demyelination	NN	O	demyelination	prep_between	2	SENT_51	[p3l1616t1981r1814b2012],
6	,	,	O	,	_	0	SENT_51	[p3l1616t1981r1814b2012],
7	axonal	JJ	O	axonal	amod	8	SENT_51	[p3l1822t1981r1908b2005],
8	injury	NN	O	injury	prep_between	2	SENT_51	[p3l1918t1983r1998b2012],
9	,	,	O	,	_	0	SENT_51	[p3l1918t1983r1998b2012],
10	and	CC	O	and	_	0	SENT_51	[p3l2005t1981r2054b2005],
11	remyelination	NN	O	remyelination	prep_between	2	SENT_51	[p3l17t2022r199b2053],
12	is	VBZ	O	be	auxpass	13	SENT_51	[p3l209t2023r226b2046],
13	emphasized	VBN	O	emphasize	_	0	SENT_51	[p3l234t2022r459b2052],
14	.	.	O	.	_	0	SENT_51	[p3l234t2022r459b2052],

1	This	DT	O	this	det	2	SENT_52	[p3l234t2022r459b2052],
2	model	NN	O	model	nsubj	3	SENT_52	[p3l468t2022r551b2046],
3	utilizes	VBZ	O	utilize	_	0	SENT_52	[p3l561t2022r651b2046],
4	knowledge	NN	O	knowledge	dobj	3	SENT_52	[p3l660t2022r808b2053],
5	gained	VBN	O	gain	partmod	4	SENT_52	[p3l816t2022r906b2053],
6	through	IN	O	through	_	0	SENT_52	[p3l914t2022r1022b2053],
7	studies	NNS	O	study	prep_through	5	SENT_52	[p3l1031t2022r1124b2046],
8	ofthe	VBP	O	ofthe	rcmod	7	SENT_52	[p3l1132t2022r1208b2046],
9	natural	JJ	O	natural	amod	10	SENT_52	[p3l1217t2022r1308b2046],
10	history	NN	O	history	dobj	8	SENT_52	[p3l1318t2022r1408b2053],
11	of	IN	O	of	_	0	SENT_52	[p3l1416t2022r1443b2046],
12	MS	NN	O	m	nn	14	SENT_52	[p3l1449t2023r1495b2050],
13	,	,	O	,	_	0	SENT_52	[p3l1449t2023r1495b2050],
14	animal	NN	O	animal	nn	17	SENT_52	[p3l1503t2022r1591b2046],
15	and	CC	O	and	_	0	SENT_52	[p3l1600t2022r1648b2046],
16	toxic	JJ	O	toxic	nn	17	SENT_52	[p3l1657t2023r1720b2046],
17	models	NNS	O	model	prep_of	10	SENT_52	[p3l1729t2022r1825b2046],
18	of	IN	O	of	_	0	SENT_52	[p3l1833t2022r1860b2046],
19	MS	NN	O	m	prep_of	17	SENT_52	[p3l1867t2023r1912b2050],
20	,	,	O	,	_	0	SENT_52	[p3l1867t2023r1912b2050],
21	pathological	JJ	O	pathological	amod	22	SENT_52	[p3l1922t2022r2085b2053],
22	samples	NNS	O	sample	appos	7	SENT_52	[p3l16t2063r124b2094],
23	obtained	VBN	O	obtain	partmod	22	SENT_52	[p3l132t2063r251b2088],
24	at	IN	O	at	_	0	SENT_52	[p3l260t2067r284b2088],
25	various	JJ	O	various	amod	26	SENT_52	[p3l291t2064r387b2088],
26	stages	NNS	O	stage	prep_at	23	SENT_52	[p3l395t2067r478b2094],
27	of	IN	O	of	_	0	SENT_52	[p3l487t2063r514b2088],
28	disease	NN	O	disease	nn	29	SENT_52	[p3l520t2063r617b2088],
29	progression	NN	O	progression	prep_of	26	SENT_52	[p3l625t2064r788b2094],
30	,	,	O	,	_	0	SENT_52	[p3l625t2064r788b2094],
31	proposed	VBN	O	propose	amod	32	SENT_52	[p3l797t2063r922b2094],
32	mechanisms	NNS	O	mechanism	appos	7	SENT_52	[p3l932t2063r1097b2088],
33	of	IN	O	of	_	0	SENT_52	[p3l1105t2063r1133b2088],
34	action	NN	O	action	prep_of	32	SENT_52	[p3l1138t2064r1219b2088],
35	of	IN	O	of	_	0	SENT_52	[p3l1228t2063r1256b2088],
36	current	JJ	DATE	current	amod	40	SENT_52	[p3l1261t2067r1357b2088],
37	and	CC	O	and	_	0	SENT_52	[p3l1365t2063r1414b2088],
38	upcoming	JJ	O	upcoming	amod	40	SENT_52	[p3l1423t2064r1558b2094],
39	disease-modifying	JJ	O	disease-modifying	amod	40	SENT_52	[p3l1567t2063r1811b2094],
40	medications	NNS	O	medication	prep_of	32	SENT_52	[p3l1821t2063r1989b2091],
41	,	,	O	,	_	0	SENT_52	[p3l1821t2063r1989b2091],
42	known	JJ	O	known	amod	43	SENT_52	[p3l1998t2063r2087b2088],
43	failure	NN	O	failure	appos	7	SENT_52	[p3l15t2104r98b2129],
44	of	IN	O	of	_	0	SENT_52	[p3l106t2104r133b2129],
45	these	DT	O	these	det	46	SENT_52	[p3l138t2104r211b2129],
46	medications	NNS	O	medication	prep_of	43	SENT_52	[p3l219t2104r381b2129],
47	in	IN	O	in	_	0	SENT_52	[p3l390t2106r412b2128],
48	preventing	VBG	O	prevent	prepc_in	46	SENT_52	[p3l422t2105r565b2135],
49	or	CC	O	or	_	0	SENT_52	[p3l574t2111r601b2129],
50	slowing	VBG	O	slow	prepc_in	46	SENT_52	[p3l609t2104r710b2135],
51	down	RP	O	down	prt	50	SENT_52	[p3l719t2104r794b2129],
52	the	DT	O	the	det	55	SENT_52	[p3l802t2104r845b2129],
53	purely	RB	O	purely	advmod	55	SENT_52	[p3l854t2104r937b2135],
54	progressive	JJ	O	progressive	amod	55	SENT_52	[p3l945t2105r1097b2135],
55	phase	NN	O	phase	dobj	50	SENT_52	[p3l1105t2104r1183b2135],
56	of	IN	O	of	_	0	SENT_52	[p3l1191t2104r1219b2129],
57	MS	NN	O	m	prep_of	55	SENT_52	[p3l1225t2105r1271b2132],
58	,	,	O	,	_	0	SENT_52	[p3l1225t2105r1271b2132],
59	and	CC	O	and	cc	3	SENT_52	[p3l1279t2104r1335b2132],
60	,	,	O	,	_	0	SENT_52	[p3l1279t2104r1335b2132],
61	last	JJ	O	last	dep	3	SENT_52	[p3l1344t2104r1393b2132],
62	,	,	O	,	_	0	SENT_52	[p3l1344t2104r1393b2132],
63	the	DT	O	the	det	67	SENT_52	[p3l1401t2104r1444b2129],
64	vast	JJ	O	vast	amod	67	SENT_52	[p3l1451t2108r1505b2129],
65	genetic	JJ	O	genetic	amod	67	SENT_52	[p3l1512t2105r1611b2135],
66	epidemiology	NN	O	epidemiology	nn	67	SENT_52	[p3l1619t2104r1804b2135],
67	studies	NNS	O	study	nsubj	76	SENT_52	[p3l1812t2104r1905b2129],
68	indicating	VBG	O	indicate	partmod	67	SENT_52	[p3l1914t2104r2045b2135],
69	multiple	JJ	O	multiple	amod	70	SENT_52	[p3l17t2145r127b2175],
70	pathways	NNS	O	pathway	dobj	68	SENT_52	[p3l135t2145r261b2176],
71	in	IN	O	in	_	0	SENT_52	[p3l270t2146r291b2169],
72	MS.	NNP	O	MS.	prep_in	68	SENT_52	[p3l301t2145r401b2169],
73	The	DT	O	the	det	74	SENT_52	[p3l301t2145r401b2169],
74	mechanisms	NNS	O	mechanism	nsubj	75	SENT_52	[p3l410t2145r575b2169],
75	illustrated	VBD	O	illustrate	dep	68	SENT_52	[p3l584t2145r714b2169],
76	represent	VBP	O	represent	ccomp	3	SENT_52	[p3l724t2149r850b2175],
77	a	DT	O	a	det	79	SENT_52	[p3l857t2152r870b2169],
78	combination	NN	O	combination	nn	79	SENT_52	[p3l879t2145r1048b2169],
79	ofall	NN	O	ofall	nsubj	81	SENT_52	[p3l1057t2145r1117b2169],
80	major	JJ	O	major	amod	81	SENT_52	[p3l1127t2146r1203b2176],
81	pathways	NNS	O	pathway	xcomp	76	SENT_52	[p3l1212t2145r1337b2176],
82	involved	VBN	O	involve	partmod	81	SENT_52	[p3l1346t2145r1457b2169],
83	in	IN	O	in	_	0	SENT_52	[p3l1466t2146r1488b2169],
84	MS	NN	O	m	nn	85	SENT_52	[p3l1498t2146r1537b2169],
85	pathogenesis	NN	O	pathogenesis	prep_in	82	SENT_52	[p3l1546t2145r1730b2176],
86	.	.	O	.	_	0	SENT_52	[p3l1546t2145r1730b2176],

1	Based	VBN	O	base	_	0	SENT_53	[p3l1739t2145r1815b2169],
2	on	IN	O	on	prepc_based_on	12	SENT_53	[p3l1824t2152r1857b2169],
3	the	DT	O	the	det	6	SENT_53	[p3l1865t2145r1908b2169],
4	known	JJ	O	known	amod	6	SENT_53	[p3l1917t2145r2006b2169],
5	interindividual	JJ	O	interindividual	amod	6	SENT_53	[p3l17t2186r208b2211],
6	heterogeneity	NN	O	heterogeneity	pobj	12	SENT_53	[p3l218t2186r406b2217],
7	of	IN	O	of	_	0	SENT_53	[p3l413t2186r441b2211],
8	MS	NN	O	m	prep_of	6	SENT_53	[p3l447t2187r493b2214],
9	,	,	O	,	_	0	SENT_53	[p3l447t2187r493b2214],
10	speciﬁc	NN	O	speciﬁc	nn	11	SENT_53	[p3l501t2186r599b2217],
11	mechanisms	NNS	O	mechanism	nsubj	12	SENT_53	[p3l608t2186r773b2211],
12	predominate	VBP	O	predominate	_	0	SENT_53	[p3l783t2186r954b2217],
13	in	IN	O	in	_	0	SENT_53	[p3l963t2187r985b2210],
14	an	DT	O	a	det	16	SENT_53	[p3l993t2193r1024b2211],
15	immunopattern-specific	JJ	O	immunopattern-specific	amod	16	SENT_53	[p3l1034t2186r1355b2217],
16	manner	NN	O	manner	prep_in	12	SENT_53	[p3l1364t2193r1466b2211],
17	during	IN	O	during	_	0	SENT_53	[p3l1474t2186r1561b2217],
18	new	JJ	O	new	amod	20	SENT_53	[p3l1571t2193r1626b2211],
19	lesion	NN	O	lesion	nn	20	SENT_53	[p3l1634t2186r1710b2211],
20	formation	NN	O	formation	prep_during	12	SENT_53	[p3l1718t2186r1857b2211],
21	.	.	O	.	_	0	SENT_53	[p3l1718t2186r1857b2211],

1	In	IN	O	in	_	0	SENT_54	[p3l1866t2187r1887b2210],
2	addition	NN	O	addition	prep_in	7	SENT_54	[p3l1896t2186r2014b2214],
3	,	,	O	,	_	0	SENT_54	[p3l1896t2186r2014b2214],
4	some	DT	O	some	det	5	SENT_54	[p3l2022t2193r2093b2211],
5	mechanisms	NNS	O	mechanism	nsubjpass	7	SENT_54	[p3l17t2227r183b2252],
6	are	VBP	O	be	auxpass	7	SENT_54	[p3l191t2234r231b2252],
7	tied	VBN	O	tie	_	0	SENT_54	[p3l238t2227r288b2252],
8	to	TO	O	to	_	0	SENT_54	[p3l296t2231r323b2252],
9	stages	NNS	O	stage	prep_to	7	SENT_54	[p3l331t2231r415b2258],
10	of	IN	O	of	_	0	SENT_54	[p3l423t2227r450b2252],
11	MS	NN	O	m	prep_of	9	SENT_54	[p3l456t2228r496b2252],
12	(	CD	NUMBER	(	num	11	SENT_54	[p3l504t2228r564b2258],
13	e.g.	FW	O	e.g.	dep	11	SENT_54	[p3l504t2228r564b2258],
14	,	,	O	,	_	0	SENT_54	[p3l504t2228r564b2258],
15	induction	NN	O	induction	prep_of	9	SENT_54	[p3l572t2227r698b2252],
16	of	IN	O	of	_	0	SENT_54	[p3l707t2227r735b2252],
17	MS	NN	O	m	prep_of	15	SENT_54	[p3l741t2228r787b2255],
18	,	,	O	,	_	0	SENT_54	[p3l741t2228r787b2255],
19	maintenance	NN	O	maintenance	prep_of	9	SENT_54	[p3l796t2228r969b2252],
20	of	IN	O	of	_	0	SENT_54	[p3l977t2227r1004b2252],
21	MS	NN	O	m	prep_of	19	SENT_54	[p3l1010t2228r1056b2255],
22	,	,	O	,	_	0	SENT_54	[p3l1010t2228r1056b2255],
23	provocation	NN	O	provocation	prep_of	9	SENT_54	[p3l1065t2229r1223b2258],
24	of	IN	O	of	_	0	SENT_54	[p3l1232t2227r1260b2252],
25	relapses	NNS	O	relapse	prep_of	23	SENT_54	[p3l1266t2227r1379b2258],
26	,	,	O	,	_	0	SENT_54	[p3l1266t2227r1379b2258],
27	induction	NN	O	induction	prep_of	9	SENT_54	[p3l1387t2227r1513b2252],
28	of	IN	O	of	_	0	SENT_54	[p3l1522t2227r1550b2252],
29	progressive	JJ	O	progressive	amod	30	SENT_54	[p3l1556t2228r1708b2258],
30	phase	NN	O	phase	prep_of	27	SENT_54	[p3l1717t2227r1801b2258],
31	,	,	O	,	_	0	SENT_54	[p3l1717t2227r1801b2258],
32	and	CC	O	and	_	0	SENT_54	[p3l1809t2227r1857b2252],
33	maintenance	NN	O	maintenance	conj_and	11	SENT_54	[p3l1867t2228r2040b2252],
34	of	IN	O	of	_	0	SENT_54	[p3l2048t2227r2075b2252],
35	progressive	JJ	O	progressive	amod	37	SENT_54	[p3l17t2269r169b2298],
36	phase	NN	O	phase	nn	37	SENT_54	[p3l178t2268r271b2298],
37	)	NN	O	)	prep_of	33	SENT_54	[p3l178t2268r271b2298],
38	.	.	O	.	_	0	SENT_54	[p3l178t2268r271b2298],

1	A	DT	O	a	det	5	SENT_55	[p3l279t2269r297b2292],
2	clear	JJ	O	clear	amod	5	SENT_55	[p3l304t2268r367b2292],
3	understanding	NN	O	understanding	nn	5	SENT_55	[p3l376t2268r570b2298],
4	ofthe	NN	O	ofthe	nn	5	SENT_55	[p3l579t2268r655b2292],
5	phases	NNS	O	phase	nsubj	16	SENT_55	[p3l664t2268r754b2298],
6	of	IN	O	of	_	0	SENT_55	[p3l762t2268r790b2292],
7	MS	NN	O	m	prep_of	5	SENT_55	[p3l796t2269r842b2295],
8	,	,	O	,	_	0	SENT_55	[p3l796t2269r842b2295],
9	as	IN	O	as	mark	10	SENT_55	[p3l850t2275r876b2292],
10	illustrated	VBN	O	illustrate	dep	5	SENT_55	[p3l885t2268r1015b2292],
11	in	IN	O	in	_	0	SENT_55	[p3l1025t2269r1046b2292],
12	Figure	NN	O	figure	prep_in	10	SENT_55	[p3l1056t2268r1145b2298],
13	2	CD	NUMBER	2	num	12	SENT_55	[p3l1153t2270r1175b2296],
14	,	,	O	,	_	0	SENT_55	[p3l1153t2270r1175b2296],
15	will	MD	O	will	aux	16	SENT_55	[p3l1183t2268r1226b2292],
16	aid	VB	O	aid	_	0	SENT_55	[p3l1235t2268r1274b2292],
17	in	IN	O	in	_	0	SENT_55	[p3l1283t2269r1305b2292],
18	choosing	VBG	O	choose	prepc_in	16	SENT_55	[p3l1314t2268r1435b2298],
19	the	DT	O	the	det	21	SENT_55	[p3l1443t2268r1486b2292],
20	best	JJS	O	best	amod	21	SENT_55	[p3l1495t2268r1550b2292],
21	medications	NNS	O	medication	dobj	18	SENT_55	[p3l1559t2268r1721b2292],
22	for	IN	O	for	_	0	SENT_55	[p3l1728t2268r1765b2292],
23	different	JJ	O	different	amod	24	SENT_55	[p3l1772t2268r1885b2292],
24	phases	NNS	O	phase	prep_for	21	SENT_55	[p3l1893t2268r1984b2298],
25	of	IN	O	of	_	0	SENT_55	[p3l1992t2268r2019b2292],
26	MS.	NNP	O	MS.	prep_of	24	SENT_55	[p3l2025t2269r2071b2292],
27	The	DT	O	the	det	28	SENT_55	[p3l15t2309r64b2334],
28	text	NN	O	text	nsubj	29	SENT_55	[p3l71t2313r123b2334],
29	discusses	VBZ	O	discuss	rcmod	21	SENT_55	[p3l130t2309r253b2334],
30	effects	NNS	O	effect	dobj	29	SENT_55	[p3l261t2309r348b2334],
31	of	IN	O	of	_	0	SENT_55	[p3l356t2309r383b2334],
32	medications	NNS	O	medication	prep_of	30	SENT_55	[p3l390t2309r558b2334],
33	.	.	O	.	_	0	SENT_55	[p3l390t2309r558b2334],

1	Although	IN	O	although	mark	6	SENT_56	[p3l565t2309r690b2340],
2	many	JJ	O	many	amod	4	SENT_56	[p3l700t2316r773b2340],
3	other	JJ	O	other	amod	4	SENT_56	[p3l780t2309r851b2334],
4	effects	NNS	O	effect	nsubj	6	SENT_56	[p3l859t2309r945b2334],
5	are	VBP	O	be	cop	6	SENT_56	[p3l953t2316r993b2334],
6	possible	JJ	O	possible	advcl	13	SENT_56	[p3l1002t2309r1116b2340],
7	,	,	O	,	_	0	SENT_56	[p3l1002t2309r1116b2340],
8	the	DT	O	the	det	11	SENT_56	[p3l1123t2309r1167b2334],
9	most	RBS	O	most	advmod	10	SENT_56	[p3l1176t2313r1241b2334],
10	likely	JJ	O	likely	amod	11	SENT_56	[p3l1250t2309r1316b2340],
11	ones	NNS	O	one	nsubjpass	13	SENT_56	[p3l1324t2316r1386b2334],
12	are	VBP	O	be	auxpass	13	SENT_56	[p3l1394t2316r1434b2334],
13	illustrated	VBN	O	illustrate	_	0	SENT_56	[p3l1443t2309r1580b2334],
14	.	.	O	.	_	0	SENT_56	[p3l1443t2309r1580b2334],

1	Most	JJS	O	most	nsubj	6	SENT_57	[p3l1589t2310r1654b2334],
2	of	IN	O	of	_	0	SENT_57	[p3l1661t2309r1689b2334],
3	the	DT	O	the	det	5	SENT_57	[p3l1693t2309r1737b2334],
4	medication	NN	O	medication	nn	5	SENT_57	[p3l1746t2309r1894b2334],
5	effects	NNS	O	effect	prep_of	1	SENT_57	[p3l1903t2309r1989b2334],
6	occur	VBP	O	occur	_	0	SENT_57	[p3l1998t2316r2071b2334],
7	outside	IN	O	outside	_	0	SENT_57	[p3l16t2350r115b2375],
8	the	DT	O	the	det	11	SENT_57	[p3l122t2350r165b2375],
9	central	JJ	O	central	amod	11	SENT_57	[p3l173t2350r262b2375],
10	nervous	JJ	O	nervous	amod	11	SENT_57	[p3l272t2357r378b2375],
11	system	NN	O	system	prep_outside	6	SENT_57	[p3l386t2354r484b2381],
12	,	,	O	,	_	0	SENT_57	[p3l386t2354r484b2381],
13	but	CC	O	but	_	0	SENT_57	[p3l493t2350r538b2375],
14	some	DT	O	some	det	15	SENT_57	[p3l545t2357r617b2375],
15	actions	NNS	O	action	nsubj	17	SENT_57	[p3l624t2351r719b2375],
16	may	MD	O	may	aux	17	SENT_57	[p3l728t2357r784b2381],
17	affect	VB	O	affect	conj_but	6	SENT_57	[p3l791t2350r864b2375],
18	the	DT	O	the	det	21	SENT_57	[p3l871t2350r915b2375],
19	central	JJ	O	central	amod	21	SENT_57	[p3l923t2350r1011b2375],
20	nervous	JJ	O	nervous	amod	21	SENT_57	[p3l1021t2357r1127b2375],
21	system	NN	O	system	dobj	17	SENT_57	[p3l1135t2350r1288b2381],
22	.	.	O	.	_	0	SENT_57	[p3l1135t2350r1288b2381],

1	The	DT	O	the	det	3	SENT_58	[p3l1135t2350r1288b2381],
2	neuroprotective	JJ	O	neuroprotective	amod	3	SENT_58	[p3l1297t2351r1511b2381],
3	effects	NNS	O	effect	nsubj	4	SENT_58	[p3l1518t2350r1605b2375],
4	suggested	VBD	O	suggest	_	0	SENT_58	[p3l1613t2350r1750b2381],
5	for	IN	O	for	mark	8	SENT_58	[p3l1758t2350r1795b2375],
6	some	DT	O	some	det	7	SENT_58	[p3l1802t2357r1874b2375],
7	medications	NNS	O	medication	nsubj	8	SENT_58	[p3l1883t2350r2044b2375],
8	(	VBP	O	(	advcl	4	SENT_58	[p3l2053t2351r2108b2378],
9	BG	NNP	O	BG	dobj	8	SENT_58	[p3l2053t2351r2108b2378],
10	—	CD	NUMBER	—	num	9	SENT_58	[p3l2053t2351r2108b2378],
11	12	CD	NUMBER	12	nsubjpass	18	SENT_58	[p3l18t2393r47b2415],
12	and	CC	O	and	_	0	SENT_58	[p3l55t2391r104b2415],
13	glatiramer	NN	O	glatiramer	nn	15	SENT_58	[p3l113t2391r250b2422],
14	acetate	NN	O	acetate	nn	15	SENT_58	[p3l257t2392r362b2419],
15	)	NN	O	)	conj_and	11	SENT_58	[p3l257t2392r362b2419],
16	are	VBP	O	be	auxpass	18	SENT_58	[p3l370t2398r410b2415],
17	not	RB	O	not	neg	18	SENT_58	[p3l419t2395r463b2415],
18	proven	VBN	O	prove	rcmod	9	SENT_58	[p3l472t2398r570b2422],
19	.	.	O	.	_	0	SENT_58	[p3l472t2398r570b2422],

1	However	RB	O	however	advmod	6	SENT_59	[p3l579t2393r701b2419],
2	,	,	O	,	_	0	SENT_59	[p3l579t2393r701b2419],
3	this	DT	O	this	det	4	SENT_59	[p3l708t2391r756b2415],
4	area	NN	O	area	nsubj	6	SENT_59	[p3l763t2398r818b2415],
5	may	MD	O	may	aux	6	SENT_59	[p3l828t2398r883b2422],
6	yield	VB	O	yield	_	0	SENT_59	[p3l889t2391r952b2422],
7	future	JJ	DATE	future	amod	8	SENT_59	[p3l960t2391r1040b2415],
8	success	NN	O	success	dobj	6	SENT_59	[p3l1048t2398r1147b2415],
9	in	IN	O	in	_	0	SENT_59	[p3l1156t2393r1177b2415],
10	helping	VBG	O	help	prepc_in	6	SENT_59	[p3l1187t2391r1286b2422],
11	MS	NN	O	m	nn	12	SENT_59	[p3l1296t2392r1335b2415],
12	patients	NNS	O	patient	dobj	10	SENT_59	[p3l1344t2393r1456b2421],
13	.	.	O	.	_	0	SENT_59	[p3l1344t2393r1456b2421],

1	B	NN	O	b	_	0	SENT_60	[p3l1466t2392r1486b2419],
2	,	,	O	,	_	0	SENT_60	[p3l1466t2392r1486b2419],
3	B	NN	O	b	nn	4	SENT_60	[p3l1495t2392r1510b2415],
4	cells	NNS	O	cell	appos	1	SENT_60	[p3l1518t2391r1580b2419],
5	;	:	O	;	_	0	SENT_60	[p3l1518t2391r1580b2419],
6	CD4	NN	O	cd4	dep	1	SENT_60	[p3l1588t2392r1649b2419],
7	,	,	O	,	_	0	SENT_60	[p3l1588t2392r1649b2419],
8	CD4	NN	O	cd4	dep	1	SENT_60	[p3l1657t2391r1818b2419],
9	+	CC	O	+	_	0	SENT_60	[p3l1657t2391r1818b2419],
10	Tce	NN	O	tce	conj_+	6	SENT_60	[p3l1657t2391r1818b2419],
11	|	CD	NUMBER	|	num	13	SENT_60	[p3l1657t2391r1818b2419],
12	|	NN	O	|	nn	13	SENT_60	[p3l1657t2391r1818b2419],
13	s	NNS	O	s	dep	6	SENT_60	[p3l1657t2391r1818b2419],
14	;	:	O	;	_	0	SENT_60	[p3l1657t2391r1818b2419],
15	CD8	NN	O	cd8	dep	6	SENT_60	[p3l1826t2392r1887b2419],
16	,	,	O	,	_	0	SENT_60	[p3l1826t2392r1887b2419],
17	CD8	NN	O	cd8	nn	20	SENT_60	[p3l1895t2391r1986b2415],
18	+	CC	O	+	_	0	SENT_60	[p3l1895t2391r1986b2415],
19	T	NN	O	t	conj_+	17	SENT_60	[p3l1895t2391r1986b2415],
20	cells	NNS	O	cell	appos	15	SENT_60	[p3l1993t2391r2056b2419],
21	;	:	O	;	_	0	SENT_60	[p3l1993t2391r2056b2419],
22	Mo	NN	PERSON	mo	dep	6	SENT_60	[p3l2064t2393r2111b2419],
23	,	,	O	,	_	0	SENT_60	[p3l2064t2393r2111b2419],
24	macrophage	NN	O	macrophage	appos	22	SENT_60	[p3l17t2433r192b2463],
25	;	:	O	;	_	0	SENT_60	[p3l17t2433r192b2463],
26	MS	NN	O	m	dep	6	SENT_60	[p3l200t2434r246b2460],
27	,	,	O	,	_	0	SENT_60	[p3l200t2434r246b2460],
28	multiple	JJ	O	multiple	amod	29	SENT_60	[p3l255t2433r364b2463],
29	sclerosis	NN	O	sclerosis	appos	26	SENT_60	[p3l372t2433r488b2460],
30	;	:	O	;	_	0	SENT_60	[p3l372t2433r488b2460],
31	NK	NN	O	nk	dep	6	SENT_60	[p3l497t2434r540b2460],
32	,	,	O	,	_	0	SENT_60	[p3l497t2434r540b2460],
33	natural	JJ	O	natural	amod	35	SENT_60	[p3l549t2433r640b2457],
34	killer	NN	O	killer	nn	35	SENT_60	[p3l650t2433r712b2457],
35	cells	NNS	O	cell	appos	31	SENT_60	[p3l719t2433r782b2460],
36	;	:	O	;	_	0	SENT_60	[p3l719t2433r782b2460],
37	NO	NN	O	no	dep	6	SENT_60	[p3l791t2434r837b2460],
38	,	,	O	,	_	0	SENT_60	[p3l791t2434r837b2460],
39	nitric	JJ	O	nitric	amod	40	SENT_60	[p3l846t2434r912b2457],
40	oxide	NN	O	oxide	appos	37	SENT_60	[p3l919t2433r998b2460],
41	;	:	O	;	_	0	SENT_60	[p3l919t2433r998b2460],
42	OG	NNP	O	OG	dep	6	SENT_60	[p3l1006t2434r1054b2460],
43	,	,	O	,	_	0	SENT_60	[p3l1006t2434r1054b2460],
44	oligodendrocytes	NNS	O	oligodendrocyte	appos	42	SENT_60	[p3l1062t2433r1302b2463],
45	;	:	O	;	_	0	SENT_60	[p3l1062t2433r1302b2463],
46	ROS	NN	O	ro	dep	6	SENT_60	[p3l1311t2434r1370b2460],
47	,	,	O	,	_	0	SENT_60	[p3l1311t2434r1370b2460],
48	reactive	JJ	O	reactive	amod	50	SENT_60	[p3l1379t2434r1482b2457],
49	oxygen	NN	O	oxygen	nn	50	SENT_60	[p3l1490t2440r1587b2463],
50	species	NNS	O	species	appos	46	SENT_60	[p3l1596t2434r1698b2463],
51	.	.	O	.	_	0	SENT_60	[p3l1596t2434r1698b2463],

1	All	DT	O	all	det	2	SENT_61	[p3l1705t2433r1737b2456],
2	cytokines	NNS	O	cytokine	nsubjpass	4	SENT_61	[p3l1746t2433r1872b2463],
3	are	VBP	O	be	auxpass	4	SENT_61	[p3l1880t2440r1920b2457],
4	labeled	VBN	O	label	_	0	SENT_61	[p3l1929t2433r2025b2457],
5	by	IN	O	by	_	0	SENT_61	[p3l2034t2433r2066b2463],
6	their	PRP$	O	they	poss	9	SENT_61	[p3l2072t2433r2134b2457],
7	common	JJ	O	common	amod	9	SENT_61	[p3l16t2472r135b2489],
8	immune	JJ	O	immune	amod	9	SENT_61	[p3l144t2466r255b2489],
9	nomenclature	NN	O	nomenclature	agent	4	SENT_61	[p3l264t2465r455b2489],
10	.	.	O	.	_	0	SENT_61	[p3l264t2465r455b2489],

1	the	DT	O	the	det	5	SENT_62	[p3l16t2564r69b2595],
2	neurodegenerative	JJ	O	neurodegenerative	amod	5	SENT_62	[p3l81t2564r409b2605],
3	,	,	O	,	_	0	SENT_62	[p3l81t2564r409b2605],
4	progressive	JJ	O	progressive	amod	5	SENT_62	[p3l421t2567r615b2605],
5	component	NN	O	component	nsubj	23	SENT_62	[p3l628t2570r822b2605],
6	of	IN	O	of	_	0	SENT_62	[p3l834t2564r871b2595],
7	MS	NN	O	m	prep_of	5	SENT_62	[p3l878t2566r944b2599],
8	,	,	O	,	_	0	SENT_62	[p3l878t2566r944b2599],
9	these	DT	O	these	appos	7	SENT_62	[p3l957t2564r1044b2595],
10	to	TO	O	to	aux	11	SENT_62	[p3l1106t2570r1138b2595],
11	incorporate	VB	O	incorporate	infmod	5	SENT_62	[p3l1150t2567r1346b2605],
12	developments	NNS	O	development	dobj	11	SENT_62	[p3l1358t2564r1592b2605],
13	of	IN	O	of	_	0	SENT_62	[p3l1604t2564r1640b2595],
14	the	DT	DURATION	the	det	17	SENT_62	[p3l1646t2564r1699b2595],
15	past	JJ	DURATION	past	amod	17	SENT_62	[p3l1709t2570r1778b2605],
16	20	CD	DURATION	20	num	17	SENT_62	[p3l1789t2567r1827b2595],
17	years	NNS	NUMBER	year	prep_of	12	SENT_62	[p3l1838t2575r1924b2605],
18	into	IN	O	into	_	0	SENT_62	[p3l1936t2567r2002b2595],
19	clinical	JJ	O	clinical	amod	20	SENT_62	[p3l2014t2564r2135b2595],
20	treatments	NNS	O	treatment	prep_into	11	SENT_62	[p3l16t2620r196b2645],
21	have	VBP	O	have	aux	23	SENT_62	[p3l207t2614r284b2645],
22	nevertheless	RB	O	nevertheless	advmod	23	SENT_62	[p3l295t2614r503b2645],
23	proven	VBN	O	prove	_	0	SENT_62	[p3l514t2625r631b2655],
24	successful	JJ	O	successful	acomp	23	SENT_62	[p3l643t2614r811b2645],
25	in	IN	O	in	_	0	SENT_62	[p3l822t2617r855b2645],
26	decreasing	VBG	O	decrease	prepc_in	24	SENT_62	[p3l866t2614r1046b2655],
27	care	NN	O	care	dobj	26	SENT_62	[p3l1106t2625r1182b2649],
28	,	,	O	,	_	0	SENT_62	[p3l1106t2625r1182b2649],
29	we	PRP	O	we	nsubj	30	SENT_62	[p3l1193t2625r1239b2645],
30	present	VBP	DATE	present	parataxis	26	SENT_62	[p3l1249t2620r1373b2655],
31	one	CD	NUMBER	one	num	33	SENT_62	[p3l1383t2625r1443b2645],
32	possible	JJ	O	possible	amod	33	SENT_62	[p3l1454t2614r1589b2655],
33	approach	NN	O	approach	dobj	30	SENT_62	[p3l1600t2614r1764b2655],
34	,	,	O	,	_	0	SENT_62	[p3l1600t2614r1764b2655],
35	certainly	RB	O	certainly	prep	26	SENT_62	[p3l1776t2614r1924b2655],
36	not	RB	O	not	neg	35	SENT_62	[p3l1933t2620r1989b2645],
37	the	DT	O	the	det	39	SENT_62	[p3l1999t2614r2051b2645],
38	only	JJ	O	only	amod	39	SENT_62	[p3l2062t2614r2136b2655],
39	inﬂammation	NN	O	inﬂammation	pobj	35	SENT_62	[p3l16t2664r242b2695],
40	and	CC	O	and	_	0	SENT_62	[p3l252t2664r313b2695],
41	preventing	VBG	O	prevent	prepc_in	24	SENT_62	[p3l323t2667r501b2705],
42	relapses	NNS	O	relapse	dobj	41	SENT_62	[p3l511t2664r648b2705],
43	.	.	O	.	_	0	SENT_62	[p3l511t2664r648b2705],

1	approach	NN	O	approach	_	0	SENT_63	[p3l1106t2664r1274b2705],
2	,	,	O	,	_	0	SENT_63	[p3l1106t2664r1274b2705],
3	to	TO	O	to	dep	1	SENT_63	[p3l1288t2670r1321b2695],
4	MS	NN	O	m	nn	5	SENT_63	[p3l1334t2666r1390b2695],
5	management	NN	O	management	pobj	3	SENT_63	[p3l1404t2670r1635b2705],
6	.	.	O	.	_	0	SENT_63	[p3l1404t2670r1635b2705],

1	We	PRP	O	we	nsubj	3	SENT_64	[p3l1649t2666r1703b2695],
2	would	MD	O	would	aux	3	SENT_64	[p3l1716t2664r1823b2695],
3	like	VB	O	like	_	0	SENT_64	[p3l1835t2664r1896b2695],
4	to	TO	O	to	aux	5	SENT_64	[p3l1909t2670r1942b2695],
5	emphasize	VB	O	emphasize	xcomp	3	SENT_64	[p3l1956t2664r2135b2705],
6	Selecting	VBG	O	select	xcomp	5	SENT_64	[p3l52t2714r206b2755],
7	disease-modifying	JJ	O	disease-modifying	amod	8	SENT_64	[p3l217t2714r532b2755],
8	agents	NNS	O	agent	nsubj	9	SENT_64	[p3l544t2720r650b2755],
9	(	VBP	O	(	ccomp	6	SENT_64	[p3l664t2714r801b2751],
10	DMAs	NNS	O	dma	dobj	9	SENT_64	[p3l664t2714r801b2751],
11	)	CD	NUMBER	)	num	10	SENT_64	[p3l664t2714r801b2751],
12	from	IN	O	from	_	0	SENT_64	[p3l815t2714r898b2745],
13	the	DT	O	the	det	14	SENT_64	[p3l910t2714r963b2745],
14	cur	NN	O	cur	prep_from	10	SENT_64	[p3l975t2725r1044b2745],
15	-	:	O	-	_	0	SENT_64	[p3l975t2725r1044b2745],
16	that	IN	O	that	complm	23	SENT_64	[p3l1106t2714r1169b2745],
17	ﬂexibility	NN	O	ﬂexibility	nsubj	23	SENT_64	[p3l1179t2714r1333b2755],
18	and	CC	O	and	_	0	SENT_64	[p3l1342t2714r1402b2745],
19	openness	NN	O	openness	conj_and	17	SENT_64	[p3l1412t2725r1563b2755],
20	to	TO	O	to	aux	21	SENT_64	[p3l1573t2720r1604b2745],
21	change	VB	O	change	infmod	17	SENT_64	[p3l1616t2714r1729b2755],
22	will	MD	O	will	aux	23	SENT_64	[p3l1739t2714r1799b2745],
23	alleviate	VB	O	alleviate	ccomp	9	SENT_64	[p3l1809t2714r1941b2745],
24	patient	NN	O	patient	dobj	23	SENT_64	[p3l1951t2717r2065b2755],
25	and	CC	O	and	_	0	SENT_64	[p3l2075t2714r2136b2745],
26	rently	RB	O	rently	advmod	27	SENT_64	[p3l16t2764r110b2805],
27	available	JJ	O	available	amod	28	SENT_64	[p3l117t2764r254b2795],
28	array	NN	O	array	nsubj	29	SENT_64	[p3l263t2775r346b2805],
29	requires	VBZ	O	require	ccomp	9	SENT_64	[p3l353t2767r481b2805],
30	a	DT	O	a	det	32	SENT_64	[p3l490t2775r507b2795],
31	tiered	JJ	O	tiered	amod	32	SENT_64	[p3l515t2764r607b2795],
32	approach	NN	O	approach	dobj	29	SENT_64	[p3l616t2764r771b2805],
33	.	.	O	.	_	0	SENT_64	[p3l616t2764r771b2805],

1	To	TO	O	to	aux	2	SENT_65	[p3l781t2765r821b2795],
2	illustrate	VB	O	illustrate	_	0	SENT_65	[p3l830t2764r968b2795],
3	how	WRB	O	how	advmod	10	SENT_65	[p3l976t2764r1046b2795],
4	physician	NN	O	physician	nn	5	SENT_65	[p3l1105t2764r1265b2805],
5	frustration	NN	O	frustration	nsubj	10	SENT_65	[p3l1276t2764r1456b2795],
6	as	IN	O	as	_	0	SENT_65	[p3l1467t2775r1499b2795],
7	new	JJ	O	new	amod	8	SENT_65	[p3l1510t2775r1580b2795],
8	options	NNS	O	option	prep_as	5	SENT_65	[p3l1589t2767r1714b2805],
9	become	VBP	O	become	cop	10	SENT_65	[p3l1724t2764r1855b2795],
10	available	JJ	O	available	ccomp	2	SENT_65	[p3l1866t2764r2010b2795],
11	for	IN	O	for	_	0	SENT_65	[p3l2021t2764r2068b2795],
12	MS	NN	O	m	prep_for	10	SENT_65	[p3l2079t2766r2134b2795],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_66	[p3l16t2870r136b2891],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	12	SENT_66	[p3l145t2870r369b2891],
3	&	CC	O	&	_	0	SENT_66	[p3l376t2870r596b2891],
4	THERAPEUT	NNP	O	THERAPEUT	nn	6	SENT_66	[p3l376t2870r596b2891],
5	|	CD	NUMBER	|	num	6	SENT_66	[p3l376t2870r596b2891],
6	CS	NNP	O	CS	conj_and	2	SENT_66	[p3l376t2870r596b2891],
7	[	CD	NUMBER	[	num	8	SENT_66	[p3l606t2868r724b2898],
8	VOLUME	NNP	O	VOLUME	dep	2	SENT_66	[p3l606t2868r724b2898],
9	95	CD	NUMBER	95	num	8	SENT_66	[p3l732t2870r760b2891],
10	NUMBER	NN	O	number	dep	12	SENT_66	[p3l770t2870r877b2891],
11	1	CD	NUMBER	1	num	10	SENT_66	[p3l887t2871r894b2891],
12	|	CD	NUMBER	|	dep	15	SENT_66	[p3l908t2868r910b2898],
13	JANUARY	NNP	DATE	JANUARY	dep	12	SENT_66	[p3l919t2870r1037b2891],
14	2014	CD	DATE	2014	num	15	SENT_66	[p3l1045t2870r1103b2891],
15	33	CD	DATE	33	_	0	SENT_66	[p3l2105t2870r2135b2891],

1	STATE	NN	O	state	nn	2	SENT_67	[p3l21t3013r163b3050],
2	ART	NN	O	art	_	0	SENT_67	[p3l305t3013r399b3050],

1	Phases	NNS	O	phase	_	0	SENT_68	[p3l824t3165r907b3184],
2	of	IN	O	of	_	0	SENT_68	[p3l915t3165r935b3184],
3	multiple	JJ	O	multiple	amod	4	SENT_68	[p3l944t3165r1030b3189],
4	sclerosis	NN	O	sclerosis	prep_of	1	SENT_68	[p3l1038t3165r1136b3184],
5	-	:	O	-	_	0	SENT_68	[p3l1145t3175r1152b3178],
6	defined	VBN	O	define	partmod	4	SENT_68	[p3l1160t3165r1242b3184],
7	as	IN	O	as	_	0	SENT_68	[p3l1251t3170r1277b3184],
8	of	IN	O	of	prepc_as_of	6	SENT_68	[p3l1285t3165r1306b3184],
9	2013	CD	DATE	2013	pobj	6	SENT_68	[p3l1313t3165r1369b3184],

1	Incidentally	RB	O	incidentally	advmod	2	SENT_69	[p3l414t3202r539b3227],
2	discovered	VBN	O	discover	amod	4	SENT_69	[p3l548t3202r668b3222],
3	white	JJ	O	white	amod	4	SENT_69	[p3l677t3202r735b3222],
4	matter	NN	O	matter	_	0	SENT_69	[p3l744t3204r816b3222],
5	‘	CD	NUMBER	‘	num	6	SENT_69	[p3l844t3196r907b3230],
6	Dissemination	NN	O	dissemination	npadvmod	4	SENT_69	[p3l1107t3205r1265b3224],
7	in	IN	O	in	_	0	SENT_69	[p3l1274t3205r1291b3224],
8	space	NN	O	space	nn	9	SENT_69	[p3l1300t3199r1378b3229],
9	‘	NN	O	‘	prep_in	6	SENT_69	[p3l1300t3199r1378b3229],
10	of	IN	O	of	_	0	SENT_69	[p3l1386t3204r1406b3224],
11	lesions	NNS	O	lesion	prep_of	9	SENT_69	[p3l1415t3205r1492b3224],
12	in	IN	O	in	_	0	SENT_69	[p3l1501t3205r1519b3224],
13	MRI	NNP	O	MRI	nn	14	SENT_69	[p3l1529t3205r1572b3224],
14	changes	NNS	O	change	prep_in	11	SENT_69	[p3l429t3233r525b3257],
15	in	IN	O	in	_	0	SENT_69	[p3l534t3233r551b3252],
16	an	DT	O	a	det	17	SENT_69	[p3l560t3238r586b3252],
17	MRI	NNP	MISC	MRI	prep_in	4	SENT_69	[p3l596t3233r640b3252],
18	suggestive	JJ	O	suggestive	amod	17	SENT_69	[p3l649t3233r769b3257],
19	of	IN	O	of	_	0	SENT_69	[p3l778t3233r798b3252],
20	i	FW	O	i	nn	23	SENT_69	[p3l1325t3240r1357b3264],
21	demyelmatmg	FW	O	demyelmatmg	nn	23	SENT_69	[p3l484t3263r638b3288],
22	disease	NN	O	disease	nn	23	SENT_69	[p3l647t3263r734b3283],
23	Dissemination	NN	O	dissemination	prep_of	18	SENT_69	[p3l1014t3283r1171b3302],
24	in	IN	O	in	_	0	SENT_69	[p3l1181t3283r1198b3302],
25	timel	NN	O	timel	prep_in	23	SENT_69	[p3l1207t3277r1264b3302],
26	of	IN	O	of	_	0	SENT_69	[p3l1273t3283r1293b3302],
27	lesions	NNS	O	lesion	prep_of	25	SENT_69	[p3l1302t3283r1379b3302],
28	in	IN	O	in	_	0	SENT_69	[p3l1388t3283r1405b3302],
29	MRI	NNP	O	MRI	prep_in	27	SENT_69	[p3l1415t3283r1459b3302],
30	if	IN	O	if	_	0	SENT_69	[p3l1467t3283r1507b3305],
31	Positive	JJ	O	positive	amod	33	SENT_69	[p3l1514t3283r1598b3307],
32	CSF	NN	O	csf	nn	33	SENT_69	[p3l1607t3277r1667b3302],
33	*	NN	O	*	prep_if	4	SENT_69	[p3l1607t3277r1667b3302],

1	is	VBZ	O	be	cop	2	SENT_70	[p3l1027t3320r1059b3342],
2	RIS	NNP	O	RIS	_	0	SENT_70	[p3l1022t3361r1062b3381],
3	‘	CD	NUMBER	‘	num	2	SENT_70	[p3l1110t3354r1172b3388],
4	No	DT	O	no	det	7	SENT_70	[p3l1286t3360r1315b3379],
5	proven	JJ	O	proven	amod	7	SENT_70	[p3l1325t3365r1399b3384],
6	prophylactic	NN	O	prophylactic	nn	7	SENT_70	[p3l1409t3360r1542b3384],
7	treatment	NN	O	treatment	dep	2	SENT_70	[p3l1551t3362r1657b3379],
8	I	PRP	O	I	nsubj	2	SENT_70	[p3l1767t3358r1768b3373],

1	CIS	NN	ORGANIZATION	ci	dep	8	SENT_71	[p4l761t40r802b60],
2	‘	CD	NUMBER	‘	num	5	SENT_71	[p4l847t32r910b66],
3	Previous	JJ	O	previous	amod	5	SENT_71	[p4l936t41r1032b60],
4	Ft	NN	O	ft	nn	5	SENT_71	[p4l1042t40r1082b60],
5	|	NN	O	|	dep	1	SENT_71	[p4l1042t40r1082b60],
6	S	NN	O	s	dep	8	SENT_71	[p4l1042t40r1082b60],
7	‘	CD	NUMBER	‘	num	6	SENT_71	[p4l1113t32r1175b64],
8	SAMS	NNP	O	SAMS	dep	18	SENT_71	[p4l1214t40r1287b60],
9	‘	CD	NUMBER	‘	num	8	SENT_71	[p4l1330t32r1393b66],
10	Acute	JJ	O	acute	amod	11	SENT_71	[p4l1414t38r1477b57],
11	treatment	NN	O	treatment	dep	8	SENT_71	[p4l1486t39r1593b57],
12	of	IN	O	of	_	0	SENT_71	[p4l1602t38r1621b57],
13	reIapses	NNP	O	reIapses	prep_of	11	SENT_71	[p4l1631t38r1748b62],
14	&	CC	O	&	_	0	SENT_71	[p4l1631t38r1748b62],
15	_	NNP	O	_	prep_of	11	SENT_71	[p4l767t76r795b98],
16	‘	CD	NUMBER	‘	number	17	SENT_71	[p4l767t76r795b98],
17	7	CD	NUMBER	7	num	18	SENT_71	[p4l1236t97r1241b98],
18	Treatment	NN	O	treatment	dep	26	SENT_71	[p4l1431t69r1543b87],
19	for	IN	O	for	_	0	SENT_71	[p4l1551t69r1579b87],
20	prevention	NN	O	prevention	prep_for	18	SENT_71	[p4l1588t69r1702b92],
21	of	IN	O	of	_	0	SENT_71	[p4l1712t69r1732b87],
22	_	CD	NUMBER	_	num	23	SENT_71	[p4l758t117r761b120],
23	_	CD	NUMBER	_	prep_of	20	SENT_71	[p4l825t117r828b120],
24	_	CD	NUMBER	_	num	26	SENT_71	[p4l866t117r869b120],
25	_	NN	O	_	nn	26	SENT_71	[p4l907t117r910b120],
26	T	NN	O	t	_	0	SENT_71	[p4l1001t111r1010b128],
27	_	CD	NUMBER	_	num	28	SENT_71	[p4l1080t117r1083b120],
28	reiapses	NNS	O	reiaps	dep	26	SENT_71	[p4l1535t99r1650b132],
29	_	IN	O	_	dep	26	SENT_71	[p4l1535t99r1650b132],

1	I	PRP	O	I	dep	8	SENT_72	[p4l1235t80r1267b242],
2	to	TO	O	to	_	0	SENT_72	[p4l1440t130r1722b154],
3	5	CD	NUMBER	5	prep_to	1	SENT_72	[p4l443t174r563b199],
4	'	''	O	'	_	0	SENT_72	[p4l443t174r563b199],
5	-199	CD	NUMBER	-199	dep	3	SENT_72	[p4l443t174r563b199],
6	eS	NN	O	e	dep	8	SENT_72	[p4l443t174r563b199],
7	“	CD	NUMBER	“	num	6	SENT_72	[p4l443t174r563b199],
8	Ve	FW	O	ve	dep	12	SENT_72	[p4l443t174r563b199],
9	°	FW	O	°	nn	11	SENT_72	[p4l572t174r592b194],
10	f	FW	O	f	nn	11	SENT_72	[p4l572t174r592b194],
11	potentials	NNS	O	potential	dep	8	SENT_72	[p4l895t178r1003b202],
12	inflammatorydemyelination	NN	O	inflammatorydemyelination	dep	14	SENT_72	[p4l441t205r594b229, p4l430t236r605b260],
13	“	CD	NUMBER	“	num	12	SENT_72	[p4l441t205r594b229, p4l430t236r605b260],
14	J’	NN	O	j’	_	0	SENT_72	[p4l767t222r795b244],

1	Dissemination	NN	O	dissemination	_	0	SENT_73	[p4l792t263r949b282],
2	in	IN	O	in	_	0	SENT_73	[p4l959t263r976b282],
3	timel	NN	O	timel	prep_in	1	SENT_73	[p4l985t257r1043b282],
4	of	IN	O	of	_	0	SENT_73	[p4l1051t263r1071b282],
5	lesions	NNS	O	lesion	prep_of	3	SENT_73	[p4l1080t263r1157b282],
6	by	IN	O	by	_	0	SENT_73	[p4l1166t263r1191b287],
7	MRI	NNP	O	MRI	prep_by	5	SENT_73	[p4l1200t263r1243b282],
8	2nd	JJ	ORDINAL	2nd	amod	11	SENT_73	[p4l767t330r808b349],
9	attack	NN	O	attack	nn	11	SENT_73	[p4l817t330r883b349],
10	(	NN	O	(	nn	11	SENT_73	[p4l892t329r1015b354],
11	propective	NN	O	propective	dep	1	SENT_73	[p4l892t329r1015b354],
12	or	CC	O	or	_	0	SENT_73	[p4l1025t334r1049b349],
13	objective	JJ	O	objective	amod	15	SENT_73	[p4l1054t330r1152b354],
14	historical	JJ	O	historical	amod	15	SENT_73	[p4l1162t329r1268b354],
15	)	NN	O	)	dep	1	SENT_73	[p4l1162t329r1268b354],
16	;	:	O	;	_	0	SENT_73	[p4l1330t320r1393b354],
17	RRMS	NNS	O	rrm	dep	11	SENT_73	[p4l1443t328r1516b348],

1	Previous	JJ	O	previous	amod	2	SENT_74	[p4l759t408r854b427],
2	RRMS	NNS	O	rrm	_	0	SENT_74	[p4l864t407r936b427],
3	"	``	O	"	punct	2	SENT_74	[p4l989t402r1051b434],
4	SPMS	NNP	O	SPMS	nn	5	SENT_74	[p4l1104t407r1175b427],
5	Ongoing	NNP	O	Ongoing	dep	2	SENT_74	[p4l1386t420r1481b445],
6	clinical	JJ	O	clinical	amod	7	SENT_74	[p4l1489t420r1564b440],
7	relapses	NNS	O	relapse	dep	2	SENT_74	[p4l1574t420r1668b445],
8	O/F	NN	O	o/f	dep	7	SENT_74	[p4l1676t420r1716b442],
9	?	.	O	?	_	0	SENT_74	[p4l1676t420r1716b442],

1	Insidious	JJ	O	insidious	_	0	SENT_75	[p4l434t447r532b466],
2	onset	NN	O	onset	dep	1	SENT_75	[p4l541t448r602b466],
3	,	,	O	,	_	0	SENT_75	[p4l1245t464r1260b465],
4	,	,	O	,	_	0	SENT_75	[p4l1245t464r1260b465],
5	,	,	O	,	_	0	SENT_75	[p4l1283t464r1288b465],
6	progressive	JJ	O	progressive	dep	9	SENT_75	[p4l453t477r582b502],
7	Previous	JJ	O	previous	amod	9	SENT_75	[p4l760t466r856b486],
8	SAMS	NN	O	sam	nn	9	SENT_75	[p4l865t466r935b486],
9	j	NN	O	j	dep	1	SENT_75	[p4l989t460r1051b492],
10	SAPMS	NNP	O	SAPMS	nn	11	SENT_75	[p4l1095t464r1184b484],
11	Evidence	NN	O	evidence	dep	9	SENT_75	[p4l1361t470r1463b489],
12	of	IN	O	of	_	0	SENT_75	[p4l1472t469r1492b489],
13	new	JJ	O	new	amod	15	SENT_75	[p4l1501t474r1546b489],
14	lesion	NN	O	lesion	nn	15	SENT_75	[p4l1555t470r1618b489],
15	picai	NN	O	picaus	prep_of	1	SENT_75	[p4l1661t470r1711b494],
16	of	IN	O	of	prep	1	SENT_75	[p4l1720t469r1740b489],

1	MS	NN	O	m	nsubj	7	SENT_76	[p4l1431t500r1467b520],
2	in	IN	O	in	_	0	SENT_76	[p4l1477t500r1494b519],
3	follow	VB	O	follow	prepc_in	1	SENT_76	[p4l1502t500r1602b525],
4	—	CD	NUMBER	—	npadvmod	5	SENT_76	[p4l1502t500r1602b525],
5	up	IN	O	up	advmod	3	SENT_76	[p4l1502t500r1602b525],
6	Is	VBZ	O	be	cop	7	SENT_76	[p4l1652t500r1669b520],
7	neurological	JJ	O	neurological	_	0	SENT_76	[p4l450t508r585b532],
8	.	.	O	.	_	0	SENT_76	[p4l826t521r829b524],

1	dysfunction	NN	O	dysfunction	nsubj	6	SENT_77	[p4l422t538r549b563],
2	of	IN	O	of	_	0	SENT_77	[p4l558t538r578b558],
3	21	CD	NUMBER	21	num	5	SENT_77	[p4l586t539r609b558],
4	Previous	JJ	O	previous	amod	5	SENT_77	[p4l775t521r871b541],
5	FIIS	NNS	O	fii	prep_of	1	SENT_77	[p4l880t521r920b541],
6	‘	VBP	O	‘	_	0	SENT_77	[p4l989t514r1051b548],
7	PPMS	NN	O	ppm	nn	8	SENT_77	[p4l1105t520r1175b540],
8	year	NN	DURATION	year	nsubj	9	SENT_77	[p4l478t569r556b594],
9	***	CD	NUMBER	***	xcomp	6	SENT_77	[p4l478t569r556b594],
10	i	FW	O	i	dep	9	SENT_77	[p4l1126t560r1156b582],

1	2	CD	TIME	2	number	3	SENT_78	[p4l820t603r832b621],
2	of	IN	TIME	of	quantmod	3	SENT_78	[p4l841t602r862b621],
3	3	CD	TIME	3	_	0	SENT_78	[p4l870t603r882b622],
4	of	IN	O	of	_	0	SENT_78	[p4l891t602r911b621],
5	the	DT	O	the	det	6	SENT_78	[p4l919t602r953b621],
6	following	NN	O	following	prep_of	3	SENT_78	[p4l961t602r1064b627],
7	:	:	O	:	_	0	SENT_78	[p4l961t602r1064b627],
8	21	CD	NUMBER	21	num	10	SENT_78	[p4l1073t603r1096b621],
9	T2	NN	O	t2	nn	10	SENT_78	[p4l1106t602r1135b621],
10	lesions	NNS	O	lesion	nsubj	17	SENT_78	[p4l1144t602r1222b621],
11	in	IN	O	in	_	0	SENT_78	[p4l1231t602r1248b621],
12	21	CD	TIME	21	prep_in	10	SENT_78	[p4l1257t603r1280b621],
13	of	IN	TIME	of	_	0	SENT_78	[p4l1292t602r1313b621],
14	3	CD	TIME	3	num	16	SENT_78	[p4l1321t603r1334b622],
15	brain	NN	O	brain	nn	16	SENT_78	[p4l1343t602r1397b621],
16	areas	NNS	O	area	prep_of	12	SENT_78	[p4l1406t607r1468b621],
17	(	VBP	O	(	rcmod	6	SENT_78	[p4l1478t602r1649b626],
18	periventricular	JJ	O	periventricular	amod	24	SENT_78	[p4l1478t602r1649b626],
19	,	,	O	,	_	0	SENT_78	[p4l1478t602r1649b626],
20	juxtacortical	JJ	O	juxtacortical	amod	24	SENT_78	[p4l780t633r922b657],
21	,	,	O	,	_	0	SENT_78	[p4l780t633r922b657],
22	infratentorial	JJ	O	infratentorial	amod	24	SENT_78	[p4l932t632r1078b657],
23	)	NN	O	)	nn	24	SENT_78	[p4l932t632r1078b657],
24	O_FI	NN	O	o_fi	dobj	17	SENT_78	[p4l1087t632r1127b655],
25	22	CD	NUMBER	22	num	27	SENT_78	[p4l1133t633r1159b652],
26	T2	NN	O	t2	nn	27	SENT_78	[p4l1166t633r1195b652],
27	lesions	NNS	O	lesion	npadvmod	17	SENT_78	[p4l1205t633r1282b652],
28	in	IN	O	in	_	0	SENT_78	[p4l1291t633r1308b652],
29	the	DT	O	the	det	32	SENT_78	[p4l1317t633r1351b652],
30	spinal	JJ	O	spinal	amod	32	SENT_78	[p4l1360t633r1424b657],
31	cord	NN	O	cord	nn	32	SENT_78	[p4l1433t633r1481b652],
32	o	NN	O	o	prep_in	17	SENT_78	[p4l1489t632r1529b655],
33	;	:	O	;	_	0	SENT_78	[p4l1489t632r1529b655],
34	?	.	O	?	_	0	SENT_78	[p4l1489t632r1529b655],

1	Positive	JJ	O	positive	amod	3	SENT_79	[p4l1536t633r1620b657],
2	CSF	NN	O	csf	nn	3	SENT_79	[p4l1629t627r1689b652],
3	*	NN	O	*	_	0	SENT_79	[p4l1629t627r1689b652],

1	Figure	NN	O	figure	_	0	SENT_80	[p4l21t733r111b763],
2	2	CD	NUMBER	2	num	4	SENT_80	[p4l119t734r134b756],
3	Different	JJ	O	different	amod	4	SENT_80	[p4l159t732r275b757],
4	phases	NNS	O	phase	dep	1	SENT_80	[p4l283t732r373b763],
5	of	IN	O	of	_	0	SENT_80	[p4l381t732r409b756],
6	MS	NN	O	m	prep_of	4	SENT_80	[p4l415t733r454b756],
7	ranging	VBG	O	range	partmod	1	SENT_80	[p4l463t733r564b763],
8	from	IN	O	from	_	0	SENT_80	[p4l572t732r634b756],
9	asymptomatic	JJ	O	asymptomatic	prep_from	7	SENT_80	[p4l643t733r833b763],
10	to	TO	O	to	_	0	SENT_80	[p4l840t736r867b756],
11	progressive	JJ	O	progressive	amod	12	SENT_80	[p4l876t733r1027b763],
12	disease	NN	O	disease	prep_to	7	SENT_80	[p4l1035t732r1138b757],
13	.	.	O	.	_	0	SENT_80	[p4l1035t732r1138b757],

1	We	PRP	O	we	nsubj	2	SENT_81	[p4l1145t733r1186b757],
2	utilize	VBP	O	utilize	_	0	SENT_81	[p4l1195t732r1272b757],
3	these	DT	O	these	det	5	SENT_81	[p4l1279t732r1352b756],
4	diagnostic	JJ	O	diagnostic	amod	5	SENT_81	[p4l1359t732r1497b763],
5	criteria	NNS	O	criterion	nsubj	31	SENT_81	[p4l1505t733r1602b760],
6	,	,	O	,	_	0	SENT_81	[p4l1505t733r1602b760],
7	which	WDT	O	which	dobj	9	SENT_81	[p4l1610t732r1689b757],
8	we	PRP	O	we	nsubj	9	SENT_81	[p4l1697t739r1735b756],
9	modified	VBN	O	modify	rcmod	5	SENT_81	[p4l1744t732r1862b757],
10	from	IN	O	from	_	0	SENT_81	[p4l1870t732r1932b756],
11	the	DT	O	the	det	14	SENT_81	[p4l1940t732r1983b756],
12	2010	CD	DATE	2010	num	14	SENT_81	[p4l1991t734r2056b756],
13	McDonald	NNP	ORGANIZATION	McDonald	nn	14	SENT_81	[p4l21t773r156b797],
14	criteria	NNS	O	criterion	prep_from	9	SENT_81	[p4l165t775r255b797],
15	for	IN	O	for	_	0	SENT_81	[p4l263t773r300b797],
16	diagnosis	NN	O	diagnosis	nn	18	SENT_81	[p4l307t773r432b804],
17	ofeach	NN	O	ofeach	nn	18	SENT_81	[p4l440t773r534b797],
18	phase	NN	O	phase	prep_for	9	SENT_81	[p4l544t773r622b803],
19	of	IN	O	of	_	0	SENT_81	[p4l630t773r657b797],
20	MS.	NNP	O	MS.	nn	27	SENT_81	[p4l663t774r709b797],
21	*	NNP	O	*	nn	27	SENT_81	[p4l717t773r861b797],
22	|	NN	O	|	nn	27	SENT_81	[p4l717t773r861b797],
23	ncidenta	NN	O	ncidenta	nn	27	SENT_81	[p4l717t773r861b797],
24	|	NN	O	|	nn	27	SENT_81	[p4l717t773r861b797],
25	white	JJ	O	white	amod	27	SENT_81	[p4l869t773r944b797],
26	matter	NN	O	matter	nn	27	SENT_81	[p4l952t777r1040b797],
27	changes	NNS	O	change	prep_of	18	SENT_81	[p4l1047t773r1158b804],
28	in	IN	O	in	_	0	SENT_81	[p4l1167t775r1188b797],
29	an	DT	O	a	det	30	SENT_81	[p4l1197t780r1228b797],
30	MRI	NNP	MISC	MRI	prep_in	9	SENT_81	[p4l1237t774r1285b797],
31	suggest	VBP	O	suggest	ccomp	2	SENT_81	[p4l1294t777r1398b804],
32	demyelinating	VBG	O	demyelinate	amod	33	SENT_81	[p4l1406t773r1597b804],
33	disease	NN	O	disease	dobj	31	SENT_81	[p4l1606t773r1702b797],
34	while	IN	O	while	mark	39	SENT_81	[p4l1710t773r1781b797],
35	presenting	VBG	O	present	csubj	39	SENT_81	[p4l1790t775r1931b804],
36	symptoms	NNS	O	symptom	dobj	35	SENT_81	[p4l1940t777r2079b804],
37	do	VBP	O	do	aux	39	SENT_81	[p4l20t814r54b838],
38	not	RB	O	not	neg	39	SENT_81	[p4l63t818r107b838],
39	follow	VB	O	follow	advcl	31	SENT_81	[p4l113t814r196b838],
40	an	DT	O	a	det	43	SENT_81	[p4l203t821r234b838],
41	appropriate	JJ	O	appropriate	amod	43	SENT_81	[p4l242t815r399b844],
42	time	NN	O	time	nn	43	SENT_81	[p4l406t815r466b838],
43	course	NN	O	course	dobj	39	SENT_81	[p4l474t821r561b838],
44	of	IN	O	of	_	0	SENT_81	[p4l569t814r596b838],
45	onset	NN	O	onset	prep_of	43	SENT_81	[p4l602t818r681b842],
46	,	,	O	,	_	0	SENT_81	[p4l602t818r681b842],
47	stabilization	NN	O	stabilization	prep_of	43	SENT_81	[p4l690t814r856b842],
48	,	,	O	,	_	0	SENT_81	[p4l690t814r856b842],
49	and	CC	O	and	_	0	SENT_81	[p4l864t814r913b838],
50	recovery	NN	O	recovery	nn	52	SENT_81	[p4l923t821r1036b845],
51	suggestive	JJ	O	suggestive	amod	52	SENT_81	[p4l1044t815r1186b845],
52	ofdemyelination	NN	O	ofdemyelination	prep_of	43	SENT_81	[p4l1194t814r1425b845],
53	.	.	O	.	_	0	SENT_81	[p4l1194t814r1425b845],

1	Symptoms	NNS	O	symptom	nsubjpass	4	SENT_82	[p4l1434t815r1575b845],
2	may	MD	O	may	aux	4	SENT_82	[p4l1584t821r1639b845],
3	be	VB	O	be	auxpass	4	SENT_82	[p4l1648t814r1679b838],
4	subjective	JJ	O	subjective	_	0	SENT_82	[p4l1687t814r1822b845],
5	or	CC	O	or	_	0	SENT_82	[p4l1830t821r1857b838],
6	explained	VBN	O	explain	conj_or	4	SENT_82	[p4l1864t814r1993b844],
7	by	IN	O	by	_	0	SENT_82	[p4l2003t814r2034b845],
8	alternative	JJ	O	alternative	amod	9	SENT_82	[p4l20t855r161b879],
9	diagnoses	NNS	O	diagnosis	prep_by	6	SENT_82	[p4l169t855r309b886],
10	.	.	O	.	_	0	SENT_82	[p4l169t855r309b886],

1	**	NN	O	**	nn	2	SENT_83	[p4l317t855r437b879],
2	C	NN	O	c	nsubj	7	SENT_83	[p4l317t855r437b879],
3	|	JJ	O	|	amod	6	SENT_83	[p4l317t855r437b879],
4	inica	NN	O	inica	nn	6	SENT_83	[p4l317t855r437b879],
5	|	NN	O	|	nn	6	SENT_83	[p4l317t855r437b879],
6	attack	NN	O	attack	dep	2	SENT_83	[p4l446t855r527b879],
7	suggests	VBZ	O	suggest	_	0	SENT_83	[p4l534t859r650b886],
8	inflammatory	JJ	O	inflammatory	amod	13	SENT_83	[p4l659t855r839b886],
9	demyelination	NN	O	demyelination	nn	13	SENT_83	[p4l846t855r1036b886],
10	(	NN	O	(	nn	13	SENT_83	[p4l1046t856r1211b886],
11	appropriate	JJ	O	appropriate	amod	13	SENT_83	[p4l1046t856r1211b886],
12	time	NN	O	time	nn	13	SENT_83	[p4l1218t856r1278b879],
13	course	NN	O	course	dobj	7	SENT_83	[p4l1286t862r1373b879],
14	of	IN	O	of	_	0	SENT_83	[p4l1381t855r1408b879],
15	onset	NN	O	onset	nn	17	SENT_83	[p4l1414t859r1493b883],
16	,	,	O	,	_	0	SENT_83	[p4l1414t859r1493b883],
17	stabilization	NN	O	stabilization	prep_of	13	SENT_83	[p4l1502t855r1668b883],
18	,	,	O	,	_	0	SENT_83	[p4l1502t855r1668b883],
19	and	CC	O	and	_	0	SENT_83	[p4l1676t855r1725b879],
20	recovery	NN	O	recovery	nn	21	SENT_83	[p4l1735t856r1856b886],
21	)	NN	O	)	prep_of	13	SENT_83	[p4l1735t856r1856b886],
22	in	IN	O	in	_	0	SENT_83	[p4l1865t856r1887b879],
23	the	DT	O	the	det	26	SENT_83	[p4l1895t855r1939b880],
24	absence	NN	O	absence	nn	26	SENT_83	[p4l1947t855r2056b879],
25	ofother	NN	O	ofother	nn	26	SENT_83	[p4l20t896r125b920],
26	explanation	NN	O	explanation	prep_in	13	SENT_83	[p4l132t896r288b926],
27	and	CC	O	and	_	0	SENT_83	[p4l297t896r346b920],
28	objective	JJ	O	objective	amod	29	SENT_83	[p4l355t896r477b927],
29	lesion	NN	O	lesion	dobj	7	SENT_83	[p4l486t896r561b920],
30	on	IN	O	on	_	0	SENT_83	[p4l570t903r603b920],
31	examination	NN	O	examination	prep_on	29	SENT_83	[p4l612t898r784b924],
32	,	,	O	,	_	0	SENT_83	[p4l612t898r784b924],
33	MRI	NNP	O	MRI	dobj	7	SENT_83	[p4l793t897r847b924],
34	,	,	O	,	_	0	SENT_83	[p4l793t897r847b924],
35	or	CC	O	or	_	0	SENT_83	[p4l855t903r882b920],
36	visual	JJ	O	visual	dobj	7	SENT_83	[p4l889t896r963b920],
37	evoked	VBN	O	evoke	partmod	36	SENT_83	[p4l972t896r1067b920],
38	potential	NN	O	potential	dobj	37	SENT_83	[p4l1077t896r1202b926],
39	.	.	O	.	_	0	SENT_83	[p4l1077t896r1202b926],

1	***	CD	NUMBER	***	num	2	SENT_84	[p4l1210t896r1368b920],
2	|	NN	O	|	dep	3	SENT_84	[p4l1210t896r1368b920],
3	nsidious	JJ	O	nsidious	_	0	SENT_84	[p4l1210t896r1368b920],
4	onset	NN	O	onset	nn	9	SENT_84	[p4l1376t900r1449b920],
5	progressive	JJ	O	progressive	amod	9	SENT_84	[p4l1458t898r1609b927],
6	neurological	JJ	O	neurological	amod	9	SENT_84	[p4l1618t896r1781b927],
7	dysfunction	NN	O	dysfunction	nn	9	SENT_84	[p4l1791t896r1947b927],
8	of21	NN	O	of21	nn	9	SENT_84	[p4l1956t896r2016b920],
9	year	NN	DURATION	year	nsubj	15	SENT_84	[p4l2028t903r2085b927],
10	(	RB	O	(	advmod	14	SENT_84	[p4l21t937r185b967],
11	prospective	JJ	O	prospective	amod	14	SENT_84	[p4l21t937r185b967],
12	or	CC	O	or	_	0	SENT_84	[p4l193t944r220b961],
13	retrospective	JJ	O	retrospective	conj_or	11	SENT_84	[p4l228t937r409b967],
14	)	NN	O	)	rcmod	9	SENT_84	[p4l228t937r409b967],
15	suggests	VBZ	O	suggest	ccomp	3	SENT_84	[p4l418t941r535b968],
16	demyelination	NN	O	demyelination	dobj	15	SENT_84	[p4l543t937r733b968],
17	in	IN	O	in	_	0	SENT_84	[p4l743t938r765b961],
18	the	DT	O	the	det	19	SENT_84	[p4l773t937r816b961],
19	absence	NN	O	absence	prep_in	15	SENT_84	[p4l824t937r933b961],
20	of	IN	O	of	_	0	SENT_84	[p4l941t937r969b961],
21	other	JJ	O	other	amod	22	SENT_84	[p4l974t937r1046b961],
22	explanation	NN	O	explanation	prep_of	19	SENT_84	[p4l1053t937r1217b967],
23	,	,	O	,	_	0	SENT_84	[p4l1053t937r1217b967],
24	and	CC	O	and	_	0	SENT_84	[p4l1225t937r1273b961],
25	objective	JJ	O	objective	amod	26	SENT_84	[p4l1282t937r1404b968],
26	lesion	NN	O	lesion	nsubj	27	SENT_84	[p4l1413t937r1489b961],
27	appears	VBZ	O	appear	conj_and	3	SENT_84	[p4l1498t944r1603b967],
28	on	IN	O	on	_	0	SENT_84	[p4l1611t944r1643b961],
29	examination	NN	O	examination	prep_on	27	SENT_84	[p4l1652t938r1824b965],
30	,	,	O	,	_	0	SENT_84	[p4l1652t938r1824b965],
31	MRI	NNP	O	MRI	appos	29	SENT_84	[p4l1833t938r1888b965],
32	,	,	O	,	_	0	SENT_84	[p4l1833t938r1888b965],
33	or	CC	O	or	_	0	SENT_84	[p4l1896t944r1923b961],
34	evoked	VBD	O	evoke	conj_or	27	SENT_84	[p4l1930t937r2026b961],
35	potentials	NNS	O	potential	dobj	34	SENT_84	[p4l21t978r152b1009],
36	in	IN	O	in	_	0	SENT_84	[p4l161t979r183b1002],
37	the	DT	O	the	det	40	SENT_84	[p4l191t978r234b1003],
38	area	NN	O	area	nn	40	SENT_84	[p4l242t985r297b1003],
39	ofthe	NN	O	ofthe	nn	40	SENT_84	[p4l306t978r381b1003],
40	CNS	NNS	O	cn	prep_in	34	SENT_84	[p4l389t979r443b1002],
41	indicated	VBN	O	indicate	partmod	40	SENT_84	[p4l452t978r574b1003],
42	by	IN	O	by	_	0	SENT_84	[p4l583t978r615b1009],
43	symptoms	NNS	O	symptom	agent	41	SENT_84	[p4l622t982r767b1009],
44	.	.	O	.	_	0	SENT_84	[p4l622t982r767b1009],
45	'	''	O	'	_	0	SENT_84	[p4l775t974r829b1003],

1	‘	NN	O	‘	npadvmod	12	SENT_85	[p4l775t974r829b1003],
2	For	IN	O	for	_	0	SENT_85	[p4l775t974r829b1003],
3	practical	JJ	O	practical	amod	4	SENT_85	[p4l837t978r947b1009],
4	purposes	NNS	O	purpose	prep_for	12	SENT_85	[p4l957t985r1085b1009],
5	,	,	O	,	_	0	SENT_85	[p4l957t985r1085b1009],
6	dissemination	NN	O	dissemination	nsubjpass	12	SENT_85	[p4l1093t978r1278b1003],
7	in	IN	O	in	_	0	SENT_85	[p4l1288t979r1309b1002],
8	space	NN	O	space	prep_in	6	SENT_85	[p4l1319t985r1393b1009],
9	in	IN	O	in	_	0	SENT_85	[p4l1402t979r1424b1002],
10	MRI	NNP	MISC	MRI	prep_in	8	SENT_85	[p4l1433t979r1480b1002],
11	is	VBZ	O	be	auxpass	12	SENT_85	[p4l1490t979r1508b1003],
12	deﬁned	VBN	O	deﬁned	_	0	SENT_85	[p4l1516t978r1616b1003],
13	as	IN	O	as	_	0	SENT_85	[p4l1625t985r1651b1003],
14	having	VBG	O	have	prepc_as	12	SENT_85	[p4l1660t978r1756b1009],
15	:	:	O	:	_	0	SENT_85	[p4l1660t978r1756b1009],
16	21	CD	NUMBER	21	num	18	SENT_85	[p4l1763t980r1791b1002],
17	T2	NN	O	t2	nn	18	SENT_85	[p4l1801t979r1833b1002],
18	lesions	NNS	O	lesion	dobj	14	SENT_85	[p4l1842t978r1931b1003],
19	in	IN	O	in	_	0	SENT_85	[p4l1940t979r1962b1002],
20	22	CD	NUMBER	22	num	22	SENT_85	[p4l1970t980r2002b1002],
21	of4	NN	O	of4	nn	22	SENT_85	[p4l2011t978r2059b1002],
22	areas	NNS	O	area	prep_in	18	SENT_85	[p4l2066t985r2134b1003],
23	in	IN	O	in	_	0	SENT_85	[p4l21t1021r43b1043],
24	the	DT	O	the	det	26	SENT_85	[p4l51t1019r94b1043],
25	CNS	NN	O	cn	nn	26	SENT_85	[p4l102t1020r156b1043],
26	(	NN	O	(	prep_in	22	SENT_85	[p4l165t1019r549b1050],
27	periventricular	JJ	O	periventricular	amod	31	SENT_85	[p4l165t1019r549b1050],
28	,	,	O	,	_	0	SENT_85	[p4l165t1019r549b1050],
29	juxtacortical	JJ	O	juxtacortical	amod	31	SENT_85	[p4l165t1019r549b1050],
30	,	,	O	,	_	0	SENT_85	[p4l165t1019r549b1050],
31	infratentorial	JJ	O	infratentorial	amod	26	SENT_85	[p4l558t1019r735b1047],
32	,	,	O	,	_	0	SENT_85	[p4l558t1019r735b1047],
33	and	CC	O	and	_	0	SENT_85	[p4l743t1019r792b1043],
34	spinal	JJ	O	spinal	amod	36	SENT_85	[p4l801t1019r877b1049],
35	cord	NN	O	cord	nn	36	SENT_85	[p4l886t1019r961b1047],
36	)	NN	O	)	prep_in	22	SENT_85	[p4l886t1019r961b1047],
37	;	:	O	;	_	0	SENT_85	[p4l886t1019r961b1047],
38	dissemination	NN	O	dissemination	nsubjpass	44	SENT_85	[p4l968t1019r1154b1043],
39	in	IN	O	in	_	0	SENT_85	[p4l1163t1021r1185b1043],
40	time	NN	O	time	prep_in	38	SENT_85	[p4l1193t1021r1253b1043],
41	in	IN	O	in	_	0	SENT_85	[p4l1262t1021r1284b1043],
42	MRI	NNP	MISC	MRI	prep_in	40	SENT_85	[p4l1293t1020r1340b1043],
43	is	VBZ	O	be	auxpass	44	SENT_85	[p4l1350t1021r1368b1043],
44	deﬁned	VBN	O	deﬁned	dep	18	SENT_85	[p4l1376t1019r1476b1043],
45	as	IN	O	as	_	0	SENT_85	[p4l1485t1026r1511b1043],
46	simultaneous	JJ	O	simultaneous	amod	49	SENT_85	[p4l1519t1019r1698b1043],
47	presence	NN	O	presence	nn	49	SENT_85	[p4l1707t1026r1826b1049],
48	ofasymptomatic	JJ	O	ofasymptomatic	amod	49	SENT_85	[p4l1833t1019r2056b1050],
49	Gd	NN	MISC	gd	prep_as	44	SENT_85	[p4l20t1060r77b1084],
50	+	CC	O	+	_	0	SENT_85	[p4l20t1060r77b1084],
51	and	CC	O	and	_	0	SENT_85	[p4l84t1060r133b1084],
52	Gd	JJ	MISC	gd	amod	54	SENT_85	[p4l142t1060r196b1084],
53	—	NN	O	—	nn	54	SENT_85	[p4l142t1060r196b1084],
54	lesions	NNS	O	lesion	conj_+	44	SENT_85	[p4l205t1060r293b1084],
55	or	CC	O	or	_	0	SENT_85	[p4l302t1067r329b1084],
56	a	DT	O	a	det	58	SENT_85	[p4l336t1067r349b1084],
57	newT2	NN	O	newt2	nn	58	SENT_85	[p4l358t1061r450b1084],
58	lesion	NN	O	lesion	conj_+	44	SENT_85	[p4l459t1060r535b1084],
59	on	IN	O	on	_	0	SENT_85	[p4l544t1067r576b1084],
60	follow-up	NN	O	follow-up	prep_on	54	SENT_85	[p4l584t1060r718b1090],
61	.	.	O	.	_	0	SENT_85	[p4l584t1060r718b1090],

1	*	NN	O	*	nn	3	SENT_86	[p4l725t1056r839b1084],
2	Positive	JJ	O	positive	amod	3	SENT_86	[p4l725t1056r839b1084],
3	CSF	NN	O	csf	nsubjpass	5	SENT_86	[p4l847t1061r895b1084],
4	is	VBZ	O	be	auxpass	5	SENT_86	[p4l904t1061r922b1084],
5	deﬁned	VBN	O	deﬁned	_	0	SENT_86	[p4l930t1060r1030b1084],
6	as	IN	O	as	_	0	SENT_86	[p4l1039t1067r1065b1084],
7	isoelectric-focusing	JJ	O	isoelectric-focusing	amod	8	SENT_86	[p4l1074t1060r1330b1090],
8	evidence	NN	O	evidence	prep_as	5	SENT_86	[p4l1339t1060r1459b1084],
9	of	IN	O	of	_	0	SENT_86	[p4l1467t1060r1494b1084],
10	oligoclonal	JJ	O	oligoclonal	amod	12	SENT_86	[p4l1500t1060r1646b1090],
11	bands	NNS	O	band	nn	12	SENT_86	[p4l1656t1060r1735b1084],
12	and/or	NN	O	and/or	prep_of	8	SENT_86	[p4l1743t1060r1833b1085],
13	elevated	JJ	O	elevated	amod	16	SENT_86	[p4l1840t1060r1952b1084],
14	|	NN	O	|	nn	16	SENT_86	[p4l1963t1061r2005b1090],
15	gG	NN	O	gg	nn	16	SENT_86	[p4l1963t1061r2005b1090],
16	index	NN	O	index	dep	12	SENT_86	[p4l2015t1060r2093b1084],
17	.	.	O	.	_	0	SENT_86	[p4l2015t1060r2093b1084],

1	CSF	NN	O	csf	_	0	SENT_87	[p4l20t1102r72b1129],
2	,	,	O	,	_	0	SENT_87	[p4l20t1102r72b1129],
3	cerebrospinal	JJ	O	cerebrospinal	amod	4	SENT_87	[p4l80t1101r259b1132],
4	ﬂuid	NN	O	ﬂuid	appos	1	SENT_87	[p4l267t1101r333b1129],
5	;	:	O	;	_	0	SENT_87	[p4l267t1101r333b1129],
6	CIS	NN	ORGANIZATION	ci	dep	4	SENT_87	[p4l341t1102r388b1129],
7	,	,	O	,	_	0	SENT_87	[p4l341t1102r388b1129],
8	clinically	RB	O	clinically	advmod	9	SENT_87	[p4l396t1101r509b1132],
9	isolated	VBN	O	isolate	amod	10	SENT_87	[p4l517t1101r619b1126],
10	syndrome	NN	O	syndrome	appos	6	SENT_87	[p4l628t1101r767b1132],
11	;	:	O	;	_	0	SENT_87	[p4l628t1101r767b1132],
12	CNS	NNS	O	cn	dep	4	SENT_87	[p4l775t1102r835b1129],
13	,	,	O	,	_	0	SENT_87	[p4l775t1102r835b1129],
14	central	JJ	O	central	amod	16	SENT_87	[p4l844t1101r932b1125],
15	nervous	JJ	O	nervous	amod	16	SENT_87	[p4l943t1108r1048b1126],
16	system	NN	O	system	appos	12	SENT_87	[p4l1056t1105r1155b1132],
17	;	:	O	;	_	0	SENT_87	[p4l1056t1105r1155b1132],
18	|	CD	NUMBER	|	num	19	SENT_87	[p4l1164t1102r1214b1132],
19	gG	NN	O	gg	dep	12	SENT_87	[p4l1164t1102r1214b1132],
20	,	,	O	,	_	0	SENT_87	[p4l1164t1102r1214b1132],
21	immunoglobulin	NN	O	immunoglobulin	nn	22	SENT_87	[p4l1222t1101r1445b1132],
22	G	NN	O	g	appos	19	SENT_87	[p4l1454t1102r1480b1129],
23	;	:	O	;	_	0	SENT_87	[p4l1454t1102r1480b1129],
24	MRI	NNP	MISC	MRI	dep	12	SENT_87	[p4l1488t1102r1543b1129],
25	,	,	O	,	_	0	SENT_87	[p4l1488t1102r1543b1129],
26	magnetic	JJ	O	magnetic	amod	28	SENT_87	[p4l1552t1102r1676b1132],
27	resonance	NN	O	resonance	nn	28	SENT_87	[p4l1685t1108r1820b1125],
28	imaging	NN	O	imaging	appos	24	SENT_87	[p4l1829t1102r1944b1132],
29	;	:	O	;	_	0	SENT_87	[p4l1829t1102r1944b1132],
30	MS	NN	O	m	dep	12	SENT_87	[p4l1953t1102r1998b1129],
31	,	,	O	,	_	0	SENT_87	[p4l1953t1102r1998b1129],
32	multiple	JJ	O	multiple	amod	33	SENT_87	[p4l2007t1101r2117b1132],
33	sclerosis	NN	O	sclerosis	appos	30	SENT_87	[p4l20t1142r136b1170],
34	;	:	O	;	_	0	SENT_87	[p4l20t1142r136b1170],
35	PPMS	NNP	O	PPMS	dep	12	SENT_87	[p4l145t1143r224b1170],
36	,	,	O	,	_	0	SENT_87	[p4l145t1143r224b1170],
37	primary	JJ	O	primary	amod	39	SENT_87	[p4l233t1143r336b1173],
38	progressive	JJ	O	progressive	amod	39	SENT_87	[p4l345t1143r496b1173],
39	MS	NN	O	m	appos	35	SENT_87	[p4l505t1143r551b1170],
40	;	:	O	;	_	0	SENT_87	[p4l505t1143r551b1170],
41	RIS	NNP	O	RIS	dep	4	SENT_87	[p4l560t1143r604b1170],
42	,	,	O	,	_	0	SENT_87	[p4l560t1143r604b1170],
43	radiologically	RB	O	radiologically	advmod	44	SENT_87	[p4l613t1142r790b1173],
44	isolated	VBN	O	isolate	amod	45	SENT_87	[p4l798t1142r900b1166],
45	syndrome	NN	O	syndrome	appos	41	SENT_87	[p4l909t1142r1049b1173],
46	;	:	O	;	_	0	SENT_87	[p4l909t1142r1049b1173],
47	RRMS	NNS	O	rrm	dep	4	SENT_87	[p4l1058t1143r1138b1170],
48	,	,	O	,	_	0	SENT_87	[p4l1058t1143r1138b1170],
49	relapsing-remitting	JJ	O	relapsing-remitting	amod	50	SENT_87	[p4l1147t1142r1401b1173],
50	MS	NN	O	m	appos	47	SENT_87	[p4l1411t1143r1457b1170],
51	;	:	O	;	_	0	SENT_87	[p4l1411t1143r1457b1170],
52	SAMS	NNP	O	SAMS	dep	4	SENT_87	[p4l1465t1143r1547b1170],
53	,	,	O	,	_	0	SENT_87	[p4l1465t1143r1547b1170],
54	single-attack	JJ	O	single-attack	amod	55	SENT_87	[p4l1555t1142r1726b1173],
55	MS	NN	O	m	appos	52	SENT_87	[p4l1733t1143r1779b1170],
56	;	:	O	;	_	0	SENT_87	[p4l1733t1143r1779b1170],
57	SAPMS	NNP	LOCATION	SAPMS	dep	4	SENT_87	[p4l1787t1143r1886b1170],
58	,	,	O	,	_	0	SENT_87	[p4l1787t1143r1886b1170],
59	single-attack	JJ	O	single-attack	amod	61	SENT_87	[p4l1894t1142r2065b1173],
60	progressive	JJ	O	progressive	amod	61	SENT_87	[p4l10t1198r325b1258],
61	MS	NN	O	m	appos	57	SENT_87	[p4l343t1197r439b1253],
62	;	:	O	;	_	0	SENT_87	[p4l343t1197r439b1253],
63	SPMS	NNP	O	SPMS	dep	4	SENT_87	[p4l456t1197r620b1253],
64	,	,	O	,	_	0	SENT_87	[p4l456t1197r620b1253],
65	secondary	JJ	O	secondary	amod	67	SENT_87	[p4l637t1195r923b1259],
66	progressive	JJ	O	progressive	amod	67	SENT_87	[p4l940t1198r1255b1258],
67	MS.	NNP	O	MS.	appos	63	SENT_87	[p4l1274t1197r1369b1245],

1	treatment	NN	O	treatment	_	0	SENT_88	[p4l7t1427r347b1478],
2	.	.	O	.	_	0	SENT_88	[p4l7t1427r347b1478],

1	There	EX	O	there	expl	2	SENT_89	[p4l368t1415r556b1478],
2	are	VBP	O	be	_	0	SENT_89	[p4l576t1438r673b1478],
3	many	JJ	O	many	amod	4	SENT_89	[p4l692t1438r880b1499],
4	variations	NNS	O	variation	nsubj	2	SENT_89	[p4l892t1421r1221b1478],
5	in	IN	O	in	_	0	SENT_89	[p4l1240t1421r1305b1477],
6	MS	NN	O	m	nn	7	SENT_89	[p4l1324t1419r1434b1478],
7	practice	NN	O	practice	prep_in	4	SENT_89	[p4l1454t1421r1717b1498],
8	that	WDT	O	that	nsubj	11	SENT_89	[p4l1735t1415r1865b1478],
9	may	MD	O	may	aux	11	SENT_89	[p4l1882t1438r2025b1499],
10	not	RB	O	not	neg	11	SENT_89	[p4l2040t1427r2151b1478],
11	ﬁt	VB	O	ﬁt	rcmod	4	SENT_89	[p4l7t1518r74b1581],
12	the	DT	O	the	det	14	SENT_89	[p4l91t1518r194b1581],
13	presented	VBN	O	present	amod	14	SENT_89	[p4l211t1518r533b1601],
14	model	NN	O	model	dobj	11	SENT_89	[p4l550t1518r775b1590],
15	,	,	O	,	_	0	SENT_89	[p4l550t1518r775b1590],
16	and	CC	O	and	_	0	SENT_89	[p4l796t1518r919b1581],
17	such	PDT	O	such	predet	20	SENT_89	[p4l937t1518r1087b1581],
18	an	DT	O	a	det	20	SENT_89	[p4l1106t1541r1183b1581],
19	algorithmic	JJ	O	algorithmic	amod	20	SENT_89	[p4l1203t1518r1585b1602],
20	approach	NN	O	approach	nsubjpass	24	SENT_89	[p4l1604t1518r1909b1601],
21	should	MD	O	should	aux	24	SENT_89	[p4l1929t1518r2151b1581],
22	always	RB	O	always	advmod	24	SENT_89	[p4l8t1621r222b1705],
23	be	VB	O	be	auxpass	24	SENT_89	[p4l239t1621r316b1684],
24	treated	VBN	O	treat	conj_and	2	SENT_89	[p4l334t1621r563b1684],
25	as	IN	O	as	_	0	SENT_89	[p4l582t1644r644b1684],
26	a	DT	O	a	det	28	SENT_89	[p4l664t1644r698b1684],
27	general	JJ	O	general	amod	28	SENT_89	[p4l715t1621r955b1705],
28	guideline	NN	O	guideline	prep_as	24	SENT_89	[p4l973t1621r1293b1705],
29	.	.	O	.	_	0	SENT_89	[p4l973t1621r1293b1705],

1	Even	RB	O	even	advmod	9	SENT_90	[p4l1314t1626r1476b1684],
2	in	IN	O	in	_	0	SENT_90	[p4l1495t1627r1559b1683],
3	our	PRP$	O	we	poss	5	SENT_90	[p4l1579t1644r1693b1684],
4	own	JJ	O	own	amod	5	SENT_90	[p4l1711t1644r1852b1684],
5	practice	NN	O	practice	prep_in	9	SENT_90	[p4l1869t1627r2147b1704],
6	,	,	O	,	_	0	SENT_90	[p4l1869t1627r2147b1704],
7	we	PRP	O	we	nsubj	9	SENT_90	[p4l6t1747r99b1787],
8	may	MD	O	may	aux	9	SENT_90	[p4l120t1747r267b1808],
9	deviate	VB	O	deviate	dep	30	SENT_90	[p4l286t1724r526b1787],
10	from	IN	O	from	_	0	SENT_90	[p4l548t1724r715b1787],
11	the	DT	O	the	det	13	SENT_90	[p4l736t1724r842b1787],
12	proposed	VBN	O	propose	amod	13	SENT_90	[p4l863t1724r1184b1807],
13	“	NN	O	“	prep_from	9	SENT_90	[p4l1206t1724r1703b1787],
14	standardized	JJ	O	standardized	amod	16	SENT_90	[p4l1206t1724r1703b1787],
15	”	NN	O	”	nn	16	SENT_90	[p4l1206t1724r1703b1787],
16	approach	NN	O	approach	tmod	13	SENT_90	[p4l1727t1724r2060b1807],
17	,	,	O	,	_	0	SENT_90	[p4l1727t1724r2060b1807],
18	as	IN	O	as	mark	20	SENT_90	[p4l2084t1747r2148b1787],
19	we	PRP	O	we	nsubj	20	SENT_90	[p4l6t1850r98b1890],
20	believe	VBP	O	believe	dep	16	SENT_90	[p4l116t1827r350b1890],
21	that	IN	O	that	complm	24	SENT_90	[p4l369t1827r501b1890],
22	a	DT	O	a	det	23	SENT_90	[p4l520t1850r554b1890],
23	fully	RB	O	fully	nsubj	24	SENT_90	[p4l573t1827r726b1911],
24	individualized	VBN	O	individualize	ccomp	20	SENT_90	[p4l742t1827r1243b1899],
25	,	,	O	,	_	0	SENT_90	[p4l742t1827r1243b1899],
26	patient-centered	JJ	O	patient-centered	amod	27	SENT_90	[p4l1263t1827r1820b1910],
27	approach	NN	O	approach	nsubj	30	SENT_90	[p4l1839t1827r2152b1910],
28	is	VBZ	O	be	cop	30	SENT_90	[p4l8t1936r57b1993],
29	the	DT	O	the	det	30	SENT_90	[p4l78t1930r183b1993],
30	best	JJS	O	best	_	0	SENT_90	[p4l203t1930r340b1993],
31	in	IN	O	in	_	0	SENT_90	[p4l360t1936r426b1992],
32	the	DT	O	the	det	33	SENT_90	[p4l446t1930r552b1993],
33	management	NN	O	management	prep_in	30	SENT_90	[p4l573t1942r1016b2014],
34	of	IN	O	of	_	0	SENT_90	[p4l1036t1930r1110b1993],
35	chronic	JJ	O	chronic	amod	36	SENT_90	[p4l1122t1930r1379b1993],
36	diseases	NNS	O	disease	prep_of	33	SENT_90	[p4l1401t1930r1670b1993],
37	such	JJ	O	such	_	0	SENT_90	[p4l1692t1930r1846b1993],
38	as	IN	O	as	_	0	SENT_90	[p4l1868t1953r1931b1993],
39	MS.	NNP	O	MS.	prep_such_as	36	SENT_90	[p4l1953t1934r2083b1993],

1	DEFINITION	NN	O	definition	_	0	SENT_91	[p4l11t2145r431b2201],
2	OF	IN	O	of	_	0	SENT_91	[p4l452t2145r546b2201],
3	PHASES	NNPS	O	PHASES	prep_of	1	SENT_91	[p4l569t2146r849b2201],
4	OF	IN	O	of	_	0	SENT_91	[p4l868t2145r962b2201],
5	MS	NN	O	m	nn	7	SENT_91	[p4l984t2146r1089b2201],
6	AS	JJ	O	as	amod	7	SENT_91	[p4l1107t2146r1199b2201],
7	RELATED	NN	O	related	prep_of	1	SENT_91	[p4l1221t2146r1539b2200],
8	TO	TO	O	to	infmod	7	SENT_91	[p4l1554t2145r1649b2201],
9	TREATMENT	NN	O	treatment	dobj	8	SENT_91	[p4l1664t2146r2102b2200],

1	DECISIONS	NNS	O	decision	_	0	SENT_92	[p4l11t2248r402b2304],

1	A	DT	O	a	det	2	SENT_93	[p4l7t2348r63b2406],
2	diagnosis	NN	O	diagnosis	nsubj	5	SENT_93	[p4l84t2344r402b2428],
3	of	IN	O	of	_	0	SENT_93	[p4l424t2344r497b2407],
4	MS	NN	O	m	prep_of	2	SENT_93	[p4l508t2348r620b2407],
5	requires	VBZ	O	require	_	0	SENT_93	[p4l642t2350r916b2427],
6	the	DT	O	the	det	7	SENT_93	[p4l936t2344r1042b2407],
7	dissemination	NN	O	dissemination	nsubj	16	SENT_93	[p4l1063t2344r1543b2407],
8	in	IN	O	in	_	0	SENT_93	[p4l1564t2350r1629b2406],
9	time	NN	O	time	prep_in	7	SENT_93	[p4l1650t2350r1802b2407],
10	and	CC	O	and	_	0	SENT_93	[p4l1824t2344r1949b2407],
11	space	NN	O	space	prep_in	7	SENT_93	[p4l1970t2366r2152b2427],
12	of	IN	O	of	_	0	SENT_93	[p4l8t2447r83b2510],
13	independent	JJ	O	independent	amod	15	SENT_93	[p4l97t2447r540b2530],
14	inﬂammatory-demyelinating	JJ	O	inﬂammatory-demyelinating	amod	15	SENT_93	[p4l563t2447r1580b2531],
15	attacks	NNS	O	attack	prep_of	9	SENT_93	[p4l1603t2447r1840b2510],
16	(	VBP	O	(	ccomp	5	SENT_93	[p4l1868t2448r2148b2531, p4l7t2556r267b2613],
17	asymptomatic	JJ	O	asymptomatic	amod	20	SENT_93	[p4l1868t2448r2148b2531, p4l7t2556r267b2613],
18	or	CC	O	or	_	0	SENT_93	[p4l288t2573r360b2613],
19	symptomatic	JJ	O	symptomatic	conj_or	17	SENT_93	[p4l381t2550r872b2634],
20	)	NN	O	)	dobj	16	SENT_93	[p4l381t2550r872b2634],
21	.	.	O	.	_	0	SENT_93	[p4l381t2550r872b2634],

1	Asymptomatic	JJ	O	asymptomatic	amod	2	SENT_94	[p4l895t2554r1400b2634],
2	attacks	NNS	O	attack	nsubjpass	4	SENT_94	[p4l1421t2550r1654b2613],
3	are	VBP	O	be	auxpass	4	SENT_94	[p4l1677t2573r1777b2613],
4	diagnosed	VBN	O	diagnose	_	0	SENT_94	[p4l1799t2550r2150b2634],
5	during	IN	O	during	_	0	SENT_94	[p4l8t2653r250b2737],
6	clinical	JJ	O	clinical	amod	9	SENT_94	[p4l275t2653r534b2716],
7	or	CC	O	or	_	0	SENT_94	[p4l560t2676r634b2716],
8	paraclinical	JJ	O	paraclinical	amod	9	SENT_94	[p4l659t2653r1080b2736],
9	examinations	NNS	O	examination	prep_during	4	SENT_94	[p4l1107t2659r1589b2716],
10	by	IN	O	by	_	0	SENT_94	[p4l1613t2653r1700b2737],
11	radiological	JJ	O	radiological	amod	12	SENT_94	[p4l1723t2653r2152b2737],
12	examinations	NNS	O	examination	agent	4	SENT_94	[p4l8t2761r506b2819],
13	.	.	O	.	_	0	SENT_94	[p4l8t2761r506b2819],

1	In	IN	O	in	_	0	SENT_95	[p4l535t2760r608b2818],
2	2010	CD	DATE	2010	prep_in	8	SENT_95	[p4l633t2762r821b2827],
3	,	,	O	,	_	0	SENT_95	[p4l633t2762r821b2827],
4	the	DT	O	the	det	6	SENT_95	[p4l847t2755r957b2819],
5	McDonald	NNP	O	McDonald	nn	6	SENT_95	[p4l983t2755r1367b2819],
6	criteria3	NN	O	criteria3	nsubjpass	8	SENT_95	[p4l1391t2747r1679b2819],
7	were	VBD	O	be	auxpass	8	SENT_95	[p4l1704t2778r1871b2819],
8	revised	VBN	O	revise	_	0	SENT_95	[p4l1897t2755r2152b2819],
9	to	TO	O	to	aux	10	SENT_95	[p4l7t2871r73b2922],
10	account	VB	O	account	xcomp	8	SENT_95	[p4l99t2871r371b2922],
11	for	IN	O	for	_	0	SENT_95	[p4l393t2859r492b2922],
12	subclinical	JJ	O	subclinical	amod	15	SENT_95	[p4l515t2859r887b2922],
13	magnetic	JJ	O	magnetic	amod	15	SENT_95	[p4l910t2865r1230b2943],
14	resonance	NN	O	resonance	nn	15	SENT_95	[p4l1254t2882r1602b2922],
15	imaging	NN	O	imaging	prep_for	10	SENT_95	[p4l1626t2865r1910b2943],
16	(	CD	NUMBER	(	num	19	SENT_95	[p4l1935t2860r2147b2935],
17	MRI	NNP	O	MRI	nn	19	SENT_95	[p4l1935t2860r2147b2935],
18	)	NN	O	)	nn	19	SENT_95	[p4l1935t2860r2147b2935],
19	activity	NN	O	activity	dep	15	SENT_95	[p4l8t2968r284b3046],
20	,	,	O	,	_	0	SENT_95	[p4l8t2968r284b3046],
21	in	IN	O	in	_	0	SENT_95	[p4l312t2968r381b3024],
22	addition	NN	O	addition	_	0	SENT_95	[p4l408t2962r710b3025],
23	to	TO	O	to	_	0	SENT_95	[p4l736t2974r804b3025],
24	clinical	JJ	O	clinical	amod	25	SENT_95	[p4l832t2962r1091b3025],
25	activity	NN	O	activity	prep_for	10	SENT_95	[p4l1117t2968r1393b3046],
26	,	,	O	,	_	0	SENT_95	[p4l1117t2968r1393b3046],
27	at	IN	O	at	_	0	SENT_95	[p4l1422t2974r1483b3025],
28	the	DT	O	the	det	30	SENT_95	[p4l1508t2962r1619b3025],
29	initial	JJ	O	initial	amod	30	SENT_95	[p4l1645t2962r1857b3025],
30	presentation	NN	O	presentation	prep_at	8	SENT_95	[p4l1881t2984r2148b3045, p4l7t3057r273b3129],
31	.4	CD	NUMBER	.4	num	30	SENT_95	[p4l1881t2984r2148b3045, p4l7t3057r273b3129],
32	We	PRP	O	we	nsubj	34	SENT_95	[p4l297t3071r410b3129],
33	have	VBP	O	have	aux	34	SENT_95	[p4l435t3065r598b3129],
34	adapted	VBN	O	adapt	rcmod	30	SENT_95	[p4l625t3065r908b3149],
35	and	CC	O	and	_	0	SENT_95	[p4l934t3065r1065b3129],
36	modiﬁed	VBN	O	modiﬁed	rcmod	30	SENT_95	[p4l1090t3065r1415b3129],
37	these	DT	O	these	det	38	SENT_95	[p4l1439t3065r1623b3129],
38	criteria	NNS	O	criterion	dobj	36	SENT_95	[p4l1650t3072r1909b3129],
39	in	IN	O	in	_	0	SENT_95	[p4l1934t3072r2003b3128],
40	our	PRP$	O	we	poss	44	SENT_95	[p4l2030t3088r2153b3129],
41	clinical	JJ	O	clinical	amod	44	SENT_95	[p4l8t3169r261b3232],
42	practice	NN	O	practice	nn	44	SENT_95	[p4l283t3175r563b3252],
43	(	CD	NUMBER	(	num	44	SENT_95	[p4l591t3170r857b3252],
44	Figure	NN	O	figure	prep_in	36	SENT_95	[p4l591t3170r857b3252],
45	2	CD	NUMBER	2	num	46	SENT_95	[p4l880t3170r968b3246],
46	)	NN	O	)	dobj	34	SENT_95	[p4l880t3170r968b3246],
47	.	.	O	.	_	0	SENT_95	[p4l880t3170r968b3246],

1	This	DT	O	this	nsubj	6	SENT_96	[p4l995t3169r1142b3232],
2	is	VBZ	O	be	cop	6	SENT_96	[p4l1166t3175r1218b3232],
3	not	RB	O	not	neg	6	SENT_96	[p4l1242t3181r1359b3232],
4	an	DT	O	a	det	6	SENT_96	[p4l1383t3192r1464b3232],
5	exact	JJ	O	exact	amod	6	SENT_96	[p4l1489t3181r1670b3232],
6	replica	NN	O	replica	_	0	SENT_96	[p4l1693t3169r1929b3252],
7	of	IN	O	of	_	0	SENT_96	[p4l1953t3169r2028b3232],
8	the	DT	O	the	det	9	SENT_96	[p4l2041t3169r2150b3232],
9	criteria	NNS	O	criterion	prep_of	6	SENT_96	[p4l8t3278r276b3344],
10	,	,	O	,	_	0	SENT_96	[p4l8t3278r276b3344],
11	which	WDT	O	which	nsubjpass	14	SENT_96	[p4l300t3272r513b3335],
12	were	VBD	O	be	auxpass	14	SENT_96	[p4l535t3295r699b3335],
13	originally	RB	O	originally	advmod	14	SENT_96	[p4l724t3272r1062b3356],
14	developed	VBN	O	develop	rcmod	9	SENT_96	[p4l1083t3272r1440b3355],
15	to	TO	O	to	aux	16	SENT_96	[p4l1462t3284r1529b3335],
16	guide	VB	O	guide	xcomp	14	SENT_96	[p4l1554t3272r1746b3356],
17	uniformity	NN	O	uniformity	dobj	16	SENT_96	[p4l1769t3272r2154b3356],
18	in	IN	O	in	_	0	SENT_96	[p4l8t3381r76b3437],
19	clinical	JJ	O	clinical	amod	20	SENT_96	[p4l102t3375r358b3438],
20	trials	NNS	O	trial	prep_in	17	SENT_96	[p4l381t3375r580b3447],
21	,	,	O	,	_	0	SENT_96	[p4l381t3375r580b3447],
22	but	CC	O	but	_	0	SENT_96	[p4l605t3375r722b3438],
23	rather	RB	O	rather	_	0	SENT_96	[p4l746t3375r962b3438],
24	an	DT	O	a	det	25	SENT_96	[p4l986t3398r1069b3438],
25	adaptation	NN	O	adaptation	conj_negcc	17	SENT_96	[p4l1094t3375r1473b3458],
26	appropriate	JJ	O	appropriate	amod	25	SENT_96	[p4l1499t3381r1909b3458],
27	to	TO	O	to	_	0	SENT_96	[p4l1934t3387r2002b3438],
28	our	PRP$	O	we	poss	30	SENT_96	[p4l2029t3398r2150b3438],
29	clinical	JJ	O	clinical	amod	30	SENT_96	[p4l8t3478r257b3541],
30	practice	NN	O	practice	prep_to	26	SENT_96	[p4l278t3484r571b3561],
31	.	.	O	.	_	0	SENT_96	[p4l278t3484r571b3561],

1	The	DT	O	the	det	3	SENT_97	[p4l81t3581r221b3644],
2	contemporary	JJ	O	contemporary	amod	3	SENT_97	[p4l253t3593r776b3665],
3	diagnosis	NN	O	diagnosis	nsubj	7	SENT_97	[p4l804t3581r1147b3665],
4	of	IN	O	of	_	0	SENT_97	[p4l1180t3581r1257b3644],
5	MS	NN	O	m	prep_of	3	SENT_97	[p4l1279t3585r1397b3644],
6	has	VBZ	O	have	aux	7	SENT_97	[p4l1428t3581r1547b3644],
7	evolved	VBN	O	evolve	_	0	SENT_97	[p4l1579t3581r1858b3644],
8	significantly	RB	O	significantly	advmod	7	SENT_97	[p4l1889t3581r2148b3665, p4l8t3684r219b3768],
9	with	IN	O	with	_	0	SENT_97	[p4l236t3684r392b3747],
10	multiple	JJ	O	multiple	amod	11	SENT_97	[p4l414t3684r704b3767],
11	modiﬁcations	NNS	O	modiﬁcations	prep_with	7	SENT_97	[p4l728t3684r1207b3747],
12	to	TO	O	to	_	0	SENT_97	[p4l1230t3696r1297b3747],
13	diagnostic	JJ	O	diagnostic	amod	14	SENT_97	[p4l1322t3684r1680b3768],
14	criteria	NNS	O	criterion	prep_to	7	SENT_97	[p4l1704t3690r1953b3747],
15	since	IN	O	since	advmod	7	SENT_97	[p4l1977t3690r2150b3747],

1	2005.45	CD	NUMBER	2005.45	nsubjpass	9	SENT_98	[p5l8t12r271b84],
2	The	DT	O	the	det	7	SENT_98	[p5l295t20r423b84],
3	pre	JJ	O	pre	amod	7	SENT_98	[p5l445t27r755b104],
4	—	CD	NUMBER	—	num	7	SENT_98	[p5l445t27r755b104],
5	2005	CD	DATE	2005	num	7	SENT_98	[p5l445t27r755b104],
6	diagnostic	JJ	O	diagnostic	amod	7	SENT_98	[p5l782t20r1142b105],
7	criteria	NNS	O	criterion	dep	1	SENT_98	[p5l1166t27r1416b84],
8	were	VBD	O	be	auxpass	9	SENT_98	[p5l1436t43r1600b84],
9	based	VBN	O	base	_	0	SENT_98	[p5l1622t20r1823b84],
10	solely	RB	O	solely	advmod	9	SENT_98	[p5l1846t20r2044b105],
11	on	IN	O	on	prep	9	SENT_98	[p5l2065t43r2152b84],

1	34	CD	NUMBER	34	_	0	SENT_99	[p5l7t241r72b283],
2	disseminated	VBN	O	disseminate	partmod	1	SENT_99	[p5l8t323r470b386],
3	clinical	JJ	O	clinical	amod	4	SENT_99	[p5l493t323r744b386],
4	relapses	NNS	O	relapse	dobj	2	SENT_99	[p5l767t323r1058b406],
5	.	.	O	.	_	0	SENT_99	[p5l767t323r1058b406],

1	The	DT	O	the	det	4	SENT_100	[p5l1085t323r1212b386],
2	current	JJ	DATE	current	amod	4	SENT_100	[p5l1236t335r1495b386],
3	diagnostic	JJ	O	diagnostic	amod	4	SENT_100	[p5l1517t323r1878b407],
4	criteria	NNS	O	criterion	nsubj	5	SENT_100	[p5l1902t329r2152b386],
5	include	VBP	O	include	_	0	SENT_100	[p5l7t426r259b489],
6	subclinical	JJ	O	subclinical	amod	8	SENT_100	[p5l282t426r650b489],
7	disease	NN	O	disease	nn	8	SENT_100	[p5l671t426r913b489],
8	activity	NN	O	activity	dobj	5	SENT_100	[p5l935t432r1195b510],
9	.	.	O	.	_	0	SENT_100	[p5l935t432r1195b510],

1	Although	IN	O	although	mark	50	SENT_101	[p5l80t529r416b613],
2	most	JJS	O	most	amod	3	SENT_101	[p5l439t541r614b592],
3	patients	NNS	O	patient	nsubj	50	SENT_101	[p5l635t535r912b612],
4	experience	NN	O	experience	nn	6	SENT_101	[p5l937t535r1316b612],
5	symptomatic	JJ	O	symptomatic	amod	6	SENT_101	[p5l1341t535r1797b613],
6	disease	NN	O	disease	nsubj	13	SENT_101	[p5l1821t529r2068b592],
7	at	IN	O	at	_	0	SENT_101	[p5l2093t541r2153b592],
8	one	CD	NUMBER	one	num	9	SENT_101	[p5l8t675r134b715],
9	point	NN	O	point	prep_at	6	SENT_101	[p5l157t658r364b735],
10	,	,	O	,	_	0	SENT_101	[p5l157t658r364b735],
11	some	DT	O	some	appos	9	SENT_101	[p5l391t675r574b715],
12	remain	VBP	O	remain	cop	13	SENT_101	[p5l599t658r849b715],
13	asymptomatic	JJ	O	asymptomatic	rcmod	3	SENT_101	[p5l874t658r1372b736],
14	and	CC	O	and	_	0	SENT_101	[p5l1397t652r1527b715],
15	are	VBP	O	be	auxpass	16	SENT_101	[p5l1551t675r1654b715],
16	discovered	VBN	O	discover	rcmod	3	SENT_101	[p5l1679t652r2059b715],
17	to	TO	O	to	aux	18	SENT_101	[p5l2081t664r2149b715],
18	have	VB	O	have	xcomp	16	SENT_101	[p5l6t754r162b818],
19	MS	NN	O	m	dobj	18	SENT_101	[p5l183t758r297b818],
20	during	IN	O	during	_	0	SENT_101	[p5l320t754r552b839],
21	autopsy	NN	O	autopsy	nn	23	SENT_101	[p5l572t746r926b839],
22	.6	CD	NUMBER	.6	num	23	SENT_101	[p5l572t746r926b839],
23	’	NN	O	’	prep_during	18	SENT_101	[p5l572t746r926b839],
24	7	CD	NUMBER	7	num	23	SENT_101	[p5l572t746r926b839],
25	When	WRB	O	when	advmod	28	SENT_101	[p5l946t755r1157b818],
26	patients	NNS	O	patient	nsubjpass	28	SENT_101	[p5l1178t761r1448b838],
27	are	VBP	O	be	auxpass	28	SENT_101	[p5l1471t777r1571b818],
28	discovered	VBN	O	discover	advcl	18	SENT_101	[p5l1593t754r1961b818],
29	in	IN	O	in	_	0	SENT_101	[p5l1982t761r2048b817],
30	an	DT	O	a	det	34	SENT_101	[p5l2071t777r2151b818],
31	asymptomatic	JJ	O	asymptomatic	amod	34	SENT_101	[p5l8t864r490b942],
32	or	CC	O	or	_	0	SENT_101	[p5l510t881r582b921],
33	preclinical	JJ	O	preclinical	conj_or	31	SENT_101	[p5l601t858r960b941],
34	phase	NN	O	phase	prep_in	28	SENT_101	[p5l979t858r1174b941],
35	of	IN	O	of	_	0	SENT_101	[p5l1195t858r1269b921],
36	MS	NN	O	m	prep_of	34	SENT_101	[p5l1279t862r1393b921],
37	with	IN	O	with	_	0	SENT_101	[p5l1412t858r1566b921],
38	lesion	NN	O	lesion	nn	39	SENT_101	[p5l1585t858r1786b921],
39	formation	NN	O	formation	prep_with	28	SENT_101	[p5l1807t858r2151b921],
40	and	CC	O	and	_	0	SENT_101	[p5l8t961r139b1024],
41	without	IN	O	without	_	0	SENT_101	[p5l161t961r440b1024],
42	symptoms	NNS	O	symptom	prep_without	28	SENT_101	[p5l464t973r828b1045],
43	observed	VBN	O	observe	partmod	42	SENT_101	[p5l855t961r1177b1024],
44	on	IN	O	on	_	0	SENT_101	[p5l1202t984r1291b1024],
45	MRI	NNP	O	MRI	prep_on	43	SENT_101	[p5l1315t966r1476b1024],
46	obtained	VBN	O	obtain	partmod	45	SENT_101	[p5l1503t961r1815b1024],
47	for	IN	O	for	_	0	SENT_101	[p5l1839t961r1940b1024],
48	other	JJ	O	other	amod	49	SENT_101	[p5l1965t961r2153b1024],
49	reasons	NNS	O	reason	prep_for	46	SENT_101	[p5l8t1087r259b1127],
50	(	VBP	O	(	advcl	55	SENT_101	[p5l283t1065r357b1141],
51	e.	NN	O	e.	nn	52	SENT_101	[p5l283t1065r357b1141],
52	g.	NN	O	g.	dobj	50	SENT_101	[p5l364t1087r437b1148],
53	,	,	O	,	_	0	SENT_101	[p5l364t1087r437b1148],
54	migraines	NNS	O	migraine	nsubj	55	SENT_101	[p5l459t1065r840b1148],
55	)	VBP	O	)	_	0	SENT_101	[p5l459t1065r840b1148],
56	,	,	O	,	_	0	SENT_101	[p5l459t1065r840b1148],
57	this	DT	O	this	dep	59	SENT_101	[p5l861t1064r983b1127],
58	is	VBZ	O	be	auxpass	59	SENT_101	[p5l1004t1070r1053b1127],
59	known	VBN	O	know	dep	55	SENT_101	[p5l1073t1064r1306b1127],
60	as	IN	O	as	_	0	SENT_101	[p5l1327t1087r1391b1127],
61	radiologically	RB	O	radiologically	advmod	62	SENT_101	[p5l1411t1064r1875b1148],
62	isolated	VBN	O	isolate	amod	63	SENT_101	[p5l1891t1064r2150b1127],
63	syndrome	NN	O	syndrome	prep_as	59	SENT_101	[p5l8t1158r488b1251],
64	.8	CD	NUMBER	.8	num	67	SENT_101	[p5l8t1158r488b1251],
65	‘	NN	O	‘	nn	67	SENT_101	[p5l8t1158r488b1251],
66	1	CD	NUMBER	1	num	67	SENT_101	[p5l8t1158r488b1251],
67	°	NN	O	°	nsubjpass	59	SENT_101	[p5l8t1158r488b1251],
68	Once	IN	DATE	once	mark	74	SENT_101	[p5l510t1170r688b1230],
69	the	DT	O	the	det	71	SENT_101	[p5l707t1166r812b1230],
70	ﬁrst	NN	O	ﬁrst	nn	71	SENT_101	[p5l832t1166r963b1230],
71	symptom	NN	O	symptom	nsubj	74	SENT_101	[p5l983t1178r1299b1251],
72	of	IN	O	of	_	0	SENT_101	[p5l1319t1166r1392b1230],
73	MS	NN	O	m	prep_of	71	SENT_101	[p5l1402t1170r1514b1230],
74	appears	VBZ	O	appear	advcl	80	SENT_101	[p5l1536t1189r1810b1250],
75	,	,	O	,	_	0	SENT_101	[p5l1536t1189r1810b1250],
76	this	DT	O	this	det	78	SENT_101	[p5l1831t1166r1953b1230],
77	clinical	JJ	O	clinical	amod	78	SENT_101	[p5l1975t1167r2147b1230, p5l8t1270r102b1333],
78	scenario	NN	O	scenario	nsubjpass	80	SENT_101	[p5l125t1276r411b1333],
79	is	VBZ	O	be	auxpass	80	SENT_101	[p5l436t1276r486b1333],
80	known	VBN	O	know	ccomp	55	SENT_101	[p5l508t1270r748b1333],
81	as	IN	O	as	_	0	SENT_101	[p5l771t1293r835b1333],
82	CIS	NN	ORGANIZATION	ci	prep_as	80	SENT_101	[p5l860t1274r1001b1333],
83	.	.	O	.	_	0	SENT_101	[p5l860t1274r1001b1333],

1	CIS	NN	ORGANIZATION	ci	nsubj	2	SENT_102	[p5l1029t1274r1151b1333],
2	evolves	VBZ	O	evolve	_	0	SENT_102	[p5l1176t1270r1422b1333],
3	in	IN	O	in	_	0	SENT_102	[p5l1446t1276r1513b1332],
4	an	DT	O	a	det	6	SENT_102	[p5l1536t1293r1617b1333],
5	age	NN	O	age	nn	6	SENT_102	[p5l1640t1270r2153b1354],
6	—	NN	O	—	nn	8	SENT_102	[p5l1640t1270r2153b1354],
7	dependent	JJ	O	dependent	amod	8	SENT_102	[p5l1640t1270r2153b1354],
8	fashion	NN	O	fashion	prep_in	2	SENT_102	[p5l7t1373r251b1436],
9	to	TO	O	to	infmod	8	SENT_102	[p5l269t1385r334b1436],
10	either	CC	O	either	prep	2	SENT_102	[p5l355t1373r547b1436],
11	multiple	JJ	O	multiple	amod	13	SENT_102	[p5l565t1373r843b1456],
12	symptomatic	JJ	O	symptomatic	amod	13	SENT_102	[p5l863t1379r1295b1457],
13	attacks	NNS	O	attack	dep	10	SENT_102	[p5l1315t1373r1558b1445],
14	,	,	O	,	_	0	SENT_102	[p5l1315t1373r1558b1445],
15	known	VBN	O	know	partmod	13	SENT_102	[p5l1578t1373r1810b1436],
16	as	IN	O	as	_	0	SENT_102	[p5l1830t1396r1893b1436],
17	RRMS	NN	O	rrm	prep_as	15	SENT_102	[p5l1913t1377r2147b1445],
18	,	,	O	,	_	0	SENT_102	[p5l1913t1377r2147b1445],
19	or	CC	O	or	_	0	SENT_102	[p5l8t1499r82b1539],
20	further	RB	O	further	advmod	17	SENT_102	[p5l105t1476r357b1539],
21	new	JJ	O	new	amod	22	SENT_102	[p5l380t1499r527b1539],
22	asymptomatic	JJ	O	asymptomatic	amod	24	SENT_102	[p5l549t1482r1046b1560],
23	MRI	NNP	O	MRI	nn	24	SENT_102	[p5l1069t1481r1229b1539],
24	activity	NN	O	activity	prep_as	15	SENT_102	[p5l1255t1482r1525b1560],
25	,	,	O	,	_	0	SENT_102	[p5l1255t1482r1525b1560],
26	known	VBN	O	know	partmod	17	SENT_102	[p5l1550t1476r1794b1539],
27	as	IN	O	as	_	0	SENT_102	[p5l1819t1499r1885b1539],
28	SAMS	NNP	O	SAMS	prep_as	26	SENT_102	[p5l1911t1480r2149b1539],
29	.	.	O	.	_	0	SENT_102	[p5l1911t1480r2149b1539],

1	We	PRP	O	we	nsubj	3	SENT_103	[p5l6t1584r117b1642],
2	have	VBP	O	have	aux	3	SENT_103	[p5l139t1579r297b1642],
3	introduced	VBN	O	introduce	_	0	SENT_103	[p5l320t1579r705b1642],
4	a	DT	O	a	det	7	SENT_103	[p5l728t1602r762b1642],
5	new	JJ	O	new	amod	7	SENT_103	[p5l784t1602r929b1642],
6	diagnostic	JJ	O	diagnostic	amod	7	SENT_103	[p5l950t1579r1308b1663],
7	category	NN	O	category	dobj	3	SENT_103	[p5l1331t1591r1628b1663],
8	to	TO	O	to	aux	9	SENT_103	[p5l1646t1591r1713b1642],
9	separate	VB	O	separate	xcomp	3	SENT_103	[p5l1738t1591r2021b1662],
10	the	DT	O	the	det	11	SENT_103	[p5l2043t1579r2151b1642],
11	patients	NNS	O	patient	dobj	9	SENT_103	[p5l6t1688r271b1765],
12	previously	RB	DATE	previously	advmod	9	SENT_103	[p5l290t1682r642b1766],
13	categorized	VBN	O	categorize	dep	9	SENT_103	[p5l659t1682r1042b1766],
14	as	IN	O	as	_	0	SENT_103	[p5l1062t1705r1125b1745],
15	CIS	NN	ORGANIZATION	ci	prep_as	13	SENT_103	[p5l1146t1686r1266b1745],
16	but	CC	O	but	_	0	SENT_103	[p5l1285t1682r1397b1745],
17	who	WP	O	who	nsubj	46	SENT_103	[p5l1414t1682r1575b1754],
18	,	,	O	,	_	0	SENT_103	[p5l1414t1682r1575b1754],
19	as	IN	O	as	mark	20	SENT_103	[p5l1597t1705r1660b1745],
20	deﬁned	VBN	O	deﬁned	dep	46	SENT_103	[p5l1681t1682r1932b1745],
21	by	IN	O	by	_	0	SENT_103	[p5l1949t1682r2032b1766],
22	the	DT	O	the	det	26	SENT_103	[p5l2047t1682r2152b1745],
23	most	RBS	O	most	advmod	26	SENT_103	[p5l7t1796r178b1848],
24	recent	JJ	O	recent	amod	26	SENT_103	[p5l200t1796r411b1848],
25	MS	NN	O	m	nn	26	SENT_103	[p5l433t1788r547b1848],
26	criteria	NNS	O	criterion	prep_by	20	SENT_103	[p5l571t1776r869b1857],
27	,4	CD	NUMBER	,4	num	28	SENT_103	[p5l571t1776r869b1857],
28	fulﬁll	NN	O	fulﬁll	dobj	20	SENT_103	[p5l891t1784r1074b1848],
29	the	DT	O	the	det	31	SENT_103	[p5l1095t1784r1202b1848],
30	radiological	JJ	O	radiological	amod	31	SENT_103	[p5l1225t1784r1633b1869],
31	criteria	NNS	O	criterion	dep	28	SENT_103	[p5l1656t1791r1902b1848],
32	for	IN	O	for	_	0	SENT_103	[p5l1924t1784r2022b1848],
33	the	DT	O	the	det	34	SENT_103	[p5l2042t1784r2149b1848],
34	diagnosis	NN	O	diagnosis	prep_for	28	SENT_103	[p5l8t1888r321b1972],
35	of	IN	O	of	_	0	SENT_103	[p5l342t1888r414b1951],
36	MS.	NNP	O	MS.	prep_of	34	SENT_103	[p5l425t1892r553b1951],
37	We	PRP	O	we	nsubj	38	SENT_103	[p5l575t1893r682b1951],
38	call	VBP	O	call	rcmod	28	SENT_103	[p5l703t1888r816b1951],
39	this	DT	O	this	det	40	SENT_103	[p5l834t1888r956b1951],
40	group	NN	O	group	nsubj	43	SENT_103	[p5l976t1910r1172b1972],
41	the	DT	O	the	det	43	SENT_103	[p5l1192t1888r1297b1951],
42	SAMS	NNP	ORGANIZATION	SAMS	nn	43	SENT_103	[p5l1318t1892r1527b1951],
43	group	NN	O	group	xcomp	38	SENT_103	[p5l1548t1910r1760b1972],
44	,	,	O	,	_	0	SENT_103	[p5l1548t1910r1760b1972],
45	as	IN	O	as	advmod	46	SENT_103	[p5l1782t1911r1845b1951],
46	opposed	VBN	O	oppose	dep	9	SENT_103	[p5l1866t1888r2150b1971],
47	to	TO	O	to	_	0	SENT_103	[p5l6t2003r74b2054],
48	the	DT	O	the	det	50	SENT_103	[p5l98t1991r207b2054],
49	RRMS	NNS	O	rrm	nn	50	SENT_103	[p5l232t1995r457b2054],
50	group	NN	O	group	prep_to	46	SENT_103	[p5l482t2013r705b2075],
51	,	,	O	,	_	0	SENT_103	[p5l482t2013r705b2075],
52	per	IN	O	per	_	0	SENT_103	[p5l730t2013r846b2074],
53	the	DT	O	the	det	54	SENT_103	[p5l867t1991r977b2054],
54	criteria	NNS	O	criterion	prep_per	3	SENT_103	[p5l1002t1997r1270b2054],
55	.	.	O	.	_	0	SENT_103	[p5l1002t1997r1270b2054],

1	The	DT	O	the	det	2	SENT_104	[p5l1297t1991r1425b2054],
2	separation	NN	O	separation	nsubj	16	SENT_104	[p5l1450t1997r1817b2074],
3	of	IN	O	of	_	0	SENT_104	[p5l1841t1991r1917b2054],
4	SAMS	NNP	O	SAMS	prep_of	2	SENT_104	[p5l1931t1995r2150b2054],
5	from	IN	O	from	_	0	SENT_104	[p5l7t2094r174b2157],
6	CIS	NN	ORGANIZATION	ci	prep_from	4	SENT_104	[p5l195t2098r316b2157],
7	and	CC	O	and	_	0	SENT_104	[p5l338t2094r464b2157],
8	RRMS	NN	O	rrm	prep_from	4	SENT_104	[p5l483t2098r702b2157],
9	is	VBZ	O	be	cop	16	SENT_104	[p5l723t2100r773b2157],
10	signiﬁcant	JJ	O	signiﬁcant	amod	16	SENT_104	[p5l795t2094r1147b2178],
11	from	IN	O	from	_	0	SENT_104	[p5l1166t2094r1332b2157],
12	a	DT	O	a	det	15	SENT_104	[p5l1353t2117r1388b2157],
13	treatment	NN	O	treatment	nn	15	SENT_104	[p5l1406t2094r2149b2177],
14	—	CD	NUMBER	—	num	15	SENT_104	[p5l1406t2094r2149b2177],
15	application	NN	O	application	prep_from	10	SENT_104	[p5l1406t2094r2149b2177],
16	perspective	NN	O	perspective	_	0	SENT_104	[p5l6t2204r424b2281],
17	.	.	O	.	_	0	SENT_104	[p5l6t2204r424b2281],

1	The	DT	O	the	det	4	SENT_105	[p5l451t2198r578b2261],
2	primary	JJ	O	primary	amod	4	SENT_105	[p5l601t2204r893b2282],
3	outcome	NN	O	outcome	nn	4	SENT_105	[p5l913t2210r1218b2261],
4	measure	NN	O	measure	nsubj	13	SENT_105	[p5l1241t2221r1536b2261],
5	in	IN	O	in	_	0	SENT_105	[p5l1560t2204r1628b2260],
6	earlier	JJR	O	earlier	amod	8	SENT_105	[p5l1653t2198r1876b2261],
7	clinical	JJ	O	clinical	amod	8	SENT_105	[p5l1899t2198r2152b2261],
8	trials	NNS	O	trial	prep_in	4	SENT_105	[p5l6t2301r179b2364],
9	in	IN	O	in	_	0	SENT_105	[p5l203t2307r270b2363],
10	CIS	NN	ORGANIZATION	ci	prep_in	8	SENT_105	[p5l294t2305r417b2364],
11	was	VBD	O	be	cop	13	SENT_105	[p5l439t2324r567b2364],
12	the	DT	O	the	det	13	SENT_105	[p5l590t2301r697b2364],
13	development	NN	O	development	_	0	SENT_105	[p5l721t2301r1170b2384],
14	of	IN	O	of	_	0	SENT_105	[p5l1192t2301r1267b2364],
15	a	DT	DURATION	a	det	18	SENT_105	[p5l1281t2324r1316b2364],
16	second	JJ	DURATION	second	amod	18	SENT_105	[p5l1338t2301r1579b2364],
17	clinical	JJ	O	clinical	amod	18	SENT_105	[p5l1602t2301r1849b2364],
18	event	NN	O	event	prep_of	13	SENT_105	[p5l1872t2313r2056b2364],
19	or	CC	O	or	_	0	SENT_105	[p5l2079t2324r2151b2364],
20	clinically	RB	O	clinically	advmod	21	SENT_105	[p5l8t2403r321b2488],
21	deﬁnite	JJ	O	deﬁnite	amod	22	SENT_105	[p5l341t2403r600b2467],
22	MS	NN	O	m	prep_of	13	SENT_105	[p5l623t2407r737b2467],
23	by	IN	O	by	_	0	SENT_105	[p5l759t2404r844b2488],
24	the	DT	O	the	det	26	SENT_105	[p5l863t2403r970b2467],
25	Poser	NNP	O	Poser	nn	26	SENT_105	[p5l994t2409r1184b2467],
26	criteria	NNS	O	criterion	prep_by	13	SENT_105	[p5l1207t2395r1615b2467],
27	.11	CD	NUMBER	.11	number	28	SENT_105	[p5l1207t2395r1615b2467],
28	’12	CD	NUMBER	’12	npadvmod	13	SENT_105	[p5l1207t2395r1615b2467],
29	Of	IN	O	of	_	0	SENT_105	[p5l1640t2403r1735b2467],
30	the	DT	O	the	det	31	SENT_105	[p5l1748t2403r1855b2467],
31	patients	NNS	O	patient	prep_of	13	SENT_105	[p5l1878t2410r2150b2487],
32	enrolled	VBN	O	enrol	partmod	31	SENT_105	[p5l8t2507r297b2570],
33	in	IN	O	in	_	0	SENT_105	[p5l319t2513r387b2569],
34	one	CD	NUMBER	one	prep_in	32	SENT_105	[p5l411t2530r536b2570],
35	of	IN	O	of	_	0	SENT_105	[p5l561t2507r636b2570],
36	these	DT	O	these	det	37	SENT_105	[p5l649t2507r828b2570],
37	studies	NNS	O	study	prep_of	34	SENT_105	[p5l853t2507r1113b2579],
38	,	,	O	,	_	0	SENT_105	[p5l853t2507r1113b2579],
39	72	CD	PERCENT	72	num	40	SENT_105	[p5l1139t2512r1283b2571],
40	%	NN	PERCENT	%	nsubj	41	SENT_105	[p5l1139t2512r1283b2571],
41	fulﬁlled	VBD	O	fulﬁlled	dep	13	SENT_105	[p5l1309t2507r1581b2570],
42	the	DT	O	the	det	44	SENT_105	[p5l1602t2507r1711b2570],
43	radiological	JJ	O	radiological	amod	44	SENT_105	[p5l1735t2507r2151b2591],
44	criteria	NNS	O	criterion	dobj	41	SENT_105	[p5l8t2616r266b2673],
45	for	IN	O	for	_	0	SENT_105	[p5l292t2610r395b2673],
46	MS	NN	O	m	prep_for	41	SENT_105	[p5l420t2614r537b2673],
47	during	IN	O	during	_	0	SENT_105	[p5l567t2610r808b2694],
48	enrollment	NN	O	enrollment	prep_during	41	SENT_105	[p5l835t2610r1251b2682],
49	,	,	O	,	_	0	SENT_105	[p5l835t2610r1251b2682],
50	and	CC	O	and	_	0	SENT_105	[p5l1281t2610r1413b2673],
51	30	CD	PERCENT	30	num	52	SENT_105	[p5l1440t2615r1587b2674],
52	%	NN	PERCENT	%	nsubj	53	SENT_105	[p5l1440t2615r1587b2674],
53	had	VBD	O	have	conj_and	13	SENT_105	[p5l1615t2610r1748b2673],
54	enhancing	VBG	O	enhance	xcomp	53	SENT_105	[p5l1776t2610r2152b2694],
55	lesions	NNS	O	lesion	dobj	54	SENT_105	[p5l6t2704r322b2776],
56	.	.	O	.	_	0	SENT_105	[p5l6t2704r322b2776],

1	”	NN	O	”	_	0	SENT_106	[p5l6t2704r322b2776],
2	Therefore	RB	O	therefore	advmod	8	SENT_106	[p5l346t2712r696b2785],
3	,	,	O	,	_	0	SENT_106	[p5l346t2712r696b2785],
4	approximately	RB	O	approximately	advmod	8	SENT_106	[p5l722t2712r1219b2797],
5	one	CD	NUMBER	one	num	7	SENT_106	[p5l1239t2712r1569b2776],
6	—	NN	O	—	nn	7	SENT_106	[p5l1239t2712r1569b2776],
7	third	NN	ORDINAL	third	pobj	4	SENT_106	[p5l1239t2712r1569b2776],
8	of	IN	O	of	dep	1	SENT_106	[p5l1592t2712r1666b2776],
9	these	DT	O	these	det	10	SENT_106	[p5l1679t2712r1856b2776],
10	patients	NNS	O	patient	pobj	8	SENT_106	[p5l1878t2719r2150b2796],

1	VOLUME	NN	O	volume	nn	3	SENT_107	[p5l542t2932r767b2974],
2	95	CD	NUMBER	95	num	3	SENT_107	[p5l784t2933r841b2974],
3	NUMBER	NN	O	number	_	0	SENT_107	[p5l862t2932r1086b2974],
4	1	CD	NUMBER	1	number	5	SENT_107	[p5l1108t2934r1121b2974],
5	|	CD	NUMBER	|	dep	3	SENT_107	[p5l1150t2928r1155b2989],
6	JANUARY	NNP	DATE	JANUARY	dep	5	SENT_107	[p5l1174t2932r1419b2974],
7	2014	CD	DATE	2014	num	6	SENT_107	[p5l1436t2933r1557b2974],
8	|	CD	NUMBER	|	num	9	SENT_107	[p5l1576t2928r1580b2989],
9	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	3	SENT_107	[p5l1599t2932r2151b2985],

1	STATE	NN	O	state	nn	2	SENT_108	[p5l1761t3104r1902b3141],
2	ART	NN	O	art	_	0	SENT_108	[p5l2045t3104r2139b3141],

1	qualify	VB	O	qualify	ccomp	40	SENT_109	[p6l8t93r248b178],
2	as	IN	O	as	_	0	SENT_109	[p6l267t116r331b157],
3	SAMS	NNP	O	SAMS	prep_as	1	SENT_109	[p6l356t97r588b166],
4	,	,	O	,	_	0	SENT_109	[p6l356t97r588b166],
5	whereas	IN	O	whereas	mark	8	SENT_109	[p6l610t93r888b157],
6	the	DT	O	the	det	7	SENT_109	[p6l910t93r1017b157],
7	others	NNS	O	other	nsubj	8	SENT_109	[p6l1040t93r1252b157],
8	qualify	VBP	O	qualify	advcl	1	SENT_109	[p6l1275t93r1515b178],
9	as	IN	O	as	_	0	SENT_109	[p6l1534t116r1599b157],
10	CIS	NN	ORGANIZATION	ci	prep_as	8	SENT_109	[p6l1623t85r1797b157],
11	.4	CD	NUMBER	.4	num	10	SENT_109	[p6l1623t85r1797b157],
12	Given	VBN	O	give	partmod	10	SENT_109	[p6l1820t97r2023b157],
13	the	DT	O	the	det	15	SENT_109	[p6l2044t93r2151b157],
14	high	JJ	O	high	amod	15	SENT_109	[p6l7t197r161b281],
15	correlation	NN	O	correlation	dobj	12	SENT_109	[p6l182t197r558b260],
16	between	IN	O	between	_	0	SENT_109	[p6l577t197r864b260],
17	the	DT	O	the	det	19	SENT_109	[p6l884t197r991b260],
18	effect	NN	O	effect	nn	19	SENT_109	[p6l1012t197r1195b260],
19	size	NN	O	size	prep_between	15	SENT_109	[p6l1216t203r1339b260],
20	and	CC	O	and	_	0	SENT_109	[p6l1361t197r1488b260],
21	higher	JJR	O	higher	amod	23	SENT_109	[p6l1507t197r1731b281],
22	lesion	NN	O	lesion	nn	23	SENT_109	[p6l1750t197r1952b260],
23	loads	NNS	O	load	conj_and	19	SENT_109	[p6l1971t197r2150b260],
24	from	IN	O	from	_	0	SENT_109	[p6l7t300r175b363],
25	the	DT	O	the	det	28	SENT_109	[p6l195t300r302b363],
26	original	JJ	O	original	amod	28	SENT_109	[p6l323t300r590b384],
27	CIS	NN	ORGANIZATION	ci	nn	28	SENT_109	[p6l611t304r733b363],
28	trials	NNS	O	trial	prep_from	12	SENT_109	[p6l754t300r926b363],
29	as	IN	O	as	mark	30	SENT_109	[p6l948t323r1012b363],
30	discussed	VBN	O	discuss	advcl	12	SENT_109	[p6l1034t300r1361b363],
31	in	IN	O	in	_	0	SENT_109	[p6l1381t306r1448b362],
32	detail	NN	O	detail	prepc_in	30	SENT_109	[p6l1469t300r1657b363],
33	further	RB	O	further	advmod	32	SENT_109	[p6l1678t300r1922b363],
34	in	IN	O	in	_	0	SENT_109	[p6l1941t306r2008b362],
35	this	DT	O	this	det	36	SENT_109	[p6l2028t300r2152b363],
36	review	NN	O	review	prep_in	32	SENT_109	[p6l8t409r253b475],
37	,	,	O	,	_	0	SENT_109	[p6l8t409r253b475],
38	it	PRP	O	it	nsubj	40	SENT_109	[p6l280t409r327b466],
39	is	VBZ	O	be	cop	40	SENT_109	[p6l351t409r403b466],
40	logical	JJ	O	logical	_	0	SENT_109	[p6l427t403r661b487],
41	to	TO	O	to	aux	42	SENT_109	[p6l685t415r753b466],
42	suggest	VB	O	suggest	xcomp	40	SENT_109	[p6l780t415r1038b487],
43	that	IN	O	that	complm	52	SENT_109	[p6l1061t403r1200b466],
44	the	DT	O	the	det	45	SENT_109	[p6l1223t403r1332b466],
45	responders	NNS	O	responder	nsubj	52	SENT_109	[p6l1358t403r1749b486],
46	to	TO	O	to	_	0	SENT_109	[p6l1773t415r1841b466],
47	diseasemodifying	VBG	O	diseasemodify	amod	48	SENT_109	[p6l1868t403r2147b466, p6l7t506r370b590],
48	treatments	NNS	O	treatment	prep_to	45	SENT_109	[p6l390t518r758b569],
49	in	IN	O	in	_	0	SENT_109	[p6l782t512r849b568],
50	these	DT	O	these	det	51	SENT_109	[p6l871t506r1048b569],
51	trials	NNS	O	trial	prep_in	48	SENT_109	[p6l1069t506r1242b569],
52	had	VBD	O	have	ccomp	42	SENT_109	[p6l1265t506r1393b569],
53	SAMS	NNP	O	SAMS	dobj	52	SENT_109	[p6l1416t510r1648b569],
54	.	.	O	.	_	0	SENT_109	[p6l1416t510r1648b569],

1	It	PRP	O	it	nsubj	3	SENT_110	[p6l1675t511r1724b569],
2	is	VBZ	O	be	cop	3	SENT_110	[p6l1746t512r1797b569],
3	unknown	JJ	O	unknown	_	0	SENT_110	[p6l1820t506r2152b569],
4	whether	IN	O	whether	complm	16	SENT_110	[p6l6t608r288b672],
5	CIS	NN	ORGANIZATION	ci	nsubj	16	SENT_110	[p6l309t612r450b681],
6	,	,	O	,	_	0	SENT_110	[p6l309t612r450b681],
7	as	IN	O	as	mark	8	SENT_110	[p6l473t631r537b672],
8	deﬁned	VBN	O	deﬁned	dep	5	SENT_110	[p6l559t608r813b672],
9	by	IN	O	by	_	0	SENT_110	[p6l831t609r915b693],
10	current	JJ	DATE	current	amod	12	SENT_110	[p6l932t620r1184b672],
11	MS	NN	O	m	nn	12	SENT_110	[p6l1203t612r1316b672],
12	criteria	NNS	O	criterion	prep_by	8	SENT_110	[p6l1338t600r1634b681],
13	,4	CD	NUMBER	,4	tmod	8	SENT_110	[p6l1338t600r1634b681],
14	would	MD	O	would	aux	16	SENT_110	[p6l1653t608r1867b672],
15	actually	RB	O	actually	advmod	16	SENT_110	[p6l1887t608r2154b693],
16	respond	VB	O	respond	ccomp	3	SENT_110	[p6l8t712r286b795],
17	positively	RB	O	positively	advmod	16	SENT_110	[p6l304t712r635b796],
18	to	TO	O	to	_	0	SENT_110	[p6l651t724r717b775],
19	MS	NN	O	m	nn	20	SENT_110	[p6l738t716r852b775],
20	drugs	NNS	O	drug	prep_to	16	SENT_110	[p6l875t712r1066b796],
21	within	IN	O	within	_	0	SENT_110	[p6l1086t712r1309b775],
22	the	DT	O	the	det	26	SENT_110	[p6l1329t712r1435b775],
23	previous	JJ	O	previous	amod	26	SENT_110	[p6l1455t718r1748b795],
24	trial	NN	O	trial	nn	26	SENT_110	[p6l1768t712r1909b775],
25	design	NN	O	design	nn	26	SENT_110	[p6l1930t712r2151b796],
26	paradigms	NNS	O	paradigm	prep_within	20	SENT_110	[p6l6t815r386b899],
27	.	.	O	.	_	0	SENT_110	[p6l6t815r386b899],

1	For	IN	O	for	_	0	SENT_111	[p6l82t924r200b982],
2	most	JJS	O	most	amod	3	SENT_111	[p6l221t931r394b982],
3	patients	NNS	O	patient	prep_for	10	SENT_111	[p6l415t925r708b1002],
4	,	,	O	,	_	0	SENT_111	[p6l415t925r708b1002],
5	a	DT	O	a	det	8	SENT_111	[p6l734t942r768b982],
6	progressive	JJ	O	progressive	amod	8	SENT_111	[p6l789t925r1183b1003],
7	disease	NN	O	disease	nn	8	SENT_111	[p6l1207t919r1451b982],
8	course	NN	O	course	nsubjpass	10	SENT_111	[p6l1476t942r1701b982],
9	is	VBZ	O	be	auxpass	10	SENT_111	[p6l1725t925r1775b982],
10	characterized	VBN	O	characterize	_	0	SENT_111	[p6l1800t919r2148b982, p6l8t1022r149b1085],
11	by	IN	O	by	_	0	SENT_111	[p6l168t1022r253b1106],
12	an	DT	O	a	det	17	SENT_111	[p6l274t1045r354b1085],
13	insidiously	RB	O	insidiously	advmod	14	SENT_111	[p6l378t1022r756b1106],
14	worsening	VBG	O	worsen	amod	17	SENT_111	[p6l774t1028r1138b1106],
15	neurological	JJ	O	neurological	amod	17	SENT_111	[p6l1159t1022r1593b1106],
16	dysfunction	NN	O	dysfunction	nn	17	SENT_111	[p6l1616t1022r2029b1106],
17	(	NN	O	(	agent	10	SENT_111	[p6l2056t1023r2148b1098],
18	as	IN	O	as	mark	24	SENT_111	[p6l2056t1023r2148b1098],
19	opposed	VBN	O	oppose	csubj	24	SENT_111	[p6l8t1125r295b1208],
20	to	TO	O	to	_	0	SENT_111	[p6l313t1137r379b1188],
21	discrete	JJ	O	discrete	amod	23	SENT_111	[p6l401t1125r661b1188],
22	clinical	JJ	O	clinical	amod	23	SENT_111	[p6l683t1125r925b1188],
23	attacks	NNS	O	attack	prep_to	19	SENT_111	[p6l946t1125r1222b1202],
24	)	VBP	O	)	advcl	10	SENT_111	[p6l946t1125r1222b1202],
25	.	.	O	.	_	0	SENT_111	[p6l946t1125r1222b1202],

1	When	WRB	O	when	advmod	5	SENT_112	[p6l1244t1125r1453b1188],
2	a	DT	O	a	det	4	SENT_112	[p6l1474t1148r1508b1188],
3	progressive	JJ	O	progressive	amod	4	SENT_112	[p6l1526t1131r1909b1209],
4	course	NN	O	course	nsubj	5	SENT_112	[p6l1930t1148r2150b1188],
5	follows	VBZ	O	follow	advcl	10	SENT_112	[p6l7t1228r252b1291],
6	RRMS	NNS	O	rrm	dobj	5	SENT_112	[p6l276t1232r518b1300],
7	,	,	O	,	_	0	SENT_112	[p6l276t1232r518b1300],
8	it	PRP	O	it	nsubjpass	10	SENT_112	[p6l542t1234r588b1291],
9	is	VBZ	O	be	auxpass	10	SENT_112	[p6l610t1234r661b1291],
10	labeled	VBN	O	label	_	0	SENT_112	[p6l683t1228r929b1291],
11	as	IN	O	as	_	0	SENT_112	[p6l952t1251r1017b1291],
12	SPMS	NN	O	spm	prep_as	10	SENT_112	[p6l1042t1232r1262b1291],
13	.	.	O	.	_	0	SENT_112	[p6l1042t1232r1262b1291],

1	If	IN	O	if	mark	3	SENT_113	[p6l1289t1228r1348b1290],
2	progression	NN	O	progression	nsubj	3	SENT_113	[p6l1360t1234r1767b1312],
3	starts	VBZ	O	start	advcl	10	SENT_113	[p6l1790t1240r1974b1291],
4	after	IN	O	after	_	0	SENT_113	[p6l1998t1228r2152b1291],
5	a	DT	O	a	det	7	SENT_113	[p6l8t1353r44b1394],
6	SAMS-type	JJ	O	sams-type	amod	7	SENT_113	[p6l70t1334r480b1415],
7	presentation	NN	O	presentation	prep_after	3	SENT_113	[p6l505t1337r972b1414],
8	,	,	O	,	_	0	SENT_113	[p6l505t1337r972b1414],
9	we	PRP	O	we	nsubj	10	SENT_113	[p6l998t1353r1094b1394],
10	label	VBP	O	label	_	0	SENT_113	[p6l1118t1330r1286b1394],
11	that	IN	O	that	complm	22	SENT_113	[p6l1311t1330r1451b1394],
12	as	IN	O	as	_	0	SENT_113	[p6l1476t1353r1543b1394],
13	SAPMS14	NN	O	sapms14	prep_as	22	SENT_113	[p6l1570t1322r1930b1394],
14	Some	DT	O	some	det	15	SENT_113	[p6l1956t1334r2151b1394],
15	patients	NNS	O	patient	npadvmod	22	SENT_113	[p6l6t1440r269b1517],
16	(	IN	O	(	_	0	SENT_113	[p6l292t1434r534b1511],
17	~	NN	O	~	prep_(	22	SENT_113	[p6l292t1434r534b1511],
18	25	CD	PERCENT	25	number	19	SENT_113	[p6l292t1434r534b1511],
19	%	NN	PERCENT	%	amod	17	SENT_113	[p6l292t1434r534b1511],
20	)	CD	NUMBER	)	nsubj	22	SENT_113	[p6l292t1434r534b1511],
21	will	MD	O	will	aux	22	SENT_113	[p6l556t1434r678b1497],
22	develop	VB	O	develop	ccomp	10	SENT_113	[p6l698t1434r955b1517],
23	only	RB	O	only	quantmod	24	SENT_113	[p6l977t1434r1124b1518],
24	one	CD	NUMBER	one	dobj	22	SENT_113	[p6l1141t1457r1260b1497],
25	or	CC	O	or	_	0	SENT_113	[p6l1281t1457r1351b1497],
26	a	DT	O	a	det	30	SENT_113	[p6l1370t1457r1404b1497],
27	relatively	RB	O	relatively	advmod	28	SENT_113	[p6l1423t1434r1726b1518],
28	few	JJ	O	few	amod	30	SENT_113	[p6l1742t1434r1860b1497],
29	symptomatic	JJ	O	symptomatic	amod	30	SENT_113	[p6l1878t1446r2149b1518, p6l7t1544r197b1601],
30	attacks	NNS	O	attack	conj_or	24	SENT_113	[p6l218t1538r450b1601],
31	and	CC	O	and	_	0	SENT_113	[p6l472t1537r598b1601],
32	not	RB	O	not	conj_and	22	SENT_113	[p6l617t1549r731b1601],
33	experience	VB	O	experience	dep	22	SENT_113	[p6l751t1544r1119b1621],
34	progression	NN	O	progression	dobj	33	SENT_113	[p6l1138t1529r1623b1622],
35	.	.	O	.	_	0	SENT_113	[p6l1138t1529r1623b1622],

1	”	NN	O	”	nsubj	8	SENT_114	[p6l1138t1529r1623b1622],
2	Approximately	RB	O	approximately	quantmod	3	SENT_114	[p6l1642t1537r2154b1622],
3	10	CD	PERCENT	10	num	4	SENT_114	[p6l14t1646r149b1706],
4	%	NN	PERCENT	%	npadvmod	1	SENT_114	[p6l14t1646r149b1706],
5	of	IN	O	of	_	0	SENT_114	[p6l172t1641r245b1704],
6	patients	NNS	O	patient	prep_of	1	SENT_114	[p6l255t1647r521b1724],
7	will	MD	O	will	aux	8	SENT_114	[p6l540t1641r665b1704],
8	reach	VB	O	reach	_	0	SENT_114	[p6l685t1641r868b1704],
9	the	DT	O	the	det	11	SENT_114	[p6l886t1641r992b1704],
10	typical	JJ	O	typical	amod	11	SENT_114	[p6l1011t1641r1238b1725],
11	age	NN	O	age	dobj	8	SENT_114	[p6l1258t1664r1367b1725],
12	of	IN	O	of	_	0	SENT_114	[p6l1387t1641r1461b1704],
13	progression	NN	O	progression	prep_of	11	SENT_114	[p6l1470t1647r1869b1725],
14	without	IN	O	without	_	0	SENT_114	[p6l1887t1641r2152b1704],
15	symptomatic	JJ	O	symptomatic	amod	16	SENT_114	[p6l9t1750r469b1828],
16	attacks	NNS	O	attack	prep_without	8	SENT_114	[p6l495t1744r737b1807],
17	but	CC	O	but	cc	8	SENT_114	[p6l761t1744r878b1807],
18	then	RB	O	then	advmod	8	SENT_114	[p6l901t1744r1061b1807],
19	start	VB	O	start	dep	8	SENT_114	[p6l1087t1756r1245b1807],
20	to	TO	O	to	aux	21	SENT_114	[p6l1268t1756r1336b1807],
21	have	VB	O	have	xcomp	19	SENT_114	[p6l1361t1744r1522b1807],
22	symptomatic	JJ	O	symptomatic	amod	23	SENT_114	[p6l1549t1750r2010b1828],
23	MS	NN	O	m	dobj	21	SENT_114	[p6l2034t1748r2151b1807],
24	with	IN	O	with	_	0	SENT_114	[p6l6t1847r159b1910],
25	progressive	JJ	O	progressive	amod	27	SENT_114	[p6l178t1853r566b1931],
26	disease	NN	O	disease	nn	27	SENT_114	[p6l587t1847r828b1910],
27	course	NN	O	course	prep_with	21	SENT_114	[p6l850t1870r1072b1910],
28	at	IN	O	at	_	0	SENT_114	[p6l1094t1859r1153b1910],
29	initiation	NN	O	initiation	prep_at	27	SENT_114	[p6l1173t1853r1507b1919],
30	,	,	O	,	_	0	SENT_114	[p6l1173t1853r1507b1919],
31	which	WDT	O	which	nsubjpass	33	SENT_114	[p6l1528t1847r1738b1910],
32	is	VBZ	O	be	auxpass	33	SENT_114	[p6l1758t1853r1808b1910],
33	known	VBN	O	know	rcmod	29	SENT_114	[p6l1829t1847r2066b1910],
34	as	IN	O	as	_	0	SENT_114	[p6l2088t1870r2152b1910],
35	PPMS	NNP	O	PPMS	prep_as	33	SENT_114	[p6l8t1954r236b2013],
36	.	.	O	.	_	0	SENT_114	[p6l8t1954r236b2013],

1	Attacks	NNS	O	attack	nsubj	4	SENT_115	[p6l260t1950r515b2013],
2	can	MD	O	can	aux	4	SENT_115	[p6l538t1973r655b2013],
3	also	RB	O	also	advmod	4	SENT_115	[p6l678t1950r809b2013],
4	continue	VB	O	continue	_	0	SENT_115	[p6l833t1956r1133b2013],
5	during	IN	O	during	_	0	SENT_115	[p6l1156t1950r1388b2034],
6	any	DT	O	any	prep_during	4	SENT_115	[p6l1409t1973r1530b2034],
7	of	IN	O	of	_	0	SENT_115	[p6l1550t1950r1624b2013],
8	the	DT	O	the	det	10	SENT_115	[p6l1635t1950r1742b2013],
9	progressive	JJ	O	progressive	amod	10	SENT_115	[p6l1763t1956r2151b2034],
10	disease	NN	O	disease	prep_of	6	SENT_115	[p6l8t2053r246b2117],
11	phases	NNS	O	phase	nsubj	12	SENT_115	[p6l265t2053r489b2137],
12	(	VBP	O	(	rcmod	10	SENT_115	[p6l513t2054r767b2131],
13	PPMS	NNP	O	PPMS	dobj	12	SENT_115	[p6l513t2054r767b2131],
14	,	,	O	,	_	0	SENT_115	[p6l513t2054r767b2131],
15	SAPMS	NNP	O	SAPMS	dobj	12	SENT_115	[p6l789t2057r1067b2126],
16	,	,	O	,	_	0	SENT_115	[p6l789t2057r1067b2126],
17	and	CC	O	and	_	0	SENT_115	[p6l1090t2053r1215b2117],
18	SPMS	NN	O	spm	nn	19	SENT_115	[p6l1235t2054r1460b2130],
19	)	NN	O	)	dobj	12	SENT_115	[p6l1235t2054r1460b2130],
20	of	IN	O	of	_	0	SENT_115	[p6l1486t2053r1559b2117],
21	MS.	NNP	O	MS.	nn	22	SENT_115	[p6l1569t2045r1763b2117],
22	”	NNP	O	”	prep_of	19	SENT_115	[p6l1569t2045r1763b2117],
23	We	PRP	O	we	nsubj	24	SENT_115	[p6l1782t2059r1890b2117],
24	discuss	VBP	O	discuss	rcmod	22	SENT_115	[p6l1911t2053r2151b2117],
25	clinical	JJ	O	clinical	amod	26	SENT_115	[p6l8t2157r251b2220],
26	deﬁnitions	NNS	O	deﬁnitions	dobj	24	SENT_115	[p6l271t2157r632b2220],
27	further	RBR	O	further	advmod	24	SENT_115	[p6l653t2157r895b2220],
28	in	IN	O	in	_	0	SENT_115	[p6l914t2163r980b2219],
29	speciﬁc	JJ	O	speciﬁc	amod	30	SENT_115	[p6l1001t2157r1251b2240],
30	sections	NNS	O	section	nsubj	31	SENT_115	[p6l1272t2163r1543b2220],
31	referring	VBG	O	refer	prepc_in	24	SENT_115	[p6l1563t2157r1863b2241],
32	to	TO	O	to	_	0	SENT_115	[p6l1881t2169r1946b2220],
33	treatment	NN	O	treatment	nn	34	SENT_115	[p6l1966t2169r2147b2220, p6l7t2272r185b2323],
34	approaches	NNS	O	approach	prep_to	31	SENT_115	[p6l206t2260r591b2343],
35	to	TO	O	to	_	0	SENT_115	[p6l612t2272r678b2323],
36	individual	JJ	O	individual	amod	37	SENT_115	[p6l701t2260r1052b2323],
37	phases	NNS	O	phase	prep_to	24	SENT_115	[p6l1072t2260r1299b2343],
38	of	IN	O	of	_	0	SENT_115	[p6l1321t2260r1396b2323],
39	MS.	NNP	O	MS.	prep_of	37	SENT_115	[p6l1407t2264r1539b2323],

1	ACUTE	JJ	O	acute	amod	2	SENT_116	[p6l7t2476r246b2531],
2	TREATMENT	NN	O	treatment	_	0	SENT_116	[p6l261t2476r699b2530],
3	OF	IN	O	of	_	0	SENT_116	[p6l716t2475r810b2531],
4	RELAPSES	NNP	O	RELAPSES	prep_of	2	SENT_116	[p6l833t2476r1192b2531],
5	IN	IN	O	in	_	0	SENT_116	[p6l1214t2476r1283b2530],
6	MS	NN	O	m	prep_in	2	SENT_116	[p6l1306t2476r1410b2531],

1	From	IN	O	from	_	0	SENT_117	[p6l8t2576r200b2634],
2	a	DT	O	a	det	4	SENT_117	[p6l226t2594r261b2634],
3	management	NN	O	management	nn	4	SENT_117	[p6l286t2583r749b2655],
4	perspective	NN	O	perspective	prep_from	7	SENT_117	[p6l772t2577r1197b2654],
5	,	,	O	,	_	0	SENT_117	[p6l772t2577r1197b2654],
6	we	PRP	O	we	nsubj	7	SENT_117	[p6l1223t2594r1319b2634],
7	need	VBP	O	need	_	0	SENT_117	[p6l1345t2571r1515b2634],
8	to	TO	O	to	aux	9	SENT_117	[p6l1539t2583r1607b2634],
9	give	VB	O	give	xcomp	7	SENT_117	[p6l1634t2577r1775b2655],
10	top	JJ	O	top	amod	11	SENT_117	[p6l1800t2583r1914b2654],
11	priority	NN	O	priority	dobj	9	SENT_117	[p6l1940t2577r2148b2654, p6l8t2680r100b2758],
12	to	TO	O	to	_	0	SENT_117	[p6l122t2686r191b2737],
13	treatment	NN	O	treatment	prep_to	9	SENT_117	[p6l218t2686r572b2737],
14	of	IN	O	of	_	0	SENT_117	[p6l598t2674r675b2737],
15	relapses	NNS	O	relapse	prep_of	13	SENT_117	[p6l692t2674r974b2757],
16	in	IN	O	in	_	0	SENT_117	[p6l1002t2680r1071b2736],
17	MS	NN	O	m	nn	19	SENT_117	[p6l1098t2678r1215b2737],
18	(	CD	NUMBER	(	num	19	SENT_117	[p6l1247t2675r1519b2757],
19	Figure	NNP	O	Figure	prep_in	15	SENT_117	[p6l1247t2675r1519b2757],
20	3	CD	NUMBER	3	num	21	SENT_117	[p6l1545t2675r1633b2750],
21	)	NN	O	)	dep	19	SENT_117	[p6l1545t2675r1633b2750],
22	.	.	O	.	_	0	SENT_117	[p6l1545t2675r1633b2750],

1	True	JJ	O	true	advmod	4	SENT_118	[p6l1663t2677r1828b2737],
2	symptomatic	JJ	O	symptomatic	amod	3	SENT_118	[p6l1857t2686r2148b2758, p6l7t2783r198b2840],
3	relapses	NNS	O	relapse	nsubj	4	SENT_118	[p6l220t2777r488b2860],
4	(	VBP	O	(	dep	11	SENT_118	[p6l514t2777r793b2854],
5	attacks	NNS	O	attack	dobj	4	SENT_118	[p6l514t2777r793b2854],
6	,	,	O	,	_	0	SENT_118	[p6l514t2777r793b2854],
7	exacerbations	NNS	O	exacerbation	nsubj	8	SENT_118	[p6l817t2777r1313b2854],
8	)	VBP	O	)	dep	4	SENT_118	[p6l817t2777r1313b2854],
9	should	MD	O	should	aux	11	SENT_118	[p6l1340t2777r1571b2840],
10	be	VB	O	be	auxpass	11	SENT_118	[p6l1590t2777r1670b2840],
11	differentiated	VBN	O	differentiate	_	0	SENT_118	[p6l1692t2777r2152b2840],
12	from	IN	O	from	_	0	SENT_118	[p6l7t2881r181b2944],
13	pseudorelapses	NNS	O	pseudorelaps	prep_from	11	SENT_118	[p6l205t2881r743b2964],
14	(	CD	NUMBER	(	num	15	SENT_118	[p6l772t2881r1322b2964],
15	pseudoattacks	NNS	O	pseudoattack	nsubjpass	11	SENT_118	[p6l772t2881r1322b2964],
16	,	,	O	,	_	0	SENT_118	[p6l772t2881r1322b2964],
17	pseudoexacerbations	NNS	O	pseudoexacerbation	appos	15	SENT_118	[p6l1347t2881r2146b2964],
18	)	CD	NUMBER	)	dep	17	SENT_118	[p6l1347t2881r2146b2964],
19	.	.	O	.	_	0	SENT_118	[p6l1347t2881r2146b2964],

1	Pseudorelapses	NNS	O	pseudorelaps	nsubj	27	SENT_119	[p6l8t2984r523b3067],
2	are	VBP	O	be	cop	4	SENT_119	[p6l545t3007r645b3047],
3	generally	RB	O	generally	advmod	4	SENT_119	[p6l665t2984r978b3068],
4	recurrences	NNS	O	recurrence	_	0	SENT_119	[p6l994t3007r1392b3047],
5	of	IN	O	of	_	0	SENT_119	[p6l1413t2984r1487b3047],
6	existing	VBG	O	exist	amod	7	SENT_119	[p6l1499t2990r1764b3068],
7	symptoms	NNS	O	symptom	prep_of	4	SENT_119	[p6l1783t2996r2151b3068],
8	,	,	O	,	_	0	SENT_119	[p6l1783t2996r2151b3068],
9	usually	RB	O	usually	advmod	10	SENT_119	[p6l7t3087r254b3171],
10	in	IN	O	in	dep	4	SENT_119	[p6l274t3093r341b3149],
11	the	DT	O	the	det	12	SENT_119	[p6l362t3087r470b3150],
12	setting	NN	O	setting	pobj	10	SENT_119	[p6l494t3093r724b3171],
13	of	IN	O	of	_	0	SENT_119	[p6l746t3087r821b3150],
14	infections	NNS	O	infection	prep_of	12	SENT_119	[p6l834t3087r1173b3150],
15	or	CC	O	or	_	0	SENT_119	[p6l1197t3110r1270b3150],
16	other	JJ	O	other	amod	17	SENT_119	[p6l1292t3087r1475b3150],
17	causes	NNS	O	cause	conj_or	12	SENT_119	[p6l1497t3110r1714b3150],
18	of	IN	O	of	_	0	SENT_119	[p6l1738t3087r1812b3150],
19	increased	VBN	O	increase	amod	21	SENT_119	[p6l1826t3087r2153b3150],
20	body	NN	O	body	nn	21	SENT_119	[p6l6t3190r181b3274],
21	temperature	NN	O	temperature	prep_of	17	SENT_119	[p6l197t3202r632b3273],
22	,	,	O	,	_	0	SENT_119	[p6l197t3202r632b3273],
23	fatigue	NN	O	fatigue	appos	21	SENT_119	[p6l655t3190r903b3274],
24	,	,	O	,	_	0	SENT_119	[p6l655t3190r903b3274],
25	and	CC	O	and	_	0	SENT_119	[p6l925t3190r1051b3253],
26	stress	NN	O	stress	dep	27	SENT_119	[p6l1072t3202r1254b3253],
27	unaccompanied	JJ	O	unaccompanied	conj_and	4	SENT_119	[p6l1276t3190r1824b3273],
28	by	IN	O	by	_	0	SENT_119	[p6l1841t3190r1925b3274],
29	objective	JJ	O	objective	amod	31	SENT_119	[p6l1942t3190r2148b3274, p6l7t3299r129b3356],
30	lesion	NN	O	lesion	nn	31	SENT_119	[p6l149t3293r350b3356],
31	development	NN	O	development	prep_by	27	SENT_119	[p6l371t3293r816b3376],
32	or	CC	O	or	_	0	SENT_119	[p6l835t3316r907b3356],
33	new	JJ	O	new	amod	36	SENT_119	[p6l927t3316r1070b3356],
34	neurological	JJ	O	neurological	amod	36	SENT_119	[p6l1087t3293r1515b3377],
35	examination	NN	O	examination	nn	36	SENT_119	[p6l1536t3299r1964b3356],
36	ﬁndings	NNS	O	ﬁndings	conj_or	31	SENT_119	[p6l1984t3293r2148b3356, p6l8t3402r161b3480],
37	.	.	O	.	_	0	SENT_119	[p6l1984t3293r2148b3356, p6l8t3402r161b3480],

1	They	PRP	O	they	nsubj	11	SENT_120	[p6l184t3396r352b3480],
2	typically	RB	O	typically	advmod	11	SENT_120	[p6l367t3396r657b3480],
3	last	JJ	O	last	advmod	11	SENT_120	[p6l673t3396r788b3459],
4	<	JJR	O	<	amod	6	SENT_120	[p6l809t3403r932b3458],
5	24	CD	DURATION	24	num	6	SENT_120	[p6l809t3403r932b3458],
6	hours	NNS	NUMBER	hour	nsubj	11	SENT_120	[p6l952t3396r1145b3459],
7	and	CC	O	and	cc	6	SENT_120	[p6l1166t3396r1292b3459],
8	may	MD	O	may	aux	11	SENT_120	[p6l1310t3419r1456b3480],
9	not	RB	O	not	neg	11	SENT_120	[p6l1472t3408r1585b3459],
10	be	VB	O	be	cop	11	SENT_120	[p6l1602t3396r1681b3459],
11	easy	JJ	O	easy	_	0	SENT_120	[p6l1702t3419r1846b3480],
12	to	TO	O	to	aux	13	SENT_120	[p6l1862t3408r1927b3459],
13	detect	VB	O	detect	xcomp	11	SENT_120	[p6l1949t3396r2153b3459],
14	by	IN	O	by	_	0	SENT_120	[p6l6t3499r92b3583],
15	a	DT	O	a	det	18	SENT_120	[p6l113t3522r149b3562],
16	simple	JJ	O	simple	amod	18	SENT_120	[p6l173t3499r403b3582],
17	telephone	NN	O	telephone	nn	18	SENT_120	[p6l427t3499r774b3582],
18	interview	NN	O	interview	prep_by	13	SENT_120	[p6l799t3505r1144b3562],
19	.	.	O	.	_	0	SENT_120	[p6l799t3505r1144b3562],

1	However	RB	O	however	advmod	5	SENT_121	[p6l1172t3504r1503b3571],
2	,	,	O	,	_	0	SENT_121	[p6l1172t3504r1503b3571],
3	we	PRP	O	we	nsubj	5	SENT_121	[p6l1527t3522r1623b3562],
4	have	VBP	O	have	aux	5	SENT_121	[p6l1646t3499r1807b3562],
5	observed	VBN	O	observe	_	0	SENT_121	[p6l1832t3499r2153b3562],
6	pseudorelapses	NNS	O	pseudorelaps	dobj	5	SENT_121	[p6l6t3602r510b3685],
7	that	WDT	O	that	nsubj	8	SENT_121	[p6l529t3602r660b3665],
8	exceed	VBP	O	exceed	rcmod	6	SENT_121	[p6l679t3602r903b3665],
9	24	CD	DURATION	24	num	10	SENT_121	[p6l921t3609r998b3664],
10	hours	NNS	NUMBER	hour	dobj	8	SENT_121	[p6l1017t3602r1223b3665],
11	.	.	O	.	_	0	SENT_121	[p6l1017t3602r1223b3665],

1	This	DT	O	this	nsubj	4	SENT_122	[p6l1245t3602r1385b3665],
2	is	VBZ	O	be	cop	4	SENT_122	[p6l1405t3608r1454b3665],
3	especially	RB	O	especially	advmod	4	SENT_122	[p6l1475t3602r1798b3686],
4	true	JJ	O	true	_	0	SENT_122	[p6l1812t3614r1948b3665],
5	when	WRB	O	when	advmod	11	SENT_122	[p6l1966t3602r2149b3665],
6	a	DT	O	a	det	7	SENT_122	[p6l8t3728r42b3768],
7	patient	NN	O	patient	poss	10	SENT_122	[p6l60t3705r332b3788],
8	’s	POS	O	’s	_	0	SENT_122	[p6l60t3705r332b3788],
9	provoking	VBG	O	provoke	amod	10	SENT_122	[p6l352t3705r699b3789],
10	factor	NN	O	factor	nsubj	11	SENT_122	[p6l717t3705r913b3768],
11	continues	VBZ	O	continue	advcl	4	SENT_122	[p6l932t3711r1256b3768],
12	without	IN	O	without	_	0	SENT_122	[p6l1275t3705r1539b3768],
13	intervention	NN	O	intervention	nn	16	SENT_122	[p6l1557t3711r1974b3768],
14	(	CD	NUMBER	(	num	16	SENT_122	[p6l1997t3706r2071b3781],
15	e.	NN	O	e.	nn	16	SENT_122	[p6l1997t3706r2071b3781],
16	g.	NN	O	g.	prep_without	11	SENT_122	[p6l2078t3728r2151b3789],
17	,	,	O	,	_	0	SENT_122	[p6l2078t3728r2151b3789],

1	untreated	JJ	O	untreated	amod	2	SENT_123	[p7l7t17r337b80],
2	infection	NN	O	infection	_	0	SENT_123	[p7l358t17r683b89],
3	,	,	O	,	_	0	SENT_123	[p7l358t17r683b89],
4	prolonged	JJ	O	prolonged	amod	6	SENT_123	[p7l705t17r1058b101],
5	heat	NN	O	heat	nn	6	SENT_123	[p7l1077t17r1222b80],
6	exposure	NN	O	exposure	appos	2	SENT_123	[p7l1242t39r1570b100],
7	,	,	O	,	_	0	SENT_123	[p7l1242t39r1570b100],
8	a	DT	O	a	det	10	SENT_123	[p7l1593t40r1628b80],
9	prolonged	JJ	O	prolonged	amod	10	SENT_123	[p7l1647t17r1999b101],
10	episode	NN	O	episode	appos	2	SENT_123	[p7l2020t23r2148b100, p7l8t120r161b183],
11	of	IN	O	of	dep	10	SENT_123	[p7l182t120r254b183],
12	signiﬁcant	JJ	O	signiﬁcant	amod	13	SENT_123	[p7l266t120r616b204],
13	stress	NN	O	stress	pobj	11	SENT_123	[p7l635t132r834b192],
14	,	,	O	,	_	0	SENT_123	[p7l635t132r834b192],
15	or	CC	O	or	_	0	SENT_123	[p7l856t143r927b183],
16	sleep	VB	O	sleep	dep	10	SENT_123	[p7l947t120r1110b203],
17	deprivation	NN	O	deprivation	nn	18	SENT_123	[p7l1133t120r1566b203],
18	)	NN	O	)	dobj	16	SENT_123	[p7l1133t120r1566b203],
19	.	.	O	.	_	0	SENT_123	[p7l1133t120r1566b203],

1	The	DT	O	the	det	2	SENT_124	[p7l1589t120r1712b183],
2	intervention	NN	O	intervention	nsubj	3	SENT_124	[p7l1733t126r2150b183],
3	requires	VBZ	O	require	_	0	SENT_124	[p7l8t229r284b306],
4	reassurance	NN	O	reassurance	dobj	3	SENT_124	[p7l308t246r709b286],
5	and	CC	O	and	_	0	SENT_124	[p7l733t223r859b286],
6	treatment	NN	O	treatment	dobj	3	SENT_124	[p7l881t235r1218b286],
7	to	TO	O	to	aux	8	SENT_124	[p7l1238t235r1304b286],
8	eliminate	VB	O	eliminate	xcomp	3	SENT_124	[p7l1329t223r1647b286],
9	the	DT	O	the	det	11	SENT_124	[p7l1669t223r1776b286],
10	provoking	VBG	O	provoke	amod	11	SENT_124	[p7l1798t223r2152b307],
11	factors	NNS	O	factor	dobj	8	SENT_124	[p7l7t326r254b390],
12	.	.	O	.	_	0	SENT_124	[p7l7t326r254b390],

1	True	JJ	O	true	advmod	4	SENT_125	[p7l81t433r245b493],
2	relapses	NNS	O	relapse	nsubj	4	SENT_125	[p7l270t430r548b513],
3	typically	RB	O	typically	advmod	4	SENT_125	[p7l572t430r877b514],
4	evolve	VBP	O	evolve	_	0	SENT_125	[p7l899t430r1120b493],
5	over	IN	O	over	_	0	SENT_125	[p7l1146t453r1299b493],
6	hours	NNS	DURATION	hour	prep_over	4	SENT_125	[p7l1321t430r1523b493],
7	or	CC	O	or	_	0	SENT_125	[p7l1549t453r1623b493],
8	days	NNS	DURATION	day	prep_over	4	SENT_125	[p7l1648t430r1821b514],
9	,	,	O	,	_	0	SENT_125	[p7l1648t430r1821b514],
10	followed	VBN	O	follow	_	0	SENT_125	[p7l1848t430r2153b493],
11	by	IN	O	by	prepc_followed_by	4	SENT_125	[p7l6t533r90b617],
12	a	DT	O	a	det	14	SENT_125	[p7l110t556r144b596],
13	plateau	NN	O	plateau	nn	14	SENT_125	[p7l165t533r412b616],
14	stage	NN	O	stage	pobj	4	SENT_125	[p7l435t545r603b617],
15	that	WDT	O	that	nsubj	16	SENT_125	[p7l625t533r759b596],
16	persists	VBZ	O	persist	rcmod	14	SENT_125	[p7l780t539r1036b616],
17	for	IN	O	for	_	0	SENT_125	[p7l1059t533r1157b596],
18	several	JJ	DURATION	several	amod	19	SENT_125	[p7l1180t533r1415b596],
19	days	NNS	DURATION	day	prep_for	16	SENT_125	[p7l1438t533r1587b617],
20	to	TO	O	to	_	0	SENT_125	[p7l1609t545r1675b596],
21	weeks	NNS	DURATION	week	nn	22	SENT_125	[p7l1697t533r1902b596],
22	(	NN	O	(	prep_to	16	SENT_125	[p7l1929t533r2154b617],
23	rarely	RB	O	rarely	advmod	24	SENT_125	[p7l1929t533r2154b617],
24	months	NNS	DURATION	month	rcmod	22	SENT_125	[p7l7t636r289b712],
25	)	RB	O	)	advmod	24	SENT_125	[p7l7t636r289b712],
26	and	CC	O	and	_	0	SENT_125	[p7l314t636r438b699],
27	partial	JJ	O	partial	amod	30	SENT_125	[p7l456t636r677b719],
28	or	CC	O	or	_	0	SENT_125	[p7l697t659r768b699],
29	complete	JJ	O	complete	conj_or	27	SENT_125	[p7l787t636r1093b719],
30	recovery	NN	O	recovery	rcmod	22	SENT_125	[p7l1113t659r1412b720],
31	.	.	O	.	_	0	SENT_125	[p7l1113t659r1412b720],

1	Relapses	NNS	O	relapse	nsubj	2	SENT_126	[p7l1436t636r1722b719],
2	characterize	VBP	O	characterize	_	0	SENT_126	[p7l1743t636r2150b699],
3	the	DT	O	the	det	5	SENT_126	[p7l7t739r111b802],
4	early	JJ	O	early	amod	5	SENT_126	[p7l131t739r294b823],
5	stages	NNS	O	stage	dobj	2	SENT_126	[p7l311t751r506b823],
6	of	IN	O	of	_	0	SENT_126	[p7l527t739r599b802],
7	MS	NN	O	m	nn	9	SENT_126	[p7l609t743r721b802],
8	(	CD	NUMBER	(	num	9	SENT_126	[p7l745t740r910b815],
9	CIS	NN	ORGANIZATION	ci	prep_of	5	SENT_126	[p7l745t740r910b815],
10	,	,	O	,	_	0	SENT_126	[p7l745t740r910b815],
11	SAMS	NNP	O	SAMS	prep_of	5	SENT_126	[p7l933t743r1160b811],
12	,	,	O	,	_	0	SENT_126	[p7l933t743r1160b811],
13	and	CC	O	and	_	0	SENT_126	[p7l1183t739r1306b802],
14	RRMS	NN	O	rrm	nn	15	SENT_126	[p7l1326t739r1569b816],
15	)	NN	O	)	prep_of	5	SENT_126	[p7l1326t739r1569b816],
16	but	CC	O	but	_	0	SENT_126	[p7l1590t739r1702b802],
17	can	MD	O	can	aux	18	SENT_126	[p7l1721t762r1835b802],
18	continue	VB	O	continue	conj_but	2	SENT_126	[p7l1856t745r2149b802],
19	through	IN	O	through	_	0	SENT_126	[p7l7t842r294b926],
20	the	DT	O	the	det	22	SENT_126	[p7l316t842r426b905],
21	progressive	JJ	O	progressive	amod	22	SENT_126	[p7l449t848r849b926],
22	phases	NNS	O	phase	prep_through	18	SENT_126	[p7l872t842r1106b925],
23	of	IN	O	of	_	0	SENT_126	[p7l1131t842r1207b905],
24	MS	NN	O	m	prep_of	22	SENT_126	[p7l1220t846r1337b905],
25	as	RB	O	as	_	0	SENT_126	[p7l1363t865r1429b905],
26	well	RB	O	well	_	0	SENT_126	[p7l1452t842r1594b905],
27	(	CD	NUMBER	(	num	28	SENT_126	[p7l1621t843r1884b918],
28	PPMS	NNS	O	ppm	prep_through	18	SENT_126	[p7l1621t843r1884b918],
29	,	,	O	,	_	0	SENT_126	[p7l1621t843r1884b918],
30	SAMS	NNP	O	SAMS	conj_and	22	SENT_126	[p7l1911t846r2150b914],
31	,	,	O	,	_	0	SENT_126	[p7l1911t846r2150b914],
32	and	CC	O	and	_	0	SENT_126	[p7l8t945r136b1008],
33	SPMS	NN	O	spm	nn	34	SENT_126	[p7l159t946r410b1022],
34	)	NN	O	)	conj_and	22	SENT_126	[p7l159t946r410b1022],
35	.	.	O	.	_	0	SENT_126	[p7l159t946r410b1022],

1	This	DT	O	this	nsubj	4	SENT_127	[p7l436t945r580b1008],
2	is	VBZ	O	be	cop	4	SENT_127	[p7l604t951r654b1008],
3	especially	RB	O	especially	advmod	4	SENT_127	[p7l679t945r1015b1029],
4	true	JJ	O	true	_	0	SENT_127	[p7l1033t957r1174b1008],
5	during	IN	O	during	_	0	SENT_127	[p7l1198t945r1431b1029],
6	the	DT	O	the	det	7	SENT_127	[p7l1451t945r1558b1008],
7	ﬁrst	NN	O	ﬁrst	conj_or	7	SENT_127	[p7l1582t945r1716b1008],
8	5	CD	DURATION	5	num	9	SENT_127	[p7l1740t953r1774b1008],
9	years	NNS	NUMBER	year	npadvmod	7	SENT_127	[p7l1796t968r1973b1029],
10	after	IN	O	after	_	0	SENT_127	[p7l1998t945r2151b1008],
11	the	DT	O	the	det	12	SENT_127	[p7l7t1048r117b1111],
12	onset	NN	O	onset	prep_after	7	SENT_127	[p7l143t1060r332b1111],
13	of	IN	O	of	_	0	SENT_127	[p7l358t1048r434b1111],
14	progressive	JJ	O	progressive	amod	17	SENT_127	[p7l448t1054r852b1132],
15	MS	NN	O	m	nn	17	SENT_127	[p7l878t1052r994b1111],
16	disease	NN	O	disease	nn	17	SENT_127	[p7l1022t1048r1272b1111],
17	course	NN	O	course	prep_of	12	SENT_127	[p7l1299t1071r1529b1111],
18	or	CC	O	or	_	0	SENT_127	[p7l1556t1071r1630b1111],
19	before	IN	O	before	_	0	SENT_127	[p7l1653t1048r1876b1111],
20	the	DT	O	the	det	21	SENT_127	[p7l1901t1048r2012b1111],
21	age	NN	O	age	prep_before	7	SENT_127	[p7l2038t1071r2151b1132],
22	of	IN	O	of	_	0	SENT_127	[p7l8t1150r83b1214],
23	59	CD	DURATION	59	num	24	SENT_127	[p7l98t1157r175b1214],
24	years	NNS	NUMBER	year	prep_of	21	SENT_127	[p7l197t1142r459b1235],
25	.	.	O	.	_	0	SENT_127	[p7l197t1142r459b1235],

1	”	NN	O	”	npadvmod	9	SENT_128	[p7l197t1142r459b1235],
2	After	IN	O	after	_	0	SENT_128	[p7l481t1150r660b1214],
3	this	DT	O	this	det	4	SENT_128	[p7l682t1150r808b1214],
4	point	NN	O	point	prep_after	9	SENT_128	[p7l831t1157r1033b1234],
5	,	,	O	,	_	0	SENT_128	[p7l831t1157r1033b1234],
6	relapses	NNS	O	relapse	nsubj	9	SENT_128	[p7l1059t1150r1330b1234],
7	are	VBP	O	be	cop	9	SENT_128	[p7l1355t1173r1457b1214],
8	extremely	RB	O	extremely	advmod	9	SENT_128	[p7l1481t1150r1826b1235],
9	rare	JJ	O	rare	_	0	SENT_128	[p7l1845t1173r1998b1223],
10	,	,	O	,	_	0	SENT_128	[p7l1845t1173r1998b1223],
11	and	CC	O	and	cc	9	SENT_128	[p7l2024t1150r2152b1214],
12	therefore	RB	O	therefore	advmod	9	SENT_128	[p7l7t1254r307b1317],
13	disease-modifying	JJ	O	disease-modifying	amod	14	SENT_128	[p7l328t1254r946b1338],
14	approaches	NNS	O	approach	nsubj	25	SENT_128	[p7l964t1254r1355b1337],
15	,	,	O	,	_	0	SENT_128	[p7l964t1254r1355b1337],
16	as	IN	O	as	mark	17	SENT_128	[p7l1377t1277r1440b1317],
17	discussed	VBN	O	discuss	dep	14	SENT_128	[p7l1461t1254r1779b1317],
18	later	RB	O	later	advmod	17	SENT_128	[p7l1796t1254r1944b1317],
19	in	IN	O	in	_	0	SENT_128	[p7l1962t1260r2027b1316],
20	the	DT	O	the	det	21	SENT_128	[p7l2045t1254r2149b1317],
21	review	NN	O	review	prep_in	17	SENT_128	[p7l8t1363r245b1429],
22	,	,	O	,	_	0	SENT_128	[p7l8t1363r245b1429],
23	are	VBP	O	be	cop	25	SENT_128	[p7l269t1380r369b1420],
24	generally	RB	O	generally	advmod	25	SENT_128	[p7l391t1357r706b1441],
25	ineffective	JJ	O	ineffective	ccomp	9	SENT_128	[p7l724t1357r1076b1420],
26	in	IN	O	in	_	0	SENT_128	[p7l1098t1363r1164b1419],
27	this	DT	O	this	det	29	SENT_128	[p7l1185t1357r1309b1420],
28	speciﬁc	NN	O	speciﬁc	nn	29	SENT_128	[p7l1333t1357r1586b1440],
29	setting	NN	O	setting	prep_in	25	SENT_128	[p7l1609t1363r1853b1441],
30	.	.	O	.	_	0	SENT_128	[p7l1609t1363r1853b1441],

1	Corticosteroids	NNS	MISC	corticosteroid	nsubjpass	4	SENT_129	[p7l82t1460r596b1524],
2	have	VBP	O	have	aux	4	SENT_129	[p7l615t1460r767b1524],
3	been	VBN	O	be	auxpass	4	SENT_129	[p7l784t1460r945b1524],
4	established	VBN	O	establish	_	0	SENT_129	[p7l965t1460r1331b1524],
5	as	IN	O	as	_	0	SENT_129	[p7l1351t1483r1413b1524],
6	an	DT	O	a	det	8	SENT_129	[p7l1434t1483r1512b1524],
7	effective	JJ	O	effective	amod	8	SENT_129	[p7l1532t1460r1804b1524],
8	treatment	NN	O	treatment	prep_as	4	SENT_129	[p7l1823t1472r2150b1524],
9	for	IN	O	for	_	0	SENT_129	[p7l7t1564r104b1627],
10	true	JJ	O	true	amod	12	SENT_129	[p7l123t1576r261b1627],
11	MS	NN	O	m	nn	12	SENT_129	[p7l282t1568r395b1627],
12	relapses	NNS	O	relapse	prep_for	8	SENT_129	[p7l417t1564r702b1647],
13	,	,	O	,	_	0	SENT_129	[p7l417t1564r702b1647],
14	but	CC	O	but	_	0	SENT_129	[p7l722t1564r835b1627],
15	not	RB	O	not	neg	17	SENT_129	[p7l854t1576r968b1627],
16	all	DT	O	all	det	17	SENT_129	[p7l988t1564r1066b1627],
17	relapses	NNS	O	relapse	nsubj	18	SENT_129	[p7l1086t1564r1352b1647],
18	require	VBP	O	require	conj_but	4	SENT_129	[p7l1374t1570r1617b1647],
19	acute	JJ	O	acute	amod	20	SENT_129	[p7l1638t1576r1816b1627],
20	intervention	NN	O	intervention	dobj	18	SENT_129	[p7l1836t1570r2149b1627, p7l7t1673r158b1730],
21	.	.	O	.	_	0	SENT_129	[p7l1836t1570r2149b1627, p7l7t1673r158b1730],

1	Mild	JJ	O	mild	amod	3	SENT_130	[p7l181t1667r345b1730],
2	sensory	JJ	O	sensory	amod	3	SENT_130	[p7l364t1690r626b1751],
3	events	NNS	O	event	nsubj	5	SENT_130	[p7l642t1679r852b1730],
4	seldom	RB	O	seldom	advmod	5	SENT_130	[p7l874t1667r1116b1730],
5	lead	VBP	O	lead	_	0	SENT_130	[p7l1135t1667r1274b1730],
6	to	TO	O	to	_	0	SENT_130	[p7l1292t1679r1357b1730],
7	long-term	JJ	O	long-term	amod	8	SENT_130	[p7l1377t1667r1719b1751],
8	disability	NN	O	disability	prep_to	5	SENT_130	[p7l1740t1667r2056b1751],
9	.	.	O	.	_	0	SENT_130	[p7l1740t1667r2056b1751],

1	In	IN	O	in	_	0	SENT_131	[p7l2080t1672r2150b1729],
2	general	JJ	O	general	prep_in	5	SENT_131	[p7l7t1770r267b1854],
3	,	,	O	,	_	0	SENT_131	[p7l7t1770r267b1854],
4	it	PRP	O	it	nsubj	5	SENT_131	[p7l289t1776r333b1833],
5	is	VBZ	O	be	_	0	SENT_131	[p7l352t1776r401b1833],
6	best	RB	O	best	advmod	5	SENT_131	[p7l419t1770r554b1833],
7	to	TO	O	to	aux	8	SENT_131	[p7l572t1782r636b1833],
8	treat	VB	O	treat	xcomp	5	SENT_131	[p7l656t1782r808b1833],
9	only	RB	O	only	advmod	11	SENT_131	[p7l828t1770r975b1854],
10	those	DT	O	those	det	11	SENT_131	[p7l990t1770r1169b1833],
11	attacks	NNS	O	attack	dobj	8	SENT_131	[p7l1189t1770r1416b1833],
12	potentially	RB	O	potentially	advmod	13	SENT_131	[p7l1435t1770r1797b1854],
13	associated	VBN	O	associate	partmod	11	SENT_131	[p7l1813t1770r2153b1833],
14	with	IN	O	with	_	0	SENT_131	[p7l6t1873r157b1936],
15	an	DT	O	a	det	19	SENT_131	[p7l178t1896r257b1936],
16	unfavorable	JJ	O	unfavorable	amod	19	SENT_131	[p7l278t1873r680b1936],
17	long-term	JJ	O	long-term	amod	19	SENT_131	[p7l699t1873r1043b1957],
18	disability	NN	O	disability	nn	19	SENT_131	[p7l1063t1873r1375b1957],
19	proﬁle	NN	O	proﬁle	prep_with	13	SENT_131	[p7l1390t1873r1626b1956],
20	.	.	O	.	_	0	SENT_131	[p7l1390t1873r1626b1956],

1	If	IN	O	if	mark	6	SENT_132	[p7l1650t1873r1708b1935],
2	the	DT	O	the	det	3	SENT_132	[p7l1717t1873r1823b1936],
3	relapse	NN	O	relapse	nsubj	6	SENT_132	[p7l1844t1873r2078b1956],
4	is	VBZ	O	be	cop	6	SENT_132	[p7l2099t1879r2148b1936],
5	mild	JJ	O	mild	amod	6	SENT_132	[p7l7t1976r169b2039],
6	(	NN	O	(	advcl	27	SENT_132	[p7l194t1977r336b2052],
7	i.e.	FW	O	i.e.	dep	6	SENT_132	[p7l194t1977r336b2052],
8	,	,	O	,	_	0	SENT_132	[p7l194t1977r336b2052],
9	does	VBZ	O	do	advcl	27	SENT_132	[p7l361t1976r517b2039],
10	not	RB	O	not	neg	11	SENT_132	[p7l541t1988r656b2039],
11	impact	NN	O	impact	dobj	9	SENT_132	[p7l679t1982r919b2059],
12	or	CC	O	or	_	0	SENT_132	[p7l941t1999r1014b2039],
13	limit	VB	O	limit	advcl	27	SENT_132	[p7l1034t1976r1200b2039],
14	the	DT	O	the	det	15	SENT_132	[p7l1221t1976r1329b2039],
15	patient	NN	O	patient	poss	18	SENT_132	[p7l1351t1976r1633b2059],
16	’s	POS	O	’s	_	0	SENT_132	[p7l1351t1976r1633b2059],
17	daily	JJ	SET	daily	amod	18	SENT_132	[p7l1658t1976r1827b2060],
18	activities	NNS	O	activity	dobj	13	SENT_132	[p7l1847t1982r2152b2039],
19	in	IN	O	in	_	0	SENT_132	[p7l9t2085r76b2141],
20	a	DT	O	a	det	23	SENT_132	[p7l100t2102r135b2142],
21	major	JJ	O	major	amod	23	SENT_132	[p7l157t2085r363b2163],
22	way	NN	O	way	nn	23	SENT_132	[p7l383t2079r568b2163],
23	)	NN	O	)	prep_in	13	SENT_132	[p7l383t2079r568b2163],
24	,	,	O	,	_	0	SENT_132	[p7l383t2079r568b2163],
25	it	PRP	O	it	nsubj	27	SENT_132	[p7l593t2085r640b2142],
26	can	MD	O	can	aux	27	SENT_132	[p7l663t2102r782b2142],
27	respond	VB	O	respond	_	0	SENT_132	[p7l805t2079r1088b2162],
28	to	TO	O	to	aux	29	SENT_132	[p7l1109t2091r1176b2142],
29	rest	VB	O	rest	xcomp	27	SENT_132	[p7l1201t2091r1326b2142],
30	and	CC	O	and	_	0	SENT_132	[p7l1349t2079r1477b2142],
31	resolve	VB	O	resolve	xcomp	27	SENT_132	[p7l1500t2079r1742b2142],
32	completely	RB	O	completely	advmod	31	SENT_132	[p7l1766t2079r2148b2163],
33	with	IN	O	with	_	0	SENT_132	[p7l7t2181r159b2244],
34	time	NN	O	time	prep_with	31	SENT_132	[p7l180t2187r350b2244],
35	.	.	O	.	_	0	SENT_132	[p7l180t2187r350b2244],

1	The	DT	O	the	det	4	SENT_133	[p7l82t2284r207b2347],
2	typical	JJ	O	typical	amod	4	SENT_133	[p7l228t2284r457b2368],
3	treatment	NN	O	treatment	nn	4	SENT_133	[p7l477t2296r812b2347],
4	regimen	NN	O	regimen	nsubj	11	SENT_133	[p7l833t2290r1115b2368],
5	after	IN	O	after	_	0	SENT_133	[p7l1138t2284r1290b2347],
6	an	DT	O	a	det	8	SENT_133	[p7l1312t2307r1392b2347],
7	MS	NN	O	m	nn	8	SENT_133	[p7l1414t2288r1527b2347],
8	attack	NN	O	attack	prep_after	4	SENT_133	[p7l1552t2284r1756b2347],
9	is	VBZ	O	be	cop	11	SENT_133	[p7l1774t2290r1824b2347],
10	3-7	CD	NUMBER	3-7	num	11	SENT_133	[p7l1849t2291r1971b2347],
11	days	NNS	NUMBER	day	_	0	SENT_133	[p7l1994t2284r2142b2368],
12	of	IN	O	of	_	0	SENT_133	[p7l9t2387r82b2450],
13	i.v.	NN	O	i.v.	nn	14	SENT_133	[p7l94t2393r181b2450],
14	methylprednisolone	NN	O	methylprednisolone	prep_of	11	SENT_133	[p7l205t2387r904b2471],
15	,	,	O	,	_	0	SENT_133	[p7l205t2387r904b2471],
16	1,000	CD	NUMBER	1,000	num	17	SENT_133	[p7l933t2394r1106b2459],
17	mg	NN	O	mg	appos	14	SENT_133	[p7l1120t2410r1229b2471],
18	per	IN	O	per	_	0	SENT_133	[p7l1247t2409r1359b2470],
19	day	NN	DURATION	day	prep_per	17	SENT_133	[p7l1380t2387r1506b2471],
20	.	.	O	.	_	0	SENT_133	[p7l1380t2387r1506b2471],

1	In	IN	O	in	_	0	SENT_134	[p7l1531t2392r1602b2449],
2	our	PRP$	O	we	poss	3	SENT_134	[p7l1623t2410r1740b2450],
3	experience	NN	O	experience	prep_in	13	SENT_134	[p7l1761t2393r2143b2470],
4	,	,	O	,	_	0	SENT_134	[p7l1761t2393r2143b2470],
5	a	DT	O	a	det	7	SENT_134	[p7l9t2513r44b2553],
6	slow	JJ	O	slow	amod	7	SENT_134	[p7l67t2490r223b2553],
7	infusion	NN	O	infusion	nsubjpass	13	SENT_134	[p7l243t2490r532b2553],
8	over	IN	O	over	_	0	SENT_134	[p7l555t2513r705b2553],
9	90	CD	DURATION	90	num	10	SENT_134	[p7l728t2497r806b2553],
10	min	NN	DURATION	min	prep_over	7	SENT_134	[p7l823t2496r963b2552],
11	is	VBZ	O	be	auxpass	13	SENT_134	[p7l986t2496r1037b2553],
12	well	RB	O	well	advmod	13	SENT_134	[p7l1059t2490r1199b2553],
13	tolerated	VBN	O	tolerate	_	0	SENT_134	[p7l1220t2490r1544b2553],
14	.	.	O	.	_	0	SENT_134	[p7l1220t2490r1544b2553],

1	Lasting	JJ	O	lasting	amod	2	SENT_135	[p7l1570t2495r1826b2574],
2	suppression	NN	O	suppression	nsubj	8	SENT_135	[p7l1848t2512r2141b2573, p7l9t2599r147b2656],
3	of	IN	O	of	_	0	SENT_135	[p7l168t2593r241b2656],
4	the	DT	O	the	det	6	SENT_135	[p7l250t2593r354b2656],
5	suprarenal	JJ	O	suprarenal	amod	6	SENT_135	[p7l375t2593r729b2676],
6	glands	NNS	O	gland	prep_of	2	SENT_135	[p7l748t2593r964b2677],
7	is	VBZ	O	be	cop	8	SENT_135	[p7l985t2599r1034b2656],
8	unlikely	JJ	O	unlikely	ccomp	39	SENT_135	[p7l1054t2593r1328b2677],
9	with	IN	O	with	_	0	SENT_135	[p7l1341t2593r1492b2656],
10	the	DT	O	the	det	14	SENT_135	[p7l1510t2593r1615b2656],
11	brief	JJ	O	brief	amod	14	SENT_135	[p7l1633t2593r1799b2656],
12	high-dose	JJ	O	high-dose	amod	14	SENT_135	[p7l1808t2593r2145b2677],
13	pulsed	JJ	O	pulsed	amod	14	SENT_135	[p7l7t2696r235b2779],
14	treatment	NN	O	treatment	prep_with	8	SENT_135	[p7l256t2708r611b2768],
15	,	,	O	,	_	0	SENT_135	[p7l256t2708r611b2768],
16	and	CC	O	and	_	0	SENT_135	[p7l636t2696r764b2759],
17	short-term	JJ	O	short-term	amod	21	SENT_135	[p7l786t2696r1161b2759],
18	or	CC	O	or	_	0	SENT_135	[p7l1184t2719r1257b2759],
19	long-term	JJ	O	long-term	conj_or	17	SENT_135	[p7l1277t2696r1627b2780],
20	adverse	JJ	O	adverse	amod	21	SENT_135	[p7l1650t2696r1907b2759],
21	effects	NNS	O	effect	nsubj	23	SENT_135	[p7l1930t2696r2144b2759],
22	are	VBP	O	be	cop	23	SENT_135	[p7l9t2821r107b2861],
23	uncommon	JJ	O	uncommon	conj_and	8	SENT_135	[p7l127t2790r600b2861],
24	.15	CD	NUMBER	.15	tmod	23	SENT_135	[p7l127t2790r600b2861],
25	However	RB	O	however	advmod	23	SENT_135	[p7l622t2803r935b2870],
26	,	,	O	,	_	0	SENT_135	[p7l622t2803r935b2870],
27	high-dose	JJ	O	high-dose	amod	29	SENT_135	[p7l956t2798r1293b2882],
28	corticosteroid	NN	O	corticosteroid	nn	29	SENT_135	[p7l1313t2798r1781b2861],
29	treatment	NN	O	treatment	nsubj	39	SENT_135	[p7l1798t2810r2144b2870],
30	,	,	O	,	_	0	SENT_135	[p7l1798t2810r2144b2870],
31	particularly	RB	O	particularly	advmod	33	SENT_135	[p7l7t2901r394b2985],
32	if	IN	O	if	dep	33	SENT_135	[p7l410t2901r463b2963],
33	given	VBN	O	give	dep	39	SENT_135	[p7l472t2907r649b2985],
34	by	IN	O	by	_	0	SENT_135	[p7l665t2901r747b2985],
35	rapid	JJ	O	rapid	amod	36	SENT_135	[p7l763t2901r935b2984],
36	infusion	NN	O	infusion	prep_by	33	SENT_135	[p7l953t2901r1244b2973],
37	,	,	O	,	_	0	SENT_135	[p7l953t2901r1244b2973],
38	may	MD	O	may	aux	39	SENT_135	[p7l1264t2924r1407b2985],
39	cause	VB	O	cause	_	0	SENT_135	[p7l1422t2924r1600b2964],
40	osteonecrosis	NN	O	osteonecrosis	dobj	39	SENT_135	[p7l1619t2907r2061b2964],
41	of	IN	O	of	_	0	SENT_135	[p7l2081t2901r2153b2964],
42	the	DT	O	the	det	44	SENT_135	[p7l7t3004r113b3067],
43	femur	NN	O	femur	nn	44	SENT_135	[p7l132t3004r337b3067],
44	head	NN	O	head	prep_of	40	SENT_135	[p7l354t3004r534b3076],
45	,	,	O	,	_	0	SENT_135	[p7l354t3004r534b3076],
46	which	WDT	O	which	nsubj	48	SENT_135	[p7l553t3004r761b3067],
47	may	MD	O	may	aux	48	SENT_135	[p7l780t3027r926b3088],
48	require	VB	O	require	rcmod	44	SENT_135	[p7l942t3010r1183b3087],
49	hip	NN	O	hip	nn	51	SENT_135	[p7l1203t3004r1311b3087],
50	prosthesis	NN	O	prosthesis	nn	51	SENT_135	[p7l1331t3004r1670b3087],
51	implantation	NN	O	implantation	dobj	48	SENT_135	[p7l1690t3004r2143b3087],
52	.	.	O	.	_	0	SENT_135	[p7l1690t3004r2143b3087],

1	Inherited	VBN	O	inherit	dep	27	SENT_136	[p7l9t3107r322b3170],
2	thrombophilia	NN	O	thrombophilia	nsubj	27	SENT_136	[p7l339t3107r847b3190],
3	,	,	O	,	_	0	SENT_136	[p7l339t3107r847b3190],
4	such	JJ	O	such	_	0	SENT_136	[p7l870t3107r1022b3170],
5	as	IN	O	as	_	0	SENT_136	[p7l1042t3130r1106b3170],
6	Factor	NN	O	factor	nn	8	SENT_136	[p7l1126t3112r1339b3170],
7	V	NN	O	v	nn	8	SENT_136	[p7l1356t3112r1415b3170],
8	Leyden	NN	PERSON	leyden	prep_such_as	2	SENT_136	[p7l1434t3107r1679b3191],
9	or	CC	O	or	_	0	SENT_136	[p7l1699t3130r1770b3170],
10	prothrom	NN	O	prothrom	nn	13	SENT_136	[p7l1787t3107r2143b3190],
11	—	CD	NUMBER	—	num	13	SENT_136	[p7l1787t3107r2143b3190],
12	bin	NN	O	bin	nn	13	SENT_136	[p7l6t3210r114b3273],
13	mutation	NN	O	mutation	prep_such_as	2	SENT_136	[p7l132t3216r451b3282],
14	,	,	O	,	_	0	SENT_136	[p7l132t3216r451b3282],
15	liver	NN	O	liver	nn	16	SENT_136	[p7l470t3210r615b3273],
16	cirrhosis	NN	O	cirrhosis	conj_or	8	SENT_136	[p7l633t3210r933b3282],
17	,	,	O	,	_	0	SENT_136	[p7l633t3210r933b3282],
18	and	CC	O	and	_	0	SENT_136	[p7l954t3210r1076b3273],
19	vascular	JJ	O	vascular	amod	24	SENT_136	[p7l1091t3210r1364b3273],
20	endothelial	JJ	O	endothelial	amod	24	SENT_136	[p7l1382t3210r1750b3273],
21	growth	NN	O	growth	nn	24	SENT_136	[p7l1768t3210r2002b3294],
22	factor	NN	O	factor	nn	24	SENT_136	[p7l2020t3210r2139b3273, p7l7t3324r103b3375],
23	receptor	NN	O	receptor	nn	24	SENT_136	[p7l121t3324r393b3395],
24	polymorphisms	NNS	O	polymorphism	conj_and	8	SENT_136	[p7l409t3312r947b3396],
25	,	,	O	,	_	0	SENT_136	[p7l409t3312r947b3396],
26	may	MD	O	may	aux	27	SENT_136	[p7l967t3335r1109b3396],
27	predispose	VB	O	predispose	_	0	SENT_136	[p7l1123t3312r1477b3395],
28	patients	NNS	O	patient	dobj	27	SENT_136	[p7l1495t3318r1752b3395],
29	to	TO	O	to	_	0	SENT_136	[p7l1771t3324r1834b3375],
30	this	DT	O	this	prep_to	27	SENT_136	[p7l1853t3312r1988b3375],
31	.	.	O	.	_	0	SENT_136	[p7l1853t3312r1988b3375],

1	1648	CD	DATE	1648	_	0	SENT_137	[p7l2000t3304r2144b3346],
2	It	PRP	O	it	nsubjpass	5	SENT_137	[p7l83t3420r131b3478],
3	is	VBZ	O	be	auxpass	5	SENT_137	[p7l150t3421r198b3478],
4	generally	RB	O	generally	advmod	5	SENT_137	[p7l219t3415r527b3499],
5	accepted	VBN	O	accept	rcmod	1	SENT_137	[p7l544t3415r836b3498],
6	that	IN	O	that	complm	11	SENT_137	[p7l854t3415r985b3478],
7	i.v.	NN	O	i.v.	nn	8	SENT_137	[p7l1004t3421r1091b3478],
8	corticosteroids	NNS	O	corticosteroid	nsubj	11	SENT_137	[p7l1114t3415r1611b3478],
9	do	VBP	O	do	aux	11	SENT_137	[p7l1632t3415r1715b3478],
10	not	RB	O	not	neg	11	SENT_137	[p7l1736t3427r1848b3478],
11	improve	VB	O	improve	ccomp	5	SENT_137	[p7l1866t3421r2144b3498],
12	long-term	JJ	O	long-term	amod	13	SENT_137	[p7l7t3518r351b3602],
13	recovery	NN	O	recovery	dobj	11	SENT_137	[p7l371t3541r666b3602],
14	from	IN	O	from	_	0	SENT_137	[p7l683t3518r849b3581],
15	individual	JJ	O	individual	amod	16	SENT_137	[p7l869t3518r1216b3581],
16	relapses	NNS	O	relapse	prep_from	11	SENT_137	[p7l1236t3518r1501b3601],
17	but	CC	O	but	dep	18	SENT_137	[p7l1520t3518r1633b3581],
18	make	VBP	O	make	dep	1	SENT_137	[p7l1651t3518r1834b3581],
19	recovery	NN	O	recovery	dobj	18	SENT_137	[p7l1855t3541r2150b3602],
20	faster	RBR	O	faster	advmod	18	SENT_137	[p7l8t3621r203b3684],
21	.	.	O	.	_	0	SENT_137	[p7l8t3621r203b3684],

1	However	RB	O	however	advmod	41	SENT_138	[p7l228t3626r545b3693],
2	,	,	O	,	_	0	SENT_138	[p7l228t3626r545b3693],
3	a	DT	O	a	det	5	SENT_138	[p7l567t3644r602b3684],
4	recent	JJ	O	recent	amod	5	SENT_138	[p7l621t3633r830b3684],
5	review	NN	O	review	nsubj	6	SENT_138	[p7l850t3627r1076b3684],
6	cited	VBD	O	cite	parataxis	41	SENT_138	[p7l1094t3621r1257b3684],
7	a	DT	O	a	det	8	SENT_138	[p7l1277t3644r1311b3684],
8	trial	NN	O	trial	nsubj	24	SENT_138	[p7l1329t3621r1469b3684],
9	in	IN	O	in	_	0	SENT_138	[p7l1489t3627r1555b3683],
10	which	WDT	O	which	rel	15	SENT_138	[p7l1574t3621r1782b3684],
11	long-term	JJ	O	long-term	amod	13	SENT_138	[p7l1801t3621r2145b3705],
12	beneﬁcial	JJ	O	beneﬁcial	amod	13	SENT_138	[p7l6t3723r347b3786],
13	effects	NNS	O	effect	nsubjpass	15	SENT_138	[p7l371t3723r589b3786],
14	were	VBD	O	be	auxpass	15	SENT_138	[p7l612t3746r777b3786],
15	observed	VBN	O	observe	rcmod	8	SENT_138	[p7l802t3715r1203b3786],
16	.19	CD	NUMBER	.19	num	18	SENT_138	[p7l802t3715r1203b3786],
17	Oral	JJ	O	oral	amod	18	SENT_138	[p7l1229t3723r1386b3786],
18	corticosteroids	NNS	O	corticosteroid	dobj	15	SENT_138	[p7l1409t3723r1932b3786],
19	given	VBN	O	give	prep	15	SENT_138	[p7l1957t3729r2145b3807],
20	without	IN	O	without	pcomp	19	SENT_138	[p8l7t16r269b79],
21	prior	JJ	O	prior	amod	23	SENT_138	[p8l286t22r457b99],
22	i.v.	NN	O	i.v.	nn	23	SENT_138	[p8l475t22r562b79],
23	steroids	NNS	O	steroid	pobj	20	SENT_138	[p8l586t16r843b79],
24	increase	VBP	O	increase	ccomp	6	SENT_138	[p8l863t22r1136b79],
25	the	DT	O	the	det	26	SENT_138	[p8l1154t16r1258b79],
26	risk	NN	O	risk	nsubj	36	SENT_138	[p8l1279t16r1405b79],
27	of	IN	O	of	_	0	SENT_138	[p8l1422t16r1495b79],
28	attacks	NNS	O	attack	prep_of	26	SENT_138	[p8l1506t16r1733b79],
29	in	IN	O	in	_	0	SENT_138	[p8l1754t22r1819b78],
30	the	DT	O	the	det	33	SENT_138	[p8l1837t16r1942b79],
31	ensuing	VBG	O	ensue	amod	33	SENT_138	[p8l1963t39r2143b79, p8l9t124r117b202],
32	3	CD	DURATION	3	num	33	SENT_138	[p8l140t125r173b181],
33	years	NNS	NUMBER	year	prep_in	28	SENT_138	[p8l197t110r553b202],
34	.20	CD	NUMBER	.20	number	35	SENT_138	[p8l197t110r553b202],
35	‘	CD	NUMBER	‘	num	36	SENT_138	[p8l197t110r553b202],
36	24	CD	NUMBER	24	xcomp	24	SENT_138	[p8l197t110r553b202],
37	Overall	JJ	O	overall	advmod	36	SENT_138	[p8l577t118r848b190],
38	,	,	O	,	_	0	SENT_138	[p8l577t118r848b190],
39	these	DT	O	these	det	40	SENT_138	[p8l872t118r1049b181],
40	ﬁndings	NNS	O	ﬁndings	nsubj	41	SENT_138	[p8l1072t118r1350b202],
41	suggest	VBP	O	suggest	_	0	SENT_138	[p8l1375t130r1626b202],
42	that	IN	O	that	complm	50	SENT_138	[p8l1646t118r1781b181],
43	there	EX	O	there	expl	50	SENT_138	[p8l1802t118r1977b181],
44	may	MD	O	may	aux	50	SENT_138	[p8l2000t141r2148b202],
45	still	RB	O	still	advmod	50	SENT_138	[p8l9t221r130b284],
46	be	VB	O	be	cop	50	SENT_138	[p8l148t221r227b284],
47	a	DT	O	a	det	50	SENT_138	[p8l248t244r282b284],
48	long-term	JJ	O	long-term	amod	50	SENT_138	[p8l301t221r645b305],
49	beneﬁcial	JJ	O	beneﬁcial	amod	50	SENT_138	[p8l663t221r992b284],
50	effect	NN	O	effect	ccomp	41	SENT_138	[p8l1012t221r1193b284],
51	of	IN	O	of	_	0	SENT_138	[p8l1213t221r1286b284],
52	recovery	NN	O	recovery	prep_of	50	SENT_138	[p8l1297t244r1593b305],
53	from	IN	O	from	_	0	SENT_138	[p8l1610t221r1776b284],
54	individual	JJ	O	individual	amod	55	SENT_138	[p8l1797t221r2145b284],
55	relapses	NNS	O	relapse	prep_from	52	SENT_138	[p8l9t324r276b407],
56	induced	VBN	O	induce	partmod	55	SENT_138	[p8l298t324r575b387],
57	by	IN	O	by	_	0	SENT_138	[p8l594t324r678b408],
58	i.v.	NN	O	i.v.	nn	59	SENT_138	[p8l696t330r785b387],
59	corticosteroids	NNS	O	corticosteroid	agent	56	SENT_138	[p8l810t324r1334b387],
60	.	.	O	.	_	0	SENT_138	[p8l810t324r1334b387],

1	The	DT	O	the	det	2	SENT_139	[p8l82t427r207b490],
2	effects	NNS	O	effect	nsubjpass	7	SENT_139	[p8l230t427r443b490],
3	of	IN	O	of	_	0	SENT_139	[p8l467t427r541b490],
4	corticosteroids	NNS	O	corticosteroid	prep_of	2	SENT_139	[p8l554t427r1061b490],
5	are	VBP	O	be	auxpass	7	SENT_139	[p8l1086t450r1186b490],
6	typically	RB	O	typically	advmod	7	SENT_139	[p8l1207t427r1501b511],
7	delayed	VBN	O	delay	_	0	SENT_139	[p8l1521t427r1797b511],
8	;	:	O	;	_	0	SENT_139	[p8l1521t427r1797b511],
9	following	VBG	O	follow	_	0	SENT_139	[p8l1821t427r2145b511],
10	a	DT	O	a	det	12	SENT_139	[p8l9t553r43b593],
11	5-day	JJ	DURATION	5-day	amod	12	SENT_139	[p8l64t530r255b614],
12	course	NN	O	course	prep_following	17	SENT_139	[p8l273t553r510b602],
13	,	,	O	,	_	0	SENT_139	[p8l273t553r510b602],
14	peak	JJ	O	peak	amod	15	SENT_139	[p8l531t530r695b613],
15	effect	NN	O	effect	nsubj	17	SENT_139	[p8l713t530r893b593],
16	should	MD	O	should	aux	17	SENT_139	[p8l913t530r1142b593],
17	occur	VB	O	occur	parataxis	7	SENT_139	[p8l1162t553r1354b593],
18	between	IN	O	between	_	0	SENT_139	[p8l1371t530r1656b593],
19	days	NNS	DURATION	day	prep_between	17	SENT_139	[p8l1676t530r1824b614],
20	7	CD	NUMBER	7	num	19	SENT_139	[p8l1847t538r1882b593],
21	and	CC	O	and	_	0	SENT_139	[p8l1903t530r2029b593],
22	10	CD	NUMBER	10	conj_and	19	SENT_139	[p8l2055t537r2143b593],
23	.	.	O	.	_	0	SENT_139	[p8l2055t537r2143b593],

1	Therefore	RB	O	therefore	advmod	8	SENT_140	[p8l8t633r355b705],
2	,	,	O	,	_	0	SENT_140	[p8l8t633r355b705],
3	in	IN	O	in	_	0	SENT_140	[p8l379t639r445b695],
4	general	JJ	O	general	prep_in	8	SENT_140	[p8l468t633r735b717],
5	,	,	O	,	_	0	SENT_140	[p8l468t633r735b717],
6	one	CD	NUMBER	one	advmod	8	SENT_140	[p8l760t656r882b696],
7	should	MD	O	should	aux	8	SENT_140	[p8l906t633r1137b696],
8	wait	VB	O	wait	_	0	SENT_140	[p8l1156t639r1301b696],
9	at	IN	DURATION	at	quantmod	11	SENT_140	[p8l1323t645r1382b696],
10	least	JJS	DURATION	least	mwe	9	SENT_140	[p8l1402t633r1556b696],
11	2	CD	DURATION	2	num	12	SENT_140	[p8l1578t640r1613b695],
12	weeks	NNS	NUMBER	week	tmod	8	SENT_140	[p8l1636t633r1840b696],
13	after	IN	O	after	_	0	SENT_140	[p8l1864t633r2016b696],
14	the	DT	O	the	det	15	SENT_140	[p8l2037t633r2144b696],
15	initiation	NN	O	initiation	prep_after	8	SENT_140	[p8l8t742r326b799],
16	of	IN	O	of	_	0	SENT_140	[p8l350t736r424b799],
17	the	DT	O	the	det	18	SENT_140	[p8l436t736r543b799],
18	therapy	NN	O	therapy	prep_of	15	SENT_140	[p8l565t736r829b820],
19	to	TO	O	to	aux	20	SENT_140	[p8l848t748r914b799],
20	decide	VB	O	decide	infmod	18	SENT_140	[p8l939t736r1160b799],
21	whether	IN	O	whether	complm	25	SENT_140	[p8l1181t736r1467b799],
22	treatment	NN	O	treatment	nsubj	25	SENT_140	[p8l1487t748r1825b799],
23	has	VBZ	O	have	aux	25	SENT_140	[p8l1846t736r1958b799],
24	been	VBN	O	be	cop	25	SENT_140	[p8l1980t736r2145b799],
25	successful	JJ	O	successful	ccomp	20	SENT_140	[p8l9t839r356b902],
26	(	CD	NUMBER	(	num	29	SENT_140	[p8l383t840r646b922],
27	Figure	NN	O	figure	nn	29	SENT_140	[p8l383t840r646b922],
28	3	CD	NUMBER	3	num	29	SENT_140	[p8l669t840r755b916],
29	)	NN	O	)	nsubj	8	SENT_140	[p8l669t840r755b916],
30	.	.	O	.	_	0	SENT_140	[p8l669t840r755b916],

1	Intravenous	JJ	O	intravenous	amod	3	SENT_141	[p8l782t844r1198b902],
2	corticosteroid	NN	O	corticosteroid	nn	3	SENT_141	[p8l1222t839r1708b902],
3	treatment	NN	O	treatment	nsubj	5	SENT_141	[p8l1729t851r2071b902],
4	is	VBZ	O	be	cop	5	SENT_141	[p8l2094t845r2145b902],
5	ineffective	JJ	O	ineffective	_	0	SENT_141	[p8l8t942r352b1005],
6	in	IN	O	in	_	0	SENT_141	[p8l372t948r437b1004],
7	~	NN	O	~	prep_in	5	SENT_141	[p8l460t947r647b1007],
8	15	CD	PERCENT	15	number	9	SENT_141	[p8l460t947r647b1007],
9	%	NN	PERCENT	%	amod	7	SENT_141	[p8l460t947r647b1007],
10	of	IN	O	of	_	0	SENT_141	[p8l669t942r741b1005],
11	cases	NNS	O	case	prep_of	7	SENT_141	[p8l752t965r936b1005],
12	.	.	O	.	_	0	SENT_141	[p8l752t965r936b1005],

1	The	DT	O	the	det	3	SENT_142	[p8l959t942r1082b1005],
2	ﬁrst-line	JJ	O	ﬁrst-line	amod	3	SENT_142	[p8l1102t942r1387b1005],
3	therapy	NN	O	therapy	nsubj	11	SENT_142	[p8l1406t942r1664b1026],
4	after	IN	O	after	_	0	SENT_142	[p8l1681t942r1830b1005],
5	corticosteroid	NN	O	corticosteroid	nn	6	SENT_142	[p8l1850t948r2142b1005, p8l7t1045r211b1108],
6	failure	NN	O	failure	prep_after	3	SENT_142	[p8l231t1045r448b1108],
7	or	CC	O	or	_	0	SENT_142	[p8l471t1068r542b1108],
8	unresponsiveness	NN	O	unresponsiveness	conj_or	6	SENT_142	[p8l563t1051r1164b1128],
9	is	VBZ	O	be	cop	11	SENT_142	[p8l1186t1051r1236b1108],
10	plasma	NN	O	plasma	nn	11	SENT_142	[p8l1257t1045r1500b1128],
11	exchange	NN	O	exchange	_	0	SENT_142	[p8l1522t1045r1836b1129],
12	(	CD	NUMBER	(	num	14	SENT_142	[p8l1861t1046r2131b1121],
13	PLEX	NN	O	plex	nn	14	SENT_142	[p8l1861t1046r2131b1121],
14	)	NN	O	)	dep	11	SENT_142	[p8l1861t1046r2131b1121],
15	.	.	O	.	_	0	SENT_142	[p8l1861t1046r2131b1121],

1	Relapses	NNS	O	relapse	nsubj	9	SENT_143	[p8l83t1148r373b1231],
2	that	WDT	O	that	nsubj	5	SENT_143	[p8l393t1148r527b1211],
3	do	VBP	O	do	aux	5	SENT_143	[p8l548t1148r632b1211],
4	not	RB	O	not	neg	5	SENT_143	[p8l655t1160r768b1211],
5	respond	VB	O	respond	rcmod	1	SENT_143	[p8l789t1148r1066b1231],
6	to	TO	O	to	_	0	SENT_143	[p8l1086t1160r1152b1211],
7	corticosteroids	NNS	O	corticosteroid	prep_to	5	SENT_143	[p8l1175t1148r1681b1211],
8	may	MD	O	may	aux	9	SENT_143	[p8l1703t1171r1850b1232],
9	respond	VB	O	respond	ccomp	19	SENT_143	[p8l1868t1148r2145b1231],
10	to	TO	O	to	_	0	SENT_143	[p8l7t1262r76b1313],
11	PLEX	NNP	O	PLEX	prep_to	9	SENT_143	[p8l106t1242r396b1313],
12	.25	CD	NUMBER	.25	num	11	SENT_143	[p8l106t1242r396b1313],
13	However	RB	O	however	advmod	9	SENT_143	[p8l426t1255r761b1322],
14	,	,	O	,	_	0	SENT_143	[p8l426t1255r761b1322],
15	the	DT	O	the	det	18	SENT_143	[p8l790t1250r902b1313],
16	original	JJ	O	original	amod	18	SENT_143	[p8l931t1250r1212b1334],
17	PLEX	NN	ORGANIZATION	plex	nn	18	SENT_143	[p8l1241t1255r1447b1312],
18	trial	NN	O	trial	nsubj	19	SENT_143	[p8l1472t1250r1622b1313],
19	included	VBD	O	include	_	0	SENT_143	[p8l1649t1250r1963b1313],
20	only	RB	O	only	advmod	21	SENT_143	[p8l1992t1250r2150b1334],
21	patients	NNS	O	patient	dobj	19	SENT_143	[p8l7t1359r278b1436],
22	with	IN	O	with	_	0	SENT_143	[p8l300t1353r454b1416],
23	severe	JJ	O	severe	amod	26	SENT_143	[p8l477t1376r687b1416],
24	and	CC	O	and	_	0	SENT_143	[p8l711t1353r838b1416],
25	ﬁxed	JJ	O	ﬁxed	conj_and	23	SENT_143	[p8l859t1353r1027b1416],
26	deﬁcits	NNS	O	deﬁcits	prep_with	19	SENT_143	[p8l1049t1353r1310b1425],
27	,	,	O	,	_	0	SENT_143	[p8l1049t1353r1310b1425],
28	sometimes	RB	O	sometimes	advmod	26	SENT_143	[p8l1336t1359r1704b1416],
29	many	JJ	O	many	amod	30	SENT_143	[p8l1727t1376r1921b1437],
30	weeks	NNS	DURATION	week	dep	26	SENT_143	[p8l1939t1353r2144b1416],
31	to	TO	O	to	_	0	SENT_143	[p8l7t1468r75b1519],
32	a	DT	DURATION	a	det	34	SENT_143	[p8l101t1479r136b1519],
33	few	JJ	DURATION	few	amod	34	SENT_143	[p8l159t1456r283b1519],
34	months	NNS	DURATION	month	prep_to	30	SENT_143	[p8l304t1456r570b1519],
35	after	IN	O	after	_	0	SENT_143	[p8l596t1456r753b1519],
36	the	DT	O	the	det	37	SENT_143	[p8l774t1456r884b1519],
37	attack	NN	O	attack	prep_after	19	SENT_143	[p8l909t1456r1134b1519],
38	.	.	O	.	_	0	SENT_143	[p8l909t1456r1134b1519],

1	In	IN	O	in	_	0	SENT_144	[p8l1162t1461r1234b1518],
2	addition	NN	O	addition	prep_in	6	SENT_144	[p8l1259t1456r1574b1528],
3	,	,	O	,	_	0	SENT_144	[p8l1259t1456r1574b1528],
4	several	JJ	O	several	amod	5	SENT_144	[p8l1601t1456r1843b1519],
5	patients	NNS	O	patient	nsubj	6	SENT_144	[p8l1865t1462r2143b1539],
6	had	VBD	O	have	_	0	SENT_144	[p8l7t1559r139b1622],
7	diagnoses	NNS	O	diagnosis	dobj	6	SENT_144	[p8l166t1559r514b1643],
8	other	JJ	O	other	dep	7	SENT_144	[p8l542t1559r731b1622],
9	than	IN	O	than	_	0	SENT_144	[p8l755t1559r916b1622],
10	MS	NN	O	m	prep_than	7	SENT_144	[p8l942t1563r1079b1631],
11	,	,	O	,	_	0	SENT_144	[p8l942t1563r1079b1631],
12	such	JJ	O	such	_	0	SENT_144	[p8l1108t1559r1269b1622],
13	as	IN	O	as	_	0	SENT_144	[p8l1296t1582r1362b1622],
14	neuromyelitis	NN	O	neuromyelitis	nn	15	SENT_144	[p8l1389t1559r1879b1643],
15	optica	NN	O	optica	prep_such_as	10	SENT_144	[p8l1907t1565r2142b1642],
16	.	.	O	.	_	0	SENT_144	[p8l1907t1565r2142b1642],

1	The	DT	O	the	det	2	SENT_145	[p8l8t1662r137b1725],
2	responders	NNS	O	responder	nsubj	4	SENT_145	[p8l166t1662r563b1745],
3	often	RB	O	often	advmod	4	SENT_145	[p8l592t1662r772b1725],
4	have	VBP	O	have	_	0	SENT_145	[p8l799t1662r962b1725],
5	a	DT	O	a	det	8	SENT_145	[p8l992t1685r1027b1725],
6	rather	RB	O	rather	advmod	7	SENT_145	[p8l1054t1662r1273b1725],
7	dramatic	JJ	O	dramatic	amod	8	SENT_145	[p8l1300t1662r1620b1725],
8	response	NN	O	response	dobj	4	SENT_145	[p8l1649t1684r1984b1745],
9	,	,	O	,	_	0	SENT_145	[p8l1649t1684r1984b1745],
10	and	CC	O	and	_	0	SENT_145	[p8l2015t1662r2146b1725],
11	some	DT	O	some	nsubj	14	SENT_145	[p8l9t1788r195b1828],
12	became	VBD	O	become	cop	14	SENT_145	[p8l223t1765r497b1828],
13	fully	RB	O	fully	advmod	14	SENT_145	[p8l526t1765r691b1849],
14	ambulatory	JJ	O	ambulatory	conj_and	4	SENT_145	[p8l717t1765r1137b1849],
15	after	IN	O	after	_	0	SENT_145	[p8l1163t1765r1323b1828],
16	weeks	NNS	DURATION	week	prep_after	14	SENT_145	[p8l1349t1765r1564b1828],
17	of	IN	O	of	_	0	SENT_145	[p8l1594t1765r1671b1828],
18	paralyses	NNS	O	paralysis	prep_of	16	SENT_145	[p8l1689t1765r2039b1849],
19	.	.	O	.	_	0	SENT_145	[p8l1689t1765r2039b1849],

1	In	IN	O	in	_	0	SENT_146	[p8l2072t1770r2146b1827],
2	our	PRP$	O	we	poss	3	SENT_146	[p8l9t1891r129b1931],
3	experience	NN	O	experience	prep_in	6	SENT_146	[p8l152t1874r549b1951],
4	,	,	O	,	_	0	SENT_146	[p8l152t1874r549b1951],
5	PLEX	NNP	O	PLEX	nsubj	6	SENT_146	[p8l575t1873r777b1930],
6	applied	VBD	O	apply	_	0	SENT_146	[p8l799t1868r1055b1951],
7	within	IN	O	within	_	0	SENT_146	[p8l1076t1868r1304b1931],
8	the	DT	O	the	det	10	SENT_146	[p8l1327t1868r1436b1931],
9	1-month	JJ	DURATION	1-month	amod	10	SENT_146	[p8l1467t1868r1768b1931],
10	window	NN	O	window	prep_within	6	SENT_146	[p8l1789t1868r2073b1931],
11	is	VBZ	O	be	cop	13	SENT_146	[p8l2095t1874r2146b1931],
12	more	RBR	O	more	advmod	13	SENT_146	[p8l8t1994r186b2034],
13	effective	JJ	O	effective	rcmod	10	SENT_146	[p8l209t1971r490b2034],
14	than	IN	O	than	_	0	SENT_146	[p8l512t1971r667b2034],
15	the	DT	O	the	det	18	SENT_146	[p8l689t1971r795b2034],
16	reported	VBN	O	report	amod	18	SENT_146	[p8l819t1971r1115b2054],
17	42	CD	PERCENT	42	num	18	SENT_146	[p8l1136t1976r1280b2036],
18	%	NN	PERCENT	%	prep_than	13	SENT_146	[p8l1136t1976r1280b2036],
19	in	IN	O	in	_	0	SENT_146	[p8l1305t1977r1371b2033],
20	patients	NNS	O	patient	prep_in	18	SENT_146	[p8l1393t1977r1663b2054],
21	with	IN	O	with	_	0	SENT_146	[p8l1685t1971r1838b2034],
22	MS	NN	O	m	prep_with	20	SENT_146	[p8l1860t1975r1974b2034],
23	who	WP	O	who	nsubj	24	SENT_146	[p8l1996t1971r2143b2034],
24	fail	VBP	O	fail	rcmod	18	SENT_146	[p8l8t2073r118b2136],
25	steroids	NNS	O	steroid	dobj	24	SENT_146	[p8l144t2065r503b2136],
26	.25	CD	NUMBER	.25	num	25	SENT_146	[p8l144t2065r503b2136],
27	As	IN	O	as	mark	28	SENT_146	[p8l529t2077r618b2136],
28	established	VBN	O	establish	advcl	38	SENT_146	[p8l645t2073r1038b2136],
29	in	IN	O	in	_	0	SENT_146	[p8l1063t2079r1131b2135],
30	post	NN	O	post	amod	33	SENT_146	[p8l1148t2084r1299b2157],
31	hoc	FW	O	hoc	dep	30	SENT_146	[p8l1321t2073r1440b2136],
32	extension	NN	O	extension	nn	33	SENT_146	[p8l1465t2079r1805b2136],
33	analyses	NNS	O	analysis	prep_in	28	SENT_146	[p8l1832t2073r2142b2157],
34	,	,	O	,	_	0	SENT_146	[p8l1832t2073r2142b2157],
35	meaningful	JJ	O	meaningful	amod	36	SENT_146	[p8l8t2176r403b2260],
36	improvement	NN	O	improvement	nsubj	38	SENT_146	[p8l424t2182r887b2259],
37	is	VBZ	O	be	cop	38	SENT_146	[p8l908t2182r958b2239],
38	unlikely	JJ	O	unlikely	rcmod	25	SENT_146	[p8l981t2176r1259b2260],
39	if	IN	O	if	mark	43	SENT_146	[p8l1278t2176r1332b2238],
40	it	PRP	O	it	nsubj	43	SENT_146	[p8l1345t2182r1390b2239],
41	does	VBZ	O	do	aux	43	SENT_146	[p8l1412t2176r1566b2239],
42	not	RB	O	not	neg	43	SENT_146	[p8l1588t2188r1703b2239],
43	occur	VB	O	occur	advcl	38	SENT_146	[p8l1724t2199r1917b2239],
44	by	IN	O	by	_	0	SENT_146	[p8l1936t2176r2020b2260],
45	the	DT	O	the	det	47	SENT_146	[p8l2038t2176r2144b2239],
46	fourth	JJ	ORDINAL	fourth	amod	47	SENT_146	[p8l8t2278r228b2341],
47	exchange	NN	O	exchange	prep_by	43	SENT_146	[p8l252t2270r655b2362],
48	.26	CD	NUMBER	.26	dep	52	SENT_146	[p8l252t2270r655b2362],
49	If	IN	O	if	dep	52	SENT_146	[p8l680t2278r739b2340],
50	improvement	NN	O	improvement	nsubj	52	SENT_146	[p8l753t2284r1224b2361],
51	is	VBZ	O	be	cop	52	SENT_146	[p8l1247t2284r1298b2341],
52	noticeable	JJ	O	noticeable	ccomp	13	SENT_146	[p8l1321t2278r1695b2350],
53	,	,	O	,	_	0	SENT_146	[p8l1321t2278r1695b2350],
54	then	RB	O	then	advmod	52	SENT_146	[p8l1720t2278r1876b2341],
55	the	DT	O	the	det	58	SENT_146	[p8l1898t2278r2007b2341],
56	full	JJ	O	full	amod	58	SENT_146	[p8l2030t2278r2146b2341],
57	seven-session	JJ	O	seven-session	amod	58	SENT_146	[p8l9t2387r471b2444],
58	course	NN	O	course	attr	52	SENT_146	[p8l493t2404r713b2444],
59	(	CD	NUMBER	(	number	60	SENT_146	[p8l737t2382r885b2457],
60	one	CD	NUMBER	one	num	61	SENT_146	[p8l737t2382r885b2457],
61	exchange	NN	O	exchange	nsubjpass	76	SENT_146	[p8l907t2381r1219b2465],
62	of	IN	O	of	_	0	SENT_146	[p8l1241t2381r1314b2444],
63	1.1	CD	NUMBER	1.1	num	66	SENT_146	[p8l1332t2388r1417b2444],
64	plasma	NN	O	plasma	nn	66	SENT_146	[p8l1442t2381r1684b2464],
65	volume	NN	O	volume	nn	66	SENT_146	[p8l1701t2381r1955b2444],
66	units	NNS	O	unit	prep_of	61	SENT_146	[p8l1975t2387r2144b2444],
67	every	DT	SET	every	det	69	SENT_146	[p8l9t2507r199b2568],
68	other	JJ	SET	other	amod	69	SENT_146	[p8l220t2484r405b2547],
69	day	NN	SET	day	tmod	66	SENT_146	[p8l427t2484r551b2568],
70	over	IN	O	over	_	0	SENT_146	[p8l571t2507r721b2547],
71	14	CD	DURATION	14	num	72	SENT_146	[p8l750t2491r824b2546],
72	days	NNS	NUMBER	day	prep_over	66	SENT_146	[p8l848t2484r1026b2568],
73	)	RB	O	)	advmod	76	SENT_146	[p8l848t2484r1026b2568],
74	should	MD	O	should	aux	76	SENT_146	[p8l1055t2484r1289b2547],
75	be	VB	O	be	auxpass	76	SENT_146	[p8l1310t2484r1391b2547],
76	completed	VBN	O	complete	rcmod	58	SENT_146	[p8l1415t2484r1795b2567],
77	.	.	O	.	_	0	SENT_146	[p8l1415t2484r1795b2567],

1	Male	JJ	O	male	amod	2	SENT_147	[p8l1821t2484r1993b2547],
2	sex	NN	O	sex	nsubj	13	SENT_147	[p8l2017t2507r2143b2556],
3	,	,	O	,	_	0	SENT_147	[p8l2017t2507r2143b2556],
4	preserved	JJ	O	preserved	amod	5	SENT_147	[p8l7t2587r337b2670],
5	reﬂexes	NNS	O	reﬂexes	nsubj	13	SENT_147	[p8l356t2587r624b2659],
6	,	,	O	,	_	0	SENT_147	[p8l356t2587r624b2659],
7	and	CC	O	and	_	0	SENT_147	[p8l646t2587r770b2650],
8	early	JJ	O	early	amod	9	SENT_147	[p8l790t2587r953b2671],
9	initiation	NN	O	initiation	nsubj	13	SENT_147	[p8l969t2593r1278b2650],
10	of	IN	O	of	_	0	SENT_147	[p8l1299t2587r1371b2650],
11	treatment	NN	O	treatment	prep_of	9	SENT_147	[p8l1380t2599r1710b2650],
12	were	VBD	O	be	cop	13	SENT_147	[p8l1727t2610r1885b2650],
13	predictors	NNS	O	predictor	_	0	SENT_147	[p8l1904t2587r2142b2670, p8l7t2702r133b2753],
14	of	IN	O	of	_	0	SENT_147	[p8l153t2690r225b2753],
15	moderate-to-marked	JJ	O	moderate-to-marked	amod	16	SENT_147	[p8l235t2690r938b2753],
16	improvement	NN	O	improvement	prep_of	13	SENT_147	[p8l957t2696r1408b2773],
17	following	VBG	O	follow	_	0	SENT_147	[p8l1426t2690r1741b2774],
18	PLEX	NNP	O	PLEX	prep_following	16	SENT_147	[p8l1759t2695r1966b2753],
19	.	.	O	.	_	0	SENT_147	[p8l1759t2695r1966b2753],

1	Ring	NN	O	ring	nn	2	SENT_148	[p8l1990t2695r2147b2774],
2	enhancement	NN	O	enhancement	nsubj	20	SENT_148	[p8l9t2792r473b2856],
3	and	CC	O	and	_	0	SENT_148	[p8l495t2792r621b2856],
4	mass	NN	O	mass	nn	5	SENT_148	[p8l641t2815r809b2856],
5	effect	NN	O	effect	nsubj	20	SENT_148	[p8l832t2792r1014b2856],
6	of	IN	O	of	_	0	SENT_148	[p8l1036t2792r1109b2856],
7	the	DT	O	the	det	9	SENT_148	[p8l1121t2792r1227b2856],
8	MS	NN	O	m	nn	9	SENT_148	[p8l1249t2796r1362b2856],
9	lesions	NNS	O	lesion	prep_of	2	SENT_148	[p8l1385t2792r1635b2864],
10	,	,	O	,	_	0	SENT_148	[p8l1385t2792r1635b2864],
11	as	IN	O	as	mark	12	SENT_148	[p8l1660t2815r1723b2856],
12	observed	VBN	O	observe	dep	2	SENT_148	[p8l1747t2792r2057b2856],
13	in	IN	O	in	_	0	SENT_148	[p8l2078t2798r2145b2855],
14	MRI	NNP	O	MRI	prep_in	12	SENT_148	[p8l8t2900r163b2958],
15	of	IN	O	of	_	0	SENT_148	[p8l187t2895r260b2958],
16	the	DT	O	the	det	17	SENT_148	[p8l271t2895r378b2958],
17	brain	NN	O	brain	prep_of	14	SENT_148	[p8l397t2895r596b2967],
18	,	,	O	,	_	0	SENT_148	[p8l397t2895r596b2967],
19	also	RB	O	also	advmod	20	SENT_148	[p8l619t2895r750b2958],
20	predicted	VBD	O	predict	_	0	SENT_148	[p8l772t2895r1097b2978],
21	a	DT	O	a	det	23	SENT_148	[p8l1118t2918r1153b2958],
22	beneﬁcial	JJ	O	beneﬁcial	amod	23	SENT_148	[p8l1171t2895r1501b2958],
23	response	NN	O	response	dobj	20	SENT_148	[p8l1523t2887r1981b2978],
24	.26	CD	NUMBER	.26	number	25	SENT_148	[p8l1523t2887r1981b2978],
25	’27	CD	NUMBER	’27	num	27	SENT_148	[p8l1523t2887r1981b2978],
26	Side	NN	O	side	nn	27	SENT_148	[p8l2003t2895r2145b2958],
27	effects	NNS	O	effect	nsubj	30	SENT_148	[p8l9t2998r225b3061],
28	of	IN	O	of	_	0	SENT_148	[p8l250t2998r324b3061],
29	PLEX	NN	O	plex	prep_of	27	SENT_148	[p8l339t3003r540b3060],
30	include	VBP	O	include	rcmod	23	SENT_148	[p8l561t2998r817b3061],
31	central-line	NN	O	central-line	nn	32	SENT_148	[p8l841t2998r1242b3061],
32	complications	NNS	O	complication	nsubj	36	SENT_148	[p8l1266t2998r1753b3081],
33	and	CC	O	and	_	0	SENT_148	[p8l1778t2998r1906b3061],
34	citrate	NN	O	citrate	nn	35	SENT_148	[p8l1930t3004r2145b3061],
35	toxicity	NN	O	toxicity	conj_and	32	SENT_148	[p8l7t3107r271b3185],
36	leading	VBG	O	lead	dep	30	SENT_148	[p8l289t3101r547b3185],
37	to	TO	O	to	_	0	SENT_148	[p8l567t3113r634b3164],
38	perioral	JJ	O	perioral	amod	41	SENT_148	[p8l658t3101r935b3184],
39	and	CC	O	and	_	0	SENT_148	[p8l959t3101r1087b3164],
40	acral	JJ	O	acral	amod	41	SENT_148	[p8l1111t3101r1277b3164],
41	paresthesias	NNS	O	paresthesia	prep_to	36	SENT_148	[p8l1298t3101r1739b3184],
42	,	,	O	,	_	0	SENT_148	[p8l1298t3101r1739b3184],
43	which	WDT	O	which	nsubjpass	46	SENT_148	[p8l1762t3101r1976b3164],
44	may	MD	O	may	aux	46	SENT_148	[p8l1999t3124r2148b3185],
45	be	VB	O	be	auxpass	46	SENT_148	[p8l6t3204r84b3267],
46	mistaken	VBN	O	mistake	rcmod	41	SENT_148	[p8l104t3204r412b3267],
47	for	IN	O	for	_	0	SENT_148	[p8l432t3204r527b3267],
48	new	JJ	O	new	amod	50	SENT_148	[p8l546t3227r687b3267],
49	MS	NN	O	m	nn	50	SENT_148	[p8l703t3208r815b3267],
50	attacks	NNS	O	attack	prep_for	46	SENT_148	[p8l837t3204r1082b3267],
51	.	.	O	.	_	0	SENT_148	[p8l837t3204r1082b3267],

1	Patients	NNS	O	patient	nsubj	5	SENT_149	[p8l1105t3209r1369b3267],
2	undergoing	VBG	O	undergo	partmod	1	SENT_149	[p8l1390t3204r1780b3288],
3	PLEX	NNP	ORGANIZATION	PLEX	dobj	2	SENT_149	[p8l1800t3209r1994b3266],
4	also	RB	O	also	advmod	5	SENT_149	[p8l2013t3204r2142b3267],
5	need	VBP	O	need	_	0	SENT_149	[p8l8t3306r172b3369],
6	to	TO	O	to	aux	8	SENT_149	[p8l192t3318r258b3369],
7	be	VB	O	be	auxpass	8	SENT_149	[p8l279t3306r358b3369],
8	monitored	VBN	O	monitor	xcomp	5	SENT_149	[p8l380t3306r743b3369],
9	for	IN	O	for	_	0	SENT_149	[p8l763t3306r861b3369],
10	anemia	NN	O	anemia	prep_for	8	SENT_149	[p8l882t3312r1147b3369],
11	.	.	O	.	_	0	SENT_149	[p8l882t3312r1147b3369],

1	Corticosteroids	NNS	O	corticosteroid	nsubj	8	SENT_150	[p9l83t27r635b90],
2	eﬂiciently	RB	O	eﬂiciently	advmod	3	SENT_150	[p9l663t27r1013b111],
3	address	VBP	O	address	_	0	SENT_150	[p9l1037t27r1302b90],
4	cell-mediated	JJ	O	cell-mediated	amod	6	SENT_150	[p9l1330t27r1817b90],
5	immune	JJ	O	immune	amod	6	SENT_150	[p9l1843t33r2142b90],
6	responses	NNS	O	response	dobj	3	SENT_150	[p9l9t152r342b213],
7	and	CC	O	and	_	0	SENT_150	[p9l367t130r494b193],
8	lead	VB	O	lead	conj_and	3	SENT_150	[p9l514t130r657b193],
9	to	TO	O	to	_	0	SENT_150	[p9l678t142r744b193],
10	early	JJ	O	early	amod	11	SENT_150	[p9l769t130r936b214],
11	closure	NN	O	closure	prep_to	8	SENT_150	[p9l956t130r1200b193],
12	of	IN	O	of	_	0	SENT_150	[p9l1224t130r1299b193],
13	the	DT	O	the	det	17	SENT_150	[p9l1311t130r1418b193],
14	blood	NN	O	blood	nn	17	SENT_150	[p9l1439t130r1869b193],
15	—	NN	O	—	nn	17	SENT_150	[p9l1439t130r1869b193],
16	brain	NN	O	brain	nn	17	SENT_150	[p9l1439t130r1869b193],
17	barrier	NN	O	barrier	prep_of	11	SENT_150	[p9l1890t130r2140b193],
18	.	.	O	.	_	0	SENT_150	[p9l1890t130r2140b193],

1	They	PRP	O	they	nsubj	2	SENT_151	[p9l8t233r183b317],
2	have	VBP	O	have	_	0	SENT_151	[p9l203t233r364b296],
3	only	RB	O	only	advmod	4	SENT_151	[p9l390t233r547b317],
4	minimal	JJ	O	minimal	amod	7	SENT_151	[p9l569t233r871b296],
5	and	CC	O	and	_	0	SENT_151	[p9l897t233r1028b296],
6	late	JJ	O	late	amod	7	SENT_151	[p9l1050t233r1174b296],
7	impact	NN	O	impact	dobj	2	SENT_151	[p9l1200t239r1445b316],
8	on	IN	O	on	_	0	SENT_151	[p9l1470t256r1558b296],
9	antibodymediated	JJ	O	antibodymediated	amod	10	SENT_151	[p9l1585t233r2143b317, p9l9t336r157b399],
10	immunity	NN	O	immunity	prep_on	2	SENT_151	[p9l183t342r550b420],
11	.	.	O	.	_	0	SENT_151	[p9l183t342r550b420],

1	The	DT	O	the	det	2	SENT_152	[p9l581t336r710b399],
2	mechanism	NN	O	mechanism	nsubj	7	SENT_152	[p9l737t336r1150b399],
3	of	IN	O	of	_	0	SENT_152	[p9l1178t336r1254b399],
4	action	NN	O	action	prep_of	2	SENT_152	[p9l1273t342r1494b399],
5	of	IN	O	of	_	0	SENT_152	[p9l1522t336r1598b399],
6	PLEX	NN	O	plex	prep_of	4	SENT_152	[p9l1616t341r1822b398],
7	includes	VBZ	O	include	_	0	SENT_152	[p9l1847t336r2143b399],
8	rapid	JJ	O	rapid	amod	9	SENT_152	[p9l9t439r189b522],
9	removal	NN	O	removal	dobj	7	SENT_152	[p9l212t439r493b502],
10	of	IN	O	of	_	0	SENT_152	[p9l517t439r591b502],
11	pathogenic	JJ	O	pathogenic	amod	12	SENT_152	[p9l604t439r989b523],
12	antibodies	NNS	O	antibody	prep_of	9	SENT_152	[p9l1013t439r1372b502],
13	or	CC	O	or	_	0	SENT_152	[p9l1397t462r1469b502],
14	cytokines	NNS	O	cytokine	conj_or	12	SENT_152	[p9l1492t439r1820b523],
15	from	IN	O	from	_	0	SENT_152	[p9l1844t439r2014b502],
16	the	DT	O	the	det	17	SENT_152	[p9l2036t439r2144b502],
17	circulation	NN	O	circulation	prep_from	7	SENT_152	[p9l9t542r399b605],
18	and	CC	O	and	_	0	SENT_152	[p9l428t542r560b605],
19	from	IN	O	from	_	0	SENT_152	[p9l587t542r762b605],
20	the	DT	O	the	det	21	SENT_152	[p9l789t542r901b605],
21	tissue	NN	O	tissue	prep_from	7	SENT_152	[p9l928t548r1131b605],
22	itself	PRP	O	itself	advmod	21	SENT_152	[p9l1159t542r1340b605],
23	Via	NNP	O	Via	nn	24	SENT_152	[p9l1356t548r1463b605],
24	equilibration	NNP	O	equilibration	dep	7	SENT_152	[p9l1490t542r1977b625],
25	.	.	O	.	_	0	SENT_152	[p9l1490t542r1977b625],

1	In	IN	O	in	_	0	SENT_153	[p9l2009t547r2083b604],
2	a	DT	O	a	pobj	1	SENT_153	[p9l2111t565r2147b605],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_154	[p9l21t690r140b711],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	_	0	SENT_154	[p9l149t690r374b711],
3	&	CC	O	&	_	0	SENT_154	[p9l381t690r601b711],
4	THERAPEUTlCS	NNP	O	THERAPEUTlCS	nn	6	SENT_154	[p9l381t690r601b711],
5	|	NNP	O	|	nn	6	SENT_154	[p9l611t688r613b718],
6	VOLUME	NNP	O	VOLUME	conj_and	2	SENT_154	[p9l621t690r729b711],
7	95	CD	NUMBER	95	num	8	SENT_154	[p9l737t690r764b711],
8	NUMBER	NN	O	number	dep	2	SENT_154	[p9l774t690r882b711],
9	1	CD	NUMBER	1	number	10	SENT_154	[p9l892t691r899b711],
10	]	CD	NUMBER	]	num	11	SENT_154	[p9l912t688r915b718],
11	JANUARY	NNP	DATE	JANUARY	dep	8	SENT_154	[p9l924t690r1042b711],
12	2014	CD	DATE	2014	num	13	SENT_154	[p9l1049t690r1108b711],
13	35	CD	DATE	35	dep	2	SENT_154	[p9l2109t690r2139b711],

1	STATE	NN	O	state	nn	2	SENT_155	[p9l21t833r163b870],
2	ART	NN	O	art	_	0	SENT_155	[p9l306t833r399b870],

1	Acute	JJ	O	acute	amod	2	SENT_156	[p9l760t985r840b1007],
2	treatment	NN	O	treatment	_	0	SENT_156	[p9l849t986r981b1007],
3	of	IN	O	of	_	0	SENT_156	[p9l990t985r1017b1007],
4	multiple	JJ	O	multiple	amod	6	SENT_156	[p9l1027t985r1136b1012],
5	sclerosis	NN	O	sclerosis	nn	6	SENT_156	[p9l1145t985r1269b1007],
6	relapses	NNS	O	relapse	prep_of	2	SENT_156	[p9l1280t985r1395b1012],

1	Acute	JJ	O	acute	_	0	SENT_157	[p9l572t1052r645b1074],
2	or	CC	O	or	_	0	SENT_157	[p9l655t1057r680b1074],
3	subacute	JJ	O	subacute	amod	4	SENT_157	[p9l689t1052r805b1074],
4	onset	NN	O	onset	conj_or	1	SENT_157	[p9l815t1054r885b1074],
5	of	IN	O	of	_	0	SENT_157	[p9l894t1052r918b1074],
6	a	DT	O	a	det	9	SENT_157	[p9l927t1057r942b1074],
7	central	JJ	O	central	amod	9	SENT_157	[p9l951t1052r1036b1074],
8	nervous	JJ	O	nervous	amod	9	SENT_157	[p9l1048t1057r1149b1074],
9	system	NN	O	system	prep_of	4	SENT_157	[p9l1159t1054r1249b1080],
10	demyelinating	VBG	O	demyelinate	partmod	9	SENT_157	[p9l1259t1052r1436b1080],
11	syndrome	NN	O	syndrome	dobj	10	SENT_157	[p9l1446t1052r1584b1080],
12	*	IN	O	*	prep	10	SENT_157	[p9l1446t1052r1584b1080],

1	-	:	O	-	_	0	SENT_158	[p9l1063t1092r1096b1120],
2	l	NN	O	l	nsubj	9	SENT_158	[p9l1063t1092r1096b1120],
3	is	VBZ	O	be	cop	9	SENT_158	[p9l928t1136r944b1155],
4	this	DT	O	this	det	9	SENT_158	[p9l952t1136r990b1155],
5	a	DT	O	a	det	9	SENT_158	[p9l999t1141r1011b1155],
6	“	NN	O	“	nn	9	SENT_158	[p9l1019t1130r1230b1160],
7	pseudo	NN	O	pseudo	nn	9	SENT_158	[p9l1019t1130r1230b1160],
8	—	CD	NUMBER	—	num	9	SENT_158	[p9l1019t1130r1230b1160],
9	re	NN	O	re	_	0	SENT_158	[p9l1019t1130r1230b1160],
10	|	CD	NUMBER	|	num	12	SENT_158	[p9l1019t1130r1230b1160],
11	apse	NN	O	apse	nn	12	SENT_158	[p9l1019t1130r1230b1160],
12	”	NN	O	”	dep	9	SENT_158	[p9l1019t1130r1230b1160],
13	?	.	O	?	_	0	SENT_158	[p9l1019t1130r1230b1160],

1	l	NN	O	l	_	0	SENT_159	[p9l1019t1130r1230b1160],

1	No	DT	O	no	_	0	SENT_160	[p9l757t1181r788b1200],
2	.	.	O	.	_	0	SENT_160	[p9l799t1181r831b1209],

1	|	NN	O	|	_	0	SENT_161	[p9l799t1181r831b1209],
2	,	,	O	,	_	0	SENT_161	[p9l799t1181r831b1209],
3	Yes	UH	O	yes	dep	7	SENT_161	[p9l1545t1183r1587b1202],
4	`	``	O	`	_	0	SENT_161	[p9l1602t1177r1634b1207],
5	*	NN	O	*	nsubj	7	SENT_161	[p9l1602t1177r1634b1207],
6	+	CC	O	+	cc	7	SENT_161	[p9l1602t1177r1634b1207],
7	Does	VBZ	O	do	ccomp	1	SENT_161	[p9l436t1238r492b1257],
8	the	DT	O	the	det	10	SENT_161	[p9l499t1238r533b1257],
9	relapse	NN	O	relapse	nn	10	SENT_161	[p9l543t1238r622b1262],
10	impact	NN	O	impact	nsubj	12	SENT_161	[p9l631t1238r703b1262],
11	—	CD	NUMBER	—	num	12	SENT_161	[p9l710t1248r725b1251],
12	limit	NN	O	limit	xcomp	7	SENT_161	[p9l733t1238r776b1257],
13	the	DT	O	the	det	14	SENT_161	[p9l783t1238r817b1257],
14	patient	NN	O	patient	poss	17	SENT_161	[p9l826t1238r916b1262],
15	’s	POS	O	’s	_	0	SENT_161	[p9l826t1238r916b1262],
16	daily	JJ	SET	daily	amod	17	SENT_161	[p9l924t1238r974b1262],
17	life	NN	O	life	dep	12	SENT_161	[p9l983t1238r1018b1260],
18	,	,	O	,	_	0	SENT_161	[p9l983t1238r1018b1260],
19	Q	NNP	O	Q	appos	12	SENT_161	[p9l1026t1238r1065b1260],
20	?	.	O	?	_	0	SENT_161	[p9l1026t1238r1065b1260],

1	is	VBZ	O	be	cop	2	SENT_162	[p9l1072t1238r1088b1257],
2	attributable	JJ	O	attributable	_	0	SENT_162	[p9l1097t1238r1218b1257],
3	Manage	VB	O	manage	ccomp	2	SENT_162	[p9l1552t1238r1640b1262],
4	the	DT	O	the	dobj	3	SENT_162	[p9l1648t1238r1682b1257],
5	to	TO	O	to	_	0	SENT_162	[p9l699t1270r719b1287],
6	a	DT	O	a	det	9	SENT_162	[p9l727t1273r740b1287],
7	spinal	JJ	O	spinal	amod	9	SENT_162	[p9l748t1268r811b1292],
8	cord	NN	O	cord	nn	9	SENT_162	[p9l820t1268r867b1287],
9	lesion	NN	O	lesion	prep_to	3	SENT_162	[p9l877t1268r953b1287],
10	?	.	O	?	_	0	SENT_162	[p9l877t1268r953b1287],

1	underlying	VBG	O	underlie	_	0	SENT_163	[p9l1503t1268r1616b1292],
2	provoking	VBG	O	provoke	xcomp	1	SENT_163	[p9l1625t1268r1730b1292],
3	factor	NN	O	factor	dobj	2	SENT_163	[p9l1513t1298r1575b1317],
4	&	CC	O	&	_	0	SENT_163	[p9l1582t1298r1597b1317],
5	rest	NN	O	rest	dobj	2	SENT_163	[p9l1607t1300r1652b1320],
6	;	:	O	;	_	0	SENT_163	[p9l1607t1300r1652b1320],
7	IVMP	NNP	O	IVMP	nn	10	SENT_163	[p9l1661t1298r1719b1317],
8	No	NNP	O	No	nn	10	SENT_163	[p9l523t1313r554b1332],
9	TL	NNP	O	TL	nn	10	SENT_163	[p9l567t1313r595b1341],
10	Yes	NNP	O	Yes	dep	3	SENT_163	[p9l990t1313r1031b1332],
11	*	CD	NUMBER	*	npadvmod	12	SENT_163	[p9l1043t1313r1074b1341],
12	unnecessary	JJ	O	unnecessary	amod	10	SENT_163	[p9l1547t1333r1687b1352],

1	Watchful	JJ	O	watchful	_	0	SENT_164	[p9l443t1365r538b1384],
2	waiting	VBG	O	wait	amod	1	SENT_164	[p9l546t1365r622b1389],
3	and	CC	O	and	_	0	SENT_164	[p9l631t1365r671b1384],
4	rest	NN	O	rest	nn	7	SENT_164	[p9l680t1366r720b1384],
5	IVMP	NN	O	ivmp	nn	7	SENT_164	[p9l983t1365r1042b1383],
6	infusion	NN	O	infusion	nn	7	SENT_164	[p9l1051t1365r1134b1384],
7	g	NN	O	g	conj_and	1	SENT_164	[p9l1602t1373r1634b1401],

1	U	NNP	O	U	nn	3	SENT_165	[p9l567t1401r595b1429],
2	i	FW	O	i	nn	3	SENT_165	[p9l1043t1405r1075b1433],
3	Reevaluate	NNP	O	Reevaluate	conj_and	3	SENT_165	[p9l1364t1422r1486b1441],
4	by	IN	O	by	_	0	SENT_165	[p9l1495t1422r1520b1446],
5	examination	NN	O	examination	prep_by	3	SENT_165	[p9l1528t1422r1660b1441],
6	and	CC	O	and	_	0	SENT_165	[p9l1668t1422r1708b1441],
7	No	DT	O	no	det	8	SENT_165	[p9l446t1455r476b1474],
8	improvement	NN	O	improvement	npadvmod	3	SENT_165	[p9l485t1455r627b1479],
9	after	IN	O	after	_	0	SENT_165	[p9l635t1455r684b1474],
10	15	CD	NUMBER	15	num	11	SENT_165	[p9l693t1456r718b1474],
11	~	NN	O	~	prep_after	8	SENT_165	[p9l818t1465r846b1484],
12	:	:	O	:	_	0	SENT_165	[p9l818t1465r846b1484],
13	_	CD	NUMBER	_	dep	11	SENT_165	[p9l818t1465r846b1484],
14	No	DT	O	no	det	28	SENT_165	[p9l893t1455r923b1474],
15	improvement	NN	O	improvement	dep	28	SENT_165	[p9l932t1455r1074b1479],
16	after	IN	O	after	_	0	SENT_165	[p9l1081t1455r1131b1474],
17	15	CD	DURATION	15	num	19	SENT_165	[p9l1140t1456r1165b1474],
18	days	NNS	NUMBER	day	nn	19	SENT_165	[p9l1173t1455r1224b1479],
19	imaging	NN	O	imaging	prep_after	15	SENT_165	[p9l1363t1452r1448b1476],
20	if	IN	O	if	_	0	SENT_165	[p9l1457t1452r1468b1470],
21	"	``	O	"	punct	22	SENT_165	[p9l1476t1457r1502b1471],
22	o	NN	O	o	prep_if	15	SENT_165	[p9l1476t1457r1502b1471],
23	imP	NN	O	imp	dep	22	SENT_165	[p9l1511t1452r1653b1476],
24	’	CD	NUMBER	’	number	25	SENT_165	[p9l1511t1452r1653b1476],
25	°	CD	NUMBER	°	num	26	SENT_165	[p9l1511t1452r1653b1476],
26	V9	NN	O	v9	dep	23	SENT_165	[p9l1511t1452r1653b1476],
27	"	''	O	"	punct	28	SENT_165	[p9l1511t1452r1653b1476],
28	‘	NN	O	‘	dep	13	SENT_165	[p9l1511t1452r1653b1476],
29	e	SYM	O	e	dep	8	SENT_165	[p9l1511t1452r1653b1476],
30	"	``	O	"	punct	8	SENT_165	[p9l1511t1452r1653b1476],
31	t	NN	O	t	dep	8	SENT_165	[p9l1511t1452r1653b1476],
32	after	IN	O	after	_	0	SENT_165	[p9l1661t1452r1711b1471],
33	days	NNS	DURATION	day	prep_after	3	SENT_165	[p9l439t1485r490b1509],
34	from	IN	O	from	_	0	SENT_165	[p9l498t1485r546b1504],
35	symptom	NN	O	symptom	nn	37	SENT_165	[p9l555t1487r655b1509],
36	onset	NN	O	onset	nn	37	SENT_165	[p9l664t1487r724b1504],
37	t	NN	O	t	prep_from	33	SENT_165	[p9l811t1488r818b1515],
38	+	CC	O	+	_	0	SENT_165	[p9l811t1488r818b1515],
39	from	IN	O	from	_	0	SENT_165	[p9l965t1485r1013b1504],
40	IVMP	NN	ORGANIZATION	ivmp	nn	41	SENT_165	[p9l1024t1485r1082b1504],
41	onset	NN	O	onset	prep_from	44	SENT_165	[p9l1091t1487r1151b1504],
42	15	CD	DURATION	15	num	43	SENT_165	[p9l1378t1482r1403b1501],
43	daYS	NN	DURATION	day	dep	41	SENT_165	[p9l1411t1482r1462b1506],
44	from	IN	O	from	conj_+	37	SENT_165	[p9l1469t1482r1518b1501],
45	3	CD	NUMBER	3	num	46	SENT_165	[p9l1527t1483r1626b1506],
46	)	NN	O	)	pobj	44	SENT_165	[p9l1527t1483r1626b1506],
47	/	:	O	/	punct	48	SENT_165	[p9l1527t1483r1626b1506],
48	mPt	NN	O	mpt	dep	46	SENT_165	[p9l1527t1483r1626b1506],
49	°	CD	NUMBER	°	num	48	SENT_165	[p9l1527t1483r1626b1506],
50	"	``	O	"	punct	46	SENT_165	[p9l1527t1483r1626b1506],
51	l	NN	O	l	dep	46	SENT_165	[p9l1527t1483r1626b1506],
52	0	CD	NUMBER	0	num	51	SENT_165	[p9l1635t1483r1696b1501],
53	'	''	DATE	'	_	0	SENT_165	[p9l1635t1483r1696b1501],
54	13	CD	DATE	13	dep	3	SENT_165	[p9l1635t1483r1696b1501],
55	‘	SYM	O	‘	dep	3	SENT_165	[p9l1635t1483r1696b1501],
56	-	:	O	-	_	0	SENT_165	[p9l1635t1483r1696b1501],
57	‘	NN	O	‘	nn	58	SENT_165	[p9l1635t1483r1696b1501],
58	vt	NN	O	vt	dep	3	SENT_165	[p9l1635t1483r1696b1501],

1	It	PRP	O	it	_	0	SENT_166	[p9l567t1529r595b1557],
2	o	NN	O	o	dep	1	SENT_166	[p9l811t1524r812b1563],
3	+	CC	O	+	_	0	SENT_166	[p9l811t1524r812b1563],
4	Ir	NN	O	ir	nn	6	SENT_166	[p9l1043t1526r1075b1555],
5	IVMP	NN	O	ivmp	nn	6	SENT_166	[p9l506t1580r565b1598],
6	infusion	NN	O	infusion	dep	1	SENT_166	[p9l574t1579r657b1599],
7	7	CD	NUMBER	7	num	8	SENT_166	[p9l827t1581r850b1600],
8	PLEX	NN	O	plex	dep	6	SENT_166	[p9l1028t1580r1090b1598],
9	‘	CD	NUMBER	‘	num	10	SENT_166	[p9l811t1620r812b1623],
10	Ir	NN	O	ir	dep	1	SENT_166	[p9l1043t1623r1075b1649],

1	No	DT	O	no	det	2	SENT_167	[p9l992t1673r1022b1692],
2	improvement	NN	O	improvement	_	0	SENT_167	[p9l1031t1673r1173b1697],
3	in	IN	O	in	_	0	SENT_167	[p9l1182t1673r1198b1691],
4	debility	NN	O	debility	prep_in	2	SENT_167	[p9l1207t1673r1284b1697],
5	after	IN	O	after	dep	2	SENT_167	[p9l1292t1673r1342b1692],
6	15	CD	DURATION	15	num	7	SENT_167	[p9l1350t1673r1375b1692],
7	days	NNS	NUMBER	day	pobj	5	SENT_167	[p9l1384t1673r1434b1697],
8	from	IN	O	from	dep	2	SENT_167	[p9l1442t1673r1491b1692],
9	PLEX	NNP	O	PLEX	nn	10	SENT_167	[p9l1501t1673r1562b1691],
10	onset	NN	O	onset	pobj	8	SENT_167	[p9l1570t1674r1631b1692],

1	¥	NN	O	¥	nsubj	2	SENT_168	[p9l1042t1713r1075b1741],
2	Consider	VB	O	consider	_	0	SENT_168	[p9l1009t1770r1107b1788],
3	‘	JJ	O	‘	amod	5	SENT_168	[p9l1009t1770r1107b1788],
4	alternative	JJ	O	alternative	amod	5	SENT_168	[p9l1115t1770r1228b1788],
5	explanations	NNS	O	explanation	dobj	2	SENT_168	[p9l1238t1770r1375b1793],
6	for	IN	O	for	_	0	SENT_168	[p9l1384t1770r1411b1788],
7	the	DT	O	the	det	9	SENT_168	[p9l1419t1770r1452b1788],
8	syndrome	NN	O	syndrome	nn	9	SENT_168	[p9l1461t1770r1569b1793],
9	Q	NNP	O	Q	prep_for	2	SENT_168	[p9l1577t1770r1615b1791],
10	?	.	O	?	_	0	SENT_168	[p9l1577t1770r1615b1791],

1	alternative	JJ	O	alternative	amod	3	SENT_169	[p9l922t1800r1035b1818],
2	rescue	NN	O	rescue	nn	3	SENT_169	[p9l1045t1805r1117b1818],
3	treatments	NNS	O	treatment	nsubj	7	SENT_169	[p9l1125t1802r1242b1818],
4	for	IN	O	for	_	0	SENT_169	[p9l1250t1800r1278b1818],
5	fulminant	JJ	O	fulminant	amod	6	SENT_169	[p9l1286t1800r1386b1818],
6	attacks	NNS	O	attack	prep_for	3	SENT_169	[p9l1395t1800r1471b1818],
7	(	VBP	O	(	_	0	SENT_169	[p9l1481t1800r1699b1823],
8	cyclopnosphamide	NN	O	cyclopnosphamide	dobj	7	SENT_169	[p9l1481t1800r1699b1823],
9	,	,	O	,	_	0	SENT_169	[p9l1481t1800r1699b1823],

1	alemtuzumab	NN	O	alemtuzumab	_	0	SENT_170	[p9l1159t1830r1311b1851],
2	,	,	O	,	_	0	SENT_170	[p9l1159t1830r1311b1851],
3	natalizumab	JJ	O	natalizumab	amod	4	SENT_170	[p9l1323t1830r1462b1852],
4	)	NN	O	)	appos	1	SENT_170	[p9l1323t1830r1462b1852],

1	l	NN	O	l	nn	3	SENT_171	[p9l399t1908r400b1941],
2	Future	JJ	DATE	future	amod	3	SENT_171	[p9l516t1914r586b1933],
3	direction	NN	O	direction	_	0	SENT_171	[p9l594t1914r693b1933],
4	:	:	O	:	_	0	SENT_171	[p9l594t1914r693b1933],
5	Add	VB	O	add	dep	3	SENT_171	[p9l701t1914r744b1934],
6	an	DT	O	a	det	9	SENT_171	[p9l752t1919r778b1934],
7	acute	JJ	O	acute	amod	9	SENT_171	[p9l787t1916r847b1934],
8	remye	NN	O	remye	nn	9	SENT_171	[p9l856t1914r1081b1939],
9	|	NN	O	|	dobj	5	SENT_171	[p9l856t1914r1081b1939],
10	inating	VBG	O	inate	partmod	9	SENT_171	[p9l856t1914r1081b1939],
11	—	CD	NUMBER	—	num	13	SENT_171	[p9l856t1914r1081b1939],
12	repair	NN	O	repair	nn	13	SENT_171	[p9l856t1914r1081b1939],
13	strategy	NN	O	strategy	dobj	10	SENT_171	[p9l1088t1916r1176b1939],
14	to	TO	O	to	_	0	SENT_171	[p9l1183t1916r1203b1933],
15	immunosuppression	NN	O	immunosuppression	prep_to	10	SENT_171	[p9l1212t1914r1433b1938],
16	to	TO	O	to	aux	17	SENT_171	[p9l1441t1916r1462b1933],
17	hasten	VB	O	hasten	xcomp	10	SENT_171	[p9l1471t1914r1543b1934],
18	recovery	NN	O	recovery	dobj	17	SENT_171	[p9l1553t1919r1646b1938],

1	Figure	NNP	O	Figure	nsubj	41	SENT_172	[p9l21t2014r111b2044],
2	3	CD	NUMBER	3	num	1	SENT_172	[p9l119t2015r134b2037],
3	Algorithmic	JJ	O	algorithmic	amod	4	SENT_172	[p9l158t2013r315b2044],
4	approach	NN	O	approach	nsubj	19	SENT_172	[p9l322t2013r447b2044],
5	to	TO	O	to	_	0	SENT_172	[p9l455t2017r482b2037],
6	treating	VBG	O	treat	prepc_to	4	SENT_172	[p9l490t2014r593b2044],
7	relapses	NNS	O	relapse	dobj	6	SENT_172	[p9l603t2013r710b2044],
8	in	IN	O	in	_	0	SENT_172	[p9l718t2014r740b2037],
9	MS.	NNP	O	MS.	prep_in	7	SENT_172	[p9l750t2013r854b2037],
10	This	DT	O	this	det	11	SENT_172	[p9l750t2013r854b2037],
11	approach	NN	O	approach	nsubjpass	14	SENT_172	[p9l862t2013r987b2044],
12	can	MD	O	can	aux	14	SENT_172	[p9l996t2020r1041b2037],
13	be	VB	O	be	auxpass	14	SENT_172	[p9l1051t2013r1082b2037],
14	modiﬁed	VBN	O	modiﬁed	rcmod	7	SENT_172	[p9l1091t2013r1208b2037],
15	to	TO	O	to	_	0	SENT_172	[p9l1217t2017r1244b2037],
16	the	DT	O	the	det	18	SENT_172	[p9l1251t2013r1294b2037],
17	individual	JJ	O	individual	amod	18	SENT_172	[p9l1303t2013r1432b2038],
18	needs	NNS	O	need	prep_to	14	SENT_172	[p9l1442t2013r1520b2037],
19	ofthe	VBP	O	ofthe	rcmod	1	SENT_172	[p9l1528t2013r1604b2037],
20	patient	NN	O	patient	dobj	19	SENT_172	[p9l1613t2014r1706b2044],
21	and	CC	O	and	_	0	SENT_172	[p9l1714t2013r1762b2038],
22	is	VBZ	O	be	cop	23	SENT_172	[p9l1772t2014r1790b2037],
23	subject	JJ	O	subject	rcmod	1	SENT_172	[p9l1798t2013r1894b2044],
24	to	TO	O	to	_	0	SENT_172	[p9l1901t2017r1928b2037],
25	availability	NN	O	availability	prep_to	23	SENT_172	[p9l1936t2013r2078b2044],
26	and	CC	O	and	_	0	SENT_172	[p9l20t2054r69b2078],
27	experience	NN	O	experience	prep_to	23	SENT_172	[p9l78t2056r224b2084],
28	with	IN	O	with	_	0	SENT_172	[p9l231t2054r288b2078],
29	different	JJ	O	different	amod	31	SENT_172	[p9l297t2054r410b2078],
30	treatment	NN	O	treatment	nn	31	SENT_172	[p9l417t2058r551b2078],
31	modalities	NNS	O	modality	prep_with	23	SENT_172	[p9l559t2054r696b2078],
32	in	IN	O	in	_	0	SENT_172	[p9l705t2056r727b2078],
33	different	JJ	O	different	amod	34	SENT_172	[p9l736t2054r849b2078],
34	centers	NNS	O	center	prep_in	31	SENT_172	[p9l856t2058r958b2082],
35	,	,	O	,	_	0	SENT_172	[p9l856t2058r958b2082],
36	especially	RB	O	especially	advmod	23	SENT_172	[p9l966t2054r1096b2085],
37	as	IN	O	as	_	0	SENT_172	[p9l1103t2061r1129b2078],
38	more	JJR	O	more	amod	39	SENT_172	[p9l1138t2061r1206b2078],
39	strategies	NNS	O	strategy	prep_as	23	SENT_172	[p9l1214t2056r1342b2085],
40	become	VBP	O	become	cop	41	SENT_172	[p9l1351t2054r1457b2078],
41	available	JJ	O	available	_	0	SENT_172	[p9l1465t2054r1582b2078],
42	in	IN	O	in	_	0	SENT_172	[p9l1591t2056r1612b2078],
43	the	DT	DATE	the	det	44	SENT_172	[p9l1621t2054r1664b2078],
44	future	NN	DATE	future	prep_in	41	SENT_172	[p9l1671t2054r1758b2078],
45	.	.	O	.	_	0	SENT_172	[p9l1671t2054r1758b2078],

1	*	NN	O	*	dep	2	SENT_173	[p9l1765t2055r1855b2078],
2	Acute	JJ	O	acute	_	0	SENT_173	[p9l1765t2055r1855b2078],
3	or	CC	O	or	_	0	SENT_173	[p9l1863t2061r1890b2078],
4	subacute	JJ	O	subacute	amod	5	SENT_173	[p9l1897t2054r2018b2078],
5	onset	NN	O	onset	conj_or	2	SENT_173	[p9l20t2099r94b2119],
6	of	IN	O	of	_	0	SENT_173	[p9l101t2095r129b2119],
7	a	DT	O	a	det	9	SENT_173	[p9l134t2102r147b2119],
8	neurological	JJ	O	neurological	amod	9	SENT_173	[p9l157t2095r320b2126],
9	syndrome	NN	O	syndrome	prep_of	2	SENT_173	[p9l329t2095r462b2126],
10	objectively	RB	O	objectively	advmod	11	SENT_173	[p9l470t2095r616b2126],
11	localized	JJ	O	localized	amod	9	SENT_173	[p9l624t2095r738b2119],
12	to	TO	O	to	prep	11	SENT_173	[p9l746t2099r773b2119],
13	and	CC	O	and	_	0	SENT_173	[p9l781t2095r829b2119],
14	suggestive	JJ	O	suggestive	conj_and	11	SENT_173	[p9l838t2096r981b2126],
15	of	IN	O	of	_	0	SENT_173	[p9l989t2095r1016b2119],
16	a	DT	O	a	det	21	SENT_173	[p9l1022t2102r1035b2119],
17	central	JJ	O	central	amod	21	SENT_173	[p9l1044t2095r1132b2119],
18	nervous	JJ	O	nervous	amod	21	SENT_173	[p9l1143t2102r1248b2119],
19	system	NN	O	system	nn	21	SENT_173	[p9l1256t2099r1347b2126],
20	inf	NN	O	inf	nn	21	SENT_173	[p9l1357t2095r1745b2126],
21	|	NN	O	|	prep_of	2	SENT_173	[p9l1357t2095r1745b2126],
22	ammatory	JJ	O	ammatory	amod	27	SENT_173	[p9l1357t2095r1745b2126],
23	—	NN	O	—	nn	27	SENT_173	[p9l1357t2095r1745b2126],
24	demye	NN	O	demye	nn	27	SENT_173	[p9l1357t2095r1745b2126],
25	|	NN	O	|	nn	27	SENT_173	[p9l1357t2095r1745b2126],
26	inating	VBG	O	inate	amod	27	SENT_173	[p9l1357t2095r1745b2126],
27	event	NN	O	event	dep	21	SENT_173	[p9l1754t2099r1828b2119],
28	by	IN	O	by	_	0	SENT_173	[p9l1837t2095r1868b2126],
29	history	NN	O	history	prep_by	21	SENT_173	[p9l1876t2095r1966b2126],
30	and	CC	O	and	_	0	SENT_173	[p9l1973t2095r2022b2119],
31	examination	NN	O	examination	prep_by	21	SENT_173	[p9l20t2138r185b2161],
32	(	CD	NUMBER	(	num	34	SENT_173	[p9l195t2137r367b2167],
33	neurological	JJ	O	neurological	amod	34	SENT_173	[p9l195t2137r367b2167],
34	examination	NN	O	examination	dep	2	SENT_173	[p9l376t2138r549b2164],
35	,	,	O	,	_	0	SENT_173	[p9l376t2138r549b2164],
36	ophthalmological	JJ	O	ophthalmological	amod	37	SENT_173	[p9l557t2137r791b2167],
37	examination	NN	O	examination	dep	2	SENT_173	[p9l800t2138r973b2164],
38	,	,	O	,	_	0	SENT_173	[p9l800t2138r973b2164],
39	magnetic	JJ	O	magnetic	amod	41	SENT_173	[p9l982t2138r1105b2167],
40	resonance	NN	O	resonance	nn	41	SENT_173	[p9l1114t2144r1250b2161],
41	imaging	NN	O	imaging	dep	2	SENT_173	[p9l1258t2138r1373b2167],
42	,	,	O	,	_	0	SENT_173	[p9l1258t2138r1373b2167],
43	or	CC	O	or	_	0	SENT_173	[p9l1381t2144r1408b2161],
44	visual	JJ	O	visual	conj_or	34	SENT_173	[p9l1414t2137r1488b2161],
45	evoked	VBN	O	evoke	partmod	34	SENT_173	[p9l1497t2137r1593b2161],
46	potential	JJ	O	potential	amod	47	SENT_173	[p9l1603t2137r1737b2167],
47	)	NN	O	)	dobj	45	SENT_173	[p9l1603t2137r1737b2167],
48	.	.	O	.	_	0	SENT_173	[p9l1603t2137r1737b2167],

1	Other	JJ	O	other	dep	2	SENT_174	[p9l1745t2137r1821b2161],
2	non	JJ	O	non	_	0	SENT_174	[p9l1830t2138r1932b2161],
3	.	.	O	.	_	0	SENT_174	[p9l1830t2138r1932b2161],

1	—	NN	O	—	_	0	SENT_175	[p9l1830t2138r1932b2161],
2	.	.	O	.	_	0	SENT_175	[p9l1830t2138r1932b2161],

1	MS	NN	O	m	nn	2	SENT_176	[p9l1830t2138r1932b2161],
2	considerations	NNS	O	consideration	nsubj	3	SENT_176	[p9l1940t2137r2134b2161],
3	include	VBP	O	include	_	0	SENT_176	[p9l21t2177r118b2202],
4	complicated	VBN	O	complicate	amod	6	SENT_176	[p9l125t2177r289b2208],
5	migraine	JJ	O	migraine	amod	6	SENT_176	[p9l299t2179r416b2208],
6	episodes	NNS	O	episode	dobj	3	SENT_176	[p9l424t2177r548b2208],
7	;	:	O	;	_	0	SENT_176	[p9l424t2177r548b2208],
8	ischemic	JJ	O	ischemic	amod	9	SENT_176	[p9l556t2177r860b2208],
9	—	NN	O	—	dep	6	SENT_176	[p9l556t2177r860b2208],
10	hemorrhagic	JJ	O	hemorrhagic	amod	11	SENT_176	[p9l556t2177r860b2208],
11	strokes	NNS	O	stroke	dep	9	SENT_176	[p9l868t2177r968b2205],
12	;	:	O	;	_	0	SENT_176	[p9l868t2177r968b2205],
13	spinal	JJ	O	spinal	amod	15	SENT_176	[p9l976t2177r1052b2208],
14	cord	NN	O	cord	nn	15	SENT_176	[p9l1061t2177r1118b2202],
15	infarcts	NNS	O	infarct	nsubj	16	SENT_176	[p9l1128t2177r1224b2202],
16	(	VBP	O	(	conj_and	3	SENT_176	[p9l1232t2178r1292b2208],
17	e.g.	FW	O	e.g.	dobj	16	SENT_176	[p9l1232t2178r1292b2208],
18	,	,	O	,	_	0	SENT_176	[p9l1232t2178r1292b2208],
19	dural	JJ	O	dural	amod	22	SENT_176	[p9l1300t2177r1366b2202],
20	arteriovenous	JJ	O	arteriovenous	amod	22	SENT_176	[p9l1375t2179r1559b2202],
21	ﬁstula	NN	O	ﬁstula	nn	22	SENT_176	[p9l1566t2177r1662b2205],
22	)	NN	O	)	appos	17	SENT_176	[p9l1566t2177r1662b2205],
23	;	:	O	;	_	0	SENT_176	[p9l1566t2177r1662b2205],
24	infections	NNS	O	infection	nsubj	34	SENT_176	[p9l1670t2177r1799b2202],
25	(	CD	NUMBER	(	npadvmod	26	SENT_176	[p9l1808t2177r1989b2208],
26	independent	JJ	O	independent	amod	24	SENT_176	[p9l1808t2177r1989b2208],
27	or	CC	O	or	_	0	SENT_176	[p9l1997t2184r2024b2202],
28	caused	VBN	O	cause	conj_or	26	SENT_176	[p9l20t2219r112b2243],
29	by	IN	O	by	_	0	SENT_176	[p9l122t2219r153b2250],
30	MS	NN	O	m	nn	33	SENT_176	[p9l161t2219r303b2243],
31	—	CD	NUMBER	—	num	33	SENT_176	[p9l161t2219r303b2243],
32	re	NN	O	re	nn	33	SENT_176	[p9l161t2219r303b2243],
33	|	NN	O	|	prep_by	28	SENT_176	[p9l161t2219r303b2243],
34	ated	VBD	O	ate	conj_and	3	SENT_176	[p9l161t2219r303b2243],
35	medications	NNS	O	medication	dobj	34	SENT_176	[p9l313t2219r491b2247],
36	)	CD	NUMBER	)	tmod	34	SENT_176	[p9l313t2219r491b2247],
37	;	:	O	;	_	0	SENT_176	[p9l313t2219r491b2247],
38	and	CC	O	and	_	0	SENT_176	[p9l498t2219r547b2243],
39	other	JJ	O	other	amod	46	SENT_176	[p9l556t2219r627b2243],
40	autoimmune	JJ	O	autoimmune	amod	46	SENT_176	[p9l635t2220r813b2247],
41	,	,	O	,	_	0	SENT_176	[p9l635t2220r813b2247],
42	paraneoplastic	JJ	O	paraneoplastic	conj_or	40	SENT_176	[p9l822t2219r1023b2249],
43	,	,	O	,	_	0	SENT_176	[p9l822t2219r1023b2249],
44	or	CC	O	or	_	0	SENT_176	[p9l1031t2226r1058b2243],
45	neoplastic	JJ	O	neoplastic	conj_or	40	SENT_176	[p9l1066t2219r1202b2249],
46	explanations	NNS	O	explanation	nsubj	47	SENT_176	[p9l1210t2219r1379b2250],
47	(	VBP	O	(	conj_and	3	SENT_176	[p9l1388t2219r1450b2247],
48	that	DT	O	that	nsubj	51	SENT_176	[p9l1388t2219r1450b2247],
49	may	MD	O	may	aux	51	SENT_176	[p9l1458t2226r1513b2250],
50	also	RB	O	also	advmod	51	SENT_176	[p9l1520t2219r1572b2243],
51	require	VB	O	require	ccomp	47	SENT_176	[p9l1581t2220r1674b2249],
52	and	CC	O	and	_	0	SENT_176	[p9l1682t2219r1730b2243],
53	respond	VB	O	respond	ccomp	47	SENT_176	[p9l1740t2219r1847b2249],
54	to	TO	O	to	_	0	SENT_176	[p9l1856t2223r1883b2243],
55	acute	JJ	O	acute	amod	57	SENT_176	[p9l1890t2223r1963b2243],
56	steroid	NN	O	steroid	nn	57	SENT_176	[p9l1971t2219r2060b2243],
57	use	NN	O	use	prep_to	51	SENT_176	[p9l21t2261r81b2288],
58	)	CD	NUMBER	)	dobj	51	SENT_176	[p9l21t2261r81b2288],
59	.	.	O	.	_	0	SENT_176	[p9l21t2261r81b2288],
60	"	''	O	"	punct	3	SENT_176	[p9l88t2256r342b2291],
61	"	''	O	"	punct	3	SENT_176	[p9l88t2256r342b2291],

1	Pseudore	NN	O	pseudore	nn	3	SENT_177	[p9l88t2256r342b2291],
2	|	CD	NUMBER	|	num	3	SENT_177	[p9l88t2256r342b2291],
3	apse	NN	O	apse	_	0	SENT_177	[p9l88t2256r342b2291],
4	"	''	O	"	punct	3	SENT_177	[p9l88t2256r342b2291],
5	is	VBZ	O	be	cop	11	SENT_177	[p9l88t2256r342b2291],
6	a	DT	O	a	det	11	SENT_177	[p9l350t2267r363b2284],
7	stereotypical	JJ	O	stereotypical	amod	11	SENT_177	[p9l372t2260r541b2291],
8	recurrence	NN	O	recurrence	nn	11	SENT_177	[p9l551t2267r692b2285],
9	ofa	NN	O	ofa	nn	11	SENT_177	[p9l700t2260r746b2285],
10	previous	JJ	O	previous	amod	11	SENT_177	[p9l755t2261r868b2291],
11	syndrome	NN	O	syndrome	rcmod	3	SENT_177	[p9l876t2260r1009b2291],
12	in	IN	O	in	_	0	SENT_177	[p9l1018t2261r1039b2284],
13	the	DT	O	the	det	15	SENT_177	[p9l1048t2260r1091b2284],
14	same	JJ	O	same	amod	15	SENT_177	[p9l1099t2267r1168b2285],
15	location	NN	O	location	prep_in	11	SENT_177	[p9l1177t2260r1282b2285],
16	and	CC	O	and	_	0	SENT_177	[p9l1291t2260r1340b2285],
17	distribution	NN	O	distribution	prep_in	11	SENT_177	[p9l1348t2260r1502b2285],
18	that	WDT	O	that	nsubj	20	SENT_177	[p9l1510t2260r1564b2285],
19	usually	RB	O	usually	advmod	20	SENT_177	[p9l1573t2260r1664b2291],
20	lasts	VBZ	O	last	rcmod	15	SENT_177	[p9l1673t2260r1729b2285],
21	<	JJR	O	<	acomp	20	SENT_177	[p9l1737t2262r1788b2284],
22	24	CD	DURATION	24	num	23	SENT_177	[p9l1737t2262r1788b2284],
23	hours	NNS	NUMBER	hour	tmod	20	SENT_177	[p9l1796t2260r1869b2285],
24	but	CC	O	but	_	0	SENT_177	[p9l1878t2260r1923b2285],
25	could	MD	O	could	aux	29	SENT_177	[p9l1930t2260r2003b2284],
26	be	VB	O	be	auxpass	29	SENT_177	[p9l2012t2260r2044b2285],
27	longer	RBR	O	longer	advmod	28	SENT_177	[p9l21t2301r107b2332],
28	if	IN	O	if	advmod	29	SENT_177	[p9l115t2301r131b2325],
29	provoked	VBN	O	provoke	conj_but	20	SENT_177	[p9l138t2301r262b2331],
30	by	IN	O	by	_	0	SENT_177	[p9l272t2301r303b2332],
31	increased	VBN	O	increase	amod	32	SENT_177	[p9l311t2301r436b2325],
32	fatigue	NN	O	fatigue	agent	29	SENT_177	[p9l444t2301r543b2332],
33	,	,	O	,	_	0	SENT_177	[p9l444t2301r543b2332],
34	exercise	NN	O	exercise	conj_or	3	SENT_177	[p9l551t2303r663b2329],
35	,	,	O	,	_	0	SENT_177	[p9l551t2303r663b2329],
36	infection	NN	O	infection	conj_or	3	SENT_177	[p9l672t2301r794b2329],
37	,	,	O	,	_	0	SENT_177	[p9l672t2301r794b2329],
38	environmental	JJ	O	environmental	amod	40	SENT_177	[p9l802t2301r996b2325],
39	temperature	NN	O	temperature	nn	40	SENT_177	[p9l1004t2305r1171b2331],
40	changes	NNS	O	change	conj_or	3	SENT_177	[p9l1179t2301r1296b2332],
41	,	,	O	,	_	0	SENT_177	[p9l1179t2301r1296b2332],
42	undiagnosed	JJ	O	undiagnosed	amod	44	SENT_177	[p9l1305t2301r1478b2332],
43	autonomic	JJ	O	autonomic	amod	44	SENT_177	[p9l1487t2303r1631b2325],
44	abnormalities	NNS	O	abnormality	conj_or	3	SENT_177	[p9l1639t2301r1821b2325],
45	leading	VBG	O	lead	partmod	44	SENT_177	[p9l1830t2301r1927b2332],
46	to	TO	O	to	aux	47	SENT_177	[p9l1935t2305r1962b2325],
47	hypo	VB	O	hypo	xcomp	45	SENT_177	[p9l1971t2301r2047b2332],
48	—	CD	NUMBER	—	dobj	47	SENT_177	[p9l1971t2301r2047b2332],
49	or	CC	O	or	_	0	SENT_177	[p9l2055t2308r2082b2325],
50	hyperthermia	NN	O	hyperthermium	conj_or	48	SENT_177	[p9l21t2342r208b2373],
51	,	,	O	,	_	0	SENT_177	[p9l21t2342r208b2373],
52	or	CC	O	or	_	0	SENT_177	[p9l216t2349r243b2366],
53	severe	JJ	O	severe	amod	54	SENT_177	[p9l250t2349r335b2366],
54	electrolyte	NN	O	electrolyte	nn	57	SENT_177	[p9l343t2342r483b2373],
55	and	CC	O	and	_	0	SENT_177	[p9l491t2342r540b2366],
56	nutritional	JJ	O	nutritional	nn	57	SENT_177	[p9l550t2342r686b2366],
57	abnormalities	NNS	O	abnormality	conj_or	3	SENT_177	[p9l695t2342r884b2366],
58	.	.	O	.	_	0	SENT_177	[p9l695t2342r884b2366],

1	IVMP	NN	O	ivmp	_	0	SENT_178	[p9l893t2343r961b2370],
2	,	,	O	,	_	0	SENT_178	[p9l893t2343r961b2370],
3	i.v.	NN	O	i.v.	nn	4	SENT_178	[p9l969t2343r1001b2366],
4	methylprednisolone	NN	O	methylprednisolone	appos	1	SENT_178	[p9l1010t2342r1279b2373],
5	1,000	CD	NUMBER	1,000	num	7	SENT_178	[p9l1289t2344r1358b2370],
6	mg	NN	O	mg	nn	7	SENT_178	[p9l1364t2349r1405b2373],
7	infusion	NN	O	infusion	npadvmod	8	SENT_178	[p9l1415t2342r1520b2366],
8	daily	RB	SET	daily	advmod	4	SENT_178	[p9l1528t2342r1591b2373],
9	for	IN	O	for	_	0	SENT_178	[p9l1597t2342r1634b2366],
10	3-7	CD	NUMBER	3-7	num	11	SENT_178	[p9l1642t2344r1688b2366],
11	days	NNS	NUMBER	day	prep_for	4	SENT_178	[p9l1697t2342r1762b2373],
12	;	:	O	;	_	0	SENT_178	[p9l1697t2342r1762b2373],
13	MS	NN	O	m	dep	4	SENT_178	[p9l1771t2343r1817b2370],
14	,	,	O	,	_	0	SENT_178	[p9l1771t2343r1817b2370],
15	multiple	JJ	O	multiple	amod	16	SENT_178	[p9l1826t2342r1935b2372],
16	sclerosis	NN	O	sclerosis	appos	13	SENT_178	[p9l1943t2342r2059b2370],
17	;	:	O	;	_	0	SENT_178	[p9l1943t2342r2059b2370],
18	PLEX	NNP	O	PLEX	dep	4	SENT_178	[p9l2068t2343r2138b2370],
19	,	,	O	,	_	0	SENT_178	[p9l2068t2343r2138b2370],
20	plasma	NN	O	plasma	nn	21	SENT_178	[p9l11t2396r199b2456],
21	exchange	NN	O	exchange	appos	18	SENT_178	[p9l217t2396r490b2457],
22	,	,	O	,	_	0	SENT_178	[p9l217t2396r490b2457],
23	1.1	CD	NUMBER	1.1	num	26	SENT_178	[p9l511t2400r572b2444],
24	plasma	NN	O	plasma	nn	26	SENT_178	[p9l601t2396r790b2456],
25	volume	NN	O	volume	nn	26	SENT_178	[p9l806t2396r1010b2444],
26	units	NNS	O	unit	appos	1	SENT_178	[p9l1028t2398r1156b2444],
27	at	IN	O	at	_	0	SENT_178	[p9l1173t2403r1222b2444],
28	each	DT	SET	each	det	31	SENT_178	[p9l1238t2396r1362b2444],
29	alternate	JJ	SET	alternate	amod	31	SENT_178	[p9l1380t2396r1620b2444],
30	day	NN	SET	day	nn	31	SENT_178	[p9l1636t2396r1732b2457],
31	X	NN	O	x	prep_at	26	SENT_178	[p9l1747t2408r1782b2443],
32	7	CD	NUMBER	7	num	33	SENT_178	[p9l1800t2400r1828b2443],
33	treatments	NNS	O	treatment	dep	26	SENT_178	[p9l1843t2403r2152b2444],
34	.	.	O	.	_	0	SENT_178	[p9l1843t2403r2152b2444],

1	biopsy	NN	O	biopsy	nsubj	39	SENT_179	[p9l7t2610r483b2692],
2	—	CD	NUMBER	—	num	4	SENT_179	[p9l7t2610r483b2692],
3	proVen	JJ	O	proven	amod	4	SENT_179	[p9l7t2610r483b2692],
4	cohort	NN	O	cohort	nsubj	19	SENT_179	[p9l502t2610r718b2672],
5	of	IN	O	of	_	0	SENT_179	[p9l737t2610r808b2672],
6	MS	NN	O	m	nn	7	SENT_179	[p9l818t2614r927b2672],
7	patients	NNS	O	patient	prep_of	4	SENT_179	[p9l946t2616r1222b2691],
8	,	,	O	,	_	0	SENT_179	[p9l946t2616r1222b2691],
9	only	RB	O	only	advmod	10	SENT_179	[p9l1244t2610r1389b2692],
10	those	DT	O	those	nsubj	19	SENT_179	[p9l1404t2610r1579b2672],
11	with	IN	O	with	_	0	SENT_179	[p9l1597t2610r1743b2672],
12	a	DT	O	a	det	14	SENT_179	[p9l1763t2632r1796b2672],
13	predominant	JJ	O	predominant	amod	14	SENT_179	[p9l1813t2610r2098b2691, p9l9t2716r184b2772],
14	antibody	NN	O	antibody	prep_with	10	SENT_179	[p9l207t2710r536b2792],
15	-	:	O	-	_	0	SENT_179	[p9l207t2710r536b2792],
16	and	CC	O	and	_	0	SENT_179	[p9l563t2710r688b2772],
17	complement	NN	O	complement	nn	18	SENT_179	[p9l710t2710r1488b2791],
18	—	NN	O	—	nsubj	19	SENT_179	[p9l710t2710r1488b2791],
19	mediated	VBD	O	mediate	rcmod	1	SENT_179	[p9l710t2710r1488b2791],
20	pathomechanism	NN	O	pathomechanism	nsubj	21	SENT_179	[p9l1509t2710r2102b2791],
21	responded	VBD	O	respond	ccomp	19	SENT_179	[p9l9t2810r360b2891],
22	to	TO	O	to	_	0	SENT_179	[p9l378t2822r442b2872],
23	PLEX	NNP	O	PLEX	prep_to	21	SENT_179	[p9l464t2802r733b2872],
24	.28	CD	NUMBER	.28	num	23	SENT_179	[p9l464t2802r733b2872],
25	The	DT	O	the	det	26	SENT_179	[p9l754t2810r876b2872],
26	fact	NN	O	fact	dobj	21	SENT_179	[p9l896t2810r1017b2872],
27	that	IN	O	that	complm	29	SENT_179	[p9l1036t2810r1165b2872],
28	PLEX	NN	O	plex	nsubj	29	SENT_179	[p9l1185t2815r1378b2871],
29	works	VBZ	O	work	dep	26	SENT_179	[p9l1394t2810r1594b2872],
30	Very	RB	O	very	advmod	29	SENT_179	[p9l1612t2832r1761b2892],
31	efﬁciently	RB	O	efﬁciently	advmod	29	SENT_179	[p9l1778t2810r2104b2892],
32	in	IN	O	in	_	0	SENT_179	[p9l9t2916r73b2971],
33	neuromyelitis	NN	O	neuromyelitis	nn	35	SENT_179	[p9l95t2910r554b2992],
34	optica	NN	O	optica	nn	35	SENT_179	[p9l577t2916r782b2991],
35	exacerbations	NNS	O	exacerbation	prep_in	29	SENT_179	[p9l803t2910r1262b2972],
36	is	VBZ	O	be	cop	39	SENT_179	[p9l1284t2916r1333b2972],
37	another	DT	O	another	det	39	SENT_179	[p9l1356t2910r1616b2972],
38	indirect	JJ	O	indirect	amod	39	SENT_179	[p9l1636t2910r1899b2972],
39	proof	NN	O	proof	_	0	SENT_179	[p9l1918t2910r2110b2991],
40	that	IN	O	that	complm	46	SENT_179	[p9l8t3010r138b3072],
41	the	DT	O	the	det	42	SENT_179	[p9l157t3010r261b3072],
42	mechanism	NN	O	mechanism	nsubjpass	46	SENT_179	[p9l282t3010r670b3072],
43	of	IN	O	of	_	0	SENT_179	[p9l692t3010r764b3072],
44	action	NN	O	action	prep_of	42	SENT_179	[p9l776t3016r983b3072],
45	is	VBZ	O	be	auxpass	46	SENT_179	[p9l1004t3016r1053b3072],
46	related	VBN	O	relate	ccomp	39	SENT_179	[p9l1075t3010r1301b3072],
47	to	TO	O	to	_	0	SENT_179	[p9l1320t3022r1385b3072],
48	antibody	NN	O	antibody	nn	49	SENT_179	[p9l1408t3010r1707b3092],
49	removal	NN	O	removal	prep_to	46	SENT_179	[p9l1725t3010r2014b3080],
50	,	,	O	,	_	0	SENT_179	[p9l1725t3010r2014b3080],
51	as	IN	O	as	mark	56	SENT_179	[p9l2037t3032r2099b3072],
52	neuromyelitis	NN	O	neuromyelitis	nn	53	SENT_179	[p9l8t3110r456b3192],
53	optica	NN	O	optica	nsubjpass	56	SENT_179	[p9l476t3116r676b3191],
54	has	VBZ	O	have	aux	56	SENT_179	[p9l693t3110r800b3172],
55	been	VBN	O	be	auxpass	56	SENT_179	[p9l818t3110r975b3172],
56	shown	VBN	O	show	advcl	39	SENT_179	[p9l995t3110r1208b3172],
57	to	TO	O	to	aux	62	SENT_179	[p9l1226t3122r1289b3172],
58	be	VB	O	be	cop	62	SENT_179	[p9l1307t3110r1384b3172],
59	a	DT	O	a	det	62	SENT_179	[p9l1404t3132r1437b3172],
60	primarily	RB	O	primarily	advmod	61	SENT_179	[p9l1454t3110r1765b3192],
61	antibodymediated	JJ	O	antibodymediated	amod	62	SENT_179	[p9l1782t3110r2096b3192, p9l8t3210r321b3272],
62	disease	NN	O	disease	xcomp	56	SENT_179	[p9l342t3202r656b3272],
63	.	.	O	.	_	0	SENT_179	[p9l342t3202r656b3272],

1	”	NN	O	”	_	0	SENT_180	[p9l342t3202r656b3272],

1	If	IN	O	if	mark	7	SENT_181	[p10l81t26r140b87],
2	patients	NNS	O	patient	nsubj	7	SENT_181	[p10l152t32r421b107],
3	with	IN	O	with	_	0	SENT_181	[p10l443t26r595b88],
4	severely	RB	O	severely	advmod	5	SENT_181	[p10l619t26r892b108],
5	debilitating	VBG	O	debilitate	prepc_with	2	SENT_181	[p10l912t26r1301b108],
6	attacks	NNS	O	attack	dobj	5	SENT_181	[p10l1323t26r1555b88],
7	fail	VBP	O	fail	advcl	22	SENT_181	[p10l1579t26r1684b88],
8	corticosteroids	NNS	O	corticosteroid	dobj	7	SENT_181	[p10l1707t32r2097b88, p10l9t126r146b188],
9	or	CC	O	or	_	0	SENT_181	[p10l170t148r241b188],
10	PLEX	NN	O	plex	dobj	7	SENT_181	[p10l263t131r475b196],
11	,	,	O	,	_	0	SENT_181	[p10l263t131r475b196],
12	alternative	JJ	O	alternative	amod	13	SENT_181	[p10l500t126r856b188],
13	diagnoses	NNS	O	diagnosis	nsubjpass	22	SENT_181	[p10l880t126r1211b208],
14	of	IN	O	of	_	0	SENT_181	[p10l1235t126r1308b188],
15	other	JJ	O	other	amod	16	SENT_181	[p10l1322t126r1502b188],
16	demyelinating	NN	O	demyelinating	prep_of	13	SENT_181	[p10l1524t126r2009b208],
17	or	CC	O	or	_	0	SENT_181	[p10l2031t148r2101b188],
18	nondemyelinating	JJ	O	nondemyelinating	amod	19	SENT_181	[p10l8t226r622b308],
19	disease	NN	O	disease	prep_of	13	SENT_181	[p10l642t226r877b288],
20	should	MD	O	should	aux	22	SENT_181	[p10l899t226r1125b288],
21	be	VB	O	be	auxpass	22	SENT_181	[p10l1143t226r1221b288],
22	considered	VBN	O	consider	_	0	SENT_181	[p10l1242t226r1625b296],
23	,	,	O	,	_	0	SENT_181	[p10l1242t226r1625b296],
24	in	IN	O	in	_	0	SENT_181	[p10l1647t232r1712b287],
25	addition	NN	O	addition	_	0	SENT_181	[p10l1734t226r2015b288],
26	to	TO	O	to	_	0	SENT_181	[p10l2035t238r2099b288],
27	rehabilitative	JJ	O	rehabilitative	amod	28	SENT_181	[p10l9t326r457b388],
28	treatment	NN	O	treatment	prep_in_addition_to	22	SENT_181	[p10l479t337r832b388],
29	.	.	O	.	_	0	SENT_181	[p10l479t337r832b388],

1	These	DT	O	these	det	2	SENT_182	[p10l858t326r1052b388],
2	patients	NNS	O	patient	nsubj	4	SENT_182	[p10l1074t332r1344b407],
3	could	MD	O	could	aux	4	SENT_182	[p10l1369t326r1559b388],
4	represent	VB	O	represent	_	0	SENT_182	[p10l1582t338r1901b407],
5	acute	JJ	O	acute	acomp	4	SENT_182	[p10l1924t338r2102b388],
6	progressive	JJ	O	progressive	amod	7	SENT_182	[p10l7t432r405b508],
7	Marburg	NNP	MISC	Marburg	poss	9	SENT_182	[p10l431t426r783b508],
8	’s	POS	O	’s	_	0	SENT_182	[p10l431t426r783b508],
9	variant	NN	O	variant	dobj	4	SENT_182	[p10l807t432r1074b496],
10	,	,	O	,	_	0	SENT_182	[p10l807t432r1074b496],
11	which	WDT	O	which	nsubj	13	SENT_182	[p10l1100t426r1314b488],
12	usually	RB	O	usually	advmod	13	SENT_182	[p10l1340t426r1591b508],
13	leads	VBZ	O	lead	rcmod	9	SENT_182	[p10l1613t426r1788b488],
14	to	TO	O	to	_	0	SENT_182	[p10l1814t438r1881b488],
15	death	NN	O	death	prep_to	13	SENT_182	[p10l1910t426r2102b488],
16	within	IN	O	within	_	0	SENT_182	[p10l7t526r222b588],
17	a	DT	DURATION	a	det	19	SENT_182	[p10l243t548r276b588],
18	few	JJ	DURATION	few	amod	19	SENT_182	[p10l294t526r411b588],
19	months	NNS	DURATION	month	prep_within	13	SENT_182	[p10l428t526r694b588],
20	.	.	O	.	_	0	SENT_182	[p10l428t526r694b588],

1	There	EX	O	there	_	0	SENT_183	[p10l717t526r904b588],
2	are	VBP	O	be	dep	6	SENT_183	[p10l924t548r1021b588],
3	no	RB	O	no	advmod	6	SENT_183	[p10l1041t548r1123b588],
4	well	RB	O	well	advmod	5	SENT_183	[p10l1143t526r1662b607],
5	—	JJ	O	—	advmod	6	SENT_183	[p10l1143t526r1662b607],
6	performed	VBN	O	perform	dep	1	SENT_183	[p10l1143t526r1662b607],
7	clinical	JJ	O	clinical	amod	8	SENT_183	[p10l1682t526r1918b588],
8	trials	NNS	O	trial	nsubj	19	SENT_183	[p10l1936t526r2101b588],
9	for	IN	O	for	_	0	SENT_183	[p10l9t626r104b688],
10	rare	JJ	O	rare	amod	11	SENT_183	[p10l123t648r253b688],
11	situations	NNS	O	situation	prep_for	8	SENT_183	[p10l274t632r595b688],
12	such	JJ	O	such	_	0	SENT_183	[p10l617t626r769b688],
13	as	IN	O	as	_	0	SENT_183	[p10l790t648r853b688],
14	these	DT	O	these	prep_such_as	11	SENT_183	[p10l873t626r1062b696],
15	;	:	O	;	_	0	SENT_183	[p10l873t626r1062b696],
16	most	JJS	O	most	amod	18	SENT_183	[p10l1084t637r1250b688],
17	MS	NN	O	m	nn	18	SENT_183	[p10l1269t630r1380b688],
18	experts	NNS	O	expert	dep	14	SENT_183	[p10l1402t638r1643b707],
19	utilize	VBP	O	utilize	parataxis	6	SENT_183	[p10l1664t626r1869b688],
20	strong	JJ	O	strong	amod	22	SENT_183	[p10l1891t638r2102b708],
21	immunosuppressive	JJ	O	immunosuppressive	amod	22	SENT_183	[p10l9t733r686b808],
22	therapies	NNS	O	therapy	dobj	19	SENT_183	[p10l707t727r1012b808],
23	such	JJ	O	such	_	0	SENT_183	[p10l1036t727r1187b789],
24	as	IN	O	as	_	0	SENT_183	[p10l1210t749r1273b789],
25	cyclophosphamide	NN	O	cyclophosphamide	prep_such_as	22	SENT_183	[p10l1297t727r1928b809],
26	with	IN	O	with	_	0	SENT_183	[p10l1949t727r2098b789],
27	steroids	NNS	O	steroid	prep_with	25	SENT_183	[p10l9t827r281b897],
28	,	,	O	,	_	0	SENT_183	[p10l9t827r281b897],
29	per	IN	O	per	_	0	SENT_183	[p10l301t848r411b908],
30	the	DT	O	the	det	32	SENT_183	[p10l429t827r531b889],
31	established	JJ	O	established	amod	32	SENT_183	[p10l552t827r916b889],
32	protocol	NN	O	protocol	prep_per	6	SENT_183	[p10l933t819r1363b908],
33	.29	CD	NUMBER	.29	number	34	SENT_183	[p10l933t819r1363b908],
34	’	CD	NUMBER	’	dep	36	SENT_183	[p10l933t819r1363b908],
35	3	CD	NUMBER	3	number	36	SENT_183	[p10l933t819r1363b908],
36	°	NN	O	°	amod	32	SENT_183	[p10l933t819r1363b908],
37	(	CD	NUMBER	(	dep	32	SENT_183	[p10l1387t828r1521b901],
38	See	VB	O	see	dep	37	SENT_183	[p10l1387t828r1521b901],
39	http://WWw.partnersmscenter.org/index.php?id=45&mn=5&sm=5-4	NN	O	http://www.partnersmscenter.org/index.php?id=45&mn=5&sm=5-4	dobj	38	SENT_183	[p10l1540t827r2098b908, p10l8t927r1863b1009],
40	.	.	O	.	_	0	SENT_183	[p10l1540t827r2098b908, p10l8t927r1863b1009],
41	)	SYM	O	)	dep	1	SENT_183	[p10l1540t827r2098b908, p10l8t927r1863b1009],

1	When	WRB	O	when	advmod	2	SENT_184	[p10l1890t927r2100b989],
2	considering	VBG	O	consider	advcl	11	SENT_184	[p10l9t1027r419b1109],
3	cyclophosphamide	NN	O	cyclophosphamide	dobj	2	SENT_184	[p10l442t1027r1094b1109],
4	in	IN	O	in	_	0	SENT_184	[p10l1119t1033r1185b1088],
5	early	JJ	O	early	amod	6	SENT_184	[p10l1210t1027r1379b1109],
6	MS	NN	O	m	prep_in	2	SENT_184	[p10l1400t1031r1533b1097],
7	,	,	O	,	_	0	SENT_184	[p10l1400t1031r1533b1097],
8	one	CD	NUMBER	one	nsubj	11	SENT_184	[p10l1560t1049r1683b1089],
9	should	MD	O	should	aux	11	SENT_184	[p10l1709t1027r1942b1089],
10	also	RB	O	also	advmod	11	SENT_184	[p10l1966t1027r2098b1089],
11	consider	VB	O	consider	_	0	SENT_184	[p10l9t1127r301b1189],
12	the	DT	O	the	det	15	SENT_184	[p10l321t1127r427b1189],
13	potential	JJ	O	potential	amod	15	SENT_184	[p10l449t1127r754b1208],
14	subsequent	JJ	O	subsequent	amod	15	SENT_184	[p10l777t1127r1161b1208],
15	use	NN	O	use	dobj	11	SENT_184	[p10l1183t1149r1293b1189],
16	of	IN	O	of	_	0	SENT_184	[p10l1316t1127r1390b1189],
17	natalizumab	NN	O	natalizumab	prep_of	15	SENT_184	[p10l1403t1127r1825b1189],
18	and	CC	O	and	_	0	SENT_184	[p10l1850t1127r1975b1189],
19	the	DT	O	the	conj_and	17	SENT_184	[p10l1996t1127r2102b1189],
20	associated	VBN	O	associate	partmod	17	SENT_184	[p10l9t1227r354b1289],
21	increased	VBD	O	increase	dep	20	SENT_184	[p10l376t1227r697b1289],
22	progressive	JJ	O	progressive	amod	24	SENT_184	[p10l718t1233r1101b1309],
23	multifocal	JJ	O	multifocal	amod	24	SENT_184	[p10l1124t1227r1470b1289],
24	leukoencephalopathy	NN	O	leukoencephalopathy	dobj	21	SENT_184	[p10l1491t1227r2099b1308, p10l9t1327r158b1409],
25	(	CD	NUMBER	(	num	28	SENT_184	[p10l183t1328r406b1402],
26	PML	NN	ORGANIZATION	pml	nn	28	SENT_184	[p10l183t1328r406b1402],
27	)	CD	NUMBER	)	num	28	SENT_184	[p10l183t1328r406b1402],
28	risk	NN	O	risk	nsubj	21	SENT_184	[p10l436t1327r567b1389],
29	in	IN	O	in	_	0	SENT_184	[p10l589t1333r656b1388],
30	patients	NNS	O	patient	prep_in	11	SENT_184	[p10l680t1333r954b1408],
31	who	WP	O	who	nsubjpass	34	SENT_184	[p10l978t1327r1126b1389],
32	were	VBD	O	be	auxpass	34	SENT_184	[p10l1150t1349r1313b1389],
33	previously	RB	DATE	previously	advmod	34	SENT_184	[p10l1338t1327r1703b1409],
34	exposed	VBN	O	expose	rcmod	30	SENT_184	[p10l1725t1327r2009b1408],
35	to	TO	O	to	_	0	SENT_184	[p10l2032t1339r2098b1389],
36	chemotherapy	NN	O	chemotherapy	nn	37	SENT_184	[p10l9t1428r492b1510],
37	agents	NNS	O	agent	prep_to	34	SENT_184	[p10l510t1439r735b1510],
38	.	.	O	.	_	0	SENT_184	[p10l510t1439r735b1510],

1	Most	RBS	O	most	advmod	2	SENT_185	[p10l80t1533r259b1590],
2	recently	RB	DATE	recently	advmod	9	SENT_185	[p10l288t1528r584b1610],
3	,	,	O	,	_	0	SENT_185	[p10l288t1528r584b1610],
4	alemtuzumab	JJ	O	alemtuzumab	amod	5	SENT_185	[p10l616t1528r1098b1590],
5	treatment	NN	O	treatment	nsubj	9	SENT_185	[p10l1128t1540r1477b1590],
6	became	VBD	O	become	cop	9	SENT_185	[p10l1503t1528r1773b1590],
7	an	DT	O	a	det	9	SENT_185	[p10l1803t1550r1885b1590],
8	additional	JJ	O	additional	amod	9	SENT_185	[p10l1915t1528r2097b1590, p10l8t1628r203b1690],
9	option	NN	O	option	_	0	SENT_185	[p10l225t1634r446b1709],
10	in	IN	O	in	_	0	SENT_185	[p10l469t1634r534b1689],
11	these	DT	O	these	det	12	SENT_185	[p10l556t1628r729b1690],
12	situations	NNS	O	situation	prep_in	9	SENT_185	[p10l753t1634r1095b1698],
13	,	,	O	,	_	0	SENT_185	[p10l753t1634r1095b1698],
14	but	CC	O	but	_	0	SENT_185	[p10l1117t1628r1229b1690],
15	the	DT	O	the	det	16	SENT_185	[p10l1250t1628r1355b1690],
16	treatment	NN	O	treatment	nsubj	17	SENT_185	[p10l1376t1640r1708b1690],
17	has	VBZ	O	have	conj_but	9	SENT_185	[p10l1728t1628r1839b1690],
18	signiﬁcant	JJ	O	signiﬁcant	amod	20	SENT_185	[p10l1863t1628r2095b1710, p10l9t1740r152b1790],
19	side	JJ	O	side	amod	20	SENT_185	[p10l176t1728r308b1790],
20	effects	NNS	O	effect	dobj	17	SENT_185	[p10l332t1728r564b1798],
21	,	,	O	,	_	0	SENT_185	[p10l332t1728r564b1798],
22	including	VBG	O	include	_	0	SENT_185	[p10l589t1728r918b1810],
23	the	DT	O	the	det	24	SENT_185	[p10l938t1728r1045b1790],
24	development	NN	O	development	prep_including	20	SENT_185	[p10l1069t1728r1515b1809],
25	of	IN	O	of	_	0	SENT_185	[p10l1538t1728r1612b1790],
26	drug-induced	JJ	O	drug-induced	amod	28	SENT_185	[p10l1626t1728r2101b1810],
27	autoimmune	JJ	O	autoimmune	amod	28	SENT_185	[p10l9t2030r454b2087],
28	conditions	NNS	O	condition	prep_of	24	SENT_185	[p10l479t2023r846b2087],
29	such	JJ	O	such	_	0	SENT_185	[p10l870t2023r1028b2087],
30	as	IN	O	as	_	0	SENT_185	[p10l1052t2046r1117b2087],
31	autoimmune	JJ	O	autoimmune	amod	32	SENT_185	[p10l1141t2030r1587b2087],
32	thyroiditis	NN	O	thyroiditis	prep_such_as	28	SENT_185	[p10l1609t2023r1987b2108],
33	.	.	O	.	_	0	SENT_185	[p10l1609t2023r1987b2108],

1	Natalizumab	NNP	O	Natalizumab	nn	4	SENT_186	[p10l8t2127r451b2190],
2	(	NNP	O	(	nn	4	SENT_186	[p10l479t2127r785b2211],
3	Tysabri	NNP	O	Tysabri	nn	4	SENT_186	[p10l479t2127r785b2211],
4	)	NN	O	)	nsubj	9	SENT_186	[p10l479t2127r785b2211],
5	may	MD	O	may	aux	9	SENT_186	[p10l812t2150r960b2211],
6	be	VB	O	be	cop	9	SENT_186	[p10l978t2127r1058b2190],
7	another	DT	O	another	det	9	SENT_186	[p10l1082t2127r1351b2190],
8	future	NN	DATE	future	nn	9	SENT_186	[p10l1372t2127r1581b2190],
9	option	NN	O	option	_	0	SENT_186	[p10l1605t2133r1831b2210],
10	for	IN	O	for	_	0	SENT_186	[p10l1854t2127r1952b2190],
11	these	DT	O	these	det	12	SENT_186	[p10l1973t2127r2150b2190],
12	patients	NNS	O	patient	prep_for	9	SENT_186	[p10l7t2236r287b2313],
13	,	,	O	,	_	0	SENT_186	[p10l7t2236r287b2313],
14	although	IN	O	although	mark	20	SENT_186	[p10l309t2230r604b2314],
15	no	DT	O	no	det	19	SENT_186	[p10l624t2253r708b2293],
16	established	JJ	O	established	amod	19	SENT_186	[p10l729t2230r1096b2293],
17	acute	JJ	O	acute	amod	19	SENT_186	[p10l1115t2242r1288b2293],
18	treatment	NN	O	treatment	nn	19	SENT_186	[p10l1307t2242r1633b2293],
19	protocol	NN	O	protocol	nsubj	20	SENT_186	[p10l1651t2230r1932b2313],
20	exists	VBZ	O	exist	advcl	9	SENT_186	[p10l1951t2236r2148b2293],
21	.	.	O	.	_	0	SENT_186	[p10l1951t2236r2148b2293],

1	Although	IN	O	although	mark	4	SENT_187	[p10l8t2333r347b2417],
2	some	DT	O	some	det	3	SENT_187	[p10l372t2356r556b2396],
3	centers	NNS	O	center	nsubj	4	SENT_187	[p10l582t2345r831b2396],
4	utilize	VBP	O	utilize	advcl	12	SENT_187	[p10l856t2333r1074b2396],
5	intravenous	JJ	O	intravenous	amod	6	SENT_187	[p10l1100t2339r1519b2396],
6	immunoglobulin	NN	O	immunoglobulin	dobj	4	SENT_187	[p10l1544t2333r2151b2417],
7	(	CD	NUMBER	(	num	9	SENT_187	[p10l12t2436r262b2513],
8	IVIG	NN	ORGANIZATION	ivig	nn	9	SENT_187	[p10l12t2436r262b2513],
9	)	NN	O	)	dep	6	SENT_187	[p10l12t2436r262b2513],
10	,	,	O	,	_	0	SENT_187	[p10l12t2436r262b2513],
11	there	EX	O	there	expl	12	SENT_187	[p10l283t2436r456b2499],
12	is	VBZ	O	be	_	0	SENT_187	[p10l477t2442r527b2499],
13	no	DT	O	no	det	15	SENT_187	[p10l548t2459r633b2499],
14	reliable	JJ	O	reliable	amod	15	SENT_187	[p10l656t2436r902b2499],
15	evidence	NN	O	evidence	nsubj	12	SENT_187	[p10l923t2436r1221b2499],
16	supporting	VBG	O	support	partmod	15	SENT_187	[p10l1242t2442r1618b2520],
17	the	DT	O	the	det	18	SENT_187	[p10l1635t2436r1741b2499],
18	use	NN	O	use	dobj	16	SENT_187	[p10l1761t2459r1872b2499],
19	of	IN	O	of	_	0	SENT_187	[p10l1893t2436r1967b2499],
20	IVIG	NNP	ORGANIZATION	IVIG	prep_of	18	SENT_187	[p10l1978t2440r2154b2499],
21	in	IN	O	in	_	0	SENT_187	[p10l8t2545r75b2601],
22	the	DT	O	the	det	24	SENT_187	[p10l96t2538r202b2602],
23	acute	JJ	O	acute	amod	24	SENT_187	[p10l225t2550r403b2602],
24	treatment	NN	O	treatment	prep_in	16	SENT_187	[p10l425t2550r761b2602],
25	of	IN	O	of	_	0	SENT_187	[p10l783t2538r856b2602],
26	MS.	NNP	O	MS.	prep_of	24	SENT_187	[p10l868t2530r1066b2602],
27	34	CD	NUMBER	34	num	26	SENT_187	[p10l868t2530r1066b2602],

1	FUTURE	JJ	DATE	future	amod	2	SENT_188	[p10l12t2755r294b2810],
2	DIRECTION	NN	O	direction	_	0	SENT_188	[p10l316t2754r710b2810],
3	FOR	IN	O	for	_	0	SENT_188	[p10l734t2754r876b2810],
4	ACUTE	JJ	O	acute	amod	5	SENT_188	[p10l893t2755r1132b2810],
5	TREATMENT	NN	O	treatment	prep_for	2	SENT_188	[p10l1147t2755r1585b2809],
6	OF	IN	O	of	_	0	SENT_188	[p10l1603t2754r1697b2810],
7	RELAPSES	NNS	O	relapse	prep_of	2	SENT_188	[p10l1719t2755r2078b2810],

1	IN	IN	O	in	_	0	SENT_189	[p10l12t2858r80b2912],
2	MS	NN	O	m	pobj	1	SENT_189	[p10l103t2858r208b2913],

1	Although	IN	O	although	mark	7	SENT_190	[p10l7t2953r332b3037],
2	the	DT	O	the	det	3	SENT_190	[p10l351t2953r457b3016],
3	modalities	NNS	O	modality	nsubj	7	SENT_190	[p10l477t2953r832b3016],
4	discussed	VBN	O	discuss	partmod	3	SENT_190	[p10l854t2953r1178b3016],
5	above	IN	O	above	prep	4	SENT_190	[p10l1198t2953r1393b3016],
6	have	VBP	O	have	aux	7	SENT_190	[p10l1412t2953r1567b3016],
7	achieved	VBN	O	achieve	advcl	20	SENT_190	[p10l1588t2953r1885b3016],
8	relative	JJ	O	relative	amod	9	SENT_190	[p10l1905t2953r2149b3016],
9	success	NN	O	success	dobj	7	SENT_190	[p10l9t3080r261b3120],
10	in	IN	O	in	_	0	SENT_190	[p10l286t3063r354b3119],
11	treating	VBG	O	treat	prepc_in	7	SENT_190	[p10l378t3063r653b3141],
12	an	DT	O	a	det	14	SENT_190	[p10l676t3080r758b3120],
13	acute	JJ	O	acute	amod	14	SENT_190	[p10l783t3069r966b3120],
14	relapse	NN	O	relapse	dobj	11	SENT_190	[p10l990t3057r1252b3140],
15	,	,	O	,	_	0	SENT_190	[p10l990t3057r1252b3140],
16	no	DT	O	no	det	19	SENT_190	[p10l1278t3080r1366b3120],
17	proven	JJ	O	proven	amod	19	SENT_190	[p10l1390t3079r1635b3140],
18	remyelination	NN	O	remyelination	nn	19	SENT_190	[p10l1659t3057r2151b3141],
19	strategy	NN	O	strategy	nsubj	20	SENT_190	[p10l9t3172r290b3244],
20	exists	VBZ	O	exist	_	0	SENT_190	[p10l312t3166r504b3223],
21	in	IN	O	in	_	0	SENT_190	[p10l530t3166r598b3222],
22	MS.	NNP	O	MS.	prep_in	24	SENT_190	[p10l623t3164r758b3223],
23	We	PRP	O	we	nsubj	24	SENT_190	[p10l785t3165r898b3223],
24	believe	VBP	O	believe	ccomp	20	SENT_190	[p10l921t3160r1168b3223],
25	the	DT	DATE	the	det	27	SENT_190	[p10l1192t3160r1302b3223],
26	future	JJ	DATE	future	amod	27	SENT_190	[p10l1327t3160r1541b3223],
27	direction	NN	O	direction	nsubj	29	SENT_190	[p10l1566t3160r1889b3223],
28	should	MD	O	should	aux	29	SENT_190	[p10l1915t3160r2154b3223],
29	be	VB	O	be	ccomp	24	SENT_190	[p10l6t3263r88b3326],
30	to	TO	O	to	aux	31	SENT_190	[p10l111t3275r179b3326],
31	develop	VB	O	develop	xcomp	29	SENT_190	[p10l204t3263r476b3346],
32	and	CC	O	and	_	0	SENT_190	[p10l502t3263r632b3326],
33	subsequently	RB	O	subsequently	advmod	31	SENT_190	[p10l656t3263r1119b3347],
34	introduce	VB	O	introduce	xcomp	29	SENT_190	[p10l1139t3263r1481b3326],
35	remyelination	NN	O	remyelination	nn	39	SENT_190	[p10l1505t3263r1997b3347],
36	and	CC	O	and	_	0	SENT_190	[p10l2022t3263r2151b3326],
37	axonal	JJ	O	axonal	nn	39	SENT_190	[p10l9t3366r236b3429],
38	repair	NN	O	repair	nn	39	SENT_190	[p10l259t3372r464b3449],
39	strategies	NNS	O	strategy	dobj	34	SENT_190	[p10l487t3372r806b3450],
40	to	TO	O	to	aux	41	SENT_190	[p10l829t3378r896b3429],
41	complement	VB	O	complement	xcomp	34	SENT_190	[p10l921t3366r1354b3449],
42	corticosteroids	NNS	O	corticosteroid	dobj	41	SENT_190	[p10l1376t3366r1907b3438],
43	,	,	O	,	_	0	SENT_190	[p10l1376t3366r1907b3438],
44	PLEX	NNP	O	PLEX	conj_or	42	SENT_190	[p10l1933t3371r2149b3438],
45	,	,	O	,	_	0	SENT_190	[p10l1933t3371r2149b3438],
46	or	CC	O	or	_	0	SENT_190	[p10l9t3492r80b3532],
47	immunosuppressives	NNS	O	immunosuppressive	dobj	41	SENT_190	[p10l99t3475r832b3552],
48	.	.	O	.	_	0	SENT_190	[p10l99t3475r832b3552],

1	Hypothetically	RB	O	hypothetically	advmod	6	SENT_191	[p10l856t3469r1369b3553],
2	,	,	O	,	_	0	SENT_191	[p10l856t3469r1369b3553],
3	such	PDT	O	such	predet	5	SENT_191	[p10l1391t3469r1545b3532],
4	a	DT	O	a	det	5	SENT_191	[p10l1565t3492r1600b3532],
5	strategy	NN	O	strategy	nsubj	6	SENT_191	[p10l1620t3481r1888b3553],
6	applied	VBD	O	apply	_	0	SENT_191	[p10l1905t3469r2152b3552],
7	immediately	RB	O	immediately	advmod	6	SENT_191	[p10l9t3572r440b3656],
8	after	IN	O	after	mark	12	SENT_191	[p10l459t3572r612b3635],
9	a	DT	O	a	det	10	SENT_191	[p10l634t3595r669b3635],
10	relapse	NN	O	relapse	nsubj	12	SENT_191	[p10l689t3572r926b3655],
11	could	MD	O	could	aux	12	SENT_191	[p10l950t3572r1141b3635],
12	lead	VB	O	lead	advcl	6	SENT_191	[p10l1160t3572r1302b3635],
13	to	TO	O	to	_	0	SENT_191	[p10l1322t3584r1388b3635],
14	full	JJ	O	full	amod	15	SENT_191	[p10l1411t3572r1525b3635],
15	recovery	NN	O	recovery	prep_to	12	SENT_191	[p10l1547t3595r1846b3656],
16	and	CC	O	and	_	0	SENT_191	[p10l1865t3572r1992b3635],
17	prevention	NN	O	prevention	prep_to	12	SENT_191	[p10l2011t3594r2149b3655, p10l6t3682r260b3739],
18	of	IN	O	of	_	0	SENT_191	[p10l281t3676r353b3739],
19	long	JJ	O	long	amod	22	SENT_191	[p10l362t3676r701b3760],
20	—	JJ	O	—	amod	22	SENT_191	[p10l362t3676r701b3760],
21	term	NN	O	term	nn	22	SENT_191	[p10l362t3676r701b3760],
22	neurodegeneration	NN	O	neurodegeneration	prep_of	15	SENT_191	[p10l720t3676r1358b3760],
23	and	CC	O	and	_	0	SENT_191	[p10l1379t3676r1502b3739],
24	progressive	JJ	O	progressive	amod	26	SENT_191	[p10l1519t3682r1897b3760],
25	disease	NN	O	disease	nn	26	SENT_191	[p10l1917t3676r2152b3739],
26	course	NN	O	course	conj_and	22	SENT_191	[p11l9t39r231b79],
27	associated	VBN	O	associate	partmod	26	SENT_191	[p11l254t16r603b79],
28	with	IN	O	with	_	0	SENT_191	[p11l622t16r775b79],
29	the	DT	O	the	det	31	SENT_191	[p11l795t16r902b79],
30	damaged	VBN	O	damage	amod	31	SENT_191	[p11l925t16r1236b100],
31	tract	NN	O	tract	prep_with	27	SENT_191	[p11l1256t28r1430b79],
32	.	.	O	.	_	0	SENT_191	[p11l1256t28r1430b79],

1	Remyelination	NN	O	remyelination	nsubj	2	SENT_192	[p11l83t119r584b203],
2	occurs	VBZ	O	occur	_	0	SENT_192	[p11l607t142r830b182],
3	spontaneously	RB	O	spontaneously	advmod	2	SENT_192	[p11l854t119r1351b203],
4	and	CC	O	and	_	0	SENT_192	[p11l1370t119r1497b182],
5	is	VBZ	O	be	cop	7	SENT_192	[p11l1518t125r1568b182],
6	typically	RB	O	typically	advmod	7	SENT_192	[p11l1590t119r1884b203],
7	incomplete	JJ	O	incomplete	conj_and	2	SENT_192	[p11l1904t125r2149b182, p11l7t222r196b305],
8	.	.	O	.	_	0	SENT_192	[p11l1904t125r2149b182, p11l7t222r196b305],

1	Remyelination	NN	O	remyelination	nsubj	12	SENT_193	[p11l227t222r750b306],
2	is	VBZ	O	be	cop	4	SENT_193	[p11l778t228r830b285],
3	most	RBS	O	most	advmod	4	SENT_193	[p11l857t234r1034b285],
4	noticeable	JJ	O	noticeable	ccomp	27	SENT_193	[p11l1060t222r1426b285],
5	in	IN	O	in	_	0	SENT_193	[p11l1454t228r1523b284],
6	acute	JJ	O	acute	amod	8	SENT_193	[p11l1551t234r1737b285],
7	MS	NN	O	m	nn	8	SENT_193	[p11l1763t226r1880b285],
8	lesions	NNS	O	lesion	prep_in	4	SENT_193	[p11l1907t222r2151b285],
9	but	CC	O	but	_	0	SENT_193	[p11l6t324r126b388],
10	becomes	VBZ	O	become	cop	12	SENT_193	[p11l153t325r469b388],
11	less	RBR	O	less	advmod	12	SENT_193	[p11l498t324r624b388],
12	prominent	JJ	O	prominent	conj_but	4	SENT_193	[p11l654t331r1044b408],
13	as	IN	O	as	mark	16	SENT_193	[p11l1073t347r1140b388],
14	the	DT	O	the	det	15	SENT_193	[p11l1170t325r1282b388],
15	disease	NN	O	disease	nsubj	16	SENT_193	[p11l1313t325r1570b388],
16	progresses	VBZ	O	progress	ccomp	12	SENT_193	[p11l1599t316r2152b409],
17	.35	CD	NUMBER	.35	num	18	SENT_193	[p11l1599t316r2152b409],
18	’36	CD	NUMBER	’36	dobj	16	SENT_193	[p11l1599t316r2152b409],
19	Therefore	RB	O	therefore	advmod	16	SENT_193	[p11l8t428r384b500],
20	,	,	O	,	_	0	SENT_193	[p11l8t428r384b500],
21	an	DT	O	a	det	26	SENT_193	[p11l417t451r500b491],
22	early	JJ	O	early	amod	26	SENT_193	[p11l531t428r718b512],
23	,	,	O	,	_	0	SENT_193	[p11l531t428r718b512],
24	postrelapse	JJ	O	postrelapse	amod	26	SENT_193	[p11l748t428r1159b511],
25	therapeutic	JJ	O	therapeutic	amod	26	SENT_193	[p11l1189t428r1604b511],
26	window	NN	O	window	nsubj	27	SENT_193	[p11l1632t428r1925b491],
27	exists	VBZ	O	exist	_	0	SENT_193	[p11l1953t434r2150b491],
28	for	IN	O	for	_	0	SENT_193	[p11l8t532r111b595],
29	remyelination-promoting	JJ	O	remyelination-promoting	amod	33	SENT_193	[p11l141t532r1081b616],
30	and	CC	O	and	_	0	SENT_193	[p11l1110t532r1243b595],
31	axonal	JJ	O	axonal	amod	33	SENT_193	[p11l1274t532r1512b595],
32	repair	NN	O	repair	nn	33	SENT_193	[p11l1542t538r1759b615],
33	strategies	NNS	O	strategy	prep_for	27	SENT_193	[p11l1790t538r2150b616],
34	.	.	O	.	_	0	SENT_193	[p11l1790t538r2150b616],

1	Despite	IN	O	despite	_	0	SENT_194	[p11l9t640r270b718],
2	a	DT	O	a	det	5	SENT_194	[p11l293t658r328b698],
3	shorter	JJR	O	shorter	amod	5	SENT_194	[p11l352t635r600b698],
4	internode	NN	O	internode	nn	5	SENT_194	[p11l622t635r961b698],
5	distance	NN	O	distance	prep_despite	10	SENT_194	[p11l985t635r1287b707],
6	,	,	O	,	_	0	SENT_194	[p11l985t635r1287b707],
7	the	DT	O	the	nsubj	10	SENT_194	[p11l1311t635r1419b698],
8	remyelinated	VBN	O	remyelinate	partmod	7	SENT_194	[p11l1442t635r1896b719],
9	lesions	NNS	O	lesion	dobj	8	SENT_194	[p11l1916t635r2152b698],
10	promote	VBP	O	promote	_	0	SENT_194	[p11l7t750r311b821],
11	saltatory	JJ	O	saltatory	amod	12	SENT_194	[p11l338t738r649b822],
12	conduction	NN	O	conduction	dobj	10	SENT_194	[p11l672t738r1079b801],
13	at	IN	O	at	_	0	SENT_194	[p11l1107t750r1168b801],
14	almost	RB	O	almost	advmod	16	SENT_194	[p11l1193t738r1432b801],
15	normal	JJ	O	normal	amod	16	SENT_194	[p11l1457t738r1718b801],
16	conduction	NN	O	conduction	prep_at	10	SENT_194	[p11l1744t738r2152b801],

1	VOLUME	NN	O	volume	nn	3	SENT_195	[p11l543t957r768b999],
2	95	CD	NUMBER	95	num	3	SENT_195	[p11l785t958r842b999],
3	NUMBER	NN	O	number	_	0	SENT_195	[p11l863t957r1087b999],
4	1	CD	NUMBER	1	number	5	SENT_195	[p11l1109t959r1122b999],
5	|	CD	NUMBER	|	dep	3	SENT_195	[p11l1152t953r1156b1014],
6	JANUARY	NNP	DATE	JANUARY	dep	5	SENT_195	[p11l1175t957r1420b999],
7	2014	CD	DATE	2014	num	6	SENT_195	[p11l1437t958r1558b999],
8	|	CD	NUMBER	|	num	9	SENT_195	[p11l1577t953r1581b1014],
9	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	3	SENT_195	[p11l1600t957r2152b1010],

1	STATE	NN	O	state	nn	2	SENT_196	[p11l1761t1129r1902b1166],
2	ART	NN	O	art	_	0	SENT_196	[p11l2045t1129r2139b1166],

1	velocity	NN	O	velocity	nsubj	13	SENT_197	[p11l6t1362r283b1446],
2	in	IN	O	in	_	0	SENT_197	[p11l303t1368r371b1424],
3	both	CC	O	both	preconj	5	SENT_197	[p11l393t1362r556b1425],
4	experimental	JJ	O	experimental	amod	5	SENT_197	[p11l580t1362r1044b1445],
5	animals	NNS	O	animal	prep_in	1	SENT_197	[p11l1068t1362r1339b1425],
6	and	CC	O	and	_	0	SENT_197	[p11l1365t1362r1494b1425],
7	computer	NN	O	computer	nn	8	SENT_197	[p11l1517t1374r1855b1445],
8	simulations	NNS	O	simulation	conj_and	5	SENT_197	[p11l1878t1362r2138b1425, p11l8t1456r261b1527],
9	.37	CD	NUMBER	.37	num	10	SENT_197	[p11l1878t1362r2138b1425, p11l8t1456r261b1527],
10	Remyelination	NN	O	remyelination	dep	1	SENT_197	[p11l284t1464r788b1548],
11	may	MD	O	may	aux	13	SENT_197	[p11l810t1487r958b1548],
12	be	VB	O	be	cop	13	SENT_197	[p11l975t1464r1055b1527],
13	one	CD	NUMBER	one	_	0	SENT_197	[p11l1079t1487r1202b1527],
14	of	IN	O	of	_	0	SENT_197	[p11l1226t1464r1300b1527],
15	the	DT	O	the	det	18	SENT_197	[p11l1312t1464r1420b1527],
16	most	RBS	O	most	advmod	17	SENT_197	[p11l1443t1476r1614b1527],
17	effective	JJ	O	effective	amod	18	SENT_197	[p11l1636t1464r1918b1527],
18	forms	NNS	O	form	prep_of	13	SENT_197	[p11l1941t1464r2141b1527],
19	of	IN	O	of	_	0	SENT_197	[p11l9t1566r83b1629],
20	neuroprotection	NN	O	neuroprotection	prep_of	18	SENT_197	[p11l95t1558r734b1649],
21	.38	CD	NUMBER	.38	num	20	SENT_197	[p11l95t1558r734b1649],

1	Lysolecithin	NNP	O	Lysolecithin	nn	2	SENT_198	[p11l83t1669r850b1753],
2	—	NN	O	—	nsubj	3	SENT_198	[p11l83t1669r850b1753],
3	induced	VBD	O	induce	_	0	SENT_198	[p11l83t1669r850b1753],
4	models	NNS	O	model	nsubj	10	SENT_198	[p11l877t1669r1135b1732],
5	of	IN	O	of	_	0	SENT_198	[p11l1165t1669r1242b1732],
6	demyelination	NN	O	demyelination	prep_of	4	SENT_198	[p11l1261t1669r1778b1753],
7	in	IN	O	in	_	0	SENT_198	[p11l1806t1675r1875b1731],
8	rodent	JJ	O	rodent	amod	9	SENT_198	[p11l1904t1669r2143b1732],
9	models	NNS	O	model	prep_in	6	SENT_198	[p11l8t1772r267b1835],
10	demonstrated	VBD	O	demonstrate	ccomp	3	SENT_198	[p11l297t1772r797b1835],
11	that	IN	O	that	complm	19	SENT_198	[p11l823t1772r964b1835],
12	efficient	JJ	O	efficient	amod	16	SENT_198	[p11l992t1772r1277b1835],
13	central	JJ	O	central	amod	16	SENT_198	[p11l1305t1772r1553b1835],
14	nervous	JJ	O	nervous	amod	16	SENT_198	[p11l1581t1795r1869b1835],
15	system	NN	O	system	nn	16	SENT_198	[p11l1899t1784r2142b1856],
16	remyelination	NN	O	remyelination	nsubj	19	SENT_198	[p11l9t1874r511b1958],
17	by	IN	O	by	_	0	SENT_198	[p11l538t1874r624b1958],
18	oligodendrocytes	NNS	O	oligodendrocyte	prep_by	16	SENT_198	[p11l650t1874r1273b1958],
19	requires	VBZ	O	require	ccomp	10	SENT_198	[p11l1302t1880r1592b1957],
20	T	NN	O	t	nn	21	SENT_198	[p11l1621t1877r1671b1936],
21	cells	NNS	O	cell	dobj	19	SENT_198	[p11l1701t1866r1939b1937],
22	.39	CD	NUMBER	.39	npadvmod	23	SENT_198	[p11l1701t1866r1939b1937],
23	Even	RB	O	even	advmod	19	SENT_198	[p11l1967t1879r2142b1937],
24	in	IN	O	in	_	0	SENT_198	[p11l9t1983r76b2039],
25	MS	NN	O	m	prep_in	19	SENT_198	[p11l99t1981r234b2049],
26	,	,	O	,	_	0	SENT_198	[p11l99t1981r234b2049],
27	remyelinated	VBN	O	remyelinate	partmod	25	SENT_198	[p11l260t1977r714b2061],
28	lesions	NNS	O	lesion	nsubjpass	31	SENT_198	[p11l736t1977r972b2040],
29	are	VBP	O	be	auxpass	31	SENT_198	[p11l997t2000r1099b2040],
30	frequently	RB	O	frequently	advmod	31	SENT_198	[p11l1122t1977r1484b2061],
31	associated	VBN	O	associate	ccomp	27	SENT_198	[p11l1504t1977r1859b2040],
32	with	IN	O	with	_	0	SENT_198	[p11l1880t1977r2035b2040],
33	an	DT	O	a	det	35	SENT_198	[p11l2060t2000r2141b2040],
34	inﬂammatory	JJ	O	inﬂammatory	amod	35	SENT_198	[p11l9t2080r493b2164],
35	milieu	NN	O	milieu	prep_with	31	SENT_198	[p11l513t2080r753b2143],
36	.	.	O	.	_	0	SENT_198	[p11l513t2080r753b2143],

1	Other	JJ	O	other	amod	2	SENT_199	[p11l781t2080r988b2143],
2	investigators	NNS	O	investigator	nsubj	5	SENT_199	[p11l1010t2086r1450b2164],
3	have	VBP	O	have	aux	5	SENT_199	[p11l1474t2080r1632b2143],
4	also	RB	O	also	advmod	5	SENT_199	[p11l1656t2080r1790b2143],
5	proposed	VBN	O	propose	dep	21	SENT_199	[p11l1814t2080r2143b2163],
6	that	IN	O	that	complm	11	SENT_199	[p11l8t2183r141b2246],
7	microglial	JJ	O	microglial	amod	8	SENT_199	[p11l160t2183r509b2267],
8	cells	NNS	O	cell	nsubj	11	SENT_199	[p11l529t2183r672b2246],
9	or	CC	O	or	_	0	SENT_199	[p11l694t2206r765b2246],
10	macrophages	NNS	O	macrophage	nsubj	11	SENT_199	[p11l784t2183r1235b2267],
11	affect	VBP	O	affect	ccomp	5	SENT_199	[p11l1257t2183r1439b2246],
12	the	DT	O	the	det	13	SENT_199	[p11l1457t2183r1563b2246],
13	process	NN	O	process	dobj	11	SENT_199	[p11l1582t2205r1835b2266],
14	of	IN	O	of	_	0	SENT_199	[p11l1857t2183r1930b2246],
15	remyelination	NN	O	remyelination	prep_of	13	SENT_199	[p11l1941t2206r2141b2267, p11l9t2277r388b2348],
16	.40	CD	NUMBER	.40	num	15	SENT_199	[p11l1941t2206r2141b2267, p11l9t2277r388b2348],
17	The	DT	O	the	det	20	SENT_199	[p11l409t2285r533b2348],
18	general	JJ	O	general	amod	20	SENT_199	[p11l553t2285r801b2369],
19	conceptual	JJ	O	conceptual	amod	20	SENT_199	[p11l821t2285r1191b2368],
20	idea	NN	O	idea	nsubj	21	SENT_199	[p11l1210t2285r1350b2348],
21	is	VBZ	O	be	_	0	SENT_199	[p11l1370t2291r1419b2348],
22	that	IN	O	that	complm	26	SENT_199	[p11l1439t2285r1572b2348],
23	these	DT	O	these	det	25	SENT_199	[p11l1590t2285r1764b2348],
24	inﬂammatory	JJ	O	inﬂammatory	amod	25	SENT_199	[p11l1785t2285r2139b2348, p11l8t2399r151b2471],
25	cells	NNS	O	cell	nsubj	26	SENT_199	[p11l171t2387r315b2450],
26	secrete	VBP	O	secrete	ccomp	21	SENT_199	[p11l339t2399r571b2450],
27	speciﬁc	NN	O	speciﬁc	nn	29	SENT_199	[p11l595t2387r848b2470],
28	regenerative	JJ	O	regenerative	amod	29	SENT_199	[p11l870t2393r1288b2471],
29	factors	NNS	O	factor	dobj	26	SENT_199	[p11l1311t2379r1620b2450],
30	.	.	O	.	_	0	SENT_199	[p11l1311t2379r1620b2450],

1	‘“	NN	O	‘“	nsubj	4	SENT_200	[p11l1311t2379r1620b2450],
2	These	DT	O	these	det	3	SENT_200	[p11l1647t2387r1841b2450],
3	ﬁndings	NNS	O	ﬁndings	dep	1	SENT_200	[p11l1864t2387r2141b2471],
4	indicate	VBP	O	indicate	_	0	SENT_200	[p11l9t2490r277b2553],
5	that	IN	O	that	complm	18	SENT_200	[p11l297t2490r429b2553],
6	the	DT	O	the	det	10	SENT_200	[p11l448t2490r553b2553],
7	most	RBS	O	most	advmod	8	SENT_200	[p11l573t2502r742b2553],
8	likely	JJ	O	likely	amod	10	SENT_200	[p11l760t2490r944b2574],
9	technical	JJ	O	technical	amod	10	SENT_200	[p11l960t2490r1269b2553],
10	challenge	NN	O	challenge	nsubj	18	SENT_200	[p11l1289t2490r1606b2574],
11	in	IN	O	in	_	0	SENT_200	[p11l1627t2496r1693b2552],
12	applying	VBG	O	apply	prepc_in	10	SENT_200	[p11l1714t2490r2006b2574],
13	any	DT	O	any	det	15	SENT_200	[p11l2025t2513r2146b2574],
14	remyelination-promoting	JJ	O	remyelination-promoting	amod	15	SENT_200	[p11l9t2593r919b2677],
15	strategy	NN	O	strategy	dobj	12	SENT_200	[p11l943t2605r1223b2677],
16	will	MD	O	will	aux	18	SENT_200	[p11l1243t2593r1373b2656],
17	be	VB	O	be	aux	18	SENT_200	[p11l1396t2593r1477b2656],
18	integrating	VBG	O	integrate	ccomp	4	SENT_200	[p11l1503t2599r1893b2677],
19	it	PRP	O	it	dobj	18	SENT_200	[p11l1916t2599r1963b2656],
20	with	IN	O	with	_	0	SENT_200	[p11l1985t2593r2143b2656],
21	immunosuppression	NN	O	immunosuppression	prep_with	18	SENT_200	[p11l9t2702r726b2779],
22	or	CC	O	or	_	0	SENT_200	[p11l750t2719r823b2759],
23	PLEX	NN	O	plex	conj_or	21	SENT_200	[p11l846t2701r1063b2768],
24	,	,	O	,	_	0	SENT_200	[p11l846t2701r1063b2768],
25	which	WDT	O	which	nsubj	27	SENT_200	[p11l1086t2696r1299b2759],
26	may	MD	O	may	aux	27	SENT_200	[p11l1322t2719r1471b2780],
27	impact	VB	O	impact	rcmod	21	SENT_200	[p11l1491t2702r1731b2779],
28	the	DT	O	the	det	29	SENT_200	[p11l1753t2696r1861b2759],
29	eﬂicacy	NN	O	eﬂicacy	dobj	27	SENT_200	[p11l1885t2696r2146b2780],
30	of	IN	O	of	_	0	SENT_200	[p11l9t2799r83b2862],
31	the	DT	O	the	det	33	SENT_200	[p11l94t2799r200b2862],
32	remyelination	NN	O	remyelination	nn	33	SENT_200	[p11l222t2799r698b2883],
33	application	NN	O	application	prep_of	29	SENT_200	[p11l720t2799r1116b2882],
34	.	.	O	.	_	0	SENT_200	[p11l720t2799r1116b2882],

1	There	EX	O	there	dep	101	SENT_201	[p11l82t2902r279b2965],
2	are	VBP	O	be	dep	101	SENT_201	[p11l303t2925r405b2965],
3	natural	JJ	O	natural	dep	101	SENT_201	[p11l429t2902r679b2965],
4	remyelination-promoting	JJ	O	remyelination-promoting	dep	101	SENT_201	[p11l702t2902r1602b2986],
5	autoantibodies	NNS	O	autoantibody	dep	101	SENT_201	[p11l1624t2902r2143b2965],
6	present	JJ	DATE	present	dep	101	SENT_201	[p11l7t3016r258b3087],
7	in	IN	O	in	dep	101	SENT_201	[p11l278t3010r344b3066],
8	both	CC	O	both	dep	101	SENT_201	[p11l363t3004r522b3067],
9	rodents	NNS	O	rodent	dep	101	SENT_201	[p11l543t3004r799b3067],
10	and	CC	O	and	dep	101	SENT_201	[p11l822t3004r947b3067],
11	humans	NNS	O	human	dep	101	SENT_201	[p11l966t2996r1396b3067],
12	.42	CD	NUMBER	.42	dep	101	SENT_201	[p11l966t2996r1396b3067],
13	’43	CD	NUMBER	’43	dep	101	SENT_201	[p11l966t2996r1396b3067],
14	Several	JJ	O	several	dep	101	SENT_201	[p11l1419t3004r1663b3067],
15	of	IN	O	of	dep	101	SENT_201	[p11l1683t3004r1757b3067],
16	these	DT	O	these	dep	101	SENT_201	[p11l1767t3004r1942b3067],
17	identiﬁed	JJ	O	identiﬁed	dep	101	SENT_201	[p11l1963t3004r2139b3067, p11l8t3107r188b3170],
18	human	JJ	O	human	dep	101	SENT_201	[p11l209t3107r456b3170],
19	antibodies	NNS	O	antibody	dep	101	SENT_201	[p11l481t3107r841b3170],
20	were	VBD	O	be	dep	101	SENT_201	[p11l863t3130r1027b3170],
21	adoptively	RB	O	adoptively	dep	101	SENT_201	[p11l1052t3107r1415b3191],
22	transferred	VBN	O	transfer	dep	101	SENT_201	[p11l1433t3107r1821b3170],
23	into	IN	O	into	dep	101	SENT_201	[p11l1844t3113r1980b3170],
24	animals	NNS	O	animal	dep	101	SENT_201	[p11l2006t3113r2139b3170, p11l8t3210r163b3273],
25	with	IN	O	with	dep	101	SENT_201	[p11l182t3210r332b3273],
26	either	CC	O	either	dep	101	SENT_201	[p11l352t3210r545b3273],
27	Theiler	NNP	PERSON	Theiler	dep	101	SENT_201	[p11l564t3210r838b3273],
28	’s	POS	O	’s	dep	101	SENT_201	[p11l564t3210r838b3273],
29	virus	NN	O	virus	dep	101	SENT_201	[p11l856t3210r1344b3273],
30	—	NN	O	—	dep	101	SENT_201	[p11l856t3210r1344b3273],
31	induced	VBD	O	induce	dep	101	SENT_201	[p11l856t3210r1344b3273],
32	or	CC	O	or	dep	101	SENT_201	[p11l1364t3233r1434b3273],
33	lysolecithin-induced	JJ	O	lysolecithin-induced	dep	101	SENT_201	[p11l1451t3210r2144b3294],
34	demyelination	NN	O	demyelination	dep	101	SENT_201	[p11l9t3313r514b3397],
35	,	,	O	,	_	0	SENT_201	[p11l9t3313r514b3397],
36	in	IN	O	in	dep	101	SENT_201	[p11l537t3319r603b3375],
37	which	WDT	O	which	dep	101	SENT_201	[p11l621t3313r829b3376],
38	they	PRP	O	they	dep	101	SENT_201	[p11l849t3313r998b3397],
39	were	VBD	O	be	dep	101	SENT_201	[p11l1013t3336r1173b3376],
40	shown	VBN	O	show	dep	101	SENT_201	[p11l1194t3313r1415b3376],
41	to	TO	O	to	dep	101	SENT_201	[p11l1434t3325r1499b3376],
42	promote	VB	O	promote	dep	101	SENT_201	[p11l1520t3325r1810b3396],
43	extensive	JJ	O	extensive	dep	101	SENT_201	[p11l1831t3319r2141b3376],
44	remyelination	NN	O	remyelination	dep	101	SENT_201	[p11l9t3407r642b3499],
45	.44	CD	NUMBER	.44	dep	101	SENT_201	[p11l9t3407r642b3499],
46	’45	CD	NUMBER	’45	dep	101	SENT_201	[p11l9t3407r642b3499],
47	The	DT	O	the	dep	101	SENT_201	[p11l663t3415r788b3478],
48	proposed	VBN	O	propose	dep	101	SENT_201	[p11l808t3415r1130b3498],
49	mechanism	NN	O	mechanism	dep	101	SENT_201	[p11l1149t3415r1544b3478],
50	is	VBZ	O	be	dep	101	SENT_201	[p11l1565t3421r1615b3478],
51	that	IN	O	that	dep	101	SENT_201	[p11l1635t3415r1769b3478],
52	these	DT	O	these	dep	101	SENT_201	[p11l1787t3415r1962b3478],
53	antibodies	NNS	O	antibody	dep	101	SENT_201	[p11l1984t3421r2139b3478, p11l7t3518r233b3581],
54	stimulate	VBP	O	stimulate	dep	101	SENT_201	[p11l258t3518r574b3581],
55	progenitor	NN	O	progenitor	dep	101	SENT_201	[p11l596t3524r965b3602],
56	oligodendrocytes	NNS	O	oligodendrocyte	dep	101	SENT_201	[p11l987t3518r1584b3602],
57	to	TO	O	to	dep	101	SENT_201	[p11l1607t3530r1673b3581],
58	proliferate	VB	O	proliferate	dep	101	SENT_201	[p11l1697t3518r2054b3601],
59	as	IN	O	as	dep	101	SENT_201	[p11l2078t3541r2143b3581],
60	a	DT	O	a	dep	101	SENT_201	[p11l9t3644r44b3684],
61	result	NN	O	result	dep	101	SENT_201	[p11l70t3621r268b3684],
62	of	IN	O	of	dep	101	SENT_201	[p11l294t3621r370b3684],
63	antibodies	NNS	O	antibody	dep	101	SENT_201	[p11l387t3621r757b3684],
64	binding	VBG	O	bind	dep	101	SENT_201	[p11l781t3621r1061b3705],
65	to	TO	O	to	dep	101	SENT_201	[p11l1085t3633r1153b3684],
66	lipid	NN	O	lipid	dep	101	SENT_201	[p11l1179t3621r1341b3704],
67	rafts	NNS	O	raft	dep	101	SENT_201	[p11l1367t3621r1519b3684],
68	on	IN	O	on	dep	101	SENT_201	[p11l1546t3644r1635b3684],
69	the	DT	O	the	dep	101	SENT_201	[p11l1660t3621r1770b3684],
70	surface	NN	O	surface	dep	101	SENT_201	[p11l1798t3621r2050b3684],
71	of	IN	O	of	dep	101	SENT_201	[p11l2077t3621r2153b3684],
72	oligodendrocytes	NNS	O	oligodendrocyte	dep	101	SENT_201	[p11l9t3724r615b3808],
73	and	CC	O	and	dep	101	SENT_201	[p11l640t3724r769b3787],
74	bringing	VBG	O	bring	dep	101	SENT_201	[p11l790t3724r1093b3808],
75	molecules	NNS	O	molecule	dep	101	SENT_201	[p11l1115t3724r1466b3787],
76	together	RB	O	together	dep	101	SENT_201	[p11l1489t3724r1782b3808],
77	to	TO	O	to	dep	101	SENT_201	[p11l1804t3736r1871b3787],
78	make	VB	O	make	dep	101	SENT_201	[p11l1896t3724r2084b3787],
79	a	DT	O	a	dep	101	SENT_201	[p11l2108t3747r2143b3787],
80	signaling	NN	O	signaling	dep	101	SENT_201	[p12l9t20r315b104],
81	complex	NN	O	complex	dep	101	SENT_201	[p12l334t12r700b103],
82	.46	CD	NUMBER	.46	dep	101	SENT_201	[p12l334t12r700b103],
83	A	DT	O	a	dep	101	SENT_201	[p12l719t24r775b82],
84	recombinant	JJ	O	recombinant	dep	101	SENT_201	[p12l796t20r1227b83],
85	version	NN	O	version	dep	101	SENT_201	[p12l1243t26r1491b83],
86	of	IN	O	of	dep	101	SENT_201	[p12l1512t20r1585b83],
87	this	DT	O	this	dep	101	SENT_201	[p12l1594t20r1717b83],
88	monoclonal	JJ	O	monoclonal	dep	101	SENT_201	[p12l1737t20r2143b83],
89	antibody	NN	O	antibody	dep	101	SENT_201	[p12l9t123r313b207],
90	,	,	O	,	_	0	SENT_201	[p12l9t123r313b207],
91	designated	VBN	O	designate	dep	101	SENT_201	[p12l335t123r690b207],
92	rHIgM22	NN	O	rhigm22	dep	101	SENT_201	[p12l709t128r1039b207],
93	,	,	O	,	_	0	SENT_201	[p12l709t128r1039b207],
94	is	VBZ	O	be	dep	101	SENT_201	[p12l1060t129r1108b186],
95	currently	RB	DATE	currently	dep	101	SENT_201	[p12l1129t123r1436b207],
96	undergoing	VBG	O	undergo	dep	101	SENT_201	[p12l1451t123r1837b207],
97	a	DT	O	a	dep	101	SENT_201	[p12l1855t146r1889b186],
98	phase	NN	O	phase	dep	101	SENT_201	[p12l1906t123r2095b206],
99	I	PRP	O	I	dep	101	SENT_201	[p12l2115t128r2138b185],
100	toxicity	NN	O	toxicity	dep	101	SENT_201	[p12l8t232r261b310],
101	study	NN	O	study	_	0	SENT_201	[p12l279t226r469b310],
102	.	.	O	.	_	0	SENT_201	[p12l279t226r469b310],

1	(	NN	O	(	nsubj	2	SENT_202	[p12l495t226r631b303],
2	See	VB	O	see	_	0	SENT_202	[p12l495t226r631b303],
3	http://www.clinicaltrials.gov/ct2/show/NCT	NN	O	http://www.clinicaltrials.gov/ct2/show/nct	dobj	2	SENT_202	[p12l651t226r2144b310],
4	01803867	CD	NUMBER	01803867	num	3	SENT_202	[p12l9t329r1269b413],
5	?	.	O	?	_	0	SENT_202	[p12l9t329r1269b413],

1	term	NN	O	term	_	0	SENT_203	[p12l9t329r1269b413],
2	=	JJ	O	=	amod	3	SENT_203	[p12l9t329r1269b413],
3	rHIgM22	NN	O	rhigm22	dep	1	SENT_203	[p12l9t329r1269b413],
4	&	CC	O	&	_	0	SENT_203	[p12l9t329r1269b413],
5	rank	NN	O	rank	dep	1	SENT_203	[p12l9t329r1269b413],
6	=	JJ	O	=	rcmod	5	SENT_203	[p12l9t329r1269b413],
7	1	CD	NUMBER	1	rcmod	6	SENT_203	[p12l9t329r1269b413],
8	.	.	O	.	_	0	SENT_203	[p12l9t329r1269b413],
9	)	SYM	O	)	dep	6	SENT_203	[p12l9t329r1269b413],

1	PREVENTION	NN	O	prevention	_	0	SENT_204	[p12l12t543r474b599],
2	OF	IN	O	of	_	0	SENT_204	[p12l495t543r589b599],
3	RELAPSE	NNP	O	RELAPSE	prep_of	1	SENT_204	[p12l611t544r924b599],
4	IN	IN	O	in	_	0	SENT_204	[p12l946t544r1014b598],
5	MS	NN	O	m	prep_in	1	SENT_204	[p12l1037t544r1141b599],

1	The	DT	O	the	det	2	SENT_205	[p12l8t639r136b702],
2	decision	NN	O	decision	nsubj	6	SENT_205	[p12l162t639r454b702],
3	to	TO	O	to	aux	4	SENT_205	[p12l477t651r545b702],
4	initiate	VB	O	initiate	infmod	2	SENT_205	[p12l571t645r817b702],
5	DMAS	NNP	O	DMAS	dobj	4	SENT_205	[p12l842t643r1072b702],
6	needs	VBZ	O	need	_	0	SENT_205	[p12l1097t639r1297b702],
7	to	TO	O	to	aux	9	SENT_205	[p12l1321t651r1389b702],
8	be	VB	O	be	auxpass	9	SENT_205	[p12l1413t639r1494b702],
9	guided	VBN	O	guide	xcomp	6	SENT_205	[p12l1518t639r1761b723],
10	by	IN	O	by	_	0	SENT_205	[p12l1782t639r1868b723],
11	natural	JJ	O	natural	amod	13	SENT_205	[p12l1889t639r2141b702],
12	history	NN	O	history	nn	13	SENT_205	[p12l8t742r262b826],
13	studies	NNS	O	study	agent	9	SENT_205	[p12l286t742r531b805],
14	and	CC	O	and	_	0	SENT_205	[p12l559t742r689b805],
15	the	DT	O	the	det	16	SENT_205	[p12l714t742r824b805],
16	predictors	NNS	O	predictor	agent	9	SENT_205	[p12l850t742r1212b825],
17	of	IN	O	of	_	0	SENT_205	[p12l1240t742r1316b805],
18	an	DT	O	a	det	19	SENT_205	[p12l1334t765r1416b805],
19	individual	JJ	O	individual	poss	22	SENT_205	[p12l1442t742r1849b805],
20	’s	POS	O	’s	_	0	SENT_205	[p12l1442t742r1849b805],
21	disability	NN	O	disability	nn	22	SENT_205	[p12l1877t742r2138b805, p12l9t851r100b929],
22	potential	NN	O	potential	prep_of	16	SENT_205	[p12l120t845r436b928],
23	due	JJ	O	due	_	0	SENT_205	[p12l461t845r587b908],
24	to	TO	O	to	_	0	SENT_205	[p12l611t857r679b908],
25	relapses	NNS	O	relapse	prep_due_to	22	SENT_205	[p12l705t845r1000b928],
26	.	.	O	.	_	0	SENT_205	[p12l705t845r1000b928],

1	The	DT	O	the	det	2	SENT_206	[p12l1028t845r1156b908],
2	number	NN	O	number	nsubj	15	SENT_206	[p12l1181t845r1462b908],
3	of	IN	O	of	_	0	SENT_206	[p12l1485t845r1561b908],
4	relapses	NNS	O	relapse	prep_of	2	SENT_206	[p12l1576t845r1853b928],
5	and	CC	O	and	_	0	SENT_206	[p12l1879t845r2009b908],
6	the	DT	O	the	det	7	SENT_206	[p12l2032t845r2142b908],
7	patient	NN	O	patient	poss	9	SENT_206	[p12l7t948r285b1031],
8	’s	POS	O	’s	_	0	SENT_206	[p12l7t948r285b1031],
9	recovery	NN	O	recovery	conj_and	4	SENT_206	[p12l308t971r605b1032],
10	from	IN	O	from	_	0	SENT_206	[p12l624t948r792b1011],
11	individual	JJ	O	individual	amod	12	SENT_206	[p12l814t948r1163b1011],
12	relapses	NNS	O	relapse	prep_from	9	SENT_206	[p12l1185t948r1452b1031],
13	will	MD	O	will	aux	15	SENT_206	[p12l1474t948r1599b1011],
14	be	VB	O	be	cop	15	SENT_206	[p12l1619t948r1698b1011],
15	indicative	JJ	O	indicative	ccomp	31	SENT_206	[p12l1721t948r2054b1011],
16	of	IN	O	of	_	0	SENT_206	[p12l2077t948r2151b1011],
17	the	DT	O	the	det	20	SENT_206	[p12l8t1051r111b1114],
18	cumulative	JJ	O	cumulative	amod	20	SENT_206	[p12l131t1051r500b1114],
19	long-term	JJ	O	long-term	amod	20	SENT_206	[p12l518t1051r856b1135],
20	severity	NN	O	severity	prep_of	15	SENT_206	[p12l876t1057r1135b1135],
21	resulting	VBG	O	result	partmod	20	SENT_206	[p12l1151t1051r1444b1135],
22	from	IN	O	from	_	0	SENT_206	[p12l1462t1051r1626b1114],
23	relapses	NNS	O	relapse	prep_from	21	SENT_206	[p12l1645t1051r1905b1134],
24	in	IN	O	in	_	0	SENT_206	[p12l1926t1057r1991b1113],
25	MS.	NNP	O	MS.	prep_in	23	SENT_206	[p12l2010t1055r2138b1114],
26	However	RB	O	however	advmod	21	SENT_206	[p12l9t1159r332b1226],
27	,	,	O	,	_	0	SENT_206	[p12l9t1159r332b1226],
28	symptomatic	JJ	O	symptomatic	amod	29	SENT_206	[p12l357t1160r805b1238],
29	attacks	NNS	O	attack	nsubj	31	SENT_206	[p12l828t1154r1063b1217],
30	alone	RB	O	alone	advmod	31	SENT_206	[p12l1087t1154r1271b1217],
31	lead	VBP	O	lead	_	0	SENT_206	[p12l1293t1154r1436b1217],
32	only	RB	O	only	advmod	31	SENT_206	[p12l1459t1154r1611b1238],
33	to	TO	O	to	_	0	SENT_206	[p12l1629t1166r1696b1217],
34	moderate	JJ	O	moderate	amod	37	SENT_206	[p12l1720t1154r2048b1217],
35	or	CC	O	or	_	0	SENT_206	[p12l2072t1177r2144b1217],
36	lower	JJR	O	lower	amod	37	SENT_206	[p12l7t1256r200b1319],
37	levels	NNS	O	level	prep_to	31	SENT_206	[p12l221t1256r409b1319],
38	of	IN	O	of	_	0	SENT_206	[p12l433t1256r508b1319],
39	sustained	JJ	O	sustained	amod	41	SENT_206	[p12l522t1256r848b1319],
40	long-term	JJ	O	long-term	amod	41	SENT_206	[p12l869t1256r1219b1340],
41	disability	NN	O	disability	prep_of	37	SENT_206	[p12l1244t1248r1637b1340],
42	.	.	O	.	_	0	SENT_206	[p12l1244t1248r1637b1340],

1	”	NN	O	”	ccomp	10	SENT_207	[p12l1244t1248r1637b1340],
2	Therefore	RB	O	therefore	advmod	1	SENT_207	[p12l1659t1256r2010b1328],
3	,	,	O	,	_	0	SENT_207	[p12l1659t1256r2010b1328],
4	the	DT	O	the	det	7	SENT_207	[p12l2034t1256r2141b1319],
5	actual	JJ	O	actual	amod	7	SENT_207	[p12l9t1359r211b1422],
6	long-term	JJ	O	long-term	amod	7	SENT_207	[p12l229t1359r573b1443],
7	target	NN	O	target	nsubj	10	SENT_207	[p12l592t1371r787b1443],
8	should	MD	O	should	aux	10	SENT_207	[p12l807t1359r1036b1422],
9	be	VB	O	be	cop	10	SENT_207	[p12l1053t1359r1132b1422],
10	prevention	NN	O	prevention	_	0	SENT_207	[p12l1151t1365r1521b1442],
11	of	IN	O	of	_	0	SENT_207	[p12l1542t1359r1615b1422],
12	progressive	JJ	O	progressive	amod	14	SENT_207	[p12l1624t1365r2008b1443],
13	MS	NN	O	m	nn	14	SENT_207	[p12l2028t1363r2141b1422],
14	disease	NN	O	disease	prep_of	10	SENT_207	[p12l9t1462r266b1525],
15	.	.	O	.	_	0	SENT_207	[p12l9t1462r266b1525],

1	This	DT	O	this	nsubjpass	5	SENT_208	[p12l292t1462r434b1525],
2	has	VBZ	O	have	aux	5	SENT_208	[p12l457t1462r568b1525],
3	not	RB	O	not	neg	5	SENT_208	[p12l592t1474r706b1525],
4	been	VBN	O	be	auxpass	5	SENT_208	[p12l725t1462r889b1525],
5	studied	VBN	O	study	_	0	SENT_208	[p12l913t1462r1163b1525],
6	systematically	RB	O	systematically	advmod	5	SENT_208	[p12l1186t1462r1666b1546],
7	in	IN	O	in	_	0	SENT_208	[p12l1685t1468r1751b1524],
8	any	DT	O	any	det	9	SENT_208	[p12l1775t1485r1896b1546],
9	DMAS	NNS	O	dma	prep_in	5	SENT_208	[p12l1915t1466r2140b1525],
10	because	IN	O	because	mark	16	SENT_208	[p12l7t1565r274b1628],
11	the	DT	O	the	det	13	SENT_208	[p12l295t1565r401b1628],
12	study	NN	O	study	nn	13	SENT_208	[p12l424t1565r610b1649],
13	design	NN	O	design	nsubj	16	SENT_208	[p12l628t1565r849b1649],
14	is	VBZ	O	be	cop	16	SENT_208	[p12l871t1571r921b1628],
15	cost	NN	O	cost	dep	16	SENT_208	[p12l943t1577r1078b1628],
16	prohibitive	JJ	O	prohibitive	advcl	5	SENT_208	[p12l1097t1565r1489b1648],
17	.	.	O	.	_	0	SENT_208	[p12l1097t1565r1489b1648],

1	Between	IN	O	between	_	0	SENT_209	[p12l83t1673r378b1731],
2	the	DT	O	the	det	3	SENT_209	[p12l401t1668r508b1731],
3	relapsing	NN	O	relapsing	prep_between	19	SENT_209	[p12l532t1668r848b1752],
4	and	CC	O	and	_	0	SENT_209	[p12l870t1668r998b1731],
5	progressive	JJ	O	progressive	amod	6	SENT_209	[p12l1020t1674r1413b1752],
6	phases	NNS	O	phase	prep_between	19	SENT_209	[p12l1435t1668r1684b1751],
7	,	,	O	,	_	0	SENT_209	[p12l1435t1668r1684b1751],
8	about	IN	O	about	advmod	19	SENT_209	[p12l1709t1668r1905b1731],
9	one	CD	NUMBER	one	pobj	8	SENT_209	[p12l1928t1691r2052b1731],
10	in	IN	O	in	_	0	SENT_209	[p12l2075t1674r2143b1730],
11	ﬁve	NN	O	ﬁve	nn	12	SENT_209	[p12l8t1771r130b1834],
12	patients	NNS	O	patient	prep_in	8	SENT_209	[p12l155t1777r436b1854],
13	with	IN	O	with	_	0	SENT_209	[p12l461t1771r619b1834],
14	MS	NN	O	m	prep_with	8	SENT_209	[p12l644t1775r761b1834],
15	in	IN	O	in	_	0	SENT_209	[p12l788t1777r856b1833],
16	the	DT	O	the	det	18	SENT_209	[p12l882t1771r992b1834],
17	Western	JJ	MISC	western	amod	18	SENT_209	[p12l1017t1776r1311b1834],
18	world	NN	O	world	prep_in	14	SENT_209	[p12l1335t1771r1542b1834],
19	has	VBZ	O	have	_	0	SENT_209	[p12l1566t1771r1682b1834],
20	an	DT	O	a	det	25	SENT_209	[p12l1709t1794r1791b1834],
21	“	JJ	O	“	amod	25	SENT_209	[p12l1819t1771r2139b1834, p12l8t1875r464b1959],
22	ambulatory-benign	JJ	O	ambulatory-benign	amod	25	SENT_209	[p12l1819t1771r2139b1834, p12l8t1875r464b1959],
23	”	NN	O	”	nn	25	SENT_209	[p12l1819t1771r2139b1834, p12l8t1875r464b1959],
24	disease	NN	O	disease	nn	25	SENT_209	[p12l494t1875r745b1938],
25	phenotype	NN	O	phenotype	dobj	19	SENT_209	[p12l771t1875r1169b1959],
26	,	,	O	,	_	0	SENT_209	[p12l771t1875r1169b1959],
27	even	RB	O	even	advmod	25	SENT_209	[p12l1198t1898r1361b1938],
28	in	IN	O	in	_	0	SENT_209	[p12l1388t1881r1456b1937],
29	the	DT	O	the	det	30	SENT_209	[p12l1482t1875r1592b1938],
30	absence	NN	O	absence	prep_in	27	SENT_209	[p12l1620t1875r1898b1938],
31	of	IN	O	of	_	0	SENT_209	[p12l1925t1875r2002b1938],
32	any	DT	O	any	det	33	SENT_209	[p12l2019t1898r2145b1959],
33	treatment	NN	O	treatment	prep_of	30	SENT_209	[p12l8t1969r529b2040],
34	.47	CD	NUMBER	.47	number	35	SENT_209	[p12l8t1969r529b2040],
35	‘	CD	NUMBER	‘	num	33	SENT_209	[p12l8t1969r529b2040],
36	51	CD	NUMBER	51	dep	25	SENT_209	[p12l8t1969r529b2040],
37	The	DT	O	the	det	39	SENT_209	[p12l556t1977r684b2040],
38	largest	JJS	O	largest	amod	39	SENT_209	[p12l707t1977r936b2061],
39	exception	NN	O	exception	nsubj	43	SENT_209	[p12l959t1983r1298b2060],
40	is	VBZ	O	be	cop	43	SENT_209	[p12l1321t1983r1373b2040],
41	the	DT	O	the	det	43	SENT_209	[p12l1396t1977r1505b2040],
42	Icelandic	JJ	MISC	icelandic	amod	43	SENT_209	[p12l1529t1977r1845b2040],
43	population	NN	O	population	rcmod	36	SENT_209	[p12l1867t1977r2138b2060, p12l8t2086r169b2152],
44	,	,	O	,	_	0	SENT_209	[p12l1867t1977r2138b2060, p12l8t2086r169b2152],
45	which	WDT	O	which	nsubj	46	SENT_209	[p12l194t2080r410b2143],
46	has	VBZ	O	have	rcmod	43	SENT_209	[p12l434t2080r550b2143],
47	an	DT	O	a	det	50	SENT_209	[p12l576t2103r658b2143],
48	unusually	RB	O	unusually	advmod	49	SENT_209	[p12l684t2080r1032b2164],
49	large	JJ	O	large	amod	50	SENT_209	[p12l1052t2080r1222b2164],
50	population	NN	O	population	dobj	46	SENT_209	[p12l1247t2080r1636b2163],
51	of	IN	O	of	_	0	SENT_209	[p12l1662t2080r1738b2143],
52	benign	JJ	O	benign	amod	54	SENT_209	[p12l1752t2080r1998b2164],
53	MS	NN	O	m	nn	54	SENT_209	[p12l2023t2084r2139b2143],
54	patients	NNS	O	patient	prep_of	50	SENT_209	[p12l7t2174r358b2265],
55	.52	CD	NUMBER	.52	nsubj	19	SENT_209	[p12l7t2174r358b2265],

1	The	DT	O	the	dep	158	SENT_210	[p12l82t2285r207b2348],
2	clinical	JJ	O	clinical	dep	158	SENT_210	[p12l229t2285r473b2348],
3	predictors	NNS	O	predictor	dep	158	SENT_210	[p12l492t2285r839b2368],
4	of	IN	O	of	dep	158	SENT_210	[p12l861t2285r935b2348],
5	a	DT	O	a	dep	158	SENT_210	[p12l947t2308r982b2348],
6	nonbenign	JJ	O	nonbenign	dep	158	SENT_210	[p12l1001t2285r1374b2369],
7	MS	NN	O	m	dep	158	SENT_210	[p12l1394t2289r1507b2348],
8	phenotype	NN	O	phenotype	dep	158	SENT_210	[p12l1529t2285r1892b2369],
9	during	IN	O	during	dep	158	SENT_210	[p12l1913t2285r2144b2369],
10	the	DT	O	the	dep	158	SENT_210	[p12l8t2388r114b2451],
11	relapsing	NN	O	relapsing	dep	158	SENT_210	[p12l137t2388r448b2472],
12	phase	NN	O	phase	dep	158	SENT_210	[p12l467t2388r662b2471],
13	of	IN	O	of	dep	158	SENT_210	[p12l686t2388r759b2451],
14	MS	NN	O	m	dep	158	SENT_210	[p12l772t2392r885b2451],
15	are	VBP	O	be	dep	158	SENT_210	[p12l910t2411r1010b2451],
16	male	JJ	O	male	dep	158	SENT_210	[p12l1032t2388r1196b2451],
17	sex	NN	O	sex	dep	158	SENT_210	[p12l1220t2411r1343b2460],
18	;	:	O	;	_	0	SENT_210	[p12l1220t2411r1343b2460],
19	older	JJR	O	older	dep	158	SENT_210	[p12l1368t2388r1545b2451],
20	age	NN	O	age	dep	158	SENT_210	[p12l1567t2411r1676b2472],
21	at	IN	O	at	dep	158	SENT_210	[p12l1700t2400r1759b2451],
22	onset	NN	O	onset	dep	158	SENT_210	[p12l1781t2400r1963b2451],
23	(	CD	NUMBER	(	dep	158	SENT_210	[p12l1987t2389r2140b2464],
24	>	JJR	O	>	dep	158	SENT_210	[p12l1987t2389r2140b2464],
25	40	CD	DURATION	40	dep	158	SENT_210	[p12l1987t2389r2140b2464],
26	years	NNS	NUMBER	year	dep	158	SENT_210	[p12l6t2492r229b2575],
27	)	RB	O	)	dep	158	SENT_210	[p12l6t2492r229b2575],
28	;	:	O	;	_	0	SENT_210	[p12l6t2492r229b2575],
29	motor	NN	O	motor	dep	158	SENT_210	[p12l252t2503r475b2563],
30	,	,	O	,	_	0	SENT_210	[p12l252t2503r475b2563],
31	cerebellar	NN	O	cerebellar	dep	158	SENT_210	[p12l498t2491r842b2563],
32	,	,	O	,	_	0	SENT_210	[p12l498t2491r842b2563],
33	or	CC	O	or	dep	158	SENT_210	[p12l865t2514r937b2554],
34	sphincter	NN	O	sphincter	dep	158	SENT_210	[p12l958t2491r1278b2574],
35	symptoms	NNS	O	symptom	dep	158	SENT_210	[p12l1299t2503r1649b2575],
36	at	IN	O	at	dep	158	SENT_210	[p12l1672t2503r1731b2554],
37	initial	JJ	O	initial	dep	158	SENT_210	[p12l1751t2491r1951b2554],
38	presentation	NN	O	presentation	dep	158	SENT_210	[p12l1970t2513r2139b2574, p12l9t2600r314b2666],
39	;	:	O	;	_	0	SENT_210	[p12l1970t2513r2139b2574, p12l9t2600r314b2666],
40	multifocal	JJ	O	multifocal	dep	158	SENT_210	[p12l339t2594r695b2657],
41	(	NN	O	(	dep	158	SENT_210	[p12l721t2594r1379b2678],
42	polysymptomatic	JJ	O	polysymptomatic	dep	158	SENT_210	[p12l721t2594r1379b2678],
43	)	NN	O	)	dep	158	SENT_210	[p12l721t2594r1379b2678],
44	disease	NN	O	disease	dep	158	SENT_210	[p12l1407t2594r1652b2657],
45	at	IN	O	at	dep	158	SENT_210	[p12l1676t2606r1736b2657],
46	onset	NN	O	onset	dep	158	SENT_210	[p12l1759t2606r1961b2666],
47	;	:	O	;	_	0	SENT_210	[p12l1759t2606r1961b2666],
48	relatively	RB	O	relatively	dep	158	SENT_210	[p12l1986t2594r2140b2657, p12l8t2697r198b2781],
49	frequent	JJ	O	frequent	dep	158	SENT_210	[p12l217t2697r513b2780],
50	attacks	NNS	O	attack	dep	158	SENT_210	[p12l536t2697r772b2760],
51	within	IN	O	within	dep	158	SENT_210	[p12l795t2697r1021b2760],
52	the	DT	O	the	dep	158	SENT_210	[p12l1044t2697r1152b2760],
53	ﬁrst	NN	O	ﬁrst	dep	158	SENT_210	[p12l1175t2697r1311b2760],
54	5	CD	DURATION	5	dep	158	SENT_210	[p12l1335t2705r1369b2760],
55	years	NNS	NUMBER	year	dep	158	SENT_210	[p12l1392t2720r1589b2781],
56	;	:	O	;	_	0	SENT_210	[p12l1392t2720r1589b2781],
57	a	DT	O	a	dep	158	SENT_210	[p12l1615t2720r1650b2760],
58	short	JJ	O	short	dep	158	SENT_210	[p12l1673t2697r1852b2760],
59	interval	NN	O	interval	dep	158	SENT_210	[p12l1874t2697r2142b2760],
60	between	IN	O	between	dep	158	SENT_210	[p12l7t2800r287b2863],
61	the	DT	O	the	dep	158	SENT_210	[p12l306t2800r411b2863],
62	ﬁrst	NN	O	ﬁrst	dep	158	SENT_210	[p12l431t2800r562b2863],
63	two	CD	NUMBER	two	dep	158	SENT_210	[p12l579t2812r702b2863],
64	attacks	NNS	O	attack	dep	158	SENT_210	[p12l724t2800r970b2872],
65	;	:	O	;	_	0	SENT_210	[p12l724t2800r970b2872],
66	and	CC	O	and	dep	158	SENT_210	[p12l992t2800r1116b2863],
67	a	DT	O	a	dep	158	SENT_210	[p12l1136t2823r1170b2863],
68	relatively	RB	O	relatively	dep	158	SENT_210	[p12l1189t2800r1494b2884],
69	short	JJ	O	short	dep	158	SENT_210	[p12l1511t2800r1684b2863],
70	time	NN	O	time	dep	158	SENT_210	[p12l1702t2806r1853b2863],
71	to	TO	O	to	dep	158	SENT_210	[p12l1873t2812r1937b2863],
72	reach	VB	O	reach	dep	158	SENT_210	[p12l1959t2800r2140b2863],
73	an	DT	O	a	dep	158	SENT_210	[p12l9t2925r90b2965],
74	Expanded	NNP	O	Expanded	dep	158	SENT_210	[p12l113t2902r464b2985],
75	Disability	NNP	O	Disability	dep	158	SENT_210	[p12l487t2902r824b2986],
76	Status	NNP	O	Status	dep	158	SENT_210	[p12l845t2906r1048b2965],
77	Scale	NNP	O	Scale	dep	158	SENT_210	[p12l1073t2902r1246b2965],
78	level	NN	O	level	dep	158	SENT_210	[p12l1269t2902r1426b2965],
79	of	IN	O	of	dep	158	SENT_210	[p12l1449t2902r1524b2965],
80	4.47	CD	NUMBER	4.47	dep	158	SENT_210	[p12l1536t2894r1991b2965],
81	>	JJR	O	>	dep	158	SENT_210	[p12l1536t2894r1991b2965],
82	48	CD	NUMBER	48	dep	158	SENT_210	[p12l1536t2894r1991b2965],
83	’	NN	O	’	dep	158	SENT_210	[p12l1536t2894r1991b2965],
84	50	CD	NUMBER	50	dep	158	SENT_210	[p12l1536t2894r1991b2965],
85	’	CD	NUMBER	’	dep	158	SENT_210	[p12l1536t2894r1991b2965],
86	53	CD	NUMBER	53	dep	158	SENT_210	[p12l1536t2894r1991b2965],
87	"	``	O	"	dep	158	SENT_210	[p12l1536t2894r1991b2965],
88	58	CD	NUMBER	58	dep	158	SENT_210	[p12l1536t2894r1991b2965],
89	The	DT	O	the	dep	158	SENT_210	[p12l2015t2902r2142b2965],
90	onset	NN	O	onset	dep	158	SENT_210	[p12l9t3017r195b3068],
91	of	IN	O	of	dep	158	SENT_210	[p12l217t3005r292b3068],
92	the	DT	O	the	dep	158	SENT_210	[p12l305t3005r413b3068],
93	progressive	JJ	O	progressive	dep	158	SENT_210	[p12l436t3011r830b3089],
94	phase	NN	O	phase	dep	158	SENT_210	[p12l853t3005r1051b3088],
95	is	VBZ	O	be	dep	158	SENT_210	[p12l1075t3011r1126b3068],
96	the	DT	O	the	dep	158	SENT_210	[p12l1149t3005r1257b3068],
97	strongest	JJS	O	strongest	dep	158	SENT_210	[p12l1282t3017r1597b3089],
98	determinant	NN	O	determinant	dep	158	SENT_210	[p12l1620t3005r2053b3068],
99	of	IN	O	of	dep	158	SENT_210	[p12l2076t3005r2151b3068],
100	severe	JJ	O	severe	dep	158	SENT_210	[p12l9t3130r218b3170],
101	disability	NN	O	disability	dep	158	SENT_210	[p12l240t3107r554b3191],
102	in	IN	O	in	dep	158	SENT_210	[p12l572t3113r638b3169],
103	MS.	NNP	O	MS.	dep	158	SENT_210	[p12l659t3099r1178b3170],
104	47	CD	NUMBER	47	dep	158	SENT_210	[p12l659t3099r1178b3170],
105	’	CD	NUMBER	’	dep	158	SENT_210	[p12l659t3099r1178b3170],
106	48	CD	NUMBER	48	dep	158	SENT_210	[p12l659t3099r1178b3170],
107	’	NN	O	’	dep	158	SENT_210	[p12l659t3099r1178b3170],
108	53	CD	NUMBER	53	dep	158	SENT_210	[p12l659t3099r1178b3170],
109	’	CD	NUMBER	’	dep	158	SENT_210	[p12l659t3099r1178b3170],
110	58	CD	NUMBER	58	dep	158	SENT_210	[p12l659t3099r1178b3170],
111	‘	NN	O	‘	dep	158	SENT_210	[p12l659t3099r1178b3170],
112	61	CD	NUMBER	61	dep	158	SENT_210	[p12l659t3099r1178b3170],
113	Persons	NNS	O	person	dep	158	SENT_210	[p12l1204t3112r1467b3170],
114	whose	WP$	O	whose	dep	158	SENT_210	[p12l1486t3107r1703b3170],
115	disease	NN	O	disease	dep	158	SENT_210	[p12l1725t3107r1965b3170],
116	does	VBZ	O	do	dep	158	SENT_210	[p12l1987t3107r2141b3170],
117	not	RB	O	not	dep	158	SENT_210	[p12l8t3222r121b3273],
118	convert	VB	O	convert	dep	158	SENT_210	[p12l141t3222r396b3273],
119	to	TO	O	to	dep	158	SENT_210	[p12l414t3222r480b3273],
120	progressive	JJ	O	progressive	dep	158	SENT_210	[p12l500t3216r883b3294],
121	MS	NN	O	m	dep	158	SENT_210	[p12l904t3214r1016b3273],
122	within	IN	O	within	dep	158	SENT_210	[p12l1035t3210r1256b3273],
123	the	DT	O	the	dep	158	SENT_210	[p12l1276t3210r1382b3273],
124	ﬁrst	NN	O	ﬁrst	dep	158	SENT_210	[p12l1402t3210r1534b3273],
125	15	CD	DURATION	15	dep	158	SENT_210	[p12l1560t3217r1629b3273],
126	years	NNS	NUMBER	year	dep	158	SENT_210	[p12l1649t3233r1822b3294],
127	are	VBP	O	be	dep	158	SENT_210	[p12l1844t3233r1943b3273],
128	likely	JJ	O	likely	dep	158	SENT_210	[p12l1963t3210r2147b3294],
129	to	TO	O	to	dep	158	SENT_210	[p12l7t3324r72b3376],
130	continue	VB	O	continue	dep	158	SENT_210	[p12l93t3319r385b3376],
131	to	TO	O	to	dep	158	SENT_210	[p12l403t3324r468b3376],
132	have	VB	O	have	dep	158	SENT_210	[p12l487t3312r639b3376],
133	a	DT	O	a	dep	158	SENT_210	[p12l659t3335r694b3376],
134	relatively	RB	O	relatively	dep	158	SENT_210	[p12l712t3312r1015b3397],
135	benign	JJ	O	benign	dep	158	SENT_210	[p12l1029t3312r1262b3397],
136	course	NN	O	course	dep	158	SENT_210	[p12l1282t3304r1651b3376],
137	.4756	CD	NUMBER	.4756	dep	158	SENT_210	[p12l1282t3304r1651b3376],
138	All	PDT	O	all	dep	158	SENT_210	[p12l1670t3312r1769b3375],
139	the	DT	O	the	dep	158	SENT_210	[p12l1788t3312r1891b3376],
140	clinical	JJ	O	clinical	dep	158	SENT_210	[p12l1911t3312r2150b3376],
141	trials	NNS	O	trial	dep	158	SENT_210	[p12l7t3416r177b3479],
142	conducted	VBN	O	conduct	dep	158	SENT_210	[p12l199t3416r556b3479],
143	to	TO	O	to	dep	158	SENT_210	[p12l575t3428r640b3479],
144	date	NN	O	date	dep	158	SENT_210	[p12l663t3416r802b3479],
145	indicate	VBP	O	indicate	dep	158	SENT_210	[p12l823t3416r1092b3479],
146	that	IN	O	that	dep	158	SENT_210	[p12l1111t3416r1244b3479],
147	DMAS	NNS	O	dma	dep	158	SENT_210	[p12l1264t3420r1487b3479],
148	have	VBP	O	have	dep	158	SENT_210	[p12l1507t3416r1662b3479],
149	a	DT	O	a	dep	158	SENT_210	[p12l1683t3439r1717b3479],
150	signiﬁcantly	RB	O	signiﬁcantly	dep	158	SENT_210	[p12l1738t3416r2154b3500],
151	greater	JJR	O	greater	dep	158	SENT_210	[p12l8t3531r244b3603],
152	impact	NN	O	impact	dep	158	SENT_210	[p12l264t3525r499b3602],
153	on	IN	O	on	dep	158	SENT_210	[p12l519t3542r605b3582],
154	subclinical	JJ	O	subclinical	dep	158	SENT_210	[p12l626t3519r990b3582],
155	lesion	NN	O	lesion	dep	158	SENT_210	[p12l1009t3519r1209b3582],
156	development	NN	O	development	dep	158	SENT_210	[p12l1230t3519r1672b3602],
157	than	IN	O	than	dep	158	SENT_210	[p12l1690t3519r1843b3582],
158	relapses	NNS	O	relapse	_	0	SENT_210	[p12l1864t3519r2147b3602],
159	.	.	O	.	_	0	SENT_210	[p12l1864t3519r2147b3602],

1	Therefore	RB	O	therefore	advmod	9	SENT_211	[p12l8t3622r362b3694],
2	,	,	O	,	_	0	SENT_211	[p12l8t3622r362b3694],
3	in	IN	O	in	_	0	SENT_211	[p12l387t3628r455b3684],
4	practice	NN	O	practice	prep_in	9	SENT_211	[p12l477t3628r774b3705],
5	,	,	O	,	_	0	SENT_211	[p12l477t3628r774b3705],
6	we	PRP	O	we	nsubj	9	SENT_211	[p12l797t3645r892b3685],
7	and	CC	O	and	_	0	SENT_211	[p12l916t3622r1045b3685],
8	others	NNS	O	other	nsubj	9	SENT_211	[p12l1068t3622r1284b3685],
9	utilize	VBP	O	utilize	_	0	SENT_211	[p12l1307t3622r1522b3685],
10	background	NN	O	background	nn	12	SENT_211	[p12l1543t3622r1967b3706],
11	MRI	NNP	O	MRI	nn	12	SENT_211	[p12l1989t3627r2147b3685],
12	activity	NN	O	activity	dobj	9	SENT_211	[p12l9t3731r276b3809],
13	as	IN	O	as	_	0	SENT_211	[p12l301t3748r368b3788],
14	an	DT	O	a	det	18	SENT_211	[p12l398t3748r481b3788],
15	“	NN	O	“	nn	18	SENT_211	[p12l510t3725r714b3809],
16	early	JJ	O	early	amod	18	SENT_211	[p12l510t3725r714b3809],
17	warning	NN	O	warning	nn	18	SENT_211	[p12l736t3731r1037b3809],
18	sign	NN	O	sign	prep_as	12	SENT_211	[p12l1064t3725r1237b3809],
19	”	CD	NUMBER	”	dep	18	SENT_211	[p12l1064t3725r1237b3809],
20	to	TO	O	to	aux	21	SENT_211	[p12l1266t3737r1335b3788],
21	guide	VB	O	guide	infmod	12	SENT_211	[p12l1364t3725r1561b3809],
22	treatment	NN	O	treatment	nn	23	SENT_211	[p12l1589t3737r1943b3788],
23	decisions	NNS	O	decision	dobj	21	SENT_211	[p12l1970t3725r2145b3788, p13l9t22r199b88],
24	,	,	O	,	_	0	SENT_211	[p12l1970t3725r2145b3788, p13l9t22r199b88],

1	although	IN	O	although	mark	8	SENT_212	[p13l223t16r528b100],
2	extensive	JJ	O	extensive	amod	3	SENT_212	[p13l550t22r863b79],
3	studies	NNS	O	study	nsubj	8	SENT_212	[p13l886t16r1121b79],
4	for	IN	O	for	_	0	SENT_212	[p13l1143t16r1241b79],
5	such	PDT	O	such	predet	7	SENT_212	[p13l1262t16r1418b79],
6	a	DT	O	a	det	7	SENT_212	[p13l1440t39r1474b79],
7	utility	NN	O	utility	prep_for	3	SENT_212	[p13l1495t16r1701b100],
8	remain	VBP	O	remain	_	0	SENT_212	[p13l1719t22r1962b79],
9	to	TO	O	to	aux	11	SENT_212	[p13l1982t28r2048b79],
10	be	VB	O	be	auxpass	11	SENT_212	[p13l2069t16r2148b79],
11	completed	VBN	O	complete	xcomp	8	SENT_212	[p13l9t120r382b203],
12	.	.	O	.	_	0	SENT_212	[p13l9t120r382b203],

1	Figures	NNS	O	figure	nsubj	5	SENT_213	[p13l83t227r347b306],
2	4	CD	NUMBER	4	dep	1	SENT_213	[p13l368t230r409b285],
3	and	CC	O	and	_	0	SENT_213	[p13l431t223r558b286],
4	5	CD	NUMBER	5	dep	1	SENT_213	[p13l580t231r617b286],
5	illustrate	VBP	O	illustrate	_	0	SENT_213	[p13l641t223r939b286],
6	our	PRP$	O	we	poss	8	SENT_213	[p13l963t246r1081b286],
7	tiered	JJ	O	tiered	amod	8	SENT_213	[p13l1101t223r1300b286],
8	approach	NN	O	approach	dobj	5	SENT_213	[p13l1323t223r1639b306],
9	to	TO	O	to	_	0	SENT_213	[p13l1661t235r1727b286],
10	relapse	NN	O	relapse	nn	11	SENT_213	[p13l1751t223r1987b306],
11	prevention	NN	O	prevention	prep_to	5	SENT_213	[p13l2009t245r2146b306, p13l6t332r288b389],
12	.	.	O	.	_	0	SENT_213	[p13l2009t245r2146b306, p13l6t332r288b389],

1	We	PRP	O	we	nsubj	2	SENT_214	[p13l313t331r424b389],
2	consider	VBP	O	consider	_	0	SENT_214	[p13l448t326r745b389],
3	any	DT	O	any	det	4	SENT_214	[p13l768t349r891b410],
4	medication	NN	O	medication	dobj	2	SENT_214	[p13l911t326r1303b389],
5	with	IN	O	with	_	0	SENT_214	[p13l1325t326r1480b389],
6	weak	JJ	O	weak	amod	11	SENT_214	[p13l1501t326r2147b389],
7	—	CD	NUMBER	—	number	9	SENT_214	[p13l1501t326r2147b389],
8	to	TO	O	to	dep	9	SENT_214	[p13l1501t326r2147b389],
9	—	CD	NUMBER	—	dep	6	SENT_214	[p13l1501t326r2147b389],
10	moderate	JJ	O	moderate	amod	11	SENT_214	[p13l1501t326r2147b389],
11	efﬁcacy	NN	O	efﬁcacy	prep_with	2	SENT_214	[p13l9t429r273b513],
12	and	CC	O	and	_	0	SENT_214	[p13l294t429r424b492],
13	an	DT	O	a	det	17	SENT_214	[p13l448t452r529b492],
14	established	JJ	O	established	amod	17	SENT_214	[p13l554t429r942b492],
15	long-term	JJ	O	long-term	amod	17	SENT_214	[p13l964t429r1320b513],
16	safety	NN	O	safety	nn	17	SENT_214	[p13l1345t429r1547b513],
17	record	NN	O	record	conj_and	11	SENT_214	[p13l1567t429r1795b492],
18	as	IN	O	as	_	0	SENT_214	[p13l1819t452r1885b492],
19	a	DT	O	a	det	22	SENT_214	[p13l1910t452r1945b492],
20	tier	NN	O	tier	nn	22	SENT_214	[p13l1966t435r2087b492],
21	1	CD	NUMBER	1	num	22	SENT_214	[p13l2116t436r2142b491],
22	medication	NN	O	medication	prep_as	17	SENT_214	[p13l8t532r401b595],
23	.	.	O	.	_	0	SENT_214	[p13l8t532r401b595],

1	These	DT	O	these	nsubj	2	SENT_215	[p13l424t532r614b595],
2	include	VBP	O	include	_	0	SENT_215	[p13l634t532r879b595],
3	interferon	NN	O	interferon	nn	5	SENT_215	[p13l899t532r1324b616],
4	—	CD	NUMBER	—	num	5	SENT_215	[p13l899t532r1324b616],
5	[	NN	O	[	dobj	2	SENT_215	[p13l899t532r1324b616],
6	3	CD	NUMBER	3	dep	5	SENT_215	[p13l899t532r1324b616],
7	,	,	O	,	_	0	SENT_215	[p13l899t532r1324b616],
8	glatiramer	NN	O	glatiramer	nn	9	SENT_215	[p13l1345t532r1691b616],
9	acetate	NN	O	acetate	conj_and	5	SENT_215	[p13l1711t544r1937b595],
10	(	CD	NUMBER	(	num	12	SENT_215	[p13l1960t533r2148b608],
11	GA	NN	O	ga	nn	12	SENT_215	[p13l1960t533r2148b608],
12	)	NN	O	)	dep	9	SENT_215	[p13l1960t533r2148b608],
13	,	,	O	,	_	0	SENT_215	[p13l1960t533r2148b608],
14	and	CC	O	and	_	0	SENT_215	[p13l9t635r139b698],
15	dimethyl	JJ	O	dimethyl	amod	17	SENT_215	[p13l165t635r482b719],
16	fumarate	JJ	O	fumarate	amod	17	SENT_215	[p13l506t635r825b698],
17	(	NN	O	(	conj_and	5	SENT_215	[p13l855t635r1176b719],
18	pending	VBG	O	pend	_	0	SENT_215	[p13l855t635r1176b719],
19	long-term	JJ	O	long-term	amod	20	SENT_215	[p13l1199t635r1559b719],
20	proof	NN	O	proof	prep_pending	17	SENT_215	[p13l1583t635r1786b718],
21	of	IN	O	of	_	0	SENT_215	[p13l1802t635r1878b698],
22	safety	NN	O	safety	nn	23	SENT_215	[p13l1895t635r2144b719],
23	)	NN	O	)	prep_of	20	SENT_215	[p13l1895t635r2144b719],
24	.	.	O	.	_	0	SENT_215	[p13l1895t635r2144b719],

1	Tier	NN	O	tier	nsubj	36	SENT_216	[p13l8t741r150b801],
2	2	CD	NUMBER	2	num	3	SENT_216	[p13l171t745r207b800],
3	medications	NNS	O	medication	dep	1	SENT_216	[p13l232t738r649b801],
4	currently	RB	DATE	currently	advmod	5	SENT_216	[p13l674t738r990b822],
5	include	VBP	O	include	_	0	SENT_216	[p13l1010t738r1262b801],
6	ﬁngolimod	NN	O	ﬁngolimod	nn	10	SENT_216	[p13l1284t738r1682b822],
7	,	,	O	,	_	0	SENT_216	[p13l1284t738r1682b822],
8	natalizumab	NN	O	natalizumab	dep	10	SENT_216	[p13l1706t738r2147b810],
9	,	,	O	,	_	0	SENT_216	[p13l1706t738r2147b810],
10	cyclophosphamide	NN	O	cyclophosphamide	dobj	5	SENT_216	[p13l9t841r701b925],
11	,	,	O	,	_	0	SENT_216	[p13l9t841r701b925],
12	and	CC	O	and	_	0	SENT_216	[p13l730t841r860b904],
13	mitoxantrone	NN	O	mitoxantrone	conj_and	10	SENT_216	[p13l886t847r1392b913],
14	,	,	O	,	_	0	SENT_216	[p13l886t847r1392b913],
15	which	WDT	O	which	nsubj	18	SENT_216	[p13l1418t841r1636b904],
16	not	RB	O	not	dep	17	SENT_216	[p13l1663t853r1781b904],
17	only	RB	O	only	advmod	18	SENT_216	[p13l1807t841r1964b925],
18	have	VBP	O	have	rcmod	10	SENT_216	[p13l1986t841r2148b904],
19	moderate	JJ	O	moderate	amod	24	SENT_216	[p13l8t944r832b1028],
20	—	CD	NUMBER	—	number	22	SENT_216	[p13l8t944r832b1028],
21	to	TO	O	to	dep	22	SENT_216	[p13l8t944r832b1028],
22	—	CD	NUMBER	—	dep	19	SENT_216	[p13l8t944r832b1028],
23	signiﬁcant	JJ	O	signiﬁcant	amod	24	SENT_216	[p13l8t944r832b1028],
24	eﬂicacy	NN	O	eﬂicacy	dobj	18	SENT_216	[p13l854t944r1114b1028],
25	in	IN	O	in	_	0	SENT_216	[p13l1133t950r1200b1006],
26	relapse	NN	O	relapse	nn	27	SENT_216	[p13l1223t944r1461b1027],
27	prevention	NN	O	prevention	prep_in	24	SENT_216	[p13l1483t950r1858b1027],
28	as	IN	O	as	advmod	18	SENT_216	[p13l1881t967r1946b1007],
29	compared	VBN	O	compare	_	0	SENT_216	[p13l1971t967r2146b1007, p13l7t1047r203b1130],
30	with	IN	O	with	prepc_compared_with	18	SENT_216	[p13l220t1047r374b1110],
31	tier	NN	O	tier	nn	33	SENT_216	[p13l394t1053r511b1110],
32	1	CD	NUMBER	1	num	33	SENT_216	[p13l537t1054r562b1109],
33	medications	NNS	O	medication	pobj	18	SENT_216	[p13l588t1047r1006b1110],
34	but	CC	O	but	_	0	SENT_216	[p13l1026t1047r1140b1110],
35	also	RB	O	also	advmod	5	SENT_216	[p13l1160t1047r1291b1110],
36	have	VBP	O	have	conj_but	5	SENT_216	[p13l1312t1047r1468b1110],
37	signiﬁcantly	RB	O	signiﬁcantly	advmod	38	SENT_216	[p13l1490t1047r1910b1131],
38	higher	JJR	O	higher	amod	40	SENT_216	[p13l1926t1047r2150b1131],
39	safety	NN	O	safety	nn	40	SENT_216	[p13l9t1150r206b1234],
40	concerns	NNS	O	concern	dobj	36	SENT_216	[p13l224t1173r548b1213],
41	.	.	O	.	_	0	SENT_216	[p13l224t1173r548b1213],

1	PREVENTION	NN	O	prevention	nsubj	13	SENT_217	[p13l12t1365r475b1421],
2	OF	IN	O	of	_	0	SENT_217	[p13l497t1365r590b1421],
3	RELAPSES	NNP	O	RELAPSES	prep_of	1	SENT_217	[p13l613t1366r971b1421],
4	IN	IN	O	in	_	0	SENT_217	[p13l993t1366r1062b1420],
5	SAMS	NNP	O	SAMS	prep_in	3	SENT_217	[p13l1084t1366r1287b1421],
6	AND	CC	O	and	_	0	SENT_217	[p13l1305t1366r1466b1420],
7	RRMS	NNS	O	rrm	prep_in	3	SENT_217	[p13l1487t1366r1687b1421],
8	Two	CD	NUMBER	two	num	11	SENT_217	[p13l8t1463r158b1523],
9	classic	JJ	O	classic	amod	11	SENT_217	[p13l186t1460r409b1523],
10	multicenter	JJ	O	multicenter	amod	11	SENT_217	[p13l434t1460r849b1523],
11	studies	NNS	O	study	dep	7	SENT_217	[p13l874t1460r1119b1523],
12	have	VBP	O	have	aux	13	SENT_217	[p13l1145t1460r1306b1523],
13	addressed	VBN	O	address	_	0	SENT_217	[p13l1332t1460r1686b1523],
14	DMA	NNP	ORGANIZATION	DMA	nn	15	SENT_217	[p13l1711t1464r1913b1522],
15	use	NN	O	use	dobj	13	SENT_217	[p13l1938t1483r2052b1523],
16	in	IN	O	in	_	0	SENT_217	[p13l2079t1466r2147b1522],
17	persons	NNS	O	person	prep_in	13	SENT_217	[p13l7t1585r282b1646],
18	at	IN	O	at	_	0	SENT_217	[p13l309t1575r370b1626],
19	high	JJ	O	high	amod	20	SENT_217	[p13l393t1563r552b1647],
20	risk	NN	O	risk	prep_at	17	SENT_217	[p13l578t1563r712b1626],
21	of	IN	O	of	_	0	SENT_217	[p13l734t1563r810b1626],
22	developing	VBG	O	develop	prepc_of	20	SENT_217	[p13l827t1563r1217b1647],
23	MS	NN	O	m	nsubj	29	SENT_217	[p13l1240t1567r1356b1626],
24	(	CD	NUMBER	(	num	29	SENT_217	[p13l1386t1563r1743b1647],
25	high	JJ	O	high	amod	29	SENT_217	[p13l1386t1563r1743b1647],
26	—	NN	O	—	nn	29	SENT_217	[p13l1386t1563r1743b1647],
27	risk	NN	O	risk	nn	29	SENT_217	[p13l1386t1563r1743b1647],
28	CIS	NN	O	ci	nn	29	SENT_217	[p13l1767t1567r1892b1626],
29	cases	NNS	O	case	xcomp	22	SENT_217	[p13l1920t1564r2146b1640],
30	)	CD	NUMBER	)	dep	29	SENT_217	[p13l1920t1564r2146b1640],
31	.	.	O	.	_	0	SENT_217	[p13l1920t1564r2146b1640],

1	Weekly	NNP	SET	Weekly	nn	3	SENT_218	[p13l7t1666r259b1750],
2	interferon	NN	O	interferon	nn	3	SENT_218	[p13l276t1666r688b1750],
3	—	NN	O	—	nsubj	12	SENT_218	[p13l276t1666r688b1750],
4	[	CD	NUMBER	[	number	5	SENT_218	[p13l276t1666r688b1750],
5	3	CD	NUMBER	3	num	6	SENT_218	[p13l276t1666r688b1750],
6	1a	NN	O	1a	dep	3	SENT_218	[p13l716t1673r802b1738],
7	,	,	O	,	_	0	SENT_218	[p13l716t1673r802b1738],
8	30	CD	NUMBER	30	num	10	SENT_218	[p13l826t1673r901b1729],
9	pg	NN	O	pg	nn	10	SENT_218	[p13l926t1689r1005b1750],
10	i.m.	NN	O	i.m.	appos	3	SENT_218	[p13l1023t1672r1169b1738],
11	,	,	O	,	_	0	SENT_218	[p13l1023t1672r1169b1738],
12	leads	VBZ	O	lead	_	0	SENT_218	[p13l1189t1666r1358b1729],
13	to	TO	O	to	_	0	SENT_218	[p13l1378t1678r1443b1729],
14	a	DT	O	a	det	20	SENT_218	[p13l1465t1689r1500b1729],
15	relative	JJ	O	relative	amod	20	SENT_218	[p13l1519t1666r1763b1729],
16	risk	NN	O	risk	nn	20	SENT_218	[p13l1784t1666r1912b1729],
17	reduction	NN	O	reduction	nn	20	SENT_218	[p13l1929t1666r2145b1729, p13l7t1775r145b1832],
18	(	CD	NUMBER	(	num	20	SENT_218	[p13l170t1770r380b1846],
19	RRR	NN	O	rrr	nn	20	SENT_218	[p13l170t1770r380b1846],
20	)	NN	O	)	prep_to	12	SENT_218	[p13l170t1770r380b1846],
21	of	IN	O	of	_	0	SENT_218	[p13l407t1769r481b1832],
22	38	CD	PERCENT	38	num	23	SENT_218	[p13l495t1774r656b1841],
23	%	NN	PERCENT	%	prep_of	20	SENT_218	[p13l495t1774r656b1841],
24	,	,	O	,	_	0	SENT_218	[p13l495t1774r656b1841],
25	an	DT	O	a	det	31	SENT_218	[p13l681t1792r761b1832],
26	absolute	JJ	O	absolute	amod	31	SENT_218	[p13l784t1769r1065b1832],
27	risk	NN	O	risk	nn	31	SENT_218	[p13l1087t1769r1217b1832],
28	reduction	NN	O	reduction	nn	31	SENT_218	[p13l1235t1769r1568b1832],
29	(	CD	NUMBER	(	num	31	SENT_218	[p13l1594t1769r1810b1846],
30	ARR	NN	O	arr	nn	31	SENT_218	[p13l1594t1769r1810b1846],
31	)	NN	O	)	prep_to	12	SENT_218	[p13l1594t1769r1810b1846],
32	of	IN	O	of	_	0	SENT_218	[p13l1837t1769r1911b1832],
33	14.6	CD	PERCENT	14.6	num	34	SENT_218	[p13l1930t1775r2147b1841],
34	%	NN	PERCENT	%	prep_of	31	SENT_218	[p13l1930t1775r2147b1841],
35	,	,	O	,	_	0	SENT_218	[p13l1930t1775r2147b1841],
36	and	CC	O	and	_	0	SENT_218	[p13l9t1872r135b1935],
37	a	DT	O	a	det	38	SENT_218	[p13l158t1895r192b1935],
38	number	NN	O	number	conj_and	20	SENT_218	[p13l214t1872r487b1935],
39	needed	VBN	O	need	partmod	38	SENT_218	[p13l508t1872r756b1935],
40	to	TO	O	to	aux	41	SENT_218	[p13l777t1884r843b1935],
41	treat	VB	O	treat	xcomp	39	SENT_218	[p13l866t1884r1022b1935],
42	(	CD	NUMBER	(	num	43	SENT_218	[p13l1047t1872r1278b1949],
43	NNT	NNP	O	NNT	dobj	41	SENT_218	[p13l1047t1872r1278b1949],
44	)	CD	NUMBER	)	num	43	SENT_218	[p13l1047t1872r1278b1949],
45	of	IN	O	of	_	0	SENT_218	[p13l1305t1872r1379b1935],
46	7	CD	NUMBER	7	num	47	SENT_218	[p13l1394t1880r1430b1935],
47	patients	NNS	O	patient	prep_of	43	SENT_218	[p13l1452t1878r1721b1955],
48	over	IN	O	over	_	0	SENT_218	[p13l1745t1895r1893b1935],
49	2	CD	DURATION	2	num	50	SENT_218	[p13l1915t1879r1951b1934],
50	years	NNS	NUMBER	year	prep_over	47	SENT_218	[p13l1973t1895r2148b1956],
51	to	TO	O	to	aux	52	SENT_218	[p13l7t1986r73b2038],
52	prevent	VB	O	prevent	xcomp	41	SENT_218	[p13l93t1986r351b2058],
53	1	CD	NUMBER	1	num	54	SENT_218	[p13l377t1981r402b2037],
54	conversion	NN	O	conversion	dobj	52	SENT_218	[p13l429t1981r801b2038],
55	to	TO	O	to	_	0	SENT_218	[p13l820t1986r885b2038],
56	“	CD	NUMBER	“	prep_to	52	SENT_218	[p13l908t1974r1243b2059],
57	clinically	RB	O	clinically	advmod	58	SENT_218	[p13l908t1974r1243b2059],
58	deﬁnite	JJ	O	deﬁnite	amod	56	SENT_218	[p13l1260t1974r1515b2038],
59	MS.	NNP	O	MS.	dep	56	SENT_218	[p13l1535t1966r1828b2038],
60	”	CD	NUMBER	”	num	59	SENT_218	[p13l1535t1966r1828b2038],
61	62	CD	NUMBER	62	number	62	SENT_218	[p13l1535t1966r1828b2038],
62	’63	CD	NUMBER	’63	dep	59	SENT_218	[p13l1535t1966r1828b2038],
63	It	PRP	O	it	nsubj	65	SENT_218	[p13l1850t1980r1899b2038],
64	is	VBZ	O	be	cop	65	SENT_218	[p13l1919t1981r1968b2038],
65	clear	JJ	O	clear	dep	52	SENT_218	[p13l1990t1975r2150b2038],
66	that	IN	O	that	complm	74	SENT_218	[p13l7t2078r147b2141],
67	transverse	JJ	O	transverse	amod	68	SENT_218	[p13l172t2090r538b2141],
68	myelitis	NN	O	myelitis	nsubj	74	SENT_218	[p13l564t2078r843b2162],
69	and	CC	O	and	_	0	SENT_218	[p13l871t2078r1003b2141],
70	brainstem	NN	O	brainstem	nn	71	SENT_218	[p13l1026t2078r1388b2141],
71	syndromes	NNS	O	syndrome	conj_and	68	SENT_218	[p13l1415t2078r1804b2162],
72	are	VBP	O	be	cop	74	SENT_218	[p13l1832t2101r1937b2141],
73	more	RBR	O	more	advmod	74	SENT_218	[p13l1963t2101r2148b2141],
74	likely	JJ	O	likely	ccomp	65	SENT_218	[p13l7t2180r199b2265],
75	to	TO	O	to	aux	76	SENT_218	[p13l219t2192r286b2244],
76	beneﬁt	JJ	O	beneﬁt	xcomp	74	SENT_218	[p13l310t2180r553b2244],
77	from	IN	O	from	_	0	SENT_218	[p13l576t2180r749b2244],
78	early	JJ	O	early	amod	79	SENT_218	[p13l773t2181r945b2265],
79	treatment	NN	O	treatment	prep_from	76	SENT_218	[p13l964t2192r1311b2244],
80	than	IN	O	than	mark	83	SENT_218	[p13l1333t2180r1492b2244],
81	is	VBZ	O	be	cop	83	SENT_218	[p13l1516t2187r1568b2244],
82	optic	JJ	O	optic	amod	83	SENT_218	[p13l1593t2187r1768b2264],
83	neuritis	NN	O	neuritis	advcl	52	SENT_218	[p13l1792t2172r2147b2244],
84	.	.	O	.	_	0	SENT_218	[p13l1792t2172r2147b2244],

1	“	NN	O	“	nn	3	SENT_219	[p13l1792t2172r2147b2244],
2	Weekly	NNP	SET	Weekly	nn	3	SENT_219	[p13l7t2284r272b2368],
3	interferon	NN	O	interferon	_	0	SENT_219	[p13l294t2284r730b2368],
4	-	:	O	-	_	0	SENT_219	[p13l294t2284r730b2368],
5	[	NN	O	[	dep	3	SENT_219	[p13l294t2284r730b2368],
6	3	CD	NUMBER	3	num	7	SENT_219	[p13l294t2284r730b2368],
7	1a	NN	O	1a	nsubj	13	SENT_219	[p13l764t2291r855b2356],
8	,	,	O	,	_	0	SENT_219	[p13l764t2291r855b2356],
9	22	CD	NUMBER	22	num	11	SENT_219	[p13l883t2291r962b2346],
10	pg	NN	O	pg	nn	11	SENT_219	[p13l994t2307r1076b2368],
11	s.c.	NN	O	s.c.	appos	7	SENT_219	[p13l1101t2307r1228b2356],
12	,	,	O	,	_	0	SENT_219	[p13l1101t2307r1228b2356],
13	leads	VBZ	O	lead	rcmod	5	SENT_219	[p13l1254t2284r1432b2347],
14	to	TO	O	to	_	0	SENT_219	[p13l1458t2296r1526b2347],
15	a	DT	O	a	det	18	SENT_219	[p13l1555t2307r1590b2347],
16	slightly	RB	O	slightly	advmod	17	SENT_219	[p13l1616t2284r1876b2368],
17	weaker	JJR	O	weaker	amod	18	SENT_219	[p13l1897t2284r2151b2347],
18	effect	NN	O	effect	prep_to	13	SENT_219	[p13l9t2386r197b2450],
19	than	IN	O	than	mark	23	SENT_219	[p13l219t2386r379b2450],
20	the	DT	O	the	det	22	SENT_219	[p13l402t2386r512b2450],
21	above	JJ	O	above	amod	22	SENT_219	[p13l537t2386r1162b2450],
22	—	NN	O	—	nsubj	23	SENT_219	[p13l537t2386r1162b2450],
23	mentioned	VBD	O	mention	advcl	13	SENT_219	[p13l537t2386r1162b2450],
24	i.m.	JJ	O	i.m.	amod	25	SENT_219	[p13l1185t2393r1315b2450],
25	dosage	NN	O	dosage	dobj	23	SENT_219	[p13l1343t2378r1667b2471],
26	.64	CD	NUMBER	.64	num	27	SENT_219	[p13l1343t2378r1667b2471],
27	GA	NN	O	ga	dep	23	SENT_219	[p13l1692t2390r1812b2450],
28	based	VBN	O	base	_	0	SENT_219	[p13l1834t2386r2037b2450],
29	on	IN	O	on	prepc_based_on	27	SENT_219	[p13l2061t2409r2149b2450],
30	approximation	NN	O	approximation	pobj	27	SENT_219	[p13l9t2496r512b2573],
31	(	CD	NUMBER	(	num	33	SENT_219	[p13l536t2490r689b2567],
32	raw	JJ	O	raw	amod	33	SENT_219	[p13l536t2490r689b2567],
33	data	NNS	O	datum	tmod	23	SENT_219	[p13l707t2490r850b2553],
34	not	RB	O	not	neg	35	SENT_219	[p13l869t2502r983b2553],
35	available	JJ	O	available	amod	36	SENT_219	[p13l1003t2490r1321b2567],
36	)	NN	O	)	nsubj	37	SENT_219	[p13l1003t2490r1321b2567],
37	leads	VBZ	O	lead	rcmod	33	SENT_219	[p13l1345t2490r1515b2553],
38	to	TO	O	to	_	0	SENT_219	[p13l1535t2502r1600b2553],
39	an	DT	O	a	det	40	SENT_219	[p13l1623t2513r1702b2553],
40	RRR	NN	O	rrr	prep_to	37	SENT_219	[p13l1723t2495r1882b2553],
41	of	IN	O	of	_	0	SENT_219	[p13l1901t2490r1974b2553],
42	40	CD	PERCENT	40	num	43	SENT_219	[p13l1984t2496r2147b2562],
43	%	NN	PERCENT	%	prep_of	40	SENT_219	[p13l1984t2496r2147b2562],
44	,	,	O	,	_	0	SENT_219	[p13l1984t2496r2147b2562],
45	an	DT	O	a	det	46	SENT_219	[p13l9t2615r89b2656],
46	ARR	NN	O	arr	prep_to	37	SENT_219	[p13l109t2596r276b2656],
47	of	IN	O	of	_	0	SENT_219	[p13l294t2592r368b2656],
48	10	CD	PERCENT	10	num	49	SENT_219	[p13l386t2598r522b2657],
49	%	NN	PERCENT	%	prep_of	46	SENT_219	[p13l386t2598r522b2657],
50	at	IN	O	at	_	0	SENT_219	[p13l545t2604r604b2656],
51	1	CD	DURATION	1	num	52	SENT_219	[p13l631t2599r655b2655],
52	year	NN	NUMBER	year	prep_at	49	SENT_219	[p13l680t2615r836b2677],
53	,	,	O	,	_	0	SENT_219	[p13l680t2615r836b2677],
54	and	CC	O	and	_	0	SENT_219	[p13l860t2592r986b2656],
55	an	DT	O	a	det	56	SENT_219	[p13l1006t2615r1086b2656],
56	NNT	NN	O	nnt	prep_to	37	SENT_219	[p13l1106t2595r1285b2656],
57	of	IN	O	of	_	0	SENT_219	[p13l1306t2592r1380b2656],
58	10	CD	NUMBER	10	number	60	SENT_219	[p13l1398t2599r1469b2656],
59	over	IN	O	over	quantmod	60	SENT_219	[p13l1491t2615r1639b2656],
60	1	CD	DURATION	1	num	61	SENT_219	[p13l1665t2599r1690b2655],
61	year	NN	NUMBER	year	prep_of	56	SENT_219	[p13l1714t2584r1933b2677],
62	.65	CD	NUMBER	.65	dobj	37	SENT_219	[p13l1714t2584r1933b2677],
63	These	DT	O	these	det	64	SENT_219	[p13l1954t2592r2149b2656],
64	studies	NNS	O	study	nsubj	65	SENT_219	[p13l9t2716r244b2779],
65	support	VBP	O	support	rcmod	62	SENT_219	[p13l266t2728r532b2799],
66	initiating	VBG	O	initiate	xcomp	65	SENT_219	[p13l552t2722r866b2800],
67	treatment	NN	O	treatment	dobj	66	SENT_219	[p13l884t2728r1220b2779],
68	in	IN	O	in	_	0	SENT_219	[p13l1240t2722r1306b2778],
69	patients	NNS	O	patient	prep_in	66	SENT_219	[p13l1326t2722r1596b2799],
70	presenting	VBG	O	present	partmod	69	SENT_219	[p13l1616t2722r1979b2800],
71	with	IN	O	with	_	0	SENT_219	[p13l1997t2716r2150b2779],
72	a	DT	O	a	det	86	SENT_219	[p13l9t2842r44b2882],
73	ﬁrst	NN	O	ﬁrst	nn	86	SENT_219	[p13l65t2819r200b2882],
74	attack	NN	O	attack	nn	86	SENT_219	[p13l222t2819r428b2882],
75	(	CD	NUMBER	(	num	86	SENT_219	[p13l451t2819r719b2903],
76	mainly	RB	O	mainly	amod	86	SENT_219	[p13l451t2819r719b2903],
77	with	IN	O	with	_	0	SENT_219	[p13l736t2819r890b2882],
78	brainstem	NN	O	brainstem	prep_with	76	SENT_219	[p13l911t2819r1277b2891],
79	,	,	O	,	_	0	SENT_219	[p13l911t2819r1277b2891],
80	cerebellar	NN	O	cerebellar	conj_or	78	SENT_219	[p13l1302t2819r1649b2891],
81	,	,	O	,	_	0	SENT_219	[p13l1302t2819r1649b2891],
82	or	CC	O	or	_	0	SENT_219	[p13l1674t2842r1746b2882],
83	spinal	JJ	O	spinal	amod	85	SENT_219	[p13l1769t2819r1973b2902],
84	cord	NN	O	cord	nn	85	SENT_219	[p13l1996t2819r2150b2882],
85	syndrome	NN	O	syndrome	conj_or	78	SENT_219	[p13l9t2922r384b3006],
86	)	NN	O	)	prep_with	70	SENT_219	[p13l9t2922r384b3006],
87	and	CC	O	and	_	0	SENT_219	[p13l413t2922r541b2985],
88	multiple	JJ	O	multiple	amod	90	SENT_219	[p13l563t2922r855b3005],
89	MRI	NNP	O	MRI	nn	90	SENT_219	[p13l878t2927r1037b2985],
90	lesions	NNS	O	lesion	conj_and	86	SENT_219	[p13l1060t2922r1315b2985],
91	.	.	O	.	_	0	SENT_219	[p13l1060t2922r1315b2985],

1	As	IN	O	as	mark	2	SENT_220	[p13l1341t2926r1429b2985],
2	discussed	VBN	O	discuss	advcl	6	SENT_220	[p13l1454t2922r1788b2985],
3	above	IN	O	above	prep	2	SENT_220	[p13l1812t2922r2030b2994],
4	,	,	O	,	_	0	SENT_220	[p13l1812t2922r2030b2994],
5	we	PRP	O	we	nsubj	6	SENT_220	[p13l2053t2945r2148b2985],
6	feel	VBP	O	feel	_	0	SENT_220	[p13l8t3025r126b3088],
7	many	JJ	O	many	amod	8	SENT_220	[p13l145t3048r338b3109],
8	cases	NNS	O	case	nsubjpass	19	SENT_220	[p13l356t3048r526b3088],
9	enrolled	VBN	O	enrol	partmod	8	SENT_220	[p13l548t3025r831b3088],
10	in	IN	O	in	_	0	SENT_220	[p13l851t3031r917b3087],
11	these	DT	O	these	det	15	SENT_220	[p13l937t3025r1113b3088],
12	“	CD	NUMBER	“	num	15	SENT_220	[p13l1135t3025r1321b3088],
13	CIS	NN	O	ci	nn	15	SENT_220	[p13l1135t3025r1321b3088],
14	”	NN	O	”	nn	15	SENT_220	[p13l1135t3025r1321b3088],
15	trials	NNS	O	trial	prep_in	9	SENT_220	[p13l1342t3025r1513b3088],
16	should	MD	O	should	aux	19	SENT_220	[p13l1536t3025r1766b3088],
17	actually	RB	O	actually	advmod	19	SENT_220	[p13l1787t3025r2055b3109],
18	be	VB	O	be	auxpass	19	SENT_220	[p13l2070t3025r2149b3088],
19	classiﬁed	VBN	O	classiﬁed	ccomp	6	SENT_220	[p13l9t3128r317b3191],
20	as	IN	O	as	_	0	SENT_220	[p13l340t3151r404b3191],
21	SAMS	NNP	PERSON	SAMS	prep_as	19	SENT_220	[p13l428t3132r642b3191],
22	(	CD	NUMBER	(	num	21	SENT_220	[p13l669t3129r808b3211],
23	per	IN	O	per	_	0	SENT_220	[p13l669t3129r808b3211],
24	our	PRP$	O	we	poss	26	SENT_220	[p13l830t3151r949b3191],
25	terminology	NN	O	terminology	nn	26	SENT_220	[p13l969t3128r1421b3212],
26	)	NN	O	)	prep_per	21	SENT_220	[p13l969t3128r1421b3212],
27	after	IN	O	after	_	0	SENT_220	[p13l1449t3128r1601b3191],
28	the	DT	O	the	det	30	SENT_220	[p13l1622t3128r1729b3191],
29	2010	CD	DATE	2010	num	30	SENT_220	[p13l1751t3135r1913b3191],
30	modiﬁcations	NNS	O	modiﬁcations	prep_after	19	SENT_220	[p13l1936t3128r2145b3191, p13l8t3230r295b3293],
31	to	TO	O	to	_	0	SENT_220	[p13l317t3242r383b3293],
32	the	DT	O	the	det	34	SENT_220	[p13l404t3230r511b3293],
33	McDonald	NNP	O	McDonald	nn	34	SENT_220	[p13l532t3230r902b3293],
34	criteria	NNS	O	criterion	prep_to	19	SENT_220	[p13l923t3236r1184b3293],
35	.	.	O	.	_	0	SENT_220	[p13l923t3236r1184b3293],

1	Interferon	NN	O	interferon	_	0	SENT_221	[p13l11t3442r435b3515],
2	-	:	O	-	_	0	SENT_221	[p13l11t3442r435b3515],
3	[	NN	O	[	dep	1	SENT_221	[p13l11t3442r435b3515],
4	3	CD	NUMBER	3	num	3	SENT_221	[p13l11t3442r435b3515],

1	Interferon	NN	O	interferon	nn	2	SENT_222	[p14l9t19r437b103],
2	—	NN	O	—	nsubj	13	SENT_222	[p14l9t19r437b103],
3	[	CD	NUMBER	[	num	5	SENT_222	[p14l9t19r437b103],
4	3	CD	NUMBER	3	num	5	SENT_222	[p14l9t19r437b103],
5	(	NN	O	(	dep	2	SENT_222	[p14l464t20r527b95],
6	8	CD	NUMBER	8	number	7	SENT_222	[p14l464t20r527b95],
7	million	CD	NUMBER	million	dep	2	SENT_222	[p14l552t19r804b82],
8	IU	NN	O	iu	nn	9	SENT_222	[p14l828t20r944b95],
9	)	NN	O	)	dep	7	SENT_222	[p14l828t20r944b95],
10	was	VBD	O	be	cop	13	SENT_222	[p14l969t42r1097b82],
11	the	DT	O	the	det	13	SENT_222	[p14l1120t19r1228b82],
12	ﬁrst	NN	O	ﬁrst	nn	13	SENT_222	[p14l1251t19r1386b82],
13	drug	NN	O	drug	_	0	SENT_222	[p14l1408t19r1573b103],
14	approved	VBN	O	approve	partmod	13	SENT_222	[p14l1595t19r1917b102],
15	by	IN	O	by	_	0	SENT_222	[p14l1937t19r2022b103],
16	the	DT	O	the	det	18	SENT_222	[p14l2040t19r2149b82],
17	US	NNP	ORGANIZATION	US	nn	18	SENT_222	[p14l9t126r108b185],
18	Food	NNP	ORGANIZATION	Food	agent	14	SENT_222	[p14l133t122r310b185],
19	and	CC	ORGANIZATION	and	_	0	SENT_222	[p14l332t122r459b185],
20	Drug	NNP	ORGANIZATION	Drug	nn	21	SENT_222	[p14l481t127r662b206],
21	Administration	NNP	ORGANIZATION	Administration	conj_and	18	SENT_222	[p14l682t122r1216b185],
22	speciﬁcally	RB	O	speciﬁcally	advmod	24	SENT_222	[p14l1239t122r1619b206],
23	to	TO	O	to	aux	24	SENT_222	[p14l1637t134r1703b185],
24	treat	VB	O	treat	xcomp	14	SENT_222	[p14l1726t134r1883b185],
25	RRMS	NNP	O	RRMS	dobj	24	SENT_222	[p14l1905t126r2144b185],
26	.	.	O	.	_	0	SENT_222	[p14l1905t126r2144b185],

1	Interferon	NN	O	interferon	nn	2	SENT_223	[p14l9t225r456b309],
2	—	NN	O	—	nsubjpass	41	SENT_223	[p14l9t225r456b309],
3	[	CD	NUMBER	[	number	4	SENT_223	[p14l9t225r456b309],
4	3	CD	NUMBER	3	nsubj	5	SENT_223	[p14l9t225r456b309],
5	requires	VBZ	O	require	rcmod	2	SENT_223	[p14l486t231r778b308],
6	an	DT	O	a	det	7	SENT_223	[p14l808t248r891b288],
7	RRR	NN	O	rrr	dobj	5	SENT_223	[p14l921t230r1086b288],
8	of	IN	O	of	_	0	SENT_223	[p14l1113t225r1190b288],
9	18	CD	PERCENT	18	num	10	SENT_223	[p14l1216t230r1379b297],
10	%	NN	PERCENT	%	prep_of	7	SENT_223	[p14l1216t230r1379b297],
11	,	,	O	,	_	0	SENT_223	[p14l1216t230r1379b297],
12	an	DT	O	a	det	13	SENT_223	[p14l1410t248r1494b288],
13	ARR	NN	ORGANIZATION	arr	dobj	5	SENT_223	[p14l1521t229r1695b288],
14	of	IN	O	of	_	0	SENT_223	[p14l1721t225r1798b288],
15	15	CD	PERCENT	15	num	16	SENT_223	[p14l1824t231r1988b297],
16	%	NN	PERCENT	%	prep_of	13	SENT_223	[p14l1824t231r1988b297],
17	,	,	O	,	_	0	SENT_223	[p14l1824t231r1988b297],
18	and	CC	O	and	_	0	SENT_223	[p14l2019t225r2151b288],
19	an	DT	O	a	det	20	SENT_223	[p14l9t351r92b391],
20	NNT	NN	O	nnt	dobj	5	SENT_223	[p14l118t331r304b391],
21	of	IN	O	of	_	0	SENT_223	[p14l332t328r409b391],
22	7	CD	NUMBER	7	number	24	SENT_223	[p14l428t336r464b391],
23	over	IN	O	over	quantmod	24	SENT_223	[p14l493t351r647b391],
24	3	CD	DURATION	3	num	25	SENT_223	[p14l675t335r709b391],
25	years	NNS	NUMBER	year	prep_of	20	SENT_223	[p14l737t351r921b412],
26	to	TO	O	to	aux	27	SENT_223	[p14l948t340r1016b391],
27	increase	VB	O	increase	xcomp	5	SENT_223	[p14l1045t334r1338b391],
28	the	DT	O	the	det	30	SENT_223	[p14l1364t328r1476b391],
29	relapse-free	JJ	O	relapse-free	amod	30	SENT_223	[p14l1504t328r1924b411],
30	number	NN	O	number	dep	36	SENT_223	[p14l1952t351r2146b391, p14l6t430r121b494],
31	by	IN	O	by	_	0	SENT_223	[p14l141t430r226b515],
32	1	CD	NUMBER	1	prep_by	30	SENT_223	[p14l252t437r277b493],
33	patient	NN	O	patient	dep	36	SENT_223	[p14l305t422r630b514],
34	.66	CD	NUMBER	.66	num	33	SENT_223	[p14l305t422r630b514],
35	The	DT	O	the	det	36	SENT_223	[p14l654t430r780b494],
36	severity	NN	O	severity	dep	27	SENT_223	[p14l805t437r1075b515],
37	of	IN	O	of	_	0	SENT_223	[p14l1095t430r1170b494],
38	relapses	NNS	O	relapse	prep_of	36	SENT_223	[p14l1184t430r1455b514],
39	was	VBD	O	be	auxpass	41	SENT_223	[p14l1478t453r1605b494],
40	also	RB	O	also	advmod	41	SENT_223	[p14l1630t430r1763b494],
41	decreased	VBN	O	decrease	_	0	SENT_223	[p14l1788t430r2146b494],
42	.	.	O	.	_	0	SENT_223	[p14l1788t430r2146b494],

1	Interferon	NN	O	interferon	_	0	SENT_224	[p14l9t534r444b618],
2	-	:	O	-	_	0	SENT_224	[p14l9t534r444b618],
3	[	NN	O	[	dep	1	SENT_224	[p14l9t534r444b618],
4	3	CD	NUMBER	3	num	5	SENT_224	[p14l9t534r444b618],
5	1a	NN	O	1a	nsubj	19	SENT_224	[p14l476t541r548b597],
6	has	VBZ	O	have	rcmod	3	SENT_224	[p14l570t534r685b597],
7	the	DT	O	the	det	11	SENT_224	[p14l709t534r819b597],
8	same	JJ	O	same	amod	11	SENT_224	[p14l844t557r1020b597],
9	amino	NN	O	amino	nn	11	SENT_224	[p14l1046t540r1268b597],
10	acid	NN	O	acid	nn	11	SENT_224	[p14l1295t534r1439b597],
11	sequence	NN	O	sequence	dobj	6	SENT_224	[p14l1462t557r1783b617],
12	as	IN	O	as	_	0	SENT_224	[p14l1809t557r1874b597],
13	natural	JJ	O	natural	amod	14	SENT_224	[p14l1899t534r2151b597],
14	interferon	NN	O	interferon	prep_as	11	SENT_224	[p14l8t637r420b721],
15	-	:	O	-	_	0	SENT_224	[p14l8t637r420b721],
16	[	NN	O	[	dep	11	SENT_224	[p14l8t637r420b721],
17	3	CD	NUMBER	3	num	16	SENT_224	[p14l8t637r420b721],
18	and	CC	O	and	_	0	SENT_224	[p14l442t637r567b700],
19	differs	VBZ	O	differ	conj_and	6	SENT_224	[p14l587t637r796b700],
20	from	IN	O	from	_	0	SENT_224	[p14l816t637r982b700],
21	interferon	NN	O	interferon	prep_from	19	SENT_224	[p14l1002t637r1414b721],
22	-	:	O	-	_	0	SENT_224	[p14l1002t637r1414b721],
23	[	NN	O	[	nn	25	SENT_224	[p14l1002t637r1414b721],
24	3	CD	NUMBER	3	num	25	SENT_224	[p14l1002t637r1414b721],
25	1b	NN	O	1b	dep	1	SENT_224	[p14l1442t637r1515b700],
26	by	IN	O	by	_	0	SENT_224	[p14l1534t637r1617b721],
27	one	CD	NUMBER	one	num	29	SENT_224	[p14l1635t660r1756b700],
28	amino	NN	O	amino	nn	29	SENT_224	[p14l1776t643r1991b700],
29	acid	NN	O	acid	prep_by	25	SENT_224	[p14l2013t637r2151b700],
30	as	RB	O	as	_	0	SENT_224	[p14l9t763r72b803],
31	well	RB	O	well	_	0	SENT_224	[p14l90t740r224b803],
32	as	IN	O	as	_	0	SENT_224	[p14l243t763r306b803],
33	by	IN	O	by	_	0	SENT_224	[p14l324t740r406b824],
34	the	DT	O	the	det	35	SENT_224	[p14l421t740r524b803],
35	presence	NN	O	presence	conj_and	29	SENT_224	[p14l543t762r833b823],
36	of	IN	O	of	_	0	SENT_224	[p14l853t740r926b803],
37	carbohydrate	NN	O	carbohydrate	nn	38	SENT_224	[p14l936t740r1373b824],
38	moieties	NNS	O	moiety	prep_of	35	SENT_224	[p14l1392t746r1688b803],
39	.	.	O	.	_	0	SENT_224	[p14l1392t746r1688b803],

1	Once-weekly	JJ	O	once-weekly	amod	3	SENT_225	[p14l1712t740r2151b824],
2	i.m.	NN	O	i.m.	nn	3	SENT_225	[p14l8t849r135b906],
3	interferon	NN	O	interferon	nsubj	8	SENT_225	[p14l162t843r582b927],
4	-	:	O	-	_	0	SENT_225	[p14l162t843r582b927],
5	[	NN	O	[	nn	7	SENT_225	[p14l162t843r582b927],
6	3	CD	NUMBER	3	num	7	SENT_225	[p14l162t843r582b927],
7	1a	NN	O	1a	dep	3	SENT_225	[p14l614t850r684b906],
8	has	VBZ	O	have	dep	25	SENT_225	[p14l705t843r818b906],
9	a	DT	O	a	det	11	SENT_225	[p14l842t866r877b906],
10	similar	JJ	O	similar	amod	11	SENT_225	[p14l900t843r1139b906],
11	efficacy	NN	O	efficacy	dobj	8	SENT_225	[p14l1162t843r1422b927],
12	as	IN	O	as	_	0	SENT_225	[p14l1442t866r1506b906],
13	interferon	NN	O	interferon	prep_as	11	SENT_225	[p14l1530t843r1951b927],
14	-	:	O	-	_	0	SENT_225	[p14l1530t843r1951b927],
15	[	NN	O	[	nn	17	SENT_225	[p14l1530t843r1951b927],
16	3	CD	NUMBER	3	num	17	SENT_225	[p14l1530t843r1951b927],
17	1b	NN	O	1b	dep	11	SENT_225	[p14l1982t843r2056b906],
18	in	IN	O	in	_	0	SENT_225	[p14l2081t849r2148b905],
19	reducing	VBG	O	reduce	prepc_in	17	SENT_225	[p14l9t946r320b1030],
20	the	DT	O	the	det	21	SENT_225	[p14l342t946r450b1009],
21	frequency	NN	O	frequency	dobj	19	SENT_225	[p14l474t946r830b1030],
22	of	IN	O	of	_	0	SENT_225	[p14l850t946r926b1009],
23	MS	NN	O	m	nn	24	SENT_225	[p14l939t950r1055b1009],
24	relapses	NNS	O	relapse	prep_of	21	SENT_225	[p14l1080t946r1355b1029],
25	(	VBP	O	(	_	0	SENT_225	[p14l1384t946r1575b1023],
26	RRR	NN	O	rrr	dobj	25	SENT_225	[p14l1384t946r1575b1023],
27	16	CD	PERCENT	16	number	28	SENT_225	[p14l1603t952r1763b1018],
28	%	NN	PERCENT	%	amod	26	SENT_225	[p14l1603t952r1763b1018],
29	,	,	O	,	_	0	SENT_225	[p14l1603t952r1763b1018],
30	ARR	NN	O	arr	appos	26	SENT_225	[p14l1788t950r1959b1009],
31	12	CD	PERCENT	12	number	32	SENT_225	[p14l1986t952r2147b1018],
32	%	NN	PERCENT	%	amod	30	SENT_225	[p14l1986t952r2147b1018],
33	,	,	O	,	_	0	SENT_225	[p14l1986t952r2147b1018],
34	NNT	NN	O	nnt	appos	26	SENT_225	[p14l7t1052r190b1112],
35	of	IN	O	of	_	0	SENT_225	[p14l215t1049r290b1112],
36	8	CD	NUMBER	8	number	38	SENT_225	[p14l305t1056r340b1112],
37	over	IN	O	over	quantmod	38	SENT_225	[p14l367t1072r518b1112],
38	2	CD	DURATION	2	num	39	SENT_225	[p14l540t1056r576b1111],
39	years	NNS	NUMBER	year	prep_of	34	SENT_225	[p14l600t1072r779b1133],
40	to	TO	O	to	aux	41	SENT_225	[p14l802t1061r870b1112],
41	increase	VB	O	increase	xcomp	25	SENT_225	[p14l894t1055r1180b1112],
42	the	DT	O	the	det	44	SENT_225	[p14l1202t1049r1312b1112],
43	relapse-free	JJ	O	relapse-free	amod	44	SENT_225	[p14l1335t1049r1744b1132],
44	number	NN	O	number	dobj	41	SENT_225	[p14l1768t1049r2048b1112],
45	by	IN	O	by	_	0	SENT_225	[p14l2068t1049r2154b1133],
46	one	CD	NUMBER	one	num	47	SENT_225	[p14l9t1174r129b1215],
47	patient	NN	O	patient	prep_by	41	SENT_225	[p14l148t1143r492b1235],
48	)	CD	NUMBER	)	number	49	SENT_225	[p14l148t1143r492b1235],
49	.67	CD	NUMBER	.67	num	50	SENT_225	[p14l148t1143r492b1235],
50	Patients	NNS	O	patient	nsubj	25	SENT_225	[p14l512t1157r776b1215],
51	receiving	VBG	O	receive	partmod	50	SENT_225	[p14l796t1158r1103b1236],
52	the	DT	O	the	det	54	SENT_225	[p14l1121t1151r1225b1215],
53	higher	JJR	O	higher	amod	54	SENT_225	[p14l1244t1151r1464b1236],
54	dose	NN	O	dose	dobj	51	SENT_225	[p14l1483t1151r1635b1215],
55	of	IN	O	of	_	0	SENT_225	[p14l1656t1151r1728b1215],
56	interferon	NN	O	interferon	prep_of	54	SENT_225	[p14l1739t1151r2148b1236],
57	.	.	O	.	_	0	SENT_225	[p14l1739t1151r2148b1236],

1	—	NN	O	—	_	0	SENT_226	[p14l1739t1151r2148b1236],
2	.	.	O	.	_	0	SENT_226	[p14l1739t1151r2148b1236],

1	B	NN	O	b	nn	2	SENT_227	[p14l1739t1151r2148b1236],
2	1a	NN	O	1a	dep	7	SENT_227	[p14l15t1262r87b1318],
3	(	CD	NUMBER	(	dep	2	SENT_227	[p14l113t1255r222b1332],
4	44	CD	NUMBER	44	num	5	SENT_227	[p14l113t1255r222b1332],
5	pg	NN	O	pg	dep	7	SENT_227	[p14l249t1278r331b1339],
6	three	CD	NUMBER	three	num	7	SENT_227	[p14l351t1255r531b1318],
7	times	NNS	O	time	dep	13	SENT_227	[p14l554t1261r745b1318],
8	a	DT	DURATION	a	det	9	SENT_227	[p14l771t1278r806b1318],
9	week	NN	DURATION	week	dep	7	SENT_227	[p14l827t1255r1031b1332],
10	)	RB	O	)	advmod	11	SENT_227	[p14l827t1255r1031b1332],
11	seemingly	RB	O	seemingly	dep	13	SENT_227	[p14l1060t1255r1419b1339],
12	do	VB	O	do	dep	13	SENT_227	[p14l1439t1255r1525b1318],
13	better	JJR	O	better	_	0	SENT_227	[p14l1548t1255r1756b1318],
14	than	IN	O	than	mark	24	SENT_227	[p14l1777t1255r1936b1318],
15	those	DT	O	those	nsubj	24	SENT_227	[p14l1959t1255r2147b1318],
16	receiving	VBG	O	receive	partmod	15	SENT_227	[p14l9t1364r318b1442],
17	half	PDT	O	half	dep	20	SENT_227	[p14l335t1358r472b1421],
18	this	DT	O	this	det	20	SENT_227	[p14l482t1358r605b1421],
19	weekly	JJ	SET	weekly	amod	20	SENT_227	[p14l624t1358r860b1442],
20	dose	NN	O	dose	dobj	16	SENT_227	[p14l877t1358r1030b1421],
21	or	CC	O	or	_	0	SENT_227	[p14l1051t1381r1122b1421],
22	the	DT	O	the	det	23	SENT_227	[p14l1141t1358r1246b1421],
23	dosages	NNS	O	dosage	dobj	16	SENT_227	[p14l1267t1358r1527b1442],
24	indicated	VBD	O	indicate	ccomp	13	SENT_227	[p14l1548t1358r1863b1421],
25	in	IN	O	in	_	0	SENT_227	[p14l1882t1364r1948b1420],
26	other	JJ	O	other	prep_in	24	SENT_227	[p14l1969t1358r2149b1421],
27	earlier	JJR	O	earlier	amod	28	SENT_227	[p14l9t1461r226b1524],
28	interferon	NN	O	interferon	dobj	24	SENT_227	[p14l247t1461r665b1545],
29	—	CD	NUMBER	—	num	30	SENT_227	[p14l247t1461r665b1545],
30	[	NN	O	[	nsubj	33	SENT_227	[p14l247t1461r665b1545],
31	3	CD	NUMBER	3	num	32	SENT_227	[p14l247t1461r665b1545],
32	studies	NNS	O	study	dep	30	SENT_227	[p14l690t1461r925b1524],
33	(	VBP	O	(	rcmod	28	SENT_227	[p14l951t1462r1138b1537],
34	RRR	NN	O	rrr	dobj	33	SENT_227	[p14l951t1462r1138b1537],
35	19	CD	PERCENT	19	number	36	SENT_227	[p14l1165t1467r1321b1533],
36	%	NN	PERCENT	%	amod	34	SENT_227	[p14l1165t1467r1321b1533],
37	,	,	O	,	_	0	SENT_227	[p14l1165t1467r1321b1533],
38	ARR	NN	O	arr	conj_and	34	SENT_227	[p14l1344t1465r1511b1524],
39	16	CD	PERCENT	16	number	40	SENT_227	[p14l1538t1466r1694b1533],
40	%	NN	PERCENT	%	amod	38	SENT_227	[p14l1538t1466r1694b1533],
41	,	,	O	,	_	0	SENT_227	[p14l1538t1466r1694b1533],
42	and	CC	O	and	_	0	SENT_227	[p14l1719t1461r1845b1524],
43	an	DT	O	a	det	44	SENT_227	[p14l1868t1484r1947b1524],
44	NNT	NN	O	nnt	conj_and	34	SENT_227	[p14l1969t1464r2148b1524],
45	of	IN	O	of	_	0	SENT_227	[p14l9t1563r85b1627],
46	6	CD	NUMBER	6	number	48	SENT_227	[p14l100t1569r137b1627],
47	over	IN	O	over	quantmod	48	SENT_227	[p14l163t1586r315b1627],
48	2	CD	DURATION	2	num	49	SENT_227	[p14l339t1570r376b1626],
49	years	NNS	NUMBER	year	prep_of	44	SENT_227	[p14l400t1586r580b1648],
50	to	TO	O	to	aux	51	SENT_227	[p14l605t1575r672b1627],
51	increase	VB	O	increase	xcomp	24	SENT_227	[p14l698t1570r986b1627],
52	the	DT	O	the	det	54	SENT_227	[p14l1010t1563r1119b1627],
53	relapse-free	JJ	O	relapse-free	amod	54	SENT_227	[p14l1145t1563r1557b1647],
54	number	NN	O	number	dobj	51	SENT_227	[p14l1582t1563r1863b1627],
55	by	IN	O	by	_	0	SENT_227	[p14l1885t1563r1971b1648],
56	1	CD	NUMBER	1	number	57	SENT_227	[p14l1999t1555r2148b1640],
57	)	CD	NUMBER	)	num	60	SENT_227	[p14l1999t1555r2148b1640],
58	.68	CD	NUMBER	.68	num	60	SENT_227	[p14l1999t1555r2148b1640],
59	Younger	NN	O	younger	nn	60	SENT_227	[p14l7t1672r298b1751],
60	patients	NNS	O	patient	prep_by	51	SENT_227	[p14l319t1673r592b1750],
61	with	IN	O	with	_	0	SENT_227	[p14l614t1667r769b1730],
62	frequent	JJ	O	frequent	amod	63	SENT_227	[p14l791t1667r1086b1750],
63	relapses	NNS	O	relapse	prep_with	51	SENT_227	[p14l1107t1667r1379b1750],
64	and	CC	O	and	_	0	SENT_227	[p14l1403t1667r1531b1730],
65	higher	JJR	O	higher	conj_and	13	SENT_227	[p14l1552t1667r1779b1751],
66	Expanded	VBN	O	expand	ccomp	65	SENT_227	[p14l1800t1667r2151b1750],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_228	[p14l20t1816r139b1837],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	12	SENT_228	[p14l148t1816r373b1837],
3	&	CC	O	&	_	0	SENT_228	[p14l380t1816r600b1837],
4	THERAPEUT	NNP	O	THERAPEUT	nn	6	SENT_228	[p14l380t1816r600b1837],
5	|	CD	NUMBER	|	num	6	SENT_228	[p14l380t1816r600b1837],
6	CS	NNP	O	CS	conj_and	2	SENT_228	[p14l380t1816r600b1837],
7	|	NNP	O	|	nn	8	SENT_228	[p14l610t1814r612b1844],
8	VOLUME	NNP	O	VOLUME	dep	2	SENT_228	[p14l620t1816r728b1837],
9	95	CD	NUMBER	95	num	10	SENT_228	[p14l736t1816r763b1837],
10	NUMBER	NN	O	number	dep	12	SENT_228	[p14l773t1816r881b1837],
11	1	CD	NUMBER	1	num	12	SENT_228	[p14l891t1817r898b1837],
12	|	CD	NUMBER	|	dep	15	SENT_228	[p14l912t1814r914b1844],
13	JANUARY	NNP	DATE	JANUARY	dep	12	SENT_228	[p14l923t1816r1041b1837],
14	2014	CD	DATE	2014	num	15	SENT_228	[p14l1049t1816r1107b1837],
15	37	CD	DATE	37	_	0	SENT_228	[p14l2109t1816r2139b1837],

1	STATE	NN	O	state	nn	2	SENT_229	[p14l21t1959r163b1996],
2	ART	NN	O	art	_	0	SENT_229	[p14l306t1959r399b1996],

1	T	NN	O	t	_	0	SENT_230	[p14l187t2012r282b2036],

1	Prevention	NNP	O	Prevention	_	0	SENT_231	[p14l722t2111r869b2133],
2	of	IN	O	of	_	0	SENT_231	[p14l880t2111r906b2133],
3	relapses	NNS	O	relapse	prep_of	1	SENT_231	[p14l916t2111r1032b2139],
4	in	IN	O	in	_	0	SENT_231	[p14l1043t2111r1065b2133],
5	multiple	JJ	O	multiple	amod	8	SENT_231	[p14l1077t2111r1186b2139],
6	sclerosis	NN	O	sclerosis	nn	8	SENT_231	[p14l1195t2111r1319b2133],
7	(	CD	NUMBER	(	num	8	SENT_231	[p14l1329t2111r1383b2139],
8	tier	NN	O	tier	prep_in	3	SENT_231	[p14l1329t2111r1383b2139],
9	1	CD	NUMBER	1	number	10	SENT_231	[p14l1393t2111r1427b2139],
10	)	CD	NUMBER	)	num	12	SENT_231	[p14l1393t2111r1427b2139],
11	*	CD	NUMBER	*	num	12	SENT_231	[p14l1393t2111r1427b2139],
12	RRMS	NNS	O	rrm	dep	1	SENT_231	[p14l735t2152r817b2174],
13	Q	NNP	O	Q	dep	12	SENT_231	[p14l827t2152r872b2178],
14	?	.	O	?	_	0	SENT_231	[p14l827t2152r872b2178],

1	SAMS	NNP	ORGANIZATION	SAMS	_	0	SENT_232	[p14l880t2152r971b2174],
2	*	CD	NUMBER	*	dep	1	SENT_232	[p14l880t2152r971b2174],
3	with	IN	O	with	_	0	SENT_232	[p14l981t2152r1031b2174],
4	early	JJ	O	early	amod	8	SENT_232	[p14l1042t2152r1104b2180],
5	benign	JJ	O	benign	amod	8	SENT_232	[p14l1114t2152r1198b2180],
6	disease	NN	O	disease	nn	8	SENT_232	[p14l1209t2152r1308b2174],
7	course	NN	O	course	nn	8	SENT_232	[p14l1317t2146r1415b2174],
8	*	NN	O	*	prep_with	2	SENT_232	[p14l1317t2146r1415b2174],

1	High	JJ	O	high	nsubj	2	SENT_233	[p14l458t2370r569b2394],
2	—	NN	O	—	_	0	SENT_233	[p14l458t2370r569b2394],
3	dose	NN	O	dose	nn	4	SENT_233	[p14l458t2370r569b2394],
4	interferon	NN	O	interferon	dobj	2	SENT_233	[p14l578t2369r703b2394],
5	-	:	O	-	_	0	SENT_233	[p14l578t2369r703b2394],
6	[	CD	NUMBER	[	dep	4	SENT_233	[p14l578t2369r703b2394],
7	3	LS	NUMBER	3	dep	6	SENT_233	[p14l578t2369r703b2394],
8	-	:	O	-	_	0	SENT_233	[p14l773t2364r837b2398],
9	:	:	O	:	_	0	SENT_233	[p14l773t2364r837b2398],
10	Continued	VBD	O	continue	rcmod	4	SENT_233	[p14l891t2371r1003b2390],
11	MS	NN	O	m	nn	12	SENT_233	[p14l1013t2371r1048b2390],
12	activity	NN	O	activity	dobj	10	SENT_233	[p14l1056t2371r1160b2395],
13	***	CD	NUMBER	***	number	14	SENT_233	[p14l1056t2371r1160b2395],
14	«	CD	NUMBER	«	dep	12	SENT_233	[p14l1210t2364r1273b2398],
15	:	:	O	:	_	0	SENT_233	[p14l1210t2364r1273b2398],
16	MFII	CD	NUMBER	mfii	num	18	SENT_233	[p14l1448t2372r1490b2391],
17	fo	NN	O	fo	nn	18	SENT_233	[p14l1499t2332r1607b2396],
18	|	NN	O	|	dep	12	SENT_233	[p14l1499t2332r1607b2396],
19	|	CD	NUMBER	|	num	20	SENT_233	[p14l1499t2332r1607b2396],
20	ow	NN	O	ow	dep	18	SENT_233	[p14l1499t2332r1607b2396],
21	—	CD	NUMBER	—	dep	18	SENT_233	[p14l1499t2332r1607b2396],
22	up	RP	O	up	prep	10	SENT_233	[p14l1499t2332r1607b2396],
23	*	CD	NUMBER	*	dep	22	SENT_233	[p14l1499t2332r1607b2396],

1	Interferon	NN	O	interferon	_	0	SENT_234	[p14l192t2697r519b2757],
2	MRI	NNP	O	MRI	nn	3	SENT_234	[p14l1449t2704r1584b2762],
3	follow-upl	NN	O	follow-upl	dep	1	SENT_234	[p14l1613t2684r1954b2778],
4	into	IN	O	into	_	0	SENT_234	[p14l134t2792r578b2852],
5	|	NN	O	|	nn	6	SENT_234	[p14l134t2792r578b2852],
6	erance	NN	O	erance	prep_into	3	SENT_234	[p14l134t2792r578b2852],
7	**	CD	NUMBER	**	num	6	SENT_234	[p14l134t2792r578b2852],
8	It	PRP	O	it	dep	1	SENT_234	[p14l1521t2824r1623b2913],

1	oE	NN	O	oe	nsubj	4	SENT_235	[p14l415t2913r523b3002],
2	[	CD	NUMBER	[	num	3	SENT_235	[p14l415t2913r523b3002],
3	*	CD	NUMBER	*	dep	1	SENT_235	[p14l415t2913r523b3002],
4	Continued	VBD	O	continue	_	0	SENT_235	[p14l1286t2967r1642b3029],
5	MS	NN	O	m	nn	6	SENT_235	[p14l1674t2967r1784b3029],
6	activity	NN	O	activity	dobj	4	SENT_235	[p14l1812t2968r2142b3043],
7	***	CD	NUMBER	***	num	6	SENT_235	[p14l1812t2968r2142b3043],

1	Low-dose	JJ	O	low-dose	amod	2	SENT_236	[p14l119t3071r454b3131],
2	interferon	NN	O	interferon	_	0	SENT_236	[p14l483t3070r910b3148],
3	-	:	O	-	_	0	SENT_236	[p14l483t3070r910b3148],
4	[	NN	O	[	nn	6	SENT_236	[p14l483t3070r910b3148],
5	3	CD	NUMBER	3	num	6	SENT_236	[p14l483t3070r910b3148],
6	*	NN	O	*	dep	2	SENT_236	[p14l483t3070r910b3148],
7	I	PRP	O	I	dep	6	SENT_236	[p14l1521t3091r1623b3307],

1	C	NN	O	c	nsubj	7	SENT_237	[p14l6t3342r361b3447],
2	°	CD	NUMBER	°	number	3	SENT_237	[p14l6t3342r361b3447],
3	”	CD	NUMBER	”	num	5	SENT_237	[p14l6t3342r361b3447],
4	_	NN	O	_	nn	5	SENT_237	[p14l6t3342r361b3447],
5	ti	NN	O	ti	dep	1	SENT_237	[p14l6t3342r361b3447],
6	””	CD	NUMBER	””	dep	1	SENT_237	[p14l6t3342r361b3447],
7	ed	VBD	O	ed	_	0	SENT_237	[p14l6t3342r361b3447],
8	l	NN	O	l	nsubj	14	SENT_237	[p14l391t3342r716b3403],
9	”	CD	NUMBER	”	num	8	SENT_237	[p14l391t3342r716b3403],
10	te	NN	O	te	nn	13	SENT_237	[p14l391t3342r716b3403],
11	”	CD	NUMBER	”	num	13	SENT_237	[p14l391t3342r716b3403],
12	er	NN	O	er	nn	13	SENT_237	[p14l391t3342r716b3403],
13	°	NN	O	°	dep	8	SENT_237	[p14l391t3342r716b3403],
14	“	CD	NUMBER	“	xcomp	7	SENT_237	[p14l391t3342r716b3403],
15	Neutralizing	VBG	O	neutralize	partmod	14	SENT_237	[p14l1024t3372r1435b3449],
16	antibodies	NNS	O	antibody	dobj	15	SENT_237	[p14l1464t3372r1822b3433],
17	(	CD	NUMBER	(	num	16	SENT_237	[p14l1850t3372r1940b3447],
18	+	CC	O	+	_	0	SENT_237	[p14l1850t3372r1940b3447],
19	)	CD	NUMBER	)	dobj	15	SENT_237	[p14l1850t3372r1940b3447],

1	intolerance	NN	O	intolerance	_	0	SENT_238	[p14l141t3439r584b3498],
2	”	SYM	O	”	dep	1	SENT_238	[p14l141t3439r584b3498],

1	G	NN	O	g	nn	4	SENT_239	[p14l119t3729r488b3791],
2	|	NNS	O	|	nn	4	SENT_239	[p14l119t3729r488b3791],
3	atiramer	NN	O	atiramer	nn	4	SENT_239	[p14l119t3729r488b3791],
4	acetate	NN	O	acetate	_	0	SENT_239	[p14l512t3735r767b3791],
5	Oi	NNP	O	Oi	nsubj	6	SENT_239	[p14l791t3729r916b3799],
6	Continued	VBD	O	continue	rcmod	4	SENT_239	[p14l1296t3713r1652b3774],
7	MS	NN	O	m	nn	8	SENT_239	[p14l1683t3713r1794b3774],
8	activity	NN	O	activity	dobj	6	SENT_239	[p14l1822t3714r2153b3790],
9	***	CD	NUMBER	***	num	8	SENT_239	[p14l1822t3714r2153b3790],

1	dimethyl	JJ	O	dimethyl	amod	2	SENT_240	[p15l201t20r488b96],
2	fumarate	NN	O	fumarate	_	0	SENT_240	[p15l515t20r826b80],

1	MRI	NNP	O	MRI	_	0	SENT_241	[p15l1449t293r1583b351],
2	follow-upl	NN	O	follow-upl	dep	1	SENT_241	[p15l1613t273r1954b368],

1	A	DT	O	a	det	10	SENT_242	[p15l252t1329r294b1390],
2	,	,	O	,	_	0	SENT_242	[p15l252t1329r294b1390],
3	Monthly	JJ	SET	monthly	amod	4	SENT_242	[p15l431t1310r725b1392],
4	IVMP	NN	O	ivmp	nn	7	SENT_242	[p15l756t1310r955b1373],
5	complementary	JJ	O	complementary	amod	7	SENT_242	[p15l983t1310r1568b1392],
6	infusion	NN	O	infusion	nn	7	SENT_242	[p15l455t1412r739b1477],
7	therapy	NN	O	therapy	npadvmod	8	SENT_242	[p15l768t1412r1049b1494],
8	for	IN	O	for	dep	10	SENT_242	[p15l1074t1412r1170b1477],
9	6	CD	DURATION	6	pobj	8	SENT_242	[p15l1197t1414r1238b1478],
10	months	NNS	NUMBER	month	nsubj	11	SENT_242	[p15l1270t1412r1543b1477],
11	i	LS	O	i	_	0	SENT_242	[p15l842t1541r958b1644],
12	,	,	O	,	_	0	SENT_242	[p15l842t1541r958b1644],

1	Continued	VBN	O	continue	_	0	SENT_243	[p15l438t1686r821b1753],
2	lVlS	NN	O	lvl	nn	3	SENT_243	[p15l855t1645r973b1753],
3	activity	NN	O	activity	dobj	1	SENT_243	[p15l1004t1688r1358b1768],
4	***	CD	NUMBER	***	num	3	SENT_243	[p15l1004t1688r1358b1768],

1	Options	NNS	O	option	_	0	SENT_244	[p15l169t1561r251b1878],

1	V	NN	O	v	dep	2	SENT_245	[p15l261t1985r294b2025],
2	Switch	VB	O	switch	_	0	SENT_245	[p15l494t1983r735b2047],
3	to	TO	O	to	aux	4	SENT_245	[p15l766t1989r833b2047],
4	tier	VB	O	tier	xcomp	2	SENT_245	[p15l862t1984r978b2047],
5	2	CD	NUMBER	2	num	6	SENT_245	[p15l1006t1986r1045b2045],
6	medications	NNS	O	medication	dobj	4	SENT_245	[p15l1079t1984r1527b2047],

1	Patient	NN	O	patient	nsubj	5	SENT_246	[p15l482t2317r736b2382],
2	259	CD	NUMBER	259	num	1	SENT_246	[p15l763t2319r900b2382],
3	AND	CC	O	and	_	0	SENT_246	[p15l928t2317r1103b2381],
4	m	NN	O	m	conj_and	1	SENT_246	[p15l1130t2317r1242b2391],
5	continued	VBD	O	continue	_	0	SENT_246	[p15l1267t2317r1630b2382],
6	MS	NN	O	m	dobj	5	SENT_246	[p15l1664t2317r1784b2382],

1	Q	NNP	O	Q	_	0	SENT_247	[p15l198t2394r295b2510],
2	activity	NN	O	activity	dep	1	SENT_247	[p15l607t2420r961b2500],
3	***	CD	NUMBER	***	num	2	SENT_247	[p15l607t2420r961b2500],
4	in	IN	O	in	_	0	SENT_247	[p15l993t2435r1050b2483],
5	the	DT	DURATION	the	det	8	SENT_247	[p15l1079t2420r1195b2485],
6	last	JJ	DATE	last	amod	8	SENT_247	[p15l1226t2420r1353b2485],
7	5	CD	DATE	5	num	8	SENT_247	[p15l1380t2423r1423b2485],
8	years	NNS	DATE	year	prep_in	2	SENT_247	[p15l1450t2435r1654b2502],

1	Consider	VB	O	consider	_	0	SENT_248	[p15l759t2563r1125b2629],
2	*	CD	NUMBER	*	dobj	1	SENT_248	[p15l1156t2551r1271b2654],

1	No	DT	O	no	det	4	SENT_249	[p15l614t2711r713b2773],
2	further	RBR	O	further	advmod	3	SENT_249	[p15l742t2711r992b2773],
3	prophylactic	JJ	O	prophylactic	amod	4	SENT_249	[p15l1021t2711r1467b2791],
4	treatment	NN	O	treatment	_	0	SENT_249	[p15l1495t2716r1852b2773],

1	Figure	NNP	O	Figure	nsubj	57	SENT_250	[p15l24t2888r114b2918],
2	4	CD	NUMBER	4	num	1	SENT_250	[p15l121t2889r138b2911],
3	Algorithmic	JJ	O	algorithmic	amod	4	SENT_250	[p15l161t2887r318b2918],
4	approach	NN	O	approach	nsubj	43	SENT_250	[p15l325t2887r450b2918],
5	to	TO	O	to	_	0	SENT_250	[p15l458t2891r485b2911],
6	a	DT	O	a	det	33	SENT_250	[p15l493t2894r506b2911],
7	tiered	JJ	O	tiered	amod	33	SENT_250	[p15l514t2887r598b2915],
8	,	,	O	,	_	0	SENT_250	[p15l514t2887r598b2915],
9	re	VB	O	re	dep	7	SENT_250	[p15l607t2887r857b2918],
10	|	RB	O	|	advmod	11	SENT_250	[p15l607t2887r857b2918],
11	apse	JJ	O	apse	amod	12	SENT_250	[p15l607t2887r857b2918],
12	—	NN	O	—	nsubj	25	SENT_250	[p15l607t2887r857b2918],
13	preventing	VBG	O	prevent	partmod	12	SENT_250	[p15l607t2887r857b2918],
14	strategy	NN	O	strategy	dobj	13	SENT_250	[p15l867t2891r974b2918],
15	in	IN	O	in	_	0	SENT_250	[p15l982t2888r1004b2911],
16	MS.	NNP	O	MS.	nn	18	SENT_250	[p15l1013t2888r1131b2911],
17	Tier1	NN	O	tier1	nn	18	SENT_250	[p15l1013t2888r1131b2911],
18	medications	NNS	O	medication	prep_in	14	SENT_250	[p15l1145t2887r1307b2911],
19	have	VBP	O	have	aux	25	SENT_250	[p15l1316t2887r1377b2911],
20	a	DT	O	a	det	23	SENT_250	[p15l1385t2894r1398b2911],
21	long	JJ	O	long	amod	23	SENT_250	[p15l1408t2887r1546b2918],
22	—	NN	O	—	nn	23	SENT_250	[p15l1408t2887r1546b2918],
23	term	NN	O	term	dobj	25	SENT_250	[p15l1408t2887r1546b2918],
24	,	,	O	,	_	0	SENT_250	[p15l1408t2887r1546b2918],
25	established	VBN	O	establish	ccomp	9	SENT_250	[p15l1554t2887r1704b2911],
26	safety	NN	O	safety	nn	27	SENT_250	[p15l1713t2887r1791b2918],
27	record	NN	O	record	dobj	25	SENT_250	[p15l1800t2887r1882b2911],
28	in	IN	O	in	_	0	SENT_250	[p15l1892t2888r1913b2911],
29	MS.	NNP	O	MS.	prep_in	27	SENT_250	[p15l1923t2888r1969b2911],
30	However	RB	O	however	advmod	25	SENT_250	[p15l1978t2888r2099b2915],
31	,	,	O	,	_	0	SENT_250	[p15l1978t2888r2099b2915],
32	dimethyl	JJ	O	dimethyl	amod	33	SENT_250	[p15l23t2928r139b2959],
33	fumarate	NN	O	fumarate	prep_to	4	SENT_250	[p15l148t2928r268b2952],
34	or	CC	O	or	_	0	SENT_250	[p15l276t2935r303b2952],
35	BG	NN	O	bg	nn	36	SENT_250	[p15l312t2929r368b2952],
36	—	NN	O	—	prep_to	4	SENT_250	[p15l312t2929r368b2952],
37	1	CD	NUMBER	1	number	38	SENT_250	[p15l312t2929r368b2952],
38	2	CD	DATE	2	dep	36	SENT_250	[p15l375t2930r389b2952],
39	may	MD	DATE	may	aux	43	SENT_250	[p15l399t2935r454b2959],
40	be	VB	O	be	cop	43	SENT_250	[p15l462t2928r494b2952],
41	an	DT	O	a	det	43	SENT_250	[p15l501t2935r532b2952],
42	oral	JJ	O	oral	amod	43	SENT_250	[p15l541t2928r589b2952],
43	alternative	NN	O	alternative	rcmod	1	SENT_250	[p15l598t2928r739b2952],
44	to	TO	O	to	_	0	SENT_250	[p15l746t2932r773b2952],
45	established	VBN	O	establish	amod	47	SENT_250	[p15l781t2928r931b2952],
46	injectable	JJ	O	injectable	amod	47	SENT_250	[p15l941t2928r1070b2959],
47	tier	NN	O	tier	prep_to	43	SENT_250	[p15l1077t2930r1122b2952],
48	1	CD	NUMBER	1	num	49	SENT_250	[p15l1131t2930r1138b2952],
49	medications	NNS	O	medication	npadvmod	50	SENT_250	[p15l1152t2928r1314b2952],
50	as	RB	O	as	advmod	57	SENT_250	[p15l1322t2935r1348b2952],
51	long	RB	O	long	advmod	57	SENT_250	[p15l1357t2928r1488b2959],
52	—	JJ	O	—	amod	55	SENT_250	[p15l1357t2928r1488b2959],
53	term	NN	O	term	nn	55	SENT_250	[p15l1357t2928r1488b2959],
54	safety	NN	O	safety	nn	55	SENT_250	[p15l1497t2928r1576b2959],
55	data	NNS	O	datum	nsubj	57	SENT_250	[p15l1583t2928r1639b2952],
56	become	VBP	O	become	cop	57	SENT_250	[p15l1649t2928r1756b2952],
57	available	JJ	O	available	_	0	SENT_250	[p15l1764t2928r1886b2952],
58	.	.	O	.	_	0	SENT_250	[p15l1764t2928r1886b2952],

1	This	DT	O	this	det	3	SENT_251	[p15l1892t2928r1945b2952],
2	sample	NN	O	sample	nn	3	SENT_251	[p15l1953t2928r2048b2958],
3	approach	NN	O	approach	nsubjpass	6	SENT_251	[p15l23t2969r148b2999],
4	can	MD	O	can	aux	6	SENT_251	[p15l157t2976r202b2993],
5	be	VB	O	be	auxpass	6	SENT_251	[p15l212t2969r243b2993],
6	modified	VBN	O	modify	_	0	SENT_251	[p15l252t2969r370b2993],
7	to	TO	O	to	_	0	SENT_251	[p15l378t2973r405b2993],
8	the	DT	O	the	det	10	SENT_251	[p15l412t2969r456b2993],
9	individual	JJ	O	individual	amod	10	SENT_251	[p15l464t2969r593b2993],
10	needs	NNS	O	need	prep_to	6	SENT_251	[p15l603t2969r681b2993],
11	ofthe	VBP	O	ofthe	dep	6	SENT_251	[p15l689t2969r765b2993],
12	patient	NN	O	patient	dobj	11	SENT_251	[p15l774t2970r868b2999],
13	and	CC	O	and	_	0	SENT_251	[p15l875t2969r924b2993],
14	as	IN	O	as	mark	18	SENT_251	[p15l933t2976r959b2993],
15	more	JJR	O	more	amod	16	SENT_251	[p15l968t2976r1036b2993],
16	strategies	NNS	O	strategy	nsubj	18	SENT_251	[p15l1044t2970r1171b2999],
17	become	VBP	O	become	cop	18	SENT_251	[p15l1181t2969r1287b2993],
18	available	JJ	O	available	conj_and	11	SENT_251	[p15l1295t2969r1412b2993],
19	in	IN	O	in	_	0	SENT_251	[p15l1420t2970r1442b2993],
20	the	DT	DATE	the	det	21	SENT_251	[p15l1450t2969r1494b2993],
21	future	NN	DATE	future	prep_in	18	SENT_251	[p15l1501t2969r1588b2993],
22	.	.	O	.	_	0	SENT_251	[p15l1501t2969r1588b2993],

1	*	NN	O	*	npadvmod	12	SENT_252	[p15l1595t2970r1650b2993],
2	For	IN	O	for	_	0	SENT_252	[p15l1595t2970r1650b2993],
3	example	NN	O	example	prep_for	12	SENT_252	[p15l1658t2969r1777b2999],
4	,	,	O	,	_	0	SENT_252	[p15l1658t2969r1777b2999],
5	in	IN	O	in	_	0	SENT_252	[p15l1786t2970r1808b2993],
6	an	DT	O	a	det	8	SENT_252	[p15l1816t2976r1847b2993],
7	alternative	JJ	O	alternative	amod	8	SENT_252	[p15l1856t2969r1997b2993],
8	protocol	NN	O	protocol	prep_in	12	SENT_252	[p15l2006t2969r2123b2999],
9	,	,	O	,	_	0	SENT_252	[p15l2006t2969r2123b2999],
10	one	CD	NUMBER	one	nsubj	12	SENT_252	[p15l23t3017r73b3034],
11	could	MD	O	could	aux	12	SENT_252	[p15l81t3010r153b3034],
12	skip	VB	O	skip	_	0	SENT_252	[p15l162t3010r214b3041],
13	|	CD	NUMBER	|	num	14	SENT_252	[p15l223t3010r344b3034],
14	ow	NN	O	ow	nsubj	17	SENT_252	[p15l223t3010r344b3034],
15	—	CD	NUMBER	—	num	17	SENT_252	[p15l223t3010r344b3034],
16	dose	NN	O	dose	nn	17	SENT_252	[p15l223t3010r344b3034],
17	interferon	NN	O	interferon	xcomp	12	SENT_252	[p15l353t3010r512b3041],
18	.	.	O	.	_	0	SENT_252	[p15l353t3010r512b3041],

1	—	NN	O	—	_	0	SENT_253	[p15l353t3010r512b3041],
2	.	.	O	.	_	0	SENT_253	[p15l353t3010r512b3041],

1	B	NN	O	b	nn	2	SENT_254	[p15l353t3010r512b3041],
2	option	NN	O	option	_	0	SENT_254	[p15l520t3011r607b3041],
3	and	CC	O	and	_	0	SENT_254	[p15l615t3010r664b3034],
4	go	VB	O	go	conj_and	2	SENT_254	[p15l673t3017r707b3041],
5	to	TO	O	to	_	0	SENT_254	[p15l714t3014r741b3034],
6	glatiramer	NN	O	glatiramer	nn	7	SENT_254	[p15l749t3010r886b3041],
7	acetate	NN	O	acetate	prep_to	4	SENT_254	[p15l893t3014r990b3034],
8	or	CC	O	or	_	0	SENT_254	[p15l998t3017r1025b3034],
9	dimethyl	JJ	O	dimethyl	amod	10	SENT_254	[p15l1032t3010r1148b3041],
10	fumarate	NN	O	fumarate	prep_to	4	SENT_254	[p15l1156t3010r1283b3034],
11	.	.	O	.	_	0	SENT_254	[p15l1156t3010r1283b3034],

1	Please	VB	O	please	dep	2	SENT_255	[p15l1292t3010r1374b3034],
2	refer	VB	O	refer	_	0	SENT_255	[p15l1383t3010r1443b3034],
3	to	TO	O	to	_	0	SENT_255	[p15l1449t3014r1476b3034],
4	the	DT	O	the	det	5	SENT_255	[p15l1483t3010r1527b3034],
5	text	NN	O	text	prep_to	2	SENT_255	[p15l1534t3014r1586b3034],
6	and	CC	O	and	_	0	SENT_255	[p15l1593t3010r1642b3034],
7	Figure	NN	O	figure	conj_and	5	SENT_255	[p15l1652t3011r1741b3041],
8	2	CD	NUMBER	2	num	7	SENT_255	[p15l1748t3012r1764b3034],
9	for	IN	O	for	_	0	SENT_255	[p15l1771t3010r1808b3034],
10	the	DT	O	the	det	11	SENT_255	[p15l1814t3010r1858b3034],
11	deﬁnition	NN	O	deﬁnition	prep_for	2	SENT_255	[p15l1866t3010r1993b3034],
12	of	IN	O	of	_	0	SENT_255	[p15l2002t3010r2029b3034],
13	re	NN	O	re	nn	14	SENT_255	[p15l24t3051r285b3082],
14	|	NN	O	|	prep_of	11	SENT_255	[p15l24t3051r285b3082],
15	apsing	VBG	O	apse	partmod	14	SENT_255	[p15l24t3051r285b3082],
16	—	CD	NUMBER	—	dep	15	SENT_255	[p15l24t3051r285b3082],
17	remitting	VBG	O	remit	partmod	16	SENT_255	[p15l24t3051r285b3082],
18	MS	NN	O	m	nn	21	SENT_255	[p15l295t3052r334b3075],
19	(	CD	NUMBER	(	num	21	SENT_255	[p15l343t3052r434b3079],
20	RRMS	NN	O	rrm	nn	21	SENT_255	[p15l343t3052r434b3079],
21	)	NN	O	)	dobj	17	SENT_255	[p15l343t3052r434b3079],
22	and	CC	O	and	_	0	SENT_255	[p15l443t3051r491b3075],
23	sing	VB	O	sing	conj_and	21	SENT_255	[p15l500t3051r672b3082],
24	|	RB	O	|	advmod	15	SENT_255	[p15l500t3051r672b3082],
25	e	SYM	O	e	dep	27	SENT_255	[p15l500t3051r672b3082],
26	—	CD	NUMBER	—	num	27	SENT_255	[p15l500t3051r672b3082],
27	attack	NN	O	attack	dep	31	SENT_255	[p15l500t3051r672b3082],
28	MS	NN	O	m	nn	30	SENT_255	[p15l679t3052r718b3075],
29	(	CD	NUMBER	(	num	30	SENT_255	[p15l727t3052r826b3079],
30	SAMS	NNP	O	SAMS	dep	27	SENT_255	[p15l727t3052r826b3079],
31	)	CD	NUMBER	)	dep	15	SENT_255	[p15l727t3052r826b3079],
32	.	.	O	.	_	0	SENT_255	[p15l727t3052r826b3079],

1	**	NN	O	**	nn	4	SENT_256	[p15l834t3051r1010b3075],
2	|	CD	NUMBER	|	num	4	SENT_256	[p15l834t3051r1010b3075],
3	nto	NN	O	nto	nn	4	SENT_256	[p15l834t3051r1010b3075],
4	|	NN	O	|	nsubj	6	SENT_256	[p15l834t3051r1010b3075],
5	erance	NN	O	erance	dep	4	SENT_256	[p15l834t3051r1010b3075],
6	attributed	VBD	O	attribute	_	0	SENT_256	[p15l1018t3051r1151b3075],
7	to	TO	O	to	_	0	SENT_256	[p15l1159t3055r1186b3075],
8	interferon	NN	O	interferon	nn	9	SENT_256	[p15l1194t3051r1325b3075],
9	use	NN	O	use	prep_to	6	SENT_256	[p15l1335t3058r1378b3075],
10	impacting	VBG	O	impact	ccomp	6	SENT_256	[p15l1387t3053r1520b3082],
11	quality	NN	O	quality	dobj	10	SENT_256	[p15l1529t3051r1621b3082],
12	of	IN	O	of	_	0	SENT_256	[p15l1628t3051r1655b3075],
13	life	NN	O	life	prep_of	11	SENT_256	[p15l1662t3051r1705b3079],
14	,	,	O	,	_	0	SENT_256	[p15l1662t3051r1705b3079],
15	increasing	VBG	O	increase	conj_or	10	SENT_256	[p15l1714t3053r1847b3082],
16	hepatoxicity	NN	O	hepatoxicity	dobj	15	SENT_256	[p15l1858t3051r2025b3082],
17	,	,	O	,	_	0	SENT_256	[p15l1858t3051r2025b3082],
18	or	CC	O	or	_	0	SENT_256	[p15l2033t3058r2060b3075],
19	leading	VBG	O	lead	ccomp	6	SENT_256	[p15l24t3092r121b3123],
20	to	TO	O	to	_	0	SENT_256	[p15l129t3096r156b3116],
21	mood	NN	O	mood	nn	22	SENT_256	[p15l165t3092r241b3116],
22	disorder	NN	O	disorder	prep_to	19	SENT_256	[p15l250t3092r364b3116],
23	.	.	O	.	_	0	SENT_256	[p15l250t3092r364b3116],

1	***	CD	NUMBER	***	nsubj	4	SENT_257	[p15l372t3093r453b3116],
2	We	PRP	O	we	nsubj	3	SENT_257	[p15l372t3093r453b3116],
3	deﬁne	VBP	O	deﬁne	rcmod	1	SENT_257	[p15l461t3092r544b3116],
4	continued	VBN	O	continue	_	0	SENT_257	[p15l552t3092r686b3116],
5	MS	NN	O	m	nn	6	SENT_257	[p15l696t3093r735b3116],
6	activity	NN	O	activity	dobj	4	SENT_257	[p15l743t3093r839b3123],
7	as	IN	O	as	_	0	SENT_257	[p15l846t3099r873b3116],
8	a	DT	O	a	det	9	SENT_257	[p15l881t3099r894b3116],
9	relapse	NN	O	relapse	prep_as	4	SENT_257	[p15l903t3092r997b3123],
10	and	CC	O	and	_	0	SENT_257	[p15l1005t3092r1053b3116],
11	22	CD	NUMBER	22	num	15	SENT_257	[p15l1062t3094r1094b3116],
12	new	JJ	O	new	amod	15	SENT_257	[p15l1104t3099r1159b3116],
13	MS-related	JJ	O	ms-related	amod	15	SENT_257	[p15l1167t3092r1309b3116],
14	lesion	NN	O	lesion	nn	15	SENT_257	[p15l1319t3092r1394b3116],
15	formations	NNS	O	formation	prep_as	4	SENT_257	[p15l1403t3092r1547b3116],
16	in	IN	O	in	_	0	SENT_257	[p15l1556t3093r1578b3116],
17	the	DT	O	the	det	18	SENT_257	[p15l1586t3092r1629b3116],
18	MRI	NNP	O	MRI	prep_in	4	SENT_257	[p15l1638t3093r1685b3116],
19	within	IN	O	within	_	0	SENT_257	[p15l1694t3092r1776b3116],
20	the	DT	O	the	det	23	SENT_257	[p15l1785t3092r1828b3116],
21	last	JJ	O	last	amod	23	SENT_257	[p15l1837t3092r1881b3116],
22	follow-up	JJ	O	follow-up	amod	23	SENT_257	[p15l1887t3092r2015b3122],
23	period	NN	O	period	prep_within	18	SENT_257	[p15l2024t3092r2108b3122],
24	or	CC	O	or	_	0	SENT_257	[p15l23t3140r50b3157],
25	23	CD	NUMBER	23	num	28	SENT_257	[p15l57t3135r89b3157],
26	new	JJ	O	new	amod	28	SENT_257	[p15l99t3140r154b3157],
27	lesion	NN	O	lesion	nn	28	SENT_257	[p15l162t3133r238b3157],
28	formations	NNS	O	formation	prep_in	4	SENT_257	[p15l246t3133r391b3157],
29	per	IN	O	per	_	0	SENT_257	[p15l400t3140r442b3164],
30	year	NN	DURATION	year	prep_per	28	SENT_257	[p15l449t3140r509b3164],
31	,	,	O	,	_	0	SENT_257	[p15l449t3140r509b3164],
32	especially	RB	O	especially	advmod	4	SENT_257	[p15l517t3133r647b3164],
33	with	IN	O	with	_	0	SENT_257	[p15l654t3133r711b3157],
34	gadolinium	NN	O	gadolinium	nn	35	SENT_257	[p15l720t3133r871b3164],
35	enhancement	NN	O	enhancement	prep_with	4	SENT_257	[p15l880t3133r1072b3161],
36	,	,	O	,	_	0	SENT_257	[p15l880t3133r1072b3161],
37	even	RB	O	even	amod	43	SENT_257	[p15l1080t3140r1142b3157],
38	in	IN	O	in	_	0	SENT_257	[p15l1152t3134r1173b3157],
39	the	DT	O	the	det	41	SENT_257	[p15l1182t3133r1225b3157],
40	absence	NN	O	absence	nn	41	SENT_257	[p15l1233t3133r1342b3157],
41	ofany	NN	O	ofany	prep_in	37	SENT_257	[p15l1350t3133r1430b3164],
42	new	JJ	O	new	amod	43	SENT_257	[p15l1438t3140r1494b3157],
43	relapse	NN	O	relapse	dep	4	SENT_257	[p15l1502t3133r1602b3164],
44	.	.	O	.	_	0	SENT_257	[p15l1502t3133r1602b3164],

1	Either	CC	O	either	dep	3	SENT_258	[p15l1611t3133r1687b3157],
2	situation	NN	O	situation	nsubj	3	SENT_258	[p15l1694t3134r1808b3157],
3	justifies	VBZ	O	justify	_	0	SENT_258	[p15l1815t3133r1917b3164],
4	a	DT	O	a	det	5	SENT_258	[p15l1925t3140r1938b3157],
5	change	NN	O	change	dobj	3	SENT_258	[p15l1947t3133r2045b3164],
6	in	IN	O	in	_	0	SENT_258	[p15l2053t3134r2075b3157],
7	management	NN	O	management	nn	8	SENT_258	[p15l24t3178r203b3205],
8	strategy	NN	O	strategy	prep_in	5	SENT_258	[p15l211t3178r323b3205],
9	.	.	O	.	_	0	SENT_258	[p15l211t3178r323b3205],

1	*	NN	O	*	nn	2	SENT_259	[p15l330t3170r390b3198],
2	MR	NN	O	mr	_	0	SENT_259	[p15l330t3170r390b3198],
3	|	CD	NUMBER	|	num	5	SENT_259	[p15l330t3170r390b3198],
4	(	NN	O	(	nn	5	SENT_259	[p15l400t3174r475b3202],
5	brain	NN	O	brain	dep	2	SENT_259	[p15l400t3174r475b3202],
6	and	CC	O	and	_	0	SENT_259	[p15l484t3174r533b3198],
7	cervical	JJ	O	cervical	amod	9	SENT_259	[p15l542t3174r641b3198],
8	spinal	JJ	O	spinal	amod	9	SENT_259	[p15l650t3174r726b3204],
9	cord	NN	O	cord	conj_and	2	SENT_259	[p15l735t3174r802b3202],
10	)	CD	NUMBER	)	dep	9	SENT_259	[p15l735t3174r802b3202],
11	follow-up	NN	O	follow-up	amod	2	SENT_259	[p15l809t3174r937b3204],
12	at	IN	O	at	_	0	SENT_259	[p15l945t3178r969b3198],
13	6	CD	DURATION	6	num	14	SENT_259	[p15l977t3176r992b3198],
14	months	NNS	NUMBER	month	prep_at	11	SENT_259	[p15l1001t3174r1107b3202],
15	,	,	O	,	_	0	SENT_259	[p15l1001t3174r1107b3202],
16	12	CD	DURATION	12	num	17	SENT_259	[p15l1118t3176r1146b3198],
17	months	NNS	NUMBER	month	conj_and	14	SENT_259	[p15l1155t3174r1262b3202],
18	,	,	O	,	_	0	SENT_259	[p15l1155t3174r1262b3202],
19	36	CD	DURATION	36	num	20	SENT_259	[p15l1271t3176r1301b3198],
20	months	NNS	NUMBER	month	conj_and	14	SENT_259	[p15l1310t3174r1417b3202],
21	,	,	O	,	_	0	SENT_259	[p15l1310t3174r1417b3202],
22	60	CD	DURATION	60	num	23	SENT_259	[p15l1425t3176r1456b3198],
23	months	NNS	NUMBER	month	conj_and	14	SENT_259	[p15l1465t3174r1572b3202],
24	,	,	O	,	_	0	SENT_259	[p15l1465t3174r1572b3202],
25	and	CC	O	and	_	0	SENT_259	[p15l1580t3174r1629b3198],
26	as	IN	O	as	conj_and	14	SENT_259	[p15l1637t3181r1664b3198],
27	needed	VBN	O	need	partmod	2	SENT_259	[p15l1673t3174r1771b3198],
28	thereafter	RB	O	thereafter	dep	27	SENT_259	[p15l1780t3174r1912b3198],
29	(	RB	O	(	acomp	27	SENT_259	[p15l1920t3174r1980b3205],
30	e.g.	FW	O	e.g.	dep	29	SENT_259	[p15l1920t3174r1980b3205],
31	,	,	O	,	_	0	SENT_259	[p15l1920t3174r1980b3205],
32	after	IN	O	after	_	0	SENT_259	[p15l1987t3174r2049b3198],
33	management	NN	O	management	nn	34	SENT_259	[p15l24t3219r203b3246],
34	changes	NNS	O	change	prep_after	2	SENT_259	[p15l211t3215r337b3246],
35	)	CD	NUMBER	)	dep	34	SENT_259	[p15l211t3215r337b3246],
36	.	.	O	.	_	0	SENT_259	[p15l211t3215r337b3246],

1	*	RB	O	*	advmod	2	SENT_260	[p15l344t3211r434b3239],
2	Based	VBN	O	base	partmod	13	SENT_260	[p15l344t3211r434b3239],
3	on	IN	O	on	_	0	SENT_260	[p15l443t3222r475b3239],
4	natural	JJ	O	natural	amod	6	SENT_260	[p15l485t3215r576b3239],
5	history	NN	O	history	nn	6	SENT_260	[p15l586t3215r677b3246],
6	studies	NNS	O	study	prep_on	2	SENT_260	[p15l684t3215r777b3239],
7	and	CC	O	and	_	0	SENT_260	[p15l785t3215r834b3239],
8	clinical	JJ	O	clinical	amod	10	SENT_260	[p15l843t3215r932b3239],
9	trial	NN	O	trial	nn	10	SENT_260	[p15l940t3215r990b3239],
10	evidence	NN	O	evidence	conj_and	6	SENT_260	[p15l999t3215r1125b3243],
11	,	,	O	,	_	0	SENT_260	[p15l999t3215r1125b3243],
12	we	PRP	O	we	nsubj	13	SENT_260	[p15l1132t3222r1170b3239],
13	define	VBP	O	define	_	0	SENT_260	[p15l1178t3215r1261b3239],
14	early	JJ	O	early	amod	16	SENT_260	[p15l1269t3215r1333b3246],
15	benign	JJ	O	benign	amod	16	SENT_260	[p15l1341t3215r1433b3246],
16	course	NN	O	course	dobj	13	SENT_260	[p15l1442t3222r1529b3239],
17	by	IN	O	by	_	0	SENT_260	[p15l1538t3215r1569b3246],
18	the	DT	O	the	det	20	SENT_260	[p15l1575t3215r1619b3239],
19	following	VBG	O	follow	amod	20	SENT_260	[p15l1626t3215r1750b3246],
20	criteria	NNS	O	criterion	prep_by	13	SENT_260	[p15l1759t3216r1856b3239],
21	:	:	O	:	_	0	SENT_260	[p15l1759t3216r1856b3239],
22	(	CD	NUMBER	(	dep	25	SENT_260	[p15l1865t3216r1887b3243],
23	i	FW	O	i	nn	25	SENT_260	[p15l1865t3216r1887b3243],
24	)	FW	O	)	nn	25	SENT_260	[p15l1865t3216r1887b3243],
25	RRMS	NNS	O	rrm	conj_and	13	SENT_260	[p15l1897t3216r1970b3239],
26	without	IN	O	without	_	0	SENT_260	[p15l1977t3215r2082b3239],
27	prophylactic	NN	O	prophylactic	nn	28	SENT_260	[p15l24t3256r189b3287],
28	treatment	NN	O	treatment	prep_without	25	SENT_260	[p15l196t3260r336b3284],
29	;	:	O	;	_	0	SENT_260	[p15l196t3260r336b3284],
30	(	CD	NUMBER	(	number	32	SENT_260	[p15l344t3257r374b3284],
31	ii	LS	O	ii	dep	32	SENT_260	[p15l344t3257r374b3284],
32	)	CD	NUMBER	)	num	34	SENT_260	[p15l344t3257r374b3284],
33	significant	JJ	O	significant	amod	34	SENT_260	[p15l383t3256r519b3287],
34	intervals	NNS	O	interval	nsubj	35	SENT_260	[p15l528t3256r639b3280],
35	(	VBP	O	(	conj_and	13	SENT_260	[p15l648t3257r689b3284],
36	25	CD	DURATION	25	num	37	SENT_260	[p15l648t3257r689b3284],
37	years	NNS	NUMBER	year	npadvmod	38	SENT_260	[p15l697t3257r774b3287],
38	)	RB	O	)	advmod	35	SENT_260	[p15l697t3257r774b3287],
39	between	IN	O	between	_	0	SENT_260	[p15l783t3256r898b3281],
40	relapses	NNS	O	relapse	prep_between	38	SENT_260	[p15l908t3256r1021b3287],
41	;	:	O	;	_	0	SENT_260	[p15l908t3256r1021b3287],
42	(	CD	NUMBER	(	dep	44	SENT_260	[p15l1030t3257r1067b3284],
43	iii	LS	O	iii	dep	44	SENT_260	[p15l1030t3257r1067b3284],
44	)	CD	NUMBER	)	advmod	40	SENT_260	[p15l1030t3257r1067b3284],
45	almost	RB	O	almost	advmod	46	SENT_260	[p15l1076t3256r1165b3280],
46	complete	JJ	O	complete	dep	40	SENT_260	[p15l1173t3256r1298b3287],
47	(	NN	O	(	dep	35	SENT_260	[p15l1307t3257r1391b3284],
48	285	CD	PERCENT	285	num	49	SENT_260	[p15l1307t3257r1391b3284],
49	%	NN	PERCENT	%	dobj	47	SENT_260	[p15l1307t3257r1391b3284],
50	by	IN	O	by	_	0	SENT_260	[p15l1400t3256r1431b3287],
51	examination	NN	O	examination	nn	55	SENT_260	[p15l1438t3257r1603b3280],
52	or	CC	O	or	_	0	SENT_260	[p15l1612t3263r1639b3280],
53	history	NN	O	history	nn	55	SENT_260	[p15l1647t3256r1745b3287],
54	)	NN	O	)	nn	55	SENT_260	[p15l1647t3256r1745b3287],
55	recovery	NN	O	recovery	prep_by	47	SENT_260	[p15l1755t3263r1868b3287],
56	from	IN	O	from	_	0	SENT_260	[p15l1874t3256r1936b3280],
57	individual	JJ	O	individual	amod	58	SENT_260	[p15l1946t3256r2075b3280],
58	relapses	NNS	O	relapse	prep_from	47	SENT_260	[p15l24t3297r137b3328],
59	;	:	O	;	_	0	SENT_260	[p15l24t3297r137b3328],
60	and	CC	O	and	_	0	SENT_260	[p15l145t3297r194b3322],
61	(	CD	NUMBER	(	num	62	SENT_260	[p15l203t3298r241b3325],
62	iv	NN	O	iv	dep	72	SENT_260	[p15l203t3298r241b3325],
63	)	CD	NUMBER	)	dep	62	SENT_260	[p15l203t3298r241b3325],
64	no	DT	O	no	det	68	SENT_260	[p15l251t3304r283b3322],
65	significant	JJ	O	significant	amod	68	SENT_260	[p15l291t3297r428b3328],
66	interval	NN	O	interval	nn	68	SENT_260	[p15l436t3297r534b3322],
67	subclinical	JJ	O	subclinical	amod	68	SENT_260	[p15l543t3297r681b3322],
68	(	NN	O	(	dep	62	SENT_260	[p15l691t3298r756b3325],
69	MRI	NNP	O	MRI	dep	68	SENT_260	[p15l691t3298r756b3325],
70	)	CD	NUMBER	)	num	72	SENT_260	[p15l691t3298r756b3325],
71	lesion	NN	O	lesion	nn	72	SENT_260	[p15l766t3297r841b3322],
72	accumulation	NN	O	accumulation	conj_and	13	SENT_260	[p15l850t3297r1038b3322],
73	.	.	O	.	_	0	SENT_260	[p15l850t3297r1038b3322],

1	Patients	NNS	O	patient	nsubj	15	SENT_261	[p15l1047t3298r1151b3322],
2	meeting	VBG	O	meet	partmod	1	SENT_261	[p15l1160t3299r1269b3328],
3	our	PRP$	O	we	poss	5	SENT_261	[p15l1278t3304r1323b3322],
4	operational	JJ	O	operational	amod	5	SENT_261	[p15l1330t3297r1481b3328],
5	definition	NN	O	definition	dobj	2	SENT_261	[p15l1490t3297r1617b3322],
6	of	IN	O	of	_	0	SENT_261	[p15l1626t3297r1654b3322],
7	SAMS	NNP	O	SAMS	prep_of	5	SENT_261	[p15l1660t3298r1734b3322],
8	(	CD	NUMBER	(	num	7	SENT_261	[p15l1743t3298r1778b3325],
9	as	IN	O	as	mark	10	SENT_261	[p15l1743t3298r1778b3325],
10	discussed	VBN	O	discuss	advcl	2	SENT_261	[p15l1786t3297r1913b3322],
11	in	IN	O	in	_	0	SENT_261	[p15l1923t3299r1945b3321],
12	the	DT	O	the	det	14	SENT_261	[p15l1953t3297r1996b3322],
13	text	NN	O	text	nn	14	SENT_261	[p15l2004t3298r2063b3325],
14	)	NN	O	)	prep_in	10	SENT_261	[p15l2004t3298r2063b3325],
15	have	VBP	O	have	_	0	SENT_261	[p15l24t3339r86b3363],
16	early	JJ	O	early	amod	18	SENT_261	[p15l94t3339r157b3370],
17	benign	JJ	O	benign	amod	18	SENT_261	[p15l165t3339r257b3370],
18	course	NN	O	course	dobj	15	SENT_261	[p15l266t3346r353b3363],
19	(	CD	NUMBER	(	num	18	SENT_261	[p15l362t3339r411b3367],
20	i.e.	FW	O	i.e.	dep	18	SENT_261	[p15l362t3339r411b3367],
21	,	,	O	,	_	0	SENT_261	[p15l362t3339r411b3367],
22	barely	RB	O	barely	advmod	18	SENT_261	[p15l420t3339r501b3370],
23	fulﬁlling	VBG	O	fulﬁlling	partmod	18	SENT_261	[p15l507t3339r615b3370],
24	2010	CD	DATE	2010	num	27	SENT_261	[p15l624t3341r688b3363],
25	McDonald	NNP	ORGANIZATION	McDonald	nn	27	SENT_261	[p15l696t3339r831b3363],
26	Radiological	NNP	ORGANIZATION	Radiological	nn	27	SENT_261	[p15l842t3339r1002b3370],
27	Criteria	NNP	ORGANIZATION	Criteria	dobj	23	SENT_261	[p15l1011t3340r1105b3363],
28	for	IN	O	for	_	0	SENT_261	[p15l1113t3339r1150b3363],
29	dissemination	NN	O	dissemination	prep_for	27	SENT_261	[p15l1157t3339r1342b3363],
30	in	IN	O	in	_	0	SENT_261	[p15l1352t3340r1373b3363],
31	time	NN	O	time	prep_in	29	SENT_261	[p15l1382t3340r1442b3363],
32	and	CC	O	and	_	0	SENT_261	[p15l1450t3339r1498b3363],
33	space	NN	O	space	prep_in	29	SENT_261	[p15l1507t3346r1582b3369],
34	for	IN	O	for	_	0	SENT_261	[p15l1589t3339r1626b3363],
35	MS	NN	O	m	nn	36	SENT_261	[p15l1634t3339r1681b3367],
36	)	NN	O	)	prep_for	29	SENT_261	[p15l1634t3339r1681b3367],
37	and	CC	O	and	_	0	SENT_261	[p15l1690t3339r1739b3363],
38	almost	RB	O	almost	advmod	39	SENT_261	[p15l1748t3339r1837b3363],
39	complete	JJ	O	complete	amod	40	SENT_261	[p15l1845t3339r1970b3369],
40	(	NN	O	(	conj_and	29	SENT_261	[p15l1979t3339r2063b3367],
41	285	CD	PERCENT	285	num	42	SENT_261	[p15l1979t3339r2063b3367],
42	%	NN	PERCENT	%	dep	40	SENT_261	[p15l1979t3339r2063b3367],
43	by	IN	O	by	_	0	SENT_261	[p15l2072t3339r2103b3370],
44	examination	NN	O	examination	nn	48	SENT_261	[p15l23t3381r188b3404],
45	or	CC	O	or	_	0	SENT_261	[p15l197t3387r224b3404],
46	history	NN	O	history	nn	48	SENT_261	[p15l232t3380r330b3411],
47	)	NN	O	)	nn	48	SENT_261	[p15l232t3380r330b3411],
48	recovery	NN	O	recovery	agent	23	SENT_261	[p15l340t3387r453b3411],
49	from	IN	O	from	_	0	SENT_261	[p15l460t3380r521b3404],
50	the	DT	O	the	det	55	SENT_261	[p15l530t3380r573b3404],
51	current	JJ	DATE	current	amod	55	SENT_261	[p15l581t3384r677b3404],
52	inflammatory	JJ	O	inflammatory	amod	55	SENT_261	[p15l685t3380r1067b3411],
53	—	NN	O	—	nn	55	SENT_261	[p15l685t3380r1067b3411],
54	demye	NN	O	demye	nn	55	SENT_261	[p15l685t3380r1067b3411],
55	|	NN	O	|	prep_from	48	SENT_261	[p15l685t3380r1067b3411],
56	inating	VBG	O	inate	xcomp	23	SENT_261	[p15l685t3380r1067b3411],
57	attack	NN	O	attack	dobj	56	SENT_261	[p15l1076t3380r1163b3404],
58	.	.	O	.	_	0	SENT_261	[p15l1076t3380r1163b3404],

1	Other	JJ	O	other	amod	2	SENT_262	[p15l1171t3380r1247b3404],
2	patients	NNS	O	patient	nsubj	4	SENT_262	[p15l1256t3381r1361b3411],
3	are	VBP	O	be	cop	4	SENT_262	[p15l1369t3387r1409b3404],
4	likely	JJ	O	likely	_	0	SENT_262	[p15l1418t3380r1485b3411],
5	to	TO	O	to	aux	6	SENT_262	[p15l1491t3384r1518b3404],
6	have	VB	O	have	xcomp	4	SENT_262	[p15l1527t3380r1589b3404],
7	nonbenign	JJ	O	nonbenign	amod	8	SENT_262	[p15l1598t3380r1743b3411],
8	MS.	NNP	O	MS.	dobj	6	SENT_262	[p15l1752t3380r1853b3404],
9	The	DT	O	the	det	10	SENT_262	[p15l1752t3380r1853b3404],
10	deﬁnition	NN	O	deﬁnition	nsubj	20	SENT_262	[p15l1861t3380r1988b3404],
11	of	IN	O	of	_	0	SENT_262	[p15l1997t3380r2024b3404],
12	severe	JJ	O	severe	amod	13	SENT_262	[p15l2030t3387r2114b3404],
13	M5	NN	O	m5	prep_of	10	SENT_262	[p15l24t3422r63b3445],
14	at	IN	O	at	_	0	SENT_262	[p15l71t3425r96b3445],
15	onset	NN	O	onset	prep_at	13	SENT_262	[p15l103t3425r177b3445],
16	is	VBZ	O	be	cop	20	SENT_262	[p15l185t3423r202b3445],
17	largely	RB	O	largely	advmod	20	SENT_262	[p15l211t3421r299b3452],
18	a	DT	O	a	det	20	SENT_262	[p15l306t3428r319b3445],
19	judgment	NN	O	judgment	nn	20	SENT_262	[p15l325t3421r459b3452],
20	call	NN	O	call	rcmod	8	SENT_262	[p15l467t3421r509b3445],
21	by	IN	O	by	_	0	SENT_262	[p15l519t3421r550b3452],
22	the	DT	O	the	det	25	SENT_262	[p15l556t3421r600b3445],
23	treating	VBG	O	treat	amod	25	SENT_262	[p15l607t3423r711b3452],
24	MS	NN	O	m	nn	25	SENT_262	[p15l721t3422r760b3445],
25	specialist	NN	O	specialist	prep_by	20	SENT_262	[p15l768t3421r895b3451],
26	.	.	O	.	_	0	SENT_262	[p15l768t3421r895b3451],

1	We	PRP	O	we	nsubj	2	SENT_263	[p15l901t3423r942b3445],
2	define	VBP	O	define	_	0	SENT_263	[p15l950t3421r1033b3445],
3	severe	JJ	O	severe	amod	6	SENT_263	[p15l1041t3421r1236b3445],
4	—	NN	O	—	nn	6	SENT_263	[p15l1041t3421r1236b3445],
5	disease	NN	O	disease	nn	6	SENT_263	[p15l1041t3421r1236b3445],
6	onset	NN	O	onset	dobj	2	SENT_263	[p15l1244t3425r1317b3445],
7	conservatively	RB	O	conservatively	advmod	2	SENT_263	[p15l1325t3421r1523b3452],
8	:	:	O	:	_	0	SENT_263	[p15l1325t3421r1523b3452],
9	>	JJR	O	>	amod	11	SENT_263	[p15l1532t3423r1564b3445],
10	3	CD	NUMBER	3	num	11	SENT_263	[p15l1532t3423r1564b3445],
11	relapses	NNS	O	relapse	nsubj	32	SENT_263	[p15l1573t3421r1680b3451],
12	within	IN	O	within	_	0	SENT_263	[p15l1687t3421r1770b3445],
13	6	CD	DURATION	6	num	14	SENT_263	[p15l1779t3423r1793b3445],
14	months	NNS	NUMBER	month	prep_within	11	SENT_263	[p15l1802t3421r1909b3449],
15	,	,	O	,	_	0	SENT_263	[p15l1802t3421r1909b3449],
16	limited	JJ	O	limited	amod	17	SENT_263	[p15l1918t3421r2008b3445],
17	recovery	NN	O	recovery	prep_within	11	SENT_263	[p15l2018t3428r2136b3452],
18	,	,	O	,	_	0	SENT_263	[p15l2018t3428r2136b3452],
19	and	CC	O	and	_	0	SENT_263	[p15l23t3462r72b3486],
20	multiple	JJ	O	multiple	prep_within	11	SENT_263	[p15l82t3462r191b3492],
21	enhancing	VBG	O	enhance	partmod	11	SENT_263	[p15l199t3462r339b3493],
22	lesions	NNS	O	lesion	nn	23	SENT_263	[p15l349t3462r438b3486],
23	(	NN	O	(	dobj	21	SENT_263	[p15l447t3462r585b3493],
24	especially	RB	O	especially	advmod	21	SENT_263	[p15l447t3462r585b3493],
25	with	IN	O	with	_	0	SENT_263	[p15l591t3462r649b3486],
26	early	JJ	O	early	amod	27	SENT_263	[p15l658t3462r721b3493],
27	evolution	NN	O	evolution	prep_with	21	SENT_263	[p15l729t3462r853b3486],
28	into	IN	O	into	_	0	SENT_263	[p15l863t3463r914b3486],
29	chronicT1	NN	O	chronict1	nn	31	SENT_263	[p15l922t3462r1052b3486],
30	black	JJ	O	black	amod	31	SENT_263	[p15l1066t3462r1135b3486],
31	holes	NNS	O	hole	prep_into	21	SENT_263	[p15l1143t3462r1227b3490],
32	)	VBP	O	)	parataxis	2	SENT_263	[p15l1143t3462r1227b3490],
33	.	.	O	.	_	0	SENT_263	[p15l1143t3462r1227b3490],

1	A	DT	O	a	det	4	SENT_264	[p15l1235t3463r1253b3486],
2	wider	JJR	O	wider	amod	4	SENT_264	[p15l1261t3462r1336b3486],
3	deﬁnition	NN	O	deﬁnition	nn	4	SENT_264	[p15l1343t3462r1470b3486],
4	ofsevere	NN	O	ofsevere	nsubj	11	SENT_264	[p15l1479t3462r1597b3486],
5	MS	NN	O	m	dep	4	SENT_264	[p15l1605t3463r1644b3486],
6	(	CD	NUMBER	(	num	5	SENT_264	[p15l1653t3463r1702b3490],
7	i.e.	FW	O	i.e.	dep	4	SENT_264	[p15l1653t3463r1702b3490],
8	,	,	O	,	_	0	SENT_264	[p15l1653t3463r1702b3490],
9	fewer	JJR	O	fewer	amod	10	SENT_264	[p15l1710t3462r1784b3486],
10	relapses	NNS	O	relapse	appos	7	SENT_264	[p15l1792t3462r1907b3492],
11	)	VBP	O	)	_	0	SENT_264	[p15l1792t3462r1907b3492],
12	may	MD	O	may	aux	13	SENT_264	[p15l1917t3469r1972b3493],
13	bejustified	VBN	O	bejustify	ccomp	11	SENT_264	[p15l1980t3462r2124b3493],
14	in	IN	O	in	_	0	SENT_264	[p15l24t3504r46b3527],
15	the	DT	DATE	the	det	16	SENT_264	[p15l54t3503r97b3527],
16	future	NN	DATE	future	prep_in	13	SENT_264	[p15l104t3503r185b3527],
17	if	IN	O	if	mark	26	SENT_264	[p15l194t3503r210b3527],
18	risk	NN	O	risk	nn	19	SENT_264	[p15l217t3503r261b3527],
19	stratification	NN	O	stratification	nsubjpass	26	SENT_264	[p15l268t3503r432b3527],
20	in	IN	O	in	_	0	SENT_264	[p15l442t3504r463b3527],
21	tier	NN	O	tier	nn	23	SENT_264	[p15l471t3504r516b3527],
22	2	CD	NUMBER	2	num	23	SENT_264	[p15l523t3505r537b3527],
23	medications	NNS	O	medication	prep_in	19	SENT_264	[p15l546t3503r708b3527],
24	can	MD	O	can	aux	26	SENT_264	[p15l716t3510r761b3527],
25	be	VB	O	be	auxpass	26	SENT_264	[p15l771t3503r803b3527],
26	done	VBN	O	do	advcl	13	SENT_264	[p15l810t3503r878b3527],
27	more	RBR	O	more	advmod	26	SENT_264	[p15l887t3510r955b3527],
28	precisely	RB	O	precisely	advmod	26	SENT_264	[p15l964t3503r1085b3534],
29	.	.	O	.	_	0	SENT_264	[p15l964t3503r1085b3534],

1	MRI	NNP	O	MRI	_	0	SENT_265	[p15l1093t3504r1148b3531],
2	,	,	O	,	_	0	SENT_265	[p15l1093t3504r1148b3531],
3	magnetic	JJ	O	magnetic	amod	5	SENT_265	[p15l1157t3504r1281b3534],
4	resonance	NN	O	resonance	nn	5	SENT_265	[p15l1290t3510r1425b3527],
5	imaging	NN	O	imaging	appos	1	SENT_265	[p15l1434t3504r1549b3534],
6	;	:	O	;	_	0	SENT_265	[p15l1434t3504r1549b3534],
7	MS	NN	O	m	dep	1	SENT_265	[p15l1557t3504r1603b3531],
8	,	,	O	,	_	0	SENT_265	[p15l1557t3504r1603b3531],
9	multiple	JJ	O	multiple	amod	10	SENT_265	[p15l1612t3503r1721b3534],
10	sclerosis	NN	O	sclerosis	appos	7	SENT_265	[p15l1730t3503r1845b3527],
11	.	.	O	.	_	0	SENT_265	[p15l1730t3503r1845b3527],

1	Disability	NN	O	disability	nn	4	SENT_266	[p16l8t85r354b169],
2	Status	NN	O	status	nn	4	SENT_266	[p16l377t89r585b148],
3	Scale	NNP	O	Scale	nn	4	SENT_266	[p16l613t85r790b148],
4	scores	NNS	O	score	nsubj	8	SENT_266	[p16l817t108r1031b148],
5	upon	IN	O	upon	_	0	SENT_266	[p16l1057t107r1241b168],
6	entry	NN	O	entry	prep_upon	4	SENT_266	[p16l1267t97r1456b169],
7	may	MD	O	may	aux	8	SENT_266	[p16l1478t108r1629b169],
8	achieve	VB	O	achieve	_	0	SENT_266	[p16l1652t85r1913b148],
9	better	JJR	O	better	amod	10	SENT_266	[p16l1937t85r2146b148],
10	response	NN	O	response	dobj	8	SENT_266	[p16l8t179r396b270],
11	.69	CD	NUMBER	.69	tmod	8	SENT_266	[p16l8t179r396b270],
12	This	DT	O	this	nsubjpass	14	SENT_266	[p16l419t187r565b250],
13	is	VBZ	O	be	auxpass	14	SENT_266	[p16l589t193r640b250],
14	expected	VBN	O	expect	rcmod	11	SENT_266	[p16l664t187r973b270],
15	because	IN	O	because	mark	20	SENT_266	[p16l993t187r1266b250],
16	the	DT	O	the	det	17	SENT_266	[p16l1289t187r1397b250],
17	RRR	NN	ORGANIZATION	rrr	nsubj	20	SENT_266	[p16l1422t192r1583b250],
18	will	MD	O	will	aux	20	SENT_266	[p16l1602t187r1730b250],
19	be	VB	O	be	cop	20	SENT_266	[p16l1751t187r1831b250],
20	easier	JJR	O	easier	advcl	14	SENT_266	[p16l1856t193r2055b250],
21	to	TO	O	to	aux	22	SENT_266	[p16l2076t199r2143b250],
22	detect	VB	O	detect	xcomp	20	SENT_266	[p16l8t291r214b354],
23	in	IN	O	in	_	0	SENT_266	[p16l234t297r301b353],
24	these	DT	O	these	det	25	SENT_266	[p16l321t291r497b354],
25	groups	NNS	O	group	prep_in	22	SENT_266	[p16l519t313r768b375],
26	.	.	O	.	_	0	SENT_266	[p16l519t313r768b375],

1	Side	NN	O	side	nn	2	SENT_267	[p16l82t394r231b457],
2	effects	NNS	O	effect	nsubj	12	SENT_267	[p16l261t394r490b457],
3	of	IN	O	of	_	0	SENT_267	[p16l520t394r597b457],
4	all	DT	O	all	det	5	SENT_267	[p16l617t394r701b457],
5	interferon	NN	O	interferon	prep_of	2	SENT_267	[p16l729t394r1172b478],
6	-	:	O	-	_	0	SENT_267	[p16l729t394r1172b478],
7	[	NN	O	[	dep	5	SENT_267	[p16l729t394r1172b478],
8	3	CD	NUMBER	3	num	9	SENT_267	[p16l729t394r1172b478],
9	compounds	NNS	O	compound	dep	7	SENT_267	[p16l1203t394r1626b477],
10	are	VBP	O	be	cop	12	SENT_267	[p16l1657t417r1762b457],
11	injectionsite	JJ	O	injectionsite	amod	12	SENT_267	[p16l1792t400r2142b478, p16l9t503r124b560],
12	reactions	NNS	O	reaction	_	0	SENT_267	[p16l150t503r492b569],
13	,	,	O	,	_	0	SENT_267	[p16l150t503r492b569],
14	ﬂu-like	JJ	O	ﬂu-like	amod	15	SENT_267	[p16l519t497r770b560],
15	symptoms	NNS	O	symptom	conj_and	12	SENT_267	[p16l796t509r1159b581],
16	(	RB	O	(	advmod	17	SENT_267	[p16l1188t497r1573b581],
17	low	JJ	O	low	amod	15	SENT_267	[p16l1188t497r1573b581],
18	—	NN	O	—	nn	20	SENT_267	[p16l1188t497r1573b581],
19	grade	NN	O	grade	nn	20	SENT_267	[p16l1188t497r1573b581],
20	fever	NN	O	fever	dep	15	SENT_267	[p16l1598t497r1785b569],
21	,	,	O	,	_	0	SENT_267	[p16l1598t497r1785b569],
22	myalgias	NN	O	myalgia	conj_and	12	SENT_267	[p16l1811t497r2140b581],
23	,	,	O	,	_	0	SENT_267	[p16l1811t497r2140b581],
24	and	CC	O	and	_	0	SENT_267	[p16l8t600r136b663],
25	headache	NN	O	headache	conj_and	12	SENT_267	[p16l157t600r501b672],
26	;	:	O	;	_	0	SENT_267	[p16l157t600r501b672],
27	these	DT	O	these	nsubj	28	SENT_267	[p16l525t600r703b663],
28	lessen	VBP	O	lessen	parataxis	12	SENT_267	[p16l725t600r931b663],
29	in	IN	O	in	_	0	SENT_267	[p16l955t606r1022b662],
30	frequency	NN	O	frequency	prep_in	28	SENT_267	[p16l1045t600r1395b684],
31	after	IN	O	after	_	0	SENT_267	[p16l1416t600r1570b663],
32	a	DT	DURATION	a	det	34	SENT_267	[p16l1592t623r1627b663],
33	few	JJ	DURATION	few	amod	34	SENT_267	[p16l1649t600r1771b663],
34	months	NNS	DURATION	month	prep_after	28	SENT_267	[p16l1791t600r2054b663],
35	of	IN	O	of	_	0	SENT_267	[p16l2078t600r2153b663],
36	treatment	NN	O	treatment	nn	37	SENT_267	[p16l7t703r408b780],
37	)	NN	O	)	prep_of	34	SENT_267	[p16l7t703r408b780],
38	,	,	O	,	_	0	SENT_267	[p16l7t703r408b780],
39	mild	JJ	O	mild	amod	41	SENT_267	[p16l436t703r602b766],
40	liver-enzyme	JJ	O	liver-enzyme	amod	41	SENT_267	[p16l626t703r1093b787],
41	elevation	NN	O	elevation	conj_and	37	SENT_267	[p16l1121t703r1463b775],
42	,	,	O	,	_	0	SENT_267	[p16l1121t703r1463b775],
43	and	CC	O	and	_	0	SENT_267	[p16l1492t703r1623b766],
44	lymphopenia	NN	O	lymphopenia	prep_of	34	SENT_267	[p16l1648t703r2139b787],
45	.	.	O	.	_	0	SENT_267	[p16l1648t703r2139b787],

1	Depression	NN	O	depression	nsubj	7	SENT_268	[p16l8t812r394b890],
2	and	CC	O	and	_	0	SENT_268	[p16l418t807r544b870],
3	attempted	VBD	O	attempt	amod	4	SENT_268	[p16l566t807r910b890],
4	suicide	NN	O	suicide	conj_and	1	SENT_268	[p16l933t807r1171b870],
5	were	VBD	O	be	cop	7	SENT_268	[p16l1192t830r1353b870],
6	more	RBR	O	more	advmod	7	SENT_268	[p16l1376t830r1554b870],
7	common	JJ	O	common	_	0	SENT_268	[p16l1577t830r1884b870],
8	among	IN	O	among	_	0	SENT_268	[p16l1908t830r2144b891],
9	the	DT	O	the	det	11	SENT_268	[p16l7t936r117b999],
10	treated	JJ	O	treated	amod	11	SENT_268	[p16l143t936r391b999],
11	patients	NNS	O	patient	prep_among	7	SENT_268	[p16l415t942r715b1019],
12	.	.	O	.	_	0	SENT_268	[p16l415t942r715b1019],

1	In	IN	O	in	_	0	SENT_269	[p16l746t941r819b998],
2	our	PRP$	O	we	poss	8	SENT_269	[p16l846t959r968b999],
3	experience	NN	O	experience	nn	8	SENT_269	[p16l994t942r1379b1019],
4	and	CC	O	and	_	0	SENT_269	[p16l1406t936r1537b999],
5	per	IN	O	per	nn	8	SENT_269	[p16l1561t958r1678b1019],
6	the	DT	O	the	det	7	SENT_269	[p16l1702t936r1813b999],
7	previous	JJ	O	previous	pobj	5	SENT_269	[p16l1838t942r2144b1019],
8	studies	NNS	O	study	prep_in	14	SENT_269	[p16l8t1039r262b1111],
9	,	,	O	,	_	0	SENT_269	[p16l8t1039r262b1111],
10	once-a-week	JJ	O	once-a-week	amod	13	SENT_269	[p16l287t1039r725b1102],
11	i.m.	NN	O	i.m.	nn	13	SENT_269	[p16l744t1045r870b1102],
12	interferon-B	NN	O	interferon-b	nn	13	SENT_269	[p16l896t1039r1313b1123],
13	administrations	NNS	O	administration	nsubj	14	SENT_269	[p16l1338t1039r1879b1102],
14	tend	VBP	O	tend	_	0	SENT_269	[p16l1901t1039r2055b1102],
15	to	TO	O	to	aux	16	SENT_269	[p16l2076t1051r2141b1102],
16	produce	VB	O	produce	xcomp	14	SENT_269	[p16l6t1142r284b1225],
17	fewer	JJR	O	fewer	amod	19	SENT_269	[p16l304t1142r489b1205],
18	side	JJ	O	side	amod	19	SENT_269	[p16l509t1142r640b1205],
19	effects	NNS	O	effect	dobj	16	SENT_269	[p16l661t1142r888b1214],
20	,	,	O	,	_	0	SENT_269	[p16l661t1142r888b1214],
21	but	CC	O	but	_	0	SENT_269	[p16l908t1142r1021b1205],
22	these	DT	O	these	nsubj	23	SENT_269	[p16l1039t1142r1212b1205],
23	tend	VBP	O	tend	conj_but	14	SENT_269	[p16l1231t1142r1383b1205],
24	to	TO	O	to	aux	27	SENT_269	[p16l1401t1154r1466b1205],
25	be	VB	O	be	cop	27	SENT_269	[p16l1485t1142r1564b1205],
26	more	RBR	O	more	advmod	27	SENT_269	[p16l1584t1165r1760b1205],
27	prolonged	JJ	O	prolonged	xcomp	23	SENT_269	[p16l1778t1142r2142b1226],
28	,	,	O	,	_	0	SENT_269	[p16l1778t1142r2142b1226],
29	particularly	RB	O	particularly	advmod	30	SENT_269	[p16l6t1245r424b1329],
30	in	IN	O	in	dep	27	SENT_269	[p16l445t1251r513b1307],
31	the	DT	O	the	det	32	SENT_269	[p16l537t1245r647b1308],
32	case	NN	O	case	pobj	30	SENT_269	[p16l673t1268r817b1308],
33	of	IN	O	of	_	0	SENT_269	[p16l842t1245r918b1308],
34	the	DT	O	the	det	37	SENT_269	[p16l932t1245r1042b1308],
35	ﬂu-like	JJ	O	ﬂu-like	amod	37	SENT_269	[p16l1067t1245r1318b1308],
36	side	NN	O	side	nn	37	SENT_269	[p16l1344t1245r1480b1308],
37	effects	NNS	O	effect	prep_of	32	SENT_269	[p16l1506t1245r1745b1317],
38	,	,	O	,	_	0	SENT_269	[p16l1506t1245r1745b1317],
39	than	IN	O	than	_	0	SENT_269	[p16l1771t1245r1930b1308],
40	other	JJ	O	other	amod	42	SENT_269	[p16l1956t1245r2143b1308],
41	interferon	NN	O	interferon	nn	42	SENT_269	[p16l8t1348r426b1432],
42	—	NN	O	—	prep_than	27	SENT_269	[p16l8t1348r426b1432],
43	[	CD	NUMBER	[	number	44	SENT_269	[p16l8t1348r426b1432],
44	3	CD	NUMBER	3	num	45	SENT_269	[p16l8t1348r426b1432],
45	administrations	NNS	O	administration	dep	27	SENT_269	[p16l451t1348r1011b1411],
46	.	.	O	.	_	0	SENT_269	[p16l451t1348r1011b1411],

1	The	DT	O	the	det	2	SENT_270	[p16l1037t1348r1163b1411],
2	patient	NN	O	patient	poss	4	SENT_270	[p16l1184t1348r1464b1431],
3	’s	POS	O	’s	_	0	SENT_270	[p16l1184t1348r1464b1431],
4	lifestyle	NN	O	lifestyle	nsubj	5	SENT_270	[p16l1486t1348r1748b1432],
5	plays	VBZ	O	play	_	0	SENT_270	[p16l1770t1348r1942b1432],
6	a	DT	O	a	det	8	SENT_270	[p16l1966t1371r2001b1411],
7	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_270	[p16l2023t1354r2142b1432, p16l7t1451r261b1514],
8	role	NN	O	role	dobj	5	SENT_270	[p16l280t1451r405b1514],
9	in	IN	O	in	_	0	SENT_270	[p16l425t1457r490b1513],
10	the	DT	O	the	det	11	SENT_270	[p16l508t1451r612b1514],
11	choice	NN	O	choice	prep_in	8	SENT_270	[p16l632t1451r843b1514],
12	of	IN	O	of	_	0	SENT_270	[p16l864t1451r936b1514],
13	individual	JJ	O	individual	amod	14	SENT_270	[p16l946t1451r1286b1514],
14	interferon	NN	O	interferon	prep_of	11	SENT_270	[p16l1305t1451r1711b1535],
15	-	:	O	-	_	0	SENT_270	[p16l1305t1451r1711b1535],
16	[	NN	O	[	dep	8	SENT_270	[p16l1305t1451r1711b1535],
17	3	CD	NUMBER	3	num	18	SENT_270	[p16l1305t1451r1711b1535],
18	compounds	NNS	O	compound	dep	16	SENT_270	[p16l1732t1451r2142b1534],
19	.	.	O	.	_	0	SENT_270	[p16l1732t1451r2142b1534],

1	Glatiramer	FW	O	glatiramer	nsubj	7	SENT_271	[p16l8t1664r381b1721],
2	acetate	NN	O	acetate	nn	3	SENT_271	[p16l397t1671r650b1721],
3	GA	NN	O	ga	dep	1	SENT_271	[p16l9t1765r129b1824],
4	is	VBZ	O	be	cop	7	SENT_271	[p16l157t1767r210b1824],
5	a	DT	O	a	det	7	SENT_271	[p16l239t1784r274b1824],
6	synthetic	JJ	O	synthetic	amod	7	SENT_271	[p16l302t1761r628b1845],
7	mixture	NN	O	mixture	_	0	SENT_271	[p16l655t1767r939b1824],
8	of	IN	O	of	_	0	SENT_271	[p16l968t1761r1044b1824],
9	polypeptides	NNS	O	polypeptide	prep_of	7	SENT_271	[p16l1061t1761r1523b1845],
10	produced	VBN	O	produce	partmod	9	SENT_271	[p16l1551t1761r1896b1844],
11	by	IN	O	by	_	0	SENT_271	[p16l1920t1761r2008b1845],
12	the	DT	O	the	det	14	SENT_271	[p16l2031t1761r2142b1824],
13	random	JJ	O	random	amod	14	SENT_271	[p16l8t1863r284b1926],
14	combinations	NNS	O	combination	agent	10	SENT_271	[p16l308t1863r782b1926],
15	of	IN	O	of	_	0	SENT_271	[p16l807t1863r882b1926],
16	the	DT	O	the	det	21	SENT_271	[p16l894t1863r1003b1926],
17	four	CD	NUMBER	four	num	21	SENT_271	[p16l1026t1863r1172b1926],
18	most	RBS	O	most	advmod	19	SENT_271	[p16l1194t1875r1367b1926],
19	common	JJ	O	common	amod	21	SENT_271	[p16l1390t1886r1702b1926],
20	amino	NN	O	amino	nn	21	SENT_271	[p16l1726t1869r1946b1926],
21	acids	NNS	O	acid	prep_of	14	SENT_271	[p16l1971t1863r2144b1926],
22	in	IN	O	in	_	0	SENT_271	[p16l8t1972r76b2028],
23	myelin	JJ	O	myelin	amod	25	SENT_271	[p16l99t1966r338b2050],
24	basic	JJ	O	basic	amod	25	SENT_271	[p16l360t1966r537b2029],
25	protein	NN	O	protein	prep_in	21	SENT_271	[p16l559t1972r833b2049],
26	.	.	O	.	_	0	SENT_271	[p16l559t1972r833b2049],

1	Daily	NNP	SET	Daily	nn	3	SENT_272	[p16l860t1966r1050b2050],
2	s.c.	NN	O	s.c.	nn	3	SENT_272	[p16l1071t1989r1174b2029],
3	injection	NN	O	injection	nsubj	6	SENT_272	[p16l1201t1972r1512b2050],
4	of	IN	O	of	_	0	SENT_272	[p16l1536t1966r1612b2029],
5	GA	NN	O	ga	prep_of	3	SENT_272	[p16l1627t1970r1746b2029],
6	leads	VBZ	O	lead	_	0	SENT_272	[p16l1769t1966r1944b2029],
7	to	TO	O	to	_	0	SENT_272	[p16l1968t1978r2035b2029],
8	an	DT	O	a	det	9	SENT_272	[p16l2061t1989r2143b2029],
9	RRR	NN	O	rrr	prep_to	6	SENT_272	[p16l8t2074r169b2132],
10	of	IN	O	of	_	0	SENT_272	[p16l190t2069r265b2132],
11	10	CD	PERCENT	10	num	12	SENT_272	[p16l285t2074r442b2141],
12	%	NN	PERCENT	%	prep_of	9	SENT_272	[p16l285t2074r442b2141],
13	,	,	O	,	_	0	SENT_272	[p16l285t2074r442b2141],
14	an	DT	O	a	det	15	SENT_272	[p16l468t2092r549b2132],
15	ARR	NN	O	arr	prep_to	6	SENT_272	[p16l571t2073r740b2132],
16	of	IN	O	of	_	0	SENT_272	[p16l761t2069r835b2132],
17	7	CD	PERCENT	7	num	18	SENT_272	[p16l850t2074r971b2141],
18	%	NN	PERCENT	%	prep_of	15	SENT_272	[p16l850t2074r971b2141],
19	,	,	O	,	_	0	SENT_272	[p16l850t2074r971b2141],
20	and	CC	O	and	_	0	SENT_272	[p16l996t2069r1124b2132],
21	an	DT	O	a	det	22	SENT_272	[p16l1147t2092r1228b2132],
22	NNT	NN	O	nnt	prep_to	6	SENT_272	[p16l1250t2072r1431b2132],
23	of	IN	O	of	_	0	SENT_272	[p16l1454t2069r1529b2132],
24	14	CD	NUMBER	14	number	26	SENT_272	[p16l1550t2076r1622b2131],
25	over	IN	O	over	quantmod	26	SENT_272	[p16l1646t2092r1796b2132],
26	2	CD	DURATION	2	num	27	SENT_272	[p16l1818t2076r1854b2131],
27	years	NNS	NUMBER	year	prep_of	22	SENT_272	[p16l1876t2092r2053b2153],
28	to	TO	O	to	prep	6	SENT_272	[p16l2076t2081r2142b2132],

1	38	CD	NUMBER	38	num	2	SENT_273	[p16l7t2289r71b2331],
2	increase	NN	O	increase	tmod	18	SENT_273	[p16l9t2376r290b2433],
3	the	DT	O	the	det	7	SENT_273	[p16l313t2370r420b2433],
4	relapse	NN	O	relapse	nn	7	SENT_273	[p16l444t2370r847b2453],
5	—	CD	NUMBER	—	num	7	SENT_273	[p16l444t2370r847b2453],
6	free	JJ	O	free	amod	7	SENT_273	[p16l444t2370r847b2453],
7	number	NN	O	number	nsubj	10	SENT_273	[p16l870t2370r1146b2433],
8	by	IN	O	by	_	0	SENT_273	[p16l1166t2370r1251b2454],
9	1.70	CD	NUMBER	1.70	prep_by	7	SENT_273	[p16l1277t2362r1391b2433],
10	Based	VBN	O	base	rcmod	2	SENT_273	[p16l1415t2370r1619b2433],
11	on	IN	O	on	_	0	SENT_273	[p16l1641t2393r1728b2433],
12	these	DT	O	these	det	13	SENT_273	[p16l1750t2370r1928b2433],
13	numbers	NNS	O	number	prep_on	10	SENT_273	[p16l1951t2393r2140b2433, p16l7t2473r171b2545],
14	,	,	O	,	_	0	SENT_273	[p16l1951t2393r2140b2433, p16l7t2473r171b2545],
15	GA	NN	O	ga	nsubj	18	SENT_273	[p16l198t2477r317b2536],
16	is	VBZ	O	be	cop	18	SENT_273	[p16l340t2479r391b2536],
17	less	RBR	O	less	advmod	18	SENT_273	[p16l413t2473r535b2536],
18	efficacious	JJ	O	efficacious	_	0	SENT_273	[p16l559t2473r922b2536],
19	than	IN	O	than	_	0	SENT_273	[p16l945t2473r1103b2536],
20	all	DT	O	all	det	25	SENT_273	[p16l1127t2473r1207b2536],
21	interferon	NN	O	interferon	nn	25	SENT_273	[p16l1230t2473r1656b2557],
22	—	NN	O	—	nn	25	SENT_273	[p16l1230t2473r1656b2557],
23	[	CD	NUMBER	[	number	24	SENT_273	[p16l1230t2473r1656b2557],
24	3	CD	NUMBER	3	num	25	SENT_273	[p16l1230t2473r1656b2557],
25	preparations	NNS	O	preparation	prep_than	18	SENT_273	[p16l1679t2479r2137b2556],
26	.	.	O	.	_	0	SENT_273	[p16l1679t2479r2137b2556],

1	It	PRP	O	it	nsubj	3	SENT_274	[p16l10t2581r60b2639],
2	is	VBZ	O	be	cop	3	SENT_274	[p16l82t2582r133b2639],
3	slower	JJR	O	slower	_	0	SENT_274	[p16l158t2576r382b2639],
4	acting	VBG	O	act	xcomp	3	SENT_274	[p16l405t2582r618b2660],
5	(	NN	O	(	dobj	4	SENT_274	[p16l643t2577r759b2652],
6	26	CD	DURATION	26	num	7	SENT_274	[p16l643t2577r759b2652],
7	months	NNS	NUMBER	month	tmod	5	SENT_274	[p16l783t2576r1046b2639],
8	of	IN	O	of	_	0	SENT_274	[p16l1071t2576r1146b2639],
9	use	NN	O	use	prep_of	5	SENT_274	[p16l1160t2577r1320b2653],
10	)	CD	NUMBER	)	num	9	SENT_274	[p16l1160t2577r1320b2653],
11	.	.	O	.	_	0	SENT_274	[p16l1160t2577r1320b2653],

1	However	RB	O	however	advmod	4	SENT_275	[p16l1347t2581r1672b2648],
2	,	,	O	,	_	0	SENT_275	[p16l1347t2581r1672b2648],
3	it	PRP	O	it	nsubj	4	SENT_275	[p16l1698t2582r1744b2639],
4	has	VBZ	O	have	_	0	SENT_275	[p16l1765t2576r1879b2639],
5	several	JJ	O	several	amod	6	SENT_275	[p16l1904t2576r2143b2639],
6	advantages	NNS	O	advantage	dobj	4	SENT_275	[p16l10t2670r616b2762],
7	.64	CD	NUMBER	.64	number	8	SENT_275	[p16l10t2670r616b2762],
8	’	CD	NUMBER	’	dep	6	SENT_275	[p16l10t2670r616b2762],
9	71	CD	NUMBER	71	number	10	SENT_275	[p16l10t2670r616b2762],
10	’72	CD	NUMBER	’72	num	11	SENT_275	[p16l10t2670r616b2762],
11	GA	NN	O	ga	nsubj	14	SENT_275	[p16l638t2682r754b2741],
12	does	VBZ	O	do	aux	14	SENT_275	[p16l775t2678r928b2741],
13	not	RB	O	not	neg	14	SENT_275	[p16l949t2690r1062b2741],
14	cause	VB	O	cause	rcmod	6	SENT_275	[p16l1082t2701r1264b2741],
15	ﬂu-like	JJ	O	ﬂu-like	amod	17	SENT_275	[p16l1284t2678r1525b2741],
16	side	JJ	O	side	amod	17	SENT_275	[p16l1546t2678r1678b2741],
17	effects	NNS	O	effect	dobj	14	SENT_275	[p16l1699t2678r1926b2741],
18	.	.	O	.	_	0	SENT_275	[p16l1699t2678r1926b2741],

1	There	EX	O	there	expl	2	SENT_276	[p16l1950t2678r2142b2741],
2	is	VBZ	O	be	_	0	SENT_276	[p16l9t2787r59b2844],
3	no	DT	O	no	det	4	SENT_276	[p16l80t2804r165b2844],
4	need	NN	O	need	nsubj	2	SENT_276	[p16l187t2781r350b2844],
5	of	IN	O	of	_	0	SENT_276	[p16l370t2781r444b2844],
6	blood	NN	O	blood	nn	7	SENT_276	[p16l452t2781r651b2844],
7	monitoring	NN	O	monitoring	prep_of	4	SENT_276	[p16l670t2787r1077b2865],
8	,	,	O	,	_	0	SENT_276	[p16l670t2787r1077b2865],
9	and	CC	O	and	_	0	SENT_276	[p16l1100t2781r1225b2844],
10	it	PRP	O	it	nsubj	13	SENT_276	[p16l1245t2787r1290b2844],
11	does	VBZ	O	do	aux	13	SENT_276	[p16l1310t2781r1463b2844],
12	not	RB	O	not	neg	13	SENT_276	[p16l1483t2793r1597b2844],
13	lead	VB	O	lead	conj_and	2	SENT_276	[p16l1615t2781r1755b2844],
14	to	TO	O	to	_	0	SENT_276	[p16l1773t2793r1839b2844],
15	the	DT	O	the	det	17	SENT_276	[p16l1859t2781r1965b2844],
16	neutralizing	VBG	O	neutralize	amod	17	SENT_276	[p16l1986t2804r2138b2844, p16l8t2884r294b2968],
17	antibodies	NNS	O	antibody	prep_to	13	SENT_276	[p16l314t2884r666b2947],
18	that	WDT	O	that	nsubj	20	SENT_276	[p16l686t2884r820b2947],
19	can	MD	O	can	aux	20	SENT_276	[p16l839t2907r956b2947],
20	plague	VB	O	plague	rcmod	17	SENT_276	[p16l975t2884r1198b2968],
21	interferon	NN	O	interferon	nn	22	SENT_276	[p16l1219t2884r1634b2968],
22	—	NN	O	—	dobj	20	SENT_276	[p16l1219t2884r1634b2968],
23	[	CD	NUMBER	[	number	24	SENT_276	[p16l1219t2884r1634b2968],
24	3	CD	NUMBER	3	num	26	SENT_276	[p16l1219t2884r1634b2968],
25	use	NN	O	use	nn	26	SENT_276	[p16l1655t2907r1765b2947],
26	(	NN	O	(	dep	22	SENT_276	[p16l1789t2884r2142b2960],
27	discussed	VBN	O	discuss	partmod	22	SENT_276	[p16l1789t2884r2142b2960],
28	later	RB	O	later	advmod	27	SENT_276	[p16l8t2987r199b3063],
29	)	RB	O	)	advmod	27	SENT_276	[p16l8t2987r199b3063],
30	.	.	O	.	_	0	SENT_276	[p16l8t2987r199b3063],

1	Therefore	RB	O	therefore	advmod	5	SENT_277	[p16l222t2987r559b3059],
2	,	,	O	,	_	0	SENT_277	[p16l222t2987r559b3059],
3	GA	NN	O	ga	nsubj	5	SENT_277	[p16l581t2991r695b3050],
4	has	VBZ	O	have	aux	5	SENT_277	[p16l714t2987r823b3050],
5	found	VBN	O	find	_	0	SENT_277	[p16l842t2987r1041b3050],
6	its	PRP$	O	its	poss	7	SENT_277	[p16l1060t2993r1133b3050],
7	place	NN	O	place	dobj	5	SENT_277	[p16l1152t2987r1323b3070],
8	in	IN	O	in	_	0	SENT_277	[p16l1343t2993r1408b3049],
9	the	DT	O	the	det	10	SENT_277	[p16l1426t2987r1530b3050],
10	tier	NN	O	tier	prep_in	5	SENT_277	[p16l1548t2993r1663b3050],
11	1	CD	NUMBER	1	num	12	SENT_277	[p16l1688t2994r1712b3049],
12	medications	NNS	O	medication	dep	10	SENT_277	[p16l1737t2987r2143b3050],
13	(	CD	NUMBER	(	num	14	SENT_277	[p16l13t3090r271b3173],
14	Figure	NN	O	figure	dep	12	SENT_277	[p16l13t3090r271b3173],
15	4	CD	NUMBER	4	num	16	SENT_277	[p16l290t3091r377b3167],
16	)	NN	O	)	dep	12	SENT_277	[p16l290t3091r377b3167],
17	.	.	O	.	_	0	SENT_277	[p16l290t3091r377b3167],

1	Natalizumab	NNP	O	Natalizumab	_	0	SENT_278	[p16l12t3303r452b3360],

1	Natalizumab	NNP	O	Natalizumab	dep	132	SENT_279	[p17l9t27r442b90],
2	is	VBZ	O	be	dep	132	SENT_279	[p17l464t33r514b90],
3	a	DT	O	a	dep	132	SENT_279	[p17l537t50r571b90],
4	humanized	JJ	O	humanized	dep	132	SENT_279	[p17l590t27r972b90],
5	or-4	NN	O	or-4	dep	132	SENT_279	[p17l993t34r1105b90],
6	integrin	NN	O	integrin	dep	132	SENT_279	[p17l1126t33r1394b111],
7	antibody	NN	O	antibody	dep	132	SENT_279	[p17l1416t27r1718b111],
8	that	WDT	O	that	dep	132	SENT_279	[p17l1734t27r1867b90],
9	inhibits	VBZ	O	inhibit	dep	132	SENT_279	[p17l1886t27r2141b90],
10	the	DT	O	the	dep	132	SENT_279	[p17l8t130r114b193],
11	migration	NN	O	migration	dep	132	SENT_279	[p17l134t136r470b214],
12	of	IN	O	of	dep	132	SENT_279	[p17l491t130r565b193],
13	all	DT	O	all	dep	132	SENT_279	[p17l576t130r654b193],
14	leukocytes	NNS	O	leukocyte	dep	132	SENT_279	[p17l672t130r1027b214],
15	(	VBP	O	(	dep	132	SENT_279	[p17l1053t131r1294b213],
16	except	IN	O	except	dep	132	SENT_279	[p17l1053t131r1294b213],
17	for	IN	O	for	dep	132	SENT_279	[p17l1313t130r1409b193],
18	neutrophils	NNS	O	neutrophil	dep	132	SENT_279	[p17l1429t130r1841b213],
19	)	CD	NUMBER	)	dep	132	SENT_279	[p17l1429t130r1841b213],
20	to	TO	O	to	dep	132	SENT_279	[p17l1865t142r1930b193],
21	target	VB	O	target	dep	132	SENT_279	[p17l1951t142r2145b214],
22	organs	NNS	O	organ	dep	132	SENT_279	[p17l10t224r304b316],
23	.73	CD	NUMBER	.73	dep	132	SENT_279	[p17l10t224r304b316],
24	A	DT	O	a	dep	132	SENT_279	[p17l323t236r379b294],
25	phase	NN	O	phase	dep	132	SENT_279	[p17l396t232r584b315],
26	II	CD	NUMBER	ii	dep	132	SENT_279	[p17l603t237r654b294],
27	study	NN	O	study	dep	132	SENT_279	[p17l674t232r854b316],
28	established	VBD	O	establish	dep	132	SENT_279	[p17l868t232r1230b295],
29	that	IN	O	that	dep	132	SENT_279	[p17l1246t232r1375b295],
30	a	DT	O	a	dep	132	SENT_279	[p17l1392t255r1426b295],
31	300	CD	NUMBER	300	dep	132	SENT_279	[p17l1444t239r1559b295],
32	mg	NN	O	mg	dep	132	SENT_279	[p17l1572t255r1679b316],
33	monthly	JJ	SET	monthly	dep	132	SENT_279	[p17l1695t232r1978b316],
34	dose	NN	O	dose	dep	132	SENT_279	[p17l1993t232r2142b295],
35	of	IN	O	of	dep	132	SENT_279	[p17l10t335r84b398],
36	natalizumab	NN	O	natalizumab	dep	132	SENT_279	[p17l97t335r520b398],
37	reduced	VBD	O	reduce	dep	132	SENT_279	[p17l544t335r820b398],
38	the	DT	O	the	dep	132	SENT_279	[p17l840t335r947b398],
39	number	NN	O	number	dep	132	SENT_279	[p17l969t335r1244b398],
40	of	IN	O	of	dep	132	SENT_279	[p17l1265t335r1340b398],
41	gadolinium-enhancing	JJ	O	gadolinium-enhancing	dep	132	SENT_279	[p17l1352t335r2143b419],
42	lesions	NNS	O	lesion	dep	132	SENT_279	[p17l8t438r236b501],
43	by	IN	O	by	dep	132	SENT_279	[p17l255t438r339b522],
44	90	CD	PERCENT	90	dep	132	SENT_279	[p17l357t443r498b502],
45	%	NN	PERCENT	%	dep	132	SENT_279	[p17l357t443r498b502],
46	and	CC	O	and	dep	132	SENT_279	[p17l521t438r647b501],
47	the	DT	O	the	dep	132	SENT_279	[p17l665t438r771b501],
48	clinical	JJ	O	clinical	dep	132	SENT_279	[p17l793t438r1033b501],
49	relapse	NN	O	relapse	dep	132	SENT_279	[p17l1053t438r1285b521],
50	rate	NN	O	rate	dep	132	SENT_279	[p17l1306t450r1431b501],
51	by	IN	O	by	dep	132	SENT_279	[p17l1450t438r1534b522],
52	over	IN	O	over	dep	132	SENT_279	[p17l1552t461r1697b501],
53	50	CD	PERCENT	50	dep	132	SENT_279	[p17l1719t443r1859b503],
54	%	NN	PERCENT	%	dep	132	SENT_279	[p17l1719t443r1859b503],
55	as	IN	O	as	dep	132	SENT_279	[p17l1882t461r1946b501],
56	compared	VBN	O	compare	dep	132	SENT_279	[p17l1968t461r2141b501, p17l8t541r199b624],
57	with	IN	O	with	dep	132	SENT_279	[p17l216t541r366b604],
58	placebo	NN	O	placebo	dep	132	SENT_279	[p17l385t541r641b624],
59	(	CD	NUMBER	(	dep	132	SENT_279	[p17l666t542r850b617],
60	RRR	NN	O	rrr	dep	132	SENT_279	[p17l666t542r850b617],
61	of	IN	O	of	dep	132	SENT_279	[p17l868t541r941b604],
62	50	CD	PERCENT	50	dep	132	SENT_279	[p17l953t546r1111b613],
63	%	NN	PERCENT	%	dep	132	SENT_279	[p17l953t546r1111b613],
64	,	,	O	,	_	0	SENT_279	[p17l953t546r1111b613],
65	ARR	NN	ORGANIZATION	arr	dep	132	SENT_279	[p17l1132t545r1297b604],
66	of	IN	O	of	dep	132	SENT_279	[p17l1315t541r1388b604],
67	19	CD	PERCENT	19	dep	132	SENT_279	[p17l1405t546r1558b613],
68	%	NN	PERCENT	%	dep	132	SENT_279	[p17l1405t546r1558b613],
69	,	,	O	,	_	0	SENT_279	[p17l1405t546r1558b613],
70	and	CC	O	and	dep	132	SENT_279	[p17l1581t541r1705b604],
71	an	DT	O	a	dep	132	SENT_279	[p17l1725t564r1804b604],
72	NNT	NN	O	nnt	dep	132	SENT_279	[p17l1823t544r2000b604],
73	of	IN	O	of	dep	132	SENT_279	[p17l2021t541r2094b604],
74	5	CD	NUMBER	5	dep	132	SENT_279	[p17l2106t549r2140b604],
75	over	IN	O	over	dep	132	SENT_279	[p17l10t667r154b707],
76	6	CD	DURATION	6	dep	132	SENT_279	[p17l174t650r210b707],
77	months	NNS	NUMBER	month	dep	132	SENT_279	[p17l231t644r484b707],
78	to	TO	O	to	dep	132	SENT_279	[p17l504t656r569b707],
79	increase	VB	O	increase	dep	132	SENT_279	[p17l591t650r860b707],
80	the	DT	O	the	dep	132	SENT_279	[p17l880t644r984b707],
81	proportion	NN	O	proportion	dep	132	SENT_279	[p17l1003t650r1372b727],
82	of	IN	O	of	dep	132	SENT_279	[p17l1392t644r1465b707],
83	relapse	NN	O	relapse	dep	132	SENT_279	[p17l1476t644r1862b727],
84	—	CD	NUMBER	—	dep	132	SENT_279	[p17l1476t644r1862b727],
85	free	JJ	O	free	dep	132	SENT_279	[p17l1476t644r1862b727],
86	patients	NNS	O	patient	dep	132	SENT_279	[p17l1881t650r2142b727],
87	by	IN	O	by	dep	132	SENT_279	[p17l7t746r90b830],
88	1	CD	NUMBER	1	dep	132	SENT_279	[p17l111t738r250b822],
89	)	CD	NUMBER	)	dep	132	SENT_279	[p17l111t738r250b822],
90	.74	CD	NUMBER	.74	dep	132	SENT_279	[p17l111t738r250b822],
91	Subsequently	NNP	O	Subsequently	dep	132	SENT_279	[p17l269t746r718b830],
92	,	,	O	,	_	0	SENT_279	[p17l269t746r718b830],
93	two	CD	NUMBER	two	dep	132	SENT_279	[p17l737t758r859b809],
94	phase	NN	O	phase	dep	132	SENT_279	[p17l878t746r1067b829],
95	III	CD	NUMBER	iii	dep	132	SENT_279	[p17l1086t751r1166b808],
96	studies	NNS	O	study	dep	132	SENT_279	[p17l1187t746r1413b809],
97	revealed	VBD	O	reveal	dep	132	SENT_279	[p17l1432t746r1708b809],
98	Very	RB	O	very	dep	132	SENT_279	[p17l1723t769r1871b830],
99	consistent	JJ	O	consistent	dep	132	SENT_279	[p17l1887t752r2139b809, p17l10t861r114b912],
100	results	NNS	O	result	dep	132	SENT_279	[p17l133t849r364b912],
101	:	:	O	:	_	0	SENT_279	[p17l133t849r364b912],
102	AFFIRM	VB	O	affirm	dep	132	SENT_279	[p17l387t853r691b912],
103	(	CD	NUMBER	(	dep	132	SENT_279	[p17l716t850r901b926],
104	RRR	NN	O	rrr	dep	132	SENT_279	[p17l716t850r901b926],
105	of	IN	O	of	dep	132	SENT_279	[p17l919t849r992b912],
106	49	CD	PERCENT	49	dep	132	SENT_279	[p17l1002t855r1163b921],
107	%	NN	PERCENT	%	dep	132	SENT_279	[p17l1002t855r1163b921],
108	,	,	O	,	_	0	SENT_279	[p17l1002t855r1163b921],
109	ARR	NN	ORGANIZATION	arr	dep	132	SENT_279	[p17l1185t853r1351b912],
110	of	IN	O	of	dep	132	SENT_279	[p17l1369t849r1442b912],
111	23	CD	PERCENT	23	dep	132	SENT_279	[p17l1453t855r1613b921],
112	%	NN	PERCENT	%	dep	132	SENT_279	[p17l1453t855r1613b921],
113	,	,	O	,	_	0	SENT_279	[p17l1453t855r1613b921],
114	and	CC	O	and	dep	132	SENT_279	[p17l1636t849r1761b912],
115	an	DT	O	a	dep	132	SENT_279	[p17l1781t872r1860b912],
116	NNT	NN	O	nnt	dep	132	SENT_279	[p17l1880t852r2058b912],
117	of	IN	O	of	dep	132	SENT_279	[p17l2079t849r2152b912],
118	4	CD	NUMBER	4	dep	132	SENT_279	[p17l9t959r48b1014],
119	over	IN	O	over	dep	132	SENT_279	[p17l71t975r221b1015],
120	1	CD	DURATION	1	dep	132	SENT_279	[p17l249t959r275b1014],
121	year	NN	NUMBER	year	dep	132	SENT_279	[p17l302t975r448b1036],
122	to	TO	O	to	dep	132	SENT_279	[p17l469t964r536b1015],
123	increase	VB	O	increase	dep	132	SENT_279	[p17l561t958r841b1015],
124	the	DT	O	the	dep	132	SENT_279	[p17l863t952r970b1015],
125	relapse	NN	O	relapse	dep	132	SENT_279	[p17l994t952r1395b1035],
126	—	CD	NUMBER	—	dep	132	SENT_279	[p17l994t952r1395b1035],
127	free	JJ	O	free	dep	132	SENT_279	[p17l994t952r1395b1035],
128	proportion	NN	O	proportion	dep	132	SENT_279	[p17l1418t958r1799b1035],
129	by	IN	O	by	dep	132	SENT_279	[p17l1820t952r1905b1036],
130	1	CD	NUMBER	1	dep	132	SENT_279	[p17l1932t953r1988b1028],
131	)	NN	O	)	dep	132	SENT_279	[p17l1932t953r1988b1028],
132	and	CC	O	and	_	0	SENT_279	[p17l2017t952r2145b1015],

1	VOLUME	NN	O	volume	nn	3	SENT_280	[p17l542t1170r765b1212],
2	95	CD	NUMBER	95	num	3	SENT_280	[p17l783t1171r839b1212],
3	NUMBER	NN	O	number	_	0	SENT_280	[p17l860t1170r1083b1212],
4	1	CD	NUMBER	1	number	5	SENT_280	[p17l1104t1172r1118b1212],
5	|	CD	NUMBER	|	dep	3	SENT_280	[p17l1147t1166r1152b1227],
6	JANUARY	NNP	DATE	JANUARY	dep	5	SENT_280	[p17l1170t1170r1415b1212],
7	2014	CD	DATE	2014	num	6	SENT_280	[p17l1431t1171r1552b1212],
8	|	CD	NUMBER	|	num	9	SENT_280	[p17l1570t1166r1575b1227],
9	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	3	SENT_280	[p17l1593t1170r2143b1223],

1	T	NN	O	t	_	0	SENT_281	[p17l1928t1395r2023b1419],

1	Prevention	NNP	O	Prevention	_	0	SENT_282	[p17l730t1494r876b1516],
2	of	IN	O	of	_	0	SENT_282	[p17l887t1494r914b1516],
3	relapses	NNS	O	relapse	prep_of	1	SENT_282	[p17l924t1495r1039b1522],
4	in	IN	O	in	_	0	SENT_282	[p17l1050t1494r1073b1516],
5	multiple	JJ	O	multiple	amod	6	SENT_282	[p17l1084t1494r1193b1522],
6	sclerosis	NN	O	sclerosis	prep_in	3	SENT_282	[p17l1203t1494r1326b1516],
7	(	CD	NUMBER	(	num	8	SENT_282	[p17l1336t1494r1398b1522],
8	Tier	NN	O	tier	dep	1	SENT_282	[p17l1336t1494r1398b1522],
9	2	CD	NUMBER	2	number	10	SENT_282	[p17l1407t1494r1443b1522],
10	)	CD	NUMBER	)	num	11	SENT_282	[p17l1407t1494r1443b1522],
11	*	NN	O	*	dep	8	SENT_282	[p17l1407t1494r1443b1522],

1	Tier1	NN	O	tier1	nn	3	SENT_283	[p17l663t1582r732b1604],
2	medication	NN	O	medication	nn	3	SENT_283	[p17l747t1582r884b1604],
3	failure	NN	O	failure	_	0	SENT_283	[p17l894t1582r972b1604],
4	Q	NNP	O	Q	dep	3	SENT_283	[p17l981t1582r1026b1607],
5	?	.	O	?	_	0	SENT_283	[p17l981t1582r1026b1607],

1	induction	NN	O	induction	nn	2	SENT_284	[p17l1034t1582r1148b1604],
2	treatment	NN	O	treatment	_	0	SENT_284	[p17l1158t1584r1280b1604],
3	for	IN	O	for	_	0	SENT_284	[p17l1289t1582r1322b1604],
4	“	CD	NUMBER	“	num	6	SENT_284	[p17l1330t1582r1424b1604],
5	severe	JJ	O	severe	amod	6	SENT_284	[p17l1330t1582r1424b1604],
6	MS	NN	O	m	prep_for	2	SENT_284	[p17l1435t1582r1508b1604],
7	”	CD	NUMBER	”	num	8	SENT_284	[p17l1435t1582r1508b1604],
8	**	NN	O	**	dep	2	SENT_284	[p17l1435t1582r1508b1604],

1	Baseline	NN	O	baseline	nn	4	SENT_285	[p17l170t1693r279b1716],
2	JCV	NN	O	jcv	nn	4	SENT_285	[p17l289t1693r343b1716],
3	PCR	NN	O	pcr	nn	4	SENT_285	[p17l354t1693r412b1716],
4	(	NN	O	(	_	0	SENT_285	[p17l423t1693r455b1721],
5	.	.	O	.	_	0	SENT_285	[p17l423t1693r455b1721],

1	—	NN	O	—	_	0	SENT_286	[p17l423t1693r455b1721],
2	.	.	O	.	_	0	SENT_286	[p17l423t1693r455b1721],
3	)	SYM	O	)	dep	1	SENT_286	[p17l423t1693r455b1721],

1	Baseline	NN	O	baseline	nn	4	SENT_287	[p17l662t1693r771b1716],
2	JCV	NN	O	jcv	nn	4	SENT_287	[p17l780t1693r835b1716],
3	PCR	NN	O	pcr	nn	4	SENT_287	[p17l846t1693r904b1716],
4	(	NN	O	(	_	0	SENT_287	[p17l915t1693r947b1721],
5	+	CC	O	+	_	0	SENT_287	[p17l915t1693r947b1721],
6	)	CD	NUMBER	)	num	7	SENT_287	[p17l915t1693r947b1721],
7	y	NN	O	y	conj_+	4	SENT_287	[p17l956t1693r997b1719],
8	no	DT	O	no	det	14	SENT_287	[p17l1006t1699r1036b1715],
9	previous	JJ	O	previous	amod	14	SENT_287	[p17l1047t1693r1154b1721],
10	chronic	JJ	O	chronic	amod	14	SENT_287	[p17l1163t1693r1256b1716],
11	Baseline	NN	O	baseline	nn	14	SENT_287	[p17l1433t1693r1542b1716],
12	JCV	NN	O	jcv	nn	14	SENT_287	[p17l1551t1693r1605b1716],
13	PCR	NN	O	pcr	nn	14	SENT_287	[p17l1616t1693r1675b1716],
14	(	NN	O	(	dep	4	SENT_287	[p17l1685t1693r1717b1721],
15	+	CC	O	+	_	0	SENT_287	[p17l1685t1693r1717b1721],
16	)	NN	O	)	dep	4	SENT_287	[p17l1685t1693r1717b1721],
17	AND	CC	O	and	_	0	SENT_287	[p17l1727t1693r1788b1715],
18	previous	JJ	O	previous	amod	19	SENT_287	[p17l1798t1693r1905b1721],
19	chronic	JJ	O	chronic	conj_+	14	SENT_287	[p17l1915t1693r2008b1716],

1	‘	NN	O	‘	nn	2	SENT_288	[p17l286t1734r336b1777],
2	immunosuppressants	NNS	O	immunosuppressant	_	0	SENT_288	[p17l822t1729r1096b1756],
3	immunosuppressants	NNS	O	immunosuppressant	dep	2	SENT_288	[p17l1583t1729r1857b1756],

1	Natalizumab	NNP	O	Natalizumab	_	0	SENT_289	[p17l233t1795r393b1817],
2	'	POS	O	'	_	0	SENT_289	[p17l930t1765r977b1808],
3	‘	JJ	O	‘	amod	1	SENT_289	[p17l930t1765r977b1808],
4	"	''	O	"	punct	1	SENT_289	[p17l1693t1765r1739b1809],

1	‘	NN	O	‘	nn	3	SENT_290	[p17l286t1838r336b1882],
2	F	NN	O	f	nn	3	SENT_290	[p17l286t1838r336b1882],
3	Fingolimod	NN	O	fingolimod	_	0	SENT_290	[p17l753t1826r892b1854],
4	alone	RB	O	alone	advmod	7	SENT_290	[p17l902t1826r971b1848],
5	as	RB	O	as	quantmod	6	SENT_290	[p17l981t1831r1010b1848],
6	below	IN	O	below	num	7	SENT_290	[p17l1021t1826r1095b1848],
7	%	NN	O	%	rcmod	3	SENT_290	[p17l1103t1826r1147b1851],
8	Fingolimod	NN	O	fingolimod	dep	3	SENT_290	[p17l1586t1824r1725b1852],
9	as	IN	O	as	prep	8	SENT_290	[p17l1735t1829r1764b1846],
10	below	IN	O	below	pobj	9	SENT_290	[p17l1775t1824r1849b1846],

1	_	NN	O	_	_	0	SENT_291	[p17l175t1901r178b1904],
2	_	SYM	O	_	dep	8	SENT_291	[p17l266t1901r269b1904],
3	Natalizumab	FW	O	natalizumab	nsubj	8	SENT_291	[p17l658t1875r817b1897],
4	x	CC	O	x	_	0	SENT_291	[p17l827t1881r842b1896],
5	1	CD	DURATION	1	num	6	SENT_291	[p17l853t1875r861b1897],
6	year	NN	NUMBER	year	conj_x	3	SENT_291	[p17l875t1880r931b1903],
7	(	RB	O	(	advmod	8	SENT_291	[p17l940t1874r1046b1903],
8	monitor	VBP	O	monitor	dep	1	SENT_291	[p17l940t1874r1046b1903],
9	brain	NN	O	brain	nn	10	SENT_291	[p17l1055t1875r1117b1897],
10	MRI	NNP	O	MRI	dobj	8	SENT_291	[p17l1129t1875r1178b1897],
11	every	DT	O	every	det	14	SENT_291	[p17l1189t1880r1258b1903],
12	M	NN	O	m	nn	14	SENT_291	[p17l118t1901r214b1923],
13	°	CD	NUMBER	°	num	14	SENT_291	[p17l118t1901r214b1923],
14	”	NN	O	”	dep	10	SENT_291	[p17l118t1901r214b1923],
15	'	''	O	'	_	0	SENT_291	[p17l118t1901r214b1923],
16	t	NN	O	t	dep	25	SENT_291	[p17l118t1901r214b1923],
17	°	NN	O	°	nn	19	SENT_291	[p17l118t1901r214b1923],
18	'	''	O	'	_	0	SENT_291	[p17l118t1901r214b1923],
19	bram	NN	O	bram	dep	16	SENT_291	[p17l223t1901r285b1923],
20	MR	NN	O	mr	dep	25	SENT_291	[p17l297t1901r346b1923],
21	‘	CD	NUMBER	‘	num	20	SENT_291	[p17l297t1901r346b1923],
22	8	CD	NUMBER	8	num	25	SENT_291	[p17l358t1901r375b1923],
23	‘	NN	O	‘	nn	25	SENT_291	[p17l358t1901r375b1923],
24	JCV	NN	O	jcv	nn	25	SENT_291	[p17l384t1900r439b1923],
25	PCR	NN	O	pcr	dep	10	SENT_291	[p17l449t1900r508b1923],
26	3	CD	DURATION	3	num	27	SENT_291	[p17l680t1910r695b1932],
27	months	NNS	NUMBER	month	dep	25	SENT_291	[p17l706t1910r808b1938],
28	)	RB	O	)	advmod	8	SENT_291	[p17l706t1910r808b1938],
29	followed	VBN	O	follow	_	0	SENT_291	[p17l818t1910r922b1932],
30	by	IN	O	by	_	0	SENT_291	[p17l932t1910r961b1938],
31	Fingolimod	NNP	PERSON	Fingolimod	prep_followed_by	8	SENT_291	[p17l972t1910r1111b1938],
32	as	IN	O	as	_	0	SENT_291	[p17l1121t1915r1150b1932],
33	below	IN	O	below	advmod	36	SENT_291	[p17l1160t1910r1234b1932],
34	every	DT	SET	every	dep	33	SENT_291	[p17l214t1941r284b1964],
35	6	CD	SET	6	num	36	SENT_291	[p17l293t1937r307b1958],
36	months	NNS	NUMBER	month	prep_as	31	SENT_291	[p17l318t1936r411b1958],
37	i	FW	O	i	nn	40	SENT_291	[p17l438t1980r486b2068],
38	Mitoxantrone	FW	O	mitoxantrone	nn	40	SENT_291	[p17l761t1982r926b2004],
39	full	JJ	O	full	amod	40	SENT_291	[p17l935t1982r970b2004],
40	dose	NN	O	dose	dobj	8	SENT_291	[p17l981t1982r1043b2004],
41	within	IN	O	within	_	0	SENT_291	[p17l1052t1982r1124b2004],
42	2	CD	DURATION	2	num	43	SENT_291	[p17l1135t1983r1149b2004],
43	years	NNS	NUMBER	year	prep_within	40	SENT_291	[p17l1159t1988r1228b2010],
44	z	SYM	O	z	dep	40	SENT_291	[p17l1273t1970r1314b2018],
45	+	CC	O	+	_	0	SENT_291	[p17l1273t1970r1314b2018],
46	Previously	RB	DATE	previously	advmod	47	SENT_291	[p17l1429t1981r1560b2009],
47	tolerated	VBD	O	tolerate	conj_+	8	SENT_291	[p17l1569t1981r1681b2003],
48	Tier	NNP	O	Tier	nsubj	50	SENT_291	[p17l1689t1981r1739b2003],
49	1	CD	NUMBER	1	num	50	SENT_291	[p17l1749t1981r1758b2002],
50	medication	NN	O	medication	xcomp	47	SENT_291	[p17l1773t1981r1911b2003],

1	Continued	VBN	O	continue	_	0	SENT_292	[p17l792t2071r922b2110],
2	MS	NN	O	m	nn	3	SENT_292	[p17l934t2088r974b2110],
3	activity	NN	O	activity	iobj	1	SENT_292	[p17l985t2088r1106b2116],
4	***	CD	NUMBER	***	num	3	SENT_292	[p17l985t2088r1106b2116],
5	it	PRP	O	it	dobj	1	SENT_292	[p17l1509t2076r1549b2122],
6	High	JJ	O	high	amod	8	SENT_292	[p17l1607t2088r1664b2116],
7	cardiac	JJ	O	cardiac	amod	8	SENT_292	[p17l1674t2088r1767b2110],
8	risk	NN	O	risk	dobj	1	SENT_292	[p17l1777t2088r1821b2110],
9	f	FW	O	f	dobj	1	SENT_292	[p17l764t2132r813b2172],
10	patient	NN	O	patient	dobj	1	SENT_292	[p17l1622t2123r1707b2151],
11	at	IN	O	at	_	0	SENT_292	[p17l1717t2125r1740b2145],
12	start	NN	O	start	nn	14	SENT_292	[p17l1749t2125r1806b2145],
13	MRI	NNP	MISC	MRI	nn	14	SENT_292	[p17l692t2198r741b2219],
14	follow-upl	NN	O	follow-upl	prep_at	1	SENT_292	[p17l752t2191r878b2225],
15	I	PRP	O	I	dep	14	SENT_292	[p17l1785t2172r1835b2264],

1	JCV	NN	O	jcv	_	0	SENT_293	[p17l198t2300r252b2323],
2	PCFI	NN	O	pcfus	nn	3	SENT_293	[p17l263t2300r322b2323],
3	(	NN	O	(	dep	1	SENT_293	[p17l332t2300r364b2328],
4	+	CC	O	+	_	0	SENT_293	[p17l332t2300r364b2328],
5	)	NN	O	)	nn	7	SENT_293	[p17l332t2300r364b2328],
6	lﬁ	NN	O	lﬁ	nn	7	SENT_293	[p17l414t2288r600b2337],
7	Fingolimod	NN	O	fingolimod	conj_+	3	SENT_293	[p17l715t2302r854b2330],
8	*	CD	NUMBER	*	npadvmod	9	SENT_293	[p17l971t2288r1012b2334],
9	Cardiac	JJ	O	cardiac	amod	7	SENT_293	[p17l1134t2300r1233b2322],
10	&	CC	O	&	_	0	SENT_293	[p17l1243t2300r1260b2322],
11	ophthalmological	JJ	O	ophthalmological	amod	13	SENT_293	[p17l1270t2300r1486b2328],
12	‘	NN	O	‘	nn	13	SENT_293	[p17l1613t2288r1653b2336],
13	Cyclophosphamide	NN	O	cyclophosphamide	conj_and	7	SENT_293	[p17l1686t2299r1932b2327],

1	Natanzumab	NN	PERSON	natanzumab	nn	2	SENT_294	[p17l427t2340r587b2362],
2	complications	NNS	O	complication	_	0	SENT_294	[p17l1112t2335r1287b2363],
3	during	IN	O	during	_	0	SENT_294	[p17l1297t2335r1377b2363],
4	treatment	NN	O	treatment	nn	5	SENT_294	[p17l1386t2337r1509b2357],
5	‘	NN	O	‘	prep_during	2	SENT_294	[p17l1824t2348r1825b2372],
6	<	JJR	O	<	amod	9	SENT_294	[p17l452t2376r482b2397],
7	2	CD	DURATION	2	num	8	SENT_294	[p17l452t2376r482b2397],
8	years	NNS	NUMBER	year	tmod	6	SENT_294	[p17l492t2381r561b2403],
9	t	NN	O	t	dep	2	SENT_294	[p17l762t2346r814b2436],
10	“	CD	NUMBER	“	dep	9	SENT_294	[p17l1785t2348r1837b2402],

1	Natalizumab	NNP	O	Natalizumab	nn	2	SENT_295	[p17l293t2432r452b2454],
2	_	NNP	O	_	nsubj	3	SENT_295	[p17l694t2457r697b2460],
3	_	VBD	O	_	_	0	SENT_295	[p17l864t2457r867b2461],
4	_	CD	NUMBER	_	num	5	SENT_295	[p17l885t2457r888b2461],
5	W	NN	O	w	dobj	3	SENT_295	[p17l914t2457r946b2466],
6	MRI	NNP	O	MRI	nn	7	SENT_295	[p17l1535t2430r1584b2451],
7	follow-upl	NN	O	follow-upl	nsubj	10	SENT_295	[p17l1595t2423r1721b2457],
8	22	CD	DURATION	22	num	9	SENT_295	[p17l317t2468r347b2489],
9	years	NNS	NUMBER	year	tmod	7	SENT_295	[p17l357t2472r426b2495],
10	Continued	VBD	O	continue	rcmod	5	SENT_295	[p17l632t2457r762b2479],
11	MS	NN	O	m	nn	12	SENT_295	[p17l774t2457r814b2479],
12	activity	NN	O	activity	dobj	10	SENT_295	[p17l824t2459r912b2485],
13	1	CD	NUMBER	1	num	12	SENT_295	[p17l1785t2476r1835b2569],

1	Previously	RB	DATE	previously	dep	2	SENT_296	[p17l228t2556r359b2583],
2	I	PRP	O	I	_	0	SENT_296	[p17l762t2496r813b2588],
3	ll	VBP	O	ll	rcmod	2	SENT_296	[p17l200t2591r229b2612],
4	tdt	NN	O	tdt	dobj	3	SENT_296	[p17l273t2591r380b2613],
5	'	''	O	'	_	0	SENT_296	[p17l273t2591r380b2613],
6	1	CD	NUMBER	1	num	7	SENT_296	[p17l273t2591r380b2613],
7	C	NN	O	c	rcmod	4	SENT_296	[p17l1656t2593r1675b2615],
8	'	''	O	'	_	0	SENT_296	[p17l1718t2593r1721b2597],
9	dMS	NN	O	dm	prep	7	SENT_296	[p17l1772t2593r1838b2615],
10	“	CD	NUMBER	“	num	11	SENT_296	[p17l1888t2593r1969b2602],
11	***	CD	NUMBER	***	dep	9	SENT_296	[p17l1888t2593r1969b2602],
12	°	NN	O	°	prep	7	SENT_296	[p17l208t2596r362b2648],
13	r	NN	O	r	dep	12	SENT_296	[p17l208t2596r362b2648],
14	:	:	O	:	_	0	SENT_296	[p17l208t2596r362b2648],
15	:	:	O	:	_	0	SENT_296	[p17l208t2596r362b2648],
16	“‘	CD	NUMBER	“‘	dep	4	SENT_296	[p17l208t2596r362b2648],
17	:	:	O	:	_	0	SENT_296	[p17l208t2596r362b2648],
18	aﬂ	NN	O	aﬂ	nn	19	SENT_296	[p17l208t2596r362b2648],
19	§	NN	O	§	dep	16	SENT_296	[p17l208t2596r362b2648],
20	:	:	O	:	_	0	SENT_296	[p17l208t2596r362b2648],
21	m	NN	O	m	nn	22	SENT_296	[p17l418t2596r602b2648],
22	MRI	NNP	O	MRI	dep	4	SENT_296	[p17l692t2609r741b2630],
23	follow-upl	JJ	O	follow-upl	amod	24	SENT_296	[p17l752t2602r878b2636],
24	°	NN	O	°	dep	22	SENT_296	[p17l1676t2595r1770b2615],
25	"	''	O	"	punct	24	SENT_296	[p17l1676t2595r1770b2615],
26	““	CD	NUMBER	““	number	27	SENT_296	[p17l1676t2595r1770b2615],
27	”	CD	NUMBER	”	dep	24	SENT_296	[p17l1676t2595r1770b2615],
28	e	SYM	O	e	dep	4	SENT_296	[p17l1676t2595r1770b2615],
29	a	DT	O	a	det	34	SENT_296	[p17l1848t2595r1936b2621],
30	°	JJ	O	°	amod	34	SENT_296	[p17l1848t2595r1936b2621],
31	"	``	O	"	punct	34	SENT_296	[p17l1848t2595r1936b2621],
32	"	``	O	"	punct	34	SENT_296	[p17l1848t2595r1936b2621],
33	"	``	O	"	punct	34	SENT_296	[p17l1848t2595r1936b2621],
34	V	NN	O	v	dep	3	SENT_296	[p17l1848t2595r1936b2621],

1	Patient	NN	O	patient	_	0	SENT_297	[p17l553t2714r640b2736],
2	259	CD	NUMBER	259	dep	1	SENT_297	[p17l649t2715r696b2736],
3	AND	CC	O	and	_	0	SENT_297	[p17l706t2714r766b2736],
4	no	DT	O	no	det	5	SENT_297	[p17l777t2720r806b2736],
5	relapse	NN	O	relapse	dep	1	SENT_297	[p17l817t2714r910b2742],
6	or	CC	O	or	_	0	SENT_297	[p17l920t2720r945b2736],
7	MRI	NNP	O	MRI	nn	8	SENT_297	[p17l955t2714r1004b2736],
8	activity	NN	O	activity	conj_or	2	SENT_297	[p17l1016t2714r1104b2742],
9	in	IN	O	in	_	0	SENT_297	[p17l1114t2714r1133b2736],
10	the	DT	DURATION	the	det	13	SENT_297	[p17l1143t2714r1182b2736],
11	last	JJ	DURATION	last	amod	13	SENT_297	[p17l1193t2714r1236b2736],
12	5	CD	DURATION	5	num	13	SENT_297	[p17l1246t2715r1260b2736],
13	years	NNS	NUMBER	year	prep_in	8	SENT_297	[p17l1270t2720r1339b2742],
14	I	PRP	O	I	dep	1	SENT_297	[p17l1787t2638r1837b2732],

1	consider	VB	O	consider	_	0	SENT_298	[p17l616t2768r741b2791],
2	*	NNP	O	*	nn	3	SENT_298	[p17l766t2768r810b2804],
3	High	NNP	O	High	dobj	1	SENT_298	[p17l1542t2757r1655b2784],
4	—	CD	NUMBER	—	num	6	SENT_298	[p17l1542t2757r1655b2784],
5	risk	NN	O	risk	nn	6	SENT_298	[p17l1542t2757r1655b2784],
6	option	NN	O	option	nsubj	1	SENT_298	[p17l1665t2757r1741b2784],
7	of	IN	O	of	_	0	SENT_298	[p17l1752t2757r1775b2778],
8	natalizumab	NN	O	natalizumab	prep_of	6	SENT_298	[p17l1786t2757r1939b2778],
9	in	IN	O	in	_	0	SENT_298	[p17l1951t2757r1970b2778],
10	patients	NNS	O	patient	prep_in	8	SENT_298	[p17l1549t2792r1648b2819],
11	who	WP	O	who	nsubj	14	SENT_298	[p17l1659t2792r1710b2813],
12	did	VBD	O	do	aux	14	SENT_298	[p17l1721t2792r1756b2813],
13	not	RB	O	not	neg	14	SENT_298	[p17l1769t2794r1806b2813],
14	fail	VB	O	fail	rcmod	6	SENT_298	[p17l1816t2792r1849b2813],
15	it	PRP	O	it	dobj	14	SENT_298	[p17l1862t2792r1873b2813],
16	before	IN	O	before	_	0	SENT_298	[p17l1884t2792r1963b2813],
17	NO	NN	O	no	prep_before	14	SENT_298	[p17l579t2832r613b2853],
18	further	JJ	O	further	amod	20	SENT_298	[p17l623t2832r707b2853],
19	prophylactic	NN	O	prophylactic	nn	20	SENT_298	[p17l717t2832r869b2859],
20	treatment	NN	O	treatment	dep	17	SENT_298	[p17l879t2834r1001b2853],
21	Otherwise	RB	O	otherwise	advmod	24	SENT_298	[p17l1539t2844r1667b2866],
22	experimental	JJ	O	experimental	amod	24	SENT_298	[p17l1678t2844r1841b2871],
23	treatment	NN	O	treatment	nn	24	SENT_298	[p17l1852t2846r1974b2865],
24	option	NN	O	option	rcmod	20	SENT_298	[p17l1700t2879r1810b2906],
25	(	CD	NUMBER	(	num	26	SENT_298	[p17l1700t2879r1810b2906],
26	s	NNS	O	s	dep	24	SENT_298	[p17l1700t2879r1810b2906],
27	)	IN	O	)	prep	14	SENT_298	[p17l1700t2879r1810b2906],

1	Figure	NNP	O	Figure	nn	4	SENT_299	[p17l21t2993r111b3023],
2	5	CD	NUMBER	5	num	1	SENT_299	[p17l119t2994r134b3016],
3	Algorithmic	JJ	O	algorithmic	amod	4	SENT_299	[p17l158t2992r315b3023],
4	approach	NN	O	approach	nsubj	11	SENT_299	[p17l322t2992r447b3023],
5	to	TO	O	to	_	0	SENT_299	[p17l455t2996r482b3016],
6	tier	NN	O	tier	nn	10	SENT_299	[p17l490t2993r534b3016],
7	2	CD	NUMBER	2	num	10	SENT_299	[p17l541t2994r555b3016],
8	re	NN	O	re	nn	10	SENT_299	[p17l564t2992r815b3023],
9	|	NN	O	|	nn	10	SENT_299	[p17l564t2992r815b3023],
10	apse	NN	O	apse	prep_to	4	SENT_299	[p17l564t2992r815b3023],
11	—	CD	NUMBER	—	_	0	SENT_299	[p17l564t2992r815b3023],
12	preventing	VBG	O	prevent	partmod	11	SENT_299	[p17l564t2992r815b3023],
13	medications	NNS	O	medication	dobj	12	SENT_299	[p17l825t2992r987b3017],
14	when	WRB	O	when	advmod	18	SENT_299	[p17l994t2992r1068b3016],
15	tier	NN	O	tier	nsubj	18	SENT_299	[p17l1076t2993r1120b3016],
16	1	CD	NUMBER	1	num	17	SENT_299	[p17l1130t2994r1137b3016],
17	medications	NNS	O	medication	dep	15	SENT_299	[p17l1151t2992r1313b3017],
18	fail	VBP	O	fail	advcl	12	SENT_299	[p17l1320t2992r1357b3016],
19	or	CC	O	or	dep	20	SENT_299	[p17l1366t2999r1393b3016],
20	as	IN	O	as	dep	11	SENT_299	[p17l1401t2999r1427b3017],
21	an	DT	O	a	det	23	SENT_299	[p17l1435t2999r1465b3017],
22	induction	NN	O	induction	nn	23	SENT_299	[p17l1475t2992r1601b3017],
23	treatment	NN	O	treatment	pobj	20	SENT_299	[p17l1609t2996r1743b3017],
24	in	IN	O	in	_	0	SENT_299	[p17l1751t2993r1773b3016],
25	select	JJ	O	select	amod	26	SENT_299	[p17l1782t2992r1858b3017],
26	patients	NNS	O	patient	prep_in	23	SENT_299	[p17l1867t2993r1972b3023],
27	with	IN	O	with	_	0	SENT_299	[p17l1980t2992r2037b3016],
28	severe-disease	NN	O	severe-disease	nn	29	SENT_299	[p17l20t3033r215b3058],
29	onset	NN	O	onset	prep_with	26	SENT_299	[p17l223t3037r302b3058],
30	.	.	O	.	_	0	SENT_299	[p17l223t3037r302b3058],

1	As	IN	O	as	prep	16	SENT_300	[p17l310t3035r340b3058],
2	with	IN	O	with	pcomp	1	SENT_300	[p17l348t3033r405b3058],
3	the	DT	O	the	det	6	SENT_300	[p17l413t3033r457b3058],
4	tier	NN	O	tier	nn	6	SENT_300	[p17l464t3035r508b3058],
5	1	CD	NUMBER	1	num	6	SENT_300	[p17l518t3035r525b3057],
6	medications	NNS	O	medication	pobj	2	SENT_300	[p17l539t3033r701b3058],
7	shown	VBN	O	show	partmod	6	SENT_300	[p17l709t3033r796b3058],
8	in	IN	O	in	_	0	SENT_300	[p17l805t3035r827b3057],
9	Figure	NNP	O	Figure	prep_in	7	SENT_300	[p17l837t3034r926b3064],
10	4	CD	NUMBER	4	num	9	SENT_300	[p17l933t3035r956b3061],
11	,	,	O	,	_	0	SENT_300	[p17l933t3035r956b3061],
12	this	DT	O	this	det	13	SENT_300	[p17l963t3033r1010b3058],
13	approach	NN	O	approach	nsubjpass	16	SENT_300	[p17l1018t3033r1143b3064],
14	can	MD	O	can	aux	16	SENT_300	[p17l1152t3040r1197b3058],
15	be	VB	O	be	auxpass	16	SENT_300	[p17l1207t3033r1239b3058],
16	modiﬁed	VBN	O	modiﬁed	conj_and	16	SENT_300	[p17l1247t3033r1365b3058],
17	to	TO	O	to	_	0	SENT_300	[p17l1373t3037r1400b3058],
18	individual	JJ	O	individual	amod	19	SENT_300	[p17l1409t3033r1538b3058],
19	needs	NNS	O	need	prep_to	16	SENT_300	[p17l1548t3033r1626b3058],
20	of	IN	O	of	_	0	SENT_300	[p17l1634t3033r1661b3058],
21	the	DT	O	the	det	22	SENT_300	[p17l1666t3033r1710b3058],
22	patient	NN	O	patient	prep_of	19	SENT_300	[p17l1718t3035r1812b3064],
23	and	CC	O	and	_	0	SENT_300	[p17l1820t3033r1868b3058],
24	as	IN	O	as	_	0	SENT_300	[p17l1877t3040r1904b3058],
25	more	JJR	O	more	amod	26	SENT_300	[p17l1913t3040r1981b3058],
26	strategies	NNS	O	strategy	prep_as	16	SENT_300	[p17l1989t3035r2116b3064],
27	become	VBP	O	become	cop	28	SENT_300	[p17l21t3075r128b3099],
28	available	JJ	O	available	rcmod	26	SENT_300	[p17l136t3075r252b3099],
29	in	IN	O	in	_	0	SENT_300	[p17l261t3076r282b3099],
30	the	DT	DATE	the	det	31	SENT_300	[p17l291t3075r334b3099],
31	future	NN	DATE	future	prep_in	28	SENT_300	[p17l341t3075r428b3099],
32	.	.	O	.	_	0	SENT_300	[p17l341t3075r428b3099],

1	*	NN	O	*	nsubj	14	SENT_301	[p17l436t3075r501b3099],
2	This	DT	O	this	nsubj	6	SENT_301	[p17l436t3075r501b3099],
3	is	VBZ	O	be	cop	6	SENT_301	[p17l510t3076r527b3099],
4	a	DT	O	a	det	6	SENT_301	[p17l535t3082r548b3099],
5	sample	NN	O	sample	nn	6	SENT_301	[p17l557t3075r652b3106],
6	protocol	NN	O	protocol	rcmod	1	SENT_301	[p17l661t3075r771b3106],
7	that	WDT	O	that	nsubjpass	10	SENT_301	[p17l779t3075r833b3099],
8	can	MD	O	can	aux	10	SENT_301	[p17l840t3082r885b3099],
9	be	VB	O	be	auxpass	10	SENT_301	[p17l895t3075r927b3099],
10	modified	VBN	O	modify	rcmod	6	SENT_301	[p17l936t3075r1053b3099],
11	to	TO	O	to	_	0	SENT_301	[p17l1061t3079r1088b3099],
12	the	DT	O	the	det	13	SENT_301	[p17l1095t3075r1139b3099],
13	needs	NNS	O	need	prep_to	10	SENT_301	[p17l1148t3075r1226b3099],
14	ofthe	VBP	O	ofthe	_	0	SENT_301	[p17l1234t3075r1310b3099],
15	individual	JJ	O	individual	amod	16	SENT_301	[p17l1318t3075r1447b3099],
16	patient	NN	O	patient	dobj	14	SENT_301	[p17l1457t3076r1551b3106],
17	and	CC	O	and	_	0	SENT_301	[p17l1558t3075r1607b3099],
18	availability	NN	O	availability	nn	20	SENT_301	[p17l1616t3075r1758b3106],
19	ofdifferent	JJ	O	ofdifferent	amod	20	SENT_301	[p17l1765t3075r1911b3099],
20	modalities	NNS	O	modality	dobj	14	SENT_301	[p17l1920t3075r2057b3099],
21	in	IN	O	in	_	0	SENT_301	[p17l2066t3076r2088b3099],
22	different	JJ	O	different	amod	23	SENT_301	[p17l20t3116r133b3141],
23	centers	NNS	O	center	prep_in	14	SENT_301	[p17l141t3120r237b3141],
24	and	CC	O	and	_	0	SENT_301	[p17l244t3116r293b3141],
25	different	JJ	O	different	amod	26	SENT_301	[p17l302t3116r415b3141],
26	countries	NNS	O	country	prep_in	14	SENT_301	[p17l423t3117r552b3141],
27	.	.	O	.	_	0	SENT_301	[p17l423t3117r552b3141],

1	**	NN	O	**	nn	3	SENT_302	[p17l560t3117r652b3141],
2	Tier1	NN	O	tier1	nn	3	SENT_302	[p17l560t3117r652b3141],
3	failure	NN	O	failure	nsubjpass	5	SENT_302	[p17l664t3116r747b3141],
4	is	VBZ	O	be	auxpass	5	SENT_302	[p17l755t3117r773b3140],
5	deﬁned	VBN	O	deﬁned	_	0	SENT_302	[p17l781t3116r881b3141],
6	as	IN	O	as	_	0	SENT_302	[p17l890t3123r916b3140],
7	failing	VBG	O	fail	prepc_as	5	SENT_302	[p17l923t3116r1004b3147],
8	the	DT	O	the	det	10	SENT_302	[p17l1013t3116r1056b3141],
9	medication	NN	O	medication	nn	10	SENT_302	[p17l1065t3116r1213b3141],
10	approach	NN	O	approach	dobj	7	SENT_302	[p17l1222t3116r1347b3147],
11	in	IN	O	in	_	0	SENT_302	[p17l1357t3117r1378b3140],
12	Figure	NNP	O	Figure	prep_in	7	SENT_302	[p17l1388t3117r1477b3147],
13	4	CD	NUMBER	4	num	12	SENT_302	[p17l1484t3118r1507b3140],
14	.	.	O	.	_	0	SENT_302	[p17l1484t3118r1507b3140],

1	We	PRP	O	we	nsubj	2	SENT_303	[p17l1513t3117r1555b3140],
2	define	VBP	O	define	_	0	SENT_303	[p17l1562t3116r1646b3141],
3	severe-disease	JJ	O	severe-disease	amod	4	SENT_303	[p17l1654t3116r1848b3141],
4	onset	NN	O	onset	dobj	2	SENT_303	[p17l1856t3120r1929b3141],
5	conservatively	RB	O	conservatively	advmod	2	SENT_303	[p17l1937t3116r2135b3147],
6	:	:	O	:	_	0	SENT_303	[p17l1937t3116r2135b3147],
7	>	JJR	O	>	amod	9	SENT_303	[p17l21t3159r53b3181],
8	3	CD	NUMBER	3	num	9	SENT_303	[p17l21t3159r53b3181],
9	relapses	NNS	O	relapse	nsubj	30	SENT_303	[p17l63t3157r169b3187],
10	within	IN	O	within	_	0	SENT_303	[p17l177t3157r259b3181],
11	6	CD	DURATION	6	num	12	SENT_303	[p17l268t3159r283b3181],
12	months	NNS	NUMBER	month	prep_within	9	SENT_303	[p17l292t3157r398b3185],
13	,	,	O	,	_	0	SENT_303	[p17l292t3157r398b3185],
14	limited	JJ	O	limited	amod	15	SENT_303	[p17l408t3157r498b3181],
15	recovery	NN	O	recovery	prep_within	9	SENT_303	[p17l507t3164r625b3188],
16	,	,	O	,	_	0	SENT_303	[p17l507t3164r625b3188],
17	and	CC	O	and	_	0	SENT_303	[p17l633t3157r682b3181],
18	multiple	JJ	O	multiple	prep_within	9	SENT_303	[p17l692t3157r801b3187],
19	enhancing	VBG	O	enhance	partmod	9	SENT_303	[p17l809t3157r949b3188],
20	lesions	NNS	O	lesion	nn	21	SENT_303	[p17l959t3157r1048b3181],
21	(	NN	O	(	dobj	19	SENT_303	[p17l1057t3157r1195b3188],
22	especially	RB	O	especially	advmod	19	SENT_303	[p17l1057t3157r1195b3188],
23	with	IN	O	with	_	0	SENT_303	[p17l1202t3157r1259b3181],
24	early	JJ	O	early	amod	25	SENT_303	[p17l1268t3157r1332b3188],
25	evolution	NN	O	evolution	prep_with	19	SENT_303	[p17l1339t3157r1464b3181],
26	into	IN	O	into	_	0	SENT_303	[p17l1474t3159r1524b3181],
27	chronicT1	NN	O	chronict1	nn	29	SENT_303	[p17l1532t3157r1662b3181],
28	black	JJ	O	black	amod	29	SENT_303	[p17l1676t3157r1745b3181],
29	holes	NNS	O	hole	prep_into	19	SENT_303	[p17l1753t3157r1838b3185],
30	)	VBP	O	)	parataxis	2	SENT_303	[p17l1753t3157r1838b3185],
31	.	.	O	.	_	0	SENT_303	[p17l1753t3157r1838b3185],

1	A	DT	O	a	det	3	SENT_304	[p17l1845t3159r1864b3181],
2	wider	JJR	O	wider	amod	3	SENT_304	[p17l1871t3157r1946b3181],
3	definition	NN	O	definition	nsubj	14	SENT_304	[p17l1953t3157r2080b3181],
4	of	IN	O	of	_	0	SENT_304	[p17l20t3198r48b3222],
5	severe	JJ	O	severe	amod	6	SENT_304	[p17l53t3205r138b3222],
6	MS	NN	O	m	prep_of	3	SENT_304	[p17l146t3199r185b3222],
7	(	CD	NUMBER	(	num	6	SENT_304	[p17l194t3199r243b3226],
8	i.e.	FW	O	i.e.	nsubj	12	SENT_304	[p17l194t3199r243b3226],
9	,	,	O	,	_	0	SENT_304	[p17l194t3199r243b3226],
10	fewer	JJR	O	fewer	amod	11	SENT_304	[p17l251t3198r325b3222],
11	relapses	NNS	O	relapse	appos	8	SENT_304	[p17l334t3198r448b3229],
12	)	VBP	O	)	rcmod	6	SENT_304	[p17l334t3198r448b3229],
13	may	MD	O	may	aux	14	SENT_304	[p17l458t3205r513b3229],
14	bejustiﬁed	VBN	O	bejustiﬁed	_	0	SENT_304	[p17l521t3198r665b3229],
15	in	IN	O	in	_	0	SENT_304	[p17l675t3199r696b3222],
16	the	DT	DATE	the	det	17	SENT_304	[p17l705t3198r748b3222],
17	future	NN	DATE	future	prep_in	14	SENT_304	[p17l755t3198r836b3222],
18	if	IN	O	if	mark	27	SENT_304	[p17l845t3198r861b3222],
19	risk	NN	O	risk	nn	20	SENT_304	[p17l868t3198r912b3222],
20	stratification	NN	O	stratification	nsubjpass	27	SENT_304	[p17l919t3198r1083b3222],
21	in	IN	O	in	_	0	SENT_304	[p17l1092t3199r1114b3222],
22	tier	NN	O	tier	nn	24	SENT_304	[p17l1122t3199r1166b3222],
23	2	CD	NUMBER	2	num	24	SENT_304	[p17l1174t3200r1188b3222],
24	medications	NNS	O	medication	prep_in	20	SENT_304	[p17l1197t3198r1359b3222],
25	can	MD	O	can	aux	27	SENT_304	[p17l1367t3205r1412b3222],
26	be	VB	O	be	auxpass	27	SENT_304	[p17l1422t3198r1453b3222],
27	done	VBN	O	do	advcl	14	SENT_304	[p17l1461t3198r1529b3222],
28	more	RBR	O	more	advmod	27	SENT_304	[p17l1538t3205r1606b3222],
29	precisely	RB	O	precisely	advmod	27	SENT_304	[p17l1615t3198r1735b3229],
30	.	.	O	.	_	0	SENT_304	[p17l1615t3198r1735b3229],

1	***	CD	NUMBER	***	nsubj	18	SENT_305	[p17l1743t3199r1824b3222],
2	We	PRP	O	we	nsubj	3	SENT_305	[p17l1743t3199r1824b3222],
3	deﬁne	VBP	O	deﬁne	rcmod	1	SENT_305	[p17l1832t3198r1915b3222],
4	continued	VBN	O	continue	amod	6	SENT_305	[p17l1923t3198r2057b3222],
5	MS	NN	O	m	nn	6	SENT_305	[p17l2067t3199r2106b3222],
6	activity	NN	O	activity	dobj	3	SENT_305	[p17l20t3240r116b3270],
7	practically	RB	O	practically	advmod	6	SENT_305	[p17l125t3239r259b3270],
8	as	IN	O	as	_	0	SENT_305	[p17l267t3246r293b3264],
9	a	DT	O	a	det	10	SENT_305	[p17l301t3246r314b3263],
10	relapse	NN	O	relapse	prep_as	6	SENT_305	[p17l323t3239r417b3270],
11	and	CC	O	and	_	0	SENT_305	[p17l425t3239r474b3264],
12	22	CD	NUMBER	22	num	14	SENT_305	[p17l482t3241r514b3263],
13	new	JJ	O	new	amod	14	SENT_305	[p17l524t3246r579b3264],
14	MS	NN	O	m	conj_and	10	SENT_305	[p17l587t3239r729b3264],
15	—	CD	NUMBER	—	num	17	SENT_305	[p17l587t3239r729b3264],
16	re	NN	O	re	nn	17	SENT_305	[p17l587t3239r729b3264],
17	|	NN	O	|	dep	14	SENT_305	[p17l587t3239r729b3264],
18	ated	VBD	O	ate	_	0	SENT_305	[p17l587t3239r729b3264],
19	lesion	NN	O	lesion	nn	20	SENT_305	[p17l739t3239r814b3264],
20	formations	NNS	O	formation	dobj	18	SENT_305	[p17l823t3239r967b3264],
21	in	IN	O	in	_	0	SENT_305	[p17l976t3240r998b3263],
22	the	DT	O	the	det	23	SENT_305	[p17l1006t3239r1049b3263],
23	MRI	NNP	O	MRI	prep_in	18	SENT_305	[p17l1058t3240r1105b3263],
24	within	IN	O	within	_	0	SENT_305	[p17l1114t3239r1196b3263],
25	the	DT	O	the	det	26	SENT_305	[p17l1205t3239r1248b3264],
26	last	JJ	O	last	nsubj	27	SENT_305	[p17l1257t3239r1301b3264],
27	follow	VB	O	follow	dep	53	SENT_305	[p17l1307t3239r1435b3270],
28	—	CD	NUMBER	—	npadvmod	29	SENT_305	[p17l1307t3239r1435b3270],
29	up	IN	O	up	advmod	27	SENT_305	[p17l1307t3239r1435b3270],
30	period	NN	O	period	pobj	29	SENT_305	[p17l1444t3239r1528b3270],
31	or	CC	O	or	_	0	SENT_305	[p17l1537t3246r1564b3263],
32	a	DT	O	a	det	33	SENT_305	[p17l1571t3246r1584b3263],
33	patient	NN	O	patient	pobj	29	SENT_305	[p17l1594t3240r1688b3270],
34	with	IN	O	with	_	0	SENT_305	[p17l1695t3239r1752b3264],
35	23	CD	NUMBER	23	num	38	SENT_305	[p17l1761t3241r1792b3264],
36	new	JJ	O	new	amod	38	SENT_305	[p17l1802t3246r1857b3263],
37	lesion	NN	O	lesion	nn	38	SENT_305	[p17l1866t3239r1941b3264],
38	formations	NNS	O	formation	prep_with	27	SENT_305	[p17l1949t3239r2094b3263],
39	per	IN	O	per	_	0	SENT_305	[p17l21t3287r64b3310],
40	year	NN	DURATION	year	prep_per	38	SENT_305	[p17l70t3287r131b3311],
41	,	,	O	,	_	0	SENT_305	[p17l70t3287r131b3311],
42	especially	RB	O	especially	advmod	27	SENT_305	[p17l139t3280r268b3311],
43	with	IN	O	with	_	0	SENT_305	[p17l275t3280r332b3304],
44	gadolinium	NN	O	gadolinium	nn	45	SENT_305	[p17l341t3280r493b3311],
45	enhancement	NN	O	enhancement	prep_with	27	SENT_305	[p17l502t3280r693b3308],
46	,	,	O	,	_	0	SENT_305	[p17l502t3280r693b3308],
47	even	RB	O	even	advmod	27	SENT_305	[p17l701t3287r764b3304],
48	in	IN	O	in	_	0	SENT_305	[p17l773t3281r795b3304],
49	the	DT	O	the	det	51	SENT_305	[p17l803t3280r847b3304],
50	absence	NN	O	absence	nn	51	SENT_305	[p17l855t3280r964b3304],
51	ofany	NN	O	ofany	prep_in	27	SENT_305	[p17l972t3280r1052b3311],
52	new	JJ	O	new	amod	53	SENT_305	[p17l1060t3287r1115b3304],
53	relapse	NN	O	relapse	prep_within	18	SENT_305	[p17l1124t3280r1223b3310],
54	.	.	O	.	_	0	SENT_305	[p17l1124t3280r1223b3310],

1	We	PRP	O	we	nsubj	2	SENT_306	[p17l1229t3281r1270b3304],
2	see	VBP	O	see	_	0	SENT_306	[p17l1279t3287r1322b3304],
3	this	DT	O	this	dobj	2	SENT_306	[p17l1329t3280r1376b3304],
4	as	IN	O	as	_	0	SENT_306	[p17l1384t3287r1410b3304],
5	a	DT	O	a	det	6	SENT_306	[p17l1418t3287r1431b3304],
6	reason	NN	O	reason	prep_as	3	SENT_306	[p17l1441t3287r1527b3304],
7	to	TO	O	to	aux	8	SENT_306	[p17l1535t3284r1562b3304],
8	change	VB	O	change	infmod	6	SENT_306	[p17l1570t3280r1668b3311],
9	management	NN	O	management	nn	10	SENT_306	[p17l1677t3284r1856b3311],
10	strategy	NN	O	strategy	dobj	8	SENT_306	[p17l1863t3284r1975b3311],
11	.	.	O	.	_	0	SENT_306	[p17l1863t3284r1975b3311],

1	IMRI	NNP	O	IMRI	nn	3	SENT_307	[p17l1983t3276r2043b3304],
2	(	CD	NUMBER	(	num	3	SENT_307	[p17l2053t3280r2128b3308],
3	brain	NN	O	brain	nn	8	SENT_307	[p17l2053t3280r2128b3308],
4	and	CC	O	and	_	0	SENT_307	[p17l20t3321r69b3345],
5	cervical	JJ	O	cervical	amod	7	SENT_307	[p17l78t3321r177b3345],
6	spinal	JJ	O	spinal	amod	7	SENT_307	[p17l186t3321r262b3352],
7	cord	NN	O	cord	nn	8	SENT_307	[p17l271t3321r338b3349],
8	)	NN	O	)	_	0	SENT_307	[p17l271t3321r338b3349],
9	fo	NN	O	fo	nn	12	SENT_307	[p17l346t3321r473b3352],
10	|	CD	NUMBER	|	num	12	SENT_307	[p17l346t3321r473b3352],
11	|	NN	O	|	nn	12	SENT_307	[p17l346t3321r473b3352],
12	ow	NN	O	ow	conj_and	12	SENT_307	[p17l346t3321r473b3352],
13	—	CD	NUMBER	—	dep	14	SENT_307	[p17l346t3321r473b3352],
14	up	RP	O	up	advmod	12	SENT_307	[p17l346t3321r473b3352],
15	at	IN	O	at	_	0	SENT_307	[p17l481t3325r506b3345],
16	6	CD	DURATION	6	num	17	SENT_307	[p17l513t3323r528b3345],
17	months	NNS	NUMBER	month	prep_at	12	SENT_307	[p17l537t3321r643b3349],
18	,	,	O	,	_	0	SENT_307	[p17l537t3321r643b3349],
19	12	CD	DURATION	12	num	20	SENT_307	[p17l654t3323r682b3345],
20	months	NNS	NUMBER	month	appos	17	SENT_307	[p17l691t3321r798b3349],
21	,	,	O	,	_	0	SENT_307	[p17l691t3321r798b3349],
22	36	CD	DURATION	36	num	23	SENT_307	[p17l806t3323r837b3345],
23	months	NNS	NUMBER	month	appos	20	SENT_307	[p17l846t3321r953b3349],
24	,	,	O	,	_	0	SENT_307	[p17l846t3321r953b3349],
25	60	CD	DURATION	60	num	26	SENT_307	[p17l961t3323r992b3345],
26	months	NNS	NUMBER	month	tmod	20	SENT_307	[p17l1001t3321r1108b3349],
27	,	,	O	,	_	0	SENT_307	[p17l1001t3321r1108b3349],
28	and	CC	O	and	_	0	SENT_307	[p17l1116t3321r1165b3345],
29	as	IN	O	as	_	0	SENT_307	[p17l1174t3328r1200b3345],
30	needed	VBN	O	need	prepc_as	12	SENT_307	[p17l1209t3321r1307b3345],
31	thereafter	RB	O	thereafter	advmod	30	SENT_307	[p17l1316t3321r1448b3345],
32	(	RB	O	(	advmod	30	SENT_307	[p17l1456t3322r1516b3352],
33	e.g.	FW	O	e.g.	dep	12	SENT_307	[p17l1456t3322r1516b3352],
34	,	,	O	,	_	0	SENT_307	[p17l1456t3322r1516b3352],
35	after	IN	O	after	dep	38	SENT_307	[p17l1523t3321r1585b3345],
36	management	NN	O	management	nn	37	SENT_307	[p17l1593t3325r1772b3352],
37	changes	NNS	O	change	pobj	35	SENT_307	[p17l1779t3321r1905b3352],
38	)	CD	NUMBER	)	rcmod	33	SENT_307	[p17l1779t3321r1905b3352],
39	.	.	O	.	_	0	SENT_307	[p17l1779t3321r1905b3352],

1	MRI	NNP	O	MRI	_	0	SENT_308	[p17l1914t3322r1969b3349],
2	,	,	O	,	_	0	SENT_308	[p17l1914t3322r1969b3349],
3	magnetic	JJ	O	magnetic	amod	5	SENT_308	[p17l1978t3322r2102b3352],
4	resonance	NN	O	resonance	nn	5	SENT_308	[p17l11t3389r292b3424],
5	imaging	NN	O	imaging	appos	1	SENT_308	[p17l311t3377r549b3437],
6	;	:	O	;	_	0	SENT_308	[p17l311t3377r549b3437],
7	MS	NN	O	m	dep	1	SENT_308	[p17l567t3376r663b3431],
8	,	,	O	,	_	0	SENT_308	[p17l567t3376r663b3431],
9	multiple	JJ	O	multiple	amod	10	SENT_308	[p17l681t3375r908b3436],
10	sclerosis	NN	O	sclerosis	appos	7	SENT_308	[p17l925t3375r1166b3424],
11	.	.	O	.	_	0	SENT_308	[p17l925t3375r1166b3424],

1	SENTINEL	NNP	O	SENTINEL	_	0	SENT_309	[p17l10t3532r400b3593],
2	(	CD	NUMBER	(	num	3	SENT_309	[p17l424t3530r610b3606],
3	RRR	NN	O	rrr	dep	1	SENT_309	[p17l424t3530r610b3606],
4	of	IN	O	of	_	0	SENT_309	[p17l629t3529r702b3592],
5	31	CD	PERCENT	31	num	6	SENT_309	[p17l715t3535r875b3601],
6	%	NN	PERCENT	%	prep_of	3	SENT_309	[p17l715t3535r875b3601],
7	,	,	O	,	_	0	SENT_309	[p17l715t3535r875b3601],
8	ARR	NN	ORGANIZATION	arr	prep_of	3	SENT_309	[p17l897t3533r1064b3592],
9	of	IN	O	of	_	0	SENT_309	[p17l1083t3529r1157b3592],
10	17	CD	PERCENT	17	num	11	SENT_309	[p17l1174t3535r1329b3601],
11	%	NN	PERCENT	%	prep_of	8	SENT_309	[p17l1174t3535r1329b3601],
12	,	,	O	,	_	0	SENT_309	[p17l1174t3535r1329b3601],
13	and	CC	O	and	_	0	SENT_309	[p17l1353t3529r1479b3592],
14	an	DT	O	a	det	15	SENT_309	[p17l1499t3552r1579b3592],
15	NNT	NN	O	nnt	conj_and	6	SENT_309	[p17l1599t3532r1778b3592],
16	of	IN	O	of	_	0	SENT_309	[p17l1800t3529r1874b3593],
17	6	CD	NUMBER	6	number	19	SENT_309	[p17l1885t3535r1922b3592],
18	over	IN	O	over	quantmod	19	SENT_309	[p17l1945t3552r2091b3592],
19	1	CD	NUMBER	1	prep_of	15	SENT_309	[p17l2117t3536r2142b3592],

1	year	NN	DURATION	year	_	0	SENT_310	[p18l6t43r153b104],
2	to	TO	O	to	aux	3	SENT_310	[p18l173t32r240b83],
3	increase	VB	O	increase	dep	1	SENT_310	[p18l264t26r543b83],
4	the	DT	O	the	det	6	SENT_310	[p18l565t20r672b83],
5	relapse-free	JJ	O	relapse-free	amod	6	SENT_310	[p18l695t20r1095b103],
6	proportion	NN	O	proportion	dobj	3	SENT_310	[p18l1117t26r1498b103],
7	by	IN	O	by	_	0	SENT_310	[p18l1519t20r1604b104],
8	1	CD	NUMBER	1	number	9	SENT_310	[p18l1630t21r1708b96],
9	)	CD	NUMBER	)	prep_by	3	SENT_310	[p18l1630t21r1708b96],
10	.	.	O	.	_	0	SENT_310	[p18l1630t21r1708b96],

1	The	DT	O	the	det	2	SENT_311	[p18l1734t20r1861b83],
2	proportion	NN	O	proportion	nsubj	12	SENT_311	[p18l1882t42r2146b103, p18l8t129r142b186],
3	of	IN	O	of	_	0	SENT_311	[p18l163t123r236b186],
4	patients	NNS	O	patient	prep_of	2	SENT_311	[p18l246t129r509b206],
5	without	IN	O	without	_	0	SENT_311	[p18l528t123r791b186],
6	clinical	JJ	O	clinical	prep_without	4	SENT_311	[p18l810t123r1048b186],
7	and	CC	O	and	_	0	SENT_311	[p18l1069t123r1193b186],
8	MRI	NNP	O	MRI	nn	9	SENT_311	[p18l1212t128r1367b186],
9	activity	NN	O	activity	conj_and	6	SENT_311	[p18l1389t129r1634b207],
10	was	VBD	O	be	cop	12	SENT_311	[p18l1649t146r1774b186],
11	46	CD	PERCENT	46	num	12	SENT_311	[p18l1794t128r1936b188],
12	%	NN	PERCENT	%	_	0	SENT_311	[p18l1794t128r1936b188],
13	in	IN	O	in	_	0	SENT_311	[p18l1958t129r2024b185],
14	the	DT	O	the	det	16	SENT_311	[p18l2044t123r2148b186],
15	natalizumab	JJ	O	natalizumab	amod	16	SENT_311	[p18l8t226r419b289],
16	group	NN	O	group	prep_in	12	SENT_311	[p18l438t248r633b310],
17	and	CC	O	and	_	0	SENT_311	[p18l653t226r777b289],
18	14	CD	PERCENT	14	num	19	SENT_311	[p18l801t232r934b291],
19	%	NN	PERCENT	%	conj_and	12	SENT_311	[p18l801t232r934b291],
20	in	IN	O	in	_	0	SENT_311	[p18l954t232r1020b288],
21	the	DT	O	the	det	23	SENT_311	[p18l1037t226r1141b289],
22	placebo	NN	O	placebo	nn	23	SENT_311	[p18l1158t226r1413b309],
23	group	NN	O	group	prep_in	19	SENT_311	[p18l1433t248r1641b310],
24	.	.	O	.	_	0	SENT_311	[p18l1433t248r1641b310],

1	Based	VBN	O	base	_	0	SENT_312	[p18l1663t226r1860b289],
2	on	IN	O	on	prepc_based_on	10	SENT_312	[p18l1877t249r1962b289],
3	these	DT	O	these	det	4	SENT_312	[p18l1979t226r2150b289],
4	studies	NNS	O	study	pobj	10	SENT_312	[p18l10t329r261b401],
5	,	,	O	,	_	0	SENT_312	[p18l10t329r261b401],
6	natalizumab	NN	O	natalizumab	nsubj	10	SENT_312	[p18l285t329r706b392],
7	is	VBZ	O	be	cop	10	SENT_312	[p18l729t335r779b392],
8	clearly	RB	O	clearly	advmod	10	SENT_312	[p18l802t329r1025b413],
9	more	RBR	O	more	advmod	10	SENT_312	[p18l1042t352r1220b392],
10	effective	JJ	O	effective	_	0	SENT_312	[p18l1243t329r1522b392],
11	than	IN	O	than	mark	15	SENT_312	[p18l1542t329r1697b392],
12	all	PDT	O	all	predet	13	SENT_312	[p18l1719t329r1797b392],
13	the	DT	O	the	nsubj	15	SENT_312	[p18l1817t329r1923b392],
14	previously	RB	DATE	previously	advmod	15	SENT_312	[p18l1944t335r2144b412, p18l9t432r186b516],
15	discussed	VBN	O	discuss	advcl	10	SENT_312	[p18l203t432r522b495],
16	tier	NN	O	tier	tmod	15	SENT_312	[p18l540t438r654b495],
17	1	CD	NUMBER	1	num	18	SENT_312	[p18l680t439r705b494],
18	medications	NNS	O	medication	dep	16	SENT_312	[p18l731t432r1154b495],
19	.	.	O	.	_	0	SENT_312	[p18l731t432r1154b495],

1	However	RB	O	however	advmod	21	SENT_313	[p18l1178t437r1491b504],
2	,	,	O	,	_	0	SENT_313	[p18l1178t437r1491b504],
3	due	JJ	O	due	_	0	SENT_313	[p18l1513t432r1634b495],
4	to	TO	O	to	_	0	SENT_313	[p18l1653t444r1718b495],
5	the	DT	O	the	det	7	SENT_313	[p18l1739t432r1843b495],
6	unfortunate	JJ	O	unfortunate	amod	7	SENT_313	[p18l1864t432r2147b495, p18l8t547r150b598],
7	incidence	NN	O	incidence	prep_due_to	21	SENT_313	[p18l171t535r496b598],
8	of	IN	O	of	_	0	SENT_313	[p18l518t535r592b598],
9	PML	NN	ORGANIZATION	pml	prep_of	7	SENT_313	[p18l604t540r773b597],
10	among	IN	O	among	_	0	SENT_313	[p18l794t558r1028b619],
11	patients	NNS	O	patient	prep_among	9	SENT_313	[p18l1046t541r1313b618],
12	taking	VBG	O	take	partmod	11	SENT_313	[p18l1333t535r1549b619],
13	natalizumab	JJ	O	natalizumab	acomp	12	SENT_313	[p18l1568t535r2003b607],
14	,	,	O	,	_	0	SENT_313	[p18l1568t535r2003b607],
15	this	DT	O	this	det	18	SENT_313	[p18l2025t535r2148b598],
16	very	RB	O	very	advmod	17	SENT_313	[p18l6t661r158b722],
17	effective	JJ	O	effective	amod	18	SENT_313	[p18l176t638r452b701],
18	treatment	NN	O	treatment	nsubjpass	21	SENT_313	[p18l473t650r805b701],
19	has	VBZ	O	have	aux	21	SENT_313	[p18l824t638r936b701],
20	been	VBN	O	be	auxpass	21	SENT_313	[p18l955t638r1119b701],
21	relegated	VBN	O	relegate	_	0	SENT_313	[p18l1140t638r1445b722],
22	to	TO	O	to	_	0	SENT_313	[p18l1464t650r1529b701],
23	second	JJ	ORDINAL	second	amod	26	SENT_313	[p18l1553t638r1945b701],
24	—	NN	O	—	nn	26	SENT_313	[p18l1553t638r1945b701],
25	line	NN	O	line	nn	26	SENT_313	[p18l1553t638r1945b701],
26	treatment	NN	O	treatment	prep_to	21	SENT_313	[p18l1965t650r2145b701, p18l8t753r187b804],
27	as	IN	O	as	mark	40	SENT_313	[p18l209t763r273b804],
28	discussed	VBN	O	discuss	csubj	40	SENT_313	[p18l297t740r625b804],
29	later	RB	O	later	advmod	32	SENT_313	[p18l645t732r949b804],
30	.7576	CD	NUMBER	.7576	pobj	29	SENT_313	[p18l645t732r949b804],
31	The	DT	O	the	det	32	SENT_313	[p18l971t740r1098b804],
32	frequency	NN	O	frequency	dobj	28	SENT_313	[p18l1121t740r1468b825],
33	of	IN	O	of	_	0	SENT_313	[p18l1487t740r1561b804],
34	PML	NN	ORGANIZATION	pml	nn	35	SENT_313	[p18l1574t746r1745b803],
35	occurrence	NN	O	occurrence	prep_of	32	SENT_313	[p18l1767t763r2150b804],
36	with	IN	O	with	_	0	SENT_313	[p18l7t844r155b907],
37	natalizumab	JJ	O	natalizumab	amod	38	SENT_313	[p18l172t844r579b907],
38	use	NN	O	use	prep_with	28	SENT_313	[p18l598t867r706b907],
39	is	VBZ	O	be	cop	40	SENT_313	[p18l724t850r772b907],
40	~	NN	O	~	advcl	21	SENT_313	[p18l793t851r870b906],
41	1	CD	NUMBER	1	npadvmod	40	SENT_313	[p18l793t851r870b906],
42	out	IN	O	out	_	0	SENT_313	[p18l895t856r1003b907],
43	of	IN	O	of	_	0	SENT_313	[p18l1020t844r1092b907],
44	1,000	CD	NUMBER	1,000	prep_out_of	40	SENT_313	[p18l1107t851r1274b916],
45	in	IN	O	in	_	0	SENT_313	[p18l1294t850r1358b906],
46	the	DT	O	the	det	48	SENT_313	[p18l1375t844r1478b907],
47	early	JJ	O	early	amod	48	SENT_313	[p18l1497t844r1657b928],
48	studies	NNS	O	study	prep_in	44	SENT_313	[p18l1671t844r1913b907],
49	.	.	O	.	_	0	SENT_313	[p18l1671t844r1913b907],

1	Newer	JJR	O	newer	amod	2	SENT_314	[p18l1933t849r2151b907],
2	observations	NNS	O	observation	nsubj	3	SENT_314	[p18l9t947r418b1010],
3	suggest	VBP	O	suggest	_	0	SENT_314	[p18l437t959r673b1031],
4	that	IN	O	that	complm	8	SENT_314	[p18l687t947r814b1010],
5	the	DT	O	the	det	6	SENT_314	[p18l829t947r931b1010],
6	risk	NN	O	risk	nsubj	8	SENT_314	[p18l948t947r1070b1010],
7	is	VBZ	O	be	cop	8	SENT_314	[p18l1084t953r1132b1010],
8	speciﬁc	NN	O	speciﬁc	ccomp	3	SENT_314	[p18l1150t947r1390b1030],
9	to	TO	O	to	_	0	SENT_314	[p18l1405t959r1469b1010],
10	patients	NNS	O	patient	prep_to	8	SENT_314	[p18l1486t953r1739b1030],
11	with	IN	O	with	_	0	SENT_314	[p18l1755t947r1901b1010],
12	anti-IC	JJ	O	anti-ic	amod	13	SENT_314	[p18l1919t951r2150b1023],
13	virus	NN	O	virus	prep_with	10	SENT_314	[p18l6t1056r175b1113],
14	(	CD	NUMBER	(	num	15	SENT_314	[p18l199t1051r393b1127],
15	ICV	NN	ORGANIZATION	icv	dep	25	SENT_314	[p18l199t1051r393b1127],
16	)	CD	NUMBER	)	num	17	SENT_314	[p18l199t1051r393b1127],
17	antibodies	NNS	O	antibody	dep	15	SENT_314	[p18l419t1050r767b1113],
18	and	CC	O	and	_	0	SENT_314	[p18l788t1050r913b1113],
19	a	DT	O	a	det	20	SENT_314	[p18l934t1073r968b1113],
20	history	NN	O	history	dep	25	SENT_314	[p18l987t1050r1227b1134],
21	of	IN	O	of	_	0	SENT_314	[p18l1245t1050r1318b1113],
22	immunosuppressant	JJ	O	immunosuppressant	amod	23	SENT_314	[p18l1329t1056r2021b1133],
23	use	NN	O	use	prep_of	20	SENT_314	[p18l2040t1073r2149b1113],
24	(	CD	NUMBER	(	dep	25	SENT_314	[p18l12t1154r165b1237],
25	e.g.	FW	O	e.g.	dep	10	SENT_314	[p18l12t1154r165b1237],
26	,	,	O	,	_	0	SENT_314	[p18l12t1154r165b1237],
27	azathioprine	NN	O	azathioprine	conj_and	25	SENT_314	[p18l189t1153r627b1236],
28	,	,	O	,	_	0	SENT_314	[p18l189t1153r627b1236],
29	methotrexate	NN	O	methotrexate	conj_and	25	SENT_314	[p18l650t1153r1114b1225],
30	,	,	O	,	_	0	SENT_314	[p18l650t1153r1114b1225],
31	mitoxantrone	NN	O	mitoxantrone	conj_and	25	SENT_314	[p18l1136t1159r1612b1225],
32	,	,	O	,	_	0	SENT_314	[p18l1136t1159r1612b1225],
33	and	CC	O	and	_	0	SENT_314	[p18l1636t1153r1761b1216],
34	cyclophos	NNS	O	cyclopho	conj_and	25	SENT_314	[p18l1781t1153r2146b1237],
35	—	CD	NUMBER	—	num	37	SENT_314	[p18l1781t1153r2146b1237],
36	phamide	NN	O	phamide	nn	37	SENT_314	[p18l7t1256r341b1339],
37	)	NN	O	)	dep	10	SENT_314	[p18l7t1256r341b1339],
38	.	.	O	.	_	0	SENT_314	[p18l7t1256r341b1339],

1	With	IN	O	with	mark	6	SENT_315	[p18l361t1256r528b1319],
2	both	DT	O	both	dep	6	SENT_315	[p18l544t1256r698b1319],
3	of	IN	O	of	_	0	SENT_315	[p18l715t1256r787b1319],
4	these	DT	O	these	det	5	SENT_315	[p18l794t1256r963b1319],
5	factors	NNS	O	factor	prep_of	2	SENT_315	[p18l980t1256r1198b1319],
6	present	JJ	DATE	present	advcl	15	SENT_315	[p18l1216t1268r1472b1339],
7	,	,	O	,	_	0	SENT_315	[p18l1216t1268r1472b1339],
8	the	DT	O	the	det	9	SENT_315	[p18l1490t1256r1593b1319],
9	risk	NN	O	risk	nsubj	15	SENT_315	[p18l1611t1256r1735b1319],
10	of	IN	O	of	_	0	SENT_315	[p18l1749t1256r1821b1319],
11	PML	NN	ORGANIZATION	pml	prep_of	9	SENT_315	[p18l1830t1261r1994b1318],
12	may	MD	O	may	aux	15	SENT_315	[p18l2011t1279r2153b1340],
13	be	VB	O	be	cop	15	SENT_315	[p18l7t1359r84b1422],
14	as	RB	O	as	advmod	15	SENT_315	[p18l105t1382r168b1422],
15	high	JJ	O	high	_	0	SENT_315	[p18l187t1359r337b1443],
16	as	IN	O	as	_	0	SENT_315	[p18l357t1382r420b1422],
17	11	CD	NUMBER	11	prep_as	15	SENT_315	[p18l447t1366r512b1421],
18	out	IN	O	out	_	0	SENT_315	[p18l538t1371r647b1422],
19	of	IN	O	of	_	0	SENT_315	[p18l666t1359r739b1422],
20	1,000	CD	NUMBER	1,000	prep_out_of	17	SENT_315	[p18l755t1366r942b1431],
21	,	,	O	,	_	0	SENT_315	[p18l755t1366r942b1431],
22	and	CC	O	and	cc	28	SENT_315	[p18l964t1359r1088b1422],
23	the	DT	O	the	det	24	SENT_315	[p18l1105t1359r1209b1422],
24	number	NN	O	number	nsubj	28	SENT_315	[p18l1228t1359r1495b1422],
25	is	VBZ	O	be	cop	28	SENT_315	[p18l1513t1365r1562b1422],
26	updated	VBN	O	update	amod	28	SENT_315	[p18l1582t1359r1854b1442],
27	multiple	JJ	O	multiple	amod	28	SENT_315	[p18l1872t1359r2148b1442],
28	times	NNS	O	time	dep	17	SENT_315	[p18l8t1468r188b1525],
29	a	DT	DURATION	a	det	30	SENT_315	[p18l208t1485r242b1525],
30	year	NN	DURATION	year	tmod	28	SENT_315	[p18l256t1485r398b1546],
31	on	IN	O	on	_	0	SENT_315	[p18l416t1485r500b1525],
32	the	DT	O	the	det	36	SENT_315	[p18l517t1462r621b1525],
33	company	NN	O	company	nn	36	SENT_315	[p18l640t1484r949b1546],
34	site	NN	O	site	nn	36	SENT_315	[p18l964t1468r1071b1525],
35	(	CD	NUMBER	(	num	36	SENT_315	[p18l1093t1462r1296b1545],
36	http	NN	O	http	prep_on	28	SENT_315	[p18l1093t1462r1296b1545],
37	:	:	O	:	_	0	SENT_315	[p18l1093t1462r1296b1545],
38	/	:	O	/	punct	17	SENT_315	[p18l1093t1462r1296b1545],
39	/	:	O	/	punct	40	SENT_315	[p18l1300t1466r1324b1528],
40	www.tysabri.com	NNP	O	www.tysabri.com	dep	17	SENT_315	[p18l1326t1462r1930b1546],
41	/	:	O	/	punct	40	SENT_315	[p18l1326t1462r1930b1546],
42	safetywith	JJ	O	safetywith	amod	44	SENT_315	[p18l1934t1462r2147b1546, p18l7t1565r604b1649],
43	—	NN	O	—	nn	44	SENT_315	[p18l1934t1462r2147b1546, p18l7t1565r604b1649],
44	tysabri	NN	O	tysabrus	dobj	15	SENT_315	[p18l1934t1462r2147b1546, p18l7t1565r604b1649],
45	.	.	O	.	_	0	SENT_315	[p18l1934t1462r2147b1546, p18l7t1565r604b1649],

1	Xml	NN	O	xml	_	0	SENT_316	[p18l1934t1462r2147b1546, p18l7t1565r604b1649],
2	)	NN	O	)	dep	1	SENT_316	[p18l1934t1462r2147b1546, p18l7t1565r604b1649],
3	.	.	O	.	_	0	SENT_316	[p18l1934t1462r2147b1546, p18l7t1565r604b1649],

1	The	DT	O	the	det	5	SENT_317	[p18l626t1565r750b1628],
2	Stratify	NNP	O	Stratify	nn	5	SENT_317	[p18l769t1565r1011b1649],
3	ICV	NNP	O	ICV	nn	5	SENT_317	[p18l1027t1569r1167b1641],
4	Antibody	NN	O	antibody	nn	5	SENT_317	[p18l1185t1565r1506b1649],
5	test	NN	O	test	nsubj	7	SENT_317	[p18l1520t1577r1635b1628],
6	is	VBZ	O	be	cop	7	SENT_317	[p18l1653t1571r1702b1628],
7	available	JJ	O	available	_	0	SENT_317	[p18l1722t1565r2006b1628],
8	free	JJ	O	free	advmod	7	SENT_317	[p18l2025t1565r2149b1628],
9	of	IN	O	of	_	0	SENT_317	[p18l10t1668r82b1731],
10	charge	NN	O	charge	prep_of	8	SENT_317	[p18l91t1668r308b1752],
11	to	TO	O	to	_	0	SENT_317	[p18l325t1680r389b1731],
12	health	NN	O	health	nn	15	SENT_317	[p18l408t1668r780b1731],
13	—	CD	NUMBER	—	num	15	SENT_317	[p18l408t1668r780b1731],
14	care	NN	O	care	nn	15	SENT_317	[p18l408t1668r780b1731],
15	providers	NNS	O	provider	prep_to	7	SENT_317	[p18l797t1668r1128b1751],
16	,	,	O	,	_	0	SENT_317	[p18l797t1668r1128b1751],
17	and	CC	O	and	_	0	SENT_317	[p18l1149t1668r1272b1731],
18	we	PRP	O	we	nsubj	19	SENT_317	[p18l1287t1691r1379b1731],
19	recommend	VBP	O	recommend	conj_and	7	SENT_317	[p18l1398t1668r1803b1731],
20	testing	NN	O	testing	dobj	19	SENT_317	[p18l1819t1674r2042b1752],
21	for	IN	O	for	_	0	SENT_317	[p18l2058t1668r2152b1731],
22	this	DT	O	this	det	23	SENT_317	[p18l8t1771r126b1834],
23	antibody	NN	O	antibody	prep_for	20	SENT_317	[p18l144t1771r433b1855],
24	before	IN	O	before	_	0	SENT_317	[p18l445t1771r648b1834],
25	treatment	NN	O	treatment	nn	26	SENT_317	[p18l664t1783r981b1834],
26	initiation	NN	O	initiation	prep_before	19	SENT_317	[p18l997t1777r1308b1834],
27	.	.	O	.	_	0	SENT_317	[p18l997t1777r1308b1834],

1	Patients	NNS	O	patient	nsubjpass	8	SENT_318	[p18l1329t1776r1581b1834],
2	with	IN	O	with	_	0	SENT_318	[p18l1597t1771r1742b1834],
3	negative	JJ	O	negative	amod	5	SENT_318	[p18l1759t1777r2025b1855],
4	test	NN	O	test	nn	5	SENT_318	[p18l2041t1783r2153b1834],
5	results	NNS	O	result	prep_with	1	SENT_318	[p18l10t1874r220b1937],
6	should	MD	O	should	aux	8	SENT_318	[p18l241t1874r464b1937],
7	be	VB	O	be	auxpass	8	SENT_318	[p18l479t1874r557b1937],
8	rechecked	VBN	O	recheck	_	0	SENT_318	[p18l575t1874r909b1937],
9	periodically	RB	O	periodically	advmod	10	SENT_318	[p18l925t1874r1321b1958],
10	(	CD	NUMBER	(	dobj	8	SENT_318	[p18l1339t1875r1471b1951],
11	i.e.	FW	O	i.e.	dep	10	SENT_318	[p18l1339t1875r1471b1951],
12	,	,	O	,	_	0	SENT_318	[p18l1339t1875r1471b1951],
13	every	DT	SET	every	quantmod	14	SENT_318	[p18l1491t1897r1673b1958],
14	6	CD	SET	6	appos	11	SENT_318	[p18l1688t1880r1766b1937],
15	-	:	SET	-	_	0	SENT_318	[p18l1688t1880r1766b1937],
16	12	CD	DATE	12	num	17	SENT_318	[p18l1777t1881r1847b1936],
17	months	NNS	DATE	month	dep	10	SENT_318	[p18l1866t1874r2143b1951],
18	)	RB	DATE	)	advmod	17	SENT_318	[p18l1866t1874r2143b1951],
19	due	JJ	O	due	_	0	SENT_318	[p18l10t1977r129b2040],
20	to	TO	O	to	_	0	SENT_318	[p18l146t1989r210b2040],
21	the	DT	O	the	det	26	SENT_318	[p18l228t1977r331b2040],
22	estimated	VBN	O	estimate	amod	26	SENT_318	[p18l349t1977r667b2040],
23	false	JJ	O	false	amod	26	SENT_318	[p18l683t1977r1130b2061],
24	—	NN	O	—	nn	26	SENT_318	[p18l683t1977r1130b2061],
25	negative	JJ	O	negative	amod	26	SENT_318	[p18l683t1977r1130b2061],
26	rate	NN	O	rate	prep_due_to	17	SENT_318	[p18l1148t1989r1270b2040],
27	of	IN	O	of	_	0	SENT_318	[p18l1288t1977r1361b2040],
28	3	CD	PERCENT	3	num	29	SENT_318	[p18l1370t1982r1468b2041],
29	%	NN	PERCENT	%	prep_of	26	SENT_318	[p18l1370t1982r1468b2041],
30	along	IN	O	along	_	0	SENT_318	[p18l1488t1977r1669b2061],
31	with	IN	O	with	_	0	SENT_318	[p18l1683t1977r1831b2040],
32	true	JJ	O	true	amod	33	SENT_318	[p18l1847t1989r1982b2040],
33	conversion	NN	O	conversion	prep_along_with	29	SENT_318	[p18l2000t2000r2145b2040, p18l7t2086r248b2143],
34	from	IN	O	from	_	0	SENT_318	[p18l265t2080r427b2143],
35	seronegative	JJ	O	seronegative	amod	37	SENT_318	[p18l446t2086r851b2164],
36	to	TO	O	to	dep	37	SENT_318	[p18l868t2092r932b2143],
37	seropositive	JJ	O	seropositive	amod	38	SENT_318	[p18l951t2086r1341b2163],
38	state	NN	O	state	prep_from	33	SENT_318	[p18l1360t2092r1520b2143],
39	.	.	O	.	_	0	SENT_318	[p18l1360t2092r1520b2143],

1	Symptoms	NNS	O	symptom	nsubj	6	SENT_319	[p18l1541t2084r1887b2164],
2	of	IN	O	of	_	0	SENT_319	[p18l1906t2080r1977b2143],
3	PML	NN	ORGANIZATION	pml	prep_of	1	SENT_319	[p18l1986t2085r2150b2142],
4	may	MD	O	may	aux	6	SENT_319	[p18l9t2206r156b2267],
5	be	VB	O	be	cop	6	SENT_319	[p18l170t2183r250b2246],
6	difficult	JJ	O	difficult	_	0	SENT_319	[p18l272t2183r535b2246],
7	to	TO	O	to	aux	8	SENT_319	[p18l553t2195r619b2246],
8	distinguish	VB	O	distinguish	xcomp	6	SENT_319	[p18l641t2183r1015b2267],
9	from	IN	O	from	_	0	SENT_319	[p18l1036t2183r1202b2246],
10	MS	NN	O	m	nn	11	SENT_319	[p18l1223t2187r1337b2246],
11	symptoms	NNS	O	symptom	prep_from	8	SENT_319	[p18l1359t2195r1708b2267],
12	solely	RB	O	solely	advmod	8	SENT_319	[p18l1730t2183r1921b2267],
13	on	IN	O	on	_	0	SENT_319	[p18l1940t2206r2025b2246],
14	the	DT	O	the	det	15	SENT_319	[p18l2045t2183r2151b2246],
15	basis	NN	O	basis	prep_on	8	SENT_319	[p18l7t2286r170b2349],
16	of	IN	O	of	_	0	SENT_319	[p18l192t2286r265b2349],
17	clinical	JJ	O	clinical	amod	18	SENT_319	[p18l276t2286r515b2349],
18	evidence	NN	O	evidence	prep_of	15	SENT_319	[p18l536t2286r845b2349],
19	.	.	O	.	_	0	SENT_319	[p18l536t2286r845b2349],

1	Therefore	RB	O	therefore	advmod	13	SENT_320	[p18l868t2286r1208b2358],
2	,	,	O	,	_	0	SENT_320	[p18l868t2286r1208b2358],
3	continued	VBD	O	continue	parataxis	13	SENT_320	[p18l1231t2286r1571b2349],
4	MRI	NNP	O	MRI	nsubj	5	SENT_320	[p18l1590t2291r1744b2349],
5	monitoring	VBG	O	monitor	dep	3	SENT_320	[p18l1766t2292r2152b2370],
6	(	CD	NUMBER	(	dobj	5	SENT_320	[p18l13t2389r221b2473],
7	every	DT	SET	every	det	9	SENT_320	[p18l13t2389r221b2473],
8	6	CD	SET	6	num	9	SENT_320	[p18l238t2395r274b2452],
9	months	NNS	NUMBER	month	tmod	5	SENT_320	[p18l295t2389r573b2466],
10	)	CD	NUMBER	)	nsubj	3	SENT_320	[p18l295t2389r573b2466],
11	is	VBZ	O	be	cop	13	SENT_320	[p18l598t2395r647b2452],
12	also	RB	O	also	advmod	13	SENT_320	[p18l668t2389r795b2452],
13	necessary	JJ	O	necessary	_	0	SENT_320	[p18l816t2412r1145b2473],
14	.	.	O	.	_	0	SENT_320	[p18l816t2412r1145b2473],

1	It	PRP	O	it	nsubj	3	SENT_321	[p18l1169t2394r1217b2452],
2	is	VBZ	O	be	cop	3	SENT_321	[p18l1236t2395r1285b2452],
3	unclear	JJ	O	unclear	_	0	SENT_321	[p18l1305t2389r1553b2452],
4	at	IN	O	at	_	0	SENT_321	[p18l1572t2401r1631b2452],
5	this	DT	O	this	det	6	SENT_321	[p18l1648t2389r1769b2452],
6	time	NN	O	time	prep_at	3	SENT_321	[p18l1789t2395r1956b2461],
7	,	,	O	,	_	0	SENT_321	[p18l1789t2395r1956b2461],
8	however	RB	O	however	advmod	3	SENT_321	[p18l1977t2389r2146b2452, p18l10t2515r157b2564],
9	,	,	O	,	_	0	SENT_321	[p18l1977t2389r2146b2452, p18l10t2515r157b2564],
10	if	IN	O	if	mark	18	SENT_321	[p18l176t2492r229b2554],
11	MRI	NNP	O	MRI	nsubj	18	SENT_321	[p18l236t2497r388b2555],
12	monitoring	VBG	O	monitor	partmod	11	SENT_321	[p18l406t2498r783b2576],
13	for	IN	O	for	_	0	SENT_321	[p18l799t2492r892b2555],
14	PML	NN	ORGANIZATION	pml	prep_for	12	SENT_321	[p18l910t2497r1073b2554],
15	will	MD	O	will	aux	18	SENT_321	[p18l1089t2492r1210b2555],
16	still	RB	O	still	advmod	18	SENT_321	[p18l1227t2492r1342b2555],
17	be	VB	O	be	cop	18	SENT_321	[p18l1357t2492r1434b2555],
18	necessary	JJ	O	necessary	advcl	3	SENT_321	[p18l1452t2515r1770b2576],
19	for	IN	O	for	_	0	SENT_321	[p18l1784t2492r1878b2555],
20	patients	NNS	O	patient	prep_for	18	SENT_321	[p18l1893t2498r2150b2575],
21	who	WP	O	who	dep	22	SENT_321	[p18l8t2595r152b2658],
22	remain	VBP	O	remain	rcmod	20	SENT_321	[p18l172t2601r408b2658],
23	ICV	NN	ORGANIZATION	icv	nn	24	SENT_321	[p18l427t2599r568b2671],
24	antibody	NN	O	antibody	nsubj	25	SENT_321	[p18l587t2595r884b2679],
25	negative	JJ	O	negative	xcomp	22	SENT_321	[p18l899t2601r1173b2679],
26	(	CD	NUMBER	(	num	29	SENT_321	[p18l1196t2596r1447b2678],
27	Figure	NN	O	figure	nn	29	SENT_321	[p18l1196t2596r1447b2678],
28	5	CD	NUMBER	5	num	29	SENT_321	[p18l1466t2596r1549b2672],
29	)	NN	O	)	nsubj	22	SENT_321	[p18l1466t2596r1549b2672],
30	.	.	O	.	_	0	SENT_321	[p18l1466t2596r1549b2672],

1	Fingolimod	NNP	MISC	Fingolimod	nn	2	SENT_322	[p18l12t2809r406b2882],
2	Fingolimod	NNP	MISC	Fingolimod	nsubj	3	SENT_322	[p18l10t2906r422b2990],
3	inhibits	VBZ	O	inhibit	_	0	SENT_322	[p18l446t2906r711b2969],
4	lymphocyte	NN	O	lymphocyte	nn	5	SENT_322	[p18l735t2906r1149b2990],
5	egress	NN	O	egress	dobj	3	SENT_322	[p18l1174t2929r1383b2990],
6	from	IN	O	from	_	0	SENT_322	[p18l1407t2906r1579b2969],
7	secondary	JJ	O	secondary	amod	9	SENT_322	[p18l1604t2906r1966b2990],
8	lymphoid	JJ	O	lymphoid	amod	9	SENT_322	[p18l1985t2906r2146b2990, p18l8t3009r215b3092],
9	tissues	NNS	O	tissue	prep_from	3	SENT_322	[p18l238t3015r469b3072],
10	and	CC	O	and	_	0	SENT_322	[p18l495t3009r625b3072],
11	the	DT	O	the	det	12	SENT_322	[p18l647t3009r757b3072],
12	thymus	NN	O	thymus	prep_from	3	SENT_322	[p18l781t3009r1043b3093],
13	by	IN	O	by	_	0	SENT_322	[p18l1066t3009r1152b3093],
14	acting	VBG	O	act	prepc_by	3	SENT_322	[p18l1174t3015r1391b3093],
15	on	IN	O	on	_	0	SENT_322	[p18l1413t3032r1502b3072],
16	the	DT	O	the	det	18	SENT_322	[p18l1525t3009r1635b3072],
17	S1P1	NN	O	s1p1	nn	18	SENT_322	[p18l1661t3013r1827b3072],
18	receptor	NN	O	receptor	prep_on	14	SENT_322	[p18l1858t3021r2152b3092],
19	and	CC	O	and	_	0	SENT_322	[p18l10t3112r134b3175],
20	is	VBZ	O	be	cop	22	SENT_322	[p18l153t3118r203b3175],
21	the	DT	O	the	det	22	SENT_322	[p18l222t3112r327b3175],
22	ﬁrst	NN	O	ﬁrst	conj_and	3	SENT_322	[p18l347t3112r478b3175],
23	approved	VBD	O	approve	rcmod	22	SENT_322	[p18l498t3112r810b3195],
24	oral	JJ	O	oral	amod	25	SENT_322	[p18l830t3112r960b3175],
25	medication	NN	O	medication	dobj	23	SENT_322	[p18l979t3112r1360b3175],
26	for	IN	O	for	_	0	SENT_322	[p18l1379t3112r1476b3175],
27	RRMS	NNS	O	rrm	prep_for	23	SENT_322	[p18l1495t3116r1729b3175],
28	.	.	O	.	_	0	SENT_322	[p18l1495t3116r1729b3175],

1	Fingolimod	NN	O	fingolimod	dep	2	SENT_323	[p18l1753t3112r2149b3196],
2	leads	VBZ	O	lead	_	0	SENT_323	[p18l8t3214r182b3278],
3	to	TO	O	to	_	0	SENT_323	[p18l204t3226r271b3278],
4	an	DT	O	a	det	5	SENT_323	[p18l297t3237r378b3278],
5	RRR	NN	O	rrr	prep_to	2	SENT_323	[p18l401t3219r563b3277],
6	of	IN	O	of	_	0	SENT_323	[p18l584t3214r658b3278],
7	50	CD	PERCENT	50	num	8	SENT_323	[p18l674t3219r837b3286],
8	%	NN	PERCENT	%	prep_of	5	SENT_323	[p18l674t3219r837b3286],
9	,	,	O	,	_	0	SENT_323	[p18l674t3219r837b3286],
10	an	DT	O	a	det	11	SENT_323	[p18l863t3237r944b3278],
11	ARR	NN	O	arr	conj_and	5	SENT_323	[p18l966t3218r1135b3277],
12	of	IN	O	of	_	0	SENT_323	[p18l1156t3214r1231b3278],
13	22	CD	PERCENT	22	num	14	SENT_323	[p18l1245t3220r1409b3286],
14	%	NN	PERCENT	%	prep_of	11	SENT_323	[p18l1245t3220r1409b3286],
15	,	,	O	,	_	0	SENT_323	[p18l1245t3220r1409b3286],
16	and	CC	O	and	_	0	SENT_323	[p18l1435t3214r1563b3278],
17	NNT	NN	O	nnt	conj_and	5	SENT_323	[p18l1585t3217r1766b3277],
18	of	IN	O	of	_	0	SENT_323	[p18l1790t3214r1864b3278],
19	4	CD	NUMBER	4	number	21	SENT_323	[p18l1877t3221r1916b3277],
20	over	IN	O	over	quantmod	21	SENT_323	[p18l1940t3237r2090b3278],
21	2	CD	DURATION	2	num	22	SENT_323	[p18l2112t3221r2148b3277],
22	years	NNS	NUMBER	year	prep_of	17	SENT_323	[p18l7t3341r187b3403],
23	to	TO	O	to	aux	24	SENT_323	[p18l212t3331r280b3382],
24	increase	VB	O	increase	xcomp	2	SENT_323	[p18l305t3325r593b3382],
25	the	DT	O	the	det	27	SENT_323	[p18l617t3318r726b3382],
26	relapse-free	JJ	O	relapse-free	amod	27	SENT_323	[p18l752t3318r1164b3402],
27	proportion	NN	O	proportion	dobj	24	SENT_323	[p18l1188t3325r1579b3402],
28	of	IN	O	of	_	0	SENT_323	[p18l1604t3318r1680b3382],
29	by	IN	O	by	quantmod	30	SENT_323	[p18l1693t3318r1779b3403],
30	1.77	CD	NUMBER	1.77	prep_of	27	SENT_323	[p18l1807t3311r1925b3382],
31	These	DT	O	these	nsubj	2	SENT_323	[p18l1949t3318r2149b3382],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_324	[p18l20t3468r139b3489],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	12	SENT_324	[p18l148t3468r373b3489],
3	&	CC	O	&	_	0	SENT_324	[p18l380t3468r600b3489],
4	THERAPEUT	NNP	O	THERAPEUT	nn	6	SENT_324	[p18l380t3468r600b3489],
5	|	CD	NUMBER	|	num	6	SENT_324	[p18l380t3468r600b3489],
6	CS	NNP	O	CS	conj_and	2	SENT_324	[p18l380t3468r600b3489],
7	|	NNP	O	|	nn	8	SENT_324	[p18l610t3466r612b3496],
8	VOLUME	NNP	O	VOLUME	dep	2	SENT_324	[p18l620t3468r728b3489],
9	95	CD	NUMBER	95	num	10	SENT_324	[p18l736t3468r763b3489],
10	NUMBER	NN	O	number	dep	12	SENT_324	[p18l773t3468r881b3489],
11	1	CD	NUMBER	1	num	12	SENT_324	[p18l891t3469r898b3489],
12	|	CD	NUMBER	|	dep	15	SENT_324	[p18l912t3466r914b3496],
13	JANUARY	NNP	DATE	JANUARY	dep	12	SENT_324	[p18l923t3468r1041b3489],
14	2014	CD	DATE	2014	num	15	SENT_324	[p18l1049t3468r1107b3489],
15	39	CD	DATE	39	_	0	SENT_324	[p18l2109t3468r2139b3489],

1	STATE	NN	O	state	nn	2	SENT_325	[p18l21t3611r163b3648],
2	ART	NN	O	art	_	0	SENT_325	[p18l306t3611r399b3648],

1	numbers	NNS	O	number	nsubj	2	SENT_326	[p19l8t90r309b153],
2	suggest	VBP	O	suggest	ccomp	25	SENT_326	[p19l331t102r579b174],
3	an	DT	O	a	det	4	SENT_326	[p19l599t113r678b153],
4	eﬂicacy	NN	O	eﬂicacy	npadvmod	5	SENT_326	[p19l700t90r956b174],
5	closer	RBR	O	closer	advmod	2	SENT_326	[p19l973t90r1172b153],
6	to	TO	O	to	_	0	SENT_326	[p19l1191t102r1256b153],
7	natalizumab	NN	O	natalizumab	prep_to	2	SENT_326	[p19l1278t90r1699b153],
8	and	CC	O	and	_	0	SENT_326	[p19l1721t90r1847b153],
9	stronger	JJR	O	stronger	conj_and	7	SENT_326	[p19l1868t102r2150b174],
10	than	IN	O	than	_	0	SENT_326	[p19l8t192r162b256],
11	interferon	NN	O	interferon	prep_than	9	SENT_326	[p19l184t192r602b277],
12	-	:	O	-	_	0	SENT_326	[p19l184t192r602b277],
13	[	NN	O	[	dep	9	SENT_326	[p19l184t192r602b277],
14	3	CD	NUMBER	3	num	15	SENT_326	[p19l184t192r602b277],
15	compounds	NNS	O	compound	tmod	13	SENT_326	[p19l625t184r1111b276],
16	.78	CD	NUMBER	.78	npadvmod	17	SENT_326	[p19l625t184r1111b276],
17	Unfortunately	RB	O	unfortunately	advmod	15	SENT_326	[p19l1134t192r1629b277],
18	,	,	O	,	_	0	SENT_326	[p19l1134t192r1629b277],
19	the	DT	O	the	det	21	SENT_326	[p19l1652t192r1758b256],
20	side	JJ	O	side	amod	21	SENT_326	[p19l1781t192r1914b256],
21	effects	NNS	O	effect	nsubj	27	SENT_326	[p19l1936t192r2148b256],
22	of	IN	O	of	_	0	SENT_326	[p19l9t296r84b359],
23	ﬁngolimod	NN	O	ﬁngolimod	prep_of	21	SENT_326	[p19l97t296r482b380],
24	are	VBP	O	be	cop	25	SENT_326	[p19l505t319r606b359],
25	substantial	JJ	O	substantial	_	0	SENT_326	[p19l630t296r1004b359],
26	and	CC	O	and	_	0	SENT_326	[p19l1027t296r1155b359],
27	include	VBP	O	include	conj_and	25	SENT_326	[p19l1177t296r1432b359],
28	fatal	JJ	O	fatal	amod	29	SENT_326	[p19l1455t296r1603b359],
29	infections	NNS	O	infection	dobj	27	SENT_326	[p19l1626t296r1967b359],
30	(	CD	NUMBER	(	num	33	SENT_326	[p19l1995t297r2147b379, p19l8t422r192b483],
31	primary	JJ	O	primary	amod	33	SENT_326	[p19l1995t297r2147b379, p19l8t422r192b483],
32	Varicella	NN	O	varicellum	nn	33	SENT_326	[p19l218t399r509b462],
33	zoster	NN	O	zoster	dep	29	SENT_326	[p19l532t410r732b463],
34	and	CC	O	and	_	0	SENT_326	[p19l752t399r879b462],
35	Herpes	NNP	MISC	Herpes	nn	38	SENT_326	[p19l900t404r1136b483],
36	simplex	JJ	O	simplex	amod	38	SENT_326	[p19l1156t399r1416b483],
37	encephalitis	NN	O	encephalitis	nn	38	SENT_326	[p19l1436t399r1897b482],
38	)	NN	O	)	conj_and	29	SENT_326	[p19l1436t399r1897b482],
39	,	,	O	,	_	0	SENT_326	[p19l1436t399r1897b482],
40	brady	JJ	O	brady	amod	42	SENT_326	[p19l1921t399r2147b483],
41	—	NN	O	—	nn	42	SENT_326	[p19l1921t399r2147b483],
42	cardia	NN	O	cardium	conj_and	29	SENT_326	[p19l9t502r213b565],
43	and	CC	O	and	_	0	SENT_326	[p19l232t502r356b565],
44	atrioventricular	JJ	O	atrioventricular	amod	45	SENT_326	[p19l375t502r900b565],
45	block	NN	O	block	conj_and	42	SENT_326	[p19l916t502r1117b574],
46	,	,	O	,	_	0	SENT_326	[p19l916t502r1117b574],
47	hypertension	NN	O	hypertension	conj_and	38	SENT_326	[p19l1137t502r1596b586],
48	,	,	O	,	_	0	SENT_326	[p19l1137t502r1596b586],
49	macular	JJ	O	macular	amod	50	SENT_326	[p19l1616t502r1891b565],
50	edema	NN	O	edema	conj_and	38	SENT_326	[p19l1911t502r2147b574],
51	,	,	O	,	_	0	SENT_326	[p19l1911t502r2147b574],
52	skin	NN	O	skin	nn	53	SENT_326	[p19l9t605r147b668],
53	cancer	NN	O	cancer	conj_and	38	SENT_326	[p19l167t628r396b677],
54	,	,	O	,	_	0	SENT_326	[p19l167t628r396b677],
55	and	CC	O	and	_	0	SENT_326	[p19l418t605r542b668],
56	elevated	JJ	O	elevated	amod	58	SENT_326	[p19l561t605r832b668],
57	liver-enzyme	JJ	O	liver-enzyme	amod	58	SENT_326	[p19l849t605r1286b689],
58	levels	NNS	O	level	conj_and	38	SENT_326	[p19l1304t605r1502b668],
59	.	.	O	.	_	0	SENT_326	[p19l1304t605r1502b668],

1	F	NN	O	f	dep	108	SENT_327	[p19l1525t610r1564b667],
2	ingolimod	NN	O	ingolimod	dep	108	SENT_327	[p19l1569t605r1918b689],
3	is	VBZ	O	be	dep	108	SENT_327	[p19l1936t611r1986b668],
4	now	RB	DATE	now	dep	108	SENT_327	[p19l2005t628r2151b668],
5	contraindicated	VBN	O	contraindicate	dep	108	SENT_327	[p19l9t708r567b771],
6	(	IN	O	(	dep	108	SENT_327	[p19l595t708r731b784],
7	the	DT	O	the	dep	108	SENT_327	[p19l595t708r731b784],
8	Food	NNP	ORGANIZATION	Food	dep	108	SENT_327	[p19l756t708r937b771],
9	and	CC	ORGANIZATION	and	dep	108	SENT_327	[p19l962t708r1092b771],
10	Drug	NNP	ORGANIZATION	Drug	dep	108	SENT_327	[p19l1116t713r1301b792],
11	Administration	NNP	ORGANIZATION	Administration	dep	108	SENT_327	[p19l1323t708r1873b771],
12	advises	VBZ	O	advise	dep	108	SENT_327	[p19l1899t708r2149b771],
13	against	IN	O	against	dep	108	SENT_327	[p19l9t817r244b895],
14	its	PRP$	O	its	dep	108	SENT_327	[p19l263t817r337b874],
15	use	NN	O	use	dep	108	SENT_327	[p19l357t811r492b888],
16	)	NN	O	)	dep	108	SENT_327	[p19l357t811r492b888],
17	in	IN	O	in	dep	108	SENT_327	[p19l516t817r581b873],
18	the	DT	O	the	dep	108	SENT_327	[p19l600t811r704b874],
19	following	VBG	O	follow	dep	108	SENT_327	[p19l724t811r1041b895],
20	situations	NNS	O	situation	dep	108	SENT_327	[p19l1061t817r1399b874],
21	:	:	O	:	_	0	SENT_327	[p19l1061t817r1399b874],
22	(	CD	NUMBER	(	dep	108	SENT_327	[p19l1425t812r1495b888],
23	i	FW	O	i	dep	108	SENT_327	[p19l1425t812r1495b888],
24	)	FW	O	)	dep	108	SENT_327	[p19l1425t812r1495b888],
25	patients	NNS	O	patient	dep	108	SENT_327	[p19l1518t817r1782b894],
26	who	WP	O	who	dep	108	SENT_327	[p19l1801t811r1945b874],
27	experienced	VBD	O	experience	dep	108	SENT_327	[p19l1967t833r2147b894, p19l9t914r260b977],
28	myocardial	JJ	O	myocardial	dep	108	SENT_327	[p19l278t914r656b998],
29	infarction	NN	O	infarction	dep	108	SENT_327	[p19l675t914r1024b986],
30	,	,	O	,	_	0	SENT_327	[p19l675t914r1024b986],
31	unstable	JJ	O	unstable	dep	108	SENT_327	[p19l1046t914r1326b977],
32	angina	NN	O	angina	dep	108	SENT_327	[p19l1348t920r1589b998],
33	,	,	O	,	_	0	SENT_327	[p19l1348t920r1589b998],
34	stroke	NN	O	stroke	dep	108	SENT_327	[p19l1612t914r1832b986],
35	,	,	O	,	_	0	SENT_327	[p19l1612t914r1832b986],
36	transient	JJ	O	transient	dep	108	SENT_327	[p19l1852t920r2151b977],
37	ischemic	JJ	O	ischemic	dep	108	SENT_327	[p19l9t1017r312b1080],
38	attack	NN	O	attack	dep	108	SENT_327	[p19l336t1017r557b1089],
39	,	,	O	,	_	0	SENT_327	[p19l336t1017r557b1089],
40	decompensated	VBN	O	decompensate	dep	108	SENT_327	[p19l582t1017r1122b1100],
41	heart	NN	O	heart	dep	108	SENT_327	[p19l1143t1017r1322b1080],
42	failure	NN	O	failure	dep	108	SENT_327	[p19l1344t1017r1563b1080],
43	requiring	VBG	O	require	dep	108	SENT_327	[p19l1586t1023r1910b1101],
44	hospitalization	NN	O	hospitalization	dep	108	SENT_327	[p19l1930t1017r2146b1100, p19l8t1120r329b1183],
45	or	CC	O	or	dep	108	SENT_327	[p19l350t1143r422b1183],
46	class	NN	O	class	dep	108	SENT_327	[p19l443t1120r597b1183],
47	III	CD	NUMBER	iii	dep	108	SENT_327	[p19l620t1124r731b1186],
48	/	:	O	/	dep	108	SENT_327	[p19l620t1124r731b1186],
49	IV	CD	NUMBER	iv	dep	108	SENT_327	[p19l737t1125r824b1183],
50	heart	NN	O	heart	dep	108	SENT_327	[p19l843t1120r1022b1183],
51	failure	NN	O	failure	dep	108	SENT_327	[p19l1042t1120r1259b1183],
52	in	IN	O	in	dep	108	SENT_327	[p19l1281t1126r1347b1182],
53	the	DT	DURATION	the	dep	108	SENT_327	[p19l1367t1120r1474b1183],
54	previous	JJ	DURATION	previous	dep	108	SENT_327	[p19l1494t1126r1788b1203],
55	6	CD	DURATION	6	dep	108	SENT_327	[p19l1811t1126r1847b1183],
56	months	NNS	NUMBER	month	dep	108	SENT_327	[p19l1869t1120r2147b1192],
57	;	:	O	;	_	0	SENT_327	[p19l1869t1120r2147b1192],
58	(	CD	NUMBER	(	dep	108	SENT_327	[p19l12t1224r104b1300],
59	ii	LS	O	ii	dep	108	SENT_327	[p19l12t1224r104b1300],
60	)	CD	NUMBER	)	dep	108	SENT_327	[p19l12t1224r104b1300],
61	history	NN	O	history	dep	108	SENT_327	[p19l127t1223r366b1307],
62	or	CC	O	or	dep	108	SENT_327	[p19l382t1246r453b1286],
63	presence	NN	O	presence	dep	108	SENT_327	[p19l471t1245r762b1306],
64	of	IN	O	of	dep	108	SENT_327	[p19l783t1223r855b1286],
65	Mobitz	NNP	PERSON	Mobitz	dep	108	SENT_327	[p19l865t1223r1104b1286],
66	type	NN	O	type	dep	108	SENT_327	[p19l1121t1235r1264b1307],
67	II	CD	NUMBER	ii	dep	108	SENT_327	[p19l1284t1228r1337b1285],
68	second-degree	JJ	O	second-degree	dep	108	SENT_327	[p19l1358t1223r1843b1307],
69	or	CC	O	or	dep	108	SENT_327	[p19l1864t1246r1934b1286],
70	thirddegree	JJ	O	thirddegree	dep	108	SENT_327	[p19l1952t1223r2145b1286, p19l9t1326r241b1410],
71	atrioventricular	JJ	O	atrioventricular	dep	108	SENT_327	[p19l267t1326r826b1389],
72	block	NN	O	block	dep	108	SENT_327	[p19l847t1326r1044b1389],
73	or	CC	O	or	dep	108	SENT_327	[p19l1067t1349r1140b1389],
74	sick	JJ	O	sick	dep	108	SENT_327	[p19l1166t1326r1302b1389],
75	sinus	NN	O	sinus	dep	108	SENT_327	[p19l1325t1332r1504b1389],
76	syndrome	NN	O	syndrome	dep	108	SENT_327	[p19l1531t1326r1901b1410],
77	,	,	O	,	_	0	SENT_327	[p19l1531t1326r1901b1410],
78	unless	IN	O	unless	dep	108	SENT_327	[p19l1928t1326r2147b1389],
79	patient	NN	O	patient	dep	108	SENT_327	[p19l7t1435r246b1512],
80	has	VBZ	O	have	dep	108	SENT_327	[p19l264t1429r375b1492],
81	a	DT	O	a	dep	108	SENT_327	[p19l397t1452r431b1492],
82	functioning	VBG	O	function	dep	108	SENT_327	[p19l451t1429r854b1513],
83	pacemaker	NN	O	pacemaker	dep	108	SENT_327	[p19l871t1429r1264b1512],
84	;	:	O	;	_	0	SENT_327	[p19l871t1429r1264b1512],
85	(	CD	NUMBER	(	dep	108	SENT_327	[p19l1289t1430r1406b1505],
86	iii	LS	O	iii	dep	108	SENT_327	[p19l1289t1430r1406b1505],
87	)	CD	NUMBER	)	dep	108	SENT_327	[p19l1289t1430r1406b1505],
88	baseline	NN	O	baseline	dep	108	SENT_327	[p19l1429t1429r1706b1492],
89	QTc	NN	O	qtc	dep	108	SENT_327	[p19l1727t1432r1867b1505],
90	interval	JJ	O	interval	dep	108	SENT_327	[p19l1888t1429r2150b1492],
91	2500	CD	NUMBER	2500	dep	108	SENT_327	[p19l11t1539r175b1595],
92	ms	NNS	O	m	dep	108	SENT_327	[p19l190t1555r305b1604],
93	;	:	O	;	_	0	SENT_327	[p19l190t1555r305b1604],
94	and	CC	O	and	dep	108	SENT_327	[p19l327t1532r451b1595],
95	(	CD	NUMBER	(	dep	108	SENT_327	[p19l473t1533r582b1608],
96	iv	NN	O	iv	dep	108	SENT_327	[p19l473t1533r582b1608],
97	)	NN	O	)	dep	108	SENT_327	[p19l473t1533r582b1608],
98	treatment	NN	O	treatment	dep	108	SENT_327	[p19l605t1544r935b1595],
99	with	IN	O	with	dep	108	SENT_327	[p19l952t1532r1102b1595],
100	class	NN	O	class	dep	108	SENT_327	[p19l1123t1532r1273b1595],
101	Ia	NN	O	ia	dep	108	SENT_327	[p19l1295t1537r1356b1595],
102	or	CC	O	or	dep	108	SENT_327	[p19l1375t1555r1446b1595],
103	class	NN	O	class	dep	108	SENT_327	[p19l1465t1532r1616b1595],
104	III	CD	NUMBER	iii	dep	108	SENT_327	[p19l1637t1537r1718b1594],
105	antiarrhyth	JJ	O	antiarrhyth	dep	108	SENT_327	[p19l1740t1532r2147b1616],
106	—	NN	O	—	dep	108	SENT_327	[p19l1740t1532r2147b1616],
107	mic	JJ	O	mic	dep	108	SENT_327	[p19l8t1642r132b1699],
108	drugs	NNS	O	drug	_	0	SENT_327	[p19l152t1636r356b1720],
109	.	.	O	.	_	0	SENT_327	[p19l152t1636r356b1720],

1	In	IN	O	in	_	0	SENT_328	[p19l379t1641r448b1698],
2	addition	NN	O	addition	prep_in	5	SENT_328	[p19l469t1636r766b1708],
3	,	,	O	,	_	0	SENT_328	[p19l469t1636r766b1708],
4	we	PRP	O	we	nsubj	5	SENT_328	[p19l786t1659r877b1699],
5	recommend	VBP	O	recommend	_	0	SENT_328	[p19l897t1636r1302b1699],
6	an	DT	O	a	det	8	SENT_328	[p19l1322t1659r1400b1699],
7	eye	NN	O	eye	nn	8	SENT_328	[p19l1420t1659r1526b1720],
8	examination	NN	O	examination	dobj	5	SENT_328	[p19l1546t1642r1964b1699],
9	prior	RB	O	prior	_	0	SENT_328	[p19l1982t1642r2152b1719],
10	to	TO	O	to	_	0	SENT_328	[p19l8t1751r76b1802],
11	treatment	NN	O	treatment	prep_prior_to	5	SENT_328	[p19l102t1751r470b1811],
12	,	,	O	,	_	0	SENT_328	[p19l102t1751r470b1811],
13	along	IN	O	along	_	0	SENT_328	[p19l498t1739r694b1823],
14	with	IN	O	with	_	0	SENT_328	[p19l715t1739r875b1802],
15	assessment	NN	O	assessment	prep_along_with	11	SENT_328	[p19l901t1751r1294b1802],
16	of	IN	O	of	_	0	SENT_328	[p19l1319t1739r1396b1802],
17	varicella	NN	O	varicellum	nn	19	SENT_328	[p19l1409t1739r1710b1802],
18	zoster	NN	O	zoster	nn	19	SENT_328	[p19l1735t1751r1947b1802],
19	virus	NN	O	virus	prep_of	15	SENT_328	[p19l1970t1745r2149b1802],
20	serum	NN	O	serum	nn	21	SENT_328	[p19l10t1865r230b1905],
21	status	NN	O	status	dep	11	SENT_328	[p19l255t1854r453b1905],
22	and	CC	O	and	_	0	SENT_328	[p19l479t1842r609b1905],
23	vaccination	NN	O	vaccination	dep	11	SENT_328	[p19l629t1848r1039b1905],
24	to	TO	O	to	_	0	SENT_328	[p19l1062t1854r1130b1905],
25	seronegative	JJ	O	seronegative	amod	26	SENT_328	[p19l1156t1848r1595b1926],
26	patients	NNS	O	patient	prep_to	21	SENT_328	[p19l1618t1848r1914b1925],
27	.	.	O	.	_	0	SENT_328	[p19l1618t1848r1914b1925],

1	Liverfunction	JJ	O	liverfunction	amod	3	SENT_329	[p19l1942t1847r2147b1905, p19l8t1945r300b2008],
2	test	NN	O	test	nn	3	SENT_329	[p19l319t1957r437b2008],
3	results	NNS	O	result	nsubjpass	7	SENT_329	[p19l456t1945r675b2008],
4	should	MD	O	should	aux	7	SENT_329	[p19l697t1945r926b2008],
5	also	RB	O	also	advmod	7	SENT_329	[p19l946t1945r1077b2008],
6	be	VB	O	be	auxpass	7	SENT_329	[p19l1096t1945r1175b2008],
7	reviewed	VBN	O	review	_	0	SENT_329	[p19l1196t1945r1502b2008],
8	prior	RB	O	prior	_	0	SENT_329	[p19l1520t1951r1693b2028],
9	to	TO	O	to	_	0	SENT_329	[p19l1711t1957r1777b2008],
10	treatment	NN	O	treatment	prep_prior_to	7	SENT_329	[p19l1797t1957r2147b2008],
11	.	.	O	.	_	0	SENT_329	[p19l1797t1957r2147b2008],

1	Due	JJ	O	due	_	0	SENT_330	[p19l9t2053r153b2111],
2	to	TO	O	to	_	0	SENT_330	[p19l175t2060r242b2111],
3	the	DT	O	the	det	6	SENT_330	[p19l266t2048r373b2111],
4	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_330	[p19l398t2048r759b2132],
5	side	NN	O	side	nn	6	SENT_330	[p19l782t2048r916b2111],
6	effects	NNS	O	effect	prep_due_to	24	SENT_330	[p19l940t2048r1155b2111],
7	and	CC	O	and	_	0	SENT_330	[p19l1180t2048r1308b2111],
8	lack	NN	O	lack	prep_due_to	24	SENT_330	[p19l1328t2048r1471b2111],
9	of	IN	O	of	_	0	SENT_330	[p19l1491t2048r1566b2111],
10	long-term	JJ	O	long-term	amod	12	SENT_330	[p19l1578t2048r1930b2132],
11	safety	NN	O	safety	nn	12	SENT_330	[p19l1954t2048r2153b2132],
12	data	NNS	O	datum	prep_of	8	SENT_330	[p19l9t2151r152b2214],
13	(	RB	O	(	amod	8	SENT_330	[p19l174t2151r265b2228],
14	as	IN	O	as	_	0	SENT_330	[p19l174t2151r265b2228],
15	compared	VBN	O	compare	prepc_as	13	SENT_330	[p19l286t2151r625b2234],
16	with	IN	O	with	pcomp	15	SENT_330	[p19l642t2151r794b2214],
17	established	JJ	O	established	amod	18	SENT_330	[p19l815t2151r1188b2214],
18	tier	NN	O	tier	pobj	16	SENT_330	[p19l1206t2157r1322b2214],
19	1	CD	NUMBER	1	num	20	SENT_330	[p19l1348t2158r1373b2213],
20	medications	NNS	O	medication	dep	21	SENT_330	[p19l1399t2151r1860b2228],
21	)	RB	O	)	amod	18	SENT_330	[p19l1399t2151r1860b2228],
22	,	,	O	,	_	0	SENT_330	[p19l1399t2151r1860b2228],
23	we	PRP	O	we	nsubj	24	SENT_330	[p19l1880t2174r1972b2214],
24	offer	VBP	O	offer	_	0	SENT_330	[p19l1994t2151r2148b2214],
25	ﬁngolimod	NN	O	ﬁngolimod	dobj	24	SENT_330	[p19l8t2254r389b2338],
26	currently	RB	DATE	currently	advmod	24	SENT_330	[p19l410t2254r727b2338],
27	as	IN	O	as	_	0	SENT_330	[p19l745t2277r810b2317],
28	a	DT	O	a	det	32	SENT_330	[p19l833t2277r867b2317],
29	tier	NN	O	tier	nn	32	SENT_330	[p19l887t2260r1004b2317],
30	2	CD	NUMBER	2	num	32	SENT_330	[p19l1025t2261r1061b2316],
31	medication	NN	O	medication	nn	32	SENT_330	[p19l1083t2254r1471b2317],
32	choice	NN	O	choice	prep_as	24	SENT_330	[p19l1493t2254r1710b2317],
33	(	CD	NUMBER	(	num	34	SENT_330	[p19l1736t2255r1995b2337],
34	Figure	NNP	O	Figure	dep	32	SENT_330	[p19l1736t2255r1995b2337],
35	5	CD	NUMBER	5	num	34	SENT_330	[p19l2016t2255r2101b2330],
36	)	NN	O	)	dep	34	SENT_330	[p19l2016t2255r2101b2330],
37	.	.	O	.	_	0	SENT_330	[p19l2016t2255r2101b2330],

1	Mitoxantrone	NN	O	mitoxantrone	_	0	SENT_331	[p19l10t2468r485b2525],

1	Mitoxantrone	NNP	O	Mitoxantrone	nsubj	6	SENT_332	[p19l8t2570r490b2628],
2	is	VBZ	O	be	cop	6	SENT_332	[p19l514t2571r565b2628],
3	an	DT	O	a	det	6	SENT_332	[p19l589t2588r671b2628],
4	anthracenedione	JJ	O	anthracenedione	amod	6	SENT_332	[p19l695t2565r1282b2628],
5	chemotherapeutic	JJ	O	chemotherapeutic	amod	6	SENT_332	[p19l1306t2565r1940b2648],
6	agent	NN	O	agent	dep	46	SENT_332	[p19l1964t2577r2151b2649],
7	mainly	RB	O	mainly	advmod	8	SENT_332	[p19l8t2668r251b2752],
8	used	VBN	O	use	partmod	6	SENT_332	[p19l269t2668r429b2731],
9	in	IN	O	in	_	0	SENT_332	[p19l451t2674r518b2730],
10	transforming	VBG	O	transform	prepc_in	8	SENT_332	[p19l539t2668r999b2752],
11	MS	NN	O	m	nn	12	SENT_332	[p19l1020t2672r1135b2731],
12	phenotypes	NNS	O	phenotype	nsubj	13	SENT_332	[p19l1157t2668r1556b2752],
13	(	VBP	O	(	ccomp	10	SENT_332	[p19l1583t2668r1924b2752],
14	relapsing	VBG	O	relapse	amod	15	SENT_332	[p19l1583t2668r1924b2752],
15	MS	NN	O	m	dobj	13	SENT_332	[p19l1944t2672r2059b2731],
16	to	TO	O	to	_	0	SENT_332	[p19l2082t2680r2148b2731],
17	progressive	JJ	O	progressive	amod	19	SENT_332	[p19l7t2777r399b2855],
18	MS	NN	O	m	nn	19	SENT_332	[p19l421t2772r586b2847],
19	)	NN	O	)	prep_to	13	SENT_332	[p19l421t2772r586b2847],
20	,	,	O	,	_	0	SENT_332	[p19l421t2772r586b2847],
21	in	IN	O	in	_	0	SENT_332	[p19l610t2777r678b2833],
22	which	WDT	O	which	nsubj	23	SENT_332	[p19l699t2771r911b2834],
23	increased	VBD	O	increase	prepc_in	13	SENT_332	[p19l934t2771r1263b2834],
24	relapse	NN	O	relapse	nn	25	SENT_332	[p19l1285t2771r1524b2854],
25	activity	NN	O	activity	nsubj	27	SENT_332	[p19l1547t2777r1803b2855],
26	is	VBZ	O	be	aux	27	SENT_332	[p19l1822t2777r1872b2834],
27	leading	VBG	O	lead	ccomp	23	SENT_332	[p19l1894t2771r2150b2855],
28	to	TO	O	to	_	0	SENT_332	[p19l8t2885r75b2937],
29	stepwise	JJ	O	stepwise	amod	31	SENT_332	[p19l103t2880r397b2957],
30	irreversible	JJ	O	irreversible	amod	31	SENT_332	[p19l423t2873r822b2937],
31	disability	NN	O	disability	prep_to	27	SENT_332	[p19l848t2873r1174b2958],
32	in	IN	O	in	_	0	SENT_332	[p19l1196t2880r1264b2936],
33	a	DT	O	a	det	35	SENT_332	[p19l1290t2896r1326b2937],
34	short	JJ	O	short	amod	35	SENT_332	[p19l1351t2873r1533b2937],
35	period	NN	O	period	prep_in	31	SENT_332	[p19l1556t2873r1791b2957],
36	of	IN	O	of	_	0	SENT_332	[p19l1816t2873r1892b2937],
37	time	NN	O	time	nn	39	SENT_332	[p19l1906t2865r2148b2937],
38	.79	CD	NUMBER	.79	num	39	SENT_332	[p19l1906t2865r2148b2937],
39	Administration	NN	O	administration	prep_of	35	SENT_332	[p19l8t2977r531b3040],
40	of	IN	O	of	_	0	SENT_332	[p19l551t2977r624b3040],
41	i.v.	NN	O	i.v.	nn	42	SENT_332	[p19l634t2983r721b3040],
42	mitoxantrone	NN	O	mitoxantrone	prep_of	39	SENT_332	[p19l743t2983r1203b3040],
43	every	DT	SET	every	det	45	SENT_332	[p19l1223t3000r1408b3061],
44	3	CD	SET	3	num	45	SENT_332	[p19l1425t2984r1458b3040],
45	months	NNS	NUMBER	month	nsubj	46	SENT_332	[p19l1480t2977r1736b3040],
46	stabilizes	VBZ	O	stabilize	_	0	SENT_332	[p19l1757t2977r2058b3040],
47	or	CC	O	or	_	0	SENT_332	[p19l2079t3000r2150b3040],
48	improves	VBZ	O	improve	conj_or	46	SENT_332	[p19l9t3086r318b3163],
49	several	JJ	O	several	amod	50	SENT_332	[p19l339t3080r569b3143],
50	clinical	JJ	O	clinical	dobj	46	SENT_332	[p19l589t3080r830b3143],
51	and	CC	O	and	_	0	SENT_332	[p19l849t3080r974b3143],
52	functional	JJ	O	functional	amod	54	SENT_332	[p19l993t3080r1341b3143],
53	outcome	NN	O	outcome	nn	54	SENT_332	[p19l1360t3092r1653b3143],
54	measures	NNS	O	measure	dobj	46	SENT_332	[p19l1672t3103r2002b3143],
55	.	.	O	.	_	0	SENT_332	[p19l1672t3103r2002b3143],

1	The	DT	O	the	det	3	SENT_333	[p19l2025t3080r2149b3143],
2	greatest	JJS	O	greatest	amod	3	SENT_333	[p19l8t3195r264b3267],
3	concern	NN	O	concern	nsubj	10	SENT_333	[p19l283t3206r552b3246],
4	regarding	VBG	O	regard	_	0	SENT_333	[p19l571t3183r893b3267],
5	this	DT	O	this	det	6	SENT_333	[p19l909t3183r1030b3246],
6	medication	NN	O	medication	prep_regarding	3	SENT_333	[p19l1050t3183r1427b3246],
7	is	VBZ	O	be	cop	10	SENT_333	[p19l1446t3189r1495b3246],
8	its	PRP$	O	its	poss	10	SENT_333	[p19l1515t3189r1588b3246],
9	dose	NN	O	dose	nn	10	SENT_333	[p19l1609t3183r2148b3266],
10	—	NN	O	—	_	0	SENT_333	[p19l1609t3183r2148b3266],
11	dependent	JJ	O	dependent	amod	13	SENT_333	[p19l1609t3183r2148b3266],
12	cardiac	JJ	O	cardiac	amod	13	SENT_333	[p19l9t3286r252b3349],
13	toxicity	NN	O	toxicity	dep	10	SENT_333	[p19l270t3292r534b3370],
14	,	,	O	,	_	0	SENT_333	[p19l270t3292r534b3370],
15	which	WDT	O	which	nsubj	16	SENT_333	[p19l554t3286r762b3349],
16	leads	VBZ	O	lead	rcmod	10	SENT_333	[p19l781t3286r951b3349],
17	to	TO	O	to	_	0	SENT_333	[p19l970t3298r1036b3349],
18	fatal	JJ	O	fatal	amod	21	SENT_333	[p19l1057t3286r1202b3349],
19	congestive	JJ	O	congestive	amod	21	SENT_333	[p19l1222t3292r1574b3370],
20	heart	NN	O	heart	nn	21	SENT_333	[p19l1593t3286r1770b3349],
21	failure	NN	O	failure	prep_to	16	SENT_333	[p19l1789t3286r2003b3349],
22	and	CC	O	and	_	0	SENT_333	[p19l2025t3286r2150b3349],
23	limits	VBZ	O	limit	rcmod	10	SENT_333	[p19l7t3389r207b3452],
24	the	DT	O	the	det	28	SENT_333	[p19l232t3388r341b3452],
25	cumulative	JJ	O	cumulative	amod	28	SENT_333	[p19l367t3388r757b3452],
26	lifetime	NN	O	lifetime	nn	28	SENT_333	[p19l781t3388r1051b3452],
27	maximum	NN	O	maximum	nn	28	SENT_333	[p19l1076t3395r1442b3452],
28	dose	NN	O	dose	dobj	23	SENT_333	[p19l1467t3388r1627b3452],
29	to	TO	O	to	_	0	SENT_333	[p19l1651t3400r1718b3452],
30	140	CD	NUMBER	140	num	31	SENT_333	[p19l1752t3395r1868b3452],
31	mg/m2	NN	O	mg/m2	prep_to	23	SENT_333	[p19l1884t3380r2146b3473],
32	.	.	O	.	_	0	SENT_333	[p19l1884t3380r2146b3473],

1	We	PRP	O	we	nsubj	3	SENT_334	[p19l7t3497r117b3555],
2	generally	RB	O	generally	advmod	3	SENT_334	[p19l140t3491r453b3576],
3	avoid	VBP	O	avoid	_	0	SENT_334	[p19l473t3491r656b3555],
4	exceeding	VBG	O	exceed	ccomp	3	SENT_334	[p19l678t3491r1019b3576],
5	a	DT	O	a	det	8	SENT_334	[p19l1041t3514r1075b3555],
6	total	JJ	O	total	amod	8	SENT_334	[p19l1095t3491r1249b3555],
7	lifetime	NN	O	lifetime	nn	8	SENT_334	[p19l1269t3491r1529b3555],
8	dose	NN	O	dose	dobj	4	SENT_334	[p19l1553t3491r1707b3555],
9	of	IN	O	of	_	0	SENT_334	[p19l1730t3491r1804b3555],
10	96	CD	NUMBER	96	num	11	SENT_334	[p19l1817t3498r1895b3555],
11	mg/m2	NN	O	mg/m2	prep_of	8	SENT_334	[p19l1911t3483r2148b3576],
12	(	CD	NUMBER	(	number	13	SENT_334	[p19l12t3595r75b3672],
13	8	CD	NUMBER	8	num	14	SENT_334	[p19l12t3595r75b3672],
14	doses	NNS	O	dose	dep	4	SENT_334	[p19l99t3594r286b3658],
15	of	IN	O	of	_	0	SENT_334	[p19l309t3594r384b3658],
16	12	CD	NUMBER	12	num	18	SENT_334	[p19l403t3601r474b3657],
17	mg/m2	NN	O	mg/m2	nn	18	SENT_334	[p19l490t3586r775b3679],
18	)	NN	O	)	prep_of	14	SENT_334	[p19l490t3586r775b3679],
19	.	.	O	.	_	0	SENT_334	[p19l490t3586r775b3679],

1	Patients	NNS	O	patient	nsubjpass	7	SENT_335	[p19l802t3600r1071b3658],
2	receiving	VBG	O	receive	partmod	1	SENT_335	[p19l1094t3601r1407b3679],
3	mitoxantrone	NN	O	mitoxantrone	dobj	2	SENT_335	[p19l1428t3601r1895b3658],
4	should	MD	O	should	aux	7	SENT_335	[p19l1919t3594r2150b3658],
5	also	RB	O	also	advmod	7	SENT_335	[p19l9t3698r145b3761],
6	be	VB	O	be	auxpass	7	SENT_335	[p19l170t3698r252b3761],
7	monitored	VBN	O	monitor	_	0	SENT_335	[p19l277t3698r654b3761],
8	every	DT	SET	every	det	10	SENT_335	[p19l680t3721r873b3782],
9	3	CD	SET	3	num	10	SENT_335	[p19l897t3705r931b3761],
10	months	NNS	NUMBER	month	tmod	7	SENT_335	[p19l960t3698r1227b3761],
11	with	IN	O	with	_	0	SENT_335	[p19l1252t3698r1410b3761],
12	echocardiograms	NNS	O	echocardiogram	prep_with	7	SENT_335	[p19l1437t3698r2047b3782],
13	or	CC	O	or	_	0	SENT_335	[p19l2075t3721r2149b3761],
14	multigated	JJ	O	multigated	amod	15	SENT_335	[p20l8t16r387b100],
15	acquisition	NN	O	acquisition	conj_or	12	SENT_335	[p20l410t22r796b99],
16	(	CD	NUMBER	(	num	19	SENT_335	[p20l823t16r1141b93],
17	MUGA	NNP	ORGANIZATION	MUGA	nn	19	SENT_335	[p20l823t16r1141b93],
18	)	CD	NUMBER	)	num	19	SENT_335	[p20l823t16r1141b93],
19	scans	NNS	O	scan	dep	15	SENT_335	[p20l1170t39r1353b79],
20	to	TO	O	to	aux	21	SENT_335	[p20l1377t28r1444b79],
21	determine	VB	O	determine	xcomp	7	SENT_335	[p20l1469t16r1829b79],
22	the	DT	O	the	det	24	SENT_335	[p20l1851t16r1960b79],
23	ejection	NN	O	ejection	nn	24	SENT_335	[p20l1985t22r2145b100, p20l8t125r144b182],
24	fraction	NN	O	fraction	dobj	21	SENT_335	[p20l166t119r450b182],
25	.	.	O	.	_	0	SENT_335	[p20l166t119r450b182],

1	Reduction	NN	O	reduction	nsubj	7	SENT_336	[p20l476t119r828b182],
2	in	IN	O	in	_	0	SENT_336	[p20l850t125r916b181],
3	the	DT	O	the	det	5	SENT_336	[p20l937t119r1043b182],
4	ejection	NN	O	ejection	nn	5	SENT_336	[p20l1066t125r1333b203],
5	fraction	NN	O	fraction	prep_in	1	SENT_336	[p20l1355t119r1623b182],
6	should	MD	O	should	aux	7	SENT_336	[p20l1645t119r1874b182],
7	prompt	VB	O	prompt	_	0	SENT_336	[p20l1894t131r2149b202],
8	discontinuation	NN	O	discontinuation	dobj	7	SENT_336	[p20l9t222r548b285],
9	of	IN	O	of	_	0	SENT_336	[p20l570t222r644b285],
10	this	DT	O	this	det	11	SENT_336	[p20l655t222r779b285],
11	therapy	NN	O	therapy	prep_of	8	SENT_336	[p20l801t222r1069b306],
12	.	.	O	.	_	0	SENT_336	[p20l801t222r1069b306],

1	Besides	IN	O	besides	_	0	SENT_337	[p20l1094t222r1347b285],
2	the	DT	O	the	det	5	SENT_337	[p20l1368t222r1475b285],
3	cardiac	JJ	O	cardiac	amod	5	SENT_337	[p20l1498t222r1741b285],
4	side	NN	O	side	nn	5	SENT_337	[p20l1764t222r1896b285],
5	effects	NNS	O	effect	prep_besides	9	SENT_337	[p20l1919t222r2148b294],
6	,	,	O	,	_	0	SENT_337	[p20l1919t222r2148b294],
7	mitoxantrone	NN	O	mitoxantrone	nsubj	9	SENT_337	[p20l8t331r465b388],
8	may	MD	O	may	aux	9	SENT_337	[p20l484t348r628b409],
9	cause	VB	O	cause	_	0	SENT_337	[p20l645t348r824b388],
10	menstrual	JJ	O	menstrual	amod	11	SENT_337	[p20l844t325r1185b388],
11	irregularities	NNS	O	irregularity	dobj	9	SENT_337	[p20l1204t325r1632b409],
12	or	CC	O	or	_	0	SENT_337	[p20l1652t348r1723b388],
13	overall	JJ	O	overall	amod	14	SENT_337	[p20l1741t325r1966b388],
14	ablation	NN	O	ablation	dobj	9	SENT_337	[p20l1986t325r2146b388, p20l8t434r144b491],
15	of	IN	O	of	_	0	SENT_337	[p20l165t428r239b491],
16	the	DT	O	the	det	18	SENT_337	[p20l249t428r355b491],
17	menstrual	JJ	O	menstrual	amod	18	SENT_337	[p20l375t428r721b491],
18	cycle	NN	O	cycle	prep_of	14	SENT_337	[p20l742t428r925b512],
19	,	,	O	,	_	0	SENT_337	[p20l742t428r925b512],
20	which	WDT	O	which	nsubj	23	SENT_337	[p20l945t428r1154b491],
21	may	MD	O	may	aux	23	SENT_337	[p20l1174t451r1320b512],
22	be	VB	O	be	cop	23	SENT_337	[p20l1335t428r1414b491],
23	permanent	JJ	O	permanent	rcmod	18	SENT_337	[p20l1434t440r1824b511],
24	.	.	O	.	_	0	SENT_337	[p20l1434t440r1824b511],

1	The	DT	O	the	det	2	SENT_338	[p20l1848t428r1972b491],
2	incidence	NN	O	incidence	nsubj	23	SENT_338	[p20l1994t434r2146b491, p20l9t531r211b594],
3	of	IN	O	of	_	0	SENT_338	[p20l235t531r311b594],
4	mitoxantrone	NN	O	mitoxantrone	nn	6	SENT_338	[p20l323t537r799b594],
5	therapy	NN	O	therapy	nn	6	SENT_338	[p20l821t531r1371b615],
6	—	NN	O	—	prep_of	2	SENT_338	[p20l821t531r1371b615],
7	related	JJ	O	related	amod	9	SENT_338	[p20l821t531r1371b615],
8	acute	JJ	O	acute	amod	9	SENT_338	[p20l1394t543r1575b594],
9	leukemia	NN	O	leukemia	nsubj	14	SENT_338	[p20l1597t531r1918b594],
10	in	IN	O	in	_	0	SENT_338	[p20l1940t537r2008b593],
11	MS	NN	O	m	nn	12	SENT_338	[p20l2030t535r2146b594],
12	patients	NNS	O	patient	prep_in	9	SENT_338	[p20l7t640r283b717],
13	is	VBZ	O	be	cop	14	SENT_338	[p20l307t640r358b697],
14	~	NN	O	~	rcmod	6	SENT_338	[p20l385t625r879b698],
15	0.05	CD	PERCENT	0.05	num	14	SENT_338	[p20l385t625r879b698],
16	—	CD	PERCENT	—	number	17	SENT_338	[p20l385t625r879b698],
17	0.1	CD	PERCENT	0.1	dep	18	SENT_338	[p20l385t625r879b698],
18	%	NN	PERCENT	%	dep	14	SENT_338	[p20l385t625r879b698],
19	.8	CD	NUMBER	.8	number	20	SENT_338	[p20l385t625r879b698],
20	°	CD	NUMBER	°	num	14	SENT_338	[p20l385t625r879b698],
21	Although	IN	O	although	mark	22	SENT_338	[p20l902t633r1237b718],
22	initially	RB	O	initially	dep	14	SENT_338	[p20l1260t633r1530b718],
23	studied	VBN	O	study	partmod	35	SENT_338	[p20l1551t633r1808b697],
24	in	IN	O	in	_	0	SENT_338	[p20l1830t640r1898b696],
25	SPMS	NNP	O	SPMS	prep_in	23	SENT_338	[p20l1923t637r2148b706],
26	,	,	O	,	_	0	SENT_338	[p20l1923t637r2148b706],
27	the	DT	O	the	det	28	SENT_338	[p20l8t737r113b800],
28	beneﬁt	NN	O	beneﬁt	nsubj	35	SENT_338	[p20l133t737r367b800],
29	for	IN	O	for	_	0	SENT_338	[p20l386t737r483b800],
30	patients	NNS	O	patient	prep_for	28	SENT_338	[p20l502t743r769b820],
31	with	IN	O	with	_	0	SENT_338	[p20l789t737r940b800],
32	relapse-independent	JJ	O	relapse-independent	amod	33	SENT_338	[p20l962t737r1660b820],
33	progression	NN	O	progression	prep_with	30	SENT_338	[p20l1679t743r2077b821],
34	is	VBZ	O	be	cop	35	SENT_338	[p20l2099t743r2148b800],
35	uncertain	JJ	O	uncertain	_	0	SENT_338	[p20l8t846r360b903],
36	.	.	O	.	_	0	SENT_338	[p20l8t846r360b903],

1	One	CD	NUMBER	one	nsubj	3	SENT_339	[p20l387t844r532b903],
2	would	MD	O	would	aux	3	SENT_339	[p20l553t840r771b903],
3	need	VB	O	need	dep	36	SENT_339	[p20l792t840r958b903],
4	to	TO	O	to	aux	5	SENT_339	[p20l979t852r1046b903],
5	treat	VB	O	treat	xcomp	3	SENT_339	[p20l1069t852r1227b903],
6	11	CD	NUMBER	11	num	7	SENT_339	[p20l1255t847r1322b902],
7	patients	NNS	O	patient	dobj	5	SENT_339	[p20l1350t846r1623b923],
8	with	IN	O	with	_	0	SENT_339	[p20l1644t840r1799b903],
9	SPMS	NN	ORGANIZATION	spm	prep_with	7	SENT_339	[p20l1823t844r2026b903],
10	for	IN	O	for	_	0	SENT_339	[p20l2050t840r2149b903],
11	2	CD	DURATION	2	num	12	SENT_339	[p20l9t950r45b1005],
12	years	NNS	NUMBER	year	prep_for	5	SENT_339	[p20l69t966r248b1027],
13	to	TO	O	to	aux	14	SENT_339	[p20l271t955r339b1006],
14	prevent	VB	O	prevent	xcomp	5	SENT_339	[p20l363t955r629b1026],
15	1	CD	NUMBER	1	num	16	SENT_339	[p20l659t950r684b1005],
16	person	NN	O	person	dobj	14	SENT_339	[p20l713t965r954b1026],
17	from	IN	O	from	_	0	SENT_339	[p20l978t943r1150b1006],
18	worsening	VBG	O	worsen	prep_from	16	SENT_339	[p20l1172t949r1541b1027],
19	by	IN	O	by	_	0	SENT_339	[p20l1561t943r1648b1027],
20	1.0	CD	NUMBER	1.0	num	25	SENT_339	[p20l1674t950r1768b1006],
21	Expanded	NNP	O	Expanded	nn	25	SENT_339	[p20l1793t943r2148b1026],
22	Disability	NNP	O	Disability	nn	25	SENT_339	[p20l9t1046r338b1130],
23	Status	NNP	O	Status	nn	25	SENT_339	[p20l357t1050r555b1109],
24	Scale	NNP	O	Scale	nn	25	SENT_339	[p20l579t1046r748b1109],
25	point	NN	O	point	prep_by	14	SENT_339	[p20l768t1052r966b1129],
26	,	,	O	,	_	0	SENT_339	[p20l768t1052r966b1129],
27	a	DT	O	a	det	30	SENT_339	[p20l990t1069r1025b1109],
28	rather	RB	O	rather	advmod	29	SENT_339	[p20l1045t1046r1251b1109],
29	modest	JJ	O	modest	amod	30	SENT_339	[p20l1271t1046r1522b1109],
30	beneﬁt	NN	O	beneﬁt	appos	25	SENT_339	[p20l1540t1046r1775b1109],
31	for	IN	O	for	_	0	SENT_339	[p20l1795t1046r1892b1109],
32	signiﬁcant	JJ	O	signiﬁcant	amod	33	SENT_339	[p20l1913t1046r2146b1130, p20l9t1160r156b1212],
33	toXicity	NN	O	toxicity	prep_for	14	SENT_339	[p20l178t1140r517b1233],
34	.79	CD	NUMBER	.79	num	33	SENT_339	[p20l178t1140r517b1233],
35	We	PRP	O	we	dep	33	SENT_339	[p20l541t1154r653b1212],
36	utilize	VBP	O	utilize	_	0	SENT_339	[p20l678t1148r893b1212],
37	mitoxantrone	NN	O	mitoxantrone	dobj	36	SENT_339	[p20l917t1155r1396b1212],
38	currently	RB	DATE	currently	advmod	36	SENT_339	[p20l1422t1149r1747b1233],
39	as	IN	O	as	_	0	SENT_339	[p20l1768t1171r1834b1212],
40	an	DT	O	a	det	41	SENT_339	[p20l1860t1171r1942b1212],
41	alternative	NN	O	alternative	prep_as	36	SENT_339	[p20l1967t1148r2146b1212, p20l8t1258r220b1315],
42	to	TO	O	to	_	0	SENT_339	[p20l244t1264r312b1315],
43	failed	VBN	O	fail	amod	44	SENT_339	[p20l338t1252r533b1315],
44	tier	NN	O	tier	prep_to	41	SENT_339	[p20l556t1258r677b1315],
45	2	CD	NUMBER	2	num	46	SENT_339	[p20l701t1259r737b1314],
46	medication	NN	O	medication	npadvmod	44	SENT_339	[p20l764t1252r1163b1315],
47	in	IN	O	in	_	0	SENT_339	[p20l1189t1258r1257b1314],
48	highly	RB	O	highly	advmod	49	SENT_339	[p20l1281t1252r1507b1336],
49	active	JJ	O	active	amod	50	SENT_339	[p20l1529t1258r1731b1315],
50	individuals	NNS	O	individual	prep_in	44	SENT_339	[p20l1757t1252r2149b1315],
51	(	CD	NUMBER	(	num	54	SENT_339	[p20l12t1356r272b1438],
52	Figure	NN	O	figure	nn	54	SENT_339	[p20l12t1356r272b1438],
53	5	CD	NUMBER	5	num	54	SENT_339	[p20l294t1356r379b1431],
54	)	NN	O	)	nsubj	36	SENT_339	[p20l294t1356r379b1431],
55	.	.	O	.	_	0	SENT_339	[p20l294t1356r379b1431],

1	Cyclophosphamide	NNP	O	Cyclophosphamide	nsubjpass	3	SENT_340	[p20l406t1355r1071b1439],
2	is	VBZ	O	be	auxpass	3	SENT_340	[p20l1094t1361r1144b1418],
3	applied	VBN	O	apply	_	0	SENT_340	[p20l1168t1355r1419b1438],
4	in	IN	O	in	_	0	SENT_340	[p20l1440t1361r1507b1417],
5	a	DT	O	a	det	6	SENT_340	[p20l1531t1378r1565b1418],
6	way	NN	O	way	prep_in	3	SENT_340	[p20l1585t1378r1723b1439],
7	very	RB	O	very	advmod	8	SENT_340	[p20l1739t1378r1892b1439],
8	similar	JJ	O	similar	amod	6	SENT_340	[p20l1912t1355r2150b1418],
9	to	TO	O	to	_	0	SENT_340	[p20l8t1470r73b1521],
10	that	DT	O	that	prep_to	8	SENT_340	[p20l94t1458r227b1521],
11	for	IN	O	for	_	0	SENT_340	[p20l246t1458r343b1521],
12	mitoxantrone	NN	O	mitoxantrone	prep_for	10	SENT_340	[p20l362t1464r825b1521],
13	as	IN	O	as	_	0	SENT_340	[p20l846t1481r910b1521],
14	a	DT	O	a	det	17	SENT_340	[p20l932t1481r967b1521],
15	tier	NN	O	tier	nn	17	SENT_340	[p20l985t1464r1101b1521],
16	2	CD	NUMBER	2	num	17	SENT_340	[p20l1121t1465r1157b1520],
17	medication	NN	O	medication	prep_as	3	SENT_340	[p20l1179t1458r1562b1521],
18	in	IN	O	in	_	0	SENT_340	[p20l1583t1464r1650b1520],
19	our	PRP$	O	we	poss	20	SENT_340	[p20l1671t1481r1788b1521],
20	practice	NN	O	practice	prep_in	17	SENT_340	[p20l1806t1464r2092b1541],
21	.	.	O	.	_	0	SENT_340	[p20l1806t1464r2092b1541],

1	AN	DT	O	a	det	3	SENT_341	[p20l8t1674r110b1728],
2	EXAMPLE	NNP	O	EXAMPLE	nn	3	SENT_341	[p20l134t1674r472b1728],
3	PROTOCOL	NNP	O	PROTOCOL	_	0	SENT_341	[p20l494t1673r884b1729],
4	FOR	IN	O	for	_	0	SENT_341	[p20l905t1673r1047b1729],
5	PREVENTION	NNP	O	PREVENTION	prep_for	3	SENT_341	[p20l1067t1673r1531b1729],
6	OF	IN	O	of	dep	3	SENT_341	[p20l1552t1673r1646b1729],
7	RELAPSES	NNP	O	RELAPSES	pobj	6	SENT_341	[p20l1668t1674r2026b1729],
8	IN	IN	O	in	dep	3	SENT_341	[p20l2049t1674r2117b1728],

1	MS	NN	O	m	_	0	SENT_342	[p20l11t1777r115b1832],
2	We	PRP	O	we	nsubj	3	SENT_342	[p20l7t1877r121b1935],
3	follow	VBP	O	follow	rcmod	1	SENT_342	[p20l148t1872r374b1935],
4	patients	NNS	O	patient	nsubj	5	SENT_342	[p20l398t1878r682b1955],
5	deemed	VBD	O	deem	ccomp	3	SENT_342	[p20l712t1872r993b1935],
6	likely	JJ	O	likely	acomp	5	SENT_342	[p20l1019t1872r1216b1956],
7	to	TO	O	to	aux	9	SENT_342	[p20l1239t1884r1308b1935],
8	remain	VB	O	remain	cop	9	SENT_342	[p20l1337t1878r1591b1935],
9	relapse	NN	O	relapse	xcomp	6	SENT_342	[p20l1620t1872r1869b1955],
10	free	JJ	O	free	dep	18	SENT_342	[p20l1897t1872r2031b1935],
11	on	IN	O	on	_	0	SENT_342	[p20l2060t1895r2149b1935],
12	the	DT	O	the	det	13	SENT_342	[p20l8t1975r121b2038],
13	basis	NN	O	basis	prep_on	10	SENT_342	[p20l151t1975r330b2038],
14	of	IN	O	of	_	0	SENT_342	[p20l364t1975r442b2038],
15	the	DT	O	the	det	16	SENT_342	[p20l463t1975r577b2038],
16	“	NN	O	“	prep_of	13	SENT_342	[p20l610t1975r929b2059],
17	benign	JJ	O	benign	amod	18	SENT_342	[p20l610t1975r929b2059],
18	”	NN	O	”	dep	19	SENT_342	[p20l610t1975r929b2059],
19	characteristics	NNS	O	characteristic	dep	1	SENT_342	[p20l964t1975r1496b2038],
20	discussed	VBN	O	discuss	partmod	19	SENT_342	[p20l1530t1975r1883b2038],
21	earlier	JJR	O	earlier	advmod	20	SENT_342	[p20l1915t1975r2150b2038],

1	40	CD	NUMBER	40	num	3	SENT_343	[p20l7t2195r72b2237],
2	(	CD	NUMBER	(	num	3	SENT_343	[p20l13t2275r304b2358],
3	Figures	NNS	O	figure	_	0	SENT_343	[p20l13t2275r304b2358],
4	4-5	CD	NUMBER	4-5	num	5	SENT_343	[p20l323t2276r498b2351],
5	)	NN	O	)	dep	3	SENT_343	[p20l323t2276r498b2351],
6	.	.	O	.	_	0	SENT_343	[p20l323t2276r498b2351],

1	In	IN	O	in	dep	107	SENT_344	[p20l523t2280r594b2337],
2	our	PRP$	O	we	dep	107	SENT_344	[p20l616t2298r734b2338],
3	practice	NN	O	practice	dep	107	SENT_344	[p20l753t2281r1042b2358],
4	,	,	O	,	_	0	SENT_344	[p20l753t2281r1042b2358],
5	these	DT	O	these	dep	107	SENT_344	[p20l1064t2275r1240b2338],
6	patients	NNS	O	patient	dep	107	SENT_344	[p20l1260t2281r1529b2358],
7	generally	RB	O	generally	dep	107	SENT_344	[p20l1551t2275r1865b2359],
8	fall	VBP	O	fall	dep	107	SENT_344	[p20l1882t2275r1987b2338],
9	into	IN	O	into	dep	107	SENT_344	[p20l2009t2281r2142b2338],
10	one	CD	TIME	one	dep	107	SENT_344	[p20l10t2401r134b2441],
11	of	IN	TIME	of	dep	107	SENT_344	[p20l158t2378r233b2441],
12	two	CD	TIME	two	dep	107	SENT_344	[p20l245t2390r372b2441],
13	categories	NNS	O	category	dep	107	SENT_344	[p20l398t2384r759b2462],
14	:	:	O	:	_	0	SENT_344	[p20l398t2384r759b2462],
15	(	CD	NUMBER	(	dep	107	SENT_344	[p20l789t2379r862b2455],
16	i	FW	O	i	dep	107	SENT_344	[p20l789t2379r862b2455],
17	)	FW	O	)	dep	107	SENT_344	[p20l789t2379r862b2455],
18	patients	NNS	O	patient	dep	107	SENT_344	[p20l888t2384r1162b2461],
19	with	IN	O	with	dep	107	SENT_344	[p20l1185t2378r1340b2441],
20	SAMS	NN	PERSON	sam	dep	107	SENT_344	[p20l1364t2382r1580b2441],
21	(	CD	NUMBER	(	dep	107	SENT_344	[p20l1608t2379r1749b2461],
22	per	IN	O	per	dep	107	SENT_344	[p20l1608t2379r1749b2461],
23	our	PRP$	O	we	dep	107	SENT_344	[p20l1772t2401r1891b2441],
24	deﬁnition	NN	O	deﬁnition	dep	107	SENT_344	[p20l1914t2378r2140b2441, p20l8t2481r171b2558],
25	)	NN	O	)	dep	107	SENT_344	[p20l1914t2378r2140b2441, p20l8t2481r171b2558],
26	barely	RB	O	barely	dep	107	SENT_344	[p20l195t2481r406b2565],
27	fulﬁlling	VBG	O	fulﬁlling	dep	107	SENT_344	[p20l425t2481r718b2565],
28	2010	CD	DATE	2010	dep	107	SENT_344	[p20l738t2488r899b2544],
29	McDonald	NNP	ORGANIZATION	McDonald	dep	107	SENT_344	[p20l921t2481r1290b2544],
30	Radiological	NNP	ORGANIZATION	Radiological	dep	107	SENT_344	[p20l1311t2481r1739b2565],
31	Criteria	NNP	ORGANIZATION	Criteria	dep	107	SENT_344	[p20l1762t2485r2026b2544],
32	for	IN	O	for	dep	107	SENT_344	[p20l2046t2481r2144b2544],
33	dissemination	NN	O	dissemination	dep	107	SENT_344	[p20l10t2584r501b2647],
34	in	IN	O	in	dep	107	SENT_344	[p20l525t2590r592b2646],
35	time	NN	O	time	dep	107	SENT_344	[p20l615t2590r771b2647],
36	and	CC	O	and	dep	107	SENT_344	[p20l796t2584r924b2647],
37	space	NN	O	space	dep	107	SENT_344	[p20l948t2606r1134b2667],
38	for	IN	O	for	dep	107	SENT_344	[p20l1158t2584r1257b2647],
39	MS	NN	O	m	dep	107	SENT_344	[p20l1279t2588r1394b2647],
40	and	CC	O	and	dep	107	SENT_344	[p20l1419t2584r1548b2647],
41	almost	RB	O	almost	dep	107	SENT_344	[p20l1570t2584r1804b2647],
42	complete	JJ	O	complete	dep	107	SENT_344	[p20l1826t2584r2142b2667],
43	(	NN	O	(	dep	107	SENT_344	[p20l13t2688r237b2763],
44	285	CD	PERCENT	285	dep	107	SENT_344	[p20l13t2688r237b2763],
45	%	NN	PERCENT	%	dep	107	SENT_344	[p20l13t2688r237b2763],
46	by	IN	O	by	dep	107	SENT_344	[p20l261t2687r347b2771],
47	examination	NN	O	examination	dep	107	SENT_344	[p20l368t2693r808b2750],
48	or	CC	O	or	dep	107	SENT_344	[p20l832t2710r906b2750],
49	history	NN	O	history	dep	107	SENT_344	[p20l927t2687r1202b2771],
50	)	NN	O	)	dep	107	SENT_344	[p20l927t2687r1202b2771],
51	recovery	NN	O	recovery	dep	107	SENT_344	[p20l1230t2710r1535b2771],
52	from	IN	O	from	dep	107	SENT_344	[p20l1556t2687r1727b2750],
53	the	DT	O	the	dep	107	SENT_344	[p20l1750t2687r1859b2750],
54	current	JJ	DATE	current	dep	107	SENT_344	[p20l1884t2699r2143b2750],
55	inﬂammatory	JJ	O	inﬂammatory	dep	107	SENT_344	[p20l9t2790r1005b2874],
56	—	NN	O	—	dep	107	SENT_344	[p20l9t2790r1005b2874],
57	demyelinating	VBG	O	demyelinate	dep	107	SENT_344	[p20l9t2790r1005b2874],
58	attack	NN	O	attack	dep	107	SENT_344	[p20l1024t2790r1226b2853],
59	and	CC	O	and	dep	107	SENT_344	[p20l1243t2790r1368b2853],
60	(	CD	NUMBER	(	dep	107	SENT_344	[p20l1390t2791r1483b2867],
61	ii	LS	O	ii	dep	107	SENT_344	[p20l1390t2791r1483b2867],
62	)	CD	NUMBER	)	dep	107	SENT_344	[p20l1390t2791r1483b2867],
63	RRMS	NN	O	rrm	dep	107	SENT_344	[p20l1508t2794r1725b2853],
64	patients	NNS	O	patient	dep	107	SENT_344	[p20l1745t2796r2011b2873],
65	not	RB	O	not	dep	107	SENT_344	[p20l2032t2802r2144b2853],
66	on	IN	O	on	dep	107	SENT_344	[p20l10t2916r95b2956],
67	any	DT	O	any	dep	107	SENT_344	[p20l116t2916r235b2977],
68	prophylactic	NN	O	prophylactic	dep	107	SENT_344	[p20l251t2893r674b2977],
69	treatment	NN	O	treatment	dep	107	SENT_344	[p20l693t2905r1025b2956],
70	for	IN	O	for	dep	107	SENT_344	[p20l1044t2893r1140b2956],
71	MS	NN	O	m	dep	107	SENT_344	[p20l1159t2897r1290b2965],
72	,	,	O	,	_	0	SENT_344	[p20l1159t2897r1290b2965],
73	with	IN	O	with	dep	107	SENT_344	[p20l1309t2893r1461b2956],
74	signiﬁcant	JJ	O	signiﬁcant	dep	107	SENT_344	[p20l1481t2893r1832b2977],
75	intervals	NNS	O	interval	dep	107	SENT_344	[p20l1851t2893r2140b2956],
76	(	VBP	O	(	dep	107	SENT_344	[p20l13t2996r124b3073],
77	25	CD	DURATION	25	dep	107	SENT_344	[p20l13t2996r124b3073],
78	years	NNS	NUMBER	year	dep	107	SENT_344	[p20l145t2997r346b3080],
79	)	RB	O	)	dep	107	SENT_344	[p20l145t2997r346b3080],
80	between	IN	O	between	dep	107	SENT_344	[p20l369t2996r654b3059],
81	relapses	NNS	O	relapse	dep	107	SENT_344	[p20l675t2996r961b3079],
82	,	,	O	,	_	0	SENT_344	[p20l675t2996r961b3079],
83	almost	RB	O	almost	dep	107	SENT_344	[p20l984t2996r1213b3059],
84	complete	JJ	O	complete	dep	107	SENT_344	[p20l1233t2996r1543b3079],
85	(	NN	O	(	dep	107	SENT_344	[p20l1567t2996r1786b3073],
86	285	CD	PERCENT	285	dep	107	SENT_344	[p20l1567t2996r1786b3073],
87	%	NN	PERCENT	%	dep	107	SENT_344	[p20l1567t2996r1786b3073],
88	by	IN	O	by	dep	107	SENT_344	[p20l1807t2996r1890b3080],
89	examination	NN	O	examination	dep	107	SENT_344	[p20l1908t3002r2140b3059, p20l9t3105r236b3162],
90	or	CC	O	or	dep	107	SENT_344	[p20l262t3122r336b3162],
91	history	NN	O	history	dep	107	SENT_344	[p20l358t3099r634b3183],
92	)	NN	O	)	dep	107	SENT_344	[p20l358t3099r634b3183],
93	recovery	NN	O	recovery	dep	107	SENT_344	[p20l663t3122r970b3183],
94	from	IN	O	from	dep	107	SENT_344	[p20l992t3099r1164b3162],
95	individual	JJ	O	individual	dep	107	SENT_344	[p20l1189t3099r1551b3162],
96	relapses	NNS	O	relapse	dep	107	SENT_344	[p20l1575t3099r1871b3182],
97	,	,	O	,	_	0	SENT_344	[p20l1575t3099r1871b3182],
98	and	CC	O	and	dep	107	SENT_344	[p20l1899t3099r2028b3162],
99	no	DT	O	no	dep	107	SENT_344	[p20l2052t3122r2140b3162],
100	signiﬁcant	JJ	O	signiﬁcant	dep	107	SENT_344	[p20l10t3202r365b3286],
101	interval	NN	O	interval	dep	107	SENT_344	[p20l385t3202r648b3265],
102	subclinical	JJ	O	subclinical	dep	107	SENT_344	[p20l670t3202r1036b3265],
103	(	NN	O	(	dep	107	SENT_344	[p20l1060t3202r1268b3279],
104	MRI	NNP	O	MRI	dep	107	SENT_344	[p20l1060t3202r1268b3279],
105	)	CD	NUMBER	)	dep	107	SENT_344	[p20l1060t3202r1268b3279],
106	lesion	NN	O	lesion	dep	107	SENT_344	[p20l1293t3202r1494b3265],
107	accumulation	NN	O	accumulation	_	0	SENT_344	[p20l1516t3202r2000b3265],
108	.	.	O	.	_	0	SENT_344	[p20l1516t3202r2000b3265],

1	In	IN	O	in	_	0	SENT_345	[p20l84t3310r156b3367],
2	select	JJ	O	select	amod	3	SENT_345	[p20l184t3305r380b3368],
3	patients	NNS	O	patient	prep_in	9	SENT_345	[p20l404t3311r685b3388],
4	with	IN	O	with	_	0	SENT_345	[p20l711t3305r869b3368],
5	severe-disease	NN	O	severe-disease	nn	6	SENT_345	[p20l896t3305r1403b3368],
6	onset	NN	O	onset	prep_with	3	SENT_345	[p20l1430t3317r1638b3377],
7	,	,	O	,	_	0	SENT_345	[p20l1430t3317r1638b3377],
8	we	PRP	O	we	nsubj	9	SENT_345	[p20l1664t3328r1759b3368],
9	skip	VBP	O	skip	_	0	SENT_345	[p20l1787t3305r1928b3388],
10	tier	NN	O	tier	dobj	9	SENT_345	[p20l1955t3311r2078b3368],
11	1	CD	NUMBER	1	num	12	SENT_345	[p20l2110t3312r2135b3367],
12	medications	NNS	O	medication	dep	10	SENT_345	[p20l9t3407r437b3470],
13	and	CC	O	and	_	0	SENT_345	[p20l462t3407r591b3470],
14	initiate	VB	O	initiate	conj_and	9	SENT_345	[p20l614t3413r858b3470],
15	induction	NN	O	induction	nn	16	SENT_345	[p20l882t3407r1225b3470],
16	treatment	NN	O	treatment	dobj	14	SENT_345	[p20l1248t3419r1593b3470],
17	with	IN	O	with	_	0	SENT_345	[p20l1614t3407r1770b3470],
18	one	CD	NUMBER	one	prep_with	14	SENT_345	[p20l1794t3430r1919b3470],
19	of	IN	O	of	_	0	SENT_345	[p20l1944t3407r2019b3470],
20	the	DT	O	the	det	21	SENT_345	[p20l2032t3407r2141b3470],
21	tier	NN	O	tier	prep_of	18	SENT_345	[p21l8t33r129b90],
22	2	CD	NUMBER	2	num	23	SENT_345	[p21l153t34r190b89],
23	medications	NNS	O	medication	dep	21	SENT_345	[p21l216t27r647b90],
24	(	CD	NUMBER	(	num	27	SENT_345	[p21l676t28r943b110],
25	Figure	NN	O	figure	nn	27	SENT_345	[p21l676t28r943b110],
26	5	CD	NUMBER	5	num	27	SENT_345	[p21l967t28r1055b104],
27	)	NN	O	)	nsubj	14	SENT_345	[p21l967t28r1055b104],
28	.	.	O	.	_	0	SENT_345	[p21l967t28r1055b104],

1	The	DT	O	the	det	2	SENT_346	[p21l1083t27r1211b90],
2	deﬁnition	NN	O	deﬁnition	nsubj	12	SENT_346	[p21l1237t27r1582b90],
3	of	IN	O	of	_	0	SENT_346	[p21l1608t27r1683b90],
4	severe	JJ	O	severe	amod	5	SENT_346	[p21l1699t50r1915b90],
5	MS	NN	O	m	prep_of	2	SENT_346	[p21l1939t31r2056b90],
6	at	IN	O	at	_	0	SENT_346	[p21l2082t39r2143b90],
7	onset	NN	O	onset	prep_at	5	SENT_346	[p21l10t142r190b193],
8	is	VBZ	O	be	cop	12	SENT_346	[p21l208t136r258b193],
9	largely	RB	O	largely	advmod	12	SENT_346	[p21l277t130r503b214],
10	a	DT	O	a	det	12	SENT_346	[p21l520t153r555b193],
11	judgment	NN	O	judgment	nn	12	SENT_346	[p21l569t130r900b214],
12	call	NN	O	call	_	0	SENT_346	[p21l919t130r1033b193],
13	by	IN	O	by	_	0	SENT_346	[p21l1050t130r1133b214],
14	the	DT	O	the	det	17	SENT_346	[p21l1149t130r1254b193],
15	treating	VBG	O	treat	amod	17	SENT_346	[p21l1273t136r1537b214],
16	MS	NN	O	m	nn	17	SENT_346	[p21l1555t134r1667b193],
17	specialist	NN	O	specialist	prep_by	12	SENT_346	[p21l1689t130r2011b213],
18	.	.	O	.	_	0	SENT_346	[p21l1689t130r2011b213],

1	We	PRP	O	we	nsubj	2	SENT_347	[p21l2034t135r2142b193],
2	deﬁne	VBP	O	deﬁne	_	0	SENT_347	[p21l10t233r216b296],
3	severe	JJ	O	severe	amod	6	SENT_347	[p21l238t233r720b296],
4	—	NN	O	—	nn	6	SENT_347	[p21l238t233r720b296],
5	disease	NN	O	disease	nn	6	SENT_347	[p21l238t233r720b296],
6	onset	NN	O	onset	dobj	2	SENT_347	[p21l741t245r922b296],
7	conservatively	RB	O	conservatively	advmod	2	SENT_347	[p21l942t233r1446b317],
8	:	:	O	:	_	0	SENT_347	[p21l942t233r1446b317],
9	>	JJR	O	>	amod	11	SENT_347	[p21l1473t240r1552b296],
10	3	CD	NUMBER	3	num	11	SENT_347	[p21l1473t240r1552b296],
11	relapses	NNS	O	relapse	nsubj	21	SENT_347	[p21l1575t233r1841b316],
12	within	IN	O	within	_	0	SENT_347	[p21l1860t233r2083b296],
13	6	CD	DURATION	6	num	14	SENT_347	[p21l2103t239r2139b296],
14	months	NNS	NUMBER	month	prep_within	11	SENT_347	[p21l9t336r281b408],
15	,	,	O	,	_	0	SENT_347	[p21l9t336r281b408],
16	limited	JJ	O	limited	amod	17	SENT_347	[p21l301t336r542b399],
17	recovery	NN	O	recovery	prep_within	11	SENT_347	[p21l561t359r859b420],
18	,	,	O	,	_	0	SENT_347	[p21l561t359r859b420],
19	and	CC	O	and	_	0	SENT_347	[p21l882t336r1006b399],
20	multiple	JJ	O	multiple	prep_within	11	SENT_347	[p21l1024t336r1303b419],
21	enhancing	VBG	O	enhance	parataxis	2	SENT_347	[p21l1324t336r1675b420],
22	lesions	NNS	O	lesion	nn	23	SENT_347	[p21l1692t336r1919b399],
23	(	NN	O	(	dobj	21	SENT_347	[p21l1943t337r2140b419, p21l10t439r192b523],
24	especially	RB	O	especially	advmod	21	SENT_347	[p21l1943t337r2140b419, p21l10t439r192b523],
25	with	IN	O	with	_	0	SENT_347	[p21l209t439r362b502],
26	evolution	NN	O	evolution	prep_with	21	SENT_347	[p21l385t439r709b502],
27	into	IN	O	into	_	0	SENT_347	[p21l732t445r866b502],
28	chronic	JJ	O	chronic	amod	29	SENT_347	[p21l890t439r1151b502],
29	T1	NN	O	t1	prep_into	21	SENT_347	[p21l1173t442r1258b501],
30	black	JJ	O	black	amod	31	SENT_347	[p21l1285t439r1470b502],
31	holes	NNS	O	hole	npadvmod	32	SENT_347	[p21l1488t439r1665b502],
32	early	RB	O	early	advmod	21	SENT_347	[p21l1689t439r1856b523],
33	on	IN	O	on	_	0	SENT_347	[p21l1876t440r2009b515],
34	)	NN	O	)	prep_on	21	SENT_347	[p21l1876t440r2009b515],
35	.	.	O	.	_	0	SENT_347	[p21l1876t440r2009b515],

1	On	IN	O	on	_	0	SENT_348	[p21l2036t443r2143b502],
2	the	DT	O	the	det	3	SENT_348	[p21l8t542r116b605],
3	basis	NN	O	basis	prep_on	11	SENT_348	[p21l138t542r307b605],
4	of	IN	O	of	_	0	SENT_348	[p21l331t542r406b605],
5	our	PRP$	O	we	poss	7	SENT_348	[p21l420t565r540b605],
6	own	JJ	O	own	amod	7	SENT_348	[p21l563t565r710b605],
7	practice	NN	O	practice	prep_of	3	SENT_348	[p21l732t548r1027b625],
8	,	,	O	,	_	0	SENT_348	[p21l732t548r1027b625],
9	we	PRP	O	we	nsubj	11	SENT_348	[p21l1051t565r1145b605],
10	would	MD	O	would	aux	11	SENT_348	[p21l1167t542r1385b605],
11	regard	VB	O	regard	_	0	SENT_348	[p21l1407t542r1630b626],
12	this	DT	O	this	det	13	SENT_348	[p21l1651t542r1778b605],
13	deﬁnition	NN	O	deﬁnition	dobj	11	SENT_348	[p21l1803t542r2143b605],
14	as	IN	O	as	_	0	SENT_348	[p21l10t668r74b708],
15	a	DT	O	a	det	16	SENT_348	[p21l95t668r130b708],
16	guideline	NN	O	guideline	prep_as	11	SENT_348	[p21l149t645r479b729],
17	.	.	O	.	_	0	SENT_348	[p21l149t645r479b729],

1	A	DT	O	a	det	4	SENT_349	[p21l501t649r558b707],
2	less	RBR	O	less	advmod	3	SENT_349	[p21l577t645r694b708],
3	conservative	JJ	O	conservative	amod	4	SENT_349	[p21l716t651r1140b708],
4	deﬁnition	NN	O	deﬁnition	nsubjpass	15	SENT_349	[p21l1161t645r1493b708],
5	that	WDT	O	that	nsubj	6	SENT_349	[p21l1512t645r1645b708],
6	requires	VBZ	O	require	rcmod	4	SENT_349	[p21l1664t651r1937b728],
7	fewer	JJR	O	fewer	amod	8	SENT_349	[p21l1958t645r2144b708],
8	relapses	NNS	O	relapse	dobj	6	SENT_349	[p21l10t748r274b831],
9	to	TO	O	to	aux	10	SENT_349	[p21l294t760r359b811],
10	deﬁne	VB	O	deﬁne	infmod	8	SENT_349	[p21l381t748r587b811],
11	severe	JJ	O	severe	amod	12	SENT_349	[p21l609t771r815b811],
12	MS	NN	O	m	dobj	10	SENT_349	[p21l835t752r948b811],
13	may	MD	O	may	aux	15	SENT_349	[p21l969t771r1114b832],
14	be	VB	O	be	auxpass	15	SENT_349	[p21l1129t748r1208b811],
15	justiﬁed	VBN	O	justiﬁed	_	0	SENT_349	[p21l1223t748r1500b832],
16	in	IN	O	in	_	0	SENT_349	[p21l1519t754r1585b810],
17	the	DT	DATE	the	det	18	SENT_349	[p21l1604t748r1710b811],
18	future	NN	DATE	future	prep_in	15	SENT_349	[p21l1730t748r1934b811],
19	if	IN	O	if	mark	28	SENT_349	[p21l1955t748r2008b810],
20	risk	NN	O	risk	nn	21	SENT_349	[p21l2019t748r2147b811],
21	stratiﬁcation	NN	O	stratiﬁcation	nsubjpass	28	SENT_349	[p21l10t851r441b914],
22	in	IN	O	in	_	0	SENT_349	[p21l463t857r529b913],
23	tier	NN	O	tier	nn	25	SENT_349	[p21l550t857r667b914],
24	2	CD	NUMBER	2	num	25	SENT_349	[p21l687t858r723b913],
25	medications	NNS	O	medication	prep_in	21	SENT_349	[p21l746t851r1162b914],
26	can	MD	O	can	aux	28	SENT_349	[p21l1185t874r1302b914],
27	be	VB	O	be	auxpass	28	SENT_349	[p21l1321t851r1401b914],
28	done	VBN	O	do	advcl	15	SENT_349	[p21l1423t851r1590b914],
29	more	RBR	O	more	advmod	28	SENT_349	[p21l1612t874r1789b914],
30	precisely	RB	O	precisely	advmod	28	SENT_349	[p21l1810t851r2119b935],
31	.	.	O	.	_	0	SENT_349	[p21l1810t851r2119b935],

1	For	IN	O	for	dep	13	SENT_350	[p21l84t959r205b1017],
2	all	DT	O	all	det	4	SENT_350	[p21l235t954r319b1017],
3	other	JJ	O	other	amod	4	SENT_350	[p21l349t954r542b1017],
4	patients	NNS	O	patient	nsubj	13	SENT_350	[p21l570t960r878b1037],
5	,	,	O	,	_	0	SENT_350	[p21l570t960r878b1037],
6	unless	IN	O	unless	mark	9	SENT_350	[p21l910t954r1134b1017],
7	the	DT	O	the	det	9	SENT_350	[p21l1164t954r1276b1017],
8	patient	NN	O	patient	nn	9	SENT_350	[p21l1306t960r1560b1037],
9	requests	NNS	O	request	advcl	13	SENT_350	[p21l1590t966r1887b1037],
10	otherwise	RB	O	otherwise	advmod	9	SENT_350	[p21l1919t954r2140b1017, p21l8t1063r174b1129],
11	,	,	O	,	_	0	SENT_350	[p21l1919t954r2140b1017, p21l8t1063r174b1129],
12	we	PRP	O	we	nsubj	13	SENT_350	[p21l197t1080r290b1120],
13	initiate	VBP	O	initiate	_	0	SENT_350	[p21l313t1063r551b1120],
14	treatment	NN	O	treatment	dobj	13	SENT_350	[p21l573t1069r909b1120],
15	with	IN	O	with	_	0	SENT_350	[p21l928t1057r1081b1120],
16	a	DT	O	a	det	19	SENT_350	[p21l1105t1080r1139b1120],
17	tier	NN	O	tier	nn	19	SENT_350	[p21l1160t1063r1277b1120],
18	1	CD	NUMBER	1	num	19	SENT_350	[p21l1305t1064r1329b1119],
19	medication	NN	O	medication	prep_with	14	SENT_350	[p21l1358t1057r1745b1120],
20	(	CD	NUMBER	(	num	21	SENT_350	[p21l1771t1057r2032b1140],
21	Figure	NNP	O	Figure	tmod	13	SENT_350	[p21l1771t1057r2032b1140],
22	4	CD	NUMBER	4	num	21	SENT_350	[p21l2052t1058r2140b1133],
23	)	CD	NUMBER	)	dep	21	SENT_350	[p21l2052t1058r2140b1133],
24	.	.	O	.	_	0	SENT_350	[p21l2052t1058r2140b1133],

1	Depending	VBG	O	depend	ccomp	15	SENT_351	[p21l10t1160r393b1244],
2	on	IN	O	on	_	0	SENT_351	[p21l412t1183r498b1223],
3	side	JJ	O	side	amod	4	SENT_351	[p21l519t1160r651b1223],
4	effects	NNS	O	effect	prep_on	1	SENT_351	[p21l672t1160r883b1223],
5	and	CC	O	and	_	0	SENT_351	[p21l905t1160r1031b1223],
6	utilizing	VBG	O	utilize	conj_and	1	SENT_351	[p21l1050t1160r1334b1244],
7	risk-stratiﬁcation	JJ	O	risk-stratiﬁcation	amod	8	SENT_351	[p21l1353t1160r1944b1223],
8	strategies	NNS	O	strategy	dobj	6	SENT_351	[p21l1966t1172r2141b1223, p21l10t1269r177b1347],
9	from	IN	O	from	_	0	SENT_351	[p21l201t1263r371b1326],
10	existing	VBG	O	exist	amod	11	SENT_351	[p21l395t1269r666b1347],
11	evidence	NN	O	evidence	prep_from	6	SENT_351	[p21l688t1263r1010b1335],
12	,	,	O	,	_	0	SENT_351	[p21l688t1263r1010b1335],
13	we	PRP	O	we	nsubj	15	SENT_351	[p21l1033t1286r1128b1326],
14	have	VBP	O	have	aux	15	SENT_351	[p21l1150t1263r1308b1326],
15	generated	VBN	O	generate	_	0	SENT_351	[p21l1332t1263r1672b1347],
16	an	DT	O	a	det	17	SENT_351	[p21l1695t1286r1776b1326],
17	algorithm	NN	O	algorithm	dobj	15	SENT_351	[p21l1800t1263r2144b1347],
18	used	VBN	O	use	partmod	17	SENT_351	[p21l9t1366r167b1429],
19	in	IN	O	in	_	0	SENT_351	[p21l189t1372r255b1428],
20	follow-up	NN	O	follow-up	prep_in	18	SENT_351	[p21l278t1366r624b1449],
21	.	.	O	.	_	0	SENT_351	[p21l278t1366r624b1449],

1	However	RB	O	however	advmod	7	SENT_352	[p21l650t1371r969b1438],
2	,	,	O	,	_	0	SENT_352	[p21l650t1371r969b1438],
3	this	DT	O	this	det	4	SENT_352	[p21l993t1366r1116b1429],
4	approach	NN	O	approach	nsubjpass	7	SENT_352	[p21l1141t1366r1457b1449],
5	should	MD	O	should	aux	7	SENT_352	[p21l1480t1366r1711b1429],
6	be	VB	O	be	auxpass	7	SENT_352	[p21l1730t1366r1810b1429],
7	modiﬁed	VBN	O	modiﬁed	_	0	SENT_352	[p21l1832t1366r2143b1429],
8	by	IN	O	by	_	0	SENT_352	[p21l7t1469r91b1553],
9	the	DT	O	the	det	10	SENT_352	[p21l109t1469r215b1532],
10	needs	NNS	O	need	agent	7	SENT_352	[p21l238t1469r432b1532],
11	of	IN	O	of	_	0	SENT_352	[p21l456t1469r530b1532],
12	individual	JJ	O	individual	amod	13	SENT_352	[p21l543t1469r893b1532],
13	patients	NNS	O	patient	prep_of	10	SENT_352	[p21l913t1475r1201b1552],
14	,	,	O	,	_	0	SENT_352	[p21l913t1475r1201b1552],
15	availability	NN	O	availability	conj_and	10	SENT_352	[p21l1226t1469r1599b1553],
16	of	IN	O	of	_	0	SENT_352	[p21l1618t1469r1692b1532],
17	medications	NNS	O	medication	prep_of	15	SENT_352	[p21l1705t1469r2140b1541],
18	,	,	O	,	_	0	SENT_352	[p21l1705t1469r2140b1541],
19	and	CC	O	and	_	0	SENT_352	[p21l10t1572r136b1635],
20	future	JJ	DATE	future	amod	21	SENT_352	[p21l156t1572r363b1635],
21	advances	NNS	O	advance	conj_and	10	SENT_352	[p21l385t1572r691b1635],
22	in	IN	O	in	_	0	SENT_352	[p21l714t1578r780b1634],
23	pharmacotherapy	NN	O	pharmacotherapy	prep_in	21	SENT_352	[p21l801t1572r1411b1656],
24	for	IN	O	for	_	0	SENT_352	[p21l1429t1572r1526b1635],
25	MS.	NNP	O	MS.	prep_for	23	SENT_352	[p21l1546t1576r1677b1635],

1	The	DT	O	the	det	2	SENT_353	[p21l83t1675r211b1738],
2	appearance	NN	O	appearance	_	0	SENT_353	[p21l239t1697r643b1758],
3	of	IN	O	of	_	0	SENT_353	[p21l670t1675r747b1738],
4	neutralizing	VBG	O	neutralize	amod	5	SENT_353	[p21l764t1675r1200b1759],
5	autoantibodies	NNS	O	autoantibody	prep_of	2	SENT_353	[p21l1226t1675r1757b1738],
6	(	CD	NUMBER	(	num	7	SENT_353	[p21l1788t1675r2041b1751],
7	NAbs	NNS	O	nab	dep	2	SENT_353	[p21l1788t1675r2041b1751],
8	)	CD	NUMBER	)	nsubj	25	SENT_353	[p21l1788t1675r2041b1751],
9	in	IN	O	in	_	0	SENT_353	[p21l2072t1681r2141b1737],
10	~	CD	PERCENT	~	number	11	SENT_353	[p21l12t1783r210b1842],
11	40	CD	PERCENT	40	num	12	SENT_353	[p21l12t1783r210b1842],
12	%	NN	PERCENT	%	prep_in	8	SENT_353	[p21l12t1783r210b1842],
13	of	IN	O	of	_	0	SENT_353	[p21l241t1778r317b1841],
14	patients	NNS	O	patient	prep_of	12	SENT_353	[p21l334t1784r620b1861],
15	after	IN	O	after	_	0	SENT_353	[p21l649t1778r809b1841],
16	3	CD	DURATION	3	num	17	SENT_353	[p21l837t1785r871b1841],
17	years	NNS	NUMBER	year	prep_after	14	SENT_353	[p21l899t1801r1083b1862],
18	of	IN	O	of	_	0	SENT_353	[p21l1112t1778r1189b1841],
19	interferon	NN	O	interferon	prep_of	17	SENT_353	[p21l1207t1778r1649b1862],
20	-	:	O	-	_	0	SENT_353	[p21l1207t1778r1649b1862],
21	[	NN	O	[	nn	24	SENT_353	[p21l1207t1778r1649b1862],
22	3	CD	NUMBER	3	num	24	SENT_353	[p21l1207t1778r1649b1862],
23	lb	NN	O	lb	nn	24	SENT_353	[p21l1685t1778r1761b1841],
24	treatment	NN	O	treatment	dep	12	SENT_353	[p21l1790t1790r2144b1841],
25	leads	VBZ	O	lead	rcmod	7	SENT_353	[p21l8t1881r180b1944],
26	to	TO	O	to	_	0	SENT_353	[p21l202t1893r268b1944],
27	failure	NN	O	failure	prep_to	25	SENT_353	[p21l291t1881r510b1944],
28	of	IN	O	of	_	0	SENT_353	[p21l533t1881r607b1944],
29	continued	JJ	O	continued	amod	30	SENT_353	[p21l620t1881r969b1944],
30	interferon	NN	O	interferon	prep_of	27	SENT_353	[p21l990t1881r1411b1965],
31	-	:	O	-	_	0	SENT_353	[p21l990t1881r1411b1965],
32	[	NN	O	[	dep	2	SENT_353	[p21l990t1881r1411b1965],
33	3	CD	NUMBER	3	num	34	SENT_353	[p21l990t1881r1411b1965],
34	treatment	NN	O	treatment	dep	32	SENT_353	[p21l1432t1893r1787b1944],
35	.	.	O	.	_	0	SENT_353	[p21l1432t1893r1787b1944],

1	NAbs	NNS	O	nab	nsubj	4	SENT_354	[p21l1811t1881r2002b1944],
2	can	MD	O	can	aux	4	SENT_354	[p21l2025t1904r2143b1944],
3	also	RB	O	also	advmod	4	SENT_354	[p21l10t1984r143b2047],
4	cross	VB	O	cross	_	0	SENT_354	[p21l170t1996r550b2047],
5	—	NN	O	—	nsubj	6	SENT_354	[p21l170t1996r550b2047],
6	react	VBP	O	react	ccomp	4	SENT_354	[p21l170t1996r550b2047],
7	with	IN	O	with	_	0	SENT_354	[p21l571t1984r727b2047],
8	natural	JJ	O	natural	amod	9	SENT_354	[p21l750t1984r1000b2047],
9	interferon	NN	O	interferon	prep_with	6	SENT_354	[p21l1024t1984r1450b2068],
10	.	.	O	.	_	0	SENT_354	[p21l1024t1984r1450b2068],

1	—	NN	O	—	_	0	SENT_355	[p21l1024t1984r1450b2068],
2	.	.	O	.	_	0	SENT_355	[p21l1024t1984r1450b2068],

1	B	NN	O	b	nsubj	13	SENT_356	[p21l1024t1984r1450b2068],
2	to	TO	O	to	aux	3	SENT_356	[p21l1474t1996r1541b2047],
3	interfere	VB	O	interfere	infmod	1	SENT_356	[p21l1566t1984r1863b2047],
4	with	IN	O	with	_	0	SENT_356	[p21l1885t1984r2041b2047],
5	its	PRP$	O	its	poss	6	SENT_356	[p21l2065t1990r2142b2047],
6	function	NN	O	function	prep_with	3	SENT_356	[p21l9t2087r323b2159],
7	,	,	O	,	_	0	SENT_356	[p21l9t2087r323b2159],
8	and	CC	O	and	_	0	SENT_356	[p21l347t2087r474b2150],
9	switching	NN	O	switching	nn	10	SENT_356	[p21l495t2087r827b2171],
10	preparations	NNS	O	preparation	prep_with	3	SENT_356	[p21l846t2093r1281b2170],
11	does	VBZ	O	do	aux	13	SENT_356	[p21l1304t2087r1459b2150],
12	not	RB	O	not	neg	13	SENT_356	[p21l1481t2099r1596b2150],
13	change	VB	O	change	_	0	SENT_356	[p21l1617t2087r1856b2171],
14	the	DT	O	the	det	15	SENT_356	[p21l1877t2087r1984b2150],
15	pattern	NN	O	pattern	dobj	13	SENT_356	[p21l2005t2099r2140b2170, p21l8t2201r149b2252],
16	of	IN	O	of	_	0	SENT_356	[p21l172t2189r246b2252],
17	antibody	NN	O	antibody	nn	18	SENT_356	[p21l259t2189r567b2273],
18	response	NN	O	response	prep_of	15	SENT_356	[p21l585t2181r969b2272],
19	.68	CD	NUMBER	.68	num	18	SENT_356	[p21l585t2181r969b2272],
20	Although	IN	O	although	mark	27	SENT_356	[p21l992t2189r1321b2273],
21	the	DT	O	the	det	23	SENT_356	[p21l1342t2189r1449b2252],
22	long-term	JJ	O	long-term	amod	23	SENT_356	[p21l1470t2189r1819b2273],
23	effects	NNS	O	effect	nsubj	27	SENT_356	[p21l1842t2189r2055b2252],
24	of	IN	O	of	_	0	SENT_356	[p21l2078t2189r2152b2252],
25	NAbs	NNS	O	nab	prep_of	23	SENT_356	[p21l8t2292r200b2355],
26	are	VBP	O	be	cop	27	SENT_356	[p21l223t2315r324b2355],
27	unknown	JJ	O	unknown	advcl	43	SENT_356	[p21l347t2292r697b2364],
28	,	,	O	,	_	0	SENT_356	[p21l347t2292r697b2364],
29	rushing	VBG	O	rush	csubj	43	SENT_356	[p21l721t2292r988b2376],
30	to	TO	O	to	_	0	SENT_356	[p21l1008t2304r1074b2355],
31	treatment	NN	O	treatment	prep_to	29	SENT_356	[p21l1096t2304r1436b2355],
32	with	IN	O	with	_	0	SENT_356	[p21l1455t2292r1609b2355],
33	interferon	NN	O	interferon	nn	35	SENT_356	[p21l1631t2292r2052b2376],
34	—	CD	NUMBER	—	num	35	SENT_356	[p21l1631t2292r2052b2376],
35	[	NN	O	[	prep_with	31	SENT_356	[p21l1631t2292r2052b2376],
36	3	CD	NUMBER	3	num	35	SENT_356	[p21l1631t2292r2052b2376],
37	in	IN	O	in	_	0	SENT_356	[p21l2076t2298r2143b2354],
38	otherwise	RB	O	otherwise	advmod	39	SENT_356	[p21l10t2395r343b2458],
39	stable	JJ	O	stable	amod	40	SENT_356	[p21l365t2395r557b2458],
40	individuals	NNS	O	individual	prep_in	29	SENT_356	[p21l578t2395r957b2458],
41	may	MD	O	may	aux	43	SENT_356	[p21l978t2418r1124b2479],
42	potentially	RB	O	potentially	advmod	43	SENT_356	[p21l1140t2395r1510b2479],
43	impair	VB	O	impair	rcmod	15	SENT_356	[p21l1527t2401r1754b2478],
44	the	DT	O	the	det	47	SENT_356	[p21l1773t2395r1879b2458],
45	natural	JJ	O	natural	amod	47	SENT_356	[p21l1900t2395r2143b2458],
46	interferon	NN	O	interferon	nn	47	SENT_356	[p21l10t2498r367b2561],
47	response	NN	O	response	dobj	43	SENT_356	[p21l392t2520r721b2581],
48	.	.	O	.	_	0	SENT_356	[p21l392t2520r721b2581],

1	This	DT	O	this	nsubj	5	SENT_357	[p21l749t2498r896b2561],
2	is	VBZ	O	be	cop	5	SENT_357	[p21l922t2504r974b2561],
3	a	DT	O	a	det	5	SENT_357	[p21l1000t2521r1035b2561],
4	hypothetical	JJ	O	hypothetical	amod	5	SENT_357	[p21l1058t2498r1503b2582],
5	consideration	NN	O	consideration	_	0	SENT_357	[p21l1529t2498r2015b2561],
6	for	IN	O	for	_	0	SENT_357	[p21l2040t2498r2141b2561],
7	delaying	VBG	O	delay	prepc_for	5	SENT_357	[p21l10t2601r310b2685],
8	the	DT	O	the	det	9	SENT_357	[p21l331t2601r442b2664],
9	initiation	NN	O	initiation	dobj	7	SENT_357	[p21l467t2607r796b2664],
10	of	IN	O	of	_	0	SENT_357	[p21l822t2601r898b2664],
11	any	DT	O	any	det	12	SENT_357	[p21l914t2624r1039b2685],
12	DMA	NN	ORGANIZATION	dma	prep_of	9	SENT_357	[p21l1060t2605r1261b2663],
13	or	CC	O	or	_	0	SENT_357	[p21l1286t2624r1360b2664],
14	trying	VBG	O	try	prepc_for	5	SENT_357	[p21l1382t2607r1601b2685],
15	GA	NN	O	ga	dobj	14	SENT_357	[p21l1625t2605r1746b2664],
16	in	IN	O	in	_	0	SENT_357	[p21l1770t2607r1839b2663],
17	patients	NNS	O	patient	prep_in	14	SENT_357	[p21l1862t2607r2143b2684],
18	with	IN	O	with	_	0	SENT_357	[p21l8t2704r165b2767],
19	limited	JJ	O	limited	amod	23	SENT_357	[p21l188t2704r459b2776],
20	,	,	O	,	_	0	SENT_357	[p21l188t2704r459b2776],
21	nondisabling	JJ	O	nondisabling	amod	23	SENT_357	[p21l486t2704r967b2788],
22	,	,	O	,	_	0	SENT_357	[p21l486t2704r967b2788],
23	early-disease	JJ	O	early-disease	amod	26	SENT_357	[p21l994t2704r1449b2788],
24	activity	NN	O	activity	nn	26	SENT_357	[p21l1475t2710r1736b2788],
25	(	CD	NUMBER	(	num	26	SENT_357	[p21l1761t2705r2028b2787],
26	Figure	NNP	O	Figure	prep_with	17	SENT_357	[p21l1761t2705r2028b2787],
27	4	CD	NUMBER	4	number	28	SENT_357	[p21l2050t2704r2140b2781],
28	)	CD	NUMBER	)	dep	26	SENT_357	[p21l2050t2704r2140b2781],
29	.	.	O	.	_	0	SENT_357	[p21l2050t2704r2140b2781],

1	Also	RB	O	also	advmod	4	SENT_358	[p21l8t2807r188b2879],
2	,	,	O	,	_	0	SENT_358	[p21l8t2807r188b2879],
3	NAbs	NNS	O	nab	nsubj	4	SENT_358	[p21l215t2807r413b2870],
4	occur	VBP	O	occur	_	0	SENT_358	[p21l442t2830r644b2870],
5	only	RB	O	only	advmod	23	SENT_358	[p21l670t2807r828b2891],
6	half	RB	O	half	advmod	8	SENT_358	[p21l851t2807r996b2870],
7	as	RB	O	as	advmod	8	SENT_358	[p21l1014t2830r1081b2870],
8	often	RB	O	often	advmod	23	SENT_358	[p21l1109t2807r1289b2870],
9	with	IN	O	with	_	0	SENT_358	[p21l1314t2807r1474b2870],
10	interferon	NN	O	interferon	nn	12	SENT_358	[p21l1501t2807r1941b2891],
11	—	CD	NUMBER	—	num	12	SENT_358	[p21l1501t2807r1941b2891],
12	[	NN	O	[	prep_with	8	SENT_358	[p21l1501t2807r1941b2891],
13	3	CD	NUMBER	3	num	14	SENT_358	[p21l1501t2807r1941b2891],
14	1a	NN	O	1a	npadvmod	15	SENT_358	[p21l1976t2814r2048b2870],
15	as	IN	O	as	advmod	8	SENT_358	[p21l2075t2830r2142b2870],
16	with	IN	O	with	_	0	SENT_358	[p21l8t2910r162b2973],
17	interferon	NN	O	interferon	nn	19	SENT_358	[p21l185t2910r606b2994],
18	—	CD	NUMBER	—	num	19	SENT_358	[p21l185t2910r606b2994],
19	[	NN	O	[	prep_with	8	SENT_358	[p21l185t2910r606b2994],
20	3	CD	NUMBER	3	num	19	SENT_358	[p21l185t2910r606b2994],
21	1b	NN	O	1b	nn	23	SENT_358	[p21l637t2910r711b2973],
22	(	CD	NUMBER	(	num	23	SENT_358	[p21l740t2911r960b2986],
23	~	NN	O	~	dobj	4	SENT_358	[p21l740t2911r960b2986],
24	20	CD	PERCENT	20	number	25	SENT_358	[p21l740t2911r960b2986],
25	%	NN	PERCENT	%	amod	23	SENT_358	[p21l740t2911r960b2986],
26	vs.	CC	O	vs.	_	0	SENT_358	[p21l983t2933r1071b2973],
27	40	CD	PERCENT	40	num	28	SENT_358	[p21l1097t2910r1292b2987],
28	%	NN	PERCENT	%	conj_vs.	23	SENT_358	[p21l1097t2910r1292b2987],
29	)	CD	NUMBER	)	dep	28	SENT_358	[p21l1097t2910r1292b2987],
30	,	,	O	,	_	0	SENT_358	[p21l1097t2910r1292b2987],
31	which	WDT	O	which	nsubj	34	SENT_358	[p21l1315t2910r1526b2973],
32	is	VBZ	O	be	cop	34	SENT_358	[p21l1550t2916r1600b2973],
33	another	DT	O	another	det	34	SENT_358	[p21l1625t2910r1893b2973],
34	reason	NN	O	reason	rcmod	23	SENT_358	[p21l1915t2933r2142b2973],
35	to	TO	O	to	aux	36	SENT_358	[p21l8t3025r74b3076],
36	prefer	VB	O	prefer	infmod	34	SENT_358	[p21l97t3013r303b3096],
37	interferon	NN	O	interferon	nn	38	SENT_358	[p21l324t3013r745b3097],
38	—	NN	O	—	nsubj	41	SENT_358	[p21l324t3013r745b3097],
39	[	CD	NUMBER	[	number	40	SENT_358	[p21l324t3013r745b3097],
40	3	CD	NUMBER	3	num	41	SENT_358	[p21l324t3013r745b3097],
41	1a	NN	O	1a	xcomp	36	SENT_358	[p21l775t3020r862b3076],
42	.	.	O	.	_	0	SENT_358	[p21l775t3020r862b3076],

1	In	IN	O	in	_	0	SENT_359	[p21l83t3121r156b3178],
2	our	PRP$	O	we	poss	3	SENT_359	[p21l180t3139r300b3179],
3	practice	NN	O	practice	prep_in	6	SENT_359	[p21l322t3122r619b3199],
4	,	,	O	,	_	0	SENT_359	[p21l322t3122r619b3199],
5	we	PRP	O	we	nsubj	6	SENT_359	[p21l642t3139r737b3179],
6	test	VBP	O	test	_	0	SENT_359	[p21l760t3128r882b3179],
7	NAbs	NNS	O	nab	dobj	6	SENT_359	[p21l903t3116r1098b3179],
8	in	IN	O	in	_	0	SENT_359	[p21l1122t3122r1190b3178],
9	patients	NNS	O	patient	prep_in	7	SENT_359	[p21l1212t3122r1488b3199],
10	with	IN	O	with	_	0	SENT_359	[p21l1511t3116r1667b3179],
11	severe	JJ	O	severe	amod	12	SENT_359	[p21l1691t3139r1905b3179],
12	recurrences	NNS	O	recurrence	prep_with	9	SENT_359	[p21l1929t3139r2140b3179, p21l10t3242r224b3282],
13	or	CC	O	or	_	0	SENT_359	[p21l246t3242r318b3282],
14	unexpected	JJ	O	unexpected	amod	15	SENT_359	[p21l337t3219r734b3302],
15	increases	NNS	O	increase	prep_in	7	SENT_359	[p21l753t3225r1062b3282],
16	in	IN	O	in	_	0	SENT_359	[p21l1083t3225r1150b3281],
17	MRI	NNP	MISC	MRI	nn	18	SENT_359	[p21l1170t3224r1325b3282],
18	activity	NN	O	activity	prep_in	15	SENT_359	[p21l1348t3225r1600b3303],
19	in	IN	O	in	_	0	SENT_359	[p21l1617t3225r1683b3281],
20	the	DT	O	the	det	21	SENT_359	[p21l1703t3219r1809b3282],
21	setting	NN	O	setting	prep_in	6	SENT_359	[p21l1831t3225r2059b3303],
22	of	IN	O	of	_	0	SENT_359	[p21l2078t3219r2152b3282],
23	previous	JJ	O	previous	amod	24	SENT_359	[p21l8t3328r304b3405],
24	stability	NN	O	stability	prep_of	21	SENT_359	[p21l328t3322r601b3406],
25	on	IN	O	on	_	0	SENT_359	[p21l621t3345r707b3385],
26	interferons	NNS	O	interferon	prep_on	24	SENT_359	[p21l730t3322r1124b3385],
27	.	.	O	.	_	0	SENT_359	[p21l730t3322r1124b3385],

1	If	IN	O	if	mark	4	SENT_360	[p21l1150t3322r1210b3384],
2	NAbs	NNS	O	nab	nsubj	4	SENT_360	[p21l1222t3322r1413b3385],
3	are	VBP	O	be	cop	4	SENT_360	[p21l1438t3345r1538b3385],
4	positive	JJ	O	positive	advcl	7	SENT_360	[p21l1560t3328r1846b3405],
5	,	,	O	,	_	0	SENT_360	[p21l1560t3328r1846b3405],
6	we	PRP	O	we	nsubj	7	SENT_360	[p21l1870t3345r1963b3385],
7	consider	VBP	O	consider	_	0	SENT_360	[p21l1987t3345r2138b3385, p21l10t3425r178b3488],
8	switching	VBG	O	switch	xcomp	7	SENT_360	[p21l201t3425r534b3509],
9	to	TO	O	to	_	0	SENT_360	[p21l554t3437r621b3488],
10	GA	NN	O	ga	prep_to	8	SENT_360	[p21l646t3429r765b3488],
11	or	CC	O	or	_	0	SENT_360	[p21l788t3448r860b3488],
12	stronger	JJR	O	stronger	amod	13	SENT_360	[p21l883t3437r1171b3509],
13	tier	NN	O	tier	conj_or	10	SENT_360	[p21l1192t3431r1310b3488],
14	2	CD	NUMBER	2	num	15	SENT_360	[p21l1333t3432r1368b3487],
15	medications	NNS	O	medication	dobj	8	SENT_360	[p21l1393t3425r1815b3488],
16	in	IN	O	in	_	0	SENT_360	[p21l1839t3431r1906b3487],
17	severe	JJ	O	severe	amod	18	SENT_360	[p21l1931t3448r2142b3488],
18	cases	NNS	O	case	prep_in	15	SENT_360	[p21l10t3551r201b3591],
19	.	.	O	.	_	0	SENT_360	[p21l10t3551r201b3591],

1	If	IN	O	if	prep	3	SENT_361	[p21l229t3528r288b3590],
2	there	EX	O	there	expl	3	SENT_361	[p21l301t3528r478b3591],
3	are	VBP	O	be	_	0	SENT_361	[p21l503t3551r604b3591],
4	no	DT	O	no	det	8	SENT_361	[p21l628t3551r715b3591],
5	NAbs	NNS	O	nab	nn	8	SENT_361	[p21l739t3528r933b3591],
6	(	RB	O	(	advmod	7	SENT_361	[p21l960t3529r1128b3604],
7	true	JJ	O	true	amod	5	SENT_361	[p21l960t3529r1128b3604],
8	failure	NN	O	failure	nsubj	3	SENT_361	[p21l1151t3528r1373b3591],
9	of	IN	O	of	_	0	SENT_361	[p21l1397t3528r1472b3591],
10	interferon	NN	O	interferon	prep_of	8	SENT_361	[p21l1486t3528r1961b3612],
11	-	:	O	-	_	0	SENT_361	[p21l1486t3528r1961b3612],
12	[	NN	O	[	dep	8	SENT_361	[p21l1486t3528r1961b3612],
13	3	CD	NUMBER	3	num	14	SENT_361	[p21l1486t3528r1961b3612],
14	)	NN	O	)	dep	12	SENT_361	[p21l1486t3528r1961b3612],
15	,	,	O	,	_	0	SENT_361	[p21l1486t3528r1961b3612],
16	then	RB	O	then	advmod	12	SENT_361	[p21l1986t3528r2142b3591],
17	we	PRP	O	we	nsubj	18	SENT_361	[p21l8t3654r99b3694],
18	add	VBP	O	add	rcmod	12	SENT_361	[p21l121t3631r245b3694],
19	monthly	JJ	SET	monthly	amod	20	SENT_361	[p21l264t3631r554b3715],
20	corticosteroids	NNS	O	corticosteroid	dobj	18	SENT_361	[p21l571t3631r1071b3694],
21	for	IN	O	for	_	0	SENT_361	[p21l1092t3631r1188b3694],
22	a	DT	O	a	det	24	SENT_361	[p21l1207t3654r1242b3694],
23	brief	JJ	O	brief	amod	24	SENT_361	[p21l1258t3631r1425b3694],
24	period	NN	O	period	prep_for	12	SENT_361	[p21l1435t3631r1660b3714],
25	and	CC	O	and	advmod	24	SENT_361	[p21l1679t3631r1831b3697],
26	/	:	O	/	punct	12	SENT_361	[p21l1679t3631r1831b3697],
27	or	CC	O	or	_	0	SENT_361	[p21l1836t3654r1907b3694],
28	switch	VB	O	switch	conj_or	3	SENT_361	[p21l1927t3631r2141b3694],
29	to	TO	O	to	aux	30	SENT_361	[p21l8t3746r74b3797],
30	tier	VB	O	tier	xcomp	28	SENT_361	[p21l96t3740r213b3797],
31	2	CD	NUMBER	2	num	32	SENT_361	[p21l233t3741r269b3796],
32	medications	NNS	O	medication	dobj	30	SENT_361	[p21l292t3734r708b3797],
33	(	CD	NUMBER	(	num	36	SENT_361	[p21l734t3735r992b3817],
34	Figure	NN	O	figure	nn	36	SENT_361	[p21l734t3735r992b3817],
35	5	CD	NUMBER	5	num	36	SENT_361	[p21l1013t3735r1099b3810],
36	)	NN	O	)	nsubj	28	SENT_361	[p21l1013t3735r1099b3810],
37	.	.	O	.	_	0	SENT_361	[p21l1013t3735r1099b3810],

1	The	DT	O	the	det	2	SENT_362	[p22l83t18r210b81],
2	initiation	NN	O	initiation	dep	8	SENT_362	[p22l235t24r560b81],
3	of	IN	O	of	_	0	SENT_362	[p22l585t18r661b81],
4	tier	NN	O	tier	prep_of	2	SENT_362	[p22l674t24r795b81],
5	2	CD	NUMBER	2	num	6	SENT_362	[p22l819t25r855b80],
6	medications	NNS	O	medication	dep	8	SENT_362	[p22l881t18r1309b81],
7	(	CD	NUMBER	(	num	8	SENT_362	[p22l1338t19r1603b101],
8	Figure	NN	O	figure	dep	12	SENT_362	[p22l1338t19r1603b101],
9	5	CD	NUMBER	5	num	10	SENT_362	[p22l1627t18r1692b95],
10	)	NN	O	)	dep	8	SENT_362	[p22l1627t18r1692b95],
11	is	VBZ	O	be	auxpass	12	SENT_362	[p22l1721t24r1773b81],
12	guided	VBN	O	guide	_	0	SENT_362	[p22l1798t18r2039b102],
13	by	IN	O	by	_	0	SENT_362	[p22l2061t18r2147b102],
14	several	JJ	O	several	amod	15	SENT_362	[p22l10t121r249b184],
15	principles	NNS	O	principle	agent	12	SENT_362	[p22l271t121r633b204],
16	:	:	O	:	_	0	SENT_362	[p22l271t121r633b204],
17	(	CD	NUMBER	(	dobj	12	SENT_362	[p22l663t121r736b198],
18	i	FW	O	i	nn	20	SENT_362	[p22l663t121r736b198],
19	)	FW	O	)	nn	20	SENT_362	[p22l663t121r736b198],
20	natalizumab	NN	O	natalizumab	nsubjpass	39	SENT_362	[p22l763t121r1194b184],
21	is	VBZ	O	be	cop	27	SENT_362	[p22l1219t127r1270b184],
22	a	DT	O	a	det	27	SENT_362	[p22l1295t144r1330b184],
23	very	RB	O	very	advmod	24	SENT_362	[p22l1349t144r1505b205],
24	effective	JJ	O	effective	amod	27	SENT_362	[p22l1526t121r1811b184],
25	and	CC	O	and	_	0	SENT_362	[p22l1835t121r1964b184],
26	convenient	JJ	O	convenient	conj_and	24	SENT_362	[p22l1987t144r2140b184, p22l7t230r256b287],
27	(	NN	O	(	rcmod	17	SENT_362	[p22l277t224r459b301],
28	once	RB	DATE	once	advmod	32	SENT_362	[p22l277t224r459b301],
29	monthly	JJ	SET	monthly	amod	32	SENT_362	[p22l478t224r765b308],
30	infusion	NN	O	infusion	dep	32	SENT_362	[p22l781t224r1082b300],
31	)	NN	O	)	dep	32	SENT_362	[p22l781t224r1082b300],
32	clinical	JJ	O	clinical	dep	27	SENT_362	[p22l1107t224r1345b287],
33	and	CC	O	and	_	0	SENT_362	[p22l1364t224r1488b287],
34	subclinical	JJ	O	subclinical	amod	36	SENT_362	[p22l1507t224r1864b287],
35	relapseprevention	NN	O	relapseprevention	nn	36	SENT_362	[p22l1882t224r2140b307, p22l8t333r365b410],
36	strategy	NN	O	strategy	conj_and	32	SENT_362	[p22l384t339r643b411],
37	but	CC	O	but	_	0	SENT_362	[p22l656t327r765b390],
38	is	VBZ	O	be	auxpass	39	SENT_362	[p22l782t333r830b390],
39	associated	VBN	O	associate	rcmod	17	SENT_362	[p22l851t327r1183b390],
40	with	IN	O	with	_	0	SENT_362	[p22l1199t327r1346b390],
41	PML	NN	O	pml	nn	42	SENT_362	[p22l1365t332r1528b389],
42	risk	NN	O	risk	prep_with	39	SENT_362	[p22l1546t327r1684b399],
43	;	:	O	;	_	0	SENT_362	[p22l1546t327r1684b399],
44	(	CD	NUMBER	(	nsubjpass	53	SENT_362	[p22l1707t328r1797b403],
45	ii	LS	O	ii	dep	44	SENT_362	[p22l1707t328r1797b403],
46	)	IN	O	)	_	0	SENT_362	[p22l1707t328r1797b403],
47	the	DT	O	the	det	48	SENT_362	[p22l1819t327r1921b390],
48	risk	NN	O	risk	prep_)	44	SENT_362	[p22l1940t327r2064b390],
49	of	IN	O	of	_	0	SENT_362	[p22l2079t327r2151b390],
50	PML	NN	ORGANIZATION	pml	prep_of	48	SENT_362	[p22l10t435r177b492],
51	can	MD	O	can	aux	53	SENT_362	[p22l197t453r312b493],
52	be	VB	O	be	auxpass	53	SENT_362	[p22l330t430r409b493],
53	stratiﬁed	VBN	O	stratiﬁed	conj_and	53	SENT_362	[p22l430t430r728b493],
54	by	IN	O	by	_	0	SENT_362	[p22l744t430r827b514],
55	the	DT	O	the	det	56	SENT_362	[p22l843t430r948b493],
56	presence	NN	O	presence	agent	53	SENT_362	[p22l967t452r1262b513],
57	of	IN	O	of	_	0	SENT_362	[p22l1282t430r1355b493],
58	ICV	NN	ORGANIZATION	icv	nn	59	SENT_362	[p22l1365t434r1507b506],
59	antibody	NN	O	antibody	prep_of	56	SENT_362	[p22l1527t430r1829b514],
60	in	IN	O	in	_	0	SENT_362	[p22l1845t436r1912b492],
61	serum	NN	O	serum	nn	62	SENT_362	[p22l1932t453r2144b493],
62	testing	NN	O	testing	prep_in	53	SENT_362	[p22l8t539r246b617],
63	,	,	O	,	_	0	SENT_362	[p22l8t539r246b617],
64	both	DT	O	both	preconj	53	SENT_362	[p22l264t533r419b596],
65	at	IN	O	at	_	0	SENT_362	[p22l439t545r496b596],
66	the	DT	O	the	det	67	SENT_362	[p22l513t533r616b596],
67	beginning	NN	O	beginning	prep_at	53	SENT_362	[p22l633t533r972b617],
68	and	CC	O	and	_	0	SENT_362	[p22l990t533r1113b596],
69	throughout	IN	O	throughout	_	0	SENT_362	[p22l1130t533r1510b617],
70	the	DT	O	the	det	71	SENT_362	[p22l1527t533r1631b596],
71	course	NN	O	course	prep_throughout	53	SENT_362	[p22l1650t556r1865b596],
72	of	IN	O	of	_	0	SENT_362	[p22l1885t533r1956b596],
73	treatment	NN	O	treatment	prep_of	71	SENT_362	[p22l1965t545r2141b596, p22l9t648r198b708],
74	;	:	O	;	_	0	SENT_362	[p22l1965t545r2141b596, p22l9t648r198b708],
75	(	CD	NUMBER	(	nsubj	83	SENT_362	[p22l223t636r337b713],
76	iii	LS	O	iii	dep	75	SENT_362	[p22l223t636r337b713],
77	)	CD	NUMBER	)	num	79	SENT_362	[p22l223t636r337b713],
78	chemotherapy	NN	O	chemotherapy	nn	79	SENT_362	[p22l361t636r843b720],
79	use	NN	O	use	npadvmod	75	SENT_362	[p22l858t659r967b699],
80	ahead	RB	O	ahead	_	0	SENT_362	[p22l987t636r1184b699],
81	of	IN	O	of	_	0	SENT_362	[p22l1203t636r1275b699],
82	natalizumab	NN	O	natalizumab	prep_ahead_of	75	SENT_362	[p22l1285t636r1697b699],
83	increases	VBZ	O	increase	parataxis	27	SENT_362	[p22l1718t642r2019b699],
84	the	DT	O	the	dobj	83	SENT_362	[p22l2038t636r2142b699],

1	VOLUME	NN	O	volume	nn	3	SENT_363	[p22l542t854r765b896],
2	95	CD	NUMBER	95	num	3	SENT_363	[p22l783t855r839b896],
3	NUMBER	NN	O	number	_	0	SENT_363	[p22l860t854r1083b896],
4	1	CD	NUMBER	1	number	5	SENT_363	[p22l1104t856r1118b896],
5	|	CD	NUMBER	|	dep	3	SENT_363	[p22l1147t850r1152b911],
6	JANUARY	NNP	DATE	JANUARY	dep	5	SENT_363	[p22l1170t854r1415b896],
7	2014	CD	DATE	2014	num	6	SENT_363	[p22l1431t855r1552b896],
8	|	CD	NUMBER	|	num	9	SENT_363	[p22l1570t850r1575b911],
9	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	3	SENT_363	[p22l1593t854r2143b907],

1	STATE	NN	O	state	nn	2	SENT_364	[p22l1761t1026r1902b1063],
2	ART	NN	O	art	_	0	SENT_364	[p22l2045t1026r2139b1063],

1	risk	NN	O	risk	nsubj	9	SENT_365	[p22l9t1259r134b1322],
2	of	IN	O	of	_	0	SENT_365	[p22l150t1259r223b1322],
3	PML	NN	ORGANIZATION	pml	prep_of	1	SENT_365	[p22l233t1264r414b1331],
4	;	:	O	;	_	0	SENT_365	[p22l233t1264r414b1331],
5	(	CD	NUMBER	(	num	8	SENT_365	[p22l438t1259r545b1336],
6	iv	NN	O	iv	nn	8	SENT_365	[p22l438t1259r545b1336],
7	)	NN	O	)	nn	8	SENT_365	[p22l438t1259r545b1336],
8	ﬁngolimod	NN	O	ﬁngolimod	dep	3	SENT_365	[p22l568t1259r937b1343],
9	carries	VBZ	O	carry	_	0	SENT_365	[p22l956t1265r1175b1322],
10	the	DT	O	the	det	11	SENT_365	[p22l1194t1259r1297b1322],
11	risk	NN	O	risk	dobj	9	SENT_365	[p22l1316t1259r1442b1322],
12	of	IN	O	of	_	0	SENT_365	[p22l1458t1259r1530b1322],
13	signiﬁcant	JJ	O	signiﬁcant	amod	14	SENT_365	[p22l1541t1259r1885b1343],
14	cardiac	JJ	O	cardiac	prep_of	11	SENT_365	[p22l1904t1259r2141b1322],
15	and	CC	O	and	_	0	SENT_365	[p22l9t1362r134b1425],
16	visual	JJ	O	visual	amod	17	SENT_365	[p22l150t1362r348b1425],
17	toxicity	NN	O	toxicity	prep_of	11	SENT_365	[p22l367t1368r638b1446],
18	;	:	O	;	_	0	SENT_365	[p22l367t1368r638b1446],
19	and	CC	O	and	_	0	SENT_365	[p22l661t1362r786b1425],
20	(	CD	NUMBER	(	nsubj	24	SENT_365	[p22l808t1362r895b1439],
21	v	LS	O	v	prep	20	SENT_365	[p22l808t1362r895b1439],
22	)	CD	NUMBER	)	num	23	SENT_365	[p22l808t1362r895b1439],
23	mitoxantrone	NN	O	mitoxantrone	dep	21	SENT_365	[p22l919t1368r1380b1425],
24	has	VBZ	O	have	conj_and	9	SENT_365	[p22l1398t1362r1509b1425],
25	signiﬁcant	JJ	O	signiﬁcant	amod	26	SENT_365	[p22l1531t1362r1881b1446],
26	cardiac	JJ	O	cardiac	dobj	24	SENT_365	[p22l1900t1362r2142b1425],
27	and	CC	O	and	_	0	SENT_365	[p22l9t1465r134b1528],
28	bone	NN	O	bone	nn	30	SENT_365	[p22l152t1465r320b1528],
29	marrow	NN	O	marrow	nn	30	SENT_365	[p22l341t1488r611b1528],
30	toxicity	NN	O	toxicity	conj_and	26	SENT_365	[p22l628t1471r882b1549],
31	with	IN	O	with	_	0	SENT_365	[p22l898t1465r1049b1528],
32	limited	JJ	O	limited	amod	34	SENT_365	[p22l1068t1465r1310b1528],
33	lifetime	NN	O	lifetime	nn	34	SENT_365	[p22l1329t1465r1586b1528],
34	dose	NN	O	dose	prep_with	24	SENT_365	[p22l1608t1465r1777b1528],
35	.	.	O	.	_	0	SENT_365	[p22l1608t1465r1777b1528],

1	In	IN	O	in	_	0	SENT_366	[p22l83t1573r155b1630],
2	practice	NN	O	practice	prep_in	5	SENT_366	[p22l178t1574r475b1651],
3	,	,	O	,	_	0	SENT_366	[p22l178t1574r475b1651],
4	we	PRP	O	we	nsubj	5	SENT_366	[p22l498t1591r593b1631],
5	recommend	VBP	O	recommend	_	0	SENT_366	[p22l617t1568r1042b1631],
6	natalizumab	NN	O	natalizumab	dobj	5	SENT_366	[p22l1064t1568r1498b1631],
7	with	IN	O	with	_	0	SENT_366	[p22l1521t1568r1677b1631],
8	active	JJ	O	active	amod	9	SENT_366	[p22l1702t1574r1902b1631],
9	monitoring	NN	O	monitoring	prep_with	6	SENT_366	[p22l1926t1574r2139b1631, p22l8t1677r223b1755],
10	through	IN	O	through	_	0	SENT_366	[p22l243t1671r527b1755],
11	the	DT	O	the	det	13	SENT_366	[p22l549t1671r658b1734],
12	TOUCH	NN	O	touch	nn	13	SENT_366	[p22l682t1674r986b1734],
13	program	NN	O	program	prep_through	5	SENT_366	[p22l1009t1693r1313b1755],
14	in	IN	O	in	_	0	SENT_366	[p22l1337t1677r1405b1733],
15	the	DT	O	the	det	17	SENT_366	[p22l1427t1671r1536b1734],
16	United	NNP	LOCATION	United	nn	17	SENT_366	[p22l1560t1671r1800b1734],
17	States	NNPS	LOCATION	States	prep_in	13	SENT_366	[p22l1823t1675r2019b1734],
18	for	IN	O	for	_	0	SENT_366	[p22l2043t1671r2143b1734],
19	patients	NNS	O	patient	prep_for	17	SENT_366	[p22l7t1780r280b1857],
20	who	WP	O	who	nsubj	32	SENT_366	[p22l302t1774r450b1837],
21	fail	VBP	O	fail	rcmod	19	SENT_366	[p22l474t1774r581b1837],
22	tier	NN	O	tier	nsubj	24	SENT_366	[p22l602t1780r721b1837],
23	1	CD	NUMBER	1	num	24	SENT_366	[p22l750t1781r774b1836],
24	medications	NNS	O	medication	xcomp	21	SENT_366	[p22l803t1774r1245b1846],
25	,	,	O	,	_	0	SENT_366	[p22l803t1774r1245b1846],
26	test	NN	O	test	appos	24	SENT_366	[p22l1269t1786r1388b1837],
27	negative	JJ	O	negative	amod	26	SENT_366	[p22l1411t1780r1696b1858],
28	for	IN	O	for	_	0	SENT_366	[p22l1719t1774r1817b1837],
29	ICV	NNP	ORGANIZATION	ICV	prep_for	26	SENT_366	[p22l1840t1778r1989b1850],
30	,	,	O	,	_	0	SENT_366	[p22l1840t1778r1989b1850],
31	and	CC	O	and	_	0	SENT_366	[p22l2015t1774r2143b1837],
32	have	VBP	O	have	conj_and	21	SENT_366	[p22l8t1877r164b1940],
33	no	DT	O	no	det	34	SENT_366	[p22l186t1900r273b1940],
34	history	NN	O	history	dobj	32	SENT_366	[p22l295t1877r541b1961],
35	of	IN	O	of	_	0	SENT_366	[p22l561t1877r635b1940],
36	chemotherapy	NN	O	chemotherapy	nn	37	SENT_366	[p22l649t1877r1143b1961],
37	exposure	NN	O	exposure	prep_of	34	SENT_366	[p22l1163t1899r1489b1960],
38	.	.	O	.	_	0	SENT_366	[p22l1163t1899r1489b1960],

1	If	IN	O	if	mark	5	SENT_367	[p22l1515t1877r1575b1939],
2	ICV	NN	ORGANIZATION	icv	nn	3	SENT_367	[p22l1588t1881r1731b1953],
3	tests	NNS	O	test	nsubj	5	SENT_367	[p22l1752t1889r1901b1940],
4	subsequently	RB	O	subsequently	advmod	5	SENT_367	[p22l1926t1877r2140b1940, p22l9t1980r261b2064],
5	turn	VBP	O	turn	advcl	9	SENT_367	[p22l276t1992r421b2043],
6	positive	JJ	O	positive	acomp	5	SENT_367	[p22l440t1986r717b2063],
7	,	,	O	,	_	0	SENT_367	[p22l440t1986r717b2063],
8	we	PRP	O	we	nsubj	9	SENT_367	[p22l736t2003r827b2043],
9	offer	VBP	O	offer	_	0	SENT_367	[p22l848t1980r1000b2043],
10	to	TO	O	to	aux	11	SENT_367	[p22l1018t1992r1082b2043],
11	discontinue	VB	O	discontinue	xcomp	9	SENT_367	[p22l1104t1980r1493b2043],
12	the	DT	O	the	det	13	SENT_367	[p22l1512t1980r1616b2043],
13	medication	NN	O	medication	dobj	11	SENT_367	[p22l1636t1980r2012b2043],
14	but	CC	O	but	_	0	SENT_367	[p22l2030t1980r2141b2043],
15	inform	VBP	O	inform	conj_but	9	SENT_367	[p22l9t2083r249b2146],
16	patients	NNS	O	patient	dobj	15	SENT_367	[p22l271t2089r543b2166],
17	that	IN	O	that	complm	27	SENT_367	[p22l566t2083r701b2146],
18	the	DT	O	the	det	19	SENT_367	[p22l721t2083r829b2146],
19	ﬁrst	NN	O	ﬁrst	nsubj	27	SENT_367	[p22l852t2083r986b2146],
20	2	CD	DURATION	2	num	21	SENT_367	[p22l1008t2090r1044b2145],
21	years	NNS	NUMBER	year	tmod	19	SENT_367	[p22l1066t2106r1243b2167],
22	of	IN	O	of	_	0	SENT_367	[p22l1267t2083r1341b2146],
23	natalizumab	NN	O	natalizumab	nn	24	SENT_367	[p22l1355t2083r1782b2146],
24	treatment	NN	O	treatment	prep_of	19	SENT_367	[p22l1805t2095r2144b2146],
25	are	VBP	O	be	cop	27	SENT_367	[p22l9t2209r113b2249],
26	relatively	RB	O	relatively	advmod	27	SENT_367	[p22l138t2186r462b2270],
27	safe	JJ	O	safe	ccomp	15	SENT_367	[p22l484t2186r632b2249],
28	.	.	O	.	_	0	SENT_367	[p22l484t2186r632b2249],

1	At	IN	O	at	_	0	SENT_368	[p22l659t2190r742b2249],
2	the	DT	O	the	det	5	SENT_368	[p22l765t2186r875b2249],
3	2-year	JJ	DURATION	2-year	amod	5	SENT_368	[p22l900t2193r1123b2270],
4	time	NN	O	time	nn	5	SENT_368	[p22l1145t2192r1305b2249],
5	point	NN	O	point	prep_at	14	SENT_368	[p22l1329t2192r1536b2269],
6	,	,	O	,	_	0	SENT_368	[p22l1329t2192r1536b2269],
7	due	JJ	O	due	_	0	SENT_368	[p22l1563t2186r1690b2249],
8	to	TO	O	to	_	0	SENT_368	[p22l1714t2198r1781b2249],
9	increased	VBN	O	increase	amod	10	SENT_368	[p22l1808t2186r2145b2249],
10	risk	NN	O	risk	prep_due_to	5	SENT_368	[p22l9t2289r151b2361],
11	,	,	O	,	_	0	SENT_368	[p22l9t2289r151b2361],
12	we	PRP	O	we	nsubj	14	SENT_368	[p22l171t2312r263b2352],
13	again	RB	O	again	advmod	14	SENT_368	[p22l285t2295r464b2373],
14	offer	VBP	O	offer	_	0	SENT_368	[p22l485t2289r640b2352],
15	patients	NNS	O	patient	nsubj	17	SENT_368	[p22l658t2295r925b2372],
16	the	DT	O	the	det	17	SENT_368	[p22l945t2289r1050b2352],
17	option	NN	O	option	xcomp	14	SENT_368	[p22l1072t2295r1293b2372],
18	to	TO	O	to	aux	19	SENT_368	[p22l1312t2301r1378b2352],
19	discontinue	VB	O	discontinue	infmod	17	SENT_368	[p22l1400t2289r1796b2352],
20	the	DT	O	the	det	21	SENT_368	[p22l1816t2289r1921b2352],
21	medication	NN	O	medication	dobj	19	SENT_368	[p22l1941t2289r2140b2352, p22l9t2398r247b2455],
22	.	.	O	.	_	0	SENT_368	[p22l1941t2289r2140b2352, p22l9t2398r247b2455],

1	If	IN	O	if	mark	4	SENT_369	[p22l279t2392r340b2454],
2	patients	NNS	O	patient	nsubj	4	SENT_369	[p22l357t2398r640b2475],
3	remain	VBP	O	remain	cop	4	SENT_369	[p22l669t2398r922b2455],
4	negative	JJ	O	negative	advcl	9	SENT_369	[p22l950t2398r1246b2476],
5	for	IN	O	for	_	0	SENT_369	[p22l1275t2392r1376b2455],
6	ICV	NNP	ORGANIZATION	ICV	prep_for	4	SENT_369	[p22l1403t2396r1558b2468],
7	,	,	O	,	_	0	SENT_369	[p22l1403t2396r1558b2468],
8	We	PRP	O	we	nsubj	9	SENT_369	[p22l1585t2415r1681b2455],
9	recommend	VBP	O	recommend	_	0	SENT_369	[p22l1710t2392r2144b2455],
10	continuing	VBG	O	continue	xcomp	9	SENT_369	[p22l9t2501r390b2579],
11	medication	NN	O	medication	dobj	10	SENT_369	[p22l411t2495r821b2558],
12	.	.	O	.	_	0	SENT_369	[p22l411t2495r821b2558],

1	The	DT	O	the	det	3	SENT_370	[p22l848t2495r974b2558],
2	current	JJ	DATE	current	amod	3	SENT_370	[p22l998t2507r1255b2558],
3	data	NNS	O	datum	nsubj	4	SENT_370	[p22l1277t2495r1423b2558],
4	indicate	VBP	O	indicate	_	0	SENT_370	[p22l1446t2495r1721b2558],
5	that	IN	O	that	complm	18	SENT_370	[p22l1743t2495r1879b2558],
6	<	JJR	O	<	nsubj	18	SENT_370	[p22l1904t2500r2052b2560],
7	2	CD	PERCENT	2	number	8	SENT_370	[p22l1904t2500r2052b2560],
8	%	NN	PERCENT	%	amod	6	SENT_370	[p22l1904t2500r2052b2560],
9	of	IN	O	of	_	0	SENT_370	[p22l2078t2495r2153b2558],
10	patients	NNS	O	patient	prep_of	6	SENT_370	[p22l7t2604r276b2681],
11	who	WP	O	who	nsubj	13	SENT_370	[p22l297t2598r444b2661],
12	remained	VBD	O	remain	cop	13	SENT_370	[p22l467t2598r792b2661],
13	ICV	NNP	ORGANIZATION	ICV	rcmod	10	SENT_370	[p22l813t2602r956b2674],
14	negative	JJ	O	negative	amod	13	SENT_370	[p22l978t2604r1260b2682],
15	while	IN	O	while	mark	16	SENT_370	[p22l1280t2598r1466b2661],
16	on	IN	O	on	dep	13	SENT_370	[p22l1489t2621r1575b2661],
17	Tysabri	NNP	MISC	Tysabri	pobj	16	SENT_370	[p22l1597t2598r1848b2682],
18	went	VBD	O	go	ccomp	4	SENT_370	[p22l1868t2610r2034b2661],
19	on	IN	O	on	prep	18	SENT_370	[p22l2056t2621r2142b2661],
20	to	TO	O	to	aux	21	SENT_370	[p22l8t2713r73b2764],
21	develop	VB	O	develop	xcomp	18	SENT_370	[p22l98t2701r361b2784],
22	PML	NN	O	pml	dobj	21	SENT_370	[p22l386t2706r570b2764],
23	.	.	O	.	_	0	SENT_370	[p22l386t2706r570b2764],

1	(	NN	O	(	_	0	SENT_371	[p22l599t2702r863b2785],
2	Biogen	NNP	ORGANIZATION	Biogen	tmod	1	SENT_371	[p22l599t2702r863b2785],
3	continually	RB	O	continually	advmod	2	SENT_371	[p22l886t2701r1274b2785],
4	updates	NNS	O	update	dep	1	SENT_371	[p22l1293t2701r1556b2784],
5	this	DT	O	this	det	6	SENT_371	[p22l1579t2701r1703b2764],
6	information	NN	O	information	dep	4	SENT_371	[p22l1727t2701r2141b2764],
7	on	IN	O	on	prep	6	SENT_371	[p22l9t2827r95b2867],
8	its	PRP$	O	its	poss	9	SENT_371	[p22l117t2810r192b2867],
9	website	NN	O	website	dep	7	SENT_371	[p22l212t2804r510b2881],
10	.	.	O	.	_	0	SENT_371	[p22l212t2804r510b2881],
11	)	SYM	O	)	dep	6	SENT_371	[p22l212t2804r510b2881],

1	Dimethyl	JJ	O	dimethyl	amod	4	SENT_372	[p22l11t3017r323b3090],
2	fumarate	JJ	O	fumarate	amod	4	SENT_372	[p22l342t3016r660b3074],
3	Dimethyl	NN	O	dimethyl	nn	4	SENT_372	[p22l9t3114r330b3198],
4	fumarate	NN	O	fumarate	nsubjpass	8	SENT_372	[p22l350t3114r654b3177],
5	has	VBZ	O	have	aux	8	SENT_372	[p22l674t3114r785b3177],
6	recently	RB	DATE	recently	advmod	8	SENT_372	[p22l806t3114r1078b3198],
7	been	VBN	O	be	auxpass	8	SENT_372	[p22l1093t3114r1256b3177],
8	approved	VBN	O	approve	_	0	SENT_372	[p22l1277t3114r1592b3197],
9	as	IN	O	as	_	0	SENT_372	[p22l1612t3137r1676b3177],
10	an	DT	O	a	det	12	SENT_372	[p22l1698t3137r1777b3177],
11	oral	JJ	O	oral	amod	12	SENT_372	[p22l1798t3114r1928b3177],
12	DMA	NN	ORGANIZATION	dma	prep_as	8	SENT_372	[p22l1948t3118r2142b3176],
13	in	IN	O	in	_	0	SENT_372	[p22l9t3222r77b3278],
14	MS.	NNP	O	MS.	prep_in	12	SENT_372	[p22l103t3220r238b3279],
15	The	DT	O	the	det	16	SENT_372	[p22l267t3216r395b3279],
16	mechanism	NN	O	mechanism	nsubj	21	SENT_372	[p22l421t3216r832b3279],
17	of	IN	O	of	_	0	SENT_372	[p22l858t3216r934b3279],
18	action	NN	O	action	prep_of	16	SENT_372	[p22l951t3222r1170b3279],
19	is	VBZ	O	be	cop	21	SENT_372	[p22l1197t3222r1248b3279],
20	the	DT	O	the	det	21	SENT_372	[p22l1274t3216r1384b3279],
21	activation	NN	O	activation	rcmod	14	SENT_372	[p22l1411t3222r1762b3279],
22	of	IN	O	of	_	0	SENT_372	[p22l1789t3216r1865b3279],
23	nuclear	JJ	O	nuclear	amod	25	SENT_372	[p22l1880t3216r2144b3279],
24	factor-E2	NN	O	factor-e2	nn	25	SENT_372	[p22l8t3319r602b3382],
25	—	NN	O	—	prep_of	21	SENT_372	[p22l8t3319r602b3382],
26	related	JJ	O	related	amod	21	SENT_372	[p22l8t3319r602b3382],
27	factor	NN	O	factor	dep	26	SENT_372	[p22l621t3319r819b3382],
28	2	CD	NUMBER	2	num	27	SENT_372	[p22l838t3326r893b3391],
29	,	,	O	,	_	0	SENT_372	[p22l838t3326r893b3391],
30	resulting	VBG	O	result	partmod	21	SENT_372	[p22l915t3319r1214b3403],
31	in	IN	O	in	_	0	SENT_372	[p22l1233t3325r1299b3381],
32	anti	JJ	O	anti	amod	34	SENT_372	[p22l1320t3319r1961b3403],
33	—	NN	O	—	nn	34	SENT_372	[p22l1320t3319r1961b3403],
34	inﬂammatory	NN	O	inﬂammatory	prep_in	30	SENT_372	[p22l1320t3319r1961b3403],
35	,	,	O	,	_	0	SENT_372	[p22l1320t3319r1961b3403],
36	antioxidant	NN	O	antioxidant	appos	34	SENT_372	[p22l1984t3325r2139b3382, p22l9t3421r289b3493],
37	,	,	O	,	_	0	SENT_372	[p22l1984t3325r2139b3382, p22l9t3421r289b3493],
38	and	CC	O	and	_	0	SENT_372	[p22l315t3421r460b3493],
39	,	,	O	,	_	0	SENT_372	[p22l315t3421r460b3493],
40	overall	RB	O	overall	dep	21	SENT_372	[p22l486t3421r737b3493],
41	,	,	O	,	_	0	SENT_372	[p22l486t3421r737b3493],
42	neuroprotective	JJ	O	neuroprotective	amod	43	SENT_372	[p22l762t3427r1316b3504],
43	effects	NNS	O	effect	rcmod	14	SENT_372	[p22l1340t3413r1635b3484],
44	.	.	O	.	_	0	SENT_372	[p22l1340t3413r1635b3484],

1	“	NN	O	“	npadvmod	17	SENT_373	[p22l1340t3413r1635b3484],
2	In	IN	O	in	_	0	SENT_373	[p22l1663t3426r1735b3483],
3	addition	NN	O	addition	_	0	SENT_373	[p22l1759t3421r2052b3484],
4	to	TO	O	to	_	0	SENT_373	[p22l2074t3433r2141b3484],
5	demonstrating	VBG	O	demonstrate	prepc_in_addition_to	17	SENT_373	[p23l9t17r531b101],
6	positive	JJ	O	positive	amod	7	SENT_373	[p23l553t23r829b100],
7	effects	NNS	O	effect	dobj	5	SENT_373	[p23l855t17r1075b80],
8	in	IN	O	in	_	0	SENT_373	[p23l1101t23r1169b79],
9	experimental	JJ	O	experimental	amod	11	SENT_373	[p23l1195t17r1664b100],
10	autoimmune	JJ	O	autoimmune	amod	11	SENT_373	[p23l1689t23r2142b80],
11	encephalomyelitis	NN	O	encephalomyelitis	prep_in	5	SENT_373	[p23l9t120r678b204],
12	,	,	O	,	_	0	SENT_373	[p23l9t120r678b204],
13	it	PRP	O	it	nsubjpass	17	SENT_373	[p23l708t126r756b183],
14	has	VBZ	O	have	aux	17	SENT_373	[p23l781t120r898b183],
15	also	RB	O	also	advmod	17	SENT_373	[p23l927t120r1064b183],
16	been	VBN	O	be	auxpass	17	SENT_373	[p23l1091t120r1263b183],
17	used	VBN	O	use	_	0	SENT_373	[p23l1290t120r1456b183],
18	in	IN	O	in	_	0	SENT_373	[p23l1483t126r1552b182],
19	psoriasis	NN	O	psoriasis	prep_in	17	SENT_373	[p23l1578t126r1892b203],
20	with	IN	O	with	_	0	SENT_373	[p23l1919t120r2079b183],
21	a	DT	O	a	det	24	SENT_373	[p23l2107t143r2142b183],
22	slightly	RB	O	slightly	advmod	23	SENT_373	[p23l10t223r265b307],
23	different	JJ	O	different	amod	24	SENT_373	[p23l286t223r583b286],
24	formulation	NN	O	formulation	prep_with	17	SENT_373	[p23l606t223r1045b286],
25	.	.	O	.	_	0	SENT_373	[p23l606t223r1045b286],

1	A	DT	O	a	det	4	SENT_374	[p23l1071t227r1129b285],
2	phase	NN	O	phase	nn	4	SENT_374	[p23l1151t223r1351b306],
3	III	CD	NUMBER	iii	num	4	SENT_374	[p23l1375t228r1460b285],
4	trial	NN	O	trial	nsubj	5	SENT_374	[p23l1484t223r1629b286],
5	indicated	VBD	O	indicate	ccomp	39	SENT_374	[p23l1652t223r1979b286],
6	sustained	JJ	O	sustained	amod	7	SENT_374	[p23l2002t246r2137b286, p23l8t326r225b389],
7	beneﬁt	NN	O	beneﬁt	dobj	5	SENT_374	[p23l245t326r484b389],
8	on	IN	O	on	_	0	SENT_374	[p23l507t349r593b389],
9	clinical	JJ	O	clinical	amod	13	SENT_374	[p23l617t326r865b389],
10	and	CC	O	and	_	0	SENT_374	[p23l888t326r1016b389],
11	imaging	NN	O	imaging	amod	13	SENT_374	[p23l1038t332r1322b410],
12	end	NN	O	end	nn	13	SENT_374	[p23l1343t326r1471b389],
13	points	NNS	O	point	prep_on	5	SENT_374	[p23l1492t332r1707b409],
14	very	RB	O	very	advmod	15	SENT_374	[p23l1728t349r1883b410],
15	similar	JJ	O	similar	amod	13	SENT_374	[p23l1903t326r2143b389],
16	to	TO	O	to	_	0	SENT_374	[p23l8t440r72b492],
17	other	JJ	O	other	amod	20	SENT_374	[p23l94t428r272b492],
18	tier	NN	O	tier	nn	20	SENT_374	[p23l289t434r404b492],
19	1	CD	NUMBER	1	num	20	SENT_374	[p23l430t435r454b491],
20	medications	NNS	O	medication	prep_to	5	SENT_374	[p23l479t428r887b492],
21	discussed	VBN	O	discuss	partmod	20	SENT_374	[p23l909t428r1229b492],
22	above	IN	O	above	_	0	SENT_374	[p23l1249t420r1594b492],
23	.32	CD	NUMBER	.32	number	24	SENT_374	[p23l1249t420r1594b492],
24	’83	CD	NUMBER	’83	prep_above	21	SENT_374	[p23l1249t420r1594b492],
25	Overall	JJ	O	overall	advmod	21	SENT_374	[p23l1617t428r1881b500],
26	,	,	O	,	_	0	SENT_374	[p23l1617t428r1881b500],
27	BG	NNP	ORGANIZATION	BG	nsubj	39	SENT_374	[p23l1903t432r2140b500],
28	—	CD	NUMBER	—	number	29	SENT_374	[p23l1903t432r2140b500],
29	12	CD	NUMBER	12	dep	27	SENT_374	[p23l1903t432r2140b500],
30	,	,	O	,	_	0	SENT_374	[p23l1903t432r2140b500],
31	a	DT	O	a	det	32	SENT_374	[p23l9t555r44b595],
32	formulation	NN	O	formulation	appos	27	SENT_374	[p23l66t532r482b595],
33	of	IN	O	of	_	0	SENT_374	[p23l505t532r580b595],
34	dimethyl	JJ	O	dimethyl	amod	35	SENT_374	[p23l594t532r903b616],
35	fumarate	NN	O	fumarate	prep_of	32	SENT_374	[p23l925t532r1253b604],
36	,	,	O	,	_	0	SENT_374	[p23l925t532r1253b604],
37	is	VBZ	O	be	cop	39	SENT_374	[p23l1278t538r1329b595],
38	very	RB	O	very	advmod	39	SENT_374	[p23l1350t555r1504b616],
39	safe	JJ	O	safe	_	0	SENT_374	[p23l1525t532r1652b595],
40	and	CC	O	and	_	0	SENT_374	[p23l1676t532r1804b595],
41	simple	JJ	O	simple	conj_and	39	SENT_374	[p23l1827t532r2052b615],
42	to	TO	O	to	aux	43	SENT_374	[p23l2074t544r2141b595],
43	use	VB	O	use	xcomp	39	SENT_374	[p23l8t658r118b698],
44	as	IN	O	as	_	0	SENT_374	[p23l140t658r203b698],
45	a	DT	O	a	det	48	SENT_374	[p23l225t658r259b698],
46	daily	JJ	SET	daily	amod	48	SENT_374	[p23l279t635r445b719],
47	oral	JJ	O	oral	amod	48	SENT_374	[p23l462t635r593b698],
48	medication	NN	O	medication	prep_as	43	SENT_374	[p23l612t635r1012b698],
49	.	.	O	.	_	0	SENT_374	[p23l612t635r1012b698],

1	Unfortunately	RB	O	unfortunately	advmod	14	SENT_375	[p23l1036t635r1526b719],
2	,	,	O	,	_	0	SENT_375	[p23l1036t635r1526b719],
3	a	DT	O	a	det	5	SENT_375	[p23l1548t658r1583b698],
4	few	JJ	O	few	amod	5	SENT_375	[p23l1602t635r1722b698],
5	reports	NNS	O	report	nsubj	14	SENT_375	[p23l1739t647r1981b718],
6	on	IN	O	on	_	0	SENT_375	[p23l2002t658r2088b698],
7	a	DT	O	a	det	9	SENT_375	[p23l2109t658r2143b698],
8	similar	JJ	O	similar	amod	9	SENT_375	[p23l9t739r246b802],
9	compound	NN	O	compound	prep_on	5	SENT_375	[p23l267t739r640b822],
10	used	VBN	O	use	partmod	9	SENT_375	[p23l659t739r817b802],
11	in	IN	O	in	_	0	SENT_375	[p23l837t745r904b801],
12	psoriasis	NN	O	psoriasis	prep_in	10	SENT_375	[p23l924t745r1221b822],
13	have	VBP	O	have	aux	14	SENT_375	[p23l1242t739r1396b802],
14	shown	VBN	O	show	_	0	SENT_375	[p23l1419t739r1641b802],
15	an	DT	O	a	det	16	SENT_375	[p23l1662t762r1742b802],
16	association	NN	O	association	dobj	14	SENT_375	[p23l1764t745r2142b802],
17	with	IN	O	with	_	0	SENT_375	[p23l7t842r164b905],
18	PML	NN	ORGANIZATION	pml	prep_with	16	SENT_375	[p23l188t847r360b904],
19	in	IN	O	in	_	0	SENT_375	[p23l383t848r451b904],
20	the	DT	O	the	det	21	SENT_375	[p23l474t842r583b905],
21	setting	NN	O	setting	prep_in	14	SENT_375	[p23l608t848r843b926],
22	of	IN	O	of	_	0	SENT_375	[p23l865t842r941b905],
23	previous	JJ	O	previous	amod	25	SENT_375	[p23l954t848r1255b925],
24	methotrexate	NN	O	methotrexate	nn	25	SENT_375	[p23l1279t842r1745b905],
25	use	NN	O	use	prep_of	21	SENT_375	[p23l1769t865r1899b905],
26	.	.	O	.	_	0	SENT_375	[p23l1769t865r1899b905],

1	In	IN	O	in	_	0	SENT_376	[p23l1927t847r2000b904],
2	MS	NN	O	m	nn	3	SENT_376	[p23l2023t846r2139b905],
3	trials	NNS	O	trial	prep_in	11	SENT_376	[p23l8t945r197b1017],
4	,	,	O	,	_	0	SENT_376	[p23l8t945r197b1017],
5	the	DT	O	the	det	9	SENT_376	[p23l218t945r324b1008],
6	most	RBS	O	most	advmod	7	SENT_376	[p23l345t957r514b1008],
7	common	JJ	O	common	amod	9	SENT_376	[p23l535t968r841b1008],
8	side	NN	O	side	nn	9	SENT_376	[p23l862t945r994b1008],
9	effects	NNS	O	effect	nsubj	11	SENT_376	[p23l1016t945r1227b1008],
10	were	VBD	O	be	cop	11	SENT_376	[p23l1247t968r1407b1008],
11	ﬂushing	VBG	O	ﬂushing	ccomp	22	SENT_376	[p23l1428t945r1721b1029],
12	,	,	O	,	_	0	SENT_376	[p23l1428t945r1721b1029],
13	gastrointestinal	JJ	O	gastrointestinal	amod	14	SENT_376	[p23l1743t951r2139b1029, p23l8t1047r161b1110],
14	symptoms	NNS	O	symptom	conj_and	11	SENT_376	[p23l182t1059r548b1131],
15	,	,	O	,	_	0	SENT_376	[p23l182t1059r548b1131],
16	and	CC	O	and	_	0	SENT_376	[p23l571t1047r696b1110],
17	headache	NN	O	headache	nn	19	SENT_376	[p23l714t1039r1113b1110],
18	.84	CD	NUMBER	.84	num	19	SENT_376	[p23l714t1039r1113b1110],
19	Currently	NNP	DATE	Currently	ccomp	22	SENT_376	[p23l1134t1047r1474b1131],
20	,	,	O	,	_	0	SENT_376	[p23l1134t1047r1474b1131],
21	we	PRP	O	we	nsubj	22	SENT_376	[p23l1494t1070r1586b1110],
22	utilize	VBP	O	utilize	_	0	SENT_376	[p23l1606t1047r1814b1110],
23	BG-12	NN	O	bg-12	dobj	22	SENT_376	[p23l1835t1051r2056b1110],
24	as	IN	O	as	mark	25	SENT_376	[p23l2078t1070r2142b1110],
25	illustrated	VBN	O	illustrate	advcl	22	SENT_376	[p23l9t1150r348b1213],
26	in	IN	O	in	_	0	SENT_376	[p23l368t1156r433b1212],
27	Figure	NNP	O	Figure	prep_in	25	SENT_376	[p23l455t1154r683b1233],
28	4	CD	NUMBER	4	num	27	SENT_376	[p23l700t1157r758b1213],
29	.	.	O	.	_	0	SENT_376	[p23l700t1157r758b1213],

1	However	RB	O	however	advmod	4	SENT_377	[p23l781t1155r1096b1222],
2	,	,	O	,	_	0	SENT_377	[p23l781t1155r1096b1222],
3	we	PRP	O	we	nsubj	4	SENT_377	[p23l1116t1173r1208b1213],
4	believe	VBP	O	believe	_	0	SENT_377	[p23l1227t1150r1461b1213],
5	that	IN	O	that	complm	29	SENT_377	[p23l1480t1150r1612b1213],
6	with	IN	O	with	_	0	SENT_377	[p23l1630t1150r1781b1213],
7	long	JJ	O	long	amod	9	SENT_377	[p23l1799t1150r2141b1234],
8	—	JJ	O	—	amod	9	SENT_377	[p23l1799t1150r2141b1234],
9	term	NN	O	term	prep_with	29	SENT_377	[p23l1799t1150r2141b1234],
10	clinical	JJ	O	clinical	amod	11	SENT_377	[p23l9t1253r252b1316],
11	experience	NN	O	experience	dep	9	SENT_377	[p23l272t1259r638b1336],
12	and	CC	O	and	_	0	SENT_377	[p23l659t1253r784b1316],
13	maybe	RB	O	maybe	advmod	9	SENT_377	[p23l803t1253r1026b1337],
14	a	DT	O	a	det	17	SENT_377	[p23l1048t1276r1082b1316],
15	similar	JJ	O	similar	amod	17	SENT_377	[p23l1102t1253r1337b1316],
16	risk-stratiﬁcation	NN	O	risk-stratiﬁcation	nn	17	SENT_377	[p23l1357t1253r1944b1316],
17	strategy	NN	O	strategy	conj_and	9	SENT_377	[p23l1966t1265r2140b1316, p23l9t1379r130b1440],
18	to	TO	O	to	_	0	SENT_377	[p23l149t1368r216b1419],
19	that	DT	O	that	prep_to	17	SENT_377	[p23l240t1356r377b1419],
20	of	IN	O	of	_	0	SENT_377	[p23l401t1356r476b1419],
21	natalizumab	NN	O	natalizumab	prep_of	19	SENT_377	[p23l490t1356r941b1428],
22	,	,	O	,	_	0	SENT_377	[p23l490t1356r941b1428],
23	BG-12	NN	O	bg-12	nsubj	29	SENT_377	[p23l967t1360r1194b1419],
24	may	MD	O	may	aux	29	SENT_377	[p23l1220t1379r1370b1440],
25	become	VB	O	become	cop	29	SENT_377	[p23l1388t1356r1661b1419],
26	the	DT	O	the	det	29	SENT_377	[p23l1684t1356r1793b1419],
27	preferred	VBN	O	prefer	amod	29	SENT_377	[p23l1816t1356r2142b1439],
28	oral	JJ	O	oral	amod	29	SENT_377	[p23l9t1459r141b1522],
29	alternative	NN	O	alternative	ccomp	4	SENT_377	[p23l162t1459r520b1522],
30	to	TO	O	to	_	0	SENT_377	[p23l541t1471r607b1522],
31	other	JJ	O	other	amod	33	SENT_377	[p23l630t1459r811b1522],
32	injectable	JJ	O	injectable	amod	33	SENT_377	[p23l832t1459r1159b1543],
33	tier	NN	O	tier	prep_to	29	SENT_377	[p23l1180t1465r1297b1522],
34	1	CD	NUMBER	1	num	35	SENT_377	[p23l1324t1466r1349b1521],
35	medications	NNS	O	medication	attr	29	SENT_377	[p23l1376t1459r1810b1522],
36	.	.	O	.	_	0	SENT_377	[p23l1376t1459r1810b1522],

1	Teriﬂunomide	NNP	PERSON	Teriﬂunomide	nn	2	SENT_378	[p23l7t1671r495b1729],
2	Teriﬂunomide	NNP	PERSON	Teriﬂunomide	nsubj	6	SENT_378	[p23l8t1768r508b1832],
3	is	VBZ	O	be	cop	6	SENT_378	[p23l531t1774r582b1832],
4	the	DT	O	the	det	6	SENT_378	[p23l605t1768r713b1832],
5	active	JJ	O	active	amod	6	SENT_378	[p23l738t1774r937b1832],
6	metabolite	NN	O	metabolite	_	0	SENT_378	[p23l960t1768r1329b1832],
7	of	IN	O	of	_	0	SENT_378	[p23l1353t1768r1428b1832],
8	leﬂunomide	NN	O	leﬂunomide	prep_of	6	SENT_378	[p23l1440t1768r1878b1840],
9	,	,	O	,	_	0	SENT_378	[p23l1440t1768r1878b1840],
10	an	DT	O	a	det	13	SENT_378	[p23l1904t1791r1985b1832],
11	oral	JJ	O	oral	amod	13	SENT_378	[p23l2009t1768r2143b1832],
12	isoxazole	NN	O	isoxazole	nn	13	SENT_378	[p23l9t1872r317b1935],
13	drug	NN	O	drug	appos	8	SENT_378	[p23l339t1872r500b1956],
14	that	WDT	O	that	nsubjpass	22	SENT_378	[p23l517t1872r650b1935],
15	inhibits	VBZ	O	inhibit	rcmod	13	SENT_378	[p23l669t1872r925b1935],
16	de	FW	O	de	nn	18	SENT_378	[p23l947t1872r1021b1935],
17	novo	FW	O	novo	nn	18	SENT_378	[p23l1043t1895r1198b1935],
18	pyrimidine	NN	O	pyrimidine	nsubj	19	SENT_378	[p23l1219t1872r1599b1956],
19	synthesis	NN	O	synthesis	xcomp	15	SENT_378	[p23l1620t1872r1925b1956],
20	and	CC	O	and	_	0	SENT_378	[p23l1947t1872r2072b1935],
21	is	VBZ	O	be	auxpass	22	SENT_378	[p23l2092t1878r2142b1935],
22	approved	VBN	O	approve	rcmod	13	SENT_378	[p23l9t1975r326b2058],
23	for	IN	O	for	_	0	SENT_378	[p23l346t1975r443b2038],
24	the	DT	O	the	det	25	SENT_378	[p23l461t1975r567b2038],
25	treatment	NN	O	treatment	prep_for	22	SENT_378	[p23l587t1987r923b2038],
26	of	IN	O	of	_	0	SENT_378	[p23l943t1975r1016b2038],
27	rheumatoid	JJ	O	rheumatoid	amod	28	SENT_378	[p23l1028t1975r1429b2038],
28	arthritis	NN	O	arthritis	prep_of	25	SENT_378	[p23l1449t1975r1723b2038],
29	with	IN	O	with	_	0	SENT_378	[p23l1742t1975r1895b2038],
30	a	DT	O	a	det	32	SENT_378	[p23l1916t1998r1951b2038],
31	positive	JJ	O	positive	amod	32	SENT_378	[p23l1969t1981r2139b2058, p23l8t2084r134b2141],
32	impact	NN	O	impact	prep_with	22	SENT_378	[p23l158t2084r401b2161],
33	on	IN	O	on	_	0	SENT_378	[p23l425t2101r513b2141],
34	ARR	NN	ORGANIZATION	arr	prep_on	32	SENT_378	[p23l536t2082r707b2141],
35	and	CC	O	and	_	0	SENT_378	[p23l728t2078r858b2141],
36	on	IN	O	on	_	0	SENT_378	[p23l882t2101r969b2141],
37	sustained	JJ	O	sustained	amod	38	SENT_378	[p23l995t2078r1326b2141],
38	disability	NN	O	disability	prep_on	22	SENT_378	[p23l1349t2078r1680b2162],
39	.	.	O	.	_	0	SENT_378	[p23l1349t2078r1680b2162],

1	However	RB	O	however	advmod	58	SENT_379	[p23l1708t2083r2036b2150],
2	,	,	O	,	_	0	SENT_379	[p23l1708t2083r2036b2150],
3	its	PRP$	O	its	poss	4	SENT_379	[p23l2062t2084r2140b2141],
4	eﬂicacy	NN	O	eﬂicacy	nsubj	5	SENT_379	[p23l9t2180r274b2264],
5	seems	VBZ	O	seem	parataxis	58	SENT_379	[p23l295t2203r503b2243],
6	to	TO	O	to	aux	7	SENT_379	[p23l527t2192r594b2243],
7	lag	VB	O	lag	xcomp	5	SENT_379	[p23l618t2180r720b2264],
8	behind	IN	O	behind	_	0	SENT_379	[p23l740t2180r989b2243],
9	established	JJ	O	established	amod	10	SENT_379	[p23l1013t2180r1401b2243],
10	tier	NN	O	tier	prep_behind	7	SENT_379	[p23l1423t2186r1544b2243],
11	1	CD	NUMBER	1	num	12	SENT_379	[p23l1573t2187r1598b2242],
12	medications	NNS	O	medication	dobj	7	SENT_379	[p23l1628t2172r2141b2243],
13	.85	CD	NUMBER	.85	nsubj	25	SENT_379	[p23l1628t2172r2141b2243],
14	In	IN	O	in	_	0	SENT_379	[p23l9t2288r82b2345],
15	the	DT	O	the	det	17	SENT_379	[p23l104t2283r213b2346],
16	MS	NN	O	m	nn	17	SENT_379	[p23l237t2287r353b2346],
17	trials	NNS	O	trial	prep_in	13	SENT_379	[p23l377t2283r572b2355],
18	,	,	O	,	_	0	SENT_379	[p23l377t2283r572b2355],
19	the	DT	O	the	det	24	SENT_379	[p23l596t2283r705b2346],
20	most	RBS	O	most	advmod	21	SENT_379	[p23l729t2295r903b2346],
21	frequently	RB	O	frequently	advmod	22	SENT_379	[p23l925t2283r1289b2367],
22	reported	VBN	O	report	amod	24	SENT_379	[p23l1309t2283r1613b2366],
23	adverse	JJ	O	adverse	amod	24	SENT_379	[p23l1636t2283r1898b2346],
24	effects	NNS	O	effect	appos	17	SENT_379	[p23l1923t2283r2140b2346],
25	included	VBD	O	include	rcmod	12	SENT_379	[p23l9t2386r298b2449],
26	elevated	JJ	O	elevated	amod	28	SENT_379	[p23l317t2386r585b2449],
27	liver	NN	O	liver	nn	28	SENT_379	[p23l602t2386r749b2449],
28	enzymes	NNS	O	enzyme	dobj	25	SENT_379	[p23l768t2408r1071b2470],
29	,	,	O	,	_	0	SENT_379	[p23l768t2408r1071b2470],
30	neutropenia	NN	O	neutropenia	dobj	25	SENT_379	[p23l1091t2392r1513b2469],
31	,	,	O	,	_	0	SENT_379	[p23l1091t2392r1513b2469],
32	trigeminal	JJ	O	trigeminal	amod	33	SENT_379	[p23l1533t2386r1880b2470],
33	neuralgia	NN	O	neuralgia	dobj	25	SENT_379	[p23l1899t2386r2137b2449, p23l8t2494r125b2572],
34	,	,	O	,	_	0	SENT_379	[p23l1899t2386r2137b2449, p23l8t2494r125b2572],
35	diarrhea	NN	O	diarrhea	dobj	25	SENT_379	[p23l149t2488r454b2560],
36	,	,	O	,	_	0	SENT_379	[p23l149t2488r454b2560],
37	alopecia	NN	O	alopecia	dobj	25	SENT_379	[p23l478t2488r776b2571],
38	,	,	O	,	_	0	SENT_379	[p23l478t2488r776b2571],
39	nausea	NN	O	nausea	dobj	25	SENT_379	[p23l799t2511r1050b2560],
40	,	,	O	,	_	0	SENT_379	[p23l799t2511r1050b2560],
41	and	CC	O	and	_	0	SENT_379	[p23l1075t2488r1200b2551],
42	creatine	NN	O	creatine	nn	43	SENT_379	[p23l1222t2494r1492b2551],
43	kinase	NN	O	kinase	dobj	25	SENT_379	[p23l1512t2488r1730b2551],
44	elevation	NN	O	elevation	dep	52	SENT_379	[p23l1753t2480r2142b2551],
45	.86	CD	NUMBER	.86	num	44	SENT_379	[p23l1753t2480r2142b2551],
46	If	IN	O	if	dep	52	SENT_379	[p23l9t2591r68b2653],
47	long	JJ	O	long	amod	50	SENT_379	[p23l80t2591r429b2675],
48	—	JJ	O	—	amod	50	SENT_379	[p23l80t2591r429b2675],
49	term	NN	O	term	nn	50	SENT_379	[p23l80t2591r429b2675],
50	safety	NN	O	safety	nsubjpass	52	SENT_379	[p23l453t2591r650b2675],
51	is	VBZ	O	be	auxpass	52	SENT_379	[p23l669t2597r719b2654],
52	established	VBN	O	establish	dep	58	SENT_379	[p23l744t2591r1123b2654],
53	in	IN	O	in	_	0	SENT_379	[p23l1145t2597r1212b2653],
54	MS	NN	O	m	prep_in	52	SENT_379	[p23l1234t2595r1367b2663],
55	,	,	O	,	_	0	SENT_379	[p23l1234t2595r1367b2663],
56	it	PRP	O	it	nsubj	58	SENT_379	[p23l1392t2597r1438b2654],
57	may	MD	O	may	aux	58	SENT_379	[p23l1459t2614r1607b2675],
58	represent	VB	O	represent	_	0	SENT_379	[p23l1626t2603r1947b2674],
59	a	DT	O	a	det	62	SENT_379	[p23l1969t2614r2004b2654],
60	tier	NN	O	tier	nn	62	SENT_379	[p23l2024t2597r2142b2654],
61	1	CD	NUMBER	1	num	62	SENT_379	[p23l15t2700r40b2755],
62	alternative	NN	O	alternative	dobj	58	SENT_379	[p23l68t2693r443b2756],
63	.	.	O	.	_	0	SENT_379	[p23l68t2693r443b2756],

1	FUTURE	JJ	DATE	future	amod	2	SENT_380	[p23l12t2908r292b2963],
2	DIRECTION	NN	O	direction	_	0	SENT_380	[p23l315t2907r707b2963],
3	OF	IN	O	of	_	0	SENT_380	[p23l728t2907r822b2963],
4	PREVENTION	NNP	O	PREVENTION	prep_of	2	SENT_380	[p23l845t2907r1306b2963],
5	OF	IN	O	of	dep	2	SENT_380	[p23l1328t2907r1421b2963],
6	RELAPSES	NNP	O	RELAPSES	pobj	5	SENT_380	[p23l1444t2908r1801b2963],
7	IN	IN	O	in	dep	2	SENT_380	[p23l1823t2908r1891b2962],
8	MS	NN	O	m	pobj	7	SENT_380	[p23l1914t2908r2018b2963],

1	Daclizumab	NNP	PERSON	Daclizumab	_	0	SENT_381	[p23l11t3008r418b3066],

1	Daclizumab	NNP	PERSON	Daclizumab	nsubj	6	SENT_382	[p24l9t27r440b90],
2	is	VBZ	O	be	cop	6	SENT_382	[p24l470t33r522b90],
3	a	DT	O	a	det	6	SENT_382	[p24l551t50r587b90],
4	humanized	JJ	O	humanized	amod	6	SENT_382	[p24l612t27r1016b90],
5	monoclonal	JJ	O	monoclonal	amod	6	SENT_382	[p24l1043t27r1473b90],
6	antibody	NN	O	antibody	_	0	SENT_382	[p24l1502t27r1822b111],
7	directed	VBN	O	direct	partmod	6	SENT_382	[p24l1848t27r2141b90],
8	against	IN	O	against	_	0	SENT_382	[p24l9t136r261b214],
9	interleukin	NN	O	interleukin	prep_against	7	SENT_382	[p24l288t130r867b193],
10	—	CD	NUMBER	—	num	9	SENT_382	[p24l288t130r867b193],
11	2RoL	NN	O	2rol	nn	14	SENT_382	[p24l288t130r867b193],
12	(	CD	NUMBER	(	num	14	SENT_382	[p24l897t131r1161b207],
13	CD25	NN	O	cd25	nn	14	SENT_382	[p24l897t131r1161b207],
14	)	NN	O	)	dobj	7	SENT_382	[p24l897t131r1161b207],
15	that	WDT	O	that	nsubj	18	SENT_382	[p24l1193t130r1333b193],
16	is	VBZ	O	be	cop	18	SENT_382	[p24l1360t136r1412b193],
17	currently	RB	DATE	currently	advmod	18	SENT_382	[p24l1442t130r1774b214],
18	Food	NNP	ORGANIZATION	Food	rcmod	14	SENT_382	[p24l1799t130r1982b193],
19	and	CC	ORGANIZATION	and	_	0	SENT_382	[p24l2010t130r2141b193],
20	Drug	NNP	ORGANIZATION	Drug	nn	21	SENT_382	[p24l9t238r195b317],
21	Administration	NNP	ORGANIZATION	Administration	nsubj	22	SENT_382	[p24l219t233r771b296],
22	approved	VBD	O	approve	conj_and	6	SENT_382	[p24l798t233r1127b316],
23	to	TO	O	to	aux	24	SENT_382	[p24l1151t245r1219b296],
24	treat	VB	O	treat	xcomp	22	SENT_382	[p24l1246t245r1408b296],
25	acute	JJ	O	acute	amod	28	SENT_382	[p24l1433t245r1618b296],
26	renal	JJ	O	renal	amod	28	SENT_382	[p24l1645t233r1823b296],
27	allograft	NN	O	allograft	nn	28	SENT_382	[p24l1849t233r2144b317],
28	rejection	NN	O	rejection	dobj	24	SENT_382	[p24l9t342r318b419],
29	.	.	O	.	_	0	SENT_382	[p24l9t342r318b419],

1	In	IN	O	in	_	0	SENT_383	[p24l341t341r410b398],
2	combination	NN	O	combination	prep_in	23	SENT_383	[p24l431t336r855b399],
3	with	IN	O	with	_	0	SENT_383	[p24l873t336r1022b399],
4	maintained	JJ	O	maintained	amod	6	SENT_383	[p24l1041t336r1423b399],
5	interferon	NN	O	interferon	nn	6	SENT_383	[p24l1442t336r1776b399],
6	treatment	NN	O	treatment	prep_with	2	SENT_383	[p24l1794t348r2138b408],
7	,	,	O	,	_	0	SENT_383	[p24l1794t348r2138b408],
8	daclizumab	NN	O	daclizumab	nsubj	23	SENT_383	[p24l8t439r414b502],
9	leads	VBZ	O	lead	rcmod	8	SENT_383	[p24l437t439r614b502],
10	to	TO	O	to	_	0	SENT_383	[p24l637t451r705b502],
11	a	DT	O	a	det	14	SENT_383	[p24l731t462r766b502],
12	72	CD	PERCENT	72	num	14	SENT_383	[p24l790t444r935b504],
13	%	NN	PERCENT	%	nn	14	SENT_383	[p24l790t444r935b504],
14	reduction	NN	O	reduction	prep_to	9	SENT_383	[p24l961t439r1304b502],
15	in	IN	O	in	_	0	SENT_383	[p24l1328t445r1396b501],
16	the	DT	O	the	det	17	SENT_383	[p24l1419t439r1529b502],
17	number	NN	O	number	prep_in	14	SENT_383	[p24l1552t439r1833b502],
18	of	IN	O	of	_	0	SENT_383	[p24l1856t439r1932b502],
19	gadolinium-enhancing	JJ	O	gadolinium-enhancing	amod	20	SENT_383	[p24l1946t439r2144b523, p24l6t542r670b626],
20	lesions	NNS	O	lesion	prep_of	17	SENT_383	[p24l698t542r946b605],
21	on	IN	O	on	_	0	SENT_383	[p24l978t565r1067b605],
22	MRI	NNP	O	MRI	prep_on	9	SENT_383	[p24l1097t547r1260b605],
23	scans	VBZ	O	scan	_	0	SENT_383	[p24l1293t565r1483b605],
24	within	IN	O	within	_	0	SENT_383	[p24l1513t542r1750b605],
25	6	CD	DURATION	6	num	26	SENT_383	[p24l1781t548r1818b605],
26	months	NNS	NUMBER	month	prep_within	23	SENT_383	[p24l1849t542r2143b605],
27	.	.	O	.	_	0	SENT_383	[p24l1849t542r2143b605],

1	Daclizumab	NNP	PERSON	Daclizumab	nsubjpass	7	SENT_384	[p24l8t645r433b708],
2	was	VBD	O	be	auxpass	4	SENT_384	[p24l457t668r587b708],
3	generally	RB	O	generally	advmod	4	SENT_384	[p24l612t645r937b729],
4	safe	JJ	O	safe	_	0	SENT_384	[p24l959t645r1089b708],
5	and	CC	O	and	_	0	SENT_384	[p24l1115t645r1245b708],
6	well	RB	O	well	advmod	7	SENT_384	[p24l1267t645r1409b708],
7	tolerated	VBN	O	tolerate	conj_and	4	SENT_384	[p24l1432t645r1764b717],
8	;	:	O	;	_	0	SENT_384	[p24l1432t645r1764b717],
9	long-term	JJ	O	long-term	amod	10	SENT_384	[p24l1789t645r2147b729],
10	safety	NN	O	safety	nsubj	15	SENT_384	[p24l8t748r205b832],
11	with	IN	O	with	_	0	SENT_384	[p24l222t748r375b811],
12	chronic	JJ	O	chronic	amod	13	SENT_384	[p24l398t748r658b811],
13	use	NN	O	use	prep_with	10	SENT_384	[p24l681t771r792b811],
14	is	VBZ	O	be	cop	15	SENT_384	[p24l815t754r865b811],
15	unknown	JJ	O	unknown	parataxis	4	SENT_384	[p24l888t748r1235b811],
16	.	.	O	.	_	0	SENT_384	[p24l888t748r1235b811],

1	Some	DT	O	some	det	2	SENT_385	[p24l1262t752r1450b811],
2	centers	NNS	O	center	nsubj	4	SENT_385	[p24l1474t760r1714b811],
3	already	RB	O	already	advmod	4	SENT_385	[p24l1738t748r1989b832],
4	prescribe	VB	O	prescribe	_	0	SENT_385	[p24l2007t770r2144b831, p24l8t851r204b914],
5	it	PRP	O	it	dobj	4	SENT_385	[p24l224t857r269b914],
6	as	IN	O	as	_	0	SENT_385	[p24l288t874r351b914],
7	a	DT	O	a	det	8	SENT_385	[p24l372t874r406b914],
8	part	NN	O	part	prep_as	4	SENT_385	[p24l423t863r561b934],
9	of	IN	O	of	_	0	SENT_385	[p24l580t851r652b914],
10	combination	NN	O	combination	nn	11	SENT_385	[p24l663t851r1088b914],
11	therapy	NN	O	therapy	prep_of	8	SENT_385	[p24l1106t851r1369b935],
12	.	.	O	.	_	0	SENT_385	[p24l1106t851r1369b935],

1	If	IN	O	if	mark	5	SENT_386	[p24l1392t851r1450b913],
2	widespread	JJ	O	widespread	amod	3	SENT_386	[p24l1458t851r1841b934],
3	approval	NN	O	approval	nsubjpass	5	SENT_386	[p24l1860t851r2148b934],
4	is	VBZ	O	be	auxpass	5	SENT_386	[p24l7t960r57b1017],
5	granted	VBN	O	grant	advcl	19	SENT_386	[p24l81t954r343b1038],
6	and	CC	O	and	_	0	SENT_386	[p24l366t954r492b1017],
7	long-term	JJ	O	long-term	amod	8	SENT_386	[p24l512t954r859b1038],
8	safety	NN	O	safety	nsubjpass	10	SENT_386	[p24l883t954r1080b1038],
9	is	VBZ	O	be	auxpass	10	SENT_386	[p24l1099t960r1149b1017],
10	established	VBN	O	establish	advcl	19	SENT_386	[p24l1173t954r1568b1026],
11	,	,	O	,	_	0	SENT_386	[p24l1173t954r1568b1026],
12	it	PRP	O	it	nsubj	19	SENT_386	[p24l1592t960r1638b1017],
13	may	MD	O	may	aux	19	SENT_386	[p24l1659t977r1806b1038],
14	become	VB	O	become	cop	19	SENT_386	[p24l1823t954r2091b1017],
15	a	DT	O	a	det	19	SENT_386	[p24l2114t977r2149b1017],
16	tier	NN	O	tier	nn	19	SENT_386	[p24l6t1063r124b1120],
17	1	CD	NUMBER	1	num	19	SENT_386	[p24l151t1063r175b1119],
18	medication	NN	O	medication	nn	19	SENT_386	[p24l203t1056r591b1120],
19	adjunct	NN	O	adjunct	_	0	SENT_386	[p24l612t1048r1027b1141],
20	.87	CD	NUMBER	.87	number	21	SENT_386	[p24l612t1048r1027b1141],
21	’88	CD	NUMBER	’88	attr	19	SENT_386	[p24l612t1048r1027b1141],

1	Alemtuzumab	NNP	O	Alemtuzumab	_	0	SENT_387	[p24l6t1269r499b1327],

1	Alemtuzumab	NNP	O	Alemtuzumab	nsubj	6	SENT_388	[p24l6t1367r508b1430],
2	is	VBZ	O	be	cop	6	SENT_388	[p24l533t1373r584b1430],
3	a	DT	O	a	det	6	SENT_388	[p24l609t1390r644b1430],
4	humanized	JJ	O	humanized	amod	6	SENT_388	[p24l665t1367r1061b1430],
5	monoclonal	JJ	O	monoclonal	amod	6	SENT_388	[p24l1083t1367r1505b1430],
6	antibody	NN	O	antibody	_	0	SENT_388	[p24l1529t1367r1842b1451],
7	directed	VBN	O	direct	partmod	6	SENT_388	[p24l1863t1367r2150b1430],
8	against	IN	O	against	_	0	SENT_388	[p24l8t1476r241b1554],
9	the	DT	O	the	det	12	SENT_388	[p24l258t1470r362b1533],
10	surface	NN	O	surface	nn	12	SENT_388	[p24l383t1470r619b1533],
11	antigen	NN	O	antigen	nn	12	SENT_388	[p24l639t1476r885b1554],
12	CD52	NN	O	cd52	prep_against	7	SENT_388	[p24l906t1474r1118b1542],
13	,	,	O	,	_	0	SENT_388	[p24l906t1474r1118b1542],
14	which	WDT	O	which	nsubjpass	16	SENT_388	[p24l1137t1470r1342b1533],
15	is	VBZ	O	be	auxpass	16	SENT_388	[p24l1361t1476r1410b1533],
16	expressed	VBN	O	express	rcmod	12	SENT_388	[p24l1431t1470r1755b1553],
17	by	IN	O	by	_	0	SENT_388	[p24l1772t1470r1854b1554],
18	a	DT	O	a	det	19	SENT_388	[p24l1871t1493r1905b1533],
19	variety	NN	O	variety	agent	16	SENT_388	[p24l1920t1476r2153b1554],
20	of	IN	O	of	_	0	SENT_388	[p24l8t1573r82b1636],
21	immune	JJ	O	immune	amod	22	SENT_388	[p24l95t1579r387b1636],
22	cells	NNS	O	cell	prep_of	19	SENT_388	[p24l411t1573r556b1636],
23	including	VBG	O	include	_	0	SENT_388	[p24l580t1573r910b1657],
24	T	NN	O	t	prep_including	22	SENT_388	[p24l931t1576r990b1645],
25	,	,	O	,	_	0	SENT_388	[p24l931t1576r990b1645],
26	B	NN	O	b	prep_including	22	SENT_388	[p24l1016t1578r1079b1645],
27	,	,	O	,	_	0	SENT_388	[p24l1016t1578r1079b1645],
28	and	CC	O	and	_	0	SENT_388	[p24l1104t1573r1232b1636],
29	natural	JJ	O	natural	amod	30	SENT_388	[p24l1254t1573r1500b1636],
30	killer	NN	O	killer	prep_including	22	SENT_388	[p24l1521t1573r1702b1636],
31	cells	NNS	O	cell	dep	30	SENT_388	[p24l1724t1573r1888b1645],
32	;	:	O	;	_	0	SENT_388	[p24l1724t1573r1888b1645],
33	monocytes	NNS	O	monocyte	prep_including	22	SENT_388	[p24l1912t1596r2143b1636, p24l8t1688r190b1760],
34	;	:	O	;	_	0	SENT_388	[p24l1912t1596r2143b1636, p24l8t1688r190b1760],
35	macrophages	NNS	O	macrophage	prep_including	22	SENT_388	[p24l212t1676r675b1760],
36	;	:	O	;	_	0	SENT_388	[p24l212t1676r675b1760],
37	and	CC	O	and	_	0	SENT_388	[p24l698t1676r822b1739],
38	eosinophils	NNS	O	eosinophil	prep_including	22	SENT_388	[p24l842t1676r1242b1759],
39	.	.	O	.	_	0	SENT_388	[p24l842t1676r1242b1759],

1	Alemtuzumab	NNP	O	Alemtuzumab	nsubjpass	4	SENT_389	[p24l1264t1676r1746b1739],
2	is	VBZ	O	be	auxpass	4	SENT_389	[p24l1768t1682r1817b1739],
3	currently	RB	DATE	currently	advmod	4	SENT_389	[p24l1838t1676r2150b1760],
4	approved	VBN	O	approve	_	0	SENT_389	[p24l8t1779r330b1862],
5	for	IN	O	for	_	0	SENT_389	[p24l352t1779r450b1842],
6	the	DT	O	the	det	7	SENT_389	[p24l471t1779r579b1842],
7	treatment	NN	O	treatment	prep_for	4	SENT_389	[p24l601t1791r942b1842],
8	of	IN	O	of	_	0	SENT_389	[p24l965t1779r1039b1842],
9	B-cell	NN	MISC	b-cell	nn	12	SENT_389	[p24l1053t1779r1251b1842],
10	chronic	JJ	O	chronic	amod	12	SENT_389	[p24l1274t1779r1537b1842],
11	lymphocytic	JJ	O	lymphocytic	amod	12	SENT_389	[p24l1558t1779r1992b1863],
12	leukemia	NN	O	leukemia	prep_of	7	SENT_389	[p24l2014t1779r2145b1842, p24l6t1882r237b1945],
13	.	.	O	.	_	0	SENT_389	[p24l2014t1779r2145b1842, p24l6t1882r237b1945],

1	Alemtuzumab	NNP	O	Alemtuzumab	nsubj	2	SENT_390	[p24l263t1882r766b1945],
2	reduced	VBD	O	reduce	dep	29	SENT_390	[p24l791t1882r1073b1945],
3	the	DT	O	the	det	4	SENT_390	[p24l1095t1882r1204b1945],
4	rate	NN	O	rate	dobj	2	SENT_390	[p24l1228t1894r1359b1945],
5	of	IN	O	of	_	0	SENT_390	[p24l1383t1882r1459b1945],
6	sustained	JJ	O	sustained	amod	8	SENT_390	[p24l1474t1882r1805b1945],
7	disability	NN	O	disability	nn	8	SENT_390	[p24l1828t1882r2151b1966],
8	progression	NN	O	progression	prep_of	4	SENT_390	[p24l6t1991r424b2069],
9	vs.	CC	O	vs.	prep	2	SENT_390	[p24l446t2008r537b2048],
10	interferon	NN	O	interferon	dep	9	SENT_390	[p24l565t1985r999b2069],
11	-	:	O	-	_	0	SENT_390	[p24l565t1985r999b2069],
12	[	NN	O	[	nn	14	SENT_390	[p24l565t1985r999b2069],
13	3	CD	NUMBER	3	num	14	SENT_390	[p24l565t1985r999b2069],
14	1a	NN	O	1a	dobj	2	SENT_390	[p24l1032t1992r1105b2048],
15	with	IN	O	with	_	0	SENT_390	[p24l1127t1985r1285b2048],
16	a	DT	O	a	det	18	SENT_390	[p24l1311t2008r1346b2048],
17	sustained	JJ	O	sustained	amod	18	SENT_390	[p24l1371t1985r1705b2048],
18	beneﬁt	NN	O	beneﬁt	prep_with	14	SENT_390	[p24l1727t1985r1972b2048],
19	over	IN	O	over	_	0	SENT_390	[p24l1997t2008r2150b2048],
20	5	CD	DURATION	5	num	21	SENT_390	[p24l9t2095r43b2151],
21	years	NNS	NUMBER	year	prep_over	18	SENT_390	[p24l66t2110r243b2172],
22	of	IN	O	of	_	0	SENT_390	[p24l268t2087r343b2151],
23	follow-up	JJ	O	follow-up	amod	25	SENT_390	[p24l356t2079r774b2171],
24	.89	CD	NUMBER	.89	num	25	SENT_390	[p24l356t2079r774b2171],
25	Antihistamines	NNS	O	antihistamine	prep_of	21	SENT_390	[p24l796t2087r1331b2151],
26	and	CC	O	and	_	0	SENT_390	[p24l1356t2087r1483b2151],
27	corticosteroids	NNS	O	corticosteroid	prep_of	21	SENT_390	[p24l1506t2087r2021b2151],
28	are	VBP	O	be	cop	29	SENT_390	[p24l2046t2110r2147b2151],
29	useful	JJ	O	useful	_	0	SENT_390	[p24l7t2191r215b2254],
30	in	IN	O	in	_	0	SENT_390	[p24l237t2197r304b2253],
31	preventing	VBG	O	prevent	prepc_in	29	SENT_390	[p24l326t2197r699b2275],
32	or	CC	O	or	_	0	SENT_390	[p24l721t2214r793b2254],
33	reducing	VBG	O	reduce	conj_or	31	SENT_390	[p24l815t2191r1121b2275],
34	severe	JJ	O	severe	amod	36	SENT_390	[p24l1143t2214r1353b2254],
35	infusion	NN	O	infusion	nn	36	SENT_390	[p24l1376t2191r1662b2254],
36	reactions	NNS	O	reaction	dobj	31	SENT_390	[p24l1685t2197r1998b2254],
37	and	CC	O	and	_	0	SENT_390	[p24l2022t2191r2149b2254],
38	cytokine-release	JJ	O	cytokine-release	amod	39	SENT_390	[p24l8t2293r585b2378],
39	syndrome	NN	O	syndrome	dobj	31	SENT_390	[p24l610t2285r1126b2378],
40	.33	CD	NUMBER	.33	number	41	SENT_390	[p24l610t2285r1126b2378],
41	’	CD	NUMBER	’	nsubj	29	SENT_390	[p24l610t2285r1126b2378],
42	9	CD	NUMBER	9	num	43	SENT_390	[p24l610t2285r1126b2378],
43	°	NN	O	°	nsubj	60	SENT_390	[p24l610t2285r1126b2378],
44	Due	JJ	O	due	_	0	SENT_390	[p24l1151t2299r1297b2357],
45	to	TO	O	to	_	0	SENT_390	[p24l1321t2305r1389b2357],
46	the	DT	O	the	det	48	SENT_390	[p24l1413t2293r1523b2357],
47	lasting	JJ	O	lasting	amod	48	SENT_390	[p24l1546t2293r1782b2378],
48	reduction	NN	O	reduction	prep_due_to	43	SENT_390	[p24l1804t2293r2149b2357],
49	of	IN	O	of	_	0	SENT_390	[p24l8t2397r83b2460],
50	immune	JJ	O	immune	amod	51	SENT_390	[p24l97t2403r392b2460],
51	cells	NNS	O	cell	prep_of	48	SENT_390	[p24l417t2397r583b2469],
52	,	,	O	,	_	0	SENT_390	[p24l417t2397r583b2469],
53	infections	NNS	O	infection	conj_and	51	SENT_390	[p24l608t2397r953b2460],
54	and	CC	O	and	_	0	SENT_390	[p24l978t2397r1107b2460],
55	even	RB	O	even	advmod	51	SENT_390	[p24l1130t2420r1290b2460],
56	cancer	NN	O	cancer	nn	57	SENT_390	[p24l1314t2420r1543b2460],
57	development	NN	O	development	dep	51	SENT_390	[p24l1566t2397r2020b2480],
58	are	VBP	O	be	cop	60	SENT_390	[p24l2044t2420r2145b2460],
59	major	JJ	O	major	amod	60	SENT_390	[p24l7t2506r217b2584],
60	concerns	NNS	O	concern	rcmod	41	SENT_390	[p24l243t2523r583b2572],
61	,	,	O	,	_	0	SENT_390	[p24l243t2523r583b2572],
62	although	IN	O	although	mark	71	SENT_390	[p24l611t2500r929b2584],
63	serious	JJ	O	serious	amod	65	SENT_390	[p24l956t2506r1227b2572],
64	,	,	O	,	_	0	SENT_390	[p24l956t2506r1227b2572],
65	infection-related	JJ	O	infection-related	amod	67	SENT_390	[p24l1256t2500r1857b2563],
66	adverse	JJ	O	adverse	amod	67	SENT_390	[p24l1882t2500r2149b2563],
67	effects	NNS	O	effect	nsubjpass	71	SENT_390	[p24l8t2603r216b2666],
68	have	VBP	O	have	aux	71	SENT_390	[p24l236t2603r389b2666],
69	not	RB	O	not	neg	71	SENT_390	[p24l409t2615r521b2666],
70	been	VBN	O	be	auxpass	71	SENT_390	[p24l538t2603r700b2666],
71	seen	VBN	O	see	advcl	60	SENT_390	[p24l721t2626r867b2666],
72	in	IN	O	in	_	0	SENT_390	[p24l888t2609r953b2665],
73	the	DT	O	the	det	75	SENT_390	[p24l972t2603r1077b2666],
74	MS	NN	O	m	nn	75	SENT_390	[p24l1097t2607r1209b2666],
75	population	NN	O	population	prep_in	71	SENT_390	[p24l1229t2603r1615b2686],
76	.	.	O	.	_	0	SENT_390	[p24l1229t2603r1615b2686],

1	However	RB	O	however	advmod	37	SENT_391	[p24l1639t2608r1953b2675],
2	,	,	O	,	_	0	SENT_391	[p24l1639t2608r1953b2675],
3	there	EX	O	there	expl	8	SENT_391	[p24l1974t2603r2146b2666],
4	has	VBZ	O	have	aux	8	SENT_391	[p24l6t2706r120b2769],
5	been	VBN	O	be	cop	8	SENT_391	[p24l142t2706r310b2769],
6	a	DT	O	a	det	8	SENT_391	[p24l334t2729r369b2769],
7	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_391	[p24l393t2706r755b2790],
8	increase	NN	O	increase	parataxis	37	SENT_391	[p24l778t2712r1062b2769],
9	in	IN	O	in	_	0	SENT_391	[p24l1086t2712r1153b2768],
10	antibody-mediated	JJ	O	antibody-mediated	amod	15	SENT_391	[p24l1177t2706r1848b2790],
11	autoimmunity	NN	O	autoimmunity	nn	15	SENT_391	[p24l1871t2712r2144b2769, p24l7t2815r257b2893],
12	(	NN	O	(	nn	15	SENT_391	[p24l277t2809r550b2886],
13	Graves	NN	O	grave	nn	15	SENT_391	[p24l277t2809r550b2886],
14	’	NN	O	’	nn	15	SENT_391	[p24l277t2809r550b2886],
15	disease	NN	O	disease	prep_in	8	SENT_391	[p24l573t2809r812b2872],
16	and	CC	O	and	_	0	SENT_391	[p24l834t2809r959b2872],
17	idiopathic	JJ	O	idiopathic	amod	20	SENT_391	[p24l979t2809r1324b2892],
18	thrombocytopenic	JJ	O	thrombocytopenic	amod	20	SENT_391	[p24l1343t2809r1981b2893],
19	purpura	NN	O	purpura	nn	20	SENT_391	[p24l2000t2831r2145b2892, p24l6t2904r429b2996],
20	)	NN	O	)	conj_and	8	SENT_391	[p24l2000t2831r2145b2892, p24l6t2904r429b2996],
21	.31	CD	NUMBER	.31	number	22	SENT_391	[p24l2000t2831r2145b2892, p24l6t2904r429b2996],
22	’	CD	NUMBER	’	dep	20	SENT_391	[p24l2000t2831r2145b2892, p24l6t2904r429b2996],
23	91	CD	NUMBER	91	num	24	SENT_391	[p24l2000t2831r2145b2892, p24l6t2904r429b2996],
24	’92	CD	NUMBER	’92	dep	22	SENT_391	[p24l2000t2831r2145b2892, p24l6t2904r429b2996],
25	Due	JJ	O	due	_	0	SENT_391	[p24l451t2918r594b2976],
26	to	TO	O	to	_	0	SENT_391	[p24l614t2924r679b2976],
27	these	DT	O	these	det	30	SENT_391	[p24l701t2912r876b2976],
28	severe	JJ	O	severe	amod	30	SENT_391	[p24l898t2935r1107b2976],
29	side	NN	O	side	nn	30	SENT_391	[p24l1129t2912r1261b2976],
30	effects	NNS	O	effect	prep_due_to	8	SENT_391	[p24l1282t2912r1513b2985],
31	,	,	O	,	_	0	SENT_391	[p24l1282t2912r1513b2985],
32	alemtuzumab	NN	O	alemtuzumab	nsubjpass	37	SENT_391	[p24l1537t2912r2003b2976],
33	will	MD	O	will	aux	37	SENT_391	[p24l2023t2912r2149b2976],
34	most	RBS	O	most	advmod	37	SENT_391	[p24l7t3028r179b3079],
35	likely	JJ	O	likely	advmod	37	SENT_391	[p24l199t3016r387b3100],
36	be	VB	O	be	auxpass	37	SENT_391	[p24l404t3016r485b3079],
37	considered	VBN	O	consider	_	0	SENT_391	[p24l508t3016r886b3079],
38	only	RB	O	only	advmod	37	SENT_391	[p24l909t3016r1061b3100],
39	as	IN	O	as	_	0	SENT_391	[p24l1081t3039r1146b3079],
40	an	DT	O	a	det	41	SENT_391	[p24l1171t3039r1251b3079],
41	alternative	NN	O	alternative	prep_as	37	SENT_391	[p24l1275t3016r1637b3079],
42	to	TO	O	to	_	0	SENT_391	[p24l1660t3028r1726b3079],
43	other	JJ	O	other	prep_to	37	SENT_391	[p24l1751t3016r1935b3079],
44	failed	VBD	O	fail	partmod	43	SENT_391	[p24l1956t3016r2146b3079],
45	or	CC	O	or	_	0	SENT_391	[p24l8t3142r80b3182],
46	high	JJ	O	high	amod	49	SENT_391	[p24l99t3119r418b3203],
47	—	NN	O	—	nn	49	SENT_391	[p24l99t3119r418b3203],
48	risk	NN	O	risk	nn	49	SENT_391	[p24l99t3119r418b3203],
49	tier	NN	O	tier	conj_or	43	SENT_391	[p24l435t3125r552b3182],
50	2	CD	NUMBER	2	num	51	SENT_391	[p24l573t3126r609b3181],
51	medications	NNS	O	medication	dep	49	SENT_391	[p24l632t3119r1067b3182],
52	.	.	O	.	_	0	SENT_391	[p24l632t3119r1067b3182],

1	Rituximab	NNP	PERSON	Rituximab	_	0	SENT_392	[p24l10t3332r366b3389],

1	Rituximab	NNP	ORGANIZATION	Rituximab	nsubj	5	SENT_393	[p25l8t27r369b90],
2	is	VBZ	O	be	cop	5	SENT_393	[p25l393t33r444b90],
3	a	DT	O	a	dep	5	SENT_393	[p25l468t50r503b90],
4	chimeric	JJ	O	chimeric	amod	5	SENT_393	[p25l525t27r829b90],
5	murine	JJ	O	murine	_	0	SENT_393	[p25l851t31r1133b93],
6	/	:	O	/	punct	9	SENT_393	[p25l851t31r1133b93],
7	human	JJ	O	human	amod	9	SENT_393	[p25l1137t27r1381b90],
8	monoclonal	JJ	O	monoclonal	amod	9	SENT_393	[p25l1404t27r1819b90],
9	antibody	NN	O	antibody	dep	5	SENT_393	[p25l1842t27r2151b111],
10	directed	VBN	O	direct	partmod	9	SENT_393	[p25l8t130r300b193],
11	against	IN	O	against	_	0	SENT_393	[p25l326t136r577b214],
12	CD20	NN	O	cd20	prep_against	5	SENT_393	[p25l603t134r828b193],
13	.	.	O	.	_	0	SENT_393	[p25l603t134r828b193],

1	Rituximab	NNP	ORGANIZATION	Rituximab	nsubjpass	3	SENT_394	[p25l858t130r1231b193],
2	is	VBZ	O	be	auxpass	3	SENT_394	[p25l1259t136r1311b193],
3	approved	VBN	O	approve	_	0	SENT_394	[p25l1339t130r1670b213],
4	to	TO	O	to	aux	5	SENT_394	[p25l1694t142r1762b193],
5	treat	VB	O	treat	xcomp	3	SENT_394	[p25l1789t142r1952b193],
6	nonHodgkin	JJ	O	nonhodgkin	poss	8	SENT_394	[p25l1977t153r2145b193, p25l8t233r356b317],
7	’s	POS	O	’s	_	0	SENT_394	[p25l1977t153r2145b193, p25l8t233r356b317],
8	lymphoma	NN	O	lymphoma	dobj	5	SENT_394	[p25l379t233r758b317],
9	and	CC	O	and	_	0	SENT_394	[p25l781t233r910b296],
10	standard	JJ	O	standard	amod	12	SENT_394	[p25l934t233r1239b296],
11	treatment	NN	O	treatment	nn	12	SENT_394	[p25l1260t239r1933b296],
12	—	NN	O	—	dobj	5	SENT_394	[p25l1260t239r1933b296],
13	resistant	JJ	O	resistant	amod	15	SENT_394	[p25l1260t239r1933b296],
14	rheumatoid	JJ	O	rheumatoid	amod	15	SENT_394	[p25l1955t233r2143b296, p25l7t336r243b399],
15	arthritis	NN	O	arthritis	amod	8	SENT_394	[p25l263t336r547b399],
16	.	.	O	.	_	0	SENT_394	[p25l263t336r547b399],

1	Initial	JJ	O	initial	amod	2	SENT_395	[p25l570t336r769b399],
2	infusions	NNS	O	infusion	nsubj	4	SENT_395	[p25l788t336r1094b399],
3	may	MD	O	may	aux	4	SENT_395	[p25l1114t359r1258b420],
4	produce	VB	O	produce	_	0	SENT_395	[p25l1273t336r1548b419],
5	potentially	RB	O	potentially	advmod	6	SENT_395	[p25l1566t336r1927b420],
6	severe	JJ	O	severe	amod	7	SENT_395	[p25l1945t359r2148b399],
7	symptoms	NNS	O	symptom	dobj	4	SENT_395	[p25l8t452r373b524],
8	,	,	O	,	_	0	SENT_395	[p25l8t452r373b524],
9	including	VBG	O	include	_	0	SENT_395	[p25l395t440r718b524],
10	acute	JJ	O	acute	amod	13	SENT_395	[p25l737t452r913b503],
11	respiratory	JJ	O	respiratory	amod	13	SENT_395	[p25l934t446r1307b524],
12	distress	NN	O	distress	nn	13	SENT_395	[p25l1324t440r1574b503],
13	syndrome	NN	O	syndrome	prep_including	7	SENT_395	[p25l1595t440r1949b524],
14	,	,	O	,	_	0	SENT_395	[p25l1595t440r1949b524],
15	myocardial	JJ	O	myocardial	amod	16	SENT_395	[p25l1971t463r2145b524, p25l8t543r240b606],
16	infarction	NN	O	infarction	prep_including	7	SENT_395	[p25l263t543r621b615],
17	,	,	O	,	_	0	SENT_395	[p25l263t543r621b615],
18	or	CC	O	or	_	0	SENT_395	[p25l647t566r719b606],
19	anaphylaxis	NN	O	anaphylaxi	prep_including	7	SENT_395	[p25l741t543r1162b627],
20	.	.	O	.	_	0	SENT_395	[p25l741t543r1162b627],

1	Concomitant	JJ	O	concomitant	amod	3	SENT_396	[p25l1189t547r1647b606],
2	corticosteroid	NN	O	corticosteroid	nn	3	SENT_396	[p25l1669t543r2149b606],
3	administration	NN	O	administration	nsubj	5	SENT_396	[p25l8t646r542b709],
4	may	MD	O	may	aux	5	SENT_396	[p25l568t669r720b730],
5	reduce	VB	O	reduce	_	0	SENT_396	[p25l743t646r980b709],
6	these	DT	O	these	det	7	SENT_396	[p25l1006t646r1189b709],
7	symptoms	NNS	O	symptom	dobj	5	SENT_396	[p25l1217t658r1600b730],
8	.	.	O	.	_	0	SENT_396	[p25l1217t658r1600b730],

1	Unfortunately	RB	O	unfortunately	advmod	6	SENT_397	[p25l1630t646r2147b730],
2	,	,	O	,	_	0	SENT_397	[p25l1630t646r2147b730],
3	rituximab	NN	O	rituximab	nsubj	6	SENT_397	[p25l8t748r355b812],
4	can	MD	O	can	aux	6	SENT_397	[p25l381t771r501b812],
5	also	RB	O	also	advmod	6	SENT_397	[p25l526t748r661b812],
6	lead	VB	O	lead	_	0	SENT_397	[p25l685t748r831b812],
7	to	TO	O	to	_	0	SENT_397	[p25l853t760r920b812],
8	PML	NN	ORGANIZATION	pml	prep_to	6	SENT_397	[p25l947t753r1136b812],
9	.	.	O	.	_	0	SENT_397	[p25l947t753r1136b812],

1	Reversal	NN	O	reversal	nsubj	9	SENT_398	[p25l1164t748r1461b812],
2	of	IN	O	of	_	0	SENT_398	[p25l1485t748r1561b812],
3	this	DT	O	this	det	4	SENT_398	[p25l1574t748r1703b812],
4	medication	NN	O	medication	prep_of	1	SENT_398	[p25l1727t748r2145b820],
5	,	,	O	,	_	0	SENT_398	[p25l1727t748r2145b820],
6	unlike	IN	O	unlike	_	0	SENT_398	[p25l7t852r223b915],
7	natalizumab	NN	O	natalizumab	prep_unlike	9	SENT_398	[p25l246t852r691b924],
8	,	,	O	,	_	0	SENT_398	[p25l246t852r691b924],
9	poses	VBZ	O	pose	_	0	SENT_398	[p25l715t874r904b935],
10	a	DT	O	a	det	11	SENT_398	[p25l928t875r963b915],
11	challenge	NN	O	challenge	nsubj	12	SENT_398	[p25l985t852r1307b936],
12	due	JJ	O	due	xcomp	9	SENT_398	[p25l1331t852r1454b915],
13	to	TO	O	to	_	0	SENT_398	[p25l1477t864r1543b915],
14	its	PRP$	O	its	poss	17	SENT_398	[p25l1567t858r1643b915],
15	sustained	JJ	O	sustained	amod	17	SENT_398	[p25l1668t852r1992b915],
16	side	JJ	O	side	amod	17	SENT_398	[p25l2015t852r2148b915],
17	effects	NNS	O	effect	prep_to	12	SENT_398	[p25l8t954r240b1018],
18	.	.	O	.	_	0	SENT_398	[p25l8t954r240b1018],

1	However	RB	O	however	advmod	9	SENT_399	[p25l267t960r591b1027],
2	,	,	O	,	_	0	SENT_399	[p25l267t960r591b1027],
3	the	DT	O	the	det	4	SENT_399	[p25l615t954r722b1018],
4	incidence	NN	O	incidence	nsubj	9	SENT_399	[p25l746t954r1079b1018],
5	of	IN	O	of	_	0	SENT_399	[p25l1103t954r1178b1018],
6	PML	NN	ORGANIZATION	pml	prep_of	4	SENT_399	[p25l1192t960r1362b1017],
7	may	MD	O	may	aux	9	SENT_399	[p25l1384t977r1533b1039],
8	be	VB	O	be	cop	9	SENT_399	[p25l1550t954r1631b1018],
9	lower	JJR	O	lower	_	0	SENT_399	[p25l1652t946r1920b1018],
10	.93	CD	NUMBER	.93	dobj	22	SENT_399	[p25l1652t946r1920b1018],
11	In	IN	O	in	_	0	SENT_399	[p25l1946t960r2018b1017],
12	the	DT	O	the	det	15	SENT_399	[p25l2040t954r2148b1018],
13	phase	NN	O	phase	nn	15	SENT_399	[p25l6t1058r201b1141],
14	II	CD	NUMBER	ii	num	15	SENT_399	[p25l224t1063r277b1120],
15	trial	NN	O	trial	prep_in	10	SENT_399	[p25l299t1058r458b1130],
16	,	,	O	,	_	0	SENT_399	[p25l299t1058r458b1130],
17	~	NN	O	~	appos	15	SENT_399	[p25l484t1064r674b1123],
18	25	CD	PERCENT	25	num	19	SENT_399	[p25l484t1064r674b1123],
19	%	NN	PERCENT	%	nsubj	22	SENT_399	[p25l484t1064r674b1123],
20	of	IN	O	of	_	0	SENT_399	[p25l699t1058r773b1121],
21	patients	NNS	O	patient	prep_of	19	SENT_399	[p25l784t1064r1054b1141],
22	developed	VBD	O	develop	ccomp	9	SENT_399	[p25l1077t1058r1427b1141],
23	human	JJ	O	human	amod	25	SENT_399	[p25l1448t1058r1691b1121],
24	antichimeric	JJ	O	antichimeric	amod	25	SENT_399	[p25l1714t1058r2148b1121],
25	antibodies	NNS	O	antibody	dobj	22	SENT_399	[p25l8t1161r375b1224],
26	at	IN	O	at	_	0	SENT_399	[p25l401t1173r462b1224],
27	week	NN	DURATION	week	prep_at	22	SENT_399	[p25l483t1161r665b1224],
28	48	CD	NUMBER	48	num	27	SENT_399	[p25l685t1168r786b1233],
29	,	,	O	,	_	0	SENT_399	[p25l685t1168r786b1233],
30	which	WDT	O	which	nsubj	32	SENT_399	[p25l811t1161r1027b1224],
31	may	MD	O	may	aux	32	SENT_399	[p25l1051t1184r1202b1245],
32	represent	VB	O	represent	rcmod	27	SENT_399	[p25l1223t1173r1553b1244],
33	a	DT	O	a	det	34	SENT_399	[p25l1577t1184r1612b1224],
34	challenge	NN	O	challenge	dobj	32	SENT_399	[p25l1636t1161r1967b1245],
35	with	IN	O	with	_	0	SENT_399	[p25l1990t1161r2148b1224],
36	repeated	VBN	O	repeat	amod	37	SENT_399	[p25l8t1264r301b1347],
37	administration	NN	O	administration	prep_with	32	SENT_399	[p25l321t1264r849b1327],
38	.	.	O	.	_	0	SENT_399	[p25l321t1264r849b1327],

1	A	DT	O	a	det	5	SENT_400	[p25l871t1268r929b1326],
2	humanized	JJ	O	humanized	amod	5	SENT_400	[p25l948t1264r1334b1327],
3	anti-CD20	JJ	O	anti-cd20	amod	5	SENT_400	[p25l1355t1268r1717b1327],
4	monoclonal	JJ	O	monoclonal	amod	5	SENT_400	[p25l1739t1264r2150b1327],
5	antibody	NN	O	antibody	nsubj	10	SENT_400	[p25l8t1367r329b1451],
6	,	,	O	,	_	0	SENT_400	[p25l8t1367r329b1451],
7	ocrelizumab	NN	O	ocrelizumab	appos	5	SENT_400	[p25l355t1367r804b1439],
8	,	,	O	,	_	0	SENT_400	[p25l355t1367r804b1439],
9	may	MD	O	may	aux	10	SENT_400	[p25l829t1390r978b1451],
10	resolve	VB	O	resolve	_	0	SENT_400	[p25l998t1367r1240b1430],
11	this	DT	O	this	det	12	SENT_400	[p25l1263t1367r1390b1430],
12	problem	NN	O	problem	dobj	10	SENT_400	[p25l1413t1367r1708b1450],
13	because	IN	O	because	mark	17	SENT_400	[p25l1729t1367r2003b1430],
14	it	PRP	O	it	nsubj	17	SENT_400	[p25l2027t1373r2073b1430],
15	is	VBZ	O	be	cop	17	SENT_400	[p25l2096t1373r2147b1430],
16	less	RBR	O	less	advmod	17	SENT_400	[p25l6t1469r125b1533],
17	likely	JJ	O	likely	advcl	10	SENT_400	[p25l145t1469r332b1554],
18	to	TO	O	to	aux	19	SENT_400	[p25l349t1481r415b1533],
19	produce	VB	O	produce	xcomp	17	SENT_400	[p25l436t1469r718b1553],
20	these	DT	O	these	det	21	SENT_400	[p25l739t1469r915b1533],
21	antibodies	NNS	O	antibody	iobj	19	SENT_400	[p25l938t1461r1376b1533],
22	.94	CD	NUMBER	.94	dobj	19	SENT_400	[p25l938t1461r1376b1533],

1	IMPACTING	VBG	O	impact	csubjpass	24	SENT_401	[p25l11t1686r416b1741],
2	PROGRESSIVE	JJ	O	progressive	amod	4	SENT_401	[p25l440t1685r939b1741],
3	DISEASE	NN	O	disease	nn	4	SENT_401	[p25l961t1686r1262b1741],
4	COURSE	NN	O	course	dobj	1	SENT_401	[p25l1281t1685r1571b1741],
5	IN	IN	O	in	_	0	SENT_401	[p25l1592t1686r1661b1740],
6	MS	NN	O	m	nn	9	SENT_401	[p25l1684t1686r1788b1741],
7	Progressive	JJ	O	progressive	amod	9	SENT_401	[p25l8t1786r412b1865],
8	disease	NN	O	disease	nn	9	SENT_401	[p25l439t1781r689b1844],
9	course	NN	O	course	prep_in	4	SENT_401	[p25l715t1804r945b1844],
10	in	IN	O	in	_	0	SENT_401	[p25l971t1787r1039b1843],
11	MS	NN	O	m	prep_in	1	SENT_401	[p25l1065t1785r1181b1844],
12	is	VBZ	O	be	auxpass	13	SENT_401	[p25l1208t1787r1259b1844],
13	deﬁned	VBN	O	deﬁned	_	0	SENT_401	[p25l1286t1781r1550b1844],
14	as	IN	O	as	_	0	SENT_401	[p25l1576t1804r1642b1844],
15	insidious	JJ	O	insidious	prep_as	13	SENT_401	[p25l1668t1781r1990b1844],
16	and	CC	O	and	_	0	SENT_401	[p25l2017t1781r2147b1844],
17	irreversible	JJ	O	irreversible	conj_and	15	SENT_401	[p25l7t1884r402b1947],
18	worsening	VBG	O	worsen	amod	15	SENT_401	[p25l425t1890r794b1968],
19	neurological	JJ	O	neurological	amod	20	SENT_401	[p25l815t1884r1255b1968],
20	function	NN	O	function	tmod	15	SENT_401	[p25l1278t1884r1579b1947],
21	and	CC	O	and	_	0	SENT_401	[p25l1603t1884r1733b1947],
22	is	VBZ	O	be	auxpass	24	SENT_401	[p25l1755t1890r1807b1947],
23	generally	RB	O	generally	advmod	24	SENT_401	[p25l1831t1884r2153b1968],
24	thought	VBN	O	think	conj_and	13	SENT_401	[p25l6t1987r284b2071],
25	to	TO	O	to	aux	27	SENT_401	[p25l305t1999r372b2050],
26	be	VB	O	be	cop	27	SENT_401	[p25l394t1987r475b2050],
27	due	JJ	O	due	xcomp	24	SENT_401	[p25l499t1987r624b2050],
28	to	TO	O	to	_	0	SENT_401	[p25l646t1999r713b2050],
29	a	DT	O	a	det	32	SENT_401	[p25l739t2010r774b2050],
30	superimposed	VBN	O	superimpose	amod	32	SENT_401	[p25l797t1987r1292b2070],
31	degenerative	JJ	O	degenerative	amod	32	SENT_401	[p25l1315t1987r1756b2071],
32	phenotype	NN	O	phenotype	prep_to	27	SENT_401	[p25l1778t1987r2149b2071],
33	of	IN	O	of	_	0	SENT_401	[p25l8t2090r83b2153],
34	progressive	JJ	O	progressive	amod	36	SENT_401	[p25l96t2096r492b2174],
35	axonal	JJ	O	axonal	amod	36	SENT_401	[p25l516t2090r746b2153],
36	injury	NN	O	injury	prep_of	32	SENT_401	[p25l769t2096r984b2174],
37	on	IN	O	on	_	0	SENT_401	[p25l1004t2113r1092b2153],
38	top	NN	O	top	_	0	SENT_401	[p25l1115t2102r1227b2173],
39	of	IN	O	of	_	0	SENT_401	[p25l1253t2090r1328b2153],
40	a	DT	O	a	dep	41	SENT_401	[p25l1343t2113r1377b2153],
41	clinical	JJ	O	clinical	prep_on_top_of	36	SENT_401	[p25l1401t2090r1652b2153],
42	or	CC	O	or	_	0	SENT_401	[p25l1675t2113r1748b2153],
43	subclinical	JJ	O	subclinical	amod	45	SENT_401	[p25l1772t2090r2147b2153],
44	relapsing	NN	O	relapsing	nn	45	SENT_401	[p25l8t2194r692b2278],
45	—	NN	O	—	conj_or	41	SENT_401	[p25l8t2194r692b2278],
46	remitting	VBG	O	remit	partmod	41	SENT_401	[p25l8t2194r692b2278],
47	disease	NN	O	disease	nn	48	SENT_401	[p25l713t2194r955b2257],
48	course	NN	O	course	dobj	46	SENT_401	[p25l979t2217r1219b2257],
49	.	.	O	.	_	0	SENT_401	[p25l979t2217r1219b2257],

1	Progressive	JJ	O	progressive	amod	3	SENT_402	[p25l1245t2199r1636b2278],
2	disease	NN	O	disease	nn	3	SENT_402	[p25l1661t2194r1902b2257],
3	course	NN	O	course	nsubj	7	SENT_402	[p25l1926t2217r2149b2257],
4	is	VBZ	O	be	cop	7	SENT_402	[p25l7t2303r59b2360],
5	an	DT	O	a	det	7	SENT_402	[p25l86t2319r168b2360],
6	age-dependent	JJ	O	age-dependent	amod	7	SENT_402	[p25l194t2296r721b2381],
7	phase	NN	O	phase	_	0	SENT_402	[p25l744t2296r945b2380],
8	of	IN	O	of	_	0	SENT_402	[p25l971t2296r1047b2360],
9	MS.	NNP	O	MS.	nn	10	SENT_402	[p25l1062t2288r1266b2360],
10	”	NNP	O	”	prep_of	7	SENT_402	[p25l1062t2288r1266b2360],
11	If	IN	O	if	mark	17	SENT_402	[p25l1291t2296r1352b2359],
12	not	RB	O	not	neg	13	SENT_402	[p25l1367t2308r1485b2360],
13	preceded	VBN	O	precede	csubj	17	SENT_402	[p25l1508t2296r1832b2380],
14	by	IN	O	by	_	0	SENT_402	[p25l1854t2296r1941b2381],
15	clinical	JJ	O	clinical	amod	16	SENT_402	[p25l1963t2296r2145b2360, p25l8t2400r105b2463],
16	relapses	NNS	O	relapse	prep_by	13	SENT_402	[p25l132t2400r412b2483],
17	(	VBP	O	(	advcl	29	SENT_402	[p25l444t2401r520b2476],
18	it	PRP	O	it	nsubj	21	SENT_402	[p25l444t2401r520b2476],
19	can	MD	O	can	aux	21	SENT_402	[p25l546t2423r668b2463],
20	potentially	RB	O	potentially	advmod	21	SENT_402	[p25l693t2400r1083b2484],
21	follow	VB	O	follow	ccomp	17	SENT_402	[p25l1105t2400r1329b2463],
22	radiologically	RB	O	radiologically	advmod	23	SENT_402	[p25l1353t2400r1848b2484],
23	isolated	VBN	O	isolate	amod	25	SENT_402	[p25l1872t2400r2148b2463],
24	syndrome	NN	O	syndrome	nn	25	SENT_402	[p25l8t2503r411b2587],
25	)	NN	O	)	dobj	21	SENT_402	[p25l8t2503r411b2587],
26	,	,	O	,	_	0	SENT_402	[p25l8t2503r411b2587],
27	it	PRP	O	it	nsubjpass	29	SENT_402	[p25l438t2509r485b2566],
28	is	VBZ	O	be	auxpass	29	SENT_402	[p25l509t2509r561b2566],
29	known	VBN	O	know	rcmod	10	SENT_402	[p25l585t2503r830b2566],
30	as	IN	O	as	_	0	SENT_402	[p25l856t2526r922b2566],
31	PPMS	NNP	O	PPMS	prep_as	29	SENT_402	[p25l948t2507r1183b2566],
32	.	.	O	.	_	0	SENT_402	[p25l948t2507r1183b2566],

1	Progressive	JJ	O	progressive	amod	3	SENT_403	[p25l1212t2508r1615b2587],
2	disease	NN	O	disease	nn	3	SENT_403	[p25l1641t2503r1890b2566],
3	course	NN	O	course	nsubjpass	9	SENT_403	[p25l1916t2526r2146b2566],
4	following	VBG	O	follow	_	0	SENT_403	[p25l7t2605r331b2690],
5	SAMS	NNP	O	SAMS	prep_following	3	SENT_403	[p25l351t2609r564b2669],
6	or	CC	O	or	_	0	SENT_403	[p25l587t2628r659b2669],
7	CIS	NN	ORGANIZATION	ci	conj_or	5	SENT_403	[p25l681t2609r803b2669],
8	is	VBZ	O	be	auxpass	9	SENT_403	[p25l825t2612r875b2669],
9	known	VBN	O	know	_	0	SENT_403	[p25l895t2605r1134b2669],
10	as	IN	O	as	_	0	SENT_403	[p25l1155t2628r1219b2669],
11	SAPMS	NN	O	sapm	nn	15	SENT_403	[p25l1243t2597r1586b2669],
12	.95	CD	NUMBER	.95	num	15	SENT_403	[p25l1243t2597r1586b2669],
13	Progressive	JJ	O	progressive	amod	15	SENT_403	[p25l1610t2611r1999b2690],
14	disease	NN	O	disease	nn	15	SENT_403	[p25l2021t2605r2145b2669, p25l8t2732r147b2772],
15	course	NN	O	course	prep_as	9	SENT_403	[p25l168t2732r388b2772],
16	following	VBG	O	follow	_	0	SENT_403	[p25l409t2709r730b2793],
17	RRMS	NNS	O	rrm	prep_following	9	SENT_403	[p25l750t2713r968b2772],
18	is	VBZ	O	be	auxpass	19	SENT_403	[p25l990t2715r1040b2772],
19	known	VBN	O	know	rcmod	17	SENT_403	[p25l1060t2709r1296b2772],
20	as	IN	O	as	_	0	SENT_403	[p25l1317t2732r1381b2772],
21	SPMS	NN	O	spm	prep_as	19	SENT_403	[p25l1403t2713r1621b2772],
22	.	.	O	.	_	0	SENT_403	[p25l1403t2713r1621b2772],

1	All	DT	O	all	_	0	SENT_404	[p25l1643t2709r1745b2771],
2	progressive	JJ	O	progressive	dep	1	SENT_404	[p25l1763t2715r2148b2793],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_405	[p25l22t2858r141b2879],
2	PHARMACOLOGY	NNP	O	PHARMACOLOGY	dep	12	SENT_405	[p25l150t2858r375b2879],
3	&	CC	O	&	_	0	SENT_405	[p25l382t2858r602b2879],
4	THERAPEUT	NNP	O	THERAPEUT	nn	6	SENT_405	[p25l382t2858r602b2879],
5	|	CD	NUMBER	|	num	6	SENT_405	[p25l382t2858r602b2879],
6	CS	NNP	O	CS	conj_and	2	SENT_405	[p25l382t2858r602b2879],
7	|	NNP	O	|	nn	8	SENT_405	[p25l612t2856r614b2886],
8	VOLUME	NNP	O	VOLUME	dep	2	SENT_405	[p25l622t2858r730b2879],
9	95	CD	NUMBER	95	num	10	SENT_405	[p25l738t2858r765b2879],
10	NUMBER	NN	O	number	dep	12	SENT_405	[p25l775t2858r883b2879],
11	1	CD	NUMBER	1	num	12	SENT_405	[p25l893t2859r900b2879],
12	|	CD	NUMBER	|	dep	15	SENT_405	[p25l914t2856r916b2886],
13	JANUARY	NNP	DATE	JANUARY	dep	12	SENT_405	[p25l925t2858r1043b2879],
14	2014	CD	DATE	2014	num	15	SENT_405	[p25l1051t2858r1109b2879],
15	41	CD	DATE	41	_	0	SENT_405	[p25l2110t2859r2137b2879],

1	STATE	NN	O	state	nn	2	SENT_406	[p25l21t3001r163b3038],
2	ART	NN	O	art	_	0	SENT_406	[p25l306t3001r399b3038],

1	forms	NNS	O	form	nsubj	13	SENT_407	[p26l9t85r214b148],
2	of	IN	O	of	_	0	SENT_407	[p26l240t85r316b148],
3	MS	NN	O	m	nn	7	SENT_407	[p26l331t89r447b148],
4	(	CD	NUMBER	(	num	7	SENT_407	[p26l477t86r741b161],
5	PPMS	NNP	O	PPMS	nn	7	SENT_407	[p26l477t86r741b161],
6	,	,	O	,	_	0	SENT_407	[p26l477t86r741b161],
7	SAPMS	NNP	O	SAPMS	prep_of	1	SENT_407	[p26l769t89r1059b157],
8	,	,	O	,	_	0	SENT_407	[p26l769t89r1059b157],
9	and	CC	O	and	_	0	SENT_407	[p26l1086t85r1216b148],
10	SPMS	NN	O	spm	nn	11	SENT_407	[p26l1241t85r1476b162],
11	)	NN	O	)	prep_of	1	SENT_407	[p26l1241t85r1476b162],
12	may	MD	O	may	aux	13	SENT_407	[p26l1505t108r1656b169],
13	have	VB	O	have	_	0	SENT_407	[p26l1676t85r1837b148],
14	ongoing	JJ	O	ongoing	amod	15	SENT_407	[p26l1863t91r2152b169],
15	relapses	NNS	O	relapse	dobj	13	SENT_407	[p26l10t187r280b271],
16	reﬂecting	VBG	O	reﬂecting	partmod	15	SENT_407	[p26l304t187r630b272],
17	the	DT	O	the	det	20	SENT_407	[p26l650t187r757b251],
18	preprogression	NN	O	preprogression	nn	20	SENT_407	[p26l780t194r1298b272],
19	disease	NN	O	disease	nn	20	SENT_407	[p26l1322t187r1565b251],
20	course	NN	O	course	dobj	16	SENT_407	[p26l1589t179r1897b251],
21	.	.	O	.	_	0	SENT_407	[p26l1589t179r1897b251],

1	”	NN	O	”	nsubjpass	20	SENT_408	[p26l1589t179r1897b251],
2	All	PDT	O	all	predet	6	SENT_408	[p26l1918t187r2021b250],
3	the	DT	O	the	det	6	SENT_408	[p26l2043t187r2150b251],
4	above	JJ	O	above	amod	6	SENT_408	[p26l10t291r210b354],
5	treatment	NN	O	treatment	nn	6	SENT_408	[p26l233t303r576b354],
6	recommendations	NNS	O	recommendation	nsubj	11	SENT_408	[p26l599t291r1234b354],
7	regarding	VBG	O	regard	_	0	SENT_408	[p26l1258t291r1595b375],
8	relapses	NNS	O	relapse	prep_regarding	6	SENT_408	[p26l1617t291r1890b374],
9	should	MD	O	should	aux	11	SENT_408	[p26l1916t291r2151b354],
10	also	RB	O	also	advmod	11	SENT_408	[p26l10t395r140b458],
11	apply	VB	O	apply	rcmod	1	SENT_408	[p26l163t395r348b479],
12	to	TO	O	to	_	0	SENT_408	[p26l364t407r430b458],
13	relapses	NNS	O	relapse	prep_to	11	SENT_408	[p26l451t395r718b478],
14	after	IN	O	after	_	0	SENT_408	[p26l740t395r892b458],
15	a	DT	O	a	det	18	SENT_408	[p26l912t418r946b458],
16	progressive	JJ	O	progressive	amod	18	SENT_408	[p26l965t401r1350b479],
17	disease	NN	O	disease	nn	18	SENT_408	[p26l1372t395r1611b458],
18	course	NN	O	course	prep_after	11	SENT_408	[p26l1633t418r1854b458],
19	is	VBZ	O	be	auxpass	20	SENT_408	[p26l1875t401r1924b458],
20	established	VBN	O	establish	_	0	SENT_408	[p26l1946t395r2145b458, p26l8t498r236b561],
21	.	.	O	.	_	0	SENT_408	[p26l1946t395r2145b458, p26l8t498r236b561],

1	However	RB	O	however	advmod	26	SENT_409	[p26l266t503r598b570],
2	,	,	O	,	_	0	SENT_409	[p26l266t503r598b570],
3	because	IN	O	because	mark	6	SENT_409	[p26l623t498r901b561],
4	most	JJS	O	most	amod	5	SENT_409	[p26l927t510r1103b561],
5	patients	NNS	O	patient	nsubj	6	SENT_409	[p26l1126t504r1407b581],
6	stop	VB	O	stop	advcl	26	SENT_409	[p26l1434t510r1579b581],
7	having	VBG	O	have	xcomp	6	SENT_409	[p26l1605t498r1846b582],
8	relapses	NNS	O	relapse	dobj	7	SENT_409	[p26l1870t498r2149b581],
9	within	IN	O	within	_	0	SENT_409	[p26l8t601r232b664],
10	5	CD	DURATION	5	num	11	SENT_409	[p26l256t609r289b664],
11	years	NNS	NUMBER	year	prep_within	8	SENT_409	[p26l312t624r487b685],
12	after	IN	O	after	_	0	SENT_409	[p26l511t601r664b664],
13	onset	NN	O	onset	prep_after	7	SENT_409	[p26l686t613r869b664],
14	of	IN	O	of	_	0	SENT_409	[p26l891t601r965b664],
15	progressive	JJ	O	progressive	amod	16	SENT_409	[p26l977t607r1365b685],
16	MS	NN	O	m	prep_of	13	SENT_409	[p26l1387t605r1501b664],
17	or	CC	O	or	_	0	SENT_409	[p26l1526t624r1598b664],
18	by	IN	O	by	_	0	SENT_409	[p26l1617t601r1702b685],
19	the	DT	O	the	det	20	SENT_409	[p26l1719t601r1826b664],
20	age	NN	O	age	prep_by	7	SENT_409	[p26l1850t624r1959b685],
21	of	IN	O	of	_	0	SENT_409	[p26l1983t601r2057b664],
22	59	CD	DURATION	59	num	23	SENT_409	[p26l2072t608r2148b664],
23	years	NNS	NUMBER	year	prep_of	20	SENT_409	[p26l7t727r196b788],
24	,	,	O	,	_	0	SENT_409	[p26l7t727r196b788],
25	DMAs	NNS	O	dma	nsubj	26	SENT_409	[p26l218t708r438b767],
26	continued	VBD	O	continue	_	0	SENT_409	[p26l459t704r798b767],
27	beyond	IN	O	beyond	_	0	SENT_409	[p26l814t704r1065b788],
28	this	DT	O	this	det	29	SENT_409	[p26l1082t704r1204b767],
29	point	NN	O	point	prep_beyond	26	SENT_409	[p26l1223t710r1402b787],
30	may	MD	O	may	aux	32	SENT_409	[p26l1420t727r1564b788],
31	not	RB	O	not	neg	32	SENT_409	[p26l1580t716r1692b767],
32	have	VB	O	have	rcmod	29	SENT_409	[p26l1709t704r1861b767],
33	a	DT	O	a	det	35	SENT_409	[p26l1882t727r1916b767],
34	meaningful	JJ	O	meaningful	amod	35	SENT_409	[p26l1934t727r2146b767, p26l10t806r208b891],
35	impact	NN	O	impact	dobj	32	SENT_409	[p26l227t798r541b890],
36	.	.	O	.	_	0	SENT_409	[p26l227t798r541b890],

1	”	NN	O	”	nsubjpass	14	SENT_410	[p26l227t798r541b890],
2	We	PRP	O	we	nsubj	4	SENT_410	[p26l559t812r667b870],
3	therefore	RB	O	therefore	advmod	4	SENT_410	[p26l686t806r991b870],
4	recommend	VB	O	recommend	rcmod	1	SENT_410	[p26l1011t806r1420b870],
5	stopping	VBG	O	stop	xcomp	4	SENT_410	[p26l1440t813r1732b891],
6	DMAs	NNS	MISC	dma	dobj	5	SENT_410	[p26l1750t810r1972b870],
7	once	RB	DATE	once	advmod	6	SENT_410	[p26l1993t829r2149b870],
8	one	CD	NUMBER	one	pobj	7	SENT_410	[p26l10t933r133b973],
9	of	IN	O	of	_	0	SENT_410	[p26l156t910r230b973],
10	these	DT	O	these	det	12	SENT_410	[p26l242t910r419b973],
11	time	NN	O	time	nn	12	SENT_410	[p26l441t916r595b973],
12	points	NNS	O	point	prep_of	6	SENT_410	[p26l617t916r831b993],
13	is	VBZ	O	be	auxpass	14	SENT_410	[p26l854t916r904b973],
14	reached	VBN	O	reach	_	0	SENT_410	[p26l928t910r1197b973],
15	while	IN	O	while	mark	20	SENT_410	[p26l1217t910r1403b973],
16	managing	VBG	O	manage	amod	17	SENT_410	[p26l1426t916r1769b994],
17	relapses	NNS	O	relapse	nsubj	20	SENT_410	[p26l1791t910r2059b993],
18	as	IN	O	as	_	0	SENT_410	[p26l2083t933r2147b973],
19	they	PRP	O	they	prep_as	17	SENT_410	[p26l9t1013r159b1097],
20	happen	VB	O	happen	advcl	14	SENT_410	[p26l176t1013r449b1096],
21	,	,	O	,	_	0	SENT_410	[p26l176t1013r449b1096],
22	as	IN	O	as	prep	20	SENT_410	[p26l473t1036r537b1076],
23	in	IN	O	in	_	0	SENT_410	[p26l560t1019r626b1075],
24	SAMS	NNP	O	SAMS	nn	28	SENT_410	[p26l649t1017r862b1076],
25	or	CC	O	or	_	0	SENT_410	[p26l886t1036r957b1076],
26	RRMS	NNP	O	RRMS	nn	28	SENT_410	[p26l978t1017r1199b1076],
27	(	CD	NUMBER	(	num	28	SENT_410	[p26l1225t1014r1484b1096],
28	Figure	NNP	O	Figure	prep_in	20	SENT_410	[p26l1225t1014r1484b1096],
29	3	CD	NUMBER	3	num	30	SENT_410	[p26l1506t1014r1591b1090],
30	)	NN	O	)	dep	28	SENT_410	[p26l1506t1014r1591b1090],
31	.	.	O	.	_	0	SENT_410	[p26l1506t1014r1591b1090],

1	No	DT	O	no	det	3	SENT_411	[p26l82t1121r187b1179],
2	established	JJ	O	established	amod	3	SENT_411	[p26l215t1116r610b1179],
3	treatment	NN	O	treatment	nsubj	5	SENT_411	[p26l633t1128r984b1179],
4	signiﬁcantly	RB	O	signiﬁcantly	advmod	5	SENT_411	[p26l1009t1116r1448b1200],
5	impacts	VBZ	O	impact	ccomp	45	SENT_411	[p26l1470t1122r1748b1199],
6	the	DT	O	the	det	8	SENT_411	[p26l1773t1116r1884b1179],
7	neurodegenerative	JJ	O	neurodegenerative	amod	8	SENT_411	[p26l1910t1139r2148b1179, p26l10t1220r451b1304],
8	component	NN	O	component	dobj	5	SENT_411	[p26l476t1232r874b1303],
9	of	IN	O	of	_	0	SENT_411	[p26l897t1220r972b1283],
10	progressive	JJ	O	progressive	amod	12	SENT_411	[p26l984t1226r1379b1304],
11	disease	NN	O	disease	nn	12	SENT_411	[p26l1404t1220r1649b1283],
12	course	NN	O	course	prep_of	8	SENT_411	[p26l1673t1243r1899b1283],
13	in	IN	O	in	_	0	SENT_411	[p26l1923t1226r1991b1282],
14	MS.	NNP	O	MS.	prep_in	12	SENT_411	[p26l2014t1224r2148b1283],
15	Any	DT	O	any	det	16	SENT_411	[p26l9t1327r156b1407],
16	effect	NN	O	effect	nsubjpass	20	SENT_411	[p26l177t1323r363b1386],
17	seen	VBN	O	see	partmod	16	SENT_411	[p26l386t1346r538b1386],
18	is	VBZ	O	be	auxpass	20	SENT_411	[p26l561t1329r612b1386],
19	seemingly	RB	O	seemingly	advmod	20	SENT_411	[p26l637t1323r992b1407],
20	limited	VBN	O	limit	rcmod	8	SENT_411	[p26l1011t1323r1261b1386],
21	to	TO	O	to	_	0	SENT_411	[p26l1282t1335r1349b1386],
22	prevention	NN	O	prevention	prep_to	20	SENT_411	[p26l1373t1329r1753b1406],
23	of	IN	O	of	_	0	SENT_411	[p26l1777t1323r1852b1386],
24	ongoing	JJ	O	ongoing	amod	25	SENT_411	[p26l1867t1329r2152b1407],
25	relapses	NNS	O	relapse	prep_of	22	SENT_411	[p26l10t1417r352b1509],
26	.96	CD	NUMBER	.96	npadvmod	27	SENT_411	[p26l10t1417r352b1509],
27	Even	RB	O	even	advmod	25	SENT_411	[p26l372t1431r536b1489],
28	in	IN	O	in	_	0	SENT_411	[p26l556t1432r621b1488],
29	the	DT	O	the	det	30	SENT_411	[p26l640t1425r745b1489],
30	setting	NN	O	setting	prep_in	25	SENT_411	[p26l765t1432r989b1510],
31	of	IN	O	of	_	0	SENT_411	[p26l1008t1425r1081b1489],
32	signiﬁcant	JJ	O	signiﬁcant	amod	33	SENT_411	[p26l1092t1425r1440b1510],
33	immunosuppression	NN	O	immunosuppression	prep_of	30	SENT_411	[p26l1459t1432r2151b1509],
34	such	JJ	O	such	_	0	SENT_411	[p26l10t1529r167b1592],
35	as	IN	O	as	_	0	SENT_411	[p26l191t1552r256b1592],
36	with	IN	O	with	prepc_such_as	33	SENT_411	[p26l278t1529r433b1592],
37	mitoxantrone	NN	O	mitoxantrone	pobj	36	SENT_411	[p26l456t1535r947b1601],
38	,	,	O	,	_	0	SENT_411	[p26l456t1535r947b1601],
39	the	DT	O	the	det	42	SENT_411	[p26l970t1529r1078b1592],
40	relentless	JJ	O	relentless	amod	42	SENT_411	[p26l1102t1529r1422b1592],
41	disability	NN	O	disability	nn	42	SENT_411	[p26l1447t1529r1765b1613],
42	accumulation	NN	O	accumulation	nsubj	45	SENT_411	[p26l1786t1529r2147b1592, p26l9t1637r146b1695],
43	does	VBZ	O	do	aux	45	SENT_411	[p26l167t1631r321b1695],
44	not	RB	O	not	neg	45	SENT_411	[p26l342t1643r456b1695],
45	seem	VB	O	seem	_	0	SENT_411	[p26l476t1654r649b1695],
46	to	TO	O	to	aux	48	SENT_411	[p26l668t1643r734b1695],
47	be	VB	O	be	auxpass	48	SENT_411	[p26l754t1631r833b1695],
48	altered	VBN	O	alter	xcomp	45	SENT_411	[p26l855t1631r1102b1695],
49	.	.	O	.	_	0	SENT_411	[p26l855t1631r1102b1695],

1	We	PRP	O	we	nsubj	2	SENT_412	[p26l1125t1636r1234b1695],
2	need	VBP	O	need	_	0	SENT_412	[p26l1255t1631r1419b1695],
3	different	JJ	O	different	amod	7	SENT_412	[p26l1439t1631r1746b1703],
4	,	,	O	,	_	0	SENT_412	[p26l1439t1631r1746b1703],
5	more	RBR	O	more	advmod	6	SENT_412	[p26l1768t1654r1945b1695],
6	effective	JJ	O	effective	amod	7	SENT_412	[p26l1967t1631r2147b1695, p26l9t1741r131b1798],
7	strategies	NNS	O	strategy	nsubj	9	SENT_412	[p26l153t1741r470b1819],
8	to	TO	O	to	aux	9	SENT_412	[p26l490t1747r556b1798],
9	prevent	VB	O	prevent	xcomp	2	SENT_412	[p26l577t1747r837b1818],
10	lesions	NNS	O	lesion	dobj	9	SENT_412	[p26l855t1735r1088b1798],
11	and	CC	O	and	_	0	SENT_412	[p26l1110t1735r1236b1798],
12	disabilities	NNS	O	disability	conj_and	10	SENT_412	[p26l1257t1735r1619b1798],
13	long	RB	O	long	advmod	9	SENT_412	[p26l1639t1735r1791b1819],
14	before	IN	O	before	mark	18	SENT_412	[p26l1808t1735r2023b1798],
15	the	DT	O	the	det	17	SENT_412	[p26l2043t1735r2150b1798],
16	progressive	JJ	O	progressive	amod	17	SENT_412	[p26l8t1844r394b1922],
17	phase	NN	O	phase	nsubj	18	SENT_412	[p26l414t1838r608b1921],
18	starts	VBZ	O	start	advcl	9	SENT_412	[p26l629t1850r827b1901],
19	.	.	O	.	_	0	SENT_412	[p26l629t1850r827b1901],

1	We	PRP	O	we	nsubj	3	SENT_413	[p26l849t1843r959b1901],
2	also	RB	O	also	advmod	3	SENT_413	[p26l980t1838r1110b1901],
3	need	VBP	O	need	_	0	SENT_413	[p26l1132t1838r1296b1901],
4	efﬁcient	JJ	O	efﬁcient	amod	6	SENT_413	[p26l1316t1838r1586b1901],
5	neuroprotective	JJ	O	neuroprotective	amod	6	SENT_413	[p26l1605t1844r2148b1921],
6	strategies	NNS	O	strategy	nsubj	8	SENT_413	[p26l10t1947r333b2025],
7	to	TO	O	to	aux	8	SENT_413	[p26l355t1953r422b2004],
8	reduce	VB	O	reduce	xcomp	3	SENT_413	[p26l447t1941r678b2004],
9	axonal	JJ	O	axonal	amod	10	SENT_413	[p26l703t1941r931b2004],
10	loss	NN	O	loss	dobj	8	SENT_413	[p26l952t1941r1098b2004],
11	.	.	O	.	_	0	SENT_413	[p26l952t1941r1098b2004],

1	Remyelination	NN	O	remyelination	nn	2	SENT_414	[p26l1125t1941r1633b2025],
2	strategies	NNS	O	strategy	nsubj	13	SENT_414	[p26l1657t1947r1979b2025],
3	may	MD	O	may	aux	5	SENT_414	[p26l2003t1964r2152b2025],
4	also	RB	O	also	advmod	5	SENT_414	[p26l10t2044r137b2107],
5	serve	VB	O	serve	_	0	SENT_414	[p26l159t2067r329b2107],
6	to	TO	O	to	aux	7	SENT_414	[p26l348t2056r412b2107],
7	prevent	VB	O	prevent	xcomp	5	SENT_414	[p26l431t2056r684b2127],
8	axonal	JJ	O	axonal	amod	9	SENT_414	[p26l703t2044r921b2107],
9	loss	NN	O	loss	dobj	7	SENT_414	[p26l939t2044r1061b2107],
10	and	CC	O	and	_	0	SENT_414	[p26l1082t2044r1205b2107],
11	thereby	RB	O	thereby	advmod	13	SENT_414	[p26l1223t2044r1475b2128],
12	may	MD	O	may	aux	13	SENT_414	[p26l1491t2067r1634b2128],
13	have	VB	O	have	conj_and	5	SENT_414	[p26l1649t2044r1801b2107],
14	an	DT	O	a	det	15	SENT_414	[p26l1821t2067r1899b2107],
15	impact	NN	O	impact	dobj	13	SENT_414	[p26l1919t2050r2149b2127],
16	on	IN	O	on	_	0	SENT_414	[p26l10t2171r95b2211],
17	progression	NN	O	progression	prep_on	15	SENT_414	[p26l114t2154r528b2232],
18	;	:	O	;	_	0	SENT_414	[p26l114t2154r528b2232],
19	however	RB	O	however	advmod	26	SENT_414	[p26l548t2148r847b2220],
20	,	,	O	,	_	0	SENT_414	[p26l548t2148r847b2220],
21	remyelination	NN	O	remyelination	nn	22	SENT_414	[p26l868t2148r1339b2232],
22	therapy	NN	O	therapy	nsubj	26	SENT_414	[p26l1358t2148r1616b2232],
23	may	MD	O	may	aux	26	SENT_414	[p26l1633t2171r1778b2232],
24	not	RB	O	not	neg	26	SENT_414	[p26l1794t2160r1906b2211],
25	be	VB	O	be	cop	26	SENT_414	[p26l1923t2148r2001b2211],
26	sufﬁcient	JJ	O	sufﬁcient	parataxis	5	SENT_414	[p26l2023t2148r2147b2211, p26l9t2251r225b2314],
27	if	IN	O	if	mark	28	SENT_414	[p26l248t2251r303b2313],
28	started	VBN	O	start	dep	26	SENT_414	[p26l317t2251r555b2314],
29	after	IN	O	after	_	0	SENT_414	[p26l578t2251r732b2314],
30	progression	NN	O	progression	prep_after	28	SENT_414	[p26l754t2257r1162b2335],
31	and	CC	O	and	_	0	SENT_414	[p26l1186t2251r1315b2314],
32	if	IN	O	if	mark	37	SENT_414	[p26l1337t2251r1392b2313],
33	sustained	JJ	O	sustained	amod	34	SENT_414	[p26l1407t2251r1734b2314],
34	disability	NN	O	disability	nsubjpass	37	SENT_414	[p26l1757t2251r2076b2335],
35	is	VBZ	O	be	auxpass	37	SENT_414	[p26l2097t2257r2147b2314],
36	already	RB	O	already	advmod	37	SENT_414	[p26l10t2354r268b2438],
37	established	VBN	O	establish	conj_and	28	SENT_414	[p26l289t2354r693b2417],
38	.	.	O	.	_	0	SENT_414	[p26l289t2354r693b2417],

1	The	DT	DATE	the	det	3	SENT_415	[p26l720t2354r848b2417],
2	future	JJ	DATE	future	amod	3	SENT_415	[p26l871t2354r1084b2417],
3	prevention	NN	O	prevention	nsubj	9	SENT_415	[p26l1107t2360r1490b2437],
4	of	IN	O	of	_	0	SENT_415	[p26l1514t2354r1590b2417],
5	MS-related	JJ	O	ms-related	amod	6	SENT_415	[p26l1604t2354r1996b2417],
6	disability	NN	O	disability	prep_of	3	SENT_415	[p26l2019t2354r2146b2417, p26l10t2457r228b2541],
7	will	MD	O	will	aux	9	SENT_415	[p26l246t2457r374b2520],
8	probably	RB	O	probably	advmod	9	SENT_415	[p26l396t2457r708b2541],
9	depend	VB	O	depend	_	0	SENT_415	[p26l729t2457r988b2540],
10	on	IN	O	on	_	0	SENT_415	[p26l1012t2480r1099b2520],
11	how	WRB	O	how	advmod	15	SENT_415	[p26l1121t2457r1272b2520],
12	effectively	RB	O	effectively	advmod	15	SENT_415	[p26l1293t2457r1645b2541],
13	we	PRP	O	we	nsubj	15	SENT_415	[p26l1663t2480r1757b2520],
14	can	MD	O	can	aux	15	SENT_415	[p26l1781t2480r1900b2520],
15	design	VB	O	design	prepc_on	9	SENT_415	[p26l1925t2457r2150b2541],
16	treatment	NN	O	treatment	nn	17	SENT_415	[p26l9t2572r337b2623],
17	protocols	NNS	O	protocol	dobj	15	SENT_415	[p26l354t2560r667b2643],
18	to	TO	O	to	aux	19	SENT_415	[p26l686t2572r750b2623],
19	prevent	VB	O	prevent	xcomp	15	SENT_415	[p26l770t2572r1024b2643],
20	progressive	JJ	O	progressive	amod	22	SENT_415	[p26l1041t2566r1419b2644],
21	disease	NN	O	disease	nn	22	SENT_415	[p26l1440t2560r1675b2623],
22	course	NN	O	course	dobj	19	SENT_415	[p26l1695t2583r1912b2623],
23	in	IN	O	in	_	0	SENT_415	[p26l1932t2566r1997b2622],
24	MS.	NNP	O	MS.	prep_in	22	SENT_415	[p26l2017t2564r2145b2623],

1	SPECIAL	JJ	O	special	amod	2	SENT_416	[p26l11t2776r308b2831],
2	CONSIDERATION	NN	O	consideration	_	0	SENT_416	[p26l326t2775r1400b2831],
3	:	:	O	:	_	0	SENT_416	[p26l326t2775r1400b2831],
4	TREATMENT	NN	O	treatment	dep	2	SENT_416	[p26l326t2775r1400b2831],
5	OF	IN	O	of	_	0	SENT_416	[p26l1418t2775r1511b2831],
6	PEDIATRIC	NN	O	pediatric	nn	7	SENT_416	[p26l1534t2776r1910b2831],
7	MS	NN	O	m	prep_of	4	SENT_416	[p26l1930t2776r2035b2831],

1	Neurology	NN	O	neurology	nn	2	SENT_417	[p26l9t2871r378b2955],
2	textbooks	NNS	O	textbook	nsubj	4	SENT_417	[p26l396t2871r731b2934],
3	once	RB	DATE	once	advmod	4	SENT_417	[p26l755t2894r914b2934],
4	stated	VBD	O	state	_	0	SENT_417	[p26l938t2871r1138b2934],
5	that	IN	O	that	complm	9	SENT_417	[p26l1158t2871r1292b2934],
6	MS	NN	O	m	nsubj	9	SENT_417	[p26l1313t2875r1427b2934],
7	did	VBD	O	do	aux	9	SENT_417	[p26l1452t2871r1563b2934],
8	not	RB	O	not	neg	9	SENT_417	[p26l1585t2883r1699b2934],
9	occur	VB	O	occur	ccomp	4	SENT_417	[p26l1721t2894r1915b2934],
10	before	IN	O	before	_	0	SENT_417	[p26l1934t2871r2149b2934],
11	the	DT	O	the	det	12	SENT_417	[p26l9t2974r119b3037],
12	age	NN	O	age	prep_before	9	SENT_417	[p26l147t2997r261b3058],
13	of	IN	O	of	_	0	SENT_417	[p26l289t2974r365b3037],
14	18	CD	DURATION	18	num	15	SENT_417	[p26l389t2981r462b3037],
15	years	NNS	NUMBER	year	prep_of	12	SENT_417	[p26l488t2997r690b3058],
16	.	.	O	.	_	0	SENT_417	[p26l488t2997r690b3058],

1	However	RB	O	however	advmod	10	SENT_418	[p26l720t2979r1054b3046],
2	,	,	O	,	_	0	SENT_418	[p26l720t2979r1054b3046],
3	well-documented	JJ	O	well-documented	amod	4	SENT_418	[p26l1080t2974r1713b3037],
4	cases	NNS	O	case	nsubj	10	SENT_418	[p26l1739t2997r1918b3037],
5	in	IN	O	in	_	0	SENT_418	[p26l1945t2980r2014b3036],
6	the	DT	O	the	det	8	SENT_418	[p26l2040t2974r2151b3037],
7	medical	JJ	O	medical	amod	8	SENT_418	[p26l9t3077r288b3140],
8	literature	NN	O	literature	prep_in	4	SENT_418	[p26l310t3077r631b3140],
9	clearly	RB	O	clearly	advmod	10	SENT_418	[p26l656t3077r887b3161],
10	fulﬁlled	VBD	O	fulﬁlled	_	0	SENT_418	[p26l907t3077r1181b3140],
11	the	DT	O	the	det	13	SENT_418	[p26l1202t3077r1312b3140],
12	clinical	JJ	O	clinical	amod	13	SENT_418	[p26l1337t3077r1589b3140],
13	criteria	NNS	O	criterion	nsubj	21	SENT_418	[p26l1613t3083r1866b3140],
14	for	IN	O	for	_	0	SENT_418	[p26l1888t3077r1988b3140],
15	MS.	NNP	O	MS.	prep_for	13	SENT_418	[p26l2010t3081r2145b3140],
16	Contributing	VBG	O	contribute	partmod	15	SENT_418	[p26l11t3180r455b3264],
17	to	TO	O	to	_	0	SENT_418	[p26l472t3192r537b3243],
18	the	DT	O	the	det	19	SENT_418	[p26l557t3180r662b3243],
19	confusion	NN	O	confusion	prep_to	16	SENT_418	[p26l683t3180r1017b3243],
20	was	VBD	O	be	cop	21	SENT_418	[p26l1036t3203r1160b3243],
21	acute	JJ	O	acute	ccomp	10	SENT_418	[p26l1181t3192r1356b3243],
22	disseminated	VBN	O	disseminate	ccomp	21	SENT_418	[p26l1377t3180r1821b3243],
23	encephalomyelitis	NN	O	encephalomyelitis	dobj	22	SENT_418	[p26l1841t3180r2145b3263, p26l8t3283r355b3367],
24	,	,	O	,	_	0	SENT_418	[p26l1841t3180r2145b3263, p26l8t3283r355b3367],
25	a	DT	O	a	det	27	SENT_418	[p26l378t3306r412b3346],
26	primarily	RB	O	primarily	advmod	27	SENT_418	[p26l429t3283r753b3367],
27	pediatric	JJ	O	pediatric	conj_or	23	SENT_418	[p26l768t3283r1088b3366],
28	,	,	O	,	_	0	SENT_418	[p26l768t3283r1088b3366],
29	monophasic	JJ	O	monophasic	amod	30	SENT_418	[p26l1110t3283r1526b3366],
30	disease	NN	O	disease	conj_or	23	SENT_418	[p26l1547t3283r1785b3346],
31	characterized	VBN	O	characterize	partmod	30	SENT_418	[p26l1806t3283r2147b3346, p26l10t3386r148b3449],
32	by	IN	O	by	_	0	SENT_418	[p26l165t3386r248b3470],
33	perivenular	JJ	O	perivenular	amod	34	SENT_418	[p26l264t3386r655b3469],
34	demyelination	NN	O	demyelination	agent	31	SENT_418	[p26l675t3386r1161b3470],
35	frequently	RB	O	frequently	advmod	36	SENT_418	[p26l1180t3386r1530b3470],
36	occurring	VBG	O	occur	partmod	34	SENT_418	[p26l1548t3392r1882b3470],
37	after	IN	O	after	_	0	SENT_418	[p26l1901t3386r2051b3449],
38	an	DT	O	a	det	39	SENT_418	[p26l2071t3409r2150b3449],
39	infection	NN	O	infection	prep_after	36	SENT_418	[p26l10t3489r312b3552],
40	or	CC	O	or	_	0	SENT_418	[p26l333t3512r404b3552],
41	a	DT	O	a	det	42	SENT_418	[p26l424t3512r458b3552],
42	vaccination	NN	O	vaccination	conj_or	23	SENT_418	[p26l474t3495r883b3552],
43	.	.	O	.	_	0	SENT_418	[p26l474t3495r883b3552],

1	Acute	JJ	O	acute	nsubj	4	SENT_419	[p26l906t3493r1103b3552],
2	disseminated	VBN	O	disseminate	partmod	1	SENT_419	[p26l1124t3489r1570b3552],
3	encephalomyelitis	NN	O	encephalomyelitis	dobj	2	SENT_419	[p26l1590t3489r2147b3573, p26l9t3598r86b3655],
4	presents	VBZ	O	present	_	0	SENT_419	[p26l109t3604r391b3675],
5	with	IN	O	with	_	0	SENT_419	[p26l412t3592r565b3655],
6	symptoms	NNS	O	symptom	prep_with	4	SENT_419	[p26l588t3604r940b3676],
7	similar	JJ	O	similar	amod	6	SENT_419	[p26l964t3592r1202b3655],
8	to	TO	O	to	_	0	SENT_419	[p26l1222t3604r1288b3655],
9	those	DT	O	those	prep_to	7	SENT_419	[p26l1311t3592r1494b3655],
10	of	IN	O	of	_	0	SENT_419	[p26l1517t3592r1591b3655],
11	adult-onset	JJ	O	adult-onset	amod	12	SENT_419	[p26l1605t3592r1994b3655],
12	MS	NN	O	m	prep_of	9	SENT_419	[p26l2015t3596r2148b3664],
13	,	,	O	,	_	0	SENT_419	[p26l2015t3596r2148b3664],
14	with	IN	O	with	_	0	SENT_419	[p26l8t3694r157b3758],
15	the	DT	O	the	det	16	SENT_419	[p26l175t3694r279b3758],
16	addition	NN	O	addition	prep_with	7	SENT_419	[p26l300t3694r580b3758],
17	of	IN	O	of	_	0	SENT_419	[p26l600t3694r672b3758],
18	confusion	NN	O	confusion	nn	22	SENT_419	[p26l683t3694r1014b3758],
19	and	CC	O	and	_	0	SENT_419	[p26l1035t3694r1158b3758],
20	mental	JJ	O	mental	nn	22	SENT_419	[p26l1176t3694r1408b3758],
21	status	NN	O	status	nn	22	SENT_419	[p26l1428t3706r1614b3758],
22	change	NN	O	change	prep_of	16	SENT_419	[p26l1635t3686r1946b3779],
23	.97	CD	NUMBER	.97	nsubj	33	SENT_419	[p26l1635t3686r1946b3779],
24	Some	DT	O	some	det	25	SENT_419	[p26l1967t3698r2150b3758],
25	cases	NNS	O	case	nsubj	26	SENT_419	[p27l10t39r184b79],
26	recurred	VBD	O	recur	rcmod	23	SENT_419	[p27l209t16r510b79],
27	and	CC	O	and	_	0	SENT_419	[p27l533t16r662b79],
28	were	VBD	O	be	auxpass	29	SENT_419	[p27l683t39r847b79],
29	called	VBN	O	call	rcmod	23	SENT_419	[p27l871t16r1075b79],
30	“	RB	O	“	advmod	31	SENT_419	[p27l1099t16r1458b79],
31	recurrent	JJ	O	recurrent	dep	32	SENT_419	[p27l1099t16r1458b79],
32	acute	JJ	O	acute	acomp	29	SENT_419	[p27l1482t28r1663b79],
33	disseminated	VBN	O	disseminate	rcmod	22	SENT_419	[p27l1688t16r2150b79],
34	encephalomyelitis	NN	O	encephalomyelitis	dobj	33	SENT_419	[p27l10t119r669b203],
35	.	.	O	.	_	0	SENT_419	[p27l10t119r669b203],

1	”	NN	O	”	nsubj	3	SENT_420	[p27l10t119r669b203],
2	Follow-up	JJ	O	follow-up	amod	1	SENT_420	[p27l692t119r1042b202],
3	proved	VBD	O	prove	_	0	SENT_420	[p27l1063t119r1301b202],
4	many	JJ	O	many	acomp	3	SENT_420	[p27l1321t142r1514b203],
5	to	TO	O	to	aux	7	SENT_420	[p27l1531t131r1596b182],
6	be	VB	O	be	cop	7	SENT_420	[p27l1616t119r1696b182],
7	MS.	NNP	O	MS.	xcomp	4	SENT_420	[p27l1717t123r1848b182],
8	Since	IN	O	since	_	0	SENT_420	[p27l1873t123r2052b182],
9	its	PRP$	O	its	poss	10	SENT_420	[p27l2074t125r2149b182],
10	creation	NN	O	creation	prep_since	21	SENT_420	[p27l10t228r300b294],
11	,	,	O	,	_	0	SENT_420	[p27l10t228r300b294],
12	the	DT	O	the	det	14	SENT_420	[p27l320t222r425b285],
13	US	NNP	ORGANIZATION	US	nn	14	SENT_420	[p27l445t226r543b285],
14	Network	NNP	ORGANIZATION	Network	appos	10	SENT_420	[p27l563t222r860b285],
15	of	IN	ORGANIZATION	of	_	0	SENT_420	[p27l878t222r950b285],
16	Pediatric	NNP	ORGANIZATION	Pediatric	prep_of	14	SENT_420	[p27l962t222r1259b285],
17	Multiple	JJ	ORGANIZATION	multiple	amod	19	SENT_420	[p27l1278t222r1563b305],
18	Sclerosis	NNP	ORGANIZATION	Sclerosis	nn	19	SENT_420	[p27l1584t222r1872b285],
19	Centers	NNPS	ORGANIZATION	Centers	nsubj	21	SENT_420	[p27l1894t226r2150b285],
20	has	VBZ	O	have	aux	21	SENT_420	[p27l9t325r120b388],
21	documented	VBN	O	document	rcmod	7	SENT_420	[p27l142t325r573b388],
22	more	JJR	O	more	mwe	23	SENT_420	[p27l591t348r769b388],
23	than	IN	O	than	quantmod	24	SENT_420	[p27l788t325r942b388],
24	500	CD	NUMBER	500	num	25	SENT_420	[p27l965t332r1082b388],
25	cases	NNS	O	case	dobj	21	SENT_420	[p27l1104t348r1274b388],
26	of	IN	O	of	_	0	SENT_420	[p27l1296t325r1369b388],
27	pediatric	JJ	O	pediatric	amod	28	SENT_420	[p27l1379t325r1683b408],
28	MS	NN	O	m	prep_of	25	SENT_420	[p27l1703t329r1816b388],
29	that	WDT	O	that	nsubjpass	32	SENT_420	[p27l1837t325r1971b388],
30	were	VBD	O	be	auxpass	32	SENT_420	[p27l1988t348r2148b388],
31	prospectively	RB	O	prospectively	advmod	32	SENT_420	[p27l8t428r477b512],
32	followed	VBN	O	follow	rcmod	28	SENT_420	[p27l497t428r798b491],
33	(	NNP	O	(	nn	35	SENT_420	[p27l824t429r942b504],
34	M.	NNP	PERSON	M.	nn	35	SENT_420	[p27l824t429r942b504],
35	Rodriguez	NNP	PERSON	Rodriguez	dobj	32	SENT_420	[p27l970t428r1352b512],
36	,	,	O	,	_	0	SENT_420	[p27l970t428r1352b512],
37	personal	JJ	O	personal	amod	39	SENT_420	[p27l1377t428r1679b511],
38	communication	NN	O	communication	nn	39	SENT_420	[p27l1702t434r2146b491, p27l9t532r192b607],
39	)	NN	O	)	appos	35	SENT_420	[p27l1702t434r2146b491, p27l9t532r192b607],
40	.	.	O	.	_	0	SENT_420	[p27l1702t434r2146b491, p27l9t532r192b607],

1	If	IN	O	if	mark	5	SENT_421	[p27l216t531r275b593],
2	an	DT	O	a	det	4	SENT_421	[p27l286t554r366b594],
3	environmental	JJ	O	environmental	amod	4	SENT_421	[p27l387t531r888b594],
4	factor	NN	O	factor	nsubj	5	SENT_421	[p27l908t531r1107b594],
5	precipitates	VBZ	O	precipitate	advcl	12	SENT_421	[p27l1124t537r1515b614],
6	the	DT	O	the	det	7	SENT_421	[p27l1535t531r1641b594],
7	disease	NN	O	disease	dobj	5	SENT_421	[p27l1663t531r1919b603],
8	,	,	O	,	_	0	SENT_421	[p27l1663t531r1919b603],
9	it	PRP	O	it	nsubj	12	SENT_421	[p27l1942t537r1987b594],
10	may	MD	O	may	aux	12	SENT_421	[p27l2006t554r2153b615],
11	be	VB	O	be	cop	12	SENT_421	[p27l8t634r87b697],
12	easier	JJR	O	easier	_	0	SENT_421	[p27l110t640r306b697],
13	to	TO	O	to	aux	14	SENT_421	[p27l325t646r391b697],
14	ﬁnd	VB	O	ﬁnd	xcomp	12	SENT_421	[p27l413t634r550b697],
15	in	IN	O	in	_	0	SENT_421	[p27l571t640r637b696],
16	this	DT	O	this	det	18	SENT_421	[p27l658t634r782b697],
17	younger	JJR	O	younger	amod	18	SENT_421	[p27l802t657r1086b718],
18	cohort	NN	O	cohort	prep_in	14	SENT_421	[p27l1107t634r1332b697],
19	of	IN	O	of	_	0	SENT_421	[p27l1353t634r1427b697],
20	patients	NNS	O	patient	prep_of	18	SENT_421	[p27l1438t640r1725b717],
21	.	.	O	.	_	0	SENT_421	[p27l1438t640r1725b717],

1	Clinically	RB	O	clinically	advmod	5	SENT_422	[p27l84t737r417b821],
2	,	,	O	,	_	0	SENT_422	[p27l84t737r417b821],
3	pediatric	JJ	O	pediatric	amod	4	SENT_422	[p27l437t737r738b820],
4	MS	NN	O	m	nsubj	5	SENT_422	[p27l757t741r870b800],
5	has	VBZ	O	have	_	0	SENT_422	[p27l889t737r1000b800],
6	some	DT	O	some	det	8	SENT_422	[p27l1021t760r1197b800],
7	interesting	JJ	O	interesting	amod	8	SENT_422	[p27l1217t743r1576b821],
8	features	NNS	O	feature	dobj	5	SENT_422	[p27l1594t737r1855b800],
9	that	WDT	O	that	nsubj	10	SENT_422	[p27l1874t737r2006b800],
10	distinguish	VBP	O	distinguish	rcmod	8	SENT_422	[p27l2025t737r2147b800, p27l9t839r282b924],
11	it	PRP	O	it	nsubj	18	SENT_422	[p27l301t846r345b903],
12	from	IN	O	from	_	0	SENT_422	[p27l363t839r527b903],
13	adult-onset	JJ	O	adult-onset	amod	17	SENT_422	[p27l547t839r925b903],
14	MS.	NNP	O	MS.	nn	17	SENT_422	[p27l942t831r1134b903],
15	98	CD	NUMBER	98	num	17	SENT_422	[p27l942t831r1134b903],
16	Pediatric	NNP	O	Pediatric	nn	17	SENT_422	[p27l1154t839r1449b903],
17	patients	NNS	O	patient	prep_from	11	SENT_422	[p27l1467t846r1729b923],
18	tend	VBP	O	tend	ccomp	10	SENT_422	[p27l1747t839r1897b903],
19	to	TO	O	to	aux	20	SENT_422	[p27l1914t851r1978b903],
20	have	VB	O	have	xcomp	18	SENT_422	[p27l1998t840r2149b903],
21	greater	JJR	O	greater	amod	24	SENT_422	[p27l9t955r239b1027],
22	MRI	NNP	O	MRI	nn	24	SENT_422	[p27l256t948r408b1006],
23	lesion	NN	O	lesion	nn	24	SENT_422	[p27l427t943r622b1006],
24	load	NN	O	load	dobj	20	SENT_422	[p27l640t943r784b1006],
25	at	IN	O	at	_	0	SENT_422	[p27l803t955r860b1006],
26	presentation	NN	O	presentation	prep_at	20	SENT_422	[p27l877t949r1308b1026],
27	,	,	O	,	_	0	SENT_422	[p27l877t949r1308b1026],
28	especially	RB	O	especially	advmod	20	SENT_422	[p27l1329t943r1650b1027],
29	with	IN	O	with	_	0	SENT_422	[p27l1663t943r1812b1006],
30	respect	NN	O	respect	prep_with	20	SENT_422	[p27l1831t955r2066b1026],
31	to	TO	O	to	_	0	SENT_422	[p27l2083t955r2147b1006],
32	the	DT	O	the	det	34	SENT_422	[p27l9t1046r113b1109],
33	clinical	JJ	O	clinical	amod	34	SENT_422	[p27l133t1046r372b1109],
34	attack	NN	O	attack	prep_to	20	SENT_422	[p27l391t1046r603b1109],
35	.	.	O	.	_	0	SENT_422	[p27l391t1046r603b1109],

1	In	IN	O	in	_	0	SENT_423	[p27l627t1051r696b1108],
2	addition	NN	O	addition	prep_in	10	SENT_423	[p27l716t1046r1014b1118],
3	,	,	O	,	_	0	SENT_423	[p27l716t1046r1014b1118],
4	primary	JJ	O	primary	amod	7	SENT_423	[p27l1034t1052r1311b1130],
5	progressive	JJ	O	progressive	amod	7	SENT_423	[p27l1326t1052r1703b1130],
6	pediatric	JJ	O	pediatric	amod	7	SENT_423	[p27l1721t1046r2020b1129],
7	MS	NN	O	m	nsubj	10	SENT_423	[p27l2038t1050r2150b1109],
8	is	VBZ	O	be	cop	10	SENT_423	[p27l10t1155r60b1212],
9	very	RB	O	very	advmod	10	SENT_423	[p27l80t1172r234b1233],
10	infrequent	JJ	O	infrequent	_	0	SENT_423	[p27l253t1149r615b1232],
11	and	CC	O	and	_	0	SENT_423	[p27l637t1149r764b1212],
12	unusual	JJ	O	unusual	conj_and	10	SENT_423	[p27l785t1149r1074b1212],
13	.	.	O	.	_	0	SENT_423	[p27l785t1149r1074b1212],

1	Anecdotally	RB	O	anecdotally	advmod	5	SENT_424	[p27l1099t1149r1528b1233],
2	,	,	O	,	_	0	SENT_424	[p27l1099t1149r1528b1233],
3	pediatric	JJ	O	pediatric	amod	4	SENT_424	[p27l1551t1149r1857b1232],
4	patients	NNS	O	patient	nsubj	5	SENT_424	[p27l1878t1155r2149b1232],
5	respond	VBP	O	respond	_	0	SENT_424	[p27l10t1252r283b1335],
6	well	RB	O	well	advmod	5	SENT_424	[p27l299t1252r434b1315],
7	to	TO	O	to	_	0	SENT_424	[p27l452t1264r517b1315],
8	interferon	NN	O	interferon	prep_to	5	SENT_424	[p27l537t1252r873b1315],
9	and	CC	O	and	_	0	SENT_424	[p27l893t1252r1017b1315],
10	GA	NN	O	ga	prep_to	5	SENT_424	[p27l1037t1256r1153b1315],
11	as	IN	O	as	_	0	SENT_424	[p27l1172t1275r1236b1315],
12	ﬁrst	NN	O	ﬁrst	nn	15	SENT_424	[p27l1255t1252r1540b1315],
13	—	CD	NUMBER	—	num	15	SENT_424	[p27l1255t1252r1540b1315],
14	line	NN	O	line	nn	15	SENT_424	[p27l1255t1252r1540b1315],
15	agents	NNS	O	agent	prep_as	8	SENT_424	[p27l1561t1264r1769b1336],
16	and	CC	O	and	_	0	SENT_424	[p27l1790t1252r1914b1315],
17	natalizumab	NN	O	natalizumab	prep_to	5	SENT_424	[p27l1932t1252r2145b1315, p27l10t1355r244b1418],
18	as	IN	O	as	_	0	SENT_424	[p27l270t1378r336b1418],
19	a	DT	O	a	det	21	SENT_424	[p27l362t1378r397b1418],
20	second-line	JJ	O	second-line	amod	21	SENT_424	[p27l421t1355r828b1418],
21	agent	NN	O	agent	prep_as	17	SENT_424	[p27l853t1367r1056b1439],
22	.	.	O	.	_	0	SENT_424	[p27l853t1367r1056b1439],

1	However	RB	O	however	advmod	9	SENT_425	[p27l1084t1360r1411b1427],
2	,	,	O	,	_	0	SENT_425	[p27l1084t1360r1411b1427],
3	none	NN	O	none	nsubjpass	9	SENT_425	[p27l1437t1378r1611b1418],
4	of	IN	O	of	_	0	SENT_425	[p27l1636t1355r1712b1418],
5	these	DT	O	these	det	6	SENT_425	[p27l1725t1355r1905b1418],
6	agents	NNS	O	agent	prep_of	3	SENT_425	[p27l1930t1367r2148b1439],
7	have	VBP	O	have	aux	9	SENT_425	[p27l9t1458r167b1521],
8	been	VBN	O	be	auxpass	9	SENT_425	[p27l189t1458r357b1521],
9	tested	VBN	O	test	_	0	SENT_425	[p27l379t1458r584b1521],
10	in	IN	O	in	_	0	SENT_425	[p27l606t1464r674b1520],
11	randomized	VBN	O	randomize	prepc_in	9	SENT_425	[p27l698t1458r1122b1521],
12	trials	NNS	O	trial	dobj	11	SENT_425	[p27l1144t1458r1318b1521],
13	with	IN	O	with	_	0	SENT_425	[p27l1340t1458r1497b1521],
14	pediatric	JJ	O	pediatric	amod	15	SENT_425	[p27l1518t1458r1831b1541],
15	patients	NNS	O	patient	prep_with	12	SENT_425	[p27l1852t1464r2147b1541],
16	,	,	O	,	_	0	SENT_425	[p27l1852t1464r2147b1541],
17	despite	IN	O	despite	_	0	SENT_425	[p27l10t1561r255b1644],
18	a	DT	O	a	det	19	SENT_425	[p27l281t1584r316b1624],
19	Food	NNP	ORGANIZATION	Food	prep_despite	11	SENT_425	[p27l340t1561r520b1624],
20	and	CC	ORGANIZATION	and	_	0	SENT_425	[p27l545t1561r674b1624],
21	Drug	NNP	ORGANIZATION	Drug	nn	22	SENT_425	[p27l698t1566r883b1645],
22	Administration	NNP	ORGANIZATION	Administration	nsubj	23	SENT_425	[p27l905t1561r1451b1624],
23	mandate	VB	O	mandate	conj_and	9	SENT_425	[p27l1476t1561r1780b1624],
24	to	TO	O	to	aux	25	SENT_425	[p27l1803t1573r1870b1624],
25	test	VB	O	test	xcomp	23	SENT_425	[p27l1895t1573r2017b1624],
26	the	DT	O	the	det	27	SENT_425	[p27l2039t1561r2149b1624],
27	effectiveness	NN	O	effectiveness	dobj	25	SENT_425	[p27l10t1664r433b1727],
28	of	IN	O	of	_	0	SENT_425	[p27l456t1664r529b1727],
29	adult-onset	JJ	O	adult-onset	amod	31	SENT_425	[p27l542t1664r928b1727],
30	MS	NN	O	m	nn	31	SENT_425	[p27l948t1668r1061b1727],
31	drugs	NNS	O	drug	prep_of	27	SENT_425	[p27l1085t1664r1275b1748],
32	in	IN	O	in	_	0	SENT_425	[p27l1298t1670r1364b1726],
33	pediatric-onset	NN	O	pediatric-onset	nn	34	SENT_425	[p27l1384t1664r1902b1747],
34	MS.	NNP	O	MS.	prep_in	25	SENT_425	[p27l1923t1668r2053b1727],
35	In	IN	O	in	_	0	SENT_425	[p27l2079t1669r2149b1726],
36	addition	NN	O	addition	prep_in	9	SENT_425	[p27l10t1767r312b1839],
37	,	,	O	,	_	0	SENT_425	[p27l10t1767r312b1839],
38	severe	JJ	O	severe	amod	39	SENT_425	[p27l335t1790r542b1830],
39	attacks	NNS	O	attack	nsubj	45	SENT_425	[p27l562t1767r792b1830],
40	not	RB	O	not	neg	41	SENT_425	[p27l812t1779r926b1830],
41	responding	VBG	O	respond	partmod	39	SENT_425	[p27l944t1767r1329b1851],
42	to	TO	O	to	_	0	SENT_425	[p27l1347t1779r1412b1830],
43	intravenous	JJ	O	intravenous	amod	44	SENT_425	[p27l1433t1773r1832b1830],
44	corticosteroids	NNS	O	corticosteroid	prep_to	41	SENT_425	[p27l1853t1773r2148b1830, p27l9t1870r238b1933],
45	respond	VBP	O	respond	ccomp	9	SENT_425	[p27l259t1870r533b1953],
46	to	TO	O	to	_	0	SENT_425	[p27l551t1882r616b1933],
47	PLEX	NN	O	plex	prep_to	45	SENT_425	[p27l637t1875r833b1932],
48	with	IN	O	with	_	0	SENT_425	[p27l849t1870r1000b1933],
49	a	DT	O	a	det	50	SENT_425	[p27l1020t1893r1055b1933],
50	frequency	NN	O	frequency	prep_with	45	SENT_425	[p27l1073t1870r1413b1954],
51	similar	JJ	O	similar	amod	50	SENT_425	[p27l1430t1870r1663b1933],
52	to	TO	O	to	_	0	SENT_425	[p27l1681t1882r1746b1933],
53	that	DT	O	that	prep_to	51	SENT_425	[p27l1766t1870r1898b1933],
54	seen	VBN	O	see	partmod	53	SENT_425	[p27l1917t1893r2064b1933],
55	in	IN	O	in	_	0	SENT_425	[p27l2084t1876r2150b1932],
56	adult	JJ	O	adult	amod	57	SENT_425	[p27l10t1973r182b2036],
57	patients	NNS	O	patient	prep_in	54	SENT_425	[p27l200t1979r484b2056],
58	.	.	O	.	_	0	SENT_425	[p27l200t1979r484b2056],

1	IVIG	NNP	ORGANIZATION	IVIG	nsubjpass	4	SENT_426	[p27l509t1977r684b2036],
2	is	VBZ	O	be	auxpass	4	SENT_426	[p27l705t1979r755b2036],
3	sometimes	RB	O	sometimes	advmod	4	SENT_426	[p27l777t1979r1141b2036],
4	used	VBN	O	use	_	0	SENT_426	[p27l1162t1973r1320b2036],
5	in	IN	O	in	_	0	SENT_426	[p27l1340t1979r1406b2035],
6	this	DT	O	this	det	7	SENT_426	[p27l1426t1973r1549b2036],
7	situation	NN	O	situation	prep_in	4	SENT_426	[p27l1571t1979r1866b2036],
8	of	IN	O	of	_	0	SENT_426	[p27l1888t1973r1961b2036],
9	acute	JJ	O	acute	prep_of	7	SENT_426	[p27l1973t1985r2150b2036],

1	42	CD	NUMBER	42	num	2	SENT_427	[p27l8t2193r72b2234],
2	relapses	NNS	O	relapse	_	0	SENT_427	[p27l10t2275r266b2358],
3	in	IN	O	in	_	0	SENT_427	[p27l285t2281r350b2337],
4	pediatric	JJ	O	pediatric	amod	5	SENT_427	[p27l367t2275r660b2358],
5	patients	NNS	O	patient	prep_in	2	SENT_427	[p27l678t2281r936b2358],
6	without	IN	O	without	_	0	SENT_427	[p27l953t2275r1211b2338],
7	evidence	NN	O	evidence	prep_without	2	SENT_427	[p27l1229t2275r1517b2338],
8	of	IN	O	of	_	0	SENT_427	[p27l1536t2275r1608b2338],
9	efficacy	NN	O	efficacy	prep_of	2	SENT_427	[p27l1618t2275r1872b2359],
10	.	.	O	.	_	0	SENT_427	[p27l1618t2275r1872b2359],

1	Further	JJ	O	further	amod	2	SENT_428	[p27l1894t2275r2146b2338],
2	studies	NNS	O	study	nsubj	7	SENT_428	[p27l10t2378r237b2441],
3	in	IN	O	in	_	0	SENT_428	[p27l257t2384r321b2440],
4	pediatric-onset	NN	O	pediatric-onset	nn	5	SENT_428	[p27l340t2378r844b2461],
5	MS	NN	O	m	prep_in	2	SENT_428	[p27l862t2382r972b2441],
6	may	MD	O	may	aux	7	SENT_428	[p27l993t2401r1136b2462],
7	provide	VB	O	provide	_	0	SENT_428	[p27l1150t2378r1403b2461],
8	important	JJ	O	important	amod	9	SENT_428	[p27l1422t2384r1759b2461],
9	clues	NNS	O	clue	dobj	7	SENT_428	[p27l1777t2378r1938b2441],
10	to	TO	O	to	_	0	SENT_428	[p27l1957t2390r2021b2441],
11	the	DT	O	the	det	12	SENT_428	[p27l2040t2378r2144b2441],
12	pathogenesis	NN	O	pathogenesis	prep_to	7	SENT_428	[p27l8t2481r445b2565],
13	of	IN	O	of	_	0	SENT_428	[p27l467t2481r540b2544],
14	adult-onset	JJ	O	adult-onset	amod	15	SENT_428	[p27l552t2481r936b2544],
15	MS.	NNP	O	MS.	prep_of	12	SENT_428	[p27l955t2485r1085b2544],

1	CONCLUSION	NN	O	conclusion	nsubj	28	SENT_429	[p27l10t2695r486b2751],
2	Over	IN	O	over	_	0	SENT_429	[p27l11t2795r185b2854],
3	the	DT	DURATION	the	det	6	SENT_429	[p27l207t2791r316b2854],
4	past	JJ	DURATION	past	amod	6	SENT_429	[p27l338t2803r481b2874],
5	three	CD	DURATION	three	num	6	SENT_429	[p27l503t2791r682b2854],
6	decades	NNS	DURATION	decade	prep_over	12	SENT_429	[p27l707t2791r1000b2863],
7	,	,	O	,	_	0	SENT_429	[p27l707t2791r1000b2863],
8	effective	JJ	O	effective	amod	9	SENT_429	[p27l1026t2791r1313b2854],
9	strategies	NNS	O	strategy	nsubj	12	SENT_429	[p27l1338t2797r1663b2875],
10	have	VBP	O	have	aux	12	SENT_429	[p27l1687t2791r1846b2854],
11	become	VBN	O	become	cop	12	SENT_429	[p27l1868t2791r2141b2854],
12	available	JJ	O	available	rcmod	1	SENT_429	[p27l10t2894r303b2957],
13	to	TO	O	to	aux	14	SENT_429	[p27l324t2906r390b2957],
14	treat	VB	O	treat	dep	12	SENT_429	[p27l412t2906r568b2957],
15	MS	NN	O	m	nn	16	SENT_429	[p27l588t2898r701b2957],
16	attacks	NNS	O	attack	dobj	14	SENT_429	[p27l725t2894r957b2957],
17	and	CC	O	and	_	0	SENT_429	[p27l980t2894r1106b2957],
18	to	TO	O	to	aux	19	SENT_429	[p27l1125t2906r1191b2957],
19	address	VB	O	address	conj_and	14	SENT_429	[p27l1215t2894r1469b2957],
20	the	DT	O	the	det	22	SENT_429	[p27l1490t2894r1597b2957],
21	relapsing	NN	O	relapsing	nn	22	SENT_429	[p27l1619t2894r1929b2978],
22	phase	NN	O	phase	dobj	19	SENT_429	[p27l1948t2894r2143b2977],
23	of	IN	O	of	_	0	SENT_429	[p27l10t2997r84b3060],
24	MS.	NNP	O	MS.	nn	25	SENT_429	[p27l95t3001r226b3060],
25	DMAS	NNP	O	DMAS	prep_of	22	SENT_429	[p27l250t3001r474b3060],
26	can	MD	O	can	aux	28	SENT_429	[p27l496t3020r613b3060],
27	meaningfully	RB	O	meaningfully	advmod	28	SENT_429	[p27l634t2997r1092b3081],
28	reduce	VB	O	reduce	_	0	SENT_429	[p27l1110t2997r1337b3060],
29	the	DT	O	the	det	31	SENT_429	[p27l1358t2997r1464b3060],
30	relapse	NN	O	relapse	nn	31	SENT_429	[p27l1485t2997r1721b3080],
31	rate	NN	O	rate	dobj	28	SENT_429	[p27l1742t3009r1869b3060],
32	and	CC	O	and	_	0	SENT_429	[p27l1891t2997r2017b3060],
33	the	DT	O	the	det	34	SENT_429	[p27l2036t2997r2142b3060],
34	frequency	NN	O	frequency	dobj	28	SENT_429	[p27l9t3100r354b3184],
35	of	IN	O	of	_	0	SENT_429	[p27l374t3100r447b3163],
36	new	JJ	O	new	amod	38	SENT_429	[p27l460t3123r603b3163],
37	lesion	NN	O	lesion	nn	38	SENT_429	[p27l621t3100r822b3163],
38	formation	NN	O	formation	prep_of	34	SENT_429	[p27l845t3100r1205b3163],
39	.	.	O	.	_	0	SENT_429	[p27l845t3100r1205b3163],

1	Unfortunately	RB	O	unfortunately	advmod	5	SENT_430	[p27l1231t3100r1724b3184],
2	,	,	O	,	_	0	SENT_430	[p27l1231t3100r1724b3184],
3	it	PRP	O	it	nsubj	5	SENT_430	[p27l1749t3106r1795b3163],
4	is	VBZ	O	be	cop	5	SENT_430	[p27l1816t3106r1866b3163],
5	unclear	JJ	O	unclear	_	0	SENT_430	[p27l1889t3100r2144b3163],
6	whether	IN	O	whether	complm	8	SENT_430	[p27l8t3203r295b3266],
7	DMAs	NNS	MISC	dma	nsubj	10	SENT_430	[p27l318t3207r545b3266],
8	prevent	VBP	O	prevent	ccomp	5	SENT_430	[p27l568t3215r832b3286],
9	or	CC	O	or	_	0	SENT_430	[p27l855t3226r928b3266],
10	postpone	VBP	O	postpone	ccomp	5	SENT_430	[p27l948t3215r1271b3286],
11	the	DT	O	the	det	12	SENT_430	[p27l1293t3203r1401b3266],
12	onset	NN	O	onset	dobj	8	SENT_430	[p27l1425t3215r1610b3266],
13	of	IN	O	of	_	0	SENT_430	[p27l1633t3203r1708b3266],
14	the	DT	O	the	det	16	SENT_430	[p27l1721t3203r1829b3266],
15	progressive	JJ	O	progressive	amod	16	SENT_430	[p27l1851t3225r2141b3287, p27l10t3312r133b3369],
16	phase	NN	O	phase	prep_of	12	SENT_430	[p27l152t3306r360b3389],
17	,	,	O	,	_	0	SENT_430	[p27l152t3306r360b3389],
18	with	IN	O	with	ccomp	5	SENT_430	[p27l380t3306r530b3369],
19	most	JJS	O	most	amod	20	SENT_430	[p27l549t3318r716b3369],
20	data	NNS	O	datum	nsubj	21	SENT_430	[p27l736t3306r877b3369],
21	indicating	VBG	O	indicate	pcomp	18	SENT_430	[p27l895t3306r1236b3390],
22	that	IN	O	that	complm	27	SENT_430	[p27l1253t3306r1384b3369],
23	the	DT	O	the	det	26	SENT_430	[p27l1401t3306r1506b3369],
24	currently	RB	DATE	currently	advmod	25	SENT_430	[p27l1527t3306r1837b3390],
25	available	JJ	O	available	amod	26	SENT_430	[p27l1853t3306r2141b3369],
26	approaches	NNS	O	approach	nsubj	27	SENT_430	[p27l10t3409r408b3492],
27	fail	VBP	O	fail	ccomp	21	SENT_430	[p27l434t3409r543b3472],
28	in	IN	O	in	_	0	SENT_430	[p27l569t3415r637b3471],
29	this	DT	O	this	det	30	SENT_430	[p27l662t3409r791b3472],
30	area	NN	O	area	prep_in	27	SENT_430	[p27l818t3432r979b3472],
31	.	.	O	.	_	0	SENT_430	[p27l818t3432r979b3472],

1	In	IN	O	in	_	0	SENT_431	[p27l1008t3414r1081b3471],
2	addition	NN	O	addition	prep_in	9	SENT_431	[p27l1108t3409r1425b3481],
3	,	,	O	,	_	0	SENT_431	[p27l1108t3409r1425b3481],
4	none	NN	O	none	nsubj	9	SENT_431	[p27l1452t3432r1628b3472],
5	of	IN	O	of	_	0	SENT_431	[p27l1654t3409r1730b3472],
6	the	DT	O	the	det	8	SENT_431	[p27l1744t3409r1855b3472],
7	current	JJ	DATE	current	amod	8	SENT_431	[p27l1881t3421r2143b3472],
8	DMAs	NNS	MISC	dma	prep_of	4	SENT_431	[p27l10t3516r242b3575],
9	work	VBP	O	work	_	0	SENT_431	[p27l268t3512r453b3575],
10	in	IN	O	in	_	0	SENT_431	[p27l478t3518r546b3574],
11	the	DT	O	the	det	15	SENT_431	[p27l573t3512r684b3575],
12	“	CD	NUMBER	“	num	15	SENT_431	[p27l713t3512r999b3595],
13	purest	JJS	O	purest	amod	15	SENT_431	[p27l713t3512r999b3595],
14	”	JJ	O	”	amod	15	SENT_431	[p27l713t3512r999b3595],
15	forms	NNS	O	form	prep_in	9	SENT_431	[p27l1029t3512r1236b3575],
16	of	IN	O	of	_	0	SENT_431	[p27l1264t3512r1341b3575],
17	progression	NN	O	progression	prep_of	15	SENT_431	[p27l1358t3518r1799b3596],
18	,	,	O	,	_	0	SENT_431	[p27l1358t3518r1799b3596],
19	in	IN	O	in	_	0	SENT_431	[p27l1828t3518r1897b3574],
20	which	WDT	O	which	rel	24	SENT_431	[p27l1923t3512r2142b3575],
21	relapses	NNS	O	relapse	nsubj	24	SENT_431	[p27l10t3615r275b3698],
22	do	VBP	O	do	aux	24	SENT_431	[p27l297t3615r380b3678],
23	not	RB	O	not	neg	24	SENT_431	[p27l402t3627r515b3678],
24	occur	VB	O	occur	rcmod	17	SENT_431	[p27l535t3638r737b3678],
25	.	.	O	.	_	0	SENT_431	[p27l535t3638r737b3678],

1	Most	JJS	O	most	nsubj	7	SENT_432	[p27l760t3620r933b3678],
2	of	IN	O	of	_	0	SENT_432	[p27l953t3615r1026b3678],
3	the	DT	O	the	det	5	SENT_432	[p27l1036t3615r1142b3678],
4	upcoming	VBG	O	upcome	amod	5	SENT_432	[p27l1162t3621r1510b3699],
5	drugs	NNS	O	drug	prep_of	1	SENT_432	[p27l1529t3615r1720b3699],
6	still	RB	O	still	advmod	7	SENT_432	[p27l1741t3615r1862b3678],
7	attempt	VBP	O	attempt	_	0	SENT_432	[p27l1883t3627r2142b3698],
8	to	TO	O	to	aux	9	SENT_432	[p27l8t3730r76b3781],
9	address	VB	O	address	xcomp	7	SENT_432	[p27l101t3718r362b3781],
10	the	DT	O	the	det	12	SENT_432	[p27l385t3718r494b3781],
11	relapsing	NN	O	relapsing	nn	12	SENT_432	[p27l518t3718r836b3802],
12	phase	NN	O	phase	dobj	9	SENT_432	[p27l857t3718r1056b3801],
13	and	CC	O	and	_	0	SENT_432	[p27l1081t3718r1209b3781],
14	the	DT	O	the	det	15	SENT_432	[p27l1231t3718r1339b3781],
15	episodes	NNS	O	episode	dobj	9	SENT_432	[p27l1364t3718r1661b3801],
16	of	IN	O	of	_	0	SENT_432	[p27l1686t3718r1761b3781],
17	inﬂammatory	JJ	O	inﬂammatory	prep_of	15	SENT_432	[p27l1775t3718r2141b3781, p28l8t28r154b100],

1	demyelination	NN	O	demyelination	_	0	SENT_433	[p28l175t16r672b100],
2	leading	VBG	O	lead	partmod	1	SENT_433	[p28l694t16r950b100],
3	to	TO	O	to	_	0	SENT_433	[p28l970t28r1037b79],
4	blood	NN	O	blood	nn	8	SENT_433	[p28l1059t16r1492b79],
5	—	NN	O	—	nn	8	SENT_433	[p28l1059t16r1492b79],
6	brain	NN	O	brain	nn	8	SENT_433	[p28l1059t16r1492b79],
7	barrier	NN	O	barrier	nn	8	SENT_433	[p28l1513t16r1754b79],
8	disruption	NN	O	disruption	prep_to	2	SENT_433	[p28l1777t16r2141b99],
9	and	CC	O	and	_	0	SENT_433	[p28l10t119r141b182],
10	new	JJ	O	new	amod	12	SENT_433	[p28l166t142r314b182],
11	lesion	NN	O	lesion	nn	12	SENT_433	[p28l336t119r547b182],
12	formation	NN	O	formation	prep_to	2	SENT_433	[p28l574t119r951b182],
13	.	.	O	.	_	0	SENT_433	[p28l574t119r951b182],

1	To	TO	O	to	aux	2	SENT_434	[p28l980t122r1067b182],
2	have	VB	O	have	purpcl	13	SENT_434	[p28l1094t119r1255b182],
3	a	DT	O	a	det	5	SENT_434	[p28l1283t142r1318b182],
4	meaningful	JJ	O	meaningful	amod	5	SENT_434	[p28l1344t119r1755b203],
5	impact	NN	O	impact	dobj	2	SENT_434	[p28l1781t125r2028b202],
6	on	IN	O	on	_	0	SENT_434	[p28l2054t142r2143b182],
7	MS	NN	O	m	nn	10	SENT_434	[p28l9t222r388b285],
8	—	NN	O	—	nn	10	SENT_434	[p28l9t222r388b285],
9	related	JJ	O	related	amod	10	SENT_434	[p28l9t222r388b285],
10	disability	NN	O	disability	prep_on	5	SENT_434	[p28l408t222r728b306],
11	,	,	O	,	_	0	SENT_434	[p28l408t222r728b306],
12	we	PRP	O	we	nsubj	13	SENT_434	[p28l748t245r841b285],
13	need	VBP	O	need	_	0	SENT_434	[p28l861t222r1024b285],
14	to	TO	O	to	aux	15	SENT_434	[p28l1043t234r1108b285],
15	develop	VB	O	develop	xcomp	13	SENT_434	[p28l1131t222r1392b305],
16	new	JJ	O	new	amod	18	SENT_434	[p28l1414t245r1556b285],
17	treatment	NN	O	treatment	nn	18	SENT_434	[p28l1572t234r1906b285],
18	strategies	NNS	O	strategy	dobj	15	SENT_434	[p28l1927t234r2137b285, p28l9t331r138b409],
19	to	TO	O	to	aux	20	SENT_434	[p28l160t337r226b388],
20	address	VB	O	address	xcomp	15	SENT_434	[p28l251t325r507b388],
21	tissue	NN	O	tissue	nn	22	SENT_434	[p28l529t331r722b388],
22	repair	NN	O	repair	dobj	20	SENT_434	[p28l745t331r960b408],
23	,	,	O	,	_	0	SENT_434	[p28l745t331r960b408],
24	including	VBG	O	include	_	0	SENT_434	[p28l985t325r1313b409],
25	remyelination	NN	O	remyelination	prep_including	15	SENT_434	[p28l1334t325r1831b409],
26	,	,	O	,	_	0	SENT_434	[p28l1334t325r1831b409],
27	and	CC	O	and	_	0	SENT_434	[p28l1856t325r1983b388],
28	prevention	NN	O	prevention	conj_and	25	SENT_434	[p28l2003t347r2141b408, p28l7t434r262b491],
29	or	CC	O	or	_	0	SENT_434	[p28l283t451r353b491],
30	restoration	NN	O	restoration	conj_or	28	SENT_434	[p28l372t434r736b491],
31	of	IN	O	of	_	0	SENT_434	[p28l757t428r829b491],
32	axonal	JJ	O	axonal	amod	35	SENT_434	[p28l840t428r1060b491],
33	and	CC	O	and	_	0	SENT_434	[p28l1080t428r1204b491],
34	neuronal	JJ	O	neuronal	conj_and	32	SENT_434	[p28l1222t428r1524b491],
35	loss	NN	O	loss	prep_of	28	SENT_434	[p28l1542t428r1682b491],
36	.	.	O	.	_	0	SENT_434	[p28l1542t428r1682b491],

1	One	CD	NUMBER	one	num	2	SENT_435	[p28l1706t432r1846b491],
2	example	NN	O	example	nsubj	9	SENT_435	[p28l1867t428r2144b511],
3	of	IN	O	of	_	0	SENT_435	[p28l10t531r85b594],
4	these	DT	O	these	det	6	SENT_435	[p28l98t531r278b594],
5	upcoming	JJ	O	upcoming	amod	6	SENT_435	[p28l302t537r660b615],
6	strategies	NNS	O	strategy	prep_of	2	SENT_435	[p28l683t537r1008b615],
7	is	VBZ	O	be	cop	9	SENT_435	[p28l1032t537r1083b594],
8	the	DT	O	the	det	9	SENT_435	[p28l1107t531r1216b594],
9	use	NN	O	use	_	0	SENT_435	[p28l1239t554r1353b594],
10	of	IN	O	of	_	0	SENT_435	[p28l1377t531r1453b594],
11	remyelination	NN	O	remyelination	prep_of	9	SENT_435	[p28l1467t531r2139b615],
12	—	CD	NUMBER	—	num	16	SENT_435	[p28l1467t531r2139b615],
13	pro	JJ	O	pro	amod	16	SENT_435	[p28l1467t531r2139b615],
14	—	NN	O	—	nn	16	SENT_435	[p28l1467t531r2139b615],
15	moting	NN	O	moting	nn	16	SENT_435	[p28l9t640r265b718],
16	antibodies	NNS	O	antibody	dep	11	SENT_435	[p28l289t634r674b706],
17	,	,	O	,	_	0	SENT_435	[p28l289t634r674b706],
18	such	JJ	O	such	_	0	SENT_435	[p28l701t634r860b697],
19	as	IN	O	as	_	0	SENT_435	[p28l885t657r951b697],
20	rHIgM22	NN	O	rhigm22	prep_such_as	11	SENT_435	[p28l976t639r1327b718],
21	,	,	O	,	_	0	SENT_435	[p28l976t639r1327b718],
22	which	WDT	O	which	nsubj	23	SENT_435	[p28l1351t634r1566b697],
23	is	VBZ	O	be	rcmod	20	SENT_435	[p28l1591t640r1642b697],
24	currently	RB	DATE	currently	advmod	23	SENT_435	[p28l1668t634r1994b718],
25	in	IN	O	in	_	0	SENT_435	[p28l2015t640r2083b696],
26	a	DT	O	a	det	27	SENT_435	[p28l2108t657r2144b697],
27	phase	NN	O	phase	prep_in	23	SENT_435	[p28l8t737r208b820],
28	I	PRP	O	I	dep	29	SENT_435	[p28l234t742r258b799],
29	trial	NN	O	trial	dep	27	SENT_435	[p28l282t737r445b800],
30	.	.	O	.	_	0	SENT_435	[p28l282t737r445b800],

1	Overall	RB	O	overall	advmod	10	SENT_436	[p28l473t737r751b809],
2	,	,	O	,	_	0	SENT_436	[p28l473t737r751b809],
3	the	DT	O	the	det	5	SENT_436	[p28l776t737r885b800],
4	progressive	JJ	O	progressive	amod	5	SENT_436	[p28l909t743r1308b821],
5	stage	NN	O	stage	nsubj	10	SENT_436	[p28l1334t749r1506b821],
6	remains	VBZ	O	remain	cop	10	SENT_436	[p28l1531t743r1812b800],
7	the	DT	O	the	det	10	SENT_436	[p28l1836t737r1945b800],
8	most	RBS	O	most	advmod	9	SENT_436	[p28l1969t749r2144b800],
9	uniformly	RB	O	uniformly	advmod	10	SENT_436	[p28l9t840r363b924],
10	disabling	VBG	O	disable	_	0	SENT_436	[p28l383t840r698b924],
11	and	CC	O	and	_	0	SENT_436	[p28l720t840r848b903],
12	frustrating	VBG	O	frustrate	amod	13	SENT_436	[p28l870t840r1242b924],
13	aspect	NN	O	aspect	conj_and	10	SENT_436	[p28l1264t852r1479b923],
14	of	IN	O	of	_	0	SENT_436	[p28l1502t840r1576b903],
15	MS	NN	O	m	prep_of	13	SENT_436	[p28l1589t844r1723b912],
16	,	,	O	,	_	0	SENT_436	[p28l1589t844r1723b912],
17	for	IN	O	for	_	0	SENT_436	[p28l1748t840r1847b903],
18	patients	NNS	O	patient	prep_for	13	SENT_436	[p28l1868t846r2141b923],
19	and	CC	O	and	_	0	SENT_436	[p28l10t943r136b1006],
20	physicians	NNS	O	physician	conj_and	18	SENT_436	[p28l153t943r506b1027],
21	alike	RB	O	alike	advmod	18	SENT_436	[p28l528t943r701b1006],
22	.	.	O	.	_	0	SENT_436	[p28l528t943r701b1006],

1	What	WP	O	what	nsubjpass	3	SENT_437	[p28l723t943r912b1006],
2	is	VBZ	O	be	auxpass	3	SENT_437	[p28l931t949r981b1006],
3	needed	VBN	O	need	_	0	SENT_437	[p28l1001t943r1247b1006],
4	in	IN	O	in	_	0	SENT_437	[p28l1266t949r1332b1005],
5	preclinical	JJ	O	preclinical	amod	7	SENT_437	[p28l1351t943r1708b1026],
6	MS	NN	O	m	nn	7	SENT_437	[p28l1727t947r1839b1006],
7	research	NN	O	research	prep_in	3	SENT_437	[p28l1861t943r2143b1006],
8	to	TO	O	to	aux	9	SENT_437	[p28l8t1058r74b1109],
9	address	VB	O	address	xcomp	3	SENT_437	[p28l99t1046r355b1109],
10	this	DT	O	this	det	12	SENT_437	[p28l378t1046r503b1109],
11	disease	NN	O	disease	nn	12	SENT_437	[p28l527t1046r769b1109],
12	stage	NN	O	stage	nsubj	16	SENT_437	[p28l793t1058r961b1130],
13	is	VBZ	O	be	cop	16	SENT_437	[p28l984t1052r1035b1109],
14	a	DT	O	a	det	16	SENT_437	[p28l1059t1069r1094b1109],
15	paradigm	NN	O	paradigm	nn	16	SENT_437	[p28l1114t1046r1447b1130],
16	shift	NN	O	shift	ccomp	9	SENT_437	[p28l1471t1046r1619b1109],
17	that	WDT	O	that	nsubj	20	SENT_437	[p28l1640t1046r1774b1109],
18	will	MD	O	will	aux	20	SENT_437	[p28l1794t1046r1920b1109],
19	hopefully	RB	O	hopefully	advmod	20	SENT_437	[p28l1941t1046r2139b1129, p28l9t1149r168b1233],
20	lead	VB	O	lead	rcmod	16	SENT_437	[p28l186t1149r330b1212],
21	to	TO	O	to	_	0	SENT_437	[p28l352t1161r419b1212],
22	novel	JJ	O	novel	amod	23	SENT_437	[p28l443t1149r631b1212],
23	approaches	NNS	O	approach	prep_to	20	SENT_437	[p28l654t1149r1045b1232],
24	to	TO	O	to	aux	25	SENT_437	[p28l1068t1161r1135b1212],
25	address	VB	O	address	xcomp	20	SENT_437	[p28l1161t1149r1420b1212],
26	the	DT	O	the	det	28	SENT_437	[p28l1444t1149r1552b1212],
27	true	JJ	O	true	amod	28	SENT_437	[p28l1574t1161r1717b1212],
28	substrate	NN	O	substrate	dobj	25	SENT_437	[p28l1741t1149r2052b1212],
29	of	IN	O	of	_	0	SENT_437	[p28l2076t1149r2152b1212],
30	disability	NN	O	disability	prep_of	28	SENT_437	[p28l10t1252r323b1336],
31	in	IN	O	in	_	0	SENT_437	[p28l342t1258r408b1314],
32	MS.	NNP	O	MS.	prep_in	25	SENT_437	[p28l429t1256r560b1315],

1	ACKNOWLEDGMENTS	NNS	O	acknowledgment	nsubj	3	SENT_438	[p28l9t1430r690b1479],
2	M.R.	NNP	O	M.R.	dep	1	SENT_438	[p28l11t1516r125b1564],
3	receives	VBZ	O	receive	_	0	SENT_438	[p28l143t1516r366b1564],
4	support	NN	O	support	dobj	3	SENT_438	[p28l382t1521r605b1577],
5	from	IN	O	from	_	0	SENT_438	[p28l618t1513r750b1564],
6	the	DT	O	the	det	16	SENT_438	[p28l766t1514r858b1564],
7	National	NNP	ORGANIZATION	National	dep	16	SENT_438	[p28l876t1514r1108b1564],
8	Institutes	NNPS	ORGANIZATION	Institutes	dep	7	SENT_438	[p28l1129t1516r1385b1564],
9	of	IN	ORGANIZATION	of	_	0	SENT_438	[p28l1401t1513r1460b1564],
10	Neurological	JJ	ORGANIZATION	neurological	amod	11	SENT_438	[p28l1473t1514r1826b1577],
11	Disorders	NNS	ORGANIZATION	disorder	prep_of	7	SENT_438	[p28l1847t1514r2110b1564],
12	and	CC	O	and	_	0	SENT_438	[p28l9t1598r112b1648],
13	Stroke	NNP	O	Stroke	conj_and	11	SENT_438	[p28l131t1598r308b1648],
14	(	CD	NUMBER	(	num	13	SENT_438	[p28l325t1599r558b1656],
15	NINDS	NN	ORGANIZATION	nind	nn	16	SENT_438	[p28l325t1599r558b1656],
16	)	NN	O	)	prep_from	3	SENT_438	[p28l325t1599r558b1656],
17	;	:	O	;	_	0	SENT_438	[p28l325t1599r558b1656],
18	from	IN	O	from	_	0	SENT_438	[p28l572t1597r703b1648],
19	the	DT	O	the	det	26	SENT_438	[p28l719t1598r812b1648],
20	Mayo	NNP	ORGANIZATION	Mayo	nn	26	SENT_438	[p28l828t1600r980b1662],
21	Clinic	NNP	ORGANIZATION	Clinic	nn	26	SENT_438	[p28l995t1598r1148b1648],
22	Center	NNP	ORGANIZATION	Center	nn	26	SENT_438	[p28l1163t1600r1350b1648],
23	forTranslationa	NNP	O	forTranslationa	nn	26	SENT_438	[p28l1362t1597r1807b1648],
24	|	NNP	O	|	nn	26	SENT_438	[p28l1362t1597r1807b1648],
25	Science	NNP	O	Science	nn	26	SENT_438	[p28l1825t1600r2038b1648],
26	Activities	NNPS	O	Activities	prep_from	3	SENT_438	[p28l9t1686r279b1741],
27	;	:	O	;	_	0	SENT_438	[p28l9t1686r279b1741],
28	the	DT	O	the	det	33	SENT_438	[p28l293t1683r385b1734],
29	National	NNP	ORGANIZATION	National	nn	33	SENT_438	[p28l403t1683r634b1734],
30	Centerfor	NNP	ORGANIZATION	Centerfor	nn	33	SENT_438	[p28l652t1683r930b1734],
31	Advancing	VBG	ORGANIZATION	advance	amod	33	SENT_438	[p28l943t1683r1243b1747],
32	Translational	JJ	ORGANIZATION	translational	amod	33	SENT_438	[p28l1256t1683r1614b1734],
33	Science	NN	ORGANIZATION	science	dep	3	SENT_438	[p28l1632t1685r1845b1734],
34	(	CD	NUMBER	(	num	35	SENT_438	[p28l1863t1684r2098b1741],
35	NCATS	NNS	O	ncat	nsubj	70	SENT_438	[p28l1863t1684r2098b1741],
36	)	CD	NUMBER	)	dep	35	SENT_438	[p28l1863t1684r2098b1741],
37	,	,	O	,	_	0	SENT_438	[p28l1863t1684r2098b1741],
38	a	DT	O	a	det	39	SENT_438	[p28l9t1783r36b1819],
39	component	NN	O	component	nsubj	70	SENT_438	[p28l54t1776r385b1832],
40	of	IN	O	of	_	0	SENT_438	[p28l399t1768r458b1819],
41	the	DT	O	the	det	43	SENT_438	[p28l467t1769r559b1819],
42	National	NNP	ORGANIZATION	National	nn	43	SENT_438	[p28l577t1769r808b1819],
43	Institutes	NNPS	ORGANIZATION	Institutes	prep_of	39	SENT_438	[p28l829t1771r1086b1819],
44	of	IN	ORGANIZATION	of	_	0	SENT_438	[p28l1102t1768r1160b1819],
45	Health	NNP	ORGANIZATION	Health	prep_of	39	SENT_438	[p28l1173t1769r1369b1826],
46	;	:	O	;	_	0	SENT_438	[p28l1173t1769r1369b1826],
47	the	DT	O	the	det	50	SENT_438	[p28l1383t1769r1475b1819],
48	Minnesota	NNP	LOCATION	Minnesota	nn	50	SENT_438	[p28l1492t1771r1787b1819],
49	Partnership	NNP	O	Partnership	nn	50	SENT_438	[p28l1807t1769r2128b1832],
50	Award	NN	O	award	dep	39	SENT_438	[p28l9t1853r187b1903],
51	for	IN	O	for	_	0	SENT_438	[p28l203t1852r281b1903],
52	Biotechnology	NNP	O	Biotechnology	nn	55	SENT_438	[p28l297t1853r708b1917],
53	and	CC	O	and	_	0	SENT_438	[p28l721t1853r825b1903],
54	Medical	NNP	O	Medical	conj_and	52	SENT_438	[p28l844t1853r1059b1903],
55	Genomics	NNP	O	Genomics	prep_for	50	SENT_438	[p28l1078t1855r1373b1911],
56	;	:	O	;	_	0	SENT_438	[p28l1078t1855r1373b1911],
57	the	DT	O	the	det	58	SENT_438	[p28l1387t1853r1479b1903],
58	Applebaum	NNP	O	Applebaum	dep	39	SENT_438	[p28l1494t1853r1841b1916],
59	,	,	O	,	_	0	SENT_438	[p28l1494t1853r1841b1916],
60	Hilton	NNP	ORGANIZATION	Hilton	dep	39	SENT_438	[p28l12t1939r194b1997],
61	,	,	O	,	_	0	SENT_438	[p28l12t1939r194b1997],
62	Peterson	NNP	PERSON	Peterson	dep	39	SENT_438	[p28l212t1942r453b1990],
63	and	CC	O	and	_	0	SENT_438	[p28l471t1939r574b1990],
64	Sanford	NNP	ORGANIZATION	Sanford	nn	65	SENT_438	[p28l593t1939r808b1990],
65	Foundations	NNPS	ORGANIZATION	Foundations	dep	39	SENT_438	[p28l828t1939r1192b1997],
66	;	:	O	;	_	0	SENT_438	[p28l828t1939r1192b1997],
67	and	CC	O	and	_	0	SENT_438	[p28l1207t1939r1311b1990],
68	the	DT	O	the	det	69	SENT_438	[p28l1327t1939r1419b1990],
69	McNei	NNP	O	McNei	conj_and	35	SENT_438	[p28l1436t1939r1693b1990],
70	|	VBD	O	|	rcmod	33	SENT_438	[p28l1436t1939r1693b1990],
71	us	PRP	O	we	nsubj	72	SENT_438	[p28l1436t1939r1693b1990],
72	family	NN	O	family	xcomp	70	SENT_438	[p28l1707t1939r1890b2004],
73	.	.	O	.	_	0	SENT_438	[p28l1707t1939r1890b2004],

1	|	NN	O	|	_	0	SENT_439	[p28l1908t1942r1972b1990],
2	.	.	O	.	_	0	SENT_439	[p28l1908t1942r1972b1990],

1	P.	NNP	O	P.	nsubj	2	SENT_440	[p28l1908t1942r1972b1990],
2	receives	VBZ	O	receive	_	0	SENT_440	[p28l11t2026r234b2074],
3	support	NN	O	support	dobj	2	SENT_440	[p28l251t2031r474b2087],
4	from	IN	O	from	_	0	SENT_440	[p28l487t2023r618b2074],
5	the	DT	O	the	det	6	SENT_440	[p28l635t2024r727b2074],
6	NINDS	NN	ORGANIZATION	nind	prep_from	3	SENT_440	[p28l745t2025r938b2081],
7	,	,	O	,	_	0	SENT_440	[p28l745t2025r938b2081],
8	the	DT	O	the	det	10	SENT_440	[p28l952t2024r1044b2074],
9	US	NNP	ORGANIZATION	US	nn	10	SENT_440	[p28l1062t2025r1133b2074],
10	Department	NNP	ORGANIZATION	Department	dobj	2	SENT_440	[p28l1152t2026r1496b2087],
11	of	IN	ORGANIZATION	of	_	0	SENT_440	[p28l1511t2023r1570b2074],
12	Defense	NNP	ORGANIZATION	Defense	nn	15	SENT_440	[p28l1583t2023r1822b2082],
13	,	,	O	,	_	0	SENT_440	[p28l1583t2023r1822b2082],
14	Novartis	NNP	ORGANIZATION	Novartis	appos	15	SENT_440	[p28l1840t2026r2070b2074],
15	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	prep_of	10	SENT_440	[p28l12t2108r485b2166],
16	,	,	O	,	_	0	SENT_440	[p28l12t2108r485b2166],
17	the	DT	O	the	det	19	SENT_440	[p28l499t2108r592b2158],
18	Mayo	NNP	ORGANIZATION	Mayo	nn	19	SENT_440	[p28l608t2110r760b2172],
19	Clinic	NNP	ORGANIZATION	Clinic	appos	15	SENT_440	[p28l775t2108r928b2158],
20	Center	NNP	ORGANIZATION	Center	nn	21	SENT_440	[p28l943t2110r1130b2158],
21	forTrans	NNPS	O	forTrans	dep	19	SENT_440	[p28l1142t2107r1587b2158],
22	|	SYM	O	|	dep	10	SENT_440	[p28l1142t2107r1587b2158],
23	ationa	FW	O	ationa	nn	24	SENT_440	[p28l1142t2107r1587b2158],
24	|	FW	O	|	amod	26	SENT_440	[p28l1142t2107r1587b2158],
25	Science	NN	O	science	nn	26	SENT_440	[p28l1606t2110r1818b2158],
26	Activities	NNS	O	activity	dep	10	SENT_440	[p28l1833t2110r2102b2166],
27	,	,	O	,	_	0	SENT_440	[p28l1833t2110r2102b2166],
28	and	CC	O	and	_	0	SENT_440	[p28l9t2194r112b2245],
29	a	DT	O	a	det	32	SENT_440	[p28l130t2209r157b2245],
30	Minnesota	NNP	LOCATION	Minnesota	nn	32	SENT_440	[p28l176t2197r471b2245],
31	Partnership	NNP	O	Partnership	nn	32	SENT_440	[p28l491t2194r813b2257],
32	Award	NN	O	award	dobj	2	SENT_440	[p28l828t2194r1006b2245],
33	for	IN	O	for	_	0	SENT_440	[p28l1022t2194r1100b2245],
34	Biotechnology	NNP	O	Biotechnology	nn	37	SENT_440	[p28l1116t2194r1527b2259],
35	and	CC	O	and	_	0	SENT_440	[p28l1540t2194r1643b2245],
36	Medical	NNP	O	Medical	conj_and	34	SENT_440	[p28l1663t2194r1879b2245],
37	Genomics	NNP	O	Genomics	prep_for	32	SENT_440	[p28l9t2280r418b2330],
38	.	.	O	.	_	0	SENT_440	[p28l9t2280r418b2330],

1	The	DT	O	the	det	2	SENT_441	[p28l9t2280r418b2330],
2	authors	NNS	O	author	nsubj	9	SENT_441	[p28l433t2280r647b2330],
3	thank	VBP	O	thank	_	0	SENT_441	[p28l662t2280r825b2330],
4	Lea	NNP	PERSON	Lea	nn	5	SENT_441	[p28l841t2282r931b2330],
5	Dacy	NNP	PERSON	Dacy	dobj	3	SENT_441	[p28l950t2282r1088b2344],
6	for	IN	O	for	_	0	SENT_441	[p28l1101t2279r1178b2330],
7	editorial	NN	O	editorial	prep_for	5	SENT_441	[p28l1193t2280r1421b2330],
8	and	CC	O	and	_	0	SENT_441	[p28l1440t2280r1543b2330],
9	proofreading	VBG	O	proofread	conj_and	3	SENT_441	[p28l1563t2279r1929b2343],
10	assistance	NN	O	assistance	dobj	9	SENT_441	[p28l9t2366r307b2415],
11	.	.	O	.	_	0	SENT_441	[p28l9t2366r307b2415],

1	CONFLICT	NN	O	conflict	nsubj	6	SENT_442	[p28l10t2538r322b2587],
2	OF	IN	O	of	_	0	SENT_442	[p28l337t2538r418b2587],
3	INTEREST	NN	O	interest	prep_of	1	SENT_442	[p28l437t2538r735b2587],
4	The	DT	O	the	det	5	SENT_442	[p28l7t2622r111b2672],
5	authors	NNS	O	author	dep	3	SENT_442	[p28l126t2622r340b2672],
6	stand	VBP	O	stand	_	0	SENT_442	[p28l356t2622r509b2672],
7	to	TO	O	to	aux	8	SENT_442	[p28l525t2630r582b2672],
8	receive	VB	O	receive	xcomp	6	SENT_442	[p28l600t2624r796b2672],
9	royalties	NNS	O	royalty	dobj	8	SENT_442	[p28l814t2622r1046b2686],
10	for	IN	O	for	_	0	SENT_442	[p28l1061t2621r1138b2672],
11	their	PRP$	O	they	poss	12	SENT_442	[p28l1151t2622r1283b2672],
12	authorship	NN	O	authorship	prep_for	8	SENT_442	[p28l1297t2622r1604b2685],
13	of	IN	O	of	_	0	SENT_442	[p28l1619t2621r1677b2672],
14	Multiple	JJ	O	multiple	amod	15	SENT_442	[p28l1686t2622r1910b2685],
15	Sclerosis	NN	O	sclerosis	prep_of	12	SENT_442	[p28l8t2709r237b2760],
16	(	CD	NUMBER	(	num	15	SENT_442	[p28l254t2711r683b2774],
17	Contemporary	NNP	O	Contemporary	nn	19	SENT_442	[p28l254t2711r683b2774],
18	Neurology	NNP	O	Neurology	nn	19	SENT_442	[p28l700t2709r995b2774],
19	Series	NNP	O	Series	dep	15	SENT_442	[p28l1009t2711r1187b2767],
20	;	:	O	;	_	0	SENT_442	[p28l1009t2711r1187b2767],
21	New	NNP	LOCATION	New	nn	22	SENT_442	[p28l1205t2712r1330b2760],
22	York	NNP	LOCATION	York	dep	15	SENT_442	[p28l1339t2709r1475b2760],
23	:	:	O	:	_	0	SENT_442	[p28l1339t2709r1475b2760],
24	Oxford	NNP	ORGANIZATION	Oxford	nn	26	SENT_442	[p28l1490t2709r1679b2760],
25	University	NNP	ORGANIZATION	University	nn	26	SENT_442	[p28l1700t2712r1980b2774],
26	Press	NNP	ORGANIZATION	Press	dep	15	SENT_442	[p28l12t2798r164b2853],
27	,	,	O	,	_	0	SENT_442	[p28l12t2798r164b2853],
28	201	CD	NUMBER	201	number	29	SENT_442	[p28l180t2799r269b2846],
29	3	CD	NUMBER	3	num	30	SENT_442	[p28l285t2797r348b2853],
30	)	NN	O	)	appos	15	SENT_442	[p28l285t2797r348b2853],
31	.	.	O	.	_	0	SENT_442	[p28l285t2797r348b2853],

1	M.R.	NNP	ORGANIZATION	M.R.	nsubj	2	SENT_443	[p28l366t2798r480b2846],
2	holds	VBZ	O	hold	_	0	SENT_443	[p28l498t2796r648b2846],
3	the	DT	O	the	det	4	SENT_443	[p28l663t2796r755b2846],
4	patent	NN	O	patent	dobj	2	SENT_443	[p28l773t2803r955b2859],
5	for	IN	O	for	_	0	SENT_443	[p28l969t2795r1046b2846],
6	the	DT	O	the	det	8	SENT_443	[p28l1059t2796r1151b2846],
7	antibody	NN	O	antibody	nn	8	SENT_443	[p28l1166t2796r1420b2860],
8	rHIgM22	NN	O	rhigm22	prep_for	4	SENT_443	[p28l1437t2798r1691b2859],
9	,	,	O	,	_	0	SENT_443	[p28l1437t2798r1691b2859],
10	which	WDT	O	which	nsubjpass	12	SENT_443	[p28l1706t2796r1873b2846],
11	is	VBZ	O	be	auxpass	12	SENT_443	[p28l1893t2798r1929b2846],
12	licensed	VBN	O	license	rcmod	8	SENT_443	[p28l12t2880r237b2930],
13	to	TO	O	to	_	0	SENT_443	[p28l254t2888r310b2930],
14	Acorda	NNP	ORGANIZATION	Acorda	nn	15	SENT_443	[p28l325t2880r522b2930],
15	Therapeutics	NNPS	ORGANIZATION	Therapeutics	prep_to	12	SENT_443	[p28l534t2880r913b2943],
16	.	.	O	.	_	0	SENT_443	[p28l534t2880r913b2943],

1	©	RB	O	©	dep	2	SENT_444	[p28l9t3097r49b3138],
2	2014	CD	DATE	2014	dep	4	SENT_444	[p28l64t3096r194b3140],
3	American	NNP	ORGANIZATION	American	nn	4	SENT_444	[p28l207t3095r460b3140],
4	Society	NNP	ORGANIZATION	Society	_	0	SENT_444	[p28l478t3095r672b3154],
5	for	IN	O	for	_	0	SENT_444	[p28l684t3093r758b3140],
6	Clinical	JJ	O	clinical	amod	7	SENT_444	[p28l772t3093r960b3140],
7	Pharmacology	NN	O	pharmacology	prep_for	4	SENT_444	[p28l980t3093r1365b3154],
8	and	CC	O	and	_	0	SENT_444	[p28l1378t3093r1476b3140],
9	Therapeutics	NNS	O	therapeutics	prep_for	4	SENT_444	[p28l1488t3093r1835b3152],

1	Noseworthy	NNP	PERSON	Noseworthy	_	0	SENT_445	[p29l132t74r458b137],
2	,	,	O	,	_	0	SENT_445	[p29l132t74r458b137],
3	J.H.	NNP	LOCATION	J.H.	conj_and	1	SENT_445	[p29l470t76r572b130],
4	,	,	O	,	_	0	SENT_445	[p29l470t76r572b130],
5	Lucchinetti	NNP	PERSON	Lucchinetti	conj_and	1	SENT_445	[p29l588t74r888b130],
6	,	,	O	,	_	0	SENT_445	[p29l588t74r888b130],
7	C.	NNP	O	C.	conj_and	1	SENT_445	[p29l903t76r962b130],
8	,	,	O	,	_	0	SENT_445	[p29l903t76r962b130],
9	Rodriguez	NNP	PERSON	Rodriguez	conj_and	1	SENT_445	[p29l978t74r1255b136],
10	,	,	O	,	_	0	SENT_445	[p29l978t74r1255b136],
11	M.	NNP	ORGANIZATION	M.	conj_and	1	SENT_445	[p29l1271t76r1330b123],
12	&	CC	ORGANIZATION	&	_	0	SENT_445	[p29l1343t74r1739b131],
13	Weinshenker	NNP	ORGANIZATION	Weinshenker	conj_and	1	SENT_445	[p29l1343t74r1739b131],
14	,	,	O	,	_	0	SENT_445	[p29l1343t74r1739b131],
15	B.G.	NNP	O	B.G.	nn	17	SENT_445	[p29l1756t76r1850b123],
16	Multiple	JJ	O	multiple	amod	17	SENT_445	[p29l1866t74r2080b136],
17	sclerosis	NN	O	sclerosis	appos	1	SENT_445	[p29l132t151r359b200],
18	.	.	O	.	_	0	SENT_445	[p29l132t151r359b200],

1	N.	NNP	O	N.	nn	2	SENT_446	[p29l374t153r421b200],
2	Engl	NNP	O	Engl	_	0	SENT_446	[p29l436t151r553b213],
3	.	.	O	.	_	0	SENT_446	[p29l436t151r553b213],

1	J.	NNP	O	J.	nn	2	SENT_447	[p29l564t153r599b200],
2	Med	NNP	O	Med	_	0	SENT_447	[p29l612t151r734b200],
3	.	.	O	.	_	0	SENT_447	[p29l612t151r734b200],

1	343	CD	NUMBER	343	_	0	SENT_448	[p29l749t154r863b207],
2	,	,	O	,	_	0	SENT_448	[p29l749t154r863b207],
3	938-952	CD	NUMBER	938-952	number	4	SENT_448	[p29l878t154r1100b200],
4	(	CD	NUMBER	(	appos	1	SENT_448	[p29l1117t152r1290b207],
5	2000	CD	DATE	2000	num	6	SENT_448	[p29l1117t152r1290b207],
6	)	NN	O	)	dep	4	SENT_448	[p29l1117t152r1290b207],
7	.	.	O	.	_	0	SENT_448	[p29l1117t152r1290b207],

1	Lassmann	NNP	PERSON	Lassmann	_	0	SENT_449	[p29l132t229r404b283],
2	,	,	O	,	_	0	SENT_449	[p29l132t229r404b283],
3	H.	NNP	O	H.	conj_and	1	SENT_449	[p29l420t229r481b283],
4	,	,	O	,	_	0	SENT_449	[p29l420t229r481b283],
5	Bruck	NNP	PERSON	Bruck	conj_and	1	SENT_449	[p29l498t227r654b283],
6	,	,	O	,	_	0	SENT_449	[p29l498t227r654b283],
7	W.	NNP	ORGANIZATION	W.	conj_and	1	SENT_449	[p29l665t229r726b276],
8	&	CC	ORGANIZATION	&	_	0	SENT_449	[p29l740t229r776b276],
9	Lucchinetti	NNP	ORGANIZATION	Lucchinetti	conj_and	1	SENT_449	[p29l791t227r1091b284],
10	,	,	O	,	_	0	SENT_449	[p29l791t227r1091b284],
11	C.	NNP	O	C.	nn	12	SENT_449	[p29l1106t229r1152b276],
12	Heterogeneity	NN	O	heterogeneity	appos	1	SENT_449	[p29l1169t229r1544b290],
13	of	IN	O	of	_	0	SENT_449	[p29l1557t226r1611b276],
14	multiple	JJ	O	multiple	amod	16	SENT_449	[p29l1623t227r1838b288],
15	sclerosis	NN	O	sclerosis	nn	16	SENT_449	[p29l1852t227r2068b276],
16	pathogenesis	NN	O	pathogenesis	prep_of	12	SENT_449	[p29l133t303r497b365],
17	:	:	O	:	_	0	SENT_449	[p29l133t303r497b365],
18	implications	NNS	O	implication	dep	1	SENT_449	[p29l513t303r829b364],
19	for	IN	O	for	_	0	SENT_449	[p29l843t302r915b352],
20	diagnosis	NN	O	diagnosis	prep_for	18	SENT_449	[p29l928t303r1175b365],
21	and	CC	O	and	_	0	SENT_449	[p29l1189t303r1285b352],
22	therapy	NN	O	therapy	conj_and	20	SENT_449	[p29l1300t303r1512b366],
23	.	.	O	.	_	0	SENT_449	[p29l1300t303r1512b366],

1	Trends	NNS	O	trend	_	0	SENT_450	[p29l1528t303r1689b352],
2	Mol	NNP	O	Mol	dep	1	SENT_450	[p29l1700t303r1804b352],
3	.	.	O	.	_	0	SENT_450	[p29l1700t303r1804b352],

1	Med	NNP	O	Med	_	0	SENT_451	[p29l1818t303r1940b352],
2	.	.	O	.	_	0	SENT_451	[p29l1818t303r1940b352],

1	7	CD	NUMBER	7	_	0	SENT_452	[p29l1955t307r1999b359],
2	,	,	O	,	_	0	SENT_452	[p29l1955t307r1999b359],
3	115-121	CD	NUMBER	115-121	number	4	SENT_452	[p29l136t383r344b429],
4	(	CD	NUMBER	(	appos	1	SENT_452	[p29l371t381r544b437],
5	2001	CD	DATE	2001	num	6	SENT_452	[p29l371t381r544b437],
6	)	NN	O	)	dep	4	SENT_452	[p29l371t381r544b437],
7	.	.	O	.	_	0	SENT_452	[p29l371t381r544b437],

1	McDonald	NNP	ORGANIZATION	McDonald	_	0	SENT_453	[p29l131t456r412b513],
2	,	,	O	,	_	0	SENT_453	[p29l131t456r412b513],
3	W.I.	NNP	LOCATION	W.I.	nn	4	SENT_453	[p29l423t458r511b505],
4	etal	NNP	O	etal	appos	1	SENT_453	[p29l525t456r640b505],
5	.	.	O	.	_	0	SENT_453	[p29l525t456r640b505],

1	Recommended	VBN	O	recommend	_	0	SENT_454	[p29l657t456r1053b505],
2	diagnostic	JJ	O	diagnostic	amod	3	SENT_454	[p29l1070t456r1341b518],
3	criteria	NNS	O	criterion	dobj	1	SENT_454	[p29l1356t458r1532b505],
4	for	IN	O	for	_	0	SENT_454	[p29l1547t455r1619b505],
5	multiple	JJ	O	multiple	amod	6	SENT_454	[p29l1634t456r1849b517],
6	sclerosis	NN	O	sclerosis	prep_for	1	SENT_454	[p29l1864t456r2092b505],
7	:	:	O	:	_	0	SENT_454	[p29l1864t456r2092b505],
8	guidelines	NNS	O	guideline	dep	6	SENT_454	[p29l131t532r401b594],
9	from	IN	O	from	_	0	SENT_454	[p29l414t531r536b581],
10	the	DT	O	the	det	12	SENT_454	[p29l551t532r637b581],
11	International	NNP	ORGANIZATION	International	nn	12	SENT_454	[p29l654t532r985b581],
12	Panel	NNP	ORGANIZATION	Panel	prep_from	8	SENT_454	[p29l1004t532r1140b581],
13	on	IN	O	on	_	0	SENT_454	[p29l1157t546r1221b581],
14	the	DT	O	the	det	15	SENT_454	[p29l1236t532r1322b581],
15	diagnosis	NN	O	diagnosis	prep_on	1	SENT_454	[p29l1336t532r1582b594],
16	of	IN	O	of	_	0	SENT_454	[p29l1597t531r1651b581],
17	multiple	JJ	O	multiple	amod	18	SENT_454	[p29l1663t532r1878b593],
18	sclerosis	NN	O	sclerosis	prep_of	15	SENT_454	[p29l1893t532r2120b581],
19	.	.	O	.	_	0	SENT_454	[p29l1893t532r2120b581],

1	Ann	NNP	PERSON	Ann	_	0	SENT_455	[p29l128t611r243b658],
2	.	.	O	.	_	0	SENT_455	[p29l128t611r243b658],

1	Neurol	NNP	O	Neurol	_	0	SENT_456	[p29l258t609r436b658],
2	.	.	O	.	_	0	SENT_456	[p29l258t609r436b658],

1	50	CD	NUMBER	50	_	0	SENT_457	[p29l451t612r530b666],
2	,	,	O	,	_	0	SENT_457	[p29l451t612r530b666],
3	121-127	CD	NUMBER	121-127	number	4	SENT_457	[p29l549t612r767b658],
4	(	CD	NUMBER	(	appos	1	SENT_457	[p29l783t610r957b665],
5	2001	CD	DATE	2001	num	6	SENT_457	[p29l783t610r957b665],
6	)	NN	O	)	dep	4	SENT_457	[p29l783t610r957b665],
7	.	.	O	.	_	0	SENT_457	[p29l783t610r957b665],

1	Polman	NNP	PERSON	Polman	_	0	SENT_458	[p29l132t685r340b741],
2	,	,	O	,	_	0	SENT_458	[p29l132t685r340b741],
3	C.H.	NNP	PERSON	C.H.	nn	4	SENT_458	[p29l354t687r454b734],
4	etal	NNP	O	etal	appos	1	SENT_458	[p29l468t685r583b734],
5	.	.	O	.	_	0	SENT_458	[p29l468t685r583b734],

1	Diagnostic	JJ	O	diagnostic	amod	2	SENT_459	[p29l599t687r875b747],
2	criteria	NNS	O	criterion	_	0	SENT_459	[p29l889t687r1066b734],
3	for	IN	O	for	_	0	SENT_459	[p29l1080t684r1152b734],
4	multiple	JJ	O	multiple	amod	5	SENT_459	[p29l1167t685r1383b746],
5	sclerosis	NN	O	sclerosis	prep_for	2	SENT_459	[p29l1397t685r1626b734],
6	:	:	O	:	_	0	SENT_459	[p29l1397t685r1626b734],
7	201	CD	NUMBER	201	num	9	SENT_459	[p29l1640t688r1724b734],
8	o	NN	O	o	nn	9	SENT_459	[p29l1737t688r1766b734],
9	revisions	NNS	O	revision	dep	2	SENT_459	[p29l1783t687r2008b734],
10	to	TO	O	to	_	0	SENT_459	[p29l2021t692r2074b734],
11	the	DT	O	the	det	13	SENT_459	[p29l130t762r215b811],
12	McDonald	NNP	O	McDonald	nn	13	SENT_459	[p29l231t762r497b811],
13	criteria	NNS	O	criterion	prep_to	9	SENT_459	[p29l514t765r705b811],
14	.	.	O	.	_	0	SENT_459	[p29l514t765r705b811],

1	Ann	NNP	PERSON	Ann	_	0	SENT_460	[p29l716t765r831b811],
2	.	.	O	.	_	0	SENT_460	[p29l716t765r831b811],

1	Neurol	NNP	O	Neurol	_	0	SENT_461	[p29l846t762r1024b811],
2	.	.	O	.	_	0	SENT_461	[p29l846t762r1024b811],

1	69	CD	NUMBER	69	_	0	SENT_462	[p29l1038t765r1118b819],
2	,	,	O	,	_	0	SENT_462	[p29l1038t765r1118b819],
3	292-302	CD	NUMBER	292-302	num	4	SENT_462	[p29l1133t765r1355b811],
4	(	NN	O	(	appos	1	SENT_462	[p29l1371t763r1472b819],
5	201	CD	NUMBER	201	number	6	SENT_462	[p29l1371t763r1472b819],
6	1	CD	NUMBER	1	num	7	SENT_462	[p29l1490t763r1545b819],
7	)	NN	O	)	dep	4	SENT_462	[p29l1490t763r1545b819],
8	.	.	O	.	_	0	SENT_462	[p29l1490t763r1545b819],

1	Polman	NNP	PERSON	Polman	_	0	SENT_463	[p29l132t839r340b896],
2	,	,	O	,	_	0	SENT_463	[p29l132t839r340b896],
3	C.H.	NNP	PERSON	C.H.	nn	4	SENT_463	[p29l354t841r454b888],
4	etal	NNP	O	etal	appos	1	SENT_463	[p29l468t839r583b888],
5	.	.	O	.	_	0	SENT_463	[p29l468t839r583b888],

1	Diagnostic	JJ	O	diagnostic	amod	2	SENT_464	[p29l599t841r875b901],
2	criteria	NNS	O	criterion	_	0	SENT_464	[p29l889t842r1066b888],
3	for	IN	O	for	_	0	SENT_464	[p29l1080t839r1152b888],
4	multiple	JJ	O	multiple	amod	5	SENT_464	[p29l1167t839r1383b901],
5	sclerosis	NN	O	sclerosis	prep_for	2	SENT_464	[p29l1397t839r1626b888],
6	:	:	O	:	_	0	SENT_464	[p29l1397t839r1626b888],
7	2005	CD	DATE	2005	num	8	SENT_464	[p29l1640t842r1764b888],
8	revisions	NNS	O	revision	dep	2	SENT_464	[p29l1783t842r2008b888],
9	to	TO	O	to	_	0	SENT_464	[p29l2021t847r2074b888],
10	the	DT	O	the	det	15	SENT_464	[p29l130t916r514b965],
11	”	NN	O	”	nn	15	SENT_464	[p29l130t916r514b965],
12	McDona	NN	O	mcdona	nn	15	SENT_464	[p29l130t916r514b965],
13	|	NN	O	|	nn	15	SENT_464	[p29l130t916r514b965],
14	d	NN	O	d	nn	15	SENT_464	[p29l130t916r514b965],
15	Criteria	NNS	O	criterion	prep_to	8	SENT_464	[p29l531t917r740b965],
16	”	CD	NUMBER	”	dep	15	SENT_464	[p29l531t917r740b965],
17	.	.	O	.	_	0	SENT_464	[p29l531t917r740b965],

1	Ann	NNP	PERSON	Ann	_	0	SENT_465	[p29l751t919r866b965],
2	.	.	O	.	_	0	SENT_465	[p29l751t919r866b965],

1	Neurol	NNP	O	Neurol	_	0	SENT_466	[p29l881t916r1060b965],
2	.	.	O	.	_	0	SENT_466	[p29l881t916r1060b965],

1	58	CD	NUMBER	58	_	0	SENT_467	[p29l1075t919r1154b973],
2	,	,	O	,	_	0	SENT_467	[p29l1075t919r1154b973],
3	840-846	CD	NUMBER	840-846	number	4	SENT_467	[p29l1168t919r1391b965],
4	(	CD	NUMBER	(	appos	1	SENT_467	[p29l1407t917r1580b973],
5	2005	CD	DATE	2005	num	6	SENT_467	[p29l1407t917r1580b973],
6	)	NN	O	)	dep	4	SENT_467	[p29l1407t917r1580b973],
7	.	.	O	.	_	0	SENT_467	[p29l1407t917r1580b973],

1	VOLUME	NN	O	volume	nn	3	SENT_468	[p29l542t1125r765b1167],
2	95	CD	NUMBER	95	num	3	SENT_468	[p29l783t1126r839b1167],
3	NUMBER	NN	O	number	_	0	SENT_468	[p29l860t1125r1083b1167],
4	1	CD	NUMBER	1	number	5	SENT_468	[p29l1104t1127r1118b1167],
5	|	CD	NUMBER	|	dep	3	SENT_468	[p29l1147t1121r1152b1182],
6	JANUARY	NNP	DATE	JANUARY	dep	5	SENT_468	[p29l1170t1125r1415b1167],
7	2014	CD	DATE	2014	num	6	SENT_468	[p29l1431t1126r1552b1167],
8	|	CD	NUMBER	|	num	9	SENT_468	[p29l1570t1121r1575b1182],
9	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	3	SENT_468	[p29l1593t1125r2143b1178],

1	STATE	NN	O	state	nn	2	SENT_469	[p29l1761t1297r1902b1334],
2	ART	NN	O	art	_	0	SENT_469	[p29l2045t1297r2139b1334],

1	Enge	NNP	PERSON	Enge	nn	3	SENT_470	[p29l130t1532r349b1595],
2	|	NNP	O	|	nn	3	SENT_470	[p29l130t1532r349b1595],
3	|	NNP	O	|	_	0	SENT_470	[p29l130t1532r349b1595],
4	,	,	O	,	_	0	SENT_470	[p29l130t1532r349b1595],
5	T.	NNP	O	T.	nn	6	SENT_470	[p29l130t1532r349b1595],
6	A	NNP	O	A	appos	3	SENT_470	[p29l364t1534r400b1581],
7	clinical	JJ	O	clinical	amod	9	SENT_470	[p29l414t1532r590b1581],
8	patho-anatomical	JJ	O	patho-anatomical	amod	9	SENT_470	[p29l609t1532r1074b1594],
9	study	NN	O	study	dep	6	SENT_470	[p29l1091t1532r1236b1595],
10	ofclinically	RB	O	ofclinically	advmod	11	SENT_470	[p29l1249t1531r1538b1595],
11	silent	JJ	O	silent	amod	13	SENT_470	[p29l1551t1532r1691b1581],
12	multiple	JJ	O	multiple	amod	13	SENT_470	[p29l1707t1532r1923b1594],
13	sclerosis	NN	O	sclerosis	dep	9	SENT_470	[p29l130t1609r359b1658],
14	.	.	O	.	_	0	SENT_470	[p29l130t1609r359b1658],

1	Acta	NNP	PERSON	Acta	nn	2	SENT_471	[p29l369t1611r486b1658],
2	Neurol	NNP	PERSON	Neurol	_	0	SENT_471	[p29l498t1609r675b1658],
3	.	.	O	.	_	0	SENT_471	[p29l498t1609r675b1658],

1	Scand	NNP	O	Scand	_	0	SENT_472	[p29l689t1609r856b1658],
2	.	.	O	.	_	0	SENT_472	[p29l689t1609r856b1658],

1	79	CD	NUMBER	79	_	0	SENT_473	[p29l872t1612r951b1665],
2	,	,	O	,	_	0	SENT_473	[p29l872t1612r951b1665],
3	428-430	CD	NUMBER	428-430	num	4	SENT_473	[p29l964t1612r1190b1658],
4	(	NN	O	(	appos	1	SENT_473	[p29l1206t1610r1241b1665],
5	1	CD	NUMBER	1	number	6	SENT_473	[p29l1206t1610r1241b1665],
6	989	CD	NUMBER	989	num	7	SENT_473	[p29l1255t1610r1380b1665],
7	)	NN	O	)	dep	4	SENT_473	[p29l1255t1610r1380b1665],
8	.	.	O	.	_	0	SENT_473	[p29l1255t1610r1380b1665],

1	Mews	NNP	O	Mews	_	0	SENT_474	[p29l129t1689r292b1744],
2	,	,	O	,	_	0	SENT_474	[p29l129t1689r292b1744],
3	|	CD	NUMBER	|	appos	1	SENT_474	[p29l309t1689r344b1744],
4	.	.	O	.	_	0	SENT_474	[p29l309t1689r344b1744],

1	,	,	O	,	_	0	SENT_475	[p29l309t1689r344b1744],
2	Bergmann	NNP	PERSON	Bergmann	dep	17	SENT_475	[p29l361t1689r645b1750],
3	,	,	O	,	_	0	SENT_475	[p29l361t1689r645b1750],
4	M.	NNP	O	M.	appos	2	SENT_475	[p29l660t1689r732b1744],
5	,	,	O	,	_	0	SENT_475	[p29l660t1689r732b1744],
6	Bunkowski	NNP	PERSON	Bunkowski	conj_and	4	SENT_475	[p29l749t1687r1043b1744],
7	,	,	O	,	_	0	SENT_475	[p29l749t1687r1043b1744],
8	S.	NNP	O	S.	conj_and	4	SENT_475	[p29l1058t1688r1111b1744],
9	,	,	O	,	_	0	SENT_475	[p29l1058t1688r1111b1744],
10	Gullotta	NNP	LOCATION	Gullotta	conj_and	4	SENT_475	[p29l1125t1687r1349b1744],
11	,	,	O	,	_	0	SENT_475	[p29l1125t1687r1349b1744],
12	F.	NNP	ORGANIZATION	F.	conj_and	4	SENT_475	[p29l1365t1689r1397b1736],
13	&	CC	ORGANIZATION	&	_	0	SENT_475	[p29l1411t1688r1448b1736],
14	Briick	NNP	ORGANIZATION	Briick	conj_and	4	SENT_475	[p29l1462t1687r1619b1744],
15	,	,	O	,	_	0	SENT_475	[p29l1462t1687r1619b1744],
16	W.	NNP	PERSON	W.	nn	17	SENT_475	[p29l1630t1689r1691b1736],
17	Oligodendrocyte	NNP	PERSON	Oligodendrocyte	_	0	SENT_475	[p29l1705t1687r2152b1750],
18	and	CC	O	and	_	0	SENT_475	[p29l129t1765r226b1814],
19	axon	JJ	O	axon	amod	20	SENT_475	[p29l242t1779r366b1814],
20	pathology	NN	O	pathology	conj_and	17	SENT_475	[p29l385t1765r654b1828],
21	in	IN	O	in	_	0	SENT_475	[p29l669t1767r711b1814],
22	clinically	RB	O	clinically	advmod	23	SENT_475	[p29l728t1765r953b1828],
23	silent	JJ	O	silent	amod	26	SENT_475	[p29l966t1765r1106b1814],
24	multiple	JJ	O	multiple	amod	26	SENT_475	[p29l1122t1765r1338b1827],
25	sclerosis	NN	O	sclerosis	nn	26	SENT_475	[p29l1353t1765r1569b1814],
26	lesions	NNS	O	lesion	prep_in	20	SENT_475	[p29l1586t1765r1775b1814],
27	.	.	O	.	_	0	SENT_475	[p29l1586t1765r1775b1814],

1	Mult	NNP	O	Mult	_	0	SENT_476	[p29l1788t1765r1914b1814],
2	.	.	O	.	_	0	SENT_476	[p29l1788t1765r1914b1814],

1	Scler	NNP	O	Scler	_	0	SENT_477	[p29l1928t1765r2059b1814],
2	.	.	O	.	_	0	SENT_477	[p29l1928t1765r2059b1814],

1	4	CD	NUMBER	4	_	0	SENT_478	[p29l2073t1769r2118b1822],
2	,	,	O	,	_	0	SENT_478	[p29l2073t1769r2118b1822],
3	55-62	CD	NUMBER	55-62	number	4	SENT_478	[p29l130t1845r288b1891],
4	(	CD	NUMBER	(	appos	1	SENT_478	[p29l305t1843r479b1898],
5	1998	CD	DATE	1998	num	6	SENT_478	[p29l305t1843r479b1898],
6	)	NN	O	)	dep	4	SENT_478	[p29l305t1843r479b1898],
7	.	.	O	.	_	0	SENT_478	[p29l305t1843r479b1898],

1	Lebrun	NNP	PERSON	Lebrun	nn	5	SENT_479	[p29l130t1920r326b1977],
2	,	,	O	,	_	0	SENT_479	[p29l130t1920r326b1977],
3	C.	NNP	O	C.	appos	5	SENT_479	[p29l340t1921r387b1969],
4	et	NNP	O	et	nn	5	SENT_479	[p29l401t1927r450b1970],
5	aI.	NNP	O	aI.	_	0	SENT_479	[p29l459t1920r529b1977],
6	;	:	O	;	_	0	SENT_479	[p29l459t1920r529b1977],
7	CFSEP	NNP	O	CFSEP	dep	5	SENT_479	[p29l543t1921r708b1969],
8	.	.	O	.	_	0	SENT_479	[p29l543t1921r708b1969],

1	Unexpected	JJ	O	unexpected	amod	3	SENT_480	[p29l725t1920r1041b1982],
2	multiple	JJ	O	multiple	amod	3	SENT_480	[p29l1060t1920r1276b1982],
3	sclerosis	NN	O	sclerosis	_	0	SENT_480	[p29l1291t1920r1521b1969],
4	:	:	O	:	_	0	SENT_480	[p29l1291t1920r1521b1969],
5	follow-up	NN	O	follow-up	dep	3	SENT_480	[p29l1533t1919r1786b1982],
6	of	IN	O	of	_	0	SENT_480	[p29l1801t1919r1855b1969],
7	30	CD	NUMBER	30	num	8	SENT_480	[p29l1865t1923r1926b1969],
8	patients	NNS	O	patient	prep_of	5	SENT_480	[p29l1943t1922r2153b1982],
9	with	IN	O	with	_	0	SENT_480	[p29l128t1998r242b2047],
10	magnetic	JJ	O	magnetic	amod	12	SENT_480	[p29l260t2000r506b2061],
11	resonance	NN	O	resonance	nn	12	SENT_480	[p29l522t2012r790b2047],
12	imaging	NN	O	imaging	prep_with	8	SENT_480	[p29l806t2000r1019b2061],
13	and	CC	O	and	_	0	SENT_480	[p29l1035t1998r1132b2047],
14	clinical	JJ	O	clinical	amod	16	SENT_480	[p29l1148t1998r1324b2047],
15	conversion	NN	O	conversion	nn	16	SENT_480	[p29l1341t2000r1626b2047],
16	proﬁle	NN	O	proﬁle	prep_with	8	SENT_480	[p29l1645t1997r1823b2060],
17	.	.	O	.	_	0	SENT_480	[p29l1645t1997r1823b2060],

1	J.	NNP	PERSON	J.	nn	2	SENT_481	[p29l1833t2000r1868b2047],
2	Neurol	NNP	PERSON	Neurol	_	0	SENT_481	[p29l1883t1998r2059b2047],
3	.	.	O	.	_	0	SENT_481	[p29l1883t1998r2059b2047],

1	Neurosurg	NNP	LOCATION	Neurosurg	_	0	SENT_482	[p29l129t2078r402b2139],
2	.	.	O	.	_	0	SENT_482	[p29l129t2078r402b2139],

1	Psychiatr	NN	O	psychiatr	_	0	SENT_483	[p29l417t2076r658b2139],
2	.	.	O	.	_	0	SENT_483	[p29l417t2076r658b2139],

1	79	CD	NUMBER	79	_	0	SENT_484	[p29l673t2079r752b2133],
2	,	,	O	,	_	0	SENT_484	[p29l673t2079r752b2133],
3	195-198	CD	NUMBER	195-198	number	4	SENT_484	[p29l771t2079r991b2125],
4	(	CD	NUMBER	(	appos	1	SENT_484	[p29l1007t2077r1182b2133],
5	2008	CD	DATE	2008	num	6	SENT_484	[p29l1007t2077r1182b2133],
6	)	NN	O	)	dep	4	SENT_484	[p29l1007t2077r1182b2133],
7	.	.	O	.	_	0	SENT_484	[p29l1007t2077r1182b2133],

1	Okuda	NNP	PERSON	Okuda	_	0	SENT_485	[p29l128t2154r313b2211],
2	,	,	O	,	_	0	SENT_485	[p29l128t2154r313b2211],
3	D.T.	NNP	O	D.T.	nn	4	SENT_485	[p29l330t2156r418b2203],
4	etal	NNP	O	etal	appos	1	SENT_485	[p29l432t2154r547b2203],
5	.	.	O	.	_	0	SENT_485	[p29l432t2154r547b2203],

1	Incidental	JJ	O	incidental	amod	3	SENT_486	[p29l564t2154r820b2203],
2	MRI	NNP	O	MRI	nn	3	SENT_486	[p29l838t2156r931b2203],
3	anomalies	NNS	O	anomaly	_	0	SENT_486	[p29l948t2154r1216b2203],
4	suggestive	JJ	O	suggestive	amod	3	SENT_486	[p29l1231t2156r1514b2217],
5	of	IN	O	of	_	0	SENT_486	[p29l1528t2153r1582b2203],
6	multiple	JJ	O	multiple	amod	7	SENT_486	[p29l1594t2154r1811b2216],
7	sclerosis	NN	O	sclerosis	prep_of	4	SENT_486	[p29l1825t2154r2055b2203],
8	:	:	O	:	_	0	SENT_486	[p29l1825t2154r2055b2203],
9	the	DT	O	the	det	12	SENT_486	[p29l128t2232r214b2281],
10	radiologically	RB	O	radiologically	advmod	11	SENT_486	[p29l230t2232r582b2295],
11	isolated	VBN	O	isolate	amod	12	SENT_486	[p29l597t2232r798b2281],
12	syndrome	NN	O	syndrome	dep	7	SENT_486	[p29l815t2232r1090b2295],
13	.	.	O	.	_	0	SENT_486	[p29l815t2232r1090b2295],

1	Neurology	NN	O	neurology	_	0	SENT_487	[p29l1104t2232r1370b2295],
2	72	CD	NUMBER	72	num	1	SENT_487	[p29l1381t2235r1460b2289],
3	,	,	O	,	_	0	SENT_487	[p29l1381t2235r1460b2289],
4	800-805	CD	NUMBER	800-805	number	5	SENT_487	[p29l1475t2235r1697b2281],
5	(	CD	NUMBER	(	appos	1	SENT_487	[p29l1716t2233r1890b2289],
6	2009	CD	DATE	2009	num	7	SENT_487	[p29l1716t2233r1890b2289],
7	)	NN	O	)	dep	5	SENT_487	[p29l1716t2233r1890b2289],
8	.	.	O	.	_	0	SENT_487	[p29l1716t2233r1890b2289],

1	Siva	NNP	PERSON	Siva	dep	26	SENT_488	[p29l128t2311r244b2367],
2	,	,	O	,	_	0	SENT_488	[p29l128t2311r244b2367],
3	A.	NN	O	a.	appos	1	SENT_488	[p29l258t2312r320b2367],
4	,	,	O	,	_	0	SENT_488	[p29l258t2312r320b2367],
5	Saip	NN	PERSON	saip	appos	1	SENT_488	[p29l335t2311r456b2372],
6	,	,	O	,	_	0	SENT_488	[p29l335t2311r456b2372],
7	S.	NNP	O	S.	appos	1	SENT_488	[p29l470t2311r524b2367],
8	,	,	O	,	_	0	SENT_488	[p29l470t2311r524b2367],
9	Altintas	NNP	O	Altintas	appos	1	SENT_488	[p29l538t2310r748b2367],
10	,	,	O	,	_	0	SENT_488	[p29l538t2310r748b2367],
11	A.	NN	O	a.	appos	1	SENT_488	[p29l762t2312r824b2367],
12	,	,	O	,	_	0	SENT_488	[p29l762t2312r824b2367],
13	Jacob	NNP	PERSON	Jacob	appos	1	SENT_488	[p29l836t2310r1000b2367],
14	,	,	O	,	_	0	SENT_488	[p29l836t2310r1000b2367],
15	A.	NN	O	a.	appos	1	SENT_488	[p29l1014t2312r1076b2367],
16	,	,	O	,	_	0	SENT_488	[p29l1014t2312r1076b2367],
17	Keegan	NNP	PERSON	Keegan	appos	1	SENT_488	[p29l1093t2312r1300b2373],
18	,	,	O	,	_	0	SENT_488	[p29l1093t2312r1300b2373],
19	B.M.	NNP	ORGANIZATION	B.M.	appos	1	SENT_488	[p29l1316t2312r1422b2359],
20	&	CC	ORGANIZATION	&	_	0	SENT_488	[p29l1436t2311r1473b2359],
21	Kantarci	NNP	ORGANIZATION	Kantarci	appos	1	SENT_488	[p29l1487t2312r1711b2367],
22	,	,	O	,	_	0	SENT_488	[p29l1487t2312r1711b2367],
23	O.H.	NNP	O	O.H.	appos	1	SENT_488	[p29l1725t2311r1831b2359],
24	Multiple	JJ	O	multiple	amod	26	SENT_488	[p29l131t2388r346b2450],
25	sclerosis	NN	O	sclerosis	nn	26	SENT_488	[p29l361t2388r577b2437],
26	risk	NN	O	risk	_	0	SENT_488	[p29l594t2388r682b2437],
27	in	IN	O	in	_	0	SENT_488	[p29l695t2390r738b2437],
28	radiologically	RB	O	radiologically	advmod	29	SENT_488	[p29l756t2388r1108b2451],
29	uncovered	JJ	O	uncovered	amod	33	SENT_488	[p29l1123t2388r1398b2437],
30	asymptomatic	JJ	O	asymptomatic	amod	33	SENT_488	[p29l1415t2390r1791b2451],
31	possible	JJ	O	possible	amod	33	SENT_488	[p29l1807t2388r2021b2450],
32	inﬂammatory-demyelinating	JJ	O	inﬂammatory-demyelinating	amod	33	SENT_488	[p29l131t2465r888b2529],
33	disease	NN	O	disease	prep_in	26	SENT_488	[p29l904t2466r1108b2516],
34	.	.	O	.	_	0	SENT_488	[p29l904t2466r1108b2516],

1	Mult	NNP	O	Mult	_	0	SENT_489	[p29l1121t2466r1248b2516],
2	.	.	O	.	_	0	SENT_489	[p29l1121t2466r1248b2516],

1	Scler	NNP	O	Scler	_	0	SENT_490	[p29l1262t2466r1393b2516],
2	.	.	O	.	_	0	SENT_490	[p29l1262t2466r1393b2516],

1	15	CD	NUMBER	15	_	0	SENT_491	[p29l1410t2470r1488b2523],
2	,	,	O	,	_	0	SENT_491	[p29l1410t2470r1488b2523],
3	918-927	CD	NUMBER	918-927	number	4	SENT_491	[p29l1502t2469r1725b2516],
4	(	CD	NUMBER	(	appos	1	SENT_491	[p29l1742t2467r1916b2523],
5	2009	CD	DATE	2009	num	6	SENT_491	[p29l1742t2467r1916b2523],
6	)	NN	O	)	dep	4	SENT_491	[p29l1742t2467r1916b2523],
7	.	.	O	.	_	0	SENT_491	[p29l1742t2467r1916b2523],

1	CHAMPS	NNS	O	champ	_	0	SENT_492	[p29l128t2545r358b2594],
2	Study	NNP	O	Study	nn	3	SENT_492	[p29l373t2544r524b2607],
3	Group	NNP	O	Group	dep	1	SENT_492	[p29l537t2546r712b2606],
4	.	.	O	.	_	0	SENT_492	[p29l537t2546r712b2606],

1	Interferon	NN	O	interferon	nn	2	SENT_493	[p29l729t2543r987b2594],
2	beta-1	NN	O	beta-1	_	0	SENT_493	[p29l1006t2544r1162b2594],
3	a	DT	O	a	dep	2	SENT_493	[p29l1176t2559r1202b2594],
4	for	IN	O	for	dep	12	SENT_493	[p29l1216t2543r1288b2594],
5	optic	JJ	O	optic	amod	7	SENT_493	[p29l1302t2546r1433b2606],
6	neuritis	NN	O	neuritis	nn	7	SENT_493	[p29l1450t2546r1643b2594],
7	patients	NNS	O	patient	pobj	4	SENT_493	[p29l1659t2546r1869b2606],
8	at	IN	O	at	_	0	SENT_493	[p29l1884t2551r1933b2594],
9	high	JJ	O	high	amod	10	SENT_493	[p29l1948t2544r2062b2607],
10	riskfor	NN	O	riskfor	prep_at	7	SENT_493	[p29l131t2621r302b2672],
11	multiple	JJ	O	multiple	amod	12	SENT_493	[p29l317t2622r533b2684],
12	sclerosis	NN	O	sclerosis	dep	3	SENT_493	[p29l548t2622r777b2672],
13	.	.	O	.	_	0	SENT_493	[p29l548t2622r777b2672],

1	Am	NNP	O	Am	_	0	SENT_494	[p29l788t2624r887b2672],
2	.	.	O	.	_	0	SENT_494	[p29l788t2624r887b2672],

1	J.	NNP	PERSON	J.	nn	2	SENT_495	[p29l898t2624r933b2672],
2	Ophthalmol	NNP	PERSON	Ophthalmol	_	0	SENT_495	[p29l949t2622r1269b2684],
3	.	.	O	.	_	0	SENT_495	[p29l949t2622r1269b2684],

1	132	CD	NUMBER	132	_	0	SENT_496	[p29l1286t2625r1399b2679],
2	,	,	O	,	_	0	SENT_496	[p29l1286t2625r1399b2679],
3	463-471	CD	NUMBER	463-471	number	4	SENT_496	[p29l1411t2625r1627b2672],
4	(	CD	NUMBER	(	appos	1	SENT_496	[p29l1653t2623r1828b2679],
5	2001	CD	DATE	2001	num	6	SENT_496	[p29l1653t2623r1828b2679],
6	)	NN	O	)	dep	4	SENT_496	[p29l1653t2623r1828b2679],
7	.	.	O	.	_	0	SENT_496	[p29l1653t2623r1828b2679],

1	Anonymous	JJ	O	anonymous	_	0	SENT_497	[p29l127t2702r459b2764],
2	.	.	O	.	_	0	SENT_497	[p29l127t2702r459b2764],

1	Predictors	NNS	O	predictor	_	0	SENT_498	[p29l476t2700r736b2750],
2	of	IN	O	of	_	0	SENT_498	[p29l751t2699r805b2749],
3	short-term	JJ	O	short-term	amod	5	SENT_498	[p29l815t2700r1094b2749],
4	disease	NN	O	disease	nn	5	SENT_498	[p29l1111t2700r1303b2750],
5	activity	NN	O	activity	prep_of	1	SENT_498	[p29l1317t2702r1508b2764],
6	following	VBG	O	follow	partmod	1	SENT_498	[p29l1519t2699r1765b2763],
7	a	DT	O	a	det	11	SENT_498	[p29l1781t2715r1807b2750],
8	ﬁrst	NN	O	ﬁrst	nn	11	SENT_498	[p29l1821t2699r1920b2749],
9	clinical	JJ	O	clinical	amod	11	SENT_498	[p29l1934t2700r2110b2749],
10	demyelinating	VBG	O	demyelinate	amod	11	SENT_498	[p29l129t2778r508b2842],
11	event	NN	O	event	dobj	6	SENT_498	[p29l524t2785r683b2827],
12	:	:	O	:	_	0	SENT_498	[p29l524t2785r683b2827],
13	analysis	NN	O	analysis	dep	11	SENT_498	[p29l698t2778r900b2841],
14	of	IN	O	of	_	0	SENT_498	[p29l915t2777r969b2827],
15	the	DT	O	the	det	18	SENT_498	[p29l978t2778r1064b2827],
16	CHAMPS	NNP	MISC	CHAMPS	nn	18	SENT_498	[p29l1078t2780r1308b2827],
17	placebo	NN	O	placebo	nn	18	SENT_498	[p29l1325t2778r1533b2840],
18	group	NN	O	group	prep_of	13	SENT_498	[p29l1547t2793r1717b2841],
19	.	.	O	.	_	0	SENT_498	[p29l1547t2793r1717b2841],

1	Mult	NNP	O	Mult	_	0	SENT_499	[p29l1730t2778r1856b2828],
2	.	.	O	.	_	0	SENT_499	[p29l1730t2778r1856b2828],

1	Scler	NNP	O	Scler	_	0	SENT_500	[p29l1870t2778r2001b2827],
2	.	.	O	.	_	0	SENT_500	[p29l1870t2778r2001b2827],

1	8	CD	NUMBER	8	_	0	SENT_501	[p29l2015t2781r2060b2835],
2	,	,	O	,	_	0	SENT_501	[p29l2015t2781r2060b2835],
3	405-409	CD	NUMBER	405-409	number	4	SENT_501	[p29l128t2858r354b2904],
4	(	CD	NUMBER	(	appos	1	SENT_501	[p29l370t2856r544b2911],
5	2002	CD	DATE	2002	num	6	SENT_501	[p29l370t2856r544b2911],
6	)	NN	O	)	dep	4	SENT_501	[p29l370t2856r544b2911],
7	.	.	O	.	_	0	SENT_501	[p29l370t2856r544b2911],

1	Anonymous	JJ	O	anonymous	_	0	SENT_502	[p29l127t2935r459b2997],
2	.	.	O	.	_	0	SENT_502	[p29l127t2935r459b2997],

1	Baseline	NN	O	baseline	nn	3	SENT_503	[p29l476t2933r689b2983],
2	MRI	NNP	O	MRI	nn	3	SENT_503	[p29l705t2935r798b2982],
3	characteristics	NNS	O	characteristic	_	0	SENT_503	[p29l815t2933r1189b2983],
4	of	IN	O	of	_	0	SENT_503	[p29l1204t2932r1258b2982],
5	patients	NNS	O	patient	prep_of	3	SENT_503	[p29l1270t2935r1480b2995],
6	at	IN	O	at	_	0	SENT_503	[p29l1494t2940r1543b2983],
7	high	JJ	O	high	amod	8	SENT_503	[p29l1559t2933r1672b2996],
8	risk	NN	O	risk	prep_at	5	SENT_503	[p29l1691t2933r1778b2983],
9	for	IN	O	for	_	0	SENT_503	[p29l1789t2932r1861b2982],
10	multiple	JJ	O	multiple	amod	11	SENT_503	[p29l1876t2933r2093b2995],
11	sclerosis	NN	O	sclerosis	prep_for	8	SENT_503	[p29l129t3011r359b3061],
12	:	:	O	:	_	0	SENT_503	[p29l129t3011r359b3061],
13	results	NNS	O	result	dep	3	SENT_503	[p29l376t3011r543b3061],
14	from	IN	O	from	_	0	SENT_503	[p29l556t3010r679b3061],
15	the	DT	O	the	det	17	SENT_503	[p29l694t3011r780b3061],
16	CHAMPS	NNP	MISC	CHAMPS	nn	17	SENT_503	[p29l794t3012r1024b3061],
17	trial	NN	O	trial	prep_from	13	SENT_503	[p29l1038t3011r1150b3061],
18	.	.	O	.	_	0	SENT_503	[p29l1038t3011r1150b3061],

1	Controlled	VBN	O	control	_	0	SENT_504	[p29l1165t3011r1439b3061],
2	High-Risk	JJ	O	high-risk	amod	3	SENT_504	[p29l1458t3011r1707b3074],
3	Subjects	NNS	O	subject	nsubj	8	SENT_504	[p29l1720t3011r1940b3074],
4	Avonex	NNP	O	Avonex	nn	8	SENT_504	[p29l1955t3013r2152b3061],
5	Multiple	JJ	O	multiple	amod	8	SENT_504	[p29l130t3089r346b3151],
6	Sclerosis	NNP	O	Sclerosis	nn	8	SENT_504	[p29l361t3089r584b3138],
7	Prevention	NNP	O	Prevention	nn	8	SENT_504	[p29l601t3091r881b3139],
8	Study	NNP	O	Study	xcomp	1	SENT_504	[p29l898t3089r1058b3153],
9	.	.	O	.	_	0	SENT_504	[p29l898t3089r1058b3153],

1	Mult	NNP	O	Mult	_	0	SENT_505	[p29l1070t3089r1197b3138],
2	.	.	O	.	_	0	SENT_505	[p29l1070t3089r1197b3138],

1	Scler	NNP	O	Scler	_	0	SENT_506	[p29l1211t3089r1342b3138],
2	.	.	O	.	_	0	SENT_506	[p29l1211t3089r1342b3138],

1	8	CD	NUMBER	8	_	0	SENT_507	[p29l1356t3092r1401b3146],
2	,	,	O	,	_	0	SENT_507	[p29l1356t3092r1401b3146],
3	330-338	CD	NUMBER	330-338	number	4	SENT_507	[p29l1416t3092r1640b3138],
4	(	CD	NUMBER	(	appos	1	SENT_507	[p29l1656t3090r1830b3146],
5	2002	CD	DATE	2002	num	6	SENT_507	[p29l1656t3090r1830b3146],
6	)	NN	O	)	dep	4	SENT_507	[p29l1656t3090r1830b3146],
7	.	.	O	.	_	0	SENT_507	[p29l1656t3090r1830b3146],

1	Tutuncu	NNP	PERSON	Tutuncu	_	0	SENT_508	[p29l125t3169r356b3224],
2	,	,	O	,	_	0	SENT_508	[p29l125t3169r356b3224],
3	M.	NNP	O	M.	nn	4	SENT_508	[p29l371t3169r431b3217],
4	etal	NNP	O	etal	appos	1	SENT_508	[p29l445t3167r560b3217],
5	.	.	O	.	_	0	SENT_508	[p29l445t3167r560b3217],

1	Onset	NN	O	onset	nsubj	9	SENT_509	[p29l574t3169r729b3217],
2	of	IN	O	of	_	0	SENT_509	[p29l742t3166r797b3217],
3	progressive	JJ	O	progressive	amod	4	SENT_509	[p29l809t3169r1109b3230],
4	phase	NN	O	phase	prep_of	1	SENT_509	[p29l1125t3167r1279b3229],
5	is	VBZ	O	be	cop	9	SENT_509	[p29l1295t3169r1329b3217],
6	an	DT	O	a	det	9	SENT_509	[p29l1344t3182r1404b3217],
7	age-dependent	JJ	O	age-dependent	amod	9	SENT_509	[p29l1421t3167r1834b3230],
8	clinical	JJ	O	clinical	amod	9	SENT_509	[p29l1848t3167r2024b3217],
9	milestone	NN	O	milestone	_	0	SENT_509	[p29l131t3245r388b3295],
10	in	IN	O	in	_	0	SENT_509	[p29l404t3247r447b3294],
11	multiple	JJ	O	multiple	amod	12	SENT_509	[p29l466t3245r682b3307],
12	sclerosis	NN	O	sclerosis	prep_in	9	SENT_509	[p29l697t3245r926b3295],
13	.	.	O	.	_	0	SENT_509	[p29l697t3245r926b3295],

1	Mult	NNP	O	Mult	_	0	SENT_510	[p29l939t3245r1065b3295],
2	.	.	O	.	_	0	SENT_510	[p29l939t3245r1065b3295],

1	Scler	NNP	O	Scler	_	0	SENT_511	[p29l1079t3245r1210b3295],
2	.	.	O	.	_	0	SENT_511	[p29l1079t3245r1210b3295],

1	19	CD	NUMBER	19	_	0	SENT_512	[p29l1228t3248r1305b3302],
2	,	,	O	,	_	0	SENT_512	[p29l1228t3248r1305b3302],
3	188-198	CD	NUMBER	188-198	number	4	SENT_512	[p29l1324t3248r1544b3295],
4	(	CD	NUMBER	(	appos	1	SENT_512	[p29l1560t3246r1734b3302],
5	2013	CD	DATE	2013	num	6	SENT_512	[p29l1560t3246r1734b3302],
6	)	NN	O	)	dep	4	SENT_512	[p29l1560t3246r1734b3302],
7	.	.	O	.	_	0	SENT_512	[p29l1560t3246r1734b3302],

1	Chrousos	NNP	O	Chrousos	_	0	SENT_513	[p29l127t3323r384b3380],
2	,	,	O	,	_	0	SENT_513	[p29l127t3323r384b3380],
3	G.A.	NNP	O	G.A.	conj_and	1	SENT_513	[p29l399t3325r514b3380],
4	,	,	O	,	_	0	SENT_513	[p29l399t3325r514b3380],
5	Kattah	NNP	LOCATION	Kattah	conj_and	1	SENT_513	[p29l531t3323r712b3380],
6	,	,	O	,	_	0	SENT_513	[p29l531t3323r712b3380],
7	J.C.	NNP	LOCATION	J.C.	conj_and	1	SENT_513	[p29l725t3324r822b3380],
8	,	,	O	,	_	0	SENT_513	[p29l725t3324r822b3380],
9	Beck	NNP	PERSON	Beck	conj_and	1	SENT_513	[p29l838t3323r971b3380],
10	,	,	O	,	_	0	SENT_513	[p29l838t3323r971b3380],
11	R.W.	NNP	ORGANIZATION	R.W.	conj_and	1	SENT_513	[p29l988t3325r1093b3372],
12	&	CC	ORGANIZATION	&	_	0	SENT_513	[p29l1107t3325r1144b3372],
13	Cleary	NNP	ORGANIZATION	Cleary	conj_and	1	SENT_513	[p29l1157t3323r1330b3386],
14	,	,	O	,	_	0	SENT_513	[p29l1157t3323r1330b3386],
15	P.A.	NNP	O	P.A.	nn	17	SENT_513	[p29l1347t3325r1431b3372],
16	Side	NNP	O	Side	nn	17	SENT_513	[p29l1446t3323r1556b3373],
17	effects	NNS	O	effect	appos	1	SENT_513	[p29l1570t3322r1742b3372],
18	of	IN	O	of	_	0	SENT_513	[p29l1757t3322r1811b3373],
19	glucocorticoid	NN	O	glucocorticoid	nn	20	SENT_513	[p29l129t3401r507b3464],
20	treatment	NN	O	treatment	prep_of	17	SENT_513	[p29l522t3408r799b3451],
21	.	.	O	.	_	0	SENT_513	[p29l522t3408r799b3451],

1	Experience	NN	O	experience	_	0	SENT_514	[p29l816t3403r1102b3463],
2	of	IN	O	of	_	0	SENT_514	[p29l1117t3400r1171b3451],
3	the	DT	O	the	det	6	SENT_514	[p29l1179t3401r1265b3451],
4	Optic	NNP	O	Optic	nn	6	SENT_514	[p29l1280t3403r1421b3463],
5	NeuritisTreatmentTria	NNP	O	NeuritisTreatmentTria	nn	6	SENT_514	[p29l1437t3401r2049b3451],
6	|	NN	O	|	prep_of	1	SENT_514	[p29l1437t3401r2049b3451],
7	.	.	O	.	_	0	SENT_514	[p29l1437t3401r2049b3451],

1	JAMA	NN	O	jama	_	0	SENT_515	[p29l125t3480r269b3527],
2	269	CD	NUMBER	269	num	1	SENT_515	[p29l285t3481r400b3534],
3	,	,	O	,	_	0	SENT_515	[p29l285t3481r400b3534],
4	21	CD	NUMBER	21	num	5	SENT_515	[p29l416t3481r466b3526],
5	10-21	CD	NUMBER	10-21	appos	1	SENT_515	[p29l485t3481r629b3527],
6	12	CD	NUMBER	12	number	7	SENT_515	[p29l647t3481r704b3526],
7	(	CD	NUMBER	(	dep	5	SENT_515	[p29l721t3479r895b3534],
8	1993	CD	DATE	1993	num	9	SENT_515	[p29l721t3479r895b3534],
9	)	NN	O	)	dep	7	SENT_515	[p29l721t3479r895b3534],
10	.	.	O	.	_	0	SENT_515	[p29l721t3479r895b3534],

1	Séguin	NNP	O	Séguin	_	0	SENT_516	[p29l128t3557r321b3619],
2	,	,	O	,	_	0	SENT_516	[p29l128t3557r321b3619],
3	C.	NNP	O	C.	nn	4	SENT_516	[p29l336t3558r382b3606],
4	etal	NNP	O	etal	appos	1	SENT_516	[p29l396t3556r511b3606],
5	.	.	O	.	_	0	SENT_516	[p29l396t3556r511b3606],

1	Non-traumatic	JJ	O	non-traumatic	amod	2	SENT_517	[p29l528t3558r910b3606],
2	necrosis	NN	O	necrosis	nsubjpass	9	SENT_517	[p29l926t3558r1136b3606],
3	of	IN	O	of	_	0	SENT_517	[p29l1151t3555r1205b3606],
4	bone	NN	O	bone	nn	7	SENT_517	[p29l1217t3556r1350b3606],
5	(	CD	NUMBER	(	num	7	SENT_517	[p29l1366t3557r1759b3613],
6	osteonecrosis	NN	O	osteonecrosis	nn	7	SENT_517	[p29l1366t3557r1759b3613],
7	)	NN	O	)	prep_of	2	SENT_517	[p29l1366t3557r1759b3613],
8	is	VBZ	O	be	auxpass	9	SENT_517	[p29l1776t3558r1811b3606],
9	associated	VBN	O	associate	_	0	SENT_517	[p29l1825t3556r2098b3606],
10	with	IN	O	with	_	0	SENT_517	[p29l128t3634r241b3683],
11	endothelial	JJ	O	endothelial	amod	13	SENT_517	[p29l258t3634r554b3683],
12	cell	NN	O	cell	nn	13	SENT_517	[p29l571t3634r654b3683],
13	activation	NN	O	activation	prep_with	9	SENT_517	[p29l671t3636r928b3683],
14	but	CC	O	but	_	0	SENT_517	[p29l947t3634r1034b3683],
15	not	RB	O	not	_	0	SENT_517	[p29l1050t3641r1136b3683],
16	thrombophilia	NN	O	thrombophilia	prep_with	9	SENT_517	[p29l1149t3634r1542b3696],
17	.	.	O	.	_	0	SENT_517	[p29l1149t3634r1542b3696],

1	Rheumatology	NNP	O	Rheumatology	nn	3	SENT_518	[p29l1557t3634r1935b3698],
2	(	NNP	O	(	nn	3	SENT_518	[p29l131t3710r349b3767],
3	Oxford	NNP	LOCATION	Oxford	_	0	SENT_518	[p29l131t3710r349b3767],
4	)	NN	O	)	dep	3	SENT_518	[p29l131t3710r349b3767],
5	.	.	O	.	_	0	SENT_518	[p29l131t3710r349b3767],

1	47	CD	NUMBER	47	_	0	SENT_519	[p29l363t3715r443b3767],
2	,	,	O	,	_	0	SENT_519	[p29l363t3715r443b3767],
3	1151-1	CD	NUMBER	1151-1	number	4	SENT_519	[p29l463t3715r639b3760],
4	155	CD	NUMBER	155	appos	1	SENT_519	[p29l658t3715r746b3760],
5	(	CD	NUMBER	(	num	7	SENT_519	[p29l764t3712r938b3767],
6	2008	CD	DATE	2008	num	7	SENT_519	[p29l764t3712r938b3767],
7	)	NN	O	)	dep	4	SENT_519	[p29l764t3712r938b3767],
8	.	.	O	.	_	0	SENT_519	[p29l764t3712r938b3767],

1	Li	NNP	PERSON	Li	_	0	SENT_520	[p30l130t20r182b75],
2	,	,	O	,	_	0	SENT_520	[p30l130t20r182b75],
3	W.	NNP	O	W.	nn	4	SENT_520	[p30l193t20r253b68],
4	etal	NNP	O	etal	appos	1	SENT_520	[p30l268t18r383b68],
5	.	.	O	.	_	0	SENT_520	[p30l268t18r383b68],

1	Distribution	NN	O	distribution	_	0	SENT_521	[p30l399t18r708b68],
2	ofTRAP-positive	JJ	O	oftrap-positive	amod	3	SENT_521	[p30l725t17r1149b80],
3	cells	NNS	O	cell	dep	1	SENT_521	[p30l1164t18r1275b68],
4	and	CC	O	and	_	0	SENT_521	[p30l1289t18r1385b68],
5	expression	NN	O	expression	dep	1	SENT_521	[p30l1402t20r1682b80],
6	of	IN	O	of	_	0	SENT_521	[p30l1698t17r1753b68],
7	HIF-1	NN	MISC	hif-1	prep_of	5	SENT_521	[p30l1765t20r1888b67],
8	alpha	NN	O	alpha	dep	1	SENT_521	[p30l1902t18r2060b80],
9	,	,	O	,	_	0	SENT_521	[p30l1902t18r2060b80],
10	VEGF	NN	O	vegf	dep	1	SENT_521	[p30l127t98r271b153],
11	,	,	O	,	_	0	SENT_521	[p30l127t98r271b153],
12	and	CC	O	and	_	0	SENT_521	[p30l286t96r382b146],
13	FGF-2	NN	O	fgf-2	dep	1	SENT_521	[p30l401t98r549b145],
14	in	IN	O	in	_	0	SENT_521	[p30l566t98r609b145],
15	the	DT	O	the	det	17	SENT_521	[p30l624t96r710b146],
16	reparative	JJ	O	reparative	amod	17	SENT_521	[p30l727t98r989b158],
17	reaction	NN	O	reaction	prep_in	8	SENT_521	[p30l1005t98r1215b146],
18	in	IN	O	in	_	0	SENT_521	[p30l1234t98r1276b145],
19	patients	NNS	O	patient	prep_in	17	SENT_521	[p30l1295t98r1504b158],
20	with	IN	O	with	_	0	SENT_521	[p30l1518t96r1632b146],
21	osteonecrosis	NN	O	osteonecrosis	prep_with	19	SENT_521	[p30l1648t98r2008b146],
22	of	IN	O	of	_	0	SENT_521	[p30l2023t95r2077b146],
23	the	DT	O	the	det	25	SENT_521	[p30l128t174r214b224],
24	femoral	JJ	O	femoral	amod	25	SENT_521	[p30l226t173r426b224],
25	head	NN	O	head	prep_of	21	SENT_521	[p30l445t174r630b224],
26	.	.	O	.	_	0	SENT_521	[p30l445t174r630b224],

1	J.	NNP	PERSON	J.	nn	2	SENT_522	[p30l445t174r630b224],
2	Orthop	NNP	PERSON	Orthop	_	0	SENT_522	[p30l646t174r837b236],
3	.	.	O	.	_	0	SENT_522	[p30l646t174r837b236],

1	Res	NNP	O	Res	_	0	SENT_523	[p30l852t176r947b224],
2	.	.	O	.	_	0	SENT_523	[p30l852t176r947b224],

1	27	CD	NUMBER	27	_	0	SENT_524	[p30l962t177r1042b231],
2	,	,	O	,	_	0	SENT_524	[p30l962t177r1042b231],
3	694-700	CD	NUMBER	694-700	number	4	SENT_524	[p30l1056t177r1281b224],
4	(	CD	NUMBER	(	appos	1	SENT_524	[p30l1297t175r1471b231],
5	2009	CD	DATE	2009	num	6	SENT_524	[p30l1297t175r1471b231],
6	)	NN	O	)	dep	4	SENT_524	[p30l1297t175r1471b231],
7	.	.	O	.	_	0	SENT_524	[p30l1297t175r1471b231],

1	Radke	NNP	PERSON	Radke	_	0	SENT_525	[p30l130t251r300b308],
2	,	,	O	,	_	0	SENT_525	[p30l130t251r300b308],
3	S.	NNP	O	S.	conj_and	1	SENT_525	[p30l315t253r368b308],
4	,	,	O	,	_	0	SENT_525	[p30l315t253r368b308],
5	Battmann	NNP	PERSON	Battmann	conj_and	1	SENT_525	[p30l385t253r654b308],
6	,	,	O	,	_	0	SENT_525	[p30l385t253r654b308],
7	A.	NNP	O	A.	conj_and	1	SENT_525	[p30l667t253r729b308],
8	,	,	O	,	_	0	SENT_525	[p30l667t253r729b308],
9	Jatzke	NNP	PERSON	Jatzke	conj_and	1	SENT_525	[p30l741t251r916b308],
10	,	,	O	,	_	0	SENT_525	[p30l741t251r916b308],
11	S.	NNP	O	S.	conj_and	1	SENT_525	[p30l931t253r984b308],
12	,	,	O	,	_	0	SENT_525	[p30l931t253r984b308],
13	Eulert	NNP	O	Eulert	conj_and	1	SENT_525	[p30l1001t251r1164b308],
14	,	,	O	,	_	0	SENT_525	[p30l1001t251r1164b308],
15	J.	NNP	O	J.	conj_and	1	SENT_525	[p30l1176t253r1223b309],
16	,	,	O	,	_	0	SENT_525	[p30l1176t253r1223b309],
17	Jakob	NNP	PERSON	Jakob	conj_and	1	SENT_525	[p30l1236t251r1401b308],
18	,	,	O	,	_	0	SENT_525	[p30l1236t251r1401b308],
19	F.	NNP	ORGANIZATION	F.	conj_and	1	SENT_525	[p30l1417t253r1449b301],
20	&	CC	ORGANIZATION	&	_	0	SENT_525	[p30l1463t253r1500b301],
21	Sch	NNP	ORGANIZATION	Sch	conj_and	1	SENT_525	[p30l1513t251r1602b301],
22	utze	NN	O	utze	dep	1	SENT_525	[p30l1611t254r1732b308],
23	,	,	O	,	_	0	SENT_525	[p30l1611t254r1732b308],
24	N.	NNP	O	N.	appos	22	SENT_525	[p30l1749t253r1798b301],
25	Expression	NN	O	expression	dep	1	SENT_525	[p30l1815t253r2091b313],
26	of	IN	O	of	_	0	SENT_525	[p30l129t328r184b379],
27	the	DT	O	the	det	28	SENT_525	[p30l192t329r278b379],
28	angiomatrix	NN	O	angiomatrix	prep_of	25	SENT_525	[p30l292t331r611b392],
29	and	CC	O	and	_	0	SENT_525	[p30l624t329r721b379],
30	angiogenic	JJ	O	angiogenic	amod	32	SENT_525	[p30l737t331r1031b392],
31	proteins	NNS	O	protein	nn	32	SENT_525	[p30l1047t331r1261b392],
32	CYR61	NN	O	cyr61	conj_and	28	SENT_525	[p30l1275t331r1455b386],
33	,	,	O	,	_	0	SENT_525	[p30l1275t331r1455b386],
34	CTGF	NN	O	ctgf	conj_and	1	SENT_525	[p30l1470t331r1614b386],
35	,	,	O	,	_	0	SENT_525	[p30l1470t331r1614b386],
36	and	CC	O	and	_	0	SENT_525	[p30l1628t329r1725b379],
37	VEGF	NN	O	vegf	conj_and	1	SENT_525	[p30l1737t331r1874b379],
38	in	IN	O	in	_	0	SENT_525	[p30l1891t331r1933b378],
39	osteonecrosis	NN	O	osteonecrosis	prep_in	37	SENT_525	[p30l129t409r489b457],
40	of	IN	O	of	_	0	SENT_525	[p30l504t406r558b457],
41	the	DT	O	the	det	44	SENT_525	[p30l567t407r652b457],
42	femoral	JJ	O	femoral	amod	44	SENT_525	[p30l665t406r865b457],
43	head	NN	O	head	nn	44	SENT_525	[p30l884t407r1069b457],
44	]	NN	O	]	prep_of	39	SENT_525	[p30l884t407r1069b457],
45	.	.	O	.	_	0	SENT_525	[p30l884t407r1069b457],

1	Orthop	NNP	O	Orthop	_	0	SENT_526	[p30l1085t407r1276b470],
2	.	.	O	.	_	0	SENT_526	[p30l1085t407r1276b470],

1	Res	NNP	O	Res	_	0	SENT_527	[p30l1291t409r1386b457],
2	.	.	O	.	_	0	SENT_527	[p30l1291t409r1386b457],

1	24	CD	NUMBER	24	_	0	SENT_528	[p30l1401t410r1480b464],
2	,	,	O	,	_	0	SENT_528	[p30l1401t410r1480b464],
3	945-952	CD	NUMBER	945-952	number	4	SENT_528	[p30l1495t410r1718b457],
4	(	CD	NUMBER	(	appos	1	SENT_528	[p30l1736t408r1910b464],
5	2006	CD	DATE	2006	num	6	SENT_528	[p30l1736t408r1910b464],
6	)	NN	O	)	dep	4	SENT_528	[p30l1736t408r1910b464],
7	.	.	O	.	_	0	SENT_528	[p30l1736t408r1910b464],

1	Ciccone	NNP	PERSON	Ciccone	_	0	SENT_529	[p30l127t487r346b542],
2	,	,	O	,	_	0	SENT_529	[p30l127t487r346b542],
3	A.	NN	O	a.	appos	1	SENT_529	[p30l360t487r422b542],
4	,	,	O	,	_	0	SENT_529	[p30l360t487r422b542],
5	Beretta	NNP	O	Beretta	nn	13	SENT_529	[p30l439t487r637b542],
6	,	,	O	,	_	0	SENT_529	[p30l439t487r637b542],
7	S.	NNP	O	S.	appos	13	SENT_529	[p30l652t487r705b542],
8	,	,	O	,	_	0	SENT_529	[p30l652t487r705b542],
9	Brusaferri	NNP	LOCATION	Brusaferri	appos	13	SENT_529	[p30l722t484r982b542],
10	,	,	O	,	_	0	SENT_529	[p30l722t484r982b542],
11	F.	NNP	O	F.	appos	13	SENT_529	[p30l999t487r1043b542],
12	,	,	O	,	_	0	SENT_529	[p30l999t487r1043b542],
13	Galea	NNP	PERSON	Galea	appos	1	SENT_529	[p30l1057t485r1217b542],
14	,	,	O	,	_	0	SENT_529	[p30l1057t485r1217b542],
15	|	CD	NUMBER	|	appos	1	SENT_529	[p30l1234t487r1269b542],
16	.	.	O	.	_	0	SENT_529	[p30l1234t487r1269b542],

1	,	,	O	,	_	0	SENT_530	[p30l1234t487r1269b542],
2	Protti	NNP	PERSON	Protti	dep	9	SENT_530	[p30l1286t487r1437b543],
3	,	,	O	,	_	0	SENT_530	[p30l1286t487r1437b543],
4	A.	NNP	ORGANIZATION	A.	appos	2	SENT_530	[p30l1451t487r1500b535],
5	&	CC	ORGANIZATION	&	_	0	SENT_530	[p30l1514t487r1551b535],
6	Spreaﬁco	NNP	ORGANIZATION	Spreaﬁco	conj_and	4	SENT_530	[p30l1564t484r1818b548],
7	,	,	O	,	_	0	SENT_530	[p30l1564t484r1818b548],
8	C.	NNP	O	C.	dep	9	SENT_530	[p30l1833t487r1879b535],
9	Corticosteroids	NNS	O	corticosteroid	_	0	SENT_530	[p30l129t563r527b613],
10	for	IN	O	for	_	0	SENT_530	[p30l539t562r612b613],
11	the	DT	O	the	det	13	SENT_530	[p30l624t563r710b613],
12	long	JJ	O	long	amod	13	SENT_530	[p30l727t563r986b626],
13	—	NN	O	—	prep_for	9	SENT_530	[p30l727t563r986b626],
14	term	NN	O	term	nn	15	SENT_530	[p30l727t563r986b626],
15	treatment	NN	O	treatment	dep	9	SENT_530	[p30l1001t571r1265b613],
16	in	IN	O	in	_	0	SENT_530	[p30l1281t565r1323b612],
17	multiple	JJ	O	multiple	amod	18	SENT_530	[p30l1342t563r1558b625],
18	sclerosis	NN	O	sclerosis	prep_in	15	SENT_530	[p30l1573t563r1802b613],
19	.	.	O	.	_	0	SENT_530	[p30l1573t563r1802b613],

1	Cochrane	NNP	ORGANIZATION	Cochrane	nn	3	SENT_531	[p30l1817t563r2059b613],
2	Database	NNP	ORGANIZATION	Database	nn	3	SENT_531	[p30l129t641r374b691],
3	Syst	NNP	ORGANIZATION	Syst	_	0	SENT_531	[p30l385t643r494b705],
4	.	.	O	.	_	0	SENT_531	[p30l385t643r494b705],

1	Rev.	NNP	O	Rev.	nn	2	SENT_532	[p30l509t643r609b691],
2	CD006264	NNP	O	CD006264	_	0	SENT_532	[p30l624t643r897b691],
3	(	CD	NUMBER	(	num	5	SENT_532	[p30l912t642r1086b698],
4	2008	CD	DATE	2008	num	5	SENT_532	[p30l912t642r1086b698],
5	)	NN	O	)	dep	2	SENT_532	[p30l912t642r1086b698],
6	.	.	O	.	_	0	SENT_532	[p30l912t642r1086b698],

1	Beck	NNP	PERSON	Beck	_	0	SENT_533	[p30l130t718r263b774],
2	,	,	O	,	_	0	SENT_533	[p30l130t718r263b774],
3	R.W.	NNP	O	R.W.	nn	4	SENT_533	[p30l280t720r384b767],
4	etal	NN	O	etal	appos	1	SENT_533	[p30l399t718r513b767],
5	.	.	O	.	_	0	SENT_533	[p30l399t718r513b767],

1	A	DT	O	a	det	5	SENT_534	[p30l528t720r564b767],
2	randomized	VBN	O	randomize	amod	5	SENT_534	[p30l580t718r907b775],
3	,	,	O	,	_	0	SENT_534	[p30l580t718r907b775],
4	controlled	VBN	O	control	amod	5	SENT_534	[p30l922t718r1188b767],
5	trial	NN	O	trial	_	0	SENT_534	[p30l1203t718r1300b767],
6	of	IN	O	of	_	0	SENT_534	[p30l1317t717r1372b767],
7	corticosteroids	NNS	O	corticosteroid	prep_of	5	SENT_534	[p30l1381t718r1770b767],
8	in	IN	O	in	_	0	SENT_534	[p30l1787t720r1830b767],
9	the	DT	O	the	det	10	SENT_534	[p30l1845t718r1931b767],
10	treatment	NN	O	treatment	prep_in	7	SENT_534	[p30l128t804r392b846],
11	of	IN	O	of	_	0	SENT_534	[p30l406t795r460b846],
12	acute	JJ	O	acute	amod	14	SENT_534	[p30l470t804r613b846],
13	optic	JJ	O	optic	amod	14	SENT_534	[p30l628t798r760b858],
14	neuritis	NN	O	neuritis	prep_of	10	SENT_534	[p30l776t796r1088b846],
15	.	.	O	.	_	0	SENT_534	[p30l776t796r1088b846],

1	The	DT	O	the	det	3	SENT_535	[p30l776t796r1088b846],
2	Optic	NNP	O	Optic	nn	3	SENT_535	[p30l1102t798r1244b858],
3	Neuritis	NNP	O	Neuritis	_	0	SENT_535	[p30l1260t798r1460b846],
4	Study	NNP	O	Study	nn	5	SENT_535	[p30l1475t796r1626b860],
5	Group	NNP	O	Group	dep	3	SENT_535	[p30l1638t798r1814b858],
6	.	.	O	.	_	0	SENT_535	[p30l1638t798r1814b858],

1	N.	NNP	O	N.	nn	2	SENT_536	[p30l1828t798r1876b846],
2	Engl	NNP	O	Engl	_	0	SENT_536	[p30l1891t796r2009b859],
3	.	.	O	.	_	0	SENT_536	[p30l1891t796r2009b859],

1	J.	NNP	O	J.	nn	2	SENT_537	[p30l2020t798r2055b846],
2	Med	NNP	O	Med	_	0	SENT_537	[p30l128t873r250b922],
3	.	.	O	.	_	0	SENT_537	[p30l128t873r250b922],

1	326	CD	NUMBER	326	_	0	SENT_538	[p30l265t876r380b930],
2	,	,	O	,	_	0	SENT_538	[p30l265t876r380b930],
3	581-588	CD	NUMBER	581-588	number	4	SENT_538	[p30l395t876r619b922],
4	(	CD	NUMBER	(	appos	1	SENT_538	[p30l635t874r810b929],
5	1992	CD	DATE	1992	num	6	SENT_538	[p30l635t874r810b929],
6	)	NN	O	)	dep	4	SENT_538	[p30l635t874r810b929],
7	.	.	O	.	_	0	SENT_538	[p30l635t874r810b929],

1	Beck	NNP	PERSON	Beck	_	0	SENT_539	[p30l130t951r263b1008],
2	,	,	O	,	_	0	SENT_539	[p30l130t951r263b1008],
3	R.W.	NNP	ORGANIZATION	R.W.	conj_and	1	SENT_539	[p30l280t953r384b1001],
4	&	CC	ORGANIZATION	&	_	0	SENT_539	[p30l398t953r435b1001],
5	Gal	NNP	ORGANIZATION	Gal	conj_and	1	SENT_539	[p30l448t951r544b1008],
6	,	,	O	,	_	0	SENT_539	[p30l448t951r544b1008],
7	R.L.	NNP	O	R.L.	nn	8	SENT_539	[p30l561t953r645b1001],
8	Treatment	NN	O	treatment	appos	1	SENT_539	[p30l655t953r928b1001],
9	of	IN	O	of	_	0	SENT_539	[p30l942t950r996b1001],
10	acute	JJ	O	acute	amod	12	SENT_539	[p30l1005t959r1149b1001],
11	optic	JJ	O	optic	amod	12	SENT_539	[p30l1163t953r1296b1013],
12	neuritis	NN	O	neuritis	prep_of	8	SENT_539	[p30l1311t953r1518b1001],
13	:	:	O	:	_	0	SENT_539	[p30l1311t953r1518b1001],
14	a	DT	O	a	det	15	SENT_539	[p30l1532t966r1558b1001],
15	summary	NN	O	summary	dep	1	SENT_539	[p30l1574t966r1822b1015],
16	of	IN	O	of	_	0	SENT_539	[p30l1835t950r1889b1001],
17	ﬁndings	NNS	O	ﬁndings	prep_of	15	SENT_539	[p30l1897t950r2111b1014],
18	from	IN	O	from	_	0	SENT_539	[p30l127t1028r250b1079],
19	the	DT	O	the	det	23	SENT_539	[p30l265t1029r351b1079],
20	optic	JJ	O	optic	amod	23	SENT_539	[p30l366t1031r498b1091],
21	neuritis	NN	O	neuritis	nn	23	SENT_539	[p30l514t1031r707b1079],
22	treatment	NN	O	treatment	nn	23	SENT_539	[p30l720t1036r985b1079],
23	trial	NN	O	trial	prep_from	17	SENT_539	[p30l997t1029r1109b1079],
24	.	.	O	.	_	0	SENT_539	[p30l997t1029r1109b1079],

1	Arch	NNP	O	Arch	_	0	SENT_540	[p30l1120t1029r1249b1079],
2	.	.	O	.	_	0	SENT_540	[p30l1120t1029r1249b1079],

1	Ophthalmol	NN	O	ophthalmol	_	0	SENT_541	[p30l1264t1029r1585b1092],
2	.	.	O	.	_	0	SENT_541	[p30l1264t1029r1585b1092],

1	126	CD	NUMBER	126	_	0	SENT_542	[p30l1602t1032r1715b1086],
2	,	,	O	,	_	0	SENT_542	[p30l1602t1032r1715b1086],
3	994-995	CD	NUMBER	994-995	number	4	SENT_542	[p30l1729t1032r1951b1079],
4	(	CD	NUMBER	(	appos	1	SENT_542	[p30l1969t1030r2144b1086],
5	2008	CD	DATE	2008	num	6	SENT_542	[p30l1969t1030r2144b1086],
6	)	NN	O	)	dep	4	SENT_542	[p30l1969t1030r2144b1086],
7	.	.	O	.	_	0	SENT_542	[p30l1969t1030r2144b1086],

1	Katz	NNP	PERSON	Katz	_	0	SENT_543	[p30l130t1109r251b1164],
2	,	,	O	,	_	0	SENT_543	[p30l130t1109r251b1164],
3	B.	NNP	O	B.	conj_and	1	SENT_543	[p30l268t1107r494b1164],
4	,	,	O	,	_	0	SENT_543	[p30l268t1107r494b1164],
5	Trobe	NNP	LOCATION	Trobe	conj_and	1	SENT_543	[p30l268t1107r494b1164],
6	,	,	O	,	_	0	SENT_543	[p30l268t1107r494b1164],
7	J.D.	NNP	ORGANIZATION	J.D.	conj_and	1	SENT_543	[p30l506t1109r594b1157],
8	&	CC	ORGANIZATION	&	_	0	SENT_543	[p30l608t1109r644b1157],
9	Beck	NNP	ORGANIZATION	Beck	conj_and	1	SENT_543	[p30l660t1107r793b1164],
10	,	,	O	,	_	0	SENT_543	[p30l660t1107r793b1164],
11	R.W.	NNP	O	R.W.	appos	1	SENT_543	[p30l809t1109r914b1157],
12	.	.	O	.	_	0	SENT_543	[p30l809t1109r914b1157],

1	The	DT	O	the	det	5	SENT_544	[p30l924t1107r1021b1157],
2	optic	JJ	O	optic	amod	5	SENT_544	[p30l1035t1109r1167b1169],
3	neuritis	NN	O	neuritis	nn	5	SENT_544	[p30l1184t1109r1377b1157],
4	treatment	NN	O	treatment	nn	5	SENT_544	[p30l1390t1114r1654b1157],
5	trial	NN	O	trial	_	0	SENT_544	[p30l1667t1107r1780b1157],
6	:	:	O	:	_	0	SENT_544	[p30l1667t1107r1780b1157],
7	implications	NNS	O	implication	dep	5	SENT_544	[p30l1796t1107r2115b1170],
8	for	IN	O	for	_	0	SENT_544	[p30l127t1184r200b1235],
9	clinicians	NNS	O	clinician	prep_for	7	SENT_544	[p30l213t1185r464b1235],
10	.	.	O	.	_	0	SENT_544	[p30l213t1185r464b1235],

1	Semin	NNP	PERSON	Semin	_	0	SENT_545	[p30l477t1187r646b1235],
2	.	.	O	.	_	0	SENT_545	[p30l477t1187r646b1235],

1	Ophthalmol	NN	O	ophthalmol	_	0	SENT_546	[p30l661t1185r982b1248],
2	.	.	O	.	_	0	SENT_546	[p30l661t1185r982b1248],

1	10	CD	NUMBER	10	_	0	SENT_547	[p30l999t1188r1076b1242],
2	,	,	O	,	_	0	SENT_547	[p30l999t1188r1076b1242],
3	214-220	CD	NUMBER	214-220	num	4	SENT_547	[p30l1091t1188r1315b1235],
4	(	NN	O	(	appos	1	SENT_547	[p30l1331t1186r1366b1242],
5	1	CD	NUMBER	1	number	6	SENT_547	[p30l1331t1186r1366b1242],
6	995	CD	NUMBER	995	num	7	SENT_547	[p30l1381t1186r1505b1242],
7	)	NN	O	)	dep	4	SENT_547	[p30l1381t1186r1505b1242],
8	.	.	O	.	_	0	SENT_547	[p30l1381t1186r1505b1242],

1	Corbett	NNP	PERSON	Corbett	_	0	SENT_548	[p30l127t1263r339b1320],
2	,	,	O	,	_	0	SENT_548	[p30l127t1263r339b1320],
3	J.J.	NNP	PERSON	J.J.	appos	1	SENT_548	[p30l351t1265r421b1313],
4	.	.	O	.	_	0	SENT_548	[p30l351t1265r421b1313],

1	What	WDT	O	what	nsubj	2	SENT_549	[p30l432t1263r571b1313],
2	have	VBP	O	have	_	0	SENT_549	[p30l587t1263r708b1313],
3	the	DT	O	the	det	7	SENT_549	[p30l722t1263r807b1313],
4	optic	JJ	O	optic	amod	7	SENT_549	[p30l822t1265r954b1325],
5	neuritis	NN	O	neuritis	nn	7	SENT_549	[p30l970t1265r1163b1313],
6	treatment	NN	O	treatment	nn	7	SENT_549	[p30l1177t1271r1441b1313],
7	trial	NN	O	trial	dobj	2	SENT_549	[p30l1454t1263r1551b1313],
8	and	CC	O	and	_	0	SENT_549	[p30l1568t1263r1664b1313],
9	the	DT	O	the	det	13	SENT_549	[p30l1679t1263r1765b1313],
10	longitudinal	JJ	O	longitudinal	amod	13	SENT_549	[p30l1782t1263r2097b1326],
11	optic	JJ	O	optic	amod	13	SENT_549	[p30l129t1343r261b1403],
12	neuritis	NN	O	neuritis	nn	13	SENT_549	[p30l277t1343r470b1391],
13	study	NN	O	study	dobj	2	SENT_549	[p30l485t1341r630b1405],
14	shown	VBN	O	show	partmod	13	SENT_549	[p30l643t1341r815b1391],
15	us	PRP	O	we	dobj	14	SENT_549	[p30l833t1343r913b1391],
16	?	.	O	?	_	0	SENT_549	[p30l833t1343r913b1391],

1	J.	NNP	PERSON	J.	nn	2	SENT_550	[p30l924t1343r959b1391],
2	Neurol	NNP	PERSON	Neurol	_	0	SENT_550	[p30l973t1341r1150b1391],
3	.	.	O	.	_	0	SENT_550	[p30l973t1341r1150b1391],

1	Sci	NNP	O	Sci	_	0	SENT_551	[p30l1164t1343r1247b1391],
2	.	.	O	.	_	0	SENT_551	[p30l1164t1343r1247b1391],

1	125	CD	NUMBER	125	_	0	SENT_552	[p30l1264t1344r1376b1398],
2	,	,	O	,	_	0	SENT_552	[p30l1264t1344r1376b1398],
3	1-2	CD	NUMBER	1-2	number	4	SENT_552	[p30l1395t1344r1483b1390],
4	(	CD	NUMBER	(	appos	1	SENT_552	[p30l1500t1342r1674b1398],
5	1994	CD	DATE	1994	num	6	SENT_552	[p30l1500t1342r1674b1398],
6	)	NN	O	)	dep	4	SENT_552	[p30l1500t1342r1674b1398],
7	.	.	O	.	_	0	SENT_552	[p30l1500t1342r1674b1398],

1	Beck	NNP	PERSON	Beck	_	0	SENT_553	[p30l130t1419r263b1476],
2	,	,	O	,	_	0	SENT_553	[p30l130t1419r263b1476],
3	R.W.	NNP	ORGANIZATION	R.W.	conj_and	1	SENT_553	[p30l279t1421r384b1469],
4	&	CC	ORGANIZATION	&	_	0	SENT_553	[p30l398t1421r435b1469],
5	Cleary	NNP	ORGANIZATION	Cleary	conj_and	1	SENT_553	[p30l448t1419r622b1483],
6	,	,	O	,	_	0	SENT_553	[p30l448t1419r622b1483],
7	P.A.	NNP	O	P.A.	nn	8	SENT_553	[p30l639t1421r722b1469],
8	Optic	NNP	O	Optic	appos	1	SENT_553	[p30l737t1421r878b1481],
9	neuritis	NN	O	neuritis	nn	11	SENT_553	[p30l894t1421r1087b1469],
10	treatment	NN	O	treatment	nn	11	SENT_553	[p30l1101t1427r1365b1469],
11	trial	NN	O	trial	dep	8	SENT_553	[p30l1378t1419r1490b1469],
12	.	.	O	.	_	0	SENT_553	[p30l1378t1419r1490b1469],

1	One	CD	NUMBER	one	number	2	SENT_554	[p30l1504t1421r1747b1483],
2	—	CD	NUMBER	—	num	7	SENT_554	[p30l1504t1421r1747b1483],
3	year	NN	NUMBER	year	nn	7	SENT_554	[p30l1504t1421r1747b1483],
4	fo	NN	O	fo	nn	7	SENT_554	[p30l1758t1418r2011b1481],
5	|	CD	NUMBER	|	num	7	SENT_554	[p30l1758t1418r2011b1481],
6	|	NN	O	|	nn	7	SENT_554	[p30l1758t1418r2011b1481],
7	ow	NN	O	ow	_	0	SENT_554	[p30l1758t1418r2011b1481],
8	—	CD	NUMBER	—	dep	7	SENT_554	[p30l1758t1418r2011b1481],
9	up	RP	O	up	prep	8	SENT_554	[p30l1758t1418r2011b1481],
10	results	NNS	O	result	dep	9	SENT_554	[p30l131t1497r311b1547],
11	.	.	O	.	_	0	SENT_554	[p30l131t1497r311b1547],

1	Arch	NNP	O	Arch	_	0	SENT_555	[p30l322t1497r450b1547],
2	.	.	O	.	_	0	SENT_555	[p30l322t1497r450b1547],

1	Ophthalmol	NN	O	ophthalmol	_	0	SENT_556	[p30l466t1497r786b1559],
2	.	.	O	.	_	0	SENT_556	[p30l466t1497r786b1559],

1	1	CD	NUMBER	1	number	2	SENT_557	[p30l804t1501r823b1546],
2	1	CD	NUMBER	1	_	0	SENT_557	[p30l839t1501r859b1546],
3	1	CD	NUMBER	1	dep	2	SENT_557	[p30l875t1501r916b1554],
4	,	,	O	,	_	0	SENT_557	[p30l875t1501r916b1554],
5	773-775	CD	NUMBER	773-775	number	6	SENT_557	[p30l931t1500r1153b1547],
6	(	CD	NUMBER	(	appos	2	SENT_557	[p30l1171t1498r1345b1554],
7	1993	CD	DATE	1993	num	8	SENT_557	[p30l1171t1498r1345b1554],
8	)	NN	O	)	dep	6	SENT_557	[p30l1171t1498r1345b1554],
9	.	.	O	.	_	0	SENT_557	[p30l1171t1498r1345b1554],

1	Weinshenker	NNP	O	Weinshenker	_	0	SENT_558	[p30l126t1575r478b1632],
2	,	,	O	,	_	0	SENT_558	[p30l126t1575r478b1632],
3	B.G.	NNP	PERSON	B.G.	nn	4	SENT_558	[p30l495t1577r589b1625],
4	etal	NNP	O	etal	appos	1	SENT_558	[p30l604t1575r719b1625],
5	.	.	O	.	_	0	SENT_558	[p30l604t1575r719b1625],

1	A	DT	O	a	det	3	SENT_559	[p30l733t1577r769b1624],
2	randomized	JJ	O	randomized	amod	3	SENT_559	[p30l785t1575r1097b1625],
3	trial	NN	O	trial	_	0	SENT_559	[p30l1113t1575r1210b1625],
4	of	IN	O	of	_	0	SENT_559	[p30l1227t1574r1281b1625],
5	plasma	NN	O	plasma	nn	6	SENT_559	[p30l1293t1575r1477b1637],
6	exchange	NN	O	exchange	prep_of	3	SENT_559	[p30l1493t1575r1747b1638],
7	in	IN	O	in	_	0	SENT_559	[p30l1764t1577r1806b1624],
8	acute	JJ	O	acute	amod	14	SENT_559	[p30l1822t1583r1966b1625],
9	central	JJ	O	central	amod	14	SENT_559	[p30l129t1653r305b1703],
10	nervous	JJ	O	nervous	amod	14	SENT_559	[p30l324t1668r533b1703],
11	system	NN	O	system	nn	14	SENT_559	[p30l548t1661r728b1717],
12	inﬂammatory	JJ	O	inﬂammatory	amod	14	SENT_559	[p30l746t1652r1102b1717],
13	demyelinating	NN	O	demyelinating	nn	14	SENT_559	[p30l1115t1653r1493b1717],
14	disease	NN	O	disease	prep_in	3	SENT_559	[p30l1509t1653r1713b1703],
15	.	.	O	.	_	0	SENT_559	[p30l1509t1653r1713b1703],

1	Ann	NNP	PERSON	Ann	_	0	SENT_560	[p30l1724t1655r1840b1703],
2	.	.	O	.	_	0	SENT_560	[p30l1724t1655r1840b1703],

1	Neurol	NNP	O	Neurol	_	0	SENT_561	[p30l1855t1653r2035b1703],
2	.	.	O	.	_	0	SENT_561	[p30l1855t1653r2035b1703],

1	46	CD	NUMBER	46	_	0	SENT_562	[p30l2048t1656r2129b1710],
2	,	,	O	,	_	0	SENT_562	[p30l2048t1656r2129b1710],
3	878-886	CD	NUMBER	878-886	number	4	SENT_562	[p30l129t1734r354b1780],
4	(	CD	NUMBER	(	appos	1	SENT_562	[p30l370t1732r544b1787],
5	1999	CD	DATE	1999	num	6	SENT_562	[p30l370t1732r544b1787],
6	)	NN	O	)	dep	4	SENT_562	[p30l370t1732r544b1787],
7	.	.	O	.	_	0	SENT_562	[p30l370t1732r544b1787],

1	Keegan	NNP	PERSON	Keegan	nn	9	SENT_563	[p30l130t1811r337b1871],
2	,	,	O	,	_	0	SENT_563	[p30l130t1811r337b1871],
3	M.	NNP	O	M.	appos	9	SENT_563	[p30l353t1811r425b1866],
4	,	,	O	,	_	0	SENT_563	[p30l353t1811r425b1866],
5	Pineda	NNP	PERSON	Pineda	appos	9	SENT_563	[p30l442t1808r630b1866],
6	,	,	O	,	_	0	SENT_563	[p30l442t1808r630b1866],
7	A.A.	NNP	LOCATION	A.A.	appos	9	SENT_563	[p30l644t1811r758b1866],
8	,	,	O	,	_	0	SENT_563	[p30l644t1811r758b1866],
9	McC	NNP	O	McC	nsubj	10	SENT_563	[p30l774t1808r1077b1866],
10	|	VBD	O	|	_	0	SENT_563	[p30l774t1808r1077b1866],
11	e	SYM	O	e	dep	10	SENT_563	[p30l774t1808r1077b1866],
12	|	CD	NUMBER	|	num	13	SENT_563	[p30l774t1808r1077b1866],
13	|	NN	O	|	dobj	10	SENT_563	[p30l774t1808r1077b1866],
14	and	CC	O	and	_	0	SENT_563	[p30l774t1808r1077b1866],
15	,	,	O	,	_	0	SENT_563	[p30l774t1808r1077b1866],
16	R.L.	NNP	PERSON	R.L.	dep	13	SENT_563	[p30l1094t1810r1191b1866],
17	,	,	O	,	_	0	SENT_563	[p30l1094t1810r1191b1866],
18	Darby	NNP	PERSON	Darby	appos	16	SENT_563	[p30l1209t1808r1373b1872],
19	,	,	O	,	_	0	SENT_563	[p30l1209t1808r1373b1872],
20	C.H.	NNP	LOCATION	C.H.	conj_and	18	SENT_563	[p30l1387t1810r1501b1866],
21	,	,	O	,	_	0	SENT_563	[p30l1387t1810r1501b1866],
22	Rodriguez	NNP	PERSON	Rodriguez	conj_and	18	SENT_563	[p30l1518t1808r1796b1871],
23	,	,	O	,	_	0	SENT_563	[p30l1518t1808r1796b1871],
24	M.	NNP	ORGANIZATION	M.	conj_and	18	SENT_563	[p30l1812t1811r1872b1858],
25	&	CC	ORGANIZATION	&	_	0	SENT_563	[p30l1886t1810r1922b1858],
26	Weinshenker	NNP	ORGANIZATION	Weinshenker	conj_and	18	SENT_563	[p30l127t1886r479b1944],
27	,	,	O	,	_	0	SENT_563	[p30l127t1886r479b1944],
28	B.G.	NNP	ORGANIZATION	B.G.	nn	30	SENT_563	[p30l496t1888r591b1936],
29	Plasma	NN	ORGANIZATION	plasma	nn	30	SENT_563	[p30l608t1886r789b1936],
30	exchange	NN	O	exchange	dobj	10	SENT_563	[p30l805t1886r1059b1949],
31	for	IN	O	for	_	0	SENT_563	[p30l1072t1886r1144b1936],
32	severe	JJ	O	severe	amod	33	SENT_563	[p30l1158t1901r1325b1936],
33	attacks	NNS	O	attack	prep_for	13	SENT_563	[p30l1339t1886r1522b1936],
34	of	IN	O	of	_	0	SENT_563	[p30l1537t1886r1591b1936],
35	CNS	NN	ORGANIZATION	cn	nn	37	SENT_563	[p30l1601t1888r1707b1936],
36	demyelinationz	NN	O	demyelinationz	nn	37	SENT_563	[p30l1722t1886r2115b1950],
37	predictors	NNS	O	predictor	prep_of	33	SENT_563	[p30l131t1964r395b2027],
38	of	IN	O	of	_	0	SENT_563	[p30l410t1964r464b2014],
39	response	NN	O	response	prep_of	37	SENT_563	[p30l475t1979r723b2027],
40	.	.	O	.	_	0	SENT_563	[p30l475t1979r723b2027],

1	Neurology	NN	O	neurology	_	0	SENT_564	[p30l737t1964r1003b2028],
2	58	CD	NUMBER	58	num	1	SENT_564	[p30l1014t1967r1094b2022],
3	,	,	O	,	_	0	SENT_564	[p30l1014t1967r1094b2022],
4	143-146	CD	NUMBER	143-146	number	5	SENT_564	[p30l1113t1967r1333b2014],
5	(	CD	NUMBER	(	appos	1	SENT_564	[p30l1349t1965r1523b2022],
6	2002	CD	DATE	2002	num	7	SENT_564	[p30l1349t1965r1523b2022],
7	)	NN	O	)	dep	5	SENT_564	[p30l1349t1965r1523b2022],
8	.	.	O	.	_	0	SENT_564	[p30l1349t1965r1523b2022],

1	Magana	NNP	PERSON	Magana	_	0	SENT_565	[p30l129t2045r351b2105],
2	,	,	O	,	_	0	SENT_565	[p30l129t2045r351b2105],
3	S.M.	NNP	O	S.M.	nn	4	SENT_565	[p30l367t2044r471b2092],
4	etal	NN	O	etal	appos	1	SENT_565	[p30l486t2042r600b2092],
5	.	.	O	.	_	0	SENT_565	[p30l486t2042r600b2092],

1	Beneﬁcial	NNP	O	Beneﬁcial	nn	4	SENT_566	[p30l617t2042r865b2092],
2	plasma	NN	O	plasma	nn	4	SENT_566	[p30l884t2042r1067b2105],
3	exchange	NN	O	exchange	nn	4	SENT_566	[p30l1084t2042r1338b2105],
4	response	NN	O	response	_	0	SENT_566	[p30l1355t2057r1590b2105],
5	in	IN	O	in	_	0	SENT_566	[p30l1606t2045r1648b2091],
6	central	JJ	O	central	amod	10	SENT_566	[p30l1665t2042r1841b2092],
7	nervous	JJ	O	nervous	amod	10	SENT_566	[p30l1860t2057r2069b2092],
8	system	NN	O	system	nn	10	SENT_566	[p30l129t2128r309b2184],
9	inﬂammatory	JJ	O	inﬂammatory	amod	10	SENT_566	[p30l327t2120r683b2184],
10	demyelination	NN	O	demyelination	prep_in	4	SENT_566	[p30l696t2120r1088b2184],
11	.	.	O	.	_	0	SENT_566	[p30l696t2120r1088b2184],

1	Arch	NNP	O	Arch	_	0	SENT_567	[p30l1099t2120r1228b2170],
2	.	.	O	.	_	0	SENT_567	[p30l1099t2120r1228b2170],

1	Neurol	NNP	O	Neurol	_	0	SENT_568	[p30l1242t2120r1422b2170],
2	.	.	O	.	_	0	SENT_568	[p30l1242t2120r1422b2170],

1	68	CD	NUMBER	68	_	0	SENT_569	[p30l1436t2123r1517b2178],
2	,	,	O	,	_	0	SENT_569	[p30l1436t2123r1517b2178],
3	870-878	CD	NUMBER	870-878	num	4	SENT_569	[p30l1531t2123r1756b2170],
4	(	NN	O	(	appos	1	SENT_569	[p30l1772t2121r1872b2178],
5	201	CD	NUMBER	201	number	6	SENT_569	[p30l1772t2121r1872b2178],
6	1	CD	NUMBER	1	num	7	SENT_569	[p30l1890t2121r1946b2178],
7	)	NN	O	)	dep	4	SENT_569	[p30l1890t2121r1946b2178],
8	.	.	O	.	_	0	SENT_569	[p30l1890t2121r1946b2178],

1	Keegan	NNP	PERSON	Keegan	_	0	SENT_570	[p30l130t2201r337b2261],
2	,	,	O	,	_	0	SENT_570	[p30l130t2201r337b2261],
3	M.	NNP	O	M.	nn	4	SENT_570	[p30l353t2201r412b2248],
4	etal	NNP	O	etal	appos	1	SENT_570	[p30l426t2198r541b2248],
5	.	.	O	.	_	0	SENT_570	[p30l426t2198r541b2248],

1	Relation	NN	O	relation	_	0	SENT_571	[p30l558t2198r768b2248],
2	between	IN	O	between	_	0	SENT_571	[p30l786t2198r1014b2248],
3	humoral	JJ	O	humoral	amod	5	SENT_571	[p30l1033t2198r1249b2248],
4	pathological	JJ	O	pathological	amod	5	SENT_571	[p30l1268t2198r1592b2261],
5	changes	NNS	O	change	prep_between	1	SENT_571	[p30l1609t2198r1828b2261],
6	in	IN	O	in	_	0	SENT_571	[p30l1844t2201r1887b2247],
7	multiple	JJ	O	multiple	amod	8	SENT_571	[p30l1906t2198r2122b2261],
8	sclerosis	NN	O	sclerosis	prep_in	1	SENT_571	[p30l129t2276r345b2326],
9	and	CC	O	and	_	0	SENT_571	[p30l360t2276r457b2326],
10	response	NN	O	response	conj_and	8	SENT_571	[p30l475t2291r710b2339],
11	to	TO	O	to	_	0	SENT_571	[p30l724t2284r776b2326],
12	therapeutic	JJ	O	therapeutic	amod	14	SENT_571	[p30l790t2276r1095b2339],
13	plasma	NN	O	plasma	nn	14	SENT_571	[p30l1111t2276r1295b2339],
14	exchange	NN	O	exchange	prep_to	1	SENT_571	[p30l1311t2276r1577b2339],
15	.	.	O	.	_	0	SENT_571	[p30l1311t2276r1577b2339],

1	Lancet	NNP	O	Lancet	_	0	SENT_572	[p30l1592t2279r1762b2326],
2	366	CD	NUMBER	366	num	1	SENT_572	[p30l1773t2279r1888b2334],
3	,	,	O	,	_	0	SENT_572	[p30l1773t2279r1888b2334],
4	579-582	CD	NUMBER	579-582	num	1	SENT_572	[p30l1903t2279r2126b2326],
5	(	CD	NUMBER	(	num	7	SENT_572	[p30l130t2354r305b2410],
6	2005	CD	DATE	2005	num	7	SENT_572	[p30l130t2354r305b2410],
7	)	NN	O	)	dep	1	SENT_572	[p30l130t2354r305b2410],
8	.	.	O	.	_	0	SENT_572	[p30l130t2354r305b2410],

1	Elkhalifa	NNP	PERSON	Elkhalifa	_	0	SENT_573	[p30l130t2431r359b2489],
2	,	,	O	,	_	0	SENT_573	[p30l130t2431r359b2489],
3	A.	NNP	ORGANIZATION	A.	conj_and	1	SENT_573	[p30l372t2434r421b2481],
4	&	CC	ORGANIZATION	&	_	0	SENT_573	[p30l436t2433r675b2489],
5	Weiner	NNP	ORGANIZATION	Weiner	conj_and	1	SENT_573	[p30l436t2433r675b2489],
6	,	,	O	,	_	0	SENT_573	[p30l436t2433r675b2489],
7	H.	NNP	O	H.	nn	9	SENT_573	[p30l692t2434r741b2481],
8	Cyclophosphamide	NNP	O	Cyclophosphamide	nn	9	SENT_573	[p30l755t2431r1265b2495],
9	Treatment	NN	O	treatment	appos	1	SENT_573	[p30l1275t2434r1548b2481],
10	of	IN	O	of	_	0	SENT_573	[p30l1562t2431r1616b2481],
11	MS	NN	O	m	prep_of	9	SENT_573	[p30l1627t2433r1718b2481],
12	:	:	O	:	_	0	SENT_573	[p30l1627t2433r1718b2481],
13	Current	JJ	DATE	current	amod	15	SENT_573	[p30l1732t2433r1930b2481],
14	Therapeutic	JJ	O	therapeutic	amod	15	SENT_573	[p30l126t2509r443b2572],
15	Approaches	NNS	O	approach	dep	1	SENT_573	[p30l456t2509r771b2572],
16	and	CC	O	and	_	0	SENT_573	[p30l786t2509r882b2559],
17	Treatment	NN	O	treatment	nn	18	SENT_573	[p30l894t2512r1167b2559],
18	Regimens	NNS	O	regimen	dep	1	SENT_573	[p30l1183t2511r1452b2572],
19	.	.	O	.	_	0	SENT_573	[p30l1183t2511r1452b2572],

1	Int	NN	O	int	_	0	SENT_574	[p30l1466t2512r1542b2559],
2	.	.	O	.	_	0	SENT_574	[p30l1466t2512r1542b2559],

1	MSJ	NN	O	msj	_	0	SENT_575	[p30l1556t2511r1678b2559],
2	.	.	O	.	_	0	SENT_575	[p30l1556t2511r1678b2559],

1	17	CD	NUMBER	17	_	0	SENT_576	[p30l1696t2513r1772b2567],
2	,	,	O	,	_	0	SENT_576	[p30l1696t2513r1772b2567],
3	12-18	CD	NUMBER	12-18	number	4	SENT_576	[p30l1791t2512r1946b2559],
4	(	CD	NUMBER	(	appos	1	SENT_576	[p30l1962t2510r2136b2567],
5	2010	CD	DATE	2010	num	6	SENT_576	[p30l1962t2510r2136b2567],
6	)	NN	O	)	dep	4	SENT_576	[p30l1962t2510r2136b2567],
7	.	.	O	.	_	0	SENT_576	[p30l1962t2510r2136b2567],

1	Weiner	NNP	PERSON	Weiner	_	0	SENT_577	[p30l126t2589r320b2643],
2	,	,	O	,	_	0	SENT_577	[p30l126t2589r320b2643],
3	H.L.	NNP	O	H.L.	conj_and	1	SENT_577	[p30l337t2589r441b2643],
4	,	,	O	,	_	0	SENT_577	[p30l337t2589r441b2643],
5	Hauser	NNP	PERSON	Hauser	conj_and	1	SENT_577	[p30l458t2589r647b2643],
6	,	,	O	,	_	0	SENT_577	[p30l458t2589r647b2643],
7	S.L.	NNP	LOCATION	S.L.	conj_and	1	SENT_577	[p30l662t2588r758b2643],
8	,	,	O	,	_	0	SENT_577	[p30l662t2588r758b2643],
9	Haﬂer	NNP	O	Haﬂer	conj_and	1	SENT_577	[p30l775t2586r937b2643],
10	,	,	O	,	_	0	SENT_577	[p30l775t2586r937b2643],
11	D.A.	NNP	LOCATION	D.A.	conj_and	1	SENT_577	[p30l954t2588r1066b2643],
12	,	,	O	,	_	0	SENT_577	[p30l954t2588r1066b2643],
13	Fallis	NNP	PERSON	Fallis	conj_and	1	SENT_577	[p30l1083t2586r1217b2643],
14	,	,	O	,	_	0	SENT_577	[p30l1083t2586r1217b2643],
15	R.J.	NNP	LOCATION	R.J.	conj_and	1	SENT_577	[p30l1234t2588r1324b2643],
16	,	,	O	,	_	0	SENT_577	[p30l1234t2588r1324b2643],
17	Lehrich	NNP	LOCATION	Lehrich	conj_and	1	SENT_577	[p30l1341t2586r1544b2643],
18	,	,	O	,	_	0	SENT_577	[p30l1341t2586r1544b2643],
19	J.R.	NNP	ORGANIZATION	J.R.	conj_and	1	SENT_577	[p30l1556t2588r1638b2635],
20	&	CC	ORGANIZATION	&	_	0	SENT_577	[p30l1652t2588r1689b2635],
21	Dawson	NNP	ORGANIZATION	Dawson	conj_and	1	SENT_577	[p30l1704t2588r1926b2643],
22	,	,	O	,	_	0	SENT_577	[p30l1704t2588r1926b2643],
23	D.M.	NNP	PERSON	D.M.	appos	1	SENT_577	[p30l1943t2588r2054b2635],
24	.	.	O	.	_	0	SENT_577	[p30l1943t2588r2054b2635],

1	The	DT	O	the	det	2	SENT_578	[p30l126t2664r223b2714],
2	use	NN	O	use	_	0	SENT_578	[p30l240t2679r326b2714],
3	of	IN	O	of	_	0	SENT_578	[p30l341t2664r395b2714],
4	cyclophosphamide	NN	O	cyclophosphamide	prep_of	2	SENT_578	[p30l405t2664r910b2728],
5	in	IN	O	in	_	0	SENT_578	[p30l925t2667r968b2713],
6	the	DT	O	the	det	7	SENT_578	[p30l983t2664r1069b2714],
7	treatment	NN	O	treatment	prep_in	2	SENT_578	[p30l1082t2672r1347b2714],
8	of	IN	O	of	_	0	SENT_578	[p30l1360t2664r1415b2714],
9	multiple	JJ	O	multiple	amod	12	SENT_578	[p30l1427t2664r1643b2727],
10	sc	NN	O	sc	nn	12	SENT_578	[p30l1658t2664r2013b2714],
11	|	NN	O	|	nn	12	SENT_578	[p30l1658t2664r2013b2714],
12	erosis	NN	O	erosis	prep_of	7	SENT_578	[p30l1658t2664r2013b2714],
13	.	.	O	.	_	0	SENT_578	[p30l1658t2664r2013b2714],

1	Ann	NNP	PERSON	Ann	_	0	SENT_579	[p30l1658t2664r2013b2714],
2	.	.	O	.	_	0	SENT_579	[p30l1658t2664r2013b2714],

1	N.	NNP	PERSON	N.	nn	3	SENT_580	[p30l2028t2667r2076b2714],
2	Y.	NNP	PERSON	Y.	nn	3	SENT_580	[p30l2094t2667r2127b2714],
3	Acad	NNP	PERSON	Acad	_	0	SENT_580	[p30l125t2741r263b2790],
4	.	.	O	.	_	0	SENT_580	[p30l125t2741r263b2790],

1	Sci	NNP	O	Sci	_	0	SENT_581	[p30l277t2743r359b2790],
2	.	.	O	.	_	0	SENT_581	[p30l277t2743r359b2790],

1	436	CD	NUMBER	436	_	0	SENT_582	[p30l373t2744r489b2798],
2	,	,	O	,	_	0	SENT_582	[p30l373t2744r489b2798],
3	373-381	CD	NUMBER	373-381	number	4	SENT_582	[p30l504t2744r718b2790],
4	(	CD	NUMBER	(	appos	1	SENT_582	[p30l744t2742r919b2798],
5	1984	CD	DATE	1984	num	6	SENT_582	[p30l744t2742r919b2798],
6	)	NN	O	)	dep	4	SENT_582	[p30l744t2742r919b2798],
7	.	.	O	.	_	0	SENT_582	[p30l744t2742r919b2798],

1	Costelloe	NNP	PERSON	Costelloe	_	0	SENT_583	[p30l127t2819r381b2877],
2	,	,	O	,	_	0	SENT_583	[p30l127t2819r381b2877],
3	L.	NNP	O	L.	conj_and	1	SENT_583	[p30l398t2822r448b2877],
4	,	,	O	,	_	0	SENT_583	[p30l398t2822r448b2877],
5	Jones	NNP	PERSON	Jones	conj_and	1	SENT_583	[p30l461t2822r622b2877],
6	,	,	O	,	_	0	SENT_583	[p30l461t2822r622b2877],
7	J.	NNP	ORGANIZATION	J.	conj_and	1	SENT_583	[p30l635t2822r669b2869],
8	&	CC	ORGANIZATION	&	_	0	SENT_583	[p30l683t2821r720b2869],
9	Coles	NNP	ORGANIZATION	Coles	conj_and	1	SENT_583	[p30l732t2819r884b2877],
10	,	,	O	,	_	0	SENT_583	[p30l732t2819r884b2877],
11	A.	NNP	O	A.	nn	14	SENT_583	[p30l898t2822r947b2869],
12	Secondary	JJ	O	secondary	amod	14	SENT_583	[p30l962t2819r1241b2883],
13	autoimmune	JJ	O	autoimmune	amod	14	SENT_583	[p30l1254t2822r1595b2869],
14	diseases	NNS	O	disease	appos	1	SENT_583	[p30l1610t2819r1827b2869],
15	following	VBG	O	follow	_	0	SENT_583	[p30l1840t2819r2085b2882],
16	alemtuzumab	JJ	O	alemtuzumab	amod	17	SENT_583	[p30l129t2897r494b2947],
17	therapy	NN	O	therapy	prep_following	14	SENT_583	[p30l508t2897r712b2961],
18	for	IN	O	for	_	0	SENT_583	[p30l724t2897r796b2947],
19	multiple	JJ	O	multiple	amod	20	SENT_583	[p30l811t2897r1028b2960],
20	sclerosis	NN	O	sclerosis	prep_for	17	SENT_583	[p30l1043t2897r1272b2947],
21	.	.	O	.	_	0	SENT_583	[p30l1043t2897r1272b2947],

1	Expert	NN	O	expert	_	0	SENT_584	[p30l1286t2900r1448b2960],
2	Rev.	NNP	O	Rev.	nn	3	SENT_584	[p30l1457t2899r1553b2947],
3	Neurother	NNP	PERSON	Neurother	dep	1	SENT_584	[p30l1568t2897r1836b2947],
4	.	.	O	.	_	0	SENT_584	[p30l1568t2897r1836b2947],

1	12	CD	NUMBER	12	_	0	SENT_585	[p30l1854t2901r1931b2955],
2	,	,	O	,	_	0	SENT_585	[p30l1854t2901r1931b2955],
3	335-341	CD	NUMBER	335-341	number	4	SENT_585	[p30l129t2977r343b3023],
4	(	CD	NUMBER	(	appos	1	SENT_585	[p30l369t2975r543b3031],
5	2012	CD	DATE	2012	num	6	SENT_585	[p30l369t2975r543b3031],
6	)	NN	O	)	dep	4	SENT_585	[p30l369t2975r543b3031],
7	.	.	O	.	_	0	SENT_585	[p30l369t2975r543b3031],

1	Perumal	NNP	O	Perumal	_	0	SENT_586	[p30l129t3051r355b3108],
2	,	,	O	,	_	0	SENT_586	[p30l129t3051r355b3108],
3	J.S.	NNP	LOCATION	J.S.	conj_and	1	SENT_586	[p30l367t3053r459b3108],
4	,	,	O	,	_	0	SENT_586	[p30l367t3053r459b3108],
5	Foo	NNP	O	Foo	conj_and	1	SENT_586	[p30l475t3054r580b3108],
6	,	,	O	,	_	0	SENT_586	[p30l475t3054r580b3108],
7	F.	NNP	O	F.	conj_and	1	SENT_586	[p30l597t3054r641b3108],
8	,	,	O	,	_	0	SENT_586	[p30l597t3054r641b3108],
9	Cook	NNP	PERSON	Cook	conj_and	1	SENT_586	[p30l656t3051r802b3108],
10	,	,	O	,	_	0	SENT_586	[p30l656t3051r802b3108],
11	P.	NNP	PERSON	P.	conj_and	1	SENT_586	[p30l819t3053r851b3100],
12	&	CC	PERSON	&	_	0	SENT_586	[p30l865t3053r902b3100],
13	Khan	NNP	PERSON	Khan	conj_and	1	SENT_586	[p30l917t3051r1061b3108],
14	,	,	O	,	_	0	SENT_586	[p30l917t3051r1061b3108],
15	o.	NNP	O	o.	nn	17	SENT_586	[p30l1075t3053r1126b3100],
16	Subcutaneous	NNP	MISC	Subcutaneous	nn	17	SENT_586	[p30l1141t3051r1518b3100],
17	administration	NN	O	administration	appos	1	SENT_586	[p30l1532t3051r1915b3100],
18	of	IN	O	of	_	0	SENT_586	[p30l1932t3051r1986b3100],
19	alemtuzumab	NN	O	alemtuzumab	prep_of	17	SENT_586	[p30l129t3129r494b3179],
20	in	IN	O	in	_	0	SENT_586	[p30l511t3132r553b3178],
21	patients	NNS	O	patient	prep_in	19	SENT_586	[p30l572t3132r781b3192],
22	with	IN	O	with	_	0	SENT_586	[p30l795t3129r909b3179],
23	highly	RB	O	highly	advmod	24	SENT_586	[p30l927t3129r1089b3193],
24	active	JJ	O	active	amod	26	SENT_586	[p30l1102t3132r1256b3179],
25	multiple	JJ	O	multiple	amod	26	SENT_586	[p30l1272t3129r1489b3192],
26	sclerosis	NN	O	sclerosis	prep_with	21	SENT_586	[p30l1504t3129r1733b3179],
27	.	.	O	.	_	0	SENT_586	[p30l1504t3129r1733b3179],

1	Mult	NNP	O	Mult	_	0	SENT_587	[p30l1746t3129r1872b3179],
2	.	.	O	.	_	0	SENT_587	[p30l1746t3129r1872b3179],

1	Scler	NNP	O	Scler	_	0	SENT_588	[p30l1886t3129r2017b3179],
2	.	.	O	.	_	0	SENT_588	[p30l1886t3129r2017b3179],

1	18	CD	NUMBER	18	_	0	SENT_589	[p30l2035t3132r2111b3187],
2	,	,	O	,	_	0	SENT_589	[p30l2035t3132r2111b3187],
3	1197-1199	CD	DATE	1197-1199	number	4	SENT_589	[p30l133t3207r609b3263],
4	(	CD	NUMBER	(	appos	1	SENT_589	[p30l133t3207r609b3263],
5	2012	CD	DATE	2012	num	6	SENT_589	[p30l133t3207r609b3263],
6	)	NN	O	)	dep	4	SENT_589	[p30l133t3207r609b3263],
7	.	.	O	.	_	0	SENT_589	[p30l133t3207r609b3263],

1	Coles	NNP	PERSON	Coles	_	0	SENT_590	[p30l127t3284r279b3342],
2	,	,	O	,	_	0	SENT_590	[p30l127t3284r279b3342],
3	A.J.	NNP	PERSON	A.J.	nn	4	SENT_590	[p30l293t3287r377b3334],
4	etal	NNP	O	etal	appos	1	SENT_590	[p30l392t3284r507b3334],
5	.	.	O	.	_	0	SENT_590	[p30l392t3284r507b3334],

1	Alemtuzumab	NNP	O	Alemtuzumab	_	0	SENT_591	[p30l521t3284r895b3334],
2	vs.	CC	O	vs.	prep	1	SENT_591	[p30l908t3299r973b3334],
3	interferon	NN	O	interferon	nn	4	SENT_591	[p30l990t3284r1248b3334],
4	beta	NN	O	beta	dep	2	SENT_591	[p30l1266t3284r1423b3334],
5	—	CD	NUMBER	—	number	6	SENT_591	[p30l1266t3284r1423b3334],
6	1	CD	NUMBER	1	dep	1	SENT_591	[p30l1266t3284r1423b3334],
7	a	DT	O	a	det	11	SENT_591	[p30l1436t3299r1461b3334],
8	in	RB	O	in	advmod	11	SENT_591	[p30l1479t3287r1522b3333],
9	early	JJ	O	early	amod	11	SENT_591	[p30l1538t3284r1665b3348],
10	multiple	JJ	O	multiple	amod	11	SENT_591	[p30l1680t3284r1896b3347],
11	sclerosis	NN	O	sclerosis	dep	6	SENT_591	[p30l1911t3284r2140b3334],
12	.	.	O	.	_	0	SENT_591	[p30l1911t3284r2140b3334],

1	N.	NNP	O	N.	nn	2	SENT_592	[p30l128t3365r176b3412],
2	Engl	NNP	O	Engl	_	0	SENT_592	[p30l191t3362r310b3426],
3	.	.	O	.	_	0	SENT_592	[p30l191t3362r310b3426],

1	J.	NNP	O	J.	nn	2	SENT_593	[p30l321t3365r355b3412],
2	Med	NNP	O	Med	_	0	SENT_593	[p30l369t3362r491b3412],
3	.	.	O	.	_	0	SENT_593	[p30l369t3362r491b3412],

1	359	CD	NUMBER	359	_	0	SENT_594	[p30l506t3366r622b3420],
2	,	,	O	,	_	0	SENT_594	[p30l506t3366r622b3420],
3	1	CD	NUMBER	1	number	4	SENT_594	[p30l640t3366r655b3411],
4	786-1801	CD	NUMBER	786-1801	appos	1	SENT_594	[p30l670t3366r916b3412],
5	(	CD	NUMBER	(	num	7	SENT_594	[p30l942t3363r1116b3420],
6	2008	CD	DATE	2008	num	7	SENT_594	[p30l942t3363r1116b3420],
7	)	NN	O	)	dep	4	SENT_594	[p30l942t3363r1116b3420],
8	.	.	O	.	_	0	SENT_594	[p30l942t3363r1116b3420],

1	Noseworthy	NNP	PERSON	Noseworthy	_	0	SENT_595	[p30l133t3440r460b3504],
2	,	,	O	,	_	0	SENT_595	[p30l133t3440r460b3504],
3	J.H.	NNP	PERSON	J.H.	nn	4	SENT_595	[p30l473t3443r561b3490],
4	etal	NNP	O	etal	appos	1	SENT_595	[p30l576t3440r691b3490],
5	.	.	O	.	_	0	SENT_595	[p30l576t3440r691b3490],

1	IV	CD	NUMBER	iv	num	2	SENT_596	[p30l707t3443r754b3489],
2	immunoglobulin	NN	O	immunoglobulin	nsubj	5	SENT_596	[p30l768t3440r1209b3503],
3	does	VBZ	O	do	aux	5	SENT_596	[p30l1226t3440r1349b3490],
4	not	RB	O	not	neg	5	SENT_596	[p30l1366t3448r1452b3490],
5	reverse	VB	O	reverse	_	0	SENT_596	[p30l1468t3455r1654b3490],
6	established	JJ	O	established	amod	7	SENT_596	[p30l1668t3440r1966b3490],
7	weakness	NN	O	weakness	dobj	5	SENT_596	[p30l131t3518r386b3568],
8	in	IN	O	in	_	0	SENT_596	[p30l402t3521r445b3567],
9	MS.	NNP	ORGANIZATION	MS.	nn	10	SENT_596	[p30l463t3520r553b3568],
10	Neurology	NNP	ORGANIZATION	Neurology	prep_in	5	SENT_596	[p30l567t3518r832b3582],
11	55	CD	NUMBER	55	num	10	SENT_596	[p30l843t3522r923b3576],
12	,	,	O	,	_	0	SENT_596	[p30l843t3522r923b3576],
13	1	CD	NUMBER	1	num	10	SENT_596	[p30l942t3522r956b3567],
14	135-1	CD	NUMBER	135-1	number	15	SENT_596	[p30l975t3522r1119b3568],
15	143	CD	NUMBER	143	dep	10	SENT_596	[p30l1137t3522r1225b3568],
16	(	CD	NUMBER	(	num	18	SENT_596	[p30l1243t3519r1417b3576],
17	2000	CD	DATE	2000	num	18	SENT_596	[p30l1243t3519r1417b3576],
18	)	NN	O	)	dep	15	SENT_596	[p30l1243t3519r1417b3576],
19	.	.	O	.	_	0	SENT_596	[p30l1243t3519r1417b3576],

1	Ghatak	NNP	PERSON	Ghatak	_	0	SENT_597	[p30l131t3596r329b3654],
2	,	,	O	,	_	0	SENT_597	[p30l131t3596r329b3654],
3	N.R.	NNP	PERSON	N.R.	conj_and	1	SENT_597	[p30l346t3598r455b3654],
4	,	,	O	,	_	0	SENT_597	[p30l346t3598r455b3654],
5	Leshner	NNP	PERSON	Leshner	conj_and	1	SENT_597	[p30l472t3596r685b3654],
6	,	,	O	,	_	0	SENT_597	[p30l472t3596r685b3654],
7	R.T.	NNP	LOCATION	R.T.	conj_and	1	SENT_597	[p30l702t3598r797b3654],
8	,	,	O	,	_	0	SENT_597	[p30l702t3598r797b3654],
9	Price	NNP	O	Price	conj_and	1	SENT_597	[p30l814t3599r948b3654],
10	,	,	O	,	_	0	SENT_597	[p30l814t3599r948b3654],
11	A.C.	NNP	ORGANIZATION	A.C.	conj_and	1	SENT_597	[p30l962t3598r1061b3646],
12	&	CC	ORGANIZATION	&	_	0	SENT_597	[p30l1075t3598r1112b3646],
13	Fe	NNP	ORGANIZATION	Fe	conj_and	1	SENT_597	[p30l1127t3596r1415b3654],
14	|	CD	NUMBER	|	num	15	SENT_597	[p30l1127t3596r1415b3654],
15	ton	NN	O	ton	dep	1	SENT_597	[p30l1127t3596r1415b3654],
16	,	,	O	,	_	0	SENT_597	[p30l1127t3596r1415b3654],
17	W.L.	NNP	O	W.L.	nn	18	SENT_597	[p30l1127t3596r1415b3654],
18	3rd	NNP	ORDINAL	3rd	appos	15	SENT_597	[p30l1430t3596r1527b3646],
19	.	.	O	.	_	0	SENT_597	[p30l1430t3596r1527b3646],

1	Remyelination	NN	O	remyelination	_	0	SENT_598	[p30l1544t3596r1917b3660],
2	in	IN	O	in	_	0	SENT_598	[p30l1935t3599r1978b3646],
3	the	DT	O	the	det	7	SENT_598	[p30l131t3674r217b3724],
4	human	JJ	O	human	amod	7	SENT_598	[p30l233t3674r415b3724],
5	central	JJ	O	central	amod	7	SENT_598	[p30l432t3674r607b3724],
6	nervous	JJ	O	nervous	amod	7	SENT_598	[p30l627t3689r835b3724],
7	system	NN	O	system	prep_in	1	SENT_598	[p30l850t3677r1089b3738],
8	.	.	O	.	_	0	SENT_598	[p30l850t3677r1089b3738],

1	J.	NNP	PERSON	J.	nn	2	SENT_599	[p30l850t3677r1089b3738],
2	Neuropathol	NNP	PERSON	Neuropathol	_	0	SENT_599	[p30l1104t3674r1434b3737],
3	.	.	O	.	_	0	SENT_599	[p30l1104t3674r1434b3737],

1	Exp	NN	O	exp	_	0	SENT_600	[p30l1450t3677r1547b3737],
2	.	.	O	.	_	0	SENT_600	[p30l1450t3677r1547b3737],

1	Neurol	NNP	O	Neurol	_	0	SENT_601	[p30l1562t3674r1836b3732],
2	.48	CD	NUMBER	.48	num	1	SENT_601	[p30l1562t3674r1836b3732],
3	,	,	O	,	_	0	SENT_601	[p30l1562t3674r1836b3732],
4	507-518	CD	NUMBER	507-518	num	1	SENT_601	[p30l1851t3678r2074b3724],
5	(	CD	NUMBER	(	num	6	SENT_601	[p30l134t3752r308b3808],
6	1989	CD	DATE	1989	dep	1	SENT_601	[p30l134t3752r308b3808],
7	)	NNP	O	)	dep	6	SENT_601	[p30l134t3752r308b3808],
8	.	.	O	.	_	0	SENT_601	[p30l134t3752r308b3808],

1	Lucchinetti	NNP	PERSON	Lucchinetti	_	0	SENT_602	[p31l133t17r435b75],
2	,	,	O	,	_	0	SENT_602	[p31l133t17r435b75],
3	C.	NNP	O	C.	conj_and	1	SENT_602	[p31l449t19r508b75],
4	,	,	O	,	_	0	SENT_602	[p31l449t19r508b75],
5	Bruck	NNP	PERSON	Bruck	conj_and	1	SENT_602	[p31l525t17r767b75],
6	,	,	O	,	_	0	SENT_602	[p31l525t17r767b75],
7	W.	NNP	O	W.	conj_and	1	SENT_602	[p31l525t17r767b75],
8	,	,	O	,	_	0	SENT_602	[p31l525t17r767b75],
9	Parisi	NNP	PERSON	Parisi	conj_and	1	SENT_602	[p31l783t19r928b75],
10	,	,	O	,	_	0	SENT_602	[p31l783t19r928b75],
11	J.	NNP	O	J.	conj_and	1	SENT_602	[p31l941t20r988b75],
12	,	,	O	,	_	0	SENT_602	[p31l941t20r988b75],
13	Scheithauer	NNP	PERSON	Scheithauer	conj_and	1	SENT_602	[p31l1003t17r1325b75],
14	,	,	O	,	_	0	SENT_602	[p31l1003t17r1325b75],
15	B.	NNP	O	B.	conj_and	1	SENT_602	[p31l1342t19r1395b75],
16	,	,	O	,	_	0	SENT_602	[p31l1342t19r1395b75],
17	Rodriguez	NNP	PERSON	Rodriguez	conj_and	1	SENT_602	[p31l1412t17r1690b81],
18	,	,	O	,	_	0	SENT_602	[p31l1412t17r1690b81],
19	M.	NNP	ORGANIZATION	M.	conj_and	1	SENT_602	[p31l1706t20r1765b67],
20	&	CC	ORGANIZATION	&	_	0	SENT_602	[p31l1779t19r1816b67],
21	Lassmann	NNP	ORGANIZATION	Lassmann	conj_and	1	SENT_602	[p31l1831t20r2104b75],
22	,	,	O	,	_	0	SENT_602	[p31l1831t20r2104b75],
23	H.	NNP	O	H.	nn	26	SENT_602	[p31l135t98r183b145],
24	A	NNP	O	A	nn	26	SENT_602	[p31l197t98r233b144],
25	quantitative	JJ	O	quantitative	amod	26	SENT_602	[p31l247t98r565b158],
26	analysis	NN	O	analysis	appos	1	SENT_602	[p31l579t95r781b159],
27	of	IN	O	of	_	0	SENT_602	[p31l796t95r850b145],
28	oligodendrocytes	NNS	O	oligodendrocyte	prep_of	26	SENT_602	[p31l860t95r1323b159],
29	in	IN	O	in	_	0	SENT_602	[p31l1339t98r1381b145],
30	multiple	JJ	O	multiple	amod	32	SENT_602	[p31l1400t95r1617b158],
31	sclerosis	NN	O	sclerosis	nn	32	SENT_602	[p31l1631t95r1847b145],
32	lesions	NNS	O	lesion	prep_in	28	SENT_602	[p31l1864t95r2053b145],
33	.	.	O	.	_	0	SENT_602	[p31l1864t95r2053b145],

1	A	DT	O	a	det	2	SENT_603	[p31l2066t98r2103b144],
2	study	NN	O	study	_	0	SENT_603	[p31l133t173r277b237],
3	of	IN	O	of	_	0	SENT_603	[p31l290t173r345b223],
4	1	CD	NUMBER	1	number	5	SENT_603	[p31l359t177r373b222],
5	13	CD	NUMBER	13	num	6	SENT_603	[p31l391t177r447b223],
6	cases	NNS	O	case	prep_of	2	SENT_603	[p31l463t188r613b223],
7	.	.	O	.	_	0	SENT_603	[p31l463t188r613b223],

1	Brain	NN	O	brain	_	0	SENT_604	[p31l627t175r756b223],
2	122	CD	NUMBER	122	number	3	SENT_604	[p31l775t177r873b222],
3	(	CD	NUMBER	(	dep	1	SENT_604	[p31l890t174r958b231],
4	Pt	NN	O	pt	dep	3	SENT_604	[p31l890t174r958b231],
5	12	CD	NUMBER	12	num	6	SENT_604	[p31l977t174r1065b231],
6	)	NN	O	)	dep	1	SENT_604	[p31l977t174r1065b231],
7	,	,	O	,	_	0	SENT_604	[p31l977t174r1065b231],
8	2279-2295	CD	DATE	2279-2295	number	9	SENT_604	[p31l1080t177r1367b223],
9	(	CD	NUMBER	(	appos	6	SENT_604	[p31l1384t174r1558b231],
10	1999	CD	DATE	1999	num	11	SENT_604	[p31l1384t174r1558b231],
11	)	NN	O	)	dep	9	SENT_604	[p31l1384t174r1558b231],
12	.	.	O	.	_	0	SENT_604	[p31l1384t174r1558b231],

1	Weiner	NNP	PERSON	Weiner	_	0	SENT_605	[p31l130t254r323b309],
2	,	,	O	,	_	0	SENT_605	[p31l130t254r323b309],
3	L.P.	NNP	O	L.P.	conj_and	1	SENT_605	[p31l340t253r680b309],
4	,	,	O	,	_	0	SENT_605	[p31l340t253r680b309],
5	Waxman	NNP	PERSON	Waxman	conj_and	1	SENT_605	[p31l340t253r680b309],
6	,	,	O	,	_	0	SENT_605	[p31l340t253r680b309],
7	S.G.	NNP	LOCATION	S.G.	conj_and	1	SENT_605	[p31l695t253r802b309],
8	,	,	O	,	_	0	SENT_605	[p31l695t253r802b309],
9	Stohlman	NNP	O	Stohlman	conj_and	1	SENT_605	[p31l817t251r1082b309],
10	,	,	O	,	_	0	SENT_605	[p31l817t251r1082b309],
11	S.A.	NNP	ORGANIZATION	S.A.	conj_and	1	SENT_605	[p31l1098t253r1190b301],
12	&	CC	ORGANIZATION	&	_	0	SENT_605	[p31l1204t253r1241b301],
13	Kwan	NNP	ORGANIZATION	Kwan	conj_and	1	SENT_605	[p31l1256t254r1409b309],
14	,	,	O	,	_	0	SENT_605	[p31l1256t254r1409b309],
15	A.	NNP	O	A.	nn	16	SENT_605	[p31l1423t254r1472b301],
16	Remyelination	NNP	O	Remyelination	appos	1	SENT_605	[p31l1488t251r1862b315],
17	following	VBG	O	follow	_	0	SENT_605	[p31l1877t251r2122b315],
18	vira	NN	O	vira	nn	19	SENT_605	[p31l131t329r474b379],
19	|	NN	O	|	prep_following	16	SENT_605	[p31l131t329r474b379],
20	.	.	O	.	_	0	SENT_605	[p31l131t329r474b379],

1	—	NN	O	—	_	0	SENT_606	[p31l131t329r474b379],
2	.	.	O	.	_	0	SENT_606	[p31l131t329r474b379],

1	induced	VBN	O	induce	_	0	SENT_607	[p31l131t329r474b379],
2	demyelination	NN	O	demyelination	dobj	1	SENT_607	[p31l491t329r883b393],
3	:	:	O	:	_	0	SENT_607	[p31l491t329r883b393],
4	ferric	JJ	O	ferric	amod	8	SENT_607	[p31l896t329r1029b379],
5	ion	NN	O	ion	nn	8	SENT_607	[p31l1044t329r1477b393],
6	—	NN	O	—	nn	8	SENT_607	[p31l1044t329r1477b393],
7	ferrocyanide	NN	O	ferrocyanide	nn	8	SENT_607	[p31l1044t329r1477b393],
8	staining	NN	O	staining	dep	2	SENT_607	[p31l1492t332r1698b393],
9	of	IN	O	of	_	0	SENT_607	[p31l1715t329r1769b379],
10	nodes	NNS	O	node	prep_of	8	SENT_607	[p31l1781t329r1938b379],
11	of	IN	O	of	_	0	SENT_607	[p31l1953t329r2007b379],
12	Ranvier	NN	O	ranvier	prep_of	10	SENT_607	[p31l135t408r328b456],
13	within	IN	O	within	_	0	SENT_607	[p31l340t406r503b456],
14	the	DT	O	the	det	15	SENT_607	[p31l519t406r604b456],
15	CNS	NN	O	cn	prep_within	1	SENT_607	[p31l619t408r738b456],
16	.	.	O	.	_	0	SENT_607	[p31l619t408r738b456],

1	Ann	NNP	PERSON	Ann	_	0	SENT_608	[p31l749t409r865b456],
2	.	.	O	.	_	0	SENT_608	[p31l749t409r865b456],

1	Neurol	NNP	O	Neurol	_	0	SENT_609	[p31l880t406r1059b456],
2	.	.	O	.	_	0	SENT_609	[p31l880t406r1059b456],

1	8	CD	NUMBER	8	_	0	SENT_610	[p31l1073t410r1118b463],
2	,	,	O	,	_	0	SENT_610	[p31l1073t410r1118b463],
3	580-583	CD	NUMBER	580-583	number	4	SENT_610	[p31l1133t410r1354b456],
4	(	CD	NUMBER	(	appos	1	SENT_610	[p31l1373t407r1547b463],
5	1980	CD	DATE	1980	num	6	SENT_610	[p31l1373t407r1547b463],
6	)	NN	O	)	dep	4	SENT_610	[p31l1373t407r1547b463],
7	.	.	O	.	_	0	SENT_610	[p31l1373t407r1547b463],

1	Murray	NNP	PERSON	Murray	nsubjpass	22	SENT_611	[p31l132t487r326b548],
2	,	,	O	,	_	0	SENT_611	[p31l132t487r326b548],
3	P.D.	NNP	O	P.D.	conj_and	1	SENT_611	[p31l342t486r440b542],
4	,	,	O	,	_	0	SENT_611	[p31l342t486r440b542],
5	McGavern	NNP	O	McGavern	conj_and	1	SENT_611	[p31l456t486r734b542],
6	,	,	O	,	_	0	SENT_611	[p31l456t486r734b542],
7	D.B.	NNP	LOCATION	D.B.	conj_and	1	SENT_611	[p31l751t486r858b542],
8	,	,	O	,	_	0	SENT_611	[p31l751t486r858b542],
9	Sathornsumetee	NNP	O	Sathornsumetee	nsubjpass	22	SENT_611	[p31l873t484r1321b542],
10	,	,	O	,	_	0	SENT_611	[p31l873t484r1321b542],
11	S.	NNP	ORGANIZATION	S.	nsubjpass	22	SENT_611	[p31l1335t486r1375b534],
12	&	CC	ORGANIZATION	&	_	0	SENT_611	[p31l1389t486r1426b534],
13	Rodriguez	NNP	ORGANIZATION	Rodriguez	nsubjpass	22	SENT_611	[p31l1442t484r1720b548],
14	,	,	O	,	_	0	SENT_611	[p31l1442t484r1720b548],
15	M.	NNP	PERSON	M.	nn	17	SENT_611	[p31l1735t487r1795b534],
16	Spontaneous	NNP	PERSON	Spontaneous	nn	17	SENT_611	[p31l133t564r480b625],
17	remyelination	NN	O	remyelination	appos	1	SENT_611	[p31l497t562r856b626],
18	following	VBG	O	follow	_	0	SENT_611	[p31l871t562r1116b626],
19	extensive	JJ	O	extensive	amod	20	SENT_611	[p31l1133t565r1380b612],
20	demyelination	NN	O	demyelination	prep_following	17	SENT_611	[p31l1395t562r1772b626],
21	is	VBZ	O	be	auxpass	22	SENT_611	[p31l1790t565r1824b612],
22	associated	VBN	O	associate	_	0	SENT_611	[p31l1839t562r2111b612],
23	with	IN	O	with	_	0	SENT_611	[p31l131t640r244b690],
24	improved	VBN	O	improve	amod	26	SENT_611	[p31l262t640r512b703],
25	neurological	JJ	O	neurological	amod	26	SENT_611	[p31l530t640r853b704],
26	function	NN	O	function	prep_with	22	SENT_611	[p31l869t640r1089b690],
27	in	IN	O	in	_	0	SENT_611	[p31l1107t643r1149b689],
28	a	DT	O	a	det	30	SENT_611	[p31l1166t655r1191b690],
29	viral	JJ	O	viral	amod	30	SENT_611	[p31l1206t640r1312b690],
30	model	NN	O	model	prep_in	26	SENT_611	[p31l1331t640r1494b690],
31	of	IN	O	of	_	0	SENT_611	[p31l1511t640r1565b690],
32	multiple	JJ	O	multiple	amod	33	SENT_611	[p31l1577t640r1793b703],
33	sclerosis	NN	O	sclerosis	prep_of	30	SENT_611	[p31l1808t640r2037b690],
34	.	.	O	.	_	0	SENT_611	[p31l1808t640r2037b690],

1	Brain	NN	O	brain	_	0	SENT_612	[p31l132t719r261b767],
2	124	CD	NUMBER	124	num	1	SENT_612	[p31l280t721r392b774],
3	,	,	O	,	_	0	SENT_612	[p31l280t721r392b774],
4	1403-1416	CD	DATE	1403-1416	number	5	SENT_612	[p31l411t721r696b767],
5	(	CD	NUMBER	(	appos	1	SENT_612	[p31l712t718r886b774],
6	2001	CD	DATE	2001	num	7	SENT_612	[p31l712t718r886b774],
7	)	NN	O	)	dep	5	SENT_612	[p31l712t718r886b774],
8	.	.	O	.	_	0	SENT_612	[p31l712t718r886b774],

1	Bieber	NNP	PERSON	Bieber	_	0	SENT_613	[p31l133t795r306b853],
2	,	,	O	,	_	0	SENT_613	[p31l133t795r306b853],
3	A.J.	NNP	PERSON	A.J.	conj_and	1	SENT_613	[p31l320t798r418b853],
4	,	,	O	,	_	0	SENT_613	[p31l320t798r418b853],
5	Kerr	NNP	PERSON	Kerr	conj_and	1	SENT_613	[p31l435t798r546b853],
6	,	,	O	,	_	0	SENT_613	[p31l435t798r546b853],
7	S.	NNP	ORGANIZATION	S.	conj_and	1	SENT_613	[p31l561t797r601b845],
8	&	CC	ORGANIZATION	&	_	0	SENT_613	[p31l615t797r652b845],
9	Rodriguez	NNP	ORGANIZATION	Rodriguez	conj_and	1	SENT_613	[p31l667t795r945b859],
10	,	,	O	,	_	0	SENT_613	[p31l667t795r945b859],
11	M.	NNP	O	M.	nn	12	SENT_613	[p31l961t798r1020b845],
12	Efﬁcient	NNP	O	Efﬁcient	appos	1	SENT_613	[p31l1037t795r1246b845],
13	central	JJ	O	central	amod	18	SENT_613	[p31l1260t795r1435b845],
14	nervous	JJ	O	nervous	amod	18	SENT_613	[p31l1455t810r1663b845],
15	system	NN	O	system	nn	18	SENT_613	[p31l1678t803r1858b859],
16	remyelination	NN	O	remyelination	nn	18	SENT_613	[p31l134t873r493b937],
17	requiresT	NN	O	requirest	nn	18	SENT_613	[p31l512t876r763b936],
18	cells	NNS	O	cell	dep	12	SENT_613	[p31l775t873r898b923],
19	.	.	O	.	_	0	SENT_613	[p31l775t873r898b923],

1	Ann	NNP	PERSON	Ann	_	0	SENT_614	[p31l909t876r1025b923],
2	.	.	O	.	_	0	SENT_614	[p31l909t876r1025b923],

1	Neurol	NNP	O	Neurol	_	0	SENT_615	[p31l1040t873r1219b923],
2	.	.	O	.	_	0	SENT_615	[p31l1040t873r1219b923],

1	53	CD	NUMBER	53	_	0	SENT_616	[p31l1234t877r1313b931],
2	,	,	O	,	_	0	SENT_616	[p31l1234t877r1313b931],
3	680-684	CD	NUMBER	680-684	number	4	SENT_616	[p31l1328t877r1553b923],
4	(	CD	NUMBER	(	appos	1	SENT_616	[p31l1568t874r1742b931],
5	2003	CD	DATE	2003	num	6	SENT_616	[p31l1568t874r1742b931],
6	)	NN	O	)	dep	4	SENT_616	[p31l1568t874r1742b931],
7	.	.	O	.	_	0	SENT_616	[p31l1568t874r1742b931],

1	Kotter	NNP	O	Kotter	nsubj	23	SENT_617	[p31l133t954r300b1009],
2	,	,	O	,	_	0	SENT_617	[p31l133t954r300b1009],
3	M.R.	NNP	LOCATION	M.R.	appos	1	SENT_617	[p31l316t954r435b1009],
4	,	,	O	,	_	0	SENT_617	[p31l316t954r435b1009],
5	Setzu	NNP	O	Setzu	appos	1	SENT_617	[p31l450t953r605b1009],
6	,	,	O	,	_	0	SENT_617	[p31l450t953r605b1009],
7	A.	NN	O	a.	appos	1	SENT_617	[p31l619t954r681b1009],
8	,	,	O	,	_	0	SENT_617	[p31l619t954r681b1009],
9	Sim	NNP	PERSON	Sim	nn	14	SENT_617	[p31l696t953r804b1009],
10	,	,	O	,	_	0	SENT_617	[p31l696t953r804b1009],
11	F.J.	NNP	LOCATION	F.J.	conj_and	14	SENT_617	[p31l821t954r901b1009],
12	,	,	O	,	_	0	SENT_617	[p31l821t954r901b1009],
13	Van	NNP	PERSON	Van	conj_and	14	SENT_617	[p31l911t954r1007b1001],
14	Rooijen	NNP	PERSON	Rooijen	appos	1	SENT_617	[p31l1026t953r1234b1015],
15	,	,	O	,	_	0	SENT_617	[p31l1026t953r1234b1015],
16	N.	NNP	ORGANIZATION	N.	conj_and	14	SENT_617	[p31l1251t954r1300b1001],
17	&	CC	ORGANIZATION	&	_	0	SENT_617	[p31l1314t953r1351b1001],
18	Franklin	NNP	ORGANIZATION	Franklin	conj_and	14	SENT_617	[p31l1366t951r1584b1009],
19	,	,	O	,	_	0	SENT_617	[p31l1366t951r1584b1009],
20	R.J.	NNP	O	R.J.	nn	22	SENT_617	[p31l1602t953r1678b1001],
21	Macrophage	NN	O	macrophage	nn	22	SENT_617	[p31l1694t951r2024b1015],
22	depletion	NN	O	depletion	appos	1	SENT_617	[p31l132t1029r383b1092],
23	impairs	VBZ	O	impair	_	0	SENT_617	[p31l402t1032r591b1092],
24	oligodendrocyte	NN	O	oligodendrocyte	nn	25	SENT_617	[p31l606t1029r1044b1093],
25	remyelination	NN	O	remyelination	dobj	23	SENT_617	[p31l1060t1029r1420b1093],
26	following	VBG	O	follow	_	0	SENT_617	[p31l1434t1029r1680b1093],
27	|	NN	O	|	nn	31	SENT_617	[p31l1699t1029r2014b1093],
28	yso	NN	O	yso	nn	31	SENT_617	[p31l1699t1029r2014b1093],
29	|	NN	O	|	nn	31	SENT_617	[p31l1699t1029r2014b1093],
30	ecithin	NN	O	ecithin	nn	31	SENT_617	[p31l1699t1029r2014b1093],
31	—	NN	O	—	prep_following	25	SENT_617	[p31l1699t1029r2014b1093],
32	induced	VBD	O	induce	partmod	31	SENT_617	[p31l134t1107r343b1157],
33	demyelination	NN	O	demyelination	dobj	32	SENT_617	[p31l360t1107r752b1171],
34	.	.	O	.	_	0	SENT_617	[p31l360t1107r752b1171],

1	Glia	NN	O	glium	_	0	SENT_618	[p31l767t1107r865b1157],
2	35	CD	NUMBER	35	num	1	SENT_618	[p31l879t1111r959b1165],
3	,	,	O	,	_	0	SENT_618	[p31l879t1111r959b1165],
4	204-212	CD	NUMBER	204-212	number	5	SENT_618	[p31l974t1111r1197b1157],
5	(	CD	NUMBER	(	appos	1	SENT_618	[p31l1213t1108r1388b1165],
6	2001	CD	DATE	2001	num	7	SENT_618	[p31l1213t1108r1388b1165],
7	)	NN	O	)	dep	5	SENT_618	[p31l1213t1108r1388b1165],
8	.	.	O	.	_	0	SENT_618	[p31l1213t1108r1388b1165],

1	Yamamura	NNP	PERSON	Yamamura	nn	13	SENT_619	[p31l129t1187r485b1241],
2	,	,	O	,	_	0	SENT_619	[p31l129t1187r485b1241],
3	T.	NNP	O	T.	appos	13	SENT_619	[p31l129t1187r485b1241],
4	,	,	O	,	_	0	SENT_619	[p31l129t1187r485b1241],
5	Sun	NNP	O	Sun	appos	13	SENT_619	[p31l500t1186r611b1241],
6	,	,	O	,	_	0	SENT_619	[p31l500t1186r611b1241],
7	D.	NNP	O	D.	appos	13	SENT_619	[p31l628t1187r687b1241],
8	,	,	O	,	_	0	SENT_619	[p31l628t1187r687b1241],
9	Aloisi	NNP	PERSON	Aloisi	appos	13	SENT_619	[p31l701t1185r854b1241],
10	,	,	O	,	_	0	SENT_619	[p31l701t1185r854b1241],
11	F.	NNP	O	F.	appos	13	SENT_619	[p31l871t1187r915b1241],
12	,	,	O	,	_	0	SENT_619	[p31l871t1187r915b1241],
13	K	NNP	O	K	_	0	SENT_619	[p31l932t1185r1259b1241],
14	|	VBD	O	|	rcmod	13	SENT_619	[p31l932t1185r1259b1241],
15	inkert	NN	O	inkert	dobj	14	SENT_619	[p31l932t1185r1259b1241],
16	,	,	O	,	_	0	SENT_619	[p31l932t1185r1259b1241],
17	W.E.	NNP	ORGANIZATION	W.E.	appos	15	SENT_619	[p31l932t1185r1259b1241],
18	&	CC	ORGANIZATION	&	_	0	SENT_619	[p31l1273t1185r1542b1241],
19	Weker	NNP	ORGANIZATION	Weker	conj_and	17	SENT_619	[p31l1273t1185r1542b1241],
20	|	CD	NUMBER	|	dep	17	SENT_619	[p31l1273t1185r1542b1241],
21	e	LS	O	e	dep	24	SENT_619	[p31l1273t1185r1542b1241],
22	,	,	O	,	_	0	SENT_619	[p31l1273t1185r1542b1241],
23	H.	NNP	O	H.	nn	24	SENT_619	[p31l1558t1187r1607b1234],
24	Interaction	NN	O	interaction	dep	13	SENT_619	[p31l1623t1187r1905b1234],
25	between	IN	O	between	_	0	SENT_619	[p31l1923t1185r2150b1234],
26	oligodendroglia	NN	O	oligodendroglium	nn	29	SENT_619	[p31l132t1263r552b1326],
27	and	CC	O	and	_	0	SENT_619	[p31l568t1263r664b1312],
28	immune	JJ	O	immune	nn	29	SENT_619	[p31l683t1265r901b1312],
29	cells	NNS	O	cell	prep_between	24	SENT_619	[p31l915t1263r1039b1312],
30	:	:	O	:	_	0	SENT_619	[p31l915t1263r1039b1312],
31	mitogenic	JJ	O	mitogenic	amod	32	SENT_619	[p31l1056t1265r1320b1326],
32	effect	NN	O	effect	dep	24	SENT_619	[p31l1334t1262r1481b1312],
33	of	IN	O	of	_	0	SENT_619	[p31l1495t1262r1550b1312],
34	an	DT	O	a	det	38	SENT_619	[p31l1559t1277r1619b1312],
35	oligodendrocyte	NN	O	oligodendrocyte	nn	38	SENT_619	[p31l1636t1263r2074b1326],
36	precursor	NN	O	precursor	nn	38	SENT_619	[p31l134t1355r383b1403],
37	cell	NN	O	cell	nn	38	SENT_619	[p31l396t1341r480b1390],
38	line	NN	O	line	prep_of	32	SENT_619	[p31l499t1341r590b1390],
39	on	IN	O	on	_	0	SENT_619	[p31l604t1355r669b1390],
40	syngeneicT	NN	O	syngeneict	nn	41	SENT_619	[p31l685t1343r992b1404],
41	lymphocytes	NNS	O	lymphocyte	prep_on	38	SENT_619	[p31l1006t1341r1354b1404],
42	.	.	O	.	_	0	SENT_619	[p31l1006t1341r1354b1404],

1	J.	NNP	PERSON	J.	nn	2	SENT_620	[p31l1364t1343r1399b1390],
2	Neurosci	NNP	PERSON	Neurosci	_	0	SENT_620	[p31l1414t1343r1642b1390],
3	.	.	O	.	_	0	SENT_620	[p31l1414t1343r1642b1390],

1	Res	NNP	O	Res	_	0	SENT_621	[p31l1657t1343r1752b1390],
2	.	.	O	.	_	0	SENT_621	[p31l1657t1343r1752b1390],

1	32	CD	NUMBER	32	_	0	SENT_622	[p31l1766t1344r1847b1398],
2	,	,	O	,	_	0	SENT_622	[p31l1766t1344r1847b1398],
3	178-189	CD	NUMBER	178-189	number	4	SENT_622	[p31l1865t1344r2085b1390],
4	(	CD	NUMBER	(	appos	1	SENT_622	[p31l134t1419r308b1474],
5	1992	CD	DATE	1992	num	6	SENT_622	[p31l134t1419r308b1474],
6	)	NN	O	)	dep	4	SENT_622	[p31l134t1419r308b1474],
7	.	.	O	.	_	0	SENT_622	[p31l134t1419r308b1474],

1	Asakura	NNP	PERSON	Asakura	nsubj	23	SENT_623	[p31l130t1496r351b1553],
2	,	,	O	,	_	0	SENT_623	[p31l130t1496r351b1553],
3	K.	NNP	O	K.	nsubj	23	SENT_623	[p31l367t1498r423b1553],
4	,	,	O	,	_	0	SENT_623	[p31l367t1498r423b1553],
5	Miller	NNP	PERSON	Miller	nsubj	23	SENT_623	[p31l438t1496r593b1553],
6	,	,	O	,	_	0	SENT_623	[p31l438t1496r593b1553],
7	D.J.	NNP	PERSON	D.J.	nsubj	23	SENT_623	[p31l609t1498r705b1553],
8	,	,	O	,	_	0	SENT_623	[p31l609t1498r705b1553],
9	Pease	NNP	PERSON	Pease	conj_and	1	SENT_623	[p31l721t1498r880b1553],
10	,	,	O	,	_	0	SENT_623	[p31l721t1498r880b1553],
11	L.R.	NNP	ORGANIZATION	L.R.	conj_and	1	SENT_623	[p31l896t1498r980b1545],
12	&	CC	ORGANIZATION	&	_	0	SENT_623	[p31l995t1497r1031b1545],
13	Rodriguez	NNP	ORGANIZATION	Rodriguez	conj_and	1	SENT_623	[p31l1047t1496r1325b1559],
14	,	,	O	,	_	0	SENT_623	[p31l1047t1496r1325b1559],
15	M.	NNP	O	M.	nn	16	SENT_623	[p31l1340t1498r1658b1559],
16	Targeting	NN	O	targeting	appos	1	SENT_623	[p31l1340t1498r1658b1559],
17	of	IN	O	of	_	0	SENT_623	[p31l1675t1495r1729b1545],
18	|	CD	NUMBER	|	num	20	SENT_623	[p31l1741t1496r2000b1559],
19	gMkappa	NN	O	gmkappa	nn	20	SENT_623	[p31l1741t1496r2000b1559],
20	antibodies	NNS	O	antibody	prep_of	16	SENT_623	[p31l132t1574r408b1623],
21	to	TO	O	to	_	0	SENT_623	[p31l422t1581r475b1623],
22	oligodendrocytes	NNS	O	oligodendrocyte	prep_to	20	SENT_623	[p31l489t1574r952b1637],
23	promotes	VBZ	O	promote	_	0	SENT_623	[p31l969t1581r1220b1636],
24	CNS	NN	O	cn	nn	27	SENT_623	[p31l1235t1575r1341b1623],
25	remye	NN	O	remye	nn	27	SENT_623	[p31l1358t1574r1777b1637],
26	|	NN	O	|	nn	27	SENT_623	[p31l1358t1574r1777b1637],
27	ination	NN	O	ination	dobj	23	SENT_623	[p31l1358t1574r1777b1637],
28	.	.	O	.	_	0	SENT_623	[p31l1358t1574r1777b1637],

1	J.	NNP	PERSON	J.	nn	2	SENT_624	[p31l1358t1574r1777b1637],
2	Neurosci	NNP	PERSON	Neurosci	_	0	SENT_624	[p31l1791t1576r2022b1623],
3	.	.	O	.	_	0	SENT_624	[p31l1791t1576r2022b1623],

1	18	CD	NUMBER	18	_	0	SENT_625	[p31l2039t1577r2116b1631],
2	,	,	O	,	_	0	SENT_625	[p31l2039t1577r2116b1631],
3	7700-7708	CD	DURATION	7700-7708	number	4	SENT_625	[p31l133t1654r422b1700],
4	(	CD	NUMBER	(	appos	1	SENT_625	[p31l438t1652r612b1707],
5	1998	CD	DATE	1998	num	6	SENT_625	[p31l438t1652r612b1707],
6	)	NN	O	)	dep	4	SENT_625	[p31l438t1652r612b1707],
7	.	.	O	.	_	0	SENT_625	[p31l438t1652r612b1707],

1	Miller	NNP	PERSON	Miller	nn	15	SENT_626	[p31l132t1729r286b1786],
2	,	,	O	,	_	0	SENT_626	[p31l132t1729r286b1786],
3	D.J.	NNP	PERSON	D.J.	nn	15	SENT_626	[p31l303t1731r398b1786],
4	,	,	O	,	_	0	SENT_626	[p31l303t1731r398b1786],
5	Bright	NNP	O	Bright	nn	15	SENT_626	[p31l415t1729r583b1792],
6	,	,	O	,	_	0	SENT_626	[p31l415t1729r583b1792],
7	J.J.	NNP	PERSON	J.J.	nn	15	SENT_626	[p31l596t1731r679b1786],
8	,	,	O	,	_	0	SENT_626	[p31l596t1731r679b1786],
9	Sriram	NNP	PERSON	Sriram	nn	15	SENT_626	[p31l693t1730r874b1786],
10	,	,	O	,	_	0	SENT_626	[p31l693t1730r874b1786],
11	S.	NNP	ORGANIZATION	S.	nn	15	SENT_626	[p31l888t1730r929b1778],
12	&	CC	ORGANIZATION	&	_	0	SENT_626	[p31l943t1730r980b1778],
13	Rodriguez	NNP	ORGANIZATION	Rodriguez	nn	15	SENT_626	[p31l995t1729r1273b1792],
14	,	,	O	,	_	0	SENT_626	[p31l995t1729r1273b1792],
15	M.	NNP	O	M.	_	0	SENT_626	[p31l1288t1731r1348b1778],
16	Successful	JJ	O	successful	amod	17	SENT_626	[p31l1362t1728r1629b1778],
17	treatment	NN	O	treatment	dep	15	SENT_626	[p31l1645t1736r1908b1778],
18	of	IN	O	of	_	0	SENT_626	[p31l1923t1728r1977b1778],
19	established	JJ	O	established	amod	20	SENT_626	[p31l132t1807r429b1856],
20	relapsing	NN	O	relapsing	prep_of	17	SENT_626	[p31l448t1807r684b1870],
21	experimental	JJ	O	experimental	amod	23	SENT_626	[p31l701t1807r1047b1869],
22	autoimmune	JJ	O	autoimmune	amod	23	SENT_626	[p31l1063t1809r1405b1856],
23	encephalomyelitis	NN	O	encephalomyelitis	dep	15	SENT_626	[p31l1419t1807r1899b1870],
24	in	IN	O	in	_	0	SENT_626	[p31l1915t1809r1958b1856],
25	mice	NNS	O	mouse	prep_in	23	SENT_626	[p31l1977t1809r2099b1856],
26	with	IN	O	with	_	0	SENT_626	[p31l131t1885r244b1934],
27	a	DT	O	a	det	30	SENT_626	[p31l261t1899r286b1934],
28	monoclonal	JJ	O	monoclonal	amod	30	SENT_626	[p31l304t1885r614b1934],
29	natural	JJ	O	natural	amod	30	SENT_626	[p31l633t1885r812b1934],
30	autoantibody	NN	O	autoantibody	prep_with	25	SENT_626	[p31l829t1885r1241b1948],
31	.	.	O	.	_	0	SENT_626	[p31l829t1885r1241b1948],

1	J.	NNP	PERSON	J.	nn	2	SENT_627	[p31l829t1885r1241b1948],
2	Neuroimmunol	NNP	PERSON	Neuroimmunol	_	0	SENT_627	[p31l1256t1885r1653b1934],
3	.	.	O	.	_	0	SENT_627	[p31l1256t1885r1653b1934],

1	75	CD	NUMBER	75	_	0	SENT_628	[p31l1668t1889r1748b1942],
2	,	,	O	,	_	0	SENT_628	[p31l1668t1889r1748b1942],
3	204-209	CD	NUMBER	204-209	number	4	SENT_628	[p31l1762t1888r1986b1934],
4	(	CD	NUMBER	(	appos	1	SENT_628	[p31l134t1963r308b2018],
5	1997	CD	DATE	1997	num	6	SENT_628	[p31l134t1963r308b2018],
6	)	NN	O	)	dep	4	SENT_628	[p31l134t1963r308b2018],
7	.	.	O	.	_	0	SENT_628	[p31l134t1963r308b2018],

1	Ciric	NNP	PERSON	Ciric	nn	5	SENT_629	[p31l131t2041r255b2097],
2	,	,	O	,	_	0	SENT_629	[p31l131t2041r255b2097],
3	B.	NNP	O	B.	appos	5	SENT_629	[p31l272t2040r696b2097],
4	,	,	O	,	_	0	SENT_629	[p31l272t2040r696b2097],
5	VanKeu	NNP	O	VanKeu	nsubj	31	SENT_629	[p31l272t2040r696b2097],
6	|	CD	NUMBER	|	num	5	SENT_629	[p31l272t2040r696b2097],
7	en	IN	O	en	_	0	SENT_629	[p31l272t2040r696b2097],
8	,	,	O	,	_	0	SENT_629	[p31l272t2040r696b2097],
9	V.	NNP	O	V.	dep	5	SENT_629	[p31l272t2040r696b2097],
10	,	,	O	,	_	0	SENT_629	[p31l272t2040r696b2097],
11	Rodriguez	NNP	PERSON	Rodriguez	prep_en	5	SENT_629	[p31l713t2040r991b2103],
12	,	,	O	,	_	0	SENT_629	[p31l713t2040r991b2103],
13	M.	NNP	O	M.	prep_en	5	SENT_629	[p31l1006t2042r1079b2097],
14	,	,	O	,	_	0	SENT_629	[p31l1006t2042r1079b2097],
15	Kyle	NNP	PERSON	Kyle	prep_en	5	SENT_629	[p31l1095t2040r1212b2103],
16	,	,	O	,	_	0	SENT_629	[p31l1095t2040r1212b2103],
17	R.A.	NNP	LOCATION	R.A.	conj_and	11	SENT_629	[p31l1229t2042r1335b2097],
18	,	,	O	,	_	0	SENT_629	[p31l1229t2042r1335b2097],
19	Gertz	NNP	PERSON	Gertz	conj_and	11	SENT_629	[p31l1349t2042r1502b2097],
20	,	,	O	,	_	0	SENT_629	[p31l1349t2042r1502b2097],
21	M.A.	NNP	ORGANIZATION	M.A.	conj_and	11	SENT_629	[p31l1518t2042r1629b2089],
22	&	CC	ORGANIZATION	&	_	0	SENT_629	[p31l1643t2041r1680b2089],
23	Pease	NNP	ORGANIZATION	Pease	conj_and	11	SENT_629	[p31l1695t2042r1853b2097],
24	,	,	O	,	_	0	SENT_629	[p31l1695t2042r1853b2097],
25	L.R.	NNP	O	L.R.	nn	27	SENT_629	[p31l1870t2042r1954b2089],
26	Clonal	JJ	O	clonal	amod	27	SENT_629	[p31l1968t2040r2130b2089],
27	evolution	NN	O	evolution	appos	11	SENT_629	[p31l132t2118r379b2167],
28	in	IN	O	in	_	0	SENT_629	[p31l397t2120r440b2167],
29	Waldenstrom	NNP	LOCATION	Waldenstrom	nn	30	SENT_629	[p31l453t2118r803b2167],
30	macroglobulinemia	NN	O	macroglobulinemia	prep_in	27	SENT_629	[p31l822t2118r1335b2181],
31	highlights	VBZ	O	highlight	_	0	SENT_629	[p31l1353t2118r1614b2181],
32	functional	JJ	O	functional	amod	33	SENT_629	[p31l1627t2117r1893b2167],
33	role	NN	O	role	dobj	31	SENT_629	[p31l1911t2118r2007b2167],
34	of	IN	O	of	_	0	SENT_629	[p31l2022t2117r2076b2167],
35	B	NN	O	b	nn	38	SENT_629	[p31l134t2195r271b2244],
36	—	NN	O	—	nn	38	SENT_629	[p31l134t2195r271b2244],
37	cell	NN	O	cell	nn	38	SENT_629	[p31l134t2195r271b2244],
38	receptor	NN	O	receptor	prep_of	33	SENT_629	[p31l290t2202r518b2256],
39	.	.	O	.	_	0	SENT_629	[p31l290t2202r518b2256],

1	Blood	NN	O	blood	_	0	SENT_630	[p31l533t2195r680b2244],
2	97	CD	NUMBER	97	num	1	SENT_630	[p31l690t2198r771b2251],
3	,	,	O	,	_	0	SENT_630	[p31l690t2198r771b2251],
4	321	CD	NUMBER	321	number	5	SENT_630	[p31l786t2198r870b2244],
5	-323	CD	NUMBER	-323	appos	1	SENT_630	[p31l883t2198r1007b2244],
6	(	CD	NUMBER	(	num	8	SENT_630	[p31l1026t2196r1200b2251],
7	2001	CD	DATE	2001	num	8	SENT_630	[p31l1026t2196r1200b2251],
8	)	NN	O	)	dep	5	SENT_630	[p31l1026t2196r1200b2251],
9	.	.	O	.	_	0	SENT_630	[p31l1026t2196r1200b2251],

1	Warrington	NNP	LOCATION	Warrington	_	0	SENT_631	[p31l129t2275r441b2336],
2	,	,	O	,	_	0	SENT_631	[p31l129t2275r441b2336],
3	A.E.	NNP	PERSON	A.E.	nn	4	SENT_631	[p31l455t2275r548b2322],
4	etal	NNP	O	etal	appos	1	SENT_631	[p31l562t2273r677b2322],
5	.	.	O	.	_	0	SENT_631	[p31l562t2273r677b2322],

1	Human	JJ	O	human	amod	3	SENT_632	[p31l693t2275r881b2322],
2	monoclonal	JJ	O	monoclonal	amod	3	SENT_632	[p31l900t2273r1210b2322],
3	antibodies	NNS	O	antibody	nsubj	7	SENT_632	[p31l1226t2273r1503b2322],
4	reactive	JJ	O	reactive	amod	3	SENT_632	[p31l1520t2275r1723b2322],
5	to	TO	O	to	_	0	SENT_632	[p31l1736t2280r1790b2322],
6	oligodendrocytes	NNS	O	oligodendrocyte	prep_to	4	SENT_632	[p31l132t2351r595b2414],
7	promote	VBP	O	promote	_	0	SENT_632	[p31l611t2358r838b2413],
8	remyelination	NN	O	remyelination	dobj	7	SENT_632	[p31l854t2351r1214b2414],
9	in	IN	O	in	_	0	SENT_632	[p31l1232t2353r1274b2400],
10	a	DT	O	a	det	11	SENT_632	[p31l1290t2365r1316b2400],
11	model	NN	O	model	prep_in	7	SENT_632	[p31l1334t2351r1497b2400],
12	of	IN	O	of	_	0	SENT_632	[p31l1514t2350r1568b2400],
13	multiple	JJ	O	multiple	amod	14	SENT_632	[p31l1580t2351r1796b2413],
14	sclerosis	NN	O	sclerosis	prep_of	11	SENT_632	[p31l1811t2351r2040b2400],
15	.	.	O	.	_	0	SENT_632	[p31l1811t2351r2040b2400],

1	Proc	NNP	O	Proc	_	0	SENT_633	[p31l132t2430r250b2477],
2	.	.	O	.	_	0	SENT_633	[p31l132t2430r250b2477],

1	Natl.	NNP	O	Natl.	nn	2	SENT_634	[p31l265t2428r379b2477],
2	Acad	NNP	O	Acad	_	0	SENT_634	[p31l391t2428r529b2477],
3	.	.	O	.	_	0	SENT_634	[p31l391t2428r529b2477],

1	Sci	NNP	O	Sci	_	0	SENT_635	[p31l543t2429r623b2477],
2	.	.	O	.	_	0	SENT_635	[p31l543t2429r623b2477],

1	USA	NNP	ORGANIZATION	USA	_	0	SENT_636	[p31l640t2429r738b2477],
2	97	CD	NUMBER	97	num	1	SENT_636	[p31l753t2431r833b2484],
3	,	,	O	,	_	0	SENT_636	[p31l753t2431r833b2484],
4	6820-6825	CD	DURATION	6820-6825	num	1	SENT_636	[p31l848t2431r1135b2477],
5	(	CD	NUMBER	(	num	7	SENT_636	[p31l1154t2429r1327b2484],
6	2000	CD	DATE	2000	num	7	SENT_636	[p31l1154t2429r1327b2484],
7	)	NN	O	)	dep	1	SENT_636	[p31l1154t2429r1327b2484],
8	.	.	O	.	_	0	SENT_636	[p31l1154t2429r1327b2484],

1	Watz	NNP	O	Watz	nn	3	SENT_637	[p31l129t2506r454b2563],
2	|	CD	NUMBER	|	num	3	SENT_637	[p31l129t2506r454b2563],
3	awik	NN	O	awik	_	0	SENT_637	[p31l129t2506r454b2563],
4	,	,	O	,	_	0	SENT_637	[p31l129t2506r454b2563],
5	J.	NNP	O	J.	nn	6	SENT_637	[p31l129t2506r454b2563],
6	etal	NNP	O	etal	appos	3	SENT_637	[p31l468t2506r583b2555],
7	.	.	O	.	_	0	SENT_637	[p31l468t2506r583b2555],

1	Human	JJ	O	human	amod	2	SENT_638	[p31l600t2508r788b2555],
2	remyelination	NN	O	remyelination	nsubj	5	SENT_638	[p31l806t2506r1166b2569],
3	promoting	VBG	O	promote	partmod	2	SENT_638	[p31l1184t2508r1463b2569],
4	antibody	NN	O	antibody	dobj	3	SENT_638	[p31l1479t2506r1716b2569],
5	inhibits	VBZ	O	inhibit	_	0	SENT_638	[p31l1730t2506r1922b2555],
6	apoptotic	JJ	O	apoptotic	amod	7	SENT_638	[p31l132t2586r386b2646],
7	signaling	NN	O	signaling	dobj	5	SENT_638	[p31l401t2584r636b2647],
8	and	CC	O	and	_	0	SENT_638	[p31l653t2584r749b2633],
9	differentiation	NN	O	differentiation	dobj	5	SENT_638	[p31l766t2583r1138b2633],
10	through	IN	O	through	_	0	SENT_638	[p31l1153t2584r1367b2647],
11	Lyn	NN	PERSON	lyn	nn	12	SENT_638	[p31l1385t2586r1471b2647],
12	kinase	NN	O	kinase	prep_through	5	SENT_638	[p31l1489t2584r1652b2633],
13	in	IN	O	in	_	0	SENT_638	[p31l1668t2586r1711b2633],
14	primary	JJ	O	primary	amod	16	SENT_638	[p31l1729t2586r1933b2647],
15	rat	NN	O	rat	nn	16	SENT_638	[p31l1948t2591r2015b2633],
16	oligodendrocytes	NNS	O	oligodendrocyte	prep_in	12	SENT_638	[p31l132t2662r607b2725],
17	.	.	O	.	_	0	SENT_638	[p31l132t2662r607b2725],

1	Glia	NN	O	glium	_	0	SENT_639	[p31l622t2662r720b2711],
2	58	CD	NUMBER	58	num	1	SENT_639	[p31l735t2665r814b2719],
3	,	,	O	,	_	0	SENT_639	[p31l735t2665r814b2719],
4	1782-1793	CD	DATE	1782-1793	number	5	SENT_639	[p31l833t2665r1116b2711],
5	(	CD	NUMBER	(	appos	1	SENT_639	[p31l1134t2663r1308b2719],
6	2010	CD	DATE	2010	num	7	SENT_639	[p31l1134t2663r1308b2719],
7	)	NN	O	)	dep	5	SENT_639	[p31l1134t2663r1308b2719],
8	.	.	O	.	_	0	SENT_639	[p31l1134t2663r1308b2719],

1	Kantarci	NNP	PERSON	Kantarci	nn	3	SENT_640	[p31l133t2742r356b2797],
2	,	,	O	,	_	0	SENT_640	[p31l133t2742r356b2797],
3	O.	NNP	O	O.	_	0	SENT_640	[p31l370t2742r422b2789],
4	et	FW	O	et	nn	5	SENT_640	[p31l436t2747r484b2789],
5	al.	FW	O	al.	dep	3	SENT_640	[p31l493t2740r550b2790],
6	.	.	O	.	_	0	SENT_640	[p31l493t2740r550b2790],

1	Survival	NN	O	survival	_	0	SENT_641	[p31l565t2740r769b2789],
2	and	CC	O	and	_	0	SENT_641	[p31l785t2740r882b2789],
3	predictors	NNS	O	predictor	conj_and	1	SENT_641	[p31l901t2740r1164b2802],
4	of	IN	O	of	_	0	SENT_641	[p31l1179t2739r1233b2789],
5	disability	NN	O	disability	prep_of	1	SENT_641	[p31l1243t2740r1479b2804],
6	in	IN	O	in	_	0	SENT_641	[p31l1493t2742r1536b2789],
7	Turkish	JJ	MISC	turkish	amod	9	SENT_641	[p31l1548t2740r1735b2789],
8	MS	NN	O	m	nn	9	SENT_641	[p31l1753t2742r1830b2790],
9	patients	NNS	O	patient	prep_in	1	SENT_641	[p31l1847t2742r2069b2802],
10	.	.	O	.	_	0	SENT_641	[p31l1847t2742r2069b2802],

1	Turkish	JJ	MISC	turkish	amod	5	SENT_642	[p31l130t2818r317b2867],
2	Multiple	JJ	MISC	multiple	amod	5	SENT_642	[p31l335t2818r550b2880],
3	Sclerosis	NN	MISC	sclerosis	nn	5	SENT_642	[p31l565t2818r788b2867],
4	Study	NNP	MISC	Study	nn	5	SENT_642	[p31l803t2818r953b2882],
5	Group	NNP	MISC	Group	_	0	SENT_642	[p31l966t2820r1130b2880],
6	(	CD	NUMBER	(	num	7	SENT_642	[p31l1146t2819r1421b2875],
7	TUMSSG	NNP	O	TUMSSG	dep	5	SENT_642	[p31l1146t2819r1421b2875],
8	)	CD	NUMBER	)	num	7	SENT_642	[p31l1146t2819r1421b2875],
9	.	.	O	.	_	0	SENT_642	[p31l1146t2819r1421b2875],

1	Neurology	NN	O	neurology	_	0	SENT_643	[p31l1435t2818r1700b2882],
2	51	CD	NUMBER	51	num	1	SENT_643	[p31l1711t2822r1791b2875],
3	,	,	O	,	_	0	SENT_643	[p31l1711t2822r1791b2875],
4	765-772	CD	NUMBER	765-772	number	5	SENT_643	[p31l1807t2821r2028b2867],
5	(	CD	NUMBER	(	appos	1	SENT_643	[p31l134t2896r308b2951],
6	1998	CD	DATE	1998	num	7	SENT_643	[p31l134t2896r308b2951],
7	)	NN	O	)	dep	5	SENT_643	[p31l134t2896r308b2951],
8	.	.	O	.	_	0	SENT_643	[p31l134t2896r308b2951],

1	Runmarker	NNP	PERSON	Runmarker	_	0	SENT_644	[p31l133t2973r429b3030],
2	,	,	O	,	_	0	SENT_644	[p31l133t2973r429b3030],
3	B.	NNP	PERSON	B.	conj_and	1	SENT_644	[p31l445t2975r486b3023],
4	&	CC	PERSON	&	_	0	SENT_644	[p31l500t2975r536b3023],
5	Andersen	NNP	PERSON	Andersen	conj_and	1	SENT_644	[p31l549t2973r814b3030],
6	,	,	O	,	_	0	SENT_644	[p31l549t2973r814b3030],
7	O.	NNP	O	O.	nn	9	SENT_644	[p31l828t2975r879b3023],
8	Prognostic	NNP	O	Prognostic	nn	9	SENT_644	[p31l896t2975r1173b3036],
9	factors	NNS	O	factor	appos	1	SENT_644	[p31l1186t2972r1363b3023],
10	in	IN	O	in	_	0	SENT_644	[p31l1380t2975r1422b3022],
11	a	DT	O	a	det	15	SENT_644	[p31l1438t2988r1464b3023],
12	multiple	JJ	O	multiple	amod	15	SENT_644	[p31l1482t2973r1698b3035],
13	sclerosis	NN	O	sclerosis	nn	15	SENT_644	[p31l1713t2973r1929b3023],
14	incidence	NN	O	incidence	nn	15	SENT_644	[p31l134t3051r385b3101],
15	cohort	NN	O	cohort	prep_in	9	SENT_644	[p31l399t3051r573b3101],
16	with	IN	O	with	_	0	SENT_644	[p31l585t3051r699b3100],
17	twenty-ﬁve	JJ	O	twenty-ﬁve	amod	18	SENT_644	[p31l714t3050r1012b3114],
18	years	NNS	DURATION	year	prep_with	15	SENT_644	[p31l1025t3066r1160b3115],
19	of	IN	O	of	_	0	SENT_644	[p31l1175t3050r1229b3100],
20	follow-up	NN	O	follow-up	prep_of	18	SENT_644	[p31l1237t3050r1501b3113],
21	.	.	O	.	_	0	SENT_644	[p31l1237t3050r1501b3113],

1	Brain	NN	O	brain	_	0	SENT_645	[p31l1515t3053r1645b3100],
2	1	CD	NUMBER	1	number	3	SENT_645	[p31l1663t3055r1683b3100],
3	16	CD	NUMBER	16	dep	1	SENT_645	[p31l1699t3054r1763b3101],
4	(	CD	NUMBER	(	num	5	SENT_645	[p31l1779t3052r1847b3108],
5	Pt	NN	O	pt	dep	3	SENT_645	[p31l1779t3052r1847b3108],
6	1	CD	NUMBER	1	num	7	SENT_645	[p31l1865t3052r1921b3108],
7	)	NN	O	)	dep	1	SENT_645	[p31l1865t3052r1921b3108],
8	,	,	O	,	_	0	SENT_645	[p31l1865t3052r1921b3108],
9	1	CD	NUMBER	1	number	10	SENT_645	[p31l136t3132r151b3176],
10	1	CD	NUMBER	1	appos	7	SENT_645	[p31l169t3132r183b3176],
11	7-134	CD	NUMBER	7-134	number	12	SENT_645	[p31l199t3131r357b3177],
12	(	CD	NUMBER	(	dep	1	SENT_645	[p31l372t3129r546b3184],
13	1993	CD	DATE	1993	num	14	SENT_645	[p31l372t3129r546b3184],
14	)	NN	O	)	dep	12	SENT_645	[p31l372t3129r546b3184],
15	.	.	O	.	_	0	SENT_645	[p31l372t3129r546b3184],

1	Weinshenker	NNP	O	Weinshenker	_	0	SENT_646	[p31l129t3206r480b3263],
2	,	,	O	,	_	0	SENT_646	[p31l129t3206r480b3263],
3	B.G.	NNP	LOCATION	B.G.	conj_and	1	SENT_646	[p31l497t3208r605b3263],
4	,	,	O	,	_	0	SENT_646	[p31l497t3208r605b3263],
5	Rice	NNP	PERSON	Rice	conj_and	1	SENT_646	[p31l622t3208r738b3263],
6	,	,	O	,	_	0	SENT_646	[p31l622t3208r738b3263],
7	G.P.	NNP	LOCATION	G.P.	conj_and	1	SENT_646	[p31l752t3208r853b3263],
8	,	,	O	,	_	0	SENT_646	[p31l752t3208r853b3263],
9	Noseworthy	NNP	PERSON	Noseworthy	conj_and	1	SENT_646	[p31l870t3206r1198b3270],
10	,	,	O	,	_	0	SENT_646	[p31l870t3206r1198b3270],
11	J.H.	NNP	LOCATION	J.H.	conj_and	1	SENT_646	[p31l1210t3208r1311b3263],
12	,	,	O	,	_	0	SENT_646	[p31l1210t3208r1311b3263],
13	Carriere	NNP	PERSON	Carriere	conj_and	1	SENT_646	[p31l1326t3207r1627b3263],
14	,	,	O	,	_	0	SENT_646	[p31l1326t3207r1627b3263],
15	W.	NNP	O	W.	conj_and	1	SENT_646	[p31l1326t3207r1627b3263],
16	,	,	O	,	_	0	SENT_646	[p31l1326t3207r1627b3263],
17	Baskerville	NNP	LOCATION	Baskerville	conj_and	1	SENT_646	[p31l1644t3206r1931b3263],
18	,	,	O	,	_	0	SENT_646	[p31l1644t3206r1931b3263],
19	J.	NNP	ORGANIZATION	J.	conj_and	1	SENT_646	[p31l1943t3208r1977b3255],
20	&	CC	ORGANIZATION	&	_	0	SENT_646	[p31l1991t3207r2028b3255],
21	Ebers	NNP	ORGANIZATION	Ebers	conj_and	1	SENT_646	[p31l134t3284r286b3341],
22	,	,	O	,	_	0	SENT_646	[p31l134t3284r286b3341],
23	G.C.	NNP	O	G.C.	nn	26	SENT_646	[p31l300t3284r507b3333],
24	The	NNP	O	The	nn	26	SENT_646	[p31l300t3284r507b3333],
25	natural	JJ	O	natural	amod	26	SENT_646	[p31l524t3284r703b3333],
26	history	NN	O	history	appos	1	SENT_646	[p31l722t3284r901b3348],
27	of	IN	O	of	_	0	SENT_646	[p31l914t3283r968b3333],
28	multiple	JJ	O	multiple	amod	29	SENT_646	[p31l980t3284r1196b3346],
29	sclerosis	NN	O	sclerosis	prep_of	26	SENT_646	[p31l1211t3284r1440b3334],
30	:	:	O	:	_	0	SENT_646	[p31l1211t3284r1440b3334],
31	a	DT	O	a	det	34	SENT_646	[p31l1455t3299r1480b3333],
32	geographically	RB	O	geographically	advmod	33	SENT_646	[p31l1496t3284r1888b3347],
33	based	VBN	O	base	amod	34	SENT_646	[p31l1903t3284r2055b3333],
34	study	NN	O	study	dep	29	SENT_646	[p31l132t3362r286b3426],
35	.	.	O	.	_	0	SENT_646	[p31l132t3362r286b3426],

1	3	LS	NUMBER	3	_	0	SENT_647	[p31l301t3365r342b3411],
2	.	.	O	.	_	0	SENT_647	[p31l301t3365r342b3411],

1	Multivariate	JJ	O	multivariate	amod	2	SENT_648	[p31l358t3362r670b3411],
2	analysis	NN	O	analysis	_	0	SENT_648	[p31l684t3362r886b3425],
3	of	IN	O	of	_	0	SENT_648	[p31l901t3361r955b3411],
4	predictive	JJ	O	predictive	amod	5	SENT_648	[p31l967t3362r1227b3424],
5	factors	NNS	O	factor	prep_of	2	SENT_648	[p31l1240t3361r1418b3412],
6	and	CC	O	and	_	0	SENT_648	[p31l1432t3362r1528b3411],
7	models	NNS	O	model	conj_and	5	SENT_648	[p31l1547t3362r1737b3411],
8	of	IN	O	of	_	0	SENT_648	[p31l1752t3361r1806b3411],
9	outcome	NN	O	outcome	prep_of	2	SENT_648	[p31l1815t3369r2063b3411],
10	.	.	O	.	_	0	SENT_648	[p31l1815t3369r2063b3411],

1	Brain	NN	O	brain	_	0	SENT_649	[p31l132t3441r261b3488],
2	114	CD	NUMBER	114	number	3	SENT_649	[p31l280t3440r537b3495],
3	(	CD	NUMBER	(	num	5	SENT_649	[p31l280t3440r537b3495],
4	Pt2	NN	O	pt2	nn	5	SENT_649	[p31l280t3440r537b3495],
5	)	NN	O	)	dep	1	SENT_649	[p31l280t3440r537b3495],
6	,	,	O	,	_	0	SENT_649	[p31l280t3440r537b3495],
7	1045-1056	CD	DATE	1045-1056	number	8	SENT_649	[p31l556t3442r841b3488],
8	(	CD	NUMBER	(	appos	1	SENT_649	[p31l857t3440r1031b3495],
9	1991	CD	DATE	1991	num	10	SENT_649	[p31l857t3440r1031b3495],
10	)	NN	O	)	dep	8	SENT_649	[p31l857t3440r1031b3495],
11	.	.	O	.	_	0	SENT_649	[p31l857t3440r1031b3495],

1	Rodriguez	NNP	PERSON	Rodriguez	_	0	SENT_650	[p32l133t18r411b81],
2	,	,	O	,	_	0	SENT_650	[p32l133t18r411b81],
3	M.	NNP	O	M.	conj_and	1	SENT_650	[p32l427t20r499b75],
4	,	,	O	,	_	0	SENT_650	[p32l427t20r499b75],
5	Siva	NNP	PERSON	Siva	conj_and	1	SENT_650	[p32l513t19r630b75],
6	,	,	O	,	_	0	SENT_650	[p32l513t19r630b75],
7	A.	NN	O	a.	conj_and	1	SENT_650	[p32l643t20r705b75],
8	,	,	O	,	_	0	SENT_650	[p32l643t20r705b75],
9	Ward	NNP	PERSON	Ward	conj_and	1	SENT_650	[p32l716t18r865b75],
10	,	,	O	,	_	0	SENT_650	[p32l716t18r865b75],
11	J.	NNP	O	J.	conj_and	9	SENT_650	[p32l877t20r924b75],
12	,	,	O	,	_	0	SENT_650	[p32l877t20r924b75],
13	Stolp-Smith	NNP	PERSON	Stolp-Smith	conj_and	9	SENT_650	[p32l938t18r1262b80],
14	,	,	O	,	_	0	SENT_650	[p32l938t18r1262b80],
15	K.	NNP	O	K.	conj_and	9	SENT_650	[p32l1278t20r1334b75],
16	,	,	O	,	_	0	SENT_650	[p32l1278t20r1334b75],
17	O'Brien	NNP	PERSON	O'Brien	conj_and	9	SENT_650	[p32l1348t19r1552b75],
18	,	,	O	,	_	0	SENT_650	[p32l1348t19r1552b75],
19	P.	NNP	ORGANIZATION	P.	conj_and	9	SENT_650	[p32l1569t20r1601b68],
20	&	CC	ORGANIZATION	&	_	0	SENT_650	[p32l1615t20r1652b68],
21	Kurland	NNP	ORGANIZATION	Kurland	conj_and	9	SENT_650	[p32l1667t18r1880b75],
22	,	,	O	,	_	0	SENT_650	[p32l1667t18r1880b75],
23	L.	NNP	PERSON	L.	nn	24	SENT_650	[p32l1897t20r1934b68],
24	Impairment	NNP	PERSON	Impairment	conj_and	1	SENT_650	[p32l134t98r454b158],
25	,	,	O	,	_	0	SENT_650	[p32l134t98r454b158],
26	disability	NN	O	disability	conj_and	1	SENT_650	[p32l468t96r714b160],
27	,	,	O	,	_	0	SENT_650	[p32l468t96r714b160],
28	and	CC	O	and	_	0	SENT_650	[p32l728t96r825b145],
29	handicap	NN	O	handicap	conj_and	1	SENT_650	[p32l843t96r1084b158],
30	in	IN	O	in	_	0	SENT_650	[p32l1101t98r1143b145],
31	multiple	JJ	O	multiple	amod	32	SENT_650	[p32l1162t96r1378b158],
32	sclerosis	NN	O	sclerosis	prep_in	29	SENT_650	[p32l1393t96r1622b145],
33	:	:	O	:	_	0	SENT_650	[p32l1393t96r1622b145],
34	a	DT	O	a	det	36	SENT_650	[p32l1636t110r1662b145],
35	population-based	JJ	O	population-based	amod	36	SENT_650	[p32l1680t96r2145b158],
36	study	NN	O	study	dep	1	SENT_650	[p32l132t174r277b238],
37	in	IN	O	in	_	0	SENT_650	[p32l291t176r334b223],
38	Olmsted	NNP	LOCATION	Olmsted	nn	39	SENT_650	[p32l351t174r571b223],
39	County	NNP	LOCATION	County	prep_in	36	SENT_650	[p32l587t175r787b237],
40	,	,	O	,	_	0	SENT_650	[p32l587t175r787b237],
41	Minnesota	NNP	LOCATION	Minnesota	appos	39	SENT_650	[p32l803t176r1092b223],
42	.	.	O	.	_	0	SENT_650	[p32l803t176r1092b223],

1	Neurology	NN	O	neurology	_	0	SENT_651	[p32l1106t174r1371b238],
2	44	CD	NUMBER	44	num	1	SENT_651	[p32l1381t178r1462b231],
3	,	,	O	,	_	0	SENT_651	[p32l1381t178r1462b231],
4	28-33	CD	NUMBER	28-33	number	5	SENT_651	[p32l1476t177r1633b223],
5	(	CD	NUMBER	(	appos	1	SENT_651	[p32l1651t175r1825b231],
6	1994	CD	DATE	1994	num	7	SENT_651	[p32l1651t175r1825b231],
7	)	NN	O	)	dep	5	SENT_651	[p32l1651t175r1825b231],
8	.	.	O	.	_	0	SENT_651	[p32l1651t175r1825b231],

1	Pittock	NNP	PERSON	Pittock	nn	3	SENT_652	[p32l133t252r323b309],
2	,	,	O	,	_	0	SENT_652	[p32l133t252r323b309],
3	S.J.	NNP	O	S.J.	dep	4	SENT_652	[p32l338t253r413b301],
4	etal	JJ	O	etal	_	0	SENT_652	[p32l428t252r542b301],
5	.	.	O	.	_	0	SENT_652	[p32l428t252r542b301],

1	Change	NNP	O	Change	_	0	SENT_653	[p32l556t252r758b315],
2	in	IN	O	in	_	0	SENT_653	[p32l775t254r817b301],
3	MS-related	JJ	O	ms-related	amod	4	SENT_653	[p32l835t252r1116b301],
4	disability	NN	O	disability	prep_in	1	SENT_653	[p32l1132t252r1369b315],
5	in	IN	O	in	_	0	SENT_653	[p32l1383t254r1425b301],
6	a	DT	O	a	det	8	SENT_653	[p32l1441t266r1467b301],
7	population-based	JJ	O	population-based	amod	8	SENT_653	[p32l1485t252r1950b314],
8	cohort	NN	O	cohort	prep_in	4	SENT_653	[p32l1966t252r2152b301],
9	:	:	O	:	_	0	SENT_653	[p32l1966t252r2152b301],
10	a	DT	O	a	det	13	SENT_653	[p32l132t345r157b379],
11	10-year	JJ	DURATION	10-year	amod	13	SENT_653	[p32l178t333r368b394],
12	follow-up	NN	O	follow-up	nn	13	SENT_653	[p32l380t329r631b392],
13	study	NN	O	study	dep	1	SENT_653	[p32l646t330r800b393],
14	.	.	O	.	_	0	SENT_653	[p32l646t330r800b393],

1	Neurology	NN	O	neurology	_	0	SENT_654	[p32l814t330r1079b394],
2	62	CD	NUMBER	62	num	1	SENT_654	[p32l1089t333r1170b387],
3	,	,	O	,	_	0	SENT_654	[p32l1089t333r1170b387],
4	51	CD	NUMBER	51	num	5	SENT_654	[p32l1185t334r1236b379],
5	-59	CD	NUMBER	-59	appos	1	SENT_654	[p32l1249t333r1343b379],
6	(	CD	NUMBER	(	num	8	SENT_654	[p32l1359t331r1533b387],
7	2004	CD	DATE	2004	num	8	SENT_654	[p32l1359t331r1533b387],
8	)	NN	O	)	dep	5	SENT_654	[p32l1359t331r1533b387],
9	.	.	O	.	_	0	SENT_654	[p32l1359t331r1533b387],

1	Benedikz	NNP	PERSON	Benedikz	nn	3	SENT_655	[p32l133t408r381b465],
2	,	,	O	,	_	0	SENT_655	[p32l133t408r381b465],
3	J.	NNP	O	J.	_	0	SENT_655	[p32l394t410r428b457],
4	et	FW	O	et	nn	5	SENT_655	[p32l442t415r491b458],
5	al.	FW	O	al.	dep	3	SENT_655	[p32l500t408r556b457],
6	.	.	O	.	_	0	SENT_655	[p32l500t408r556b457],

1	The	DT	O	the	det	3	SENT_656	[p32l566t408r663b457],
2	natural	JJ	O	natural	amod	3	SENT_656	[p32l680t408r859b457],
3	history	NN	O	history	_	0	SENT_656	[p32l878t408r1057b472],
4	of	IN	O	of	_	0	SENT_656	[p32l1070t407r1124b457],
5	untreated	JJ	O	untreated	amod	6	SENT_656	[p32l1136t408r1390b457],
6	multiple	JJ	O	multiple	amod	7	SENT_656	[p32l1409t408r1625b470],
7	sclerosis	NN	O	sclerosis	prep_of	3	SENT_656	[p32l1639t408r1856b457],
8	in	IN	O	in	_	0	SENT_656	[p32l1872t410r1915b457],
9	Iceland	NNP	LOCATION	Iceland	prep_in	3	SENT_656	[p32l1934t408r2131b458],
10	.	.	O	.	_	0	SENT_656	[p32l1934t408r2131b458],

1	A	DT	O	a	det	3	SENT_657	[p32l132t488r168b535],
2	total	JJ	O	total	amod	3	SENT_657	[p32l180t486r298b535],
3	population-based	JJ	O	population-based	_	0	SENT_657	[p32l316t486r782b548],
4	50	CD	DURATION	50	num	5	SENT_657	[p32l799t489r860b535],
5	year	NN	NUMBER	year	dep	3	SENT_657	[p32l873t500r985b550],
6	prospective	JJ	O	prospective	amod	7	SENT_657	[p32l1000t488r1305b548],
7	study	NN	O	study	dep	5	SENT_657	[p32l1320t486r1474b549],
8	.	.	O	.	_	0	SENT_657	[p32l1320t486r1474b549],

1	Clin	NNP	O	Clin	_	0	SENT_658	[p32l1489t486r1594b535],
2	.	.	O	.	_	0	SENT_658	[p32l1489t486r1594b535],

1	Neurol	NNP	O	Neurol	_	0	SENT_659	[p32l1608t486r1785b535],
2	.	.	O	.	_	0	SENT_659	[p32l1608t486r1785b535],

1	Neurosurg	NNP	LOCATION	Neurosurg	_	0	SENT_660	[p32l1800t488r2075b549],
2	.	.	O	.	_	0	SENT_660	[p32l1800t488r2075b549],

1	104	CD	NUMBER	104	_	0	SENT_661	[p32l135t566r248b619],
2	,	,	O	,	_	0	SENT_661	[p32l135t566r248b619],
3	208-210	CD	NUMBER	208-210	number	4	SENT_661	[p32l262t566r486b612],
4	(	CD	NUMBER	(	appos	1	SENT_661	[p32l502t564r676b619],
5	2002	CD	DATE	2002	num	6	SENT_661	[p32l502t564r676b619],
6	)	NN	O	)	dep	4	SENT_661	[p32l502t564r676b619],
7	.	.	O	.	_	0	SENT_661	[p32l502t564r676b619],

1	Confavreux	NNP	O	Confavreux	nsubj	18	SENT_662	[p32l131t640r442b698],
2	,	,	O	,	_	0	SENT_662	[p32l131t640r442b698],
3	C.	NNP	O	C.	conj_and	1	SENT_662	[p32l457t642r516b698],
4	,	,	O	,	_	0	SENT_662	[p32l457t642r516b698],
5	Aimard	NNP	PERSON	Aimard	conj_and	1	SENT_662	[p32l530t641r732b698],
6	,	,	O	,	_	0	SENT_662	[p32l530t641r732b698],
7	G.	NNP	ORGANIZATION	G.	conj_and	1	SENT_662	[p32l747t643r797b691],
8	&	CC	ORGANIZATION	&	_	0	SENT_662	[p32l811t642r848b691],
9	Devic	NNP	ORGANIZATION	Devic	nsubj	18	SENT_662	[p32l863t643r1018b698],
10	,	,	O	,	_	0	SENT_662	[p32l863t643r1018b698],
11	M.	NNP	PERSON	M.	nn	12	SENT_662	[p32l1034t643r1093b691],
12	Course	NNP	PERSON	Course	conj_and	1	SENT_662	[p32l1107t643r1288b691],
13	and	CC	O	and	_	0	SENT_662	[p32l1302t641r1398b691],
14	prognosis	NN	O	prognosis	conj_and	1	SENT_662	[p32l1417t643r1673b704],
15	of	IN	O	of	_	0	SENT_662	[p32l1687t640r1742b691],
16	multiple	JJ	O	multiple	amod	17	SENT_662	[p32l1754t641r1970b703],
17	sclerosis	NN	O	sclerosis	prep_of	14	SENT_662	[p32l132t719r348b769],
18	assessed	VBN	O	assess	_	0	SENT_662	[p32l363t719r588b769],
19	by	IN	O	by	_	0	SENT_662	[p32l607t719r669b782],
20	the	DT	O	the	det	23	SENT_662	[p32l680t719r766b769],
21	computerized	JJ	O	computerized	amod	23	SENT_662	[p32l780t719r1145b781],
22	data	NN	O	datum	nn	23	SENT_662	[p32l1161t719r1274b769],
23	processing	NN	O	processing	prep_by	18	SENT_662	[p32l1292t721r1572b782],
24	of	IN	O	of	_	0	SENT_662	[p32l1588t718r1643b769],
25	349	CD	NUMBER	349	num	26	SENT_662	[p32l1653t722r1747b769],
26	patients	NNS	O	patient	prep_of	23	SENT_662	[p32l1763t721r1985b781],
27	.	.	O	.	_	0	SENT_662	[p32l1763t721r1985b781],

1	Brain	NN	O	brain	_	0	SENT_663	[p32l1999t721r2128b768],
2	103	CD	NUMBER	103	num	1	SENT_663	[p32l135t798r247b852],
3	,	,	O	,	_	0	SENT_663	[p32l135t798r247b852],
4	281-300	CD	NUMBER	281-300	number	5	SENT_663	[p32l262t798r486b844],
5	(	CD	NUMBER	(	appos	1	SENT_663	[p32l502t796r676b851],
6	1980	CD	DATE	1980	num	7	SENT_663	[p32l502t796r676b851],
7	)	NN	O	)	dep	5	SENT_663	[p32l502t796r676b851],
8	.	.	O	.	_	0	SENT_663	[p32l502t796r676b851],

1	Levic	NNP	PERSON	Levic	nn	3	SENT_664	[p32l133t875r274b930],
2	,	,	O	,	_	0	SENT_664	[p32l133t875r274b930],
3	Z.M.	NNP	O	Z.M.	_	0	SENT_664	[p32l288t875r397b923],
4	et	FW	O	et	nn	5	SENT_664	[p32l411t880r460b923],
5	al.	FW	O	al.	dep	3	SENT_664	[p32l469t873r526b923],
6	.	.	O	.	_	0	SENT_664	[p32l469t873r526b923],

1	Prognostic	JJ	O	prognostic	amod	2	SENT_665	[p32l543t875r820b936],
2	factors	NNS	O	factor	_	0	SENT_665	[p32l833t872r1010b923],
3	for	IN	O	for	_	0	SENT_665	[p32l1023t872r1096b923],
4	survival	NN	O	survival	prep_for	2	SENT_665	[p32l1109t873r1306b923],
5	in	IN	O	in	_	0	SENT_665	[p32l1325t875r1367b922],
6	multiple	JJ	O	multiple	amod	7	SENT_665	[p32l1386t873r1602b935],
7	sclerosis	NN	O	sclerosis	prep_in	2	SENT_665	[p32l1617t873r1846b923],
8	.	.	O	.	_	0	SENT_665	[p32l1617t873r1846b923],

1	Mult	NNP	O	Mult	_	0	SENT_666	[p32l1859t873r1984b923],
2	.	.	O	.	_	0	SENT_666	[p32l1859t873r1984b923],

1	Scler	NNP	O	Scler	_	0	SENT_667	[p32l1998t873r2129b923],
2	.	.	O	.	_	0	SENT_667	[p32l1998t873r2129b923],

1	5	CD	NUMBER	5	_	0	SENT_668	[p32l133t955r176b1007],
2	,	,	O	,	_	0	SENT_668	[p32l133t955r176b1007],
3	171-178	CD	NUMBER	171-178	number	4	SENT_668	[p32l195t954r415b1000],
4	(	CD	NUMBER	(	appos	1	SENT_668	[p32l431t952r605b1007],
5	1999	CD	DATE	1999	num	6	SENT_668	[p32l431t952r605b1007],
6	)	NN	O	)	dep	4	SENT_668	[p32l431t952r605b1007],
7	.	.	O	.	_	0	SENT_668	[p32l431t952r605b1007],

1	Myhr	NNP	O	Myhr	_	0	SENT_669	[p32l132t1028r274b1092],
2	,	,	O	,	_	0	SENT_669	[p32l132t1028r274b1092],
3	K.M.	NNP	PERSON	K.M.	nn	4	SENT_669	[p32l291t1030r398b1078],
4	etal	NNP	O	etal	appos	1	SENT_669	[p32l412t1028r527b1078],
5	.	.	O	.	_	0	SENT_669	[p32l412t1028r527b1078],

1	Disability	NN	O	disability	_	0	SENT_670	[p32l543t1028r784b1092],
2	and	CC	O	and	_	0	SENT_670	[p32l797t1028r893b1078],
3	prognosis	NN	O	prognosis	conj_and	1	SENT_670	[p32l911t1030r1168b1091],
4	in	IN	O	in	_	0	SENT_670	[p32l1184t1030r1226b1077],
5	multiple	JJ	O	multiple	amod	6	SENT_670	[p32l1245t1028r1461b1090],
6	sclerosis	NN	O	sclerosis	prep_in	1	SENT_670	[p32l1476t1028r1705b1078],
7	:	:	O	:	_	0	SENT_670	[p32l1476t1028r1705b1078],
8	demographic	JJ	O	demographic	amod	11	SENT_670	[p32l1720t1028r2074b1091],
9	and	CC	O	and	_	0	SENT_670	[p32l132t1106r228b1156],
10	clinical	JJ	O	clinical	amod	11	SENT_670	[p32l244t1106r421b1156],
11	variables	NNS	O	variable	dep	1	SENT_670	[p32l436t1106r669b1156],
12	important	JJ	O	important	amod	11	SENT_670	[p32l685t1108r950b1168],
13	for	IN	O	for	_	0	SENT_670	[p32l962t1105r1034b1156],
14	the	DT	O	the	det	15	SENT_670	[p32l1046t1106r1132b1156],
15	ability	NN	O	ability	prep_for	12	SENT_670	[p32l1146t1106r1307b1170],
16	to	TO	O	to	aux	17	SENT_670	[p32l1318t1114r1372b1156],
17	walk	VB	O	walk	infmod	15	SENT_670	[p32l1385t1106r1507b1156],
18	and	CC	O	and	_	0	SENT_670	[p32l1519t1106r1615b1156],
19	awarding	VBG	O	award	amod	11	SENT_670	[p32l1631t1106r1875b1169],
20	of	IN	O	of	_	0	SENT_670	[p32l1891t1105r1946b1156],
21	disability	NN	O	disability	nn	22	SENT_670	[p32l132t1184r369b1248],
22	pension	NN	O	pension	prep_of	19	SENT_670	[p32l383t1186r604b1246],
23	.	.	O	.	_	0	SENT_670	[p32l383t1186r604b1246],

1	Mult	NNP	O	Mult	_	0	SENT_671	[p32l617t1184r744b1234],
2	.	.	O	.	_	0	SENT_671	[p32l617t1184r744b1234],

1	Scler	NNP	O	Scler	_	0	SENT_672	[p32l757t1184r888b1234],
2	.	.	O	.	_	0	SENT_672	[p32l757t1184r888b1234],

1	7	CD	NUMBER	7	_	0	SENT_673	[p32l903t1188r947b1241],
2	,	,	O	,	_	0	SENT_673	[p32l903t1188r947b1241],
3	59-65	CD	NUMBER	59-65	number	4	SENT_673	[p32l962t1187r1118b1234],
4	(	CD	NUMBER	(	appos	1	SENT_673	[p32l1136t1185r1310b1241],
5	2001	CD	DATE	2001	num	6	SENT_673	[p32l1136t1185r1310b1241],
6	)	NN	O	)	dep	4	SENT_673	[p32l1136t1185r1310b1241],
7	.	.	O	.	_	0	SENT_673	[p32l1136t1185r1310b1241],

1	Pittock	NNP	PERSON	Pittock	nn	3	SENT_674	[p32l133t1262r323b1319],
2	,	,	O	,	_	0	SENT_674	[p32l133t1262r323b1319],
3	S.J.	NNP	O	S.J.	dep	4	SENT_674	[p32l338t1264r413b1312],
4	etal	JJ	O	etal	_	0	SENT_674	[p32l428t1262r543b1312],
5	.	.	O	.	_	0	SENT_674	[p32l428t1262r543b1312],

1	Clinical	JJ	O	clinical	amod	2	SENT_675	[p32l557t1262r742b1312],
2	implications	NNS	O	implication	nsubj	15	SENT_675	[p32l760t1262r1078b1324],
3	of	IN	O	of	_	0	SENT_675	[p32l1093t1261r1147b1312],
4	benign	JJ	O	benign	amod	6	SENT_675	[p32l1159t1262r1340b1325],
5	multiple	JJ	O	multiple	amod	6	SENT_675	[p32l1359t1262r1575b1324],
6	sclerosis	NN	O	sclerosis	prep_of	2	SENT_675	[p32l1589t1262r1819b1312],
7	:	:	O	:	_	0	SENT_675	[p32l1589t1262r1819b1312],
8	a	DT	O	a	det	13	SENT_675	[p32l1833t1277r1858b1312],
9	20-year	JJ	DURATION	20-year	amod	13	SENT_675	[p32l1875t1265r2070b1326],
10	popu	NN	O	popu	nn	13	SENT_675	[p32l134t1340r599b1402],
11	|	NN	O	|	nn	13	SENT_675	[p32l134t1340r599b1402],
12	ation	NN	O	ation	nn	13	SENT_675	[p32l134t1340r599b1402],
13	—	NN	O	—	dep	6	SENT_675	[p32l134t1340r599b1402],
14	based	VBN	O	base	partmod	13	SENT_675	[p32l134t1340r599b1402],
15	follow	VBP	O	follow	_	0	SENT_675	[p32l614t1339r867b1402],
16	—	CD	NUMBER	—	dobj	15	SENT_675	[p32l614t1339r867b1402],
17	up	IN	O	up	_	0	SENT_675	[p32l614t1339r867b1402],
18	study	NN	O	study	prep_up	15	SENT_675	[p32l881t1340r1035b1404],
19	.	.	O	.	_	0	SENT_675	[p32l881t1340r1035b1404],

1	Ann	NNP	PERSON	Ann	_	0	SENT_676	[p32l1046t1342r1161b1390],
2	.	.	O	.	_	0	SENT_676	[p32l1046t1342r1161b1390],

1	Neurol	NNP	O	Neurol	_	0	SENT_677	[p32l1176t1340r1356b1390],
2	.	.	O	.	_	0	SENT_677	[p32l1176t1340r1356b1390],

1	56	CD	NUMBER	56	_	0	SENT_678	[p32l1370t1343r1450b1397],
2	,	,	O	,	_	0	SENT_678	[p32l1370t1343r1450b1397],
3	303-306	CD	NUMBER	303-306	number	4	SENT_678	[p32l1465t1343r1689b1390],
4	(	CD	NUMBER	(	appos	1	SENT_678	[p32l1705t1341r1879b1397],
5	2004	CD	DATE	2004	num	6	SENT_678	[p32l1705t1341r1879b1397],
6	)	NN	O	)	dep	4	SENT_678	[p32l1705t1341r1879b1397],
7	.	.	O	.	_	0	SENT_678	[p32l1705t1341r1879b1397],

1	Riise	NNP	PERSON	Riise	_	0	SENT_679	[p32l133t1420r260b1475],
2	,	,	O	,	_	0	SENT_679	[p32l133t1420r260b1475],
3	T.	NNP	O	T.	nn	4	SENT_679	[p32l269t1420r309b1468],
4	etal	NNP	O	etal	appos	1	SENT_679	[p32l323t1418r438b1468],
5	.	.	O	.	_	0	SENT_679	[p32l323t1418r438b1468],

1	Early	RB	O	early	advmod	3	SENT_680	[p32l455t1418r578b1482],
2	prognostic	JJ	O	prognostic	amod	3	SENT_680	[p32l593t1420r874b1481],
3	factors	NNS	O	factor	_	0	SENT_680	[p32l886t1417r1064b1468],
4	for	IN	O	for	_	0	SENT_680	[p32l1077t1417r1149b1468],
5	disability	NN	O	disability	prep_for	3	SENT_680	[p32l1162t1418r1399b1482],
6	in	IN	O	in	_	0	SENT_680	[p32l1413t1420r1456b1467],
7	multiple	JJ	O	multiple	amod	8	SENT_680	[p32l1474t1418r1691b1480],
8	sclerosis	NN	O	sclerosis	prep_in	3	SENT_680	[p32l1705t1418r1934b1475],
9	,	,	O	,	_	0	SENT_680	[p32l1705t1418r1934b1475],
10	a	DT	O	a	det	13	SENT_680	[p32l1948t1433r1973b1468],
11	European	JJ	MISC	european	amod	13	SENT_680	[p32l134t1498r381b1558],
12	multicenter	JJ	O	multicenter	amod	13	SENT_680	[p32l400t1496r703b1546],
13	study	NN	O	study	appos	8	SENT_680	[p32l716t1496r997b1560],
14	.	.	O	.	_	0	SENT_680	[p32l716t1496r997b1560],

1	Acta	NNP	PERSON	Acta	nn	2	SENT_681	[p32l716t1496r997b1560],
2	Neurol	NNP	PERSON	Neurol	_	0	SENT_681	[p32l1009t1496r1461b1553],
3	.	.	O	.	_	0	SENT_681	[p32l1009t1496r1461b1553],

1	Scand	NNP	O	Scand	_	0	SENT_682	[p32l1009t1496r1461b1553],
2	.85	CD	NUMBER	.85	num	1	SENT_682	[p32l1009t1496r1461b1553],
3	,	,	O	,	_	0	SENT_682	[p32l1009t1496r1461b1553],
4	212-218	CD	NUMBER	212-218	num	1	SENT_682	[p32l1476t1499r1699b1546],
5	(	CD	NUMBER	(	num	7	SENT_682	[p32l1715t1497r1890b1553],
6	1992	CD	DATE	1992	num	7	SENT_682	[p32l1715t1497r1890b1553],
7	)	NN	O	)	dep	1	SENT_682	[p32l1715t1497r1890b1553],
8	.	.	O	.	_	0	SENT_682	[p32l1715t1497r1890b1553],

1	Weinshenker	NNP	O	Weinshenker	_	0	SENT_683	[p32l129t1574r480b1631],
2	,	,	O	,	_	0	SENT_683	[p32l129t1574r480b1631],
3	B.G.	NNP	PERSON	B.G.	nn	4	SENT_683	[p32l497t1576r592b1624],
4	etal	NNP	O	etal	appos	1	SENT_683	[p32l606t1574r721b1624],
5	.	.	O	.	_	0	SENT_683	[p32l606t1574r721b1624],

1	The	DT	O	the	det	3	SENT_684	[p32l730t1574r827b1624],
2	natural	JJ	O	natural	amod	3	SENT_684	[p32l843t1574r1023b1624],
3	history	NN	O	history	_	0	SENT_684	[p32l1042t1574r1221b1638],
4	of	IN	O	of	_	0	SENT_684	[p32l1234t1573r1288b1624],
5	multiple	JJ	O	multiple	amod	6	SENT_684	[p32l1300t1574r1516b1636],
6	sclerosis	NN	O	sclerosis	prep_of	3	SENT_684	[p32l1531t1574r1760b1624],
7	:	:	O	:	_	0	SENT_684	[p32l1531t1574r1760b1624],
8	a	DT	O	a	det	11	SENT_684	[p32l1775t1589r1800b1624],
9	geographically	RB	O	geographically	advmod	10	SENT_684	[p32l132t1652r524b1716],
10	based	VBN	O	base	amod	11	SENT_684	[p32l539t1652r691b1702],
11	study	NN	O	study	dep	6	SENT_684	[p32l707t1652r861b1716],
12	.	.	O	.	_	0	SENT_684	[p32l707t1652r861b1716],

1	2	LS	NUMBER	2	_	0	SENT_685	[p32l876t1655r917b1702],
2	.	.	O	.	_	0	SENT_685	[p32l876t1655r917b1702],

1	Predictive	JJ	O	predictive	amod	2	SENT_686	[p32l934t1652r1190b1702],
2	value	NN	O	value	_	0	SENT_686	[p32l1204t1652r1344b1702],
3	of	IN	O	of	_	0	SENT_686	[p32l1358t1651r1413b1702],
4	the	DT	O	the	det	7	SENT_686	[p32l1421t1652r1507b1702],
5	early	JJ	O	early	amod	7	SENT_686	[p32l1521t1652r1648b1716],
6	clinical	JJ	O	clinical	amod	7	SENT_686	[p32l1660t1652r1836b1702],
7	course	NN	O	course	prep_of	2	SENT_686	[p32l1853t1667r2038b1702],
8	.	.	O	.	_	0	SENT_686	[p32l1853t1667r2038b1702],

1	Brain	NN	O	brain	_	0	SENT_687	[p32l132t1731r261b1778],
2	1	CD	NUMBER	1	num	1	SENT_687	[p32l280t1733r299b1777],
3	12	CD	NUMBER	12	number	4	SENT_687	[p32l315t1732r378b1778],
4	(	CD	NUMBER	(	num	6	SENT_687	[p32l395t1730r536b1786],
5	Pt6	NN	O	pt6	nn	6	SENT_687	[p32l395t1730r536b1786],
6	)	NN	O	)	dep	1	SENT_687	[p32l395t1730r536b1786],
7	,	,	O	,	_	0	SENT_687	[p32l395t1730r536b1786],
8	1419-1428	CD	DATE	1419-1428	appos	6	SENT_687	[p32l556t1732r841b1778],
9	(	CD	NUMBER	(	num	10	SENT_687	[p32l857t1730r1031b1785],
10	1989	CD	DATE	1989	dep	1	SENT_687	[p32l857t1730r1031b1785],
11	)	NNP	O	)	dep	10	SENT_687	[p32l857t1730r1031b1785],
12	.	.	O	.	_	0	SENT_687	[p32l857t1730r1031b1785],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_688	[p32l21t1863r140b1884],
2	PHARMACOLOGY&THERAPEUT	NN	O	pharmacology&therapeut	dep	10	SENT_688	[p32l149t1863r601b1884],
3	|	CD	NUMBER	|	num	2	SENT_688	[p32l149t1863r601b1884],
4	CS	NNP	O	CS	nn	6	SENT_688	[p32l149t1863r601b1884],
5	|	NNP	O	|	nn	6	SENT_688	[p32l611t1861r729b1891],
6	VOLUME	NNP	O	VOLUME	dep	2	SENT_688	[p32l611t1861r729b1891],
7	95	CD	NUMBER	95	num	8	SENT_688	[p32l737t1863r764b1884],
8	NUMBER	NN	O	number	dep	10	SENT_688	[p32l774t1863r882b1884],
9	1	CD	NUMBER	1	num	10	SENT_688	[p32l892t1864r899b1884],
10	]	CD	NUMBER	]	dep	13	SENT_688	[p32l912t1861r915b1891],
11	JANUARY	NNP	DATE	JANUARY	dep	10	SENT_688	[p32l924t1863r1042b1884],
12	2014	CD	DATE	2014	num	13	SENT_688	[p32l1049t1863r1108b1884],
13	43	CD	DATE	43	_	0	SENT_688	[p32l2109t1863r2139b1884],

1	STATE	NN	O	state	_	0	SENT_689	[p32l21t2006r163b2043],

1	ART	NN	O	art	_	0	SENT_690	[p32l306t2006r399b2043],

1	Kantarci	NNP	LOCATION	Kantarci	_	0	SENT_691	[p32l131t2243r355b2298],
2	,	,	O	,	_	0	SENT_691	[p32l131t2243r355b2298],
3	O.H.	NNP	ORGANIZATION	O.H.	conj_and	1	SENT_691	[p32l370t2242r476b2290],
4	&	CC	ORGANIZATION	&	_	0	SENT_691	[p32l490t2241r888b2298],
5	Weinshenker	NNP	ORGANIZATION	Weinshenker	conj_and	1	SENT_691	[p32l490t2241r888b2298],
6	,	,	O	,	_	0	SENT_691	[p32l490t2241r888b2298],
7	B.G.	NNP	O	B.G.	nn	9	SENT_691	[p32l905t2243r1000b2290],
8	Natural	NNP	O	Natural	nn	9	SENT_691	[p32l1017t2241r1203b2290],
9	history	NN	O	history	appos	1	SENT_691	[p32l1222t2241r1402b2304],
10	of	IN	O	of	_	0	SENT_691	[p32l1414t2240r1469b2290],
11	multiple	JJ	O	multiple	amod	12	SENT_691	[p32l1481t2241r1698b2303],
12	sclerosis	NN	O	sclerosis	prep_of	9	SENT_691	[p32l1712t2241r1942b2290],
13	.	.	O	.	_	0	SENT_691	[p32l1712t2241r1942b2290],

1	Neurol	NNP	O	Neurol	_	0	SENT_692	[p32l1956t2241r2133b2290],
2	.	.	O	.	_	0	SENT_692	[p32l1956t2241r2133b2290],

1	Clin	NNP	O	Clin	_	0	SENT_693	[p32l131t2318r238b2367],
2	.	.	O	.	_	0	SENT_693	[p32l131t2318r238b2367],

1	23	CD	NUMBER	23	num	6	SENT_694	[p32l253t2321r333b2374],
2	,	,	O	,	_	0	SENT_694	[p32l253t2321r333b2374],
3	17-38	CD	DATE	17-38	num	6	SENT_694	[p32l352t2321r519b2374],
4	,	,	O	,	_	0	SENT_694	[p32l352t2321r519b2374],
5	v	LS	O	v	dep	6	SENT_694	[p32l533t2333r563b2366],
6	(	CD	NUMBER	(	_	0	SENT_694	[p32l577t2319r752b2374],
7	2005	CD	DATE	2005	num	8	SENT_694	[p32l577t2319r752b2374],
8	)	NN	O	)	dep	6	SENT_694	[p32l577t2319r752b2374],
9	.	.	O	.	_	0	SENT_694	[p32l577t2319r752b2374],

1	Confavreux	NNP	O	Confavreux	_	0	SENT_695	[p32l129t2395r442b2453],
2	,	,	O	,	_	0	SENT_695	[p32l129t2395r442b2453],
3	C.	NNP	ORGANIZATION	C.	conj_and	1	SENT_695	[p32l456t2397r502b2445],
4	&	CC	ORGANIZATION	&	_	0	SENT_695	[p32l517t2396r776b2453],
5	Vukusic	NNP	ORGANIZATION	Vukusic	conj_and	1	SENT_695	[p32l517t2396r776b2453],
6	,	,	O	,	_	0	SENT_695	[p32l517t2396r776b2453],
7	S.	NNP	O	S.	nn	9	SENT_695	[p32l791t2397r831b2445],
8	Natural	NNP	O	Natural	nn	9	SENT_695	[p32l848t2396r1035b2445],
9	history	NN	O	history	appos	1	SENT_695	[p32l1054t2396r1233b2459],
10	of	IN	O	of	_	0	SENT_695	[p32l1246t2395r1301b2445],
11	multiple	JJ	O	multiple	amod	12	SENT_695	[p32l1312t2396r1529b2458],
12	sclerosis	NN	O	sclerosis	prep_of	9	SENT_695	[p32l1544t2396r1774b2445],
13	:	:	O	:	_	0	SENT_695	[p32l1544t2396r1774b2445],
14	a	DT	O	a	det	16	SENT_695	[p32l1788t2410r1814b2445],
15	unifying	JJ	O	unifying	amod	16	SENT_695	[p32l1832t2395r2044b2459],
16	concept	NN	O	concept	dep	9	SENT_695	[p32l130t2481r356b2536],
17	.	.	O	.	_	0	SENT_695	[p32l130t2481r356b2536],

1	Brain	NN	O	brain	_	0	SENT_696	[p32l370t2476r500b2523],
2	129	CD	NUMBER	129	num	1	SENT_696	[p32l519t2477r631b2531],
3	,	,	O	,	_	0	SENT_696	[p32l519t2477r631b2531],
4	606-61	CD	NUMBER	606-61	number	5	SENT_696	[p32l645t2477r827b2523],
5	6	CD	NUMBER	6	appos	1	SENT_696	[p32l841t2477r870b2523],
6	(	CD	NUMBER	(	num	8	SENT_696	[p32l887t2475r1061b2531],
7	2006	CD	DATE	2006	num	8	SENT_696	[p32l887t2475r1061b2531],
8	)	NN	O	)	dep	5	SENT_696	[p32l887t2475r1061b2531],
9	.	.	O	.	_	0	SENT_696	[p32l887t2475r1061b2531],

1	Wolinsky	NNP	PERSON	Wolinsky	nn	3	SENT_697	[p32l128t2552r374b2615],
2	,	,	O	,	_	0	SENT_697	[p32l128t2552r374b2615],
3	J.S.	NNP	LOCATION	J.S.	_	0	SENT_697	[p32l387t2553r479b2609],
4	;	:	O	;	_	0	SENT_697	[p32l387t2553r479b2609],
5	PROMiSe	NNP	O	PROMiSe	nn	7	SENT_697	[p32l495t2553r733b2601],
6	Study	NNP	O	Study	nn	7	SENT_697	[p32l748t2552r898b2615],
7	Group	NNP	O	Group	dep	3	SENT_697	[p32l911t2554r1087b2614],
8	.	.	O	.	_	0	SENT_697	[p32l911t2554r1087b2614],

1	The	DT	O	the	det	2	SENT_698	[p32l1097t2552r1194b2601],
2	diagnosis	NN	O	diagnosis	_	0	SENT_698	[p32l1208t2552r1457b2615],
3	of	IN	O	of	_	0	SENT_698	[p32l1472t2551r1526b2601],
4	primary	JJ	O	primary	amod	9	SENT_698	[p32l1538t2554r1743b2615],
5	progressive	JJ	O	progressive	amod	9	SENT_698	[p32l1758t2554r2058b2615],
6	multiple	JJ	O	multiple	amod	9	SENT_698	[p32l133t2630r350b2692],
7	sc	NN	O	sc	nn	9	SENT_698	[p32l364t2630r638b2679],
8	|	NN	O	|	nn	9	SENT_698	[p32l364t2630r638b2679],
9	erosis	NN	O	erosis	prep_of	2	SENT_698	[p32l364t2630r638b2679],
10	.	.	O	.	_	0	SENT_698	[p32l364t2630r638b2679],

1	J.	NNP	PERSON	J.	nn	2	SENT_699	[p32l364t2630r638b2679],
2	Neurol	NNP	PERSON	Neurol	_	0	SENT_699	[p32l654t2630r831b2679],
3	.	.	O	.	_	0	SENT_699	[p32l654t2630r831b2679],

1	Sci	NNP	O	Sci	_	0	SENT_700	[p32l844t2631r927b2679],
2	.	.	O	.	_	0	SENT_700	[p32l844t2631r927b2679],

1	206	CD	NUMBER	206	_	0	SENT_701	[p32l941t2633r1057b2687],
2	,	,	O	,	_	0	SENT_701	[p32l941t2633r1057b2687],
3	145-152	CD	NUMBER	145-152	number	4	SENT_701	[p32l1076t2633r1295b2679],
4	(	CD	NUMBER	(	appos	1	SENT_701	[p32l1312t2631r1487b2687],
5	2003	CD	DATE	2003	num	6	SENT_701	[p32l1312t2631r1487b2687],
6	)	NN	O	)	dep	4	SENT_701	[p32l1312t2631r1487b2687],
7	.	.	O	.	_	0	SENT_701	[p32l1312t2631r1487b2687],

1	Jacobs	NNP	PERSON	Jacobs	_	0	SENT_702	[p32l127t2708r317b2765],
2	,	,	O	,	_	0	SENT_702	[p32l127t2708r317b2765],
3	L.D.	NNP	PERSON	L.D.	nn	4	SENT_702	[p32l334t2710r424b2757],
4	etal	NNP	O	etal	appos	1	SENT_702	[p32l438t2708r554b2757],
5	.	.	O	.	_	0	SENT_702	[p32l438t2708r554b2757],

1	Intramuscular	JJ	O	intramuscular	amod	3	SENT_703	[p32l570t2708r933b2757],
2	interferon	NN	O	interferon	nn	3	SENT_703	[p32l948t2707r1206b2757],
3	beta-1	NN	O	beta-1	nsubj	6	SENT_703	[p32l1224t2708r1381b2757],
4	a	DT	O	a	det	5	SENT_703	[p32l1395t2722r1420b2757],
5	therapy	NN	O	therapy	dep	3	SENT_703	[p32l1435t2708r1640b2771],
6	initiated	VBN	O	initiate	_	0	SENT_703	[p32l1654t2708r1867b2757],
7	during	IN	O	during	_	0	SENT_703	[p32l1883t2708r2056b2771],
8	a	DT	O	a	det	11	SENT_703	[p32l2072t2722r2098b2757],
9	ﬁrst	NN	O	ﬁrst	nn	11	SENT_703	[p32l129t2785r228b2835],
10	demyelinating	VBG	O	demyelinate	amod	11	SENT_703	[p32l242t2786r621b2849],
11	event	NN	O	event	prep_during	6	SENT_703	[p32l637t2793r785b2835],
12	in	IN	O	in	_	0	SENT_703	[p32l800t2788r843b2835],
13	multiple	JJ	O	multiple	amod	14	SENT_703	[p32l861t2786r1078b2848],
14	sclerosis	NN	O	sclerosis	prep_in	11	SENT_703	[p32l1093t2786r1322b2835],
15	.	.	O	.	_	0	SENT_703	[p32l1093t2786r1322b2835],

1	CHAMPS	NNS	O	champ	_	0	SENT_704	[p32l1337t2787r1567b2835],
2	Study	NNP	O	Study	nn	3	SENT_704	[p32l1582t2786r1733b2849],
3	Group	NNP	O	Group	dep	1	SENT_704	[p32l1746t2788r1922b2848],
4	.	.	O	.	_	0	SENT_704	[p32l1746t2788r1922b2848],

1	N.	NNP	O	N.	nn	2	SENT_705	[p32l1936t2788r1984b2835],
2	Engl	NNP	O	Engl	_	0	SENT_705	[p32l1999t2786r2118b2849],
3	.	.	O	.	_	0	SENT_705	[p32l1999t2786r2118b2849],

1	J.	NNP	O	J.	nn	2	SENT_706	[p32l127t2865r161b2912],
2	Med	NNP	O	Med	_	0	SENT_706	[p32l175t2863r298b2912],
3	.	.	O	.	_	0	SENT_706	[p32l175t2863r298b2912],

1	343	CD	NUMBER	343	_	0	SENT_707	[p32l313t2866r428b2919],
2	,	,	O	,	_	0	SENT_707	[p32l313t2866r428b2919],
3	898-904	CD	NUMBER	898-904	number	4	SENT_707	[p32l443t2866r668b2912],
4	(	CD	NUMBER	(	appos	1	SENT_707	[p32l684t2864r858b2919],
5	2000	CD	DATE	2000	num	6	SENT_707	[p32l684t2864r858b2919],
6	)	NN	O	)	dep	4	SENT_707	[p32l684t2864r858b2919],
7	.	.	O	.	_	0	SENT_707	[p32l684t2864r858b2919],

1	Beck	NNP	PERSON	Beck	_	0	SENT_708	[p32l132t2941r265b2998],
2	,	,	O	,	_	0	SENT_708	[p32l132t2941r265b2998],
3	R.W.	NNP	O	R.W.	nn	4	SENT_708	[p32l282t2943r386b2990],
4	etal	NN	O	etal	appos	1	SENT_708	[p32l401t2941r516b2990],
5	.	.	O	.	_	0	SENT_708	[p32l401t2941r516b2990],

1	Interferon	NN	O	interferon	_	0	SENT_709	[p32l533t2940r791b2990],
2	beta-1	NN	O	beta-1	dep	1	SENT_709	[p32l810t2941r966b2990],
3	a	DT	O	a	dep	2	SENT_709	[p32l980t2955r1006b2990],
4	for	IN	O	for	_	0	SENT_709	[p32l1020t2940r1093b2990],
5	early	JJ	O	early	amod	7	SENT_709	[p32l1106t2941r1232b3004],
6	multiple	JJ	O	multiple	amod	7	SENT_709	[p32l1247t2941r1464b3003],
7	sclerosis	NN	O	sclerosis	prep_for	2	SENT_709	[p32l1479t2941r1709b2990],
8	:	:	O	:	_	0	SENT_709	[p32l1479t2941r1709b2990],
9	CHAMPS	NNS	O	champ	dep	1	SENT_709	[p32l1723t2942r1954b2990],
10	trial	NN	O	trial	nn	12	SENT_709	[p32l1967t2941r2065b2990],
11	subgroup	NN	O	subgroup	nn	12	SENT_709	[p32l131t3019r386b3082],
12	analyses	NNS	O	analysis	dep	9	SENT_709	[p32l400t3019r633b3082],
13	.	.	O	.	_	0	SENT_709	[p32l400t3019r633b3082],

1	Ann	NNP	PERSON	Ann	_	0	SENT_710	[p32l643t3021r759b3068],
2	.	.	O	.	_	0	SENT_710	[p32l643t3021r759b3068],

1	Neurol	NNP	O	Neurol	_	0	SENT_711	[p32l775t3019r955b3068],
2	.	.	O	.	_	0	SENT_711	[p32l775t3019r955b3068],

1	51	CD	NUMBER	51	_	0	SENT_712	[p32l969t3023r1049b3076],
2	,	,	O	,	_	0	SENT_712	[p32l969t3023r1049b3076],
3	481	CD	NUMBER	481	number	4	SENT_712	[p32l1062t3022r1148b3068],
4	-490	CD	NUMBER	-490	appos	1	SENT_712	[p32l1161t3022r1288b3068],
5	(	CD	NUMBER	(	num	7	SENT_712	[p32l1304t3020r1479b3076],
6	2002	CD	DATE	2002	num	7	SENT_712	[p32l1304t3020r1479b3076],
7	)	NN	O	)	dep	4	SENT_712	[p32l1304t3020r1479b3076],
8	.	.	O	.	_	0	SENT_712	[p32l1304t3020r1479b3076],

1	Comi	NNP	O	Comi	nn	7	SENT_713	[p32l129t3098r278b3154],
2	,	,	O	,	_	0	SENT_713	[p32l129t3098r278b3154],
3	G.	NNP	O	G.	appos	7	SENT_713	[p32l292t3099r356b3154],
4	,	,	O	,	_	0	SENT_713	[p32l292t3099r356b3154],
5	Filippi	NNP	PERSON	Filippi	appos	7	SENT_713	[p32l373t3097r541b3159],
6	,	,	O	,	_	0	SENT_713	[p32l373t3097r541b3159],
7	M.	NNP	O	M.	nsubj	19	SENT_713	[p32l557t3099r616b3146],
8	&	CC	O	&	nsubj	10	SENT_713	[p32l631t3097r923b3160],
9	Wo	MD	O	will	aux	10	SENT_713	[p32l631t3097r923b3160],
10	|	VB	O	|	rcmod	7	SENT_713	[p32l631t3097r923b3160],
11	insky	NN	O	insky	dobj	10	SENT_713	[p32l631t3097r923b3160],
12	,	,	O	,	_	0	SENT_713	[p32l631t3097r923b3160],
13	J.S.	NNP	PERSON	J.S.	nn	15	SENT_713	[p32l936t3098r1014b3146],
14	European/Canadian	NNP	MISC	European/Canadian	nn	15	SENT_713	[p32l1031t3097r1551b3159],
15	multicenter	NNP	O	multicenter	nsubj	19	SENT_713	[p32l1570t3097r1882b3154],
16	,	,	O	,	_	0	SENT_713	[p32l1570t3097r1882b3154],
17	doubleblind	NN	O	doubleblind	appos	15	SENT_713	[p32l1896t3097r2104b3146, p32l132t3175r277b3232],
18	,	,	O	,	_	0	SENT_713	[p32l1896t3097r2104b3146, p32l132t3175r277b3232],
19	randomized	VBN	O	randomize	_	0	SENT_713	[p32l293t3175r621b3232],
20	,	,	O	,	_	0	SENT_713	[p32l293t3175r621b3232],
21	placebo-controlled	JJ	O	placebo-controlled	amod	22	SENT_713	[p32l637t3175r1138b3237],
22	study	NN	O	study	dobj	19	SENT_713	[p32l1154t3175r1299b3239],
23	of	IN	O	of	_	0	SENT_713	[p32l1312t3174r1367b3225],
24	the	DT	O	the	det	25	SENT_713	[p32l1375t3175r1461b3224],
25	effects	NNS	O	effect	prep_of	22	SENT_713	[p32l1476t3174r1648b3225],
26	of	IN	O	of	_	0	SENT_713	[p32l1663t3174r1717b3224],
27	glatiramer	NN	O	glatiramer	nn	28	SENT_713	[p32l1727t3175r1999b3238],
28	acetate	NN	O	acetate	prep_of	25	SENT_713	[p32l130t3260r322b3303],
29	on	IN	O	on	_	0	SENT_713	[p32l336t3267r401b3303],
30	magnetic	JJ	O	magnetic	amod	33	SENT_713	[p32l420t3255r666b3316],
31	resonance	NN	O	resonance	nn	33	SENT_713	[p32l682t3267r951b3303],
32	imaging	NN	O	imaging	nn	33	SENT_713	[p32l967t3253r1476b3316],
33	—	NN	O	—	prep_on	28	SENT_713	[p32l967t3253r1476b3316],
34	measured	VBN	O	measure	partmod	33	SENT_713	[p32l967t3253r1476b3316],
35	disease	NN	O	disease	nn	36	SENT_713	[p32l1493t3253r1685b3303],
36	activity	NN	O	activity	dobj	34	SENT_713	[p32l1699t3255r1890b3316],
37	and	CC	O	and	_	0	SENT_713	[p32l1903t3253r2000b3303],
38	burden	NN	O	burden	dobj	34	SENT_713	[p32l132t3331r320b3381],
39	in	IN	O	in	_	0	SENT_713	[p32l338t3333r381b3380],
40	patients	NNS	O	patient	prep_in	36	SENT_713	[p32l400t3333r610b3393],
41	with	IN	O	with	_	0	SENT_713	[p32l623t3331r737b3381],
42	relapsing	VBG	O	relapse	prepc_with	34	SENT_713	[p32l755t3331r993b3394],
43	multiple	JJ	O	multiple	amod	44	SENT_713	[p32l1011t3331r1228b3393],
44	sclerosis	NN	O	sclerosis	dobj	42	SENT_713	[p32l1243t3331r1472b3381],
45	.	.	O	.	_	0	SENT_713	[p32l1243t3331r1472b3381],

1	European/Canadian	JJ	MISC	european/canadian	amod	4	SENT_714	[p32l1489t3331r2010b3393],
2	Glatiramer	NNP	MISC	Glatiramer	nn	4	SENT_714	[p32l130t3409r408b3458],
3	Acetate	NNP	MISC	Acetate	nn	4	SENT_714	[p32l421t3411r620b3458],
4	Study	NNP	MISC	Study	_	0	SENT_714	[p32l635t3409r786b3472],
5	Grou	NNP	MISC	Grou	nn	7	SENT_714	[p32l799t3411r925b3458],
6	p.	NN	O	p.	nn	7	SENT_714	[p32l933t3423r975b3471],
7	Ann	NNP	PERSON	Ann	dep	4	SENT_714	[p32l986t3411r1102b3458],
8	.	.	O	.	_	0	SENT_714	[p32l986t3411r1102b3458],

1	Neurol	NNP	O	Neurol	_	0	SENT_715	[p32l1116t3409r1296b3458],
2	.	.	O	.	_	0	SENT_715	[p32l1116t3409r1296b3458],

1	49	CD	NUMBER	49	_	0	SENT_716	[p32l1310t3412r1391b3466],
2	,	,	O	,	_	0	SENT_716	[p32l1310t3412r1391b3466],
3	290-297	CD	NUMBER	290-297	number	4	SENT_716	[p32l1406t3412r1630b3459],
4	(	CD	NUMBER	(	appos	1	SENT_716	[p32l1646t3410r1821b3466],
5	2001	CD	DATE	2001	num	6	SENT_716	[p32l1646t3410r1821b3466],
6	)	NN	O	)	dep	4	SENT_716	[p32l1646t3410r1821b3466],
7	.	.	O	.	_	0	SENT_716	[p32l1646t3410r1821b3466],

1	Comi	NNP	O	Comi	nn	4	SENT_717	[p32l129t3489r278b3544],
2	,	,	O	,	_	0	SENT_717	[p32l129t3489r278b3544],
3	G.	NNP	O	G.	appos	4	SENT_717	[p32l292t3489r343b3537],
4	etal.	NNP	O	etal.	_	0	SENT_717	[p32l357t3487r486b3544],
5	;	:	O	;	_	0	SENT_717	[p32l357t3487r486b3544],
6	PreC	NN	O	prec	nn	9	SENT_717	[p32l502t3489r697b3537],
7	|	CD	NUMBER	|	num	9	SENT_717	[p32l502t3489r697b3537],
8	Se	NN	O	se	nn	9	SENT_717	[p32l502t3489r697b3537],
9	study	NN	O	study	dep	4	SENT_717	[p32l712t3487r857b3550],
10	group	NN	O	group	dep	9	SENT_717	[p32l870t3502r1040b3550],
11	.	.	O	.	_	0	SENT_717	[p32l870t3502r1040b3550],

1	Effect	NN	O	effect	_	0	SENT_718	[p32l1057t3486r1201b3537],
2	of	IN	O	of	_	0	SENT_718	[p32l1215t3486r1270b3537],
3	glatiramer	NN	O	glatiramer	nn	4	SENT_718	[p32l1280t3487r1551b3550],
4	acetate	NN	O	acetate	prep_of	1	SENT_718	[p32l1565t3494r1756b3537],
5	on	IN	O	on	_	0	SENT_718	[p32l1770t3502r1835b3537],
6	conversion	NN	O	conversion	prep_on	4	SENT_718	[p32l1852t3489r2137b3537],
7	to	TO	O	to	_	0	SENT_718	[p32l129t3572r183b3615],
8	clinically	RB	O	clinically	advmod	9	SENT_718	[p32l197t3565r423b3628],
9	deﬁnite	JJ	O	deﬁnite	amod	11	SENT_718	[p32l435t3564r636b3615],
10	multiple	JJ	O	multiple	amod	11	SENT_718	[p32l652t3565r869b3627],
11	sclerosis	NN	O	sclerosis	prep_to	6	SENT_718	[p32l884t3565r1101b3615],
12	in	IN	O	in	_	0	SENT_718	[p32l1117t3567r1160b3614],
13	patients	NNS	O	patient	prep_in	11	SENT_718	[p32l1178t3567r1388b3627],
14	with	IN	O	with	_	0	SENT_718	[p32l1402t3565r1516b3615],
15	clinically	RB	O	clinically	advmod	16	SENT_718	[p32l1532t3565r1758b3628],
16	isolated	VBN	O	isolate	amod	17	SENT_718	[p32l1772t3565r1974b3615],
17	syndrome	NN	O	syndrome	prep_with	13	SENT_718	[p32l131t3643r394b3706],
18	(	CD	NUMBER	(	num	19	SENT_718	[p32l410t3644r624b3700],
19	PreC	NN	O	prec	dep	1	SENT_718	[p32l410t3644r624b3700],
20	|	CD	NUMBER	|	num	22	SENT_718	[p32l410t3644r624b3700],
21	Se	NN	O	se	nn	22	SENT_718	[p32l410t3644r624b3700],
22	study	NN	O	study	dep	19	SENT_718	[p32l639t3643r814b3706],
23	)	CD	NUMBER	)	dep	19	SENT_718	[p32l639t3643r814b3706],
24	:	:	O	:	_	0	SENT_718	[p32l639t3643r814b3706],
25	a	DT	O	a	dep	1	SENT_718	[p32l828t3657r853b3692],
26	randomised	VBN	O	randomise	partmod	25	SENT_718	[p32l871t3643r1197b3700],
27	,	,	O	,	_	0	SENT_718	[p32l871t3643r1197b3700],
28	double-blind	JJ	O	double-blind	amod	31	SENT_718	[p32l1212t3643r1569b3700],
29	,	,	O	,	_	0	SENT_718	[p32l1212t3643r1569b3700],
30	placebo-controlled	JJ	O	placebo-controlled	amod	31	SENT_718	[p32l1585t3643r2085b3705],
31	trial	NN	O	trial	appos	25	SENT_718	[p32l129t3720r242b3769],
32	.	.	O	.	_	0	SENT_718	[p32l129t3720r242b3769],

1	Lancet374	NN	O	lancet374	_	0	SENT_719	[p32l256t3722r553b3776],
2	,	,	O	,	_	0	SENT_719	[p32l256t3722r553b3776],
3	1503-151	CD	NUMBER	1503-151	number	4	SENT_719	[p32l572t3723r815b3769],
4	1	CD	NUMBER	1	appos	1	SENT_719	[p32l833t3724r848b3768],
5	(	CD	NUMBER	(	num	7	SENT_719	[p32l874t3721r1049b3776],
6	2009	CD	DATE	2009	num	7	SENT_719	[p32l874t3721r1049b3776],
7	)	NN	O	)	dep	4	SENT_719	[p32l874t3721r1049b3776],
8	.	.	O	.	_	0	SENT_719	[p32l874t3721r1049b3776],

1	Paty	NNP	O	Paty	nsubj	12	SENT_720	[p33l131t20r251b82],
2	,	,	O	,	_	0	SENT_720	[p33l131t20r251b82],
3	D.W.	NNP	PERSON	D.W.	nsubj	12	SENT_720	[p33l267t20r378b67],
4	&	CC	PERSON	&	_	0	SENT_720	[p33l392t20r429b67],
5	Li	NNP	PERSON	Li	nsubj	12	SENT_720	[p33l445t20r496b75],
6	,	,	O	,	_	0	SENT_720	[p33l445t20r496b75],
7	D.K.	NNP	O	D.K.	nn	10	SENT_720	[p33l513t20r609b67],
8	Interferon	NN	O	interferon	nn	10	SENT_720	[p33l626t17r884b67],
9	beta-1	NN	O	beta-1	nn	10	SENT_720	[p33l903t18r1059b67],
10	b	NN	O	b	appos	1	SENT_720	[p33l1076t18r1106b67],
11	is	VBZ	O	be	cop	12	SENT_720	[p33l1122t20r1156b67],
12	effective	JJ	O	effective	_	0	SENT_720	[p33l1171t17r1395b68],
13	in	IN	O	in	_	0	SENT_720	[p33l1411t20r1454b67],
14	relapsing-remitting	JJ	O	relapsing-remitting	amod	16	SENT_720	[p33l1472t18r1978b81],
15	multiple	JJ	O	multiple	amod	16	SENT_720	[p33l132t96r350b158],
16	sclerosis	NN	O	sclerosis	prep_in	12	SENT_720	[p33l364t96r593b145],
17	.	.	O	.	_	0	SENT_720	[p33l364t96r593b145],

1	II	NNP	O	II	_	0	SENT_721	[p33l611t98r648b145],
2	.	.	O	.	_	0	SENT_721	[p33l611t98r648b145],

1	MRI	NNP	O	MRI	nsubj	3	SENT_722	[p33l663t98r756b145],
2	analysis	NN	O	analysis	nn	3	SENT_722	[p33l774t96r977b160],
3	results	NNS	O	result	_	0	SENT_722	[p33l993t96r1161b146],
4	of	IN	O	of	_	0	SENT_722	[p33l1176t95r1230b145],
5	a	DT	O	a	det	6	SENT_722	[p33l1240t111r1265b145],
6	multicenter	NN	O	multicenter	prep_of	3	SENT_722	[p33l1283t96r1595b153],
7	,	,	O	,	_	0	SENT_722	[p33l1283t96r1595b153],
8	randomized	VBN	O	randomize	partmod	6	SENT_722	[p33l1612t96r1939b153],
9	,	,	O	,	_	0	SENT_722	[p33l1612t96r1939b153],
10	double-blind	JJ	O	double-blind	amod	12	SENT_722	[p33l130t174r488b231],
11	,	,	O	,	_	0	SENT_722	[p33l130t174r488b231],
12	placebo-controlled	JJ	O	placebo-controlled	amod	13	SENT_722	[p33l504t174r1004b236],
13	trial	NN	O	trial	dobj	3	SENT_722	[p33l1019t174r1132b223],
14	.	.	O	.	_	0	SENT_722	[p33l1019t174r1132b223],

1	UBC	NNP	ORGANIZATION	UBC	nn	4	SENT_723	[p33l1149t175r1256b223],
2	MS/MRI	NNP	O	MS/MRI	nn	4	SENT_723	[p33l1271t175r1470b226],
3	Study	NNP	O	Study	nn	4	SENT_723	[p33l1487t174r1638b238],
4	Group	NNP	O	Group	_	0	SENT_723	[p33l1651t176r1815b236],
5	and	CC	O	and	_	0	SENT_723	[p33l1830t174r1926b223],
6	the	DT	O	the	det	7	SENT_723	[p33l1942t174r2028b223],
7	IFNB	NNP	ORGANIZATION	IFNB	conj_and	4	SENT_723	[p33l133t254r250b301],
8	Multiple	JJ	ORGANIZATION	multiple	amod	11	SENT_723	[p33l266t252r481b314],
9	Sclerosis	NNP	ORGANIZATION	Sclerosis	nn	11	SENT_723	[p33l496t252r720b301],
10	Study	NNP	ORGANIZATION	Study	nn	11	SENT_723	[p33l735t252r886b315],
11	Group	NNP	ORGANIZATION	Group	dep	4	SENT_723	[p33l899t254r1074b314],
12	.	.	O	.	_	0	SENT_723	[p33l899t254r1074b314],

1	Neurology	NN	O	neurology	_	0	SENT_724	[p33l1088t252r1354b316],
2	43	CD	NUMBER	43	num	1	SENT_724	[p33l1364t255r1446b309],
3	,	,	O	,	_	0	SENT_724	[p33l1364t255r1446b309],
4	662-667	CD	NUMBER	662-667	number	5	SENT_724	[p33l1459t255r1684b301],
5	(	CD	NUMBER	(	appos	1	SENT_724	[p33l1701t253r1875b309],
6	1993	CD	DATE	1993	num	7	SENT_724	[p33l1701t253r1875b309],
7	)	NN	O	)	dep	5	SENT_724	[p33l1701t253r1875b309],
8	.	.	O	.	_	0	SENT_724	[p33l1701t253r1875b309],

1	Jacobs	NNP	PERSON	Jacobs	_	0	SENT_725	[p33l127t330r317b387],
2	,	,	O	,	_	0	SENT_725	[p33l127t330r317b387],
3	L.D.	NNP	PERSON	L.D.	nn	4	SENT_725	[p33l334t332r424b380],
4	etal	NNP	O	etal	appos	1	SENT_725	[p33l438t330r553b380],
5	.	.	O	.	_	0	SENT_725	[p33l438t330r553b380],

1	Intramuscular	JJ	O	intramuscular	amod	3	SENT_726	[p33l570t330r933b380],
2	interferon	NN	O	interferon	nn	3	SENT_726	[p33l947t329r1206b380],
3	beta-1	NN	O	beta-1	_	0	SENT_726	[p33l1224t330r1381b380],
4	a	DT	O	a	advmod	5	SENT_726	[p33l1394t345r1420b380],
5	for	IN	O	for	dep	3	SENT_726	[p33l1434t329r1507b380],
6	disease	NN	O	disease	nn	7	SENT_726	[p33l1521t330r1712b380],
7	progression	NN	O	progression	pobj	5	SENT_726	[p33l1729t332r2036b393],
8	in	IN	O	in	_	0	SENT_726	[p33l2054t332r2097b379],
9	relapsing	VBG	O	relapse	prepc_in	7	SENT_726	[p33l132t408r370b471],
10	multiple	JJ	O	multiple	amod	11	SENT_726	[p33l389t408r606b470],
11	sclerosis	NN	O	sclerosis	dobj	9	SENT_726	[p33l620t408r849b458],
12	.	.	O	.	_	0	SENT_726	[p33l620t408r849b458],

1	The	DT	O	the	det	6	SENT_727	[p33l859t408r957b458],
2	Multiple	JJ	O	multiple	amod	6	SENT_727	[p33l972t408r1188b470],
3	Sclerosis	NNP	O	Sclerosis	nn	6	SENT_727	[p33l1203t408r1426b458],
4	Collaborative	NNP	O	Collaborative	nn	6	SENT_727	[p33l1441t408r1790b458],
5	Research	NNP	O	Research	nn	6	SENT_727	[p33l1806t408r2037b458],
6	Group	NNP	O	Group	_	0	SENT_727	[p33l130t488r295b548],
7	(	CD	NUMBER	(	num	8	SENT_727	[p33l311t487r678b543],
8	MSCRG	NNP	O	MSCRG	dep	6	SENT_727	[p33l311t487r678b543],
9	)	CD	NUMBER	)	num	8	SENT_727	[p33l311t487r678b543],
10	.	.	O	.	_	0	SENT_727	[p33l311t487r678b543],

1	Ann	NNP	PERSON	Ann	_	0	SENT_728	[p33l311t487r678b543],
2	.	.	O	.	_	0	SENT_728	[p33l311t487r678b543],

1	Neurol	NNP	O	Neurol	_	0	SENT_729	[p33l692t486r872b536],
2	.	.	O	.	_	0	SENT_729	[p33l692t486r872b536],

1	39	CD	NUMBER	39	_	0	SENT_730	[p33l887t489r967b543],
2	,	,	O	,	_	0	SENT_730	[p33l887t489r967b543],
3	285-294	CD	NUMBER	285-294	number	4	SENT_730	[p33l982t489r1207b536],
4	(	CD	NUMBER	(	appos	1	SENT_730	[p33l1222t487r1397b543],
5	1996	CD	DATE	1996	num	6	SENT_730	[p33l1222t487r1397b543],
6	)	NN	O	)	dep	4	SENT_730	[p33l1222t487r1397b543],
7	.	.	O	.	_	0	SENT_730	[p33l1222t487r1397b543],

1	Antonelli	NNP	PERSON	Antonelli	_	0	SENT_731	[p33l128t564r380b621],
2	,	,	O	,	_	0	SENT_731	[p33l128t564r380b621],
3	G.	NNP	O	G.	nn	4	SENT_731	[p33l395t566r445b614],
4	etal	NN	O	etal	appos	1	SENT_731	[p33l459t564r575b614],
5	.	.	O	.	_	0	SENT_731	[p33l459t564r575b614],

1	Further	JJ	O	further	amod	2	SENT_732	[p33l591t564r782b614],
2	study	NN	O	study	nsubj	22	SENT_732	[p33l796t564r941b627],
3	on	IN	O	on	_	0	SENT_732	[p33l954t579r1018b614],
4	the	DT	O	the	det	5	SENT_732	[p33l1034t564r1120b614],
5	speciﬁcity	NN	O	speciﬁcity	prep_on	2	SENT_732	[p33l1134t563r1397b627],
6	and	CC	O	and	_	0	SENT_732	[p33l1410t564r1507b614],
7	incidence	NN	O	incidence	conj_and	5	SENT_732	[p33l1525t564r1777b614],
8	of	IN	O	of	_	0	SENT_732	[p33l1791t563r1846b614],
9	neutralizing	VBG	O	neutralize	prepc_of	5	SENT_732	[p33l132t642r443b705],
10	antibodies	NNS	O	antibody	dobj	9	SENT_732	[p33l459t642r736b692],
11	to	TO	O	to	_	0	SENT_732	[p33l750t649r803b692],
12	interferon	NN	O	interferon	nn	15	SENT_732	[p33l819t641r1077b692],
13	(	CD	NUMBER	(	num	15	SENT_732	[p33l1096t643r1212b699],
14	IFN	NN	ORGANIZATION	ifn	nn	15	SENT_732	[p33l1096t643r1212b699],
15	)	NN	O	)	prep_to	9	SENT_732	[p33l1096t643r1212b699],
16	in	IN	O	in	_	0	SENT_732	[p33l1230t644r1273b691],
17	relapsing	VBG	O	relapse	prepc_in	9	SENT_732	[p33l1292t642r1529b705],
18	remitting	VBG	O	remit	xcomp	17	SENT_732	[p33l1548t644r1788b705],
19	multiple	JJ	O	multiple	amod	21	SENT_732	[p33l1807t642r2024b704],
20	sclerosis	NN	O	sclerosis	nn	21	SENT_732	[p33l131t720r348b770],
21	patients	NNS	O	patient	dobj	18	SENT_732	[p33l364t722r574b782],
22	treated	VBN	O	treat	_	0	SENT_732	[p33l588t720r776b770],
23	with	IN	O	with	_	0	SENT_732	[p33l791t720r905b770],
24	IFN	NN	O	ifn	nn	25	SENT_732	[p33l924t722r1003b769],
25	beta-1	NN	O	beta-1	prep_with	22	SENT_732	[p33l1022t720r1179b770],
26	a	DT	O	a	dobj	22	SENT_732	[p33l1193t735r1218b770],
27	or	CC	O	or	_	0	SENT_732	[p33l1234t735r1287b770],
28	IFN	NN	O	ifn	conj_or	26	SENT_732	[p33l1303t722r1383b769],
29	beta-1	NN	O	beta-1	nsubj	30	SENT_732	[p33l1402t720r1558b770],
30	b.	VBP	O	b.	rcmod	26	SENT_732	[p33l1574t720r1616b770],
31	J.	NNP	PERSON	J.	nn	32	SENT_732	[p33l1626t722r1661b770],
32	Neurol	NNP	PERSON	Neurol	dobj	30	SENT_732	[p33l1676t720r1853b770],
33	.	.	O	.	_	0	SENT_732	[p33l1676t720r1853b770],

1	Sci	NNP	O	Sci	_	0	SENT_733	[p33l1867t721r1949b770],
2	.	.	O	.	_	0	SENT_733	[p33l1867t721r1949b770],

1	168	CD	NUMBER	168	_	0	SENT_734	[p33l1967t723r2079b777],
2	,	,	O	,	_	0	SENT_734	[p33l1967t723r2079b777],
3	131-136	CD	NUMBER	131-136	number	4	SENT_734	[p33l135t800r355b846],
4	(	CD	NUMBER	(	appos	1	SENT_734	[p33l372t798r546b853],
5	1999	CD	DATE	1999	num	6	SENT_734	[p33l372t798r546b853],
6	)	NN	O	)	dep	4	SENT_734	[p33l372t798r546b853],
7	.	.	O	.	_	0	SENT_734	[p33l372t798r546b853],

1	Waubant	NNP	O	Waubant	nn	3	SENT_735	[p33l128t875r379b932],
2	,	,	O	,	_	0	SENT_735	[p33l128t875r379b932],
3	E.	NNP	O	E.	_	0	SENT_735	[p33l397t877r434b924],
4	et	FW	O	et	nn	5	SENT_735	[p33l449t882r497b924],
5	al.	FW	O	al.	dep	3	SENT_735	[p33l506t875r564b925],
6	.	.	O	.	_	0	SENT_735	[p33l506t875r564b925],

1	Clinical	JJ	O	clinical	amod	2	SENT_736	[p33l578t875r763b925],
2	characteristics	NNS	O	characteristic	_	0	SENT_736	[p33l780t875r1155b925],
3	of	IN	O	of	_	0	SENT_736	[p33l1170t874r1224b924],
4	responders	NNS	O	responder	prep_of	2	SENT_736	[p33l1236t875r1528b937],
5	to	TO	O	to	_	0	SENT_736	[p33l1542t882r1595b924],
6	interferon	NN	O	interferon	nn	7	SENT_736	[p33l1611t874r1869b925],
7	therapy	NN	O	therapy	prep_to	4	SENT_736	[p33l1884t875r2089b939],
8	for	IN	O	for	_	0	SENT_736	[p33l129t951r202b1002],
9	relapsing	VBG	O	relapse	prepc_for	7	SENT_736	[p33l217t952r454b1015],
10	MS.	NNP	O	MS.	nn	11	SENT_736	[p33l472t954r563b1002],
11	Neurology	NNP	O	Neurology	dobj	9	SENT_736	[p33l577t952r843b1016],
12	61	CD	NUMBER	61	num	11	SENT_736	[p33l853t955r934b1009],
13	,	,	O	,	_	0	SENT_736	[p33l853t955r934b1009],
14	184-189	CD	NUMBER	184-189	num	11	SENT_736	[p33l953t955r1173b1002],
15	(	CD	NUMBER	(	num	17	SENT_736	[p33l1189t953r1364b1009],
16	2003	CD	DATE	2003	num	17	SENT_736	[p33l1189t953r1364b1009],
17	)	NN	O	)	dep	11	SENT_736	[p33l1189t953r1364b1009],
18	.	.	O	.	_	0	SENT_736	[p33l1189t953r1364b1009],

1	Johnson	NNP	PERSON	Johnson	nn	3	SENT_737	[p33l127t1030r364b1087],
2	,	,	O	,	_	0	SENT_737	[p33l127t1030r364b1087],
3	K.P.	NNP	O	K.P.	_	0	SENT_737	[p33l380t1032r461b1080],
4	et	FW	O	et	nn	5	SENT_737	[p33l475t1037r524b1080],
5	al.	FW	O	al.	dep	3	SENT_737	[p33l533t1030r590b1080],
6	.	.	O	.	_	0	SENT_737	[p33l533t1030r590b1080],

1	Copo	NNP	O	Copo	_	0	SENT_738	[p33l605t1030r929b1094],
2	|	CD	NUMBER	|	num	3	SENT_738	[p33l605t1030r929b1094],
3	ymer1	NN	O	ymer1	nsubj	4	SENT_738	[p33l605t1030r929b1094],
4	reduces	VBZ	O	reduce	rcmod	1	SENT_738	[p33l955t1030r1158b1080],
5	relapse	NN	O	relapse	nn	6	SENT_738	[p33l1174t1030r1360b1092],
6	rate	NN	O	rate	dobj	4	SENT_738	[p33l1377t1038r1474b1080],
7	and	CC	O	and	_	0	SENT_738	[p33l1488t1030r1585b1080],
8	improves	VBZ	O	improve	rcmod	1	SENT_738	[p33l1603t1032r1844b1092],
9	disability	NN	O	disability	dobj	8	SENT_738	[p33l1859t1030r2096b1094],
10	in	IN	O	in	_	0	SENT_738	[p33l132t1110r175b1157],
11	re	NN	O	re	nn	12	SENT_738	[p33l193t1108r699b1171],
12	|	NN	O	|	prep_in	8	SENT_738	[p33l193t1108r699b1171],
13	apsing	VBG	O	apse	partmod	12	SENT_738	[p33l193t1108r699b1171],
14	—	CD	NUMBER	—	dobj	13	SENT_738	[p33l193t1108r699b1171],
15	remitting	VBG	O	remit	xcomp	13	SENT_738	[p33l193t1108r699b1171],
16	multiple	JJ	O	multiple	amod	17	SENT_738	[p33l717t1108r934b1170],
17	sclerosis	NN	O	sclerosis	dobj	15	SENT_738	[p33l949t1108r1179b1158],
18	:	:	O	:	_	0	SENT_738	[p33l949t1108r1179b1158],
19	results	NNS	O	result	dep	1	SENT_738	[p33l1196t1108r1363b1158],
20	of	IN	O	of	_	0	SENT_738	[p33l1378t1107r1432b1158],
21	a	DT	O	a	det	24	SENT_738	[p33l1442t1123r1468b1158],
22	phase	NN	O	phase	nn	24	SENT_738	[p33l1485t1108r1639b1170],
23	III	CD	NUMBER	iii	num	24	SENT_738	[p33l1657t1110r1693b1157],
24	multicenter	NN	O	multicenter	prep_of	19	SENT_738	[p33l1712t1108r2024b1166],
25	,	,	O	,	_	0	SENT_738	[p33l1712t1108r2024b1166],
26	double	JJ	O	double	amod	33	SENT_738	[p33l130t1186r473b1236],
27	—	RB	O	—	advmod	28	SENT_738	[p33l130t1186r473b1236],
28	blind	JJ	O	blind	amod	33	SENT_738	[p33l130t1186r473b1236],
29	placebo	NN	O	placebo	nn	33	SENT_738	[p33l492t1186r992b1248],
30	—	NN	O	—	nn	33	SENT_738	[p33l492t1186r992b1248],
31	controlled	JJ	O	controlled	amod	33	SENT_738	[p33l492t1186r992b1248],
32	tria	NN	O	trium	nn	33	SENT_738	[p33l1007t1186r1226b1236],
33	|	NN	O	|	appos	24	SENT_738	[p33l1007t1186r1226b1236],
34	.	.	O	.	_	0	SENT_738	[p33l1007t1186r1226b1236],

1	The	DT	O	the	det	4	SENT_739	[p33l1007t1186r1226b1236],
2	Copo	NNP	O	Copo	nn	4	SENT_739	[p33l1241t1186r1564b1250],
3	|	NN	O	|	nn	4	SENT_739	[p33l1241t1186r1564b1250],
4	ymer1	NN	O	ymer1	_	0	SENT_739	[p33l1241t1186r1564b1250],
5	Multiple	JJ	O	multiple	amod	8	SENT_739	[p33l1590t1186r1806b1248],
6	Sclerosis	NN	O	sclerosis	nn	8	SENT_739	[p33l1821t1186r2044b1236],
7	Study	NNP	O	Study	nn	8	SENT_739	[p33l131t1264r282b1328],
8	Group	NNP	O	Group	dep	4	SENT_739	[p33l295t1266r470b1326],
9	.	.	O	.	_	0	SENT_739	[p33l295t1266r470b1326],

1	Neurology	NN	O	neurology	_	0	SENT_740	[p33l485t1264r751b1328],
2	45	CD	NUMBER	45	num	1	SENT_740	[p33l760t1268r842b1321],
3	,	,	O	,	_	0	SENT_740	[p33l760t1268r842b1321],
4	1268-1276	CD	DATE	1268-1276	number	5	SENT_740	[p33l860t1267r1147b1314],
5	(	CD	NUMBER	(	appos	1	SENT_740	[p33l1162t1265r1337b1321],
6	1995	CD	DATE	1995	num	7	SENT_740	[p33l1162t1265r1337b1321],
7	)	NN	O	)	dep	5	SENT_740	[p33l1162t1265r1337b1321],
8	.	.	O	.	_	0	SENT_740	[p33l1162t1265r1337b1321],

1	Ge	NNP	O	Ge	_	0	SENT_741	[p33l129t1344r211b1399],
2	,	,	O	,	_	0	SENT_741	[p33l129t1344r211b1399],
3	Y.	NNP	O	Y.	nn	4	SENT_741	[p33l221t1344r260b1392],
4	etal	NN	O	etal	appos	1	SENT_741	[p33l274t1342r390b1392],
5	.	.	O	.	_	0	SENT_741	[p33l274t1342r390b1392],

1	Glatiramer	FW	O	glatiramer	_	0	SENT_742	[p33l404t1342r682b1392],
2	acetate	NN	O	acetate	nn	6	SENT_742	[p33l694t1350r886b1392],
3	(	CD	NUMBER	(	num	6	SENT_742	[p33l902t1343r1200b1404],
4	Copaxone	NN	O	copaxone	nn	6	SENT_742	[p33l902t1343r1200b1404],
5	)	NN	O	)	nn	6	SENT_742	[p33l902t1343r1200b1404],
6	treatment	NN	O	treatment	npadvmod	1	SENT_742	[p33l1215t1350r1479b1392],
7	in	IN	O	in	_	0	SENT_742	[p33l1495t1344r1538b1391],
8	re	NN	O	re	nn	9	SENT_742	[p33l1556t1342r2062b1405],
9	|	NN	O	|	prep_in	1	SENT_742	[p33l1556t1342r2062b1405],
10	apsing	VBG	O	apse	partmod	9	SENT_742	[p33l1556t1342r2062b1405],
11	—	CD	NUMBER	—	num	13	SENT_742	[p33l1556t1342r2062b1405],
12	remitting	VBG	O	remit	amod	13	SENT_742	[p33l1556t1342r2062b1405],
13	MS	NN	O	m	dobj	10	SENT_742	[p33l132t1422r223b1470],
14	:	:	O	:	_	0	SENT_742	[p33l132t1422r223b1470],
15	quantitative	JJ	O	quantitative	amod	17	SENT_742	[p33l238t1422r556b1482],
16	MR	NN	O	mr	nn	17	SENT_742	[p33l572t1422r653b1469],
17	assessment	NN	O	assessment	dep	13	SENT_742	[p33l667t1427r981b1470],
18	.	.	O	.	_	0	SENT_742	[p33l667t1427r981b1470],

1	Neurology	NN	O	neurology	_	0	SENT_743	[p33l995t1420r1262b1484],
2	54	CD	NUMBER	54	num	1	SENT_743	[p33l1272t1424r1352b1477],
3	,	,	O	,	_	0	SENT_743	[p33l1272t1424r1352b1477],
4	813-81	CD	NUMBER	813-81	number	5	SENT_743	[p33l1367t1423r1548b1470],
5	7	CD	NUMBER	7	appos	1	SENT_743	[p33l1564t1424r1591b1469],
6	(	CD	NUMBER	(	num	8	SENT_743	[p33l1608t1421r1782b1477],
7	2000	CD	DATE	2000	num	8	SENT_743	[p33l1608t1421r1782b1477],
8	)	NN	O	)	dep	5	SENT_743	[p33l1608t1421r1782b1477],
9	.	.	O	.	_	0	SENT_743	[p33l1608t1421r1782b1477],

1	Wolinsky	NNP	PERSON	Wolinsky	_	0	SENT_744	[p33l128t1498r374b1562],
2	,	,	O	,	_	0	SENT_744	[p33l128t1498r374b1562],
3	J.S.	NNP	LOCATION	J.S.	conj_and	1	SENT_744	[p33l386t1500r478b1555],
4	,	,	O	,	_	0	SENT_744	[p33l386t1500r478b1555],
5	Narayana	NNP	PERSON	Narayana	conj_and	1	SENT_744	[p33l495t1500r752b1562],
6	,	,	O	,	_	0	SENT_744	[p33l495t1500r752b1562],
7	P.A.	NNP	ORGANIZATION	P.A.	conj_and	1	SENT_744	[p33l769t1500r853b1548],
8	&	CC	ORGANIZATION	&	_	0	SENT_744	[p33l867t1500r904b1548],
9	Johnson	NNP	ORGANIZATION	Johnson	conj_and	1	SENT_744	[p33l915t1498r1151b1555],
10	,	,	O	,	_	0	SENT_744	[p33l915t1498r1151b1555],
11	K.P.	NNP	O	K.P.	appos	1	SENT_744	[p33l1169t1500r1262b1555],
12	;	:	O	;	_	0	SENT_744	[p33l1169t1500r1262b1555],
13	Multiple	JJ	ORGANIZATION	multiple	amod	16	SENT_744	[p33l1278t1498r1494b1560],
14	Sclerosis	NNP	ORGANIZATION	Sclerosis	nn	16	SENT_744	[p33l1509t1498r1732b1548],
15	Study	NNP	ORGANIZATION	Study	nn	16	SENT_744	[p33l1747t1498r1898b1562],
16	Group	NNP	ORGANIZATION	Group	dep	1	SENT_744	[p33l1911t1500r2075b1560],
17	and	CC	O	and	_	0	SENT_744	[p33l130t1576r227b1626],
18	the	DT	O	the	det	21	SENT_744	[p33l242t1576r328b1626],
19	MRI	NNP	MISC	MRI	nn	21	SENT_744	[p33l344t1578r438b1625],
20	Analysis	NNP	MISC	Analysis	nn	21	SENT_744	[p33l454t1576r665b1640],
21	Center	NNP	MISC	Center	dep	1	SENT_744	[p33l680t1578r863b1626],
22	.	.	O	.	_	0	SENT_744	[p33l680t1578r863b1626],

1	United	NNP	LOCATION	United	nn	11	SENT_745	[p33l880t1576r1052b1626],
2	States	NNPS	LOCATION	States	nn	11	SENT_745	[p33l1069t1578r1225b1626],
3	open	JJ	O	open	amod	11	SENT_745	[p33l1240t1576r1521b1638],
4	—	NN	O	—	nn	11	SENT_745	[p33l1240t1576r1521b1638],
5	|	NN	O	|	nn	11	SENT_745	[p33l1240t1576r1521b1638],
6	abe	NN	O	abe	nn	11	SENT_745	[p33l1240t1576r1521b1638],
7	|	NN	O	|	nn	11	SENT_745	[p33l1240t1576r1521b1638],
8	glatiramer	NN	O	glatiramer	nn	11	SENT_745	[p33l1538t1576r1810b1639],
9	acetate	NN	O	acetate	nn	11	SENT_745	[p33l1823t1583r2014b1626],
10	extension	NN	O	extension	nn	11	SENT_745	[p33l131t1656r385b1704],
11	trial	NN	O	trial	_	0	SENT_745	[p33l401t1654r498b1704],
12	for	IN	O	for	_	0	SENT_745	[p33l514t1653r586b1704],
13	relapsing	VBG	O	relapse	prepc_for	11	SENT_745	[p33l601t1654r839b1717],
14	multiple	JJ	O	multiple	amod	15	SENT_745	[p33l857t1654r1074b1716],
15	sclerosis	NN	O	sclerosis	dobj	13	SENT_745	[p33l1089t1654r1319b1704],
16	:	:	O	:	_	0	SENT_745	[p33l1089t1654r1319b1704],
17	MRI	NNP	O	MRI	dep	11	SENT_745	[p33l1335t1656r1428b1703],
18	and	CC	O	and	_	0	SENT_745	[p33l1445t1654r1542b1704],
19	clinical	JJ	O	clinical	amod	20	SENT_745	[p33l1558t1654r1735b1704],
20	correlates	NNS	O	correlate	dep	11	SENT_745	[p33l1752t1654r2020b1704],
21	.	.	O	.	_	0	SENT_745	[p33l1752t1654r2020b1704],

1	Multiple	JJ	O	multiple	_	0	SENT_746	[p33l132t1732r348b1794],
2	Sclerosis	NNP	O	Sclerosis	nn	4	SENT_746	[p33l363t1732r586b1782],
3	Study	NNP	O	Study	nn	4	SENT_746	[p33l601t1732r752b1796],
4	Group	NNP	O	Group	dep	1	SENT_746	[p33l765t1734r929b1794],
5	and	CC	O	and	_	0	SENT_746	[p33l944t1732r1040b1782],
6	the	DT	O	the	det	9	SENT_746	[p33l1055t1732r1142b1782],
7	MRI	NNP	MISC	MRI	nn	9	SENT_746	[p33l1157t1734r1251b1781],
8	Analysis	NNP	MISC	Analysis	nn	9	SENT_746	[p33l1267t1732r1478b1796],
9	Center	NNP	MISC	Center	conj_and	4	SENT_746	[p33l1493t1734r1676b1782],
10	.	.	O	.	_	0	SENT_746	[p33l1493t1734r1676b1782],

1	Mult	NNP	O	Mult	_	0	SENT_747	[p33l1689t1732r1816b1782],
2	.	.	O	.	_	0	SENT_747	[p33l1689t1732r1816b1782],

1	Scler	NNP	O	Scler	_	0	SENT_748	[p33l1829t1732r1961b1782],
2	.	.	O	.	_	0	SENT_748	[p33l1829t1732r1961b1782],

1	7	CD	NUMBER	7	_	0	SENT_749	[p33l1976t1736r2020b1789],
2	,	,	O	,	_	0	SENT_749	[p33l1976t1736r2020b1789],
3	33-41	CD	NUMBER	33-41	number	4	SENT_749	[p33l131t1812r280b1858],
4	(	CD	NUMBER	(	appos	1	SENT_749	[p33l306t1810r481b1865],
5	2001	CD	DATE	2001	num	6	SENT_749	[p33l306t1810r481b1865],
6	)	NN	O	)	dep	4	SENT_749	[p33l306t1810r481b1865],
7	.	.	O	.	_	0	SENT_749	[p33l306t1810r481b1865],

1	Noseworthy	NNP	PERSON	Noseworthy	_	0	SENT_750	[p33l131t1887r460b1951],
2	,	,	O	,	_	0	SENT_750	[p33l131t1887r460b1951],
3	J.H.	NNP	ORGANIZATION	J.H.	conj_and	1	SENT_750	[p33l472t1889r561b1937],
4	&	CC	ORGANIZATION	&	_	0	SENT_750	[p33l575t1889r612b1937],
5	Kirkpatrick	NNP	ORGANIZATION	Kirkpatrick	conj_and	1	SENT_750	[p33l627t1887r919b1950],
6	,	,	O	,	_	0	SENT_750	[p33l627t1887r919b1950],
7	P.	NNP	PERSON	P.	nn	11	SENT_750	[p33l936t1889r968b1937],
8	Natalizu	NNP	PERSON	Natalizu	nn	11	SENT_750	[p33l985t1887r1193b1937],
9	ma	NN	O	ma	nn	11	SENT_750	[p33l1201t1902r1278b1937],
10	b.	NNP	O	b.	nn	11	SENT_750	[p33l1286t1887r1328b1937],
11	Nat	NNP	PERSON	Nat	appos	1	SENT_750	[p33l1342t1889r1443b1937],
12	.	.	O	.	_	0	SENT_750	[p33l1342t1889r1443b1937],

1	Rev.	NNP	O	Rev.	nn	3	SENT_751	[p33l1458t1889r1554b1937],
2	Drug	NNP	PERSON	Drug	nn	3	SENT_751	[p33l1569t1889r1694b1950],
3	Discov	NNP	PERSON	Discov	_	0	SENT_751	[p33l1707t1889r1885b1937],
4	.	.	O	.	_	0	SENT_751	[p33l1707t1889r1885b1937],

1	4	CD	NUMBER	4	_	0	SENT_752	[p33l1898t1891r1943b1944],
2	,	,	O	,	_	0	SENT_752	[p33l1898t1891r1943b1944],
3	101-102	CD	NUMBER	101-102	number	4	SENT_752	[p33l135t1967r354b2013],
4	(	CD	NUMBER	(	appos	1	SENT_752	[p33l371t1965r546b2021],
5	2005	CD	DATE	2005	num	6	SENT_752	[p33l371t1965r546b2021],
6	)	NN	O	)	dep	4	SENT_752	[p33l371t1965r546b2021],
7	.	.	O	.	_	0	SENT_752	[p33l371t1965r546b2021],

1	Miller	NNP	PERSON	Miller	nn	4	SENT_753	[p33l130t2042r285b2099],
2	,	,	O	,	_	0	SENT_753	[p33l130t2042r285b2099],
3	D.H.	NNP	O	D.H.	appos	4	SENT_753	[p33l301t2044r403b2092],
4	etal.	NNP	O	etal.	_	0	SENT_753	[p33l417t2042r546b2099],
5	;	:	O	;	_	0	SENT_753	[p33l417t2042r546b2099],
6	International	NNP	ORGANIZATION	International	nn	9	SENT_753	[p33l563t2042r896b2092],
7	Natalizumab	NNP	ORGANIZATION	Natalizumab	nn	9	SENT_753	[p33l916t2042r1247b2092],
8	Multiple	JJ	ORGANIZATION	multiple	amod	9	SENT_753	[p33l1263t2042r1479b2105],
9	Sc	NN	ORGANIZATION	sc	dep	4	SENT_753	[p33l1494t2042r1833b2092],
10	|	CD	NUMBER	|	num	13	SENT_753	[p33l1494t2042r1833b2092],
11	erosisTria	NNP	O	erosisTria	nn	13	SENT_753	[p33l1494t2042r1833b2092],
12	|	NNP	O	|	nn	13	SENT_753	[p33l1494t2042r1833b2092],
13	Group	NNP	O	Group	dep	9	SENT_753	[p33l1850t2044r2026b2105],
14	.	.	O	.	_	0	SENT_753	[p33l1850t2044r2026b2105],

1	A	DT	O	a	det	3	SENT_754	[p33l2040t2044r2076b2091],
2	controlled	JJ	O	controlled	amod	3	SENT_754	[p33l130t2120r397b2170],
3	trial	NN	O	trial	_	0	SENT_754	[p33l412t2120r510b2170],
4	of	IN	O	of	_	0	SENT_754	[p33l527t2119r582b2170],
5	natalizumab	NN	O	natalizumab	prep_of	3	SENT_754	[p33l593t2120r918b2170],
6	for	IN	O	for	_	0	SENT_754	[p33l931t2119r1004b2170],
7	relapsing	VBG	O	relapse	prepc_for	5	SENT_754	[p33l1019t2120r1256b2183],
8	multiple	JJ	O	multiple	amod	9	SENT_754	[p33l1275t2120r1492b2182],
9	sclerosis	NN	O	sclerosis	dobj	7	SENT_754	[p33l1506t2120r1736b2170],
10	.	.	O	.	_	0	SENT_754	[p33l1506t2120r1736b2170],

1	N.	NNP	O	N.	nn	2	SENT_755	[p33l1750t2122r1798b2170],
2	Engl	NNP	O	Engl	_	0	SENT_755	[p33l1813t2120r1977b2183],
3	.	.	O	.	_	0	SENT_755	[p33l1813t2120r1977b2183],

1	J.	NNP	O	J.	nn	2	SENT_756	[p33l1813t2120r1977b2183],
2	Med	NNP	O	Med	_	0	SENT_756	[p33l1991t2120r2114b2170],
3	.	.	O	.	_	0	SENT_756	[p33l1991t2120r2114b2170],

1	348	CD	NUMBER	348	_	0	SENT_757	[p33l131t2200r246b2254],
2	,	,	O	,	_	0	SENT_757	[p33l131t2200r246b2254],
3	15-23	CD	NUMBER	15-23	number	4	SENT_757	[p33l265t2200r418b2246],
4	(	CD	NUMBER	(	appos	1	SENT_757	[p33l436t2198r610b2254],
5	2003	CD	DATE	2003	num	6	SENT_757	[p33l436t2198r610b2254],
6	)	NN	O	)	dep	4	SENT_757	[p33l436t2198r610b2254],
7	.	.	O	.	_	0	SENT_757	[p33l436t2198r610b2254],

1	Langer	NNP	PERSON	Langer	_	0	SENT_758	[p33l131t2275r506b2338],
2	.	.	O	.	_	0	SENT_758	[p33l131t2275r506b2338],

1	—	NN	O	—	_	0	SENT_759	[p33l131t2275r506b2338],
2	.	.	O	.	_	0	SENT_759	[p33l131t2275r506b2338],

1	Gou	NNP	PERSON	Gou	nn	3	SENT_760	[p33l131t2275r506b2338],
2	|	NNP	O	|	nn	3	SENT_760	[p33l131t2275r506b2338],
3	d	NN	O	d	_	0	SENT_760	[p33l131t2275r506b2338],
4	,	,	O	,	_	0	SENT_760	[p33l131t2275r506b2338],
5	A.	NN	O	a.	appos	3	SENT_760	[p33l519t2277r581b2332],
6	,	,	O	,	_	0	SENT_760	[p33l519t2277r581b2332],
7	Atlas	NNP	O	Atlas	appos	3	SENT_760	[p33l595t2275r735b2332],
8	,	,	O	,	_	0	SENT_760	[p33l595t2275r735b2332],
9	S.W.	NNP	O	S.W.	appos	3	SENT_760	[p33l750t2277r867b2332],
10	,	,	O	,	_	0	SENT_760	[p33l750t2277r867b2332],
11	Green	NNP	PERSON	Green	appos	3	SENT_760	[p33l881t2277r1052b2332],
12	,	,	O	,	_	0	SENT_760	[p33l881t2277r1052b2332],
13	A.J.	NNP	PERSON	A.J.	appos	3	SENT_760	[p33l1065t2277r1163b2332],
14	,	,	O	,	_	0	SENT_760	[p33l1065t2277r1163b2332],
15	Bollen	NNP	PERSON	Bollen	appos	3	SENT_760	[p33l1180t2275r1354b2332],
16	,	,	O	,	_	0	SENT_760	[p33l1180t2275r1354b2332],
17	A.W.	NNP	ORGANIZATION	A.W.	conj_and	7	SENT_760	[p33l1368t2277r1480b2325],
18	&	CC	ORGANIZATION	&	_	0	SENT_760	[p33l1495t2277r1531b2325],
19	Pelletier	NNP	ORGANIZATION	Pelletier	conj_and	7	SENT_760	[p33l1547t2275r1765b2332],
20	,	,	O	,	_	0	SENT_760	[p33l1547t2275r1765b2332],
21	D.	NNP	O	D.	nn	22	SENT_760	[p33l1782t2277r1829b2325],
22	Progressive	NNP	O	Progressive	appos	3	SENT_760	[p33l1846t2277r2143b2338],
23	multifocal	JJ	O	multifocal	amod	24	SENT_760	[p33l132t2352r391b2403],
24	Ieukoencephalopathy	NNP	O	Ieukoencephalopathy	dep	22	SENT_760	[p33l410t2353r985b2417],
25	in	IN	O	in	_	0	SENT_760	[p33l1000t2355r1043b2402],
26	a	DT	O	a	det	27	SENT_760	[p33l1059t2368r1084b2403],
27	patient	NN	O	patient	prep_in	22	SENT_760	[p33l1103t2355r1288b2415],
28	treated	VBN	O	treat	partmod	27	SENT_760	[p33l1301t2353r1489b2403],
29	with	IN	O	with	_	0	SENT_760	[p33l1504t2353r1618b2403],
30	natalizumab	NN	O	natalizumab	prep_with	28	SENT_760	[p33l1637t2353r1973b2403],
31	.	.	O	.	_	0	SENT_760	[p33l1637t2353r1973b2403],

1	N.	NNP	O	N.	nn	2	SENT_761	[p33l1987t2355r2035b2403],
2	Engl	NNP	O	Engl	_	0	SENT_761	[p33l130t2431r249b2494],
3	.	.	O	.	_	0	SENT_761	[p33l130t2431r249b2494],

1	J.	NNP	O	J.	nn	2	SENT_762	[p33l260t2433r294b2481],
2	Med	NNP	O	Med	_	0	SENT_762	[p33l308t2431r431b2481],
3	.	.	O	.	_	0	SENT_762	[p33l308t2431r431b2481],

1	353	CD	NUMBER	353	_	0	SENT_763	[p33l446t2434r561b2488],
2	,	,	O	,	_	0	SENT_763	[p33l446t2434r561b2488],
3	375-381	CD	NUMBER	375-381	number	4	SENT_763	[p33l576t2434r791b2481],
4	(	CD	NUMBER	(	appos	1	SENT_763	[p33l817t2432r991b2488],
5	2005	CD	DATE	2005	num	6	SENT_763	[p33l817t2432r991b2488],
6	)	NN	O	)	dep	4	SENT_763	[p33l817t2432r991b2488],
7	.	.	O	.	_	0	SENT_763	[p33l817t2432r991b2488],

1	K	NNP	O	K	_	0	SENT_764	[p33l131t2509r785b2567],
2	|	CD	NUMBER	|	num	3	SENT_764	[p33l131t2509r785b2567],
3	einschmidt	NN	O	einschmidt	dep	1	SENT_764	[p33l131t2509r785b2567],
4	.	.	O	.	_	0	SENT_764	[p33l131t2509r785b2567],

1	—	NN	O	—	_	0	SENT_765	[p33l131t2509r785b2567],
2	.	.	O	.	_	0	SENT_765	[p33l131t2509r785b2567],

1	DeMasters	NNP	PERSON	DeMasters	_	0	SENT_766	[p33l131t2509r785b2567],
2	,	,	O	,	_	0	SENT_766	[p33l131t2509r785b2567],
3	B.K.	NNP	O	B.K.	conj_and	1	SENT_766	[p33l802t2511r892b2559],
4	&	CC	O	&	_	0	SENT_766	[p33l905t2509r1085b2573],
5	TyIer	NNP	O	TyIer	conj_and	1	SENT_766	[p33l905t2509r1085b2573],
6	,	,	O	,	_	0	SENT_766	[p33l905t2509r1085b2573],
7	K.L.	NNP	ORGANIZATION	K.L.	nn	8	SENT_766	[p33l1102t2512r1188b2559],
8	Progressive	NNP	ORGANIZATION	Progressive	appos	1	SENT_766	[p33l1205t2511r1501b2572],
9	multifocal	JJ	O	multifocal	amod	8	SENT_766	[p33l1518t2509r1776b2559],
10	Ieukoencephalopathy	NNP	O	Ieukoencephalopathy	dep	9	SENT_766	[p33l133t2587r708b2651],
11	complicating	VBG	O	complicate	dep	10	SENT_766	[p33l721t2587r1064b2650],
12	treatment	NN	O	treatment	dobj	11	SENT_766	[p33l1080t2595r1344b2637],
13	with	IN	O	with	_	0	SENT_766	[p33l1357t2587r1470b2637],
14	natalizumab	NN	O	natalizumab	prep_with	11	SENT_766	[p33l1489t2587r1814b2637],
15	and	CC	O	and	_	0	SENT_766	[p33l1828t2587r1924b2637],
16	interferon	NN	O	interferon	conj_and	14	SENT_766	[p33l132t2665r390b2715],
17	beta-1	NN	O	beta-1	tmod	11	SENT_766	[p33l409t2665r565b2715],
18	a	DT	O	a	dep	17	SENT_766	[p33l579t2680r605b2715],
19	for	IN	O	for	_	0	SENT_766	[p33l619t2665r692b2715],
20	multiple	JJ	O	multiple	amod	21	SENT_766	[p33l707t2665r924b2728],
21	sclerosis	NN	O	sclerosis	prep_for	17	SENT_766	[p33l939t2665r1168b2715],
22	.	.	O	.	_	0	SENT_766	[p33l939t2665r1168b2715],

1	N.	NNP	O	N.	nn	2	SENT_767	[p33l1182t2668r1230b2715],
2	Engl	NNP	O	Engl	_	0	SENT_767	[p33l1245t2665r1363b2728],
3	.	.	O	.	_	0	SENT_767	[p33l1245t2665r1363b2728],

1	J.	NNP	O	J.	nn	2	SENT_768	[p33l1374t2668r1409b2715],
2	Med	NNP	O	Med	_	0	SENT_768	[p33l1423t2665r1546b2715],
3	.	.	O	.	_	0	SENT_768	[p33l1423t2665r1546b2715],

1	353	CD	NUMBER	353	_	0	SENT_769	[p33l1560t2668r1676b2723],
2	,	,	O	,	_	0	SENT_769	[p33l1560t2668r1676b2723],
3	369-374	CD	NUMBER	369-374	number	4	SENT_769	[p33l1691t2668r1916b2715],
4	(	CD	NUMBER	(	appos	1	SENT_769	[p33l1931t2666r2106b2723],
5	2005	CD	DATE	2005	num	6	SENT_769	[p33l1931t2666r2106b2723],
6	)	NN	O	)	dep	4	SENT_769	[p33l1931t2666r2106b2723],
7	.	.	O	.	_	0	SENT_769	[p33l1931t2666r2106b2723],

1	Kappos	NNP	PERSON	Kappos	nn	4	SENT_770	[p33l131t2746r337b2806],
2	,	,	O	,	_	0	SENT_770	[p33l131t2746r337b2806],
3	L.	NNP	O	L.	appos	4	SENT_770	[p33l354t2746r391b2793],
4	etal.	NNP	O	etal.	_	0	SENT_770	[p33l405t2743r534b2801],
5	;	:	O	;	_	0	SENT_770	[p33l405t2743r534b2801],
6	FREEDOMS	NNP	O	FREEDOMS	nn	8	SENT_770	[p33l550t2745r841b2793],
7	Study	NNP	O	Study	nn	8	SENT_770	[p33l857t2743r1008b2807],
8	Group	NNP	O	Group	dep	4	SENT_770	[p33l1020t2745r1196b2806],
9	.	.	O	.	_	0	SENT_770	[p33l1020t2745r1196b2806],

1	A	DT	O	a	det	3	SENT_771	[p33l1211t2746r1247b2792],
2	placebo	NN	O	placebo	nn	3	SENT_771	[p33l1263t2743r1763b2806],
3	—	NN	O	—	nsubj	4	SENT_771	[p33l1263t2743r1763b2806],
4	controlled	VBN	O	control	_	0	SENT_771	[p33l1263t2743r1763b2806],
5	trial	NN	O	trial	dobj	4	SENT_771	[p33l1778t2743r1875b2793],
6	of	IN	O	of	_	0	SENT_771	[p33l1893t2743r1947b2793],
7	oral	JJ	O	oral	amod	8	SENT_771	[p33l1957t2743r2052b2793],
8	ﬁngolimod	NN	O	ﬁngolimod	prep_of	5	SENT_771	[p33l129t2821r419b2884],
9	in	IN	O	in	_	0	SENT_771	[p33l437t2824r479b2870],
10	relapsing	VBG	O	relapse	prepc_in	4	SENT_771	[p33l498t2821r735b2884],
11	multiple	JJ	O	multiple	amod	12	SENT_771	[p33l754t2821r971b2884],
12	sclerosis	NN	O	sclerosis	dobj	10	SENT_771	[p33l986t2821r1215b2871],
13	.	.	O	.	_	0	SENT_771	[p33l986t2821r1215b2871],

1	N.	NNP	O	N.	nn	2	SENT_772	[p33l1229t2824r1277b2871],
2	Engl	NNP	O	Engl	_	0	SENT_772	[p33l1292t2821r1456b2884],
3	.	.	O	.	_	0	SENT_772	[p33l1292t2821r1456b2884],

1	J.	NNP	O	J.	nn	2	SENT_773	[p33l1292t2821r1456b2884],
2	Med	NNP	O	Med	_	0	SENT_773	[p33l1470t2821r1593b2871],
3	.	.	O	.	_	0	SENT_773	[p33l1470t2821r1593b2871],

1	362	CD	NUMBER	362	_	0	SENT_774	[p33l1607t2824r1723b2879],
2	,	,	O	,	_	0	SENT_774	[p33l1607t2824r1723b2879],
3	387-401	CD	NUMBER	387-401	number	4	SENT_774	[p33l1738t2824r1952b2871],
4	(	CD	NUMBER	(	appos	1	SENT_774	[p33l1978t2822r2153b2879],
5	2010	CD	DATE	2010	num	6	SENT_774	[p33l1978t2822r2153b2879],
6	)	NN	O	)	dep	4	SENT_774	[p33l1978t2822r2153b2879],
7	.	.	O	.	_	0	SENT_774	[p33l1978t2822r2153b2879],

1	Cohen	NNP	PERSON	Cohen	nsubj	6	SENT_775	[p33l129t2899r314b2957],
2	,	,	O	,	_	0	SENT_775	[p33l129t2899r314b2957],
3	J.A.	NNP	O	J.A.	nn	4	SENT_775	[p33l327t2902r415b2949],
4	etal.	NNP	O	etal.	appos	1	SENT_775	[p33l429t2899r942b2957],
5	;	:	O	;	_	0	SENT_775	[p33l429t2899r942b2957],
6	TRANSFORMS	VBZ	O	transform	_	0	SENT_775	[p33l429t2899r942b2957],
7	Study	NNP	O	Study	nn	8	SENT_775	[p33l959t2899r1111b2963],
8	Group	NNP	O	Group	dobj	6	SENT_775	[p33l1124t2901r1302b2962],
9	.	.	O	.	_	0	SENT_775	[p33l1124t2901r1302b2962],

1	Oral	JJ	O	oral	amod	2	SENT_776	[p33l1317t2899r1422b2949],
2	ﬁngolimod	NN	O	ﬁngolimod	_	0	SENT_776	[p33l1438t2899r1730b2962],
3	or	CC	O	or	_	0	SENT_776	[p33l1747t2914r1801b2949],
4	intramuscular	JJ	O	intramuscular	amod	5	SENT_776	[p33l132t2977r498b3027],
5	interferon	NN	O	interferon	conj_or	2	SENT_776	[p33l514t2977r775b3027],
6	for	IN	O	for	_	0	SENT_776	[p33l790t2977r864b3027],
7	relapsing	VBG	O	relapse	prepc_for	2	SENT_776	[p33l879t2977r1120b3040],
8	multiple	JJ	O	multiple	amod	9	SENT_776	[p33l1139t2977r1358b3040],
9	sclerosis	NN	O	sclerosis	dobj	7	SENT_776	[p33l1373t2977r1606b3027],
10	.	.	O	.	_	0	SENT_776	[p33l1373t2977r1606b3027],

1	N.	NNP	O	N.	nn	2	SENT_777	[p33l1620t2980r1669b3027],
2	Engl	NNP	O	Engl	_	0	SENT_777	[p33l1684t2977r1804b3040],
3	.	.	O	.	_	0	SENT_777	[p33l1684t2977r1804b3040],

1	J.	NNP	O	J.	nn	2	SENT_778	[p33l1816t2980r1850b3027],
2	Med	NNP	O	Med	_	0	SENT_778	[p33l1865t2977r1989b3027],
3	.	.	O	.	_	0	SENT_778	[p33l1865t2977r1989b3027],

1	362	CD	NUMBER	362	_	0	SENT_779	[p33l2004t2980r2120b3035],
2	,	,	O	,	_	0	SENT_779	[p33l2004t2980r2120b3035],
3	402-415	CD	NUMBER	402-415	number	4	SENT_779	[p33l129t3057r355b3103],
4	(	CD	NUMBER	(	appos	1	SENT_779	[p33l374t3055r550b3111],
5	2010	CD	DATE	2010	num	6	SENT_779	[p33l374t3055r550b3111],
6	)	NN	O	)	dep	4	SENT_779	[p33l374t3055r550b3111],
7	.	.	O	.	_	0	SENT_779	[p33l374t3055r550b3111],

1	Hartung	NNP	PERSON	Hartung	nn	4	SENT_780	[p33l132t3467r359b3527],
2	,	,	O	,	_	0	SENT_780	[p33l132t3467r359b3527],
3	H.P.	NNP	O	H.P.	appos	4	SENT_780	[p33l376t3466r462b3514],
4	etal.	NNP	O	etal.	_	0	SENT_780	[p33l477t3464r605b3522],
5	;	:	O	;	_	0	SENT_780	[p33l477t3464r605b3522],
6	Mitoxantrone	NNP	O	Mitoxantrone	dep	4	SENT_780	[p33l620t3467r975b3514],
7	in	IN	O	in	_	0	SENT_780	[p33l991t3467r1033b3513],
8	Multiple	JJ	MISC	multiple	amod	14	SENT_780	[p33l1052t3464r1267b3527],
9	Sclerosis	NNP	MISC	Sclerosis	nn	14	SENT_780	[p33l1282t3464r1504b3514],
10	Study	NNP	MISC	Study	nn	14	SENT_780	[p33l1519t3464r1670b3528],
11	Group	NNP	MISC	Group	nn	14	SENT_780	[p33l1683t3466r1846b3527],
12	(	NNP	O	(	nn	14	SENT_780	[p33l1863t3465r2055b3522],
13	MIMS	NNP	ORGANIZATION	MIMS	nn	14	SENT_780	[p33l1863t3465r2055b3522],
14	)	NN	O	)	prep_in	6	SENT_780	[p33l1863t3465r2055b3522],
15	.	.	O	.	_	0	SENT_780	[p33l1863t3465r2055b3522],

1	Mitoxantrone	NNP	O	Mitoxantrone	_	0	SENT_781	[p33l132t3545r487b3592],
2	in	IN	O	in	_	0	SENT_781	[p33l503t3545r546b3591],
3	progressive	JJ	O	progressive	amod	5	SENT_781	[p33l564t3545r864b3605],
4	multiple	JJ	O	multiple	amod	5	SENT_781	[p33l880t3542r1097b3605],
5	sclerosis	NN	O	sclerosis	prep_in	1	SENT_781	[p33l1111t3542r1341b3592],
6	:	:	O	:	_	0	SENT_781	[p33l1111t3542r1341b3592],
7	a	DT	O	a	det	9	SENT_781	[p33l1355t3557r1380b3592],
8	placebo	NN	O	placebo	nn	9	SENT_781	[p33l1399t3542r1912b3605],
9	—	NN	O	—	dep	1	SENT_781	[p33l1399t3542r1912b3605],
10	controlled	VBN	O	control	partmod	9	SENT_781	[p33l1399t3542r1912b3605],
11	,	,	O	,	_	0	SENT_781	[p33l1399t3542r1912b3605],
12	doubleblind	NN	O	doubleblind	appos	9	SENT_781	[p33l1926t3542r2133b3592, p33l133t3619r276b3676],
13	,	,	O	,	_	0	SENT_781	[p33l1926t3542r2133b3592, p33l133t3619r276b3676],
14	randomised	VBN	O	randomise	partmod	9	SENT_781	[p33l293t3619r618b3676],
15	,	,	O	,	_	0	SENT_781	[p33l293t3619r618b3676],
16	multicentre	JJ	O	multicentre	amod	17	SENT_781	[p33l634t3619r935b3668],
17	trial	NN	O	trial	dobj	14	SENT_781	[p33l949t3619r1061b3668],
18	.	.	O	.	_	0	SENT_781	[p33l949t3619r1061b3668],

1	Lancet	NNP	O	Lancet	_	0	SENT_782	[p33l1075t3622r1245b3668],
2	360	CD	NUMBER	360	num	1	SENT_782	[p33l1256t3622r1371b3676],
3	,	,	O	,	_	0	SENT_782	[p33l1256t3622r1371b3676],
4	201	CD	NUMBER	201	num	1	SENT_782	[p33l1386t3622r1470b3668],
5	8-2025	CD	NUMBER	8-2025	number	6	SENT_782	[p33l1484t3622r1673b3668],
6	(	CD	NUMBER	(	dep	1	SENT_782	[p33l1691t3620r1865b3676],
7	2002	CD	DATE	2002	num	8	SENT_782	[p33l1691t3620r1865b3676],
8	)	NN	O	)	dep	6	SENT_782	[p33l1691t3620r1865b3676],
9	.	.	O	.	_	0	SENT_782	[p33l1691t3620r1865b3676],

1	Ghalie	NNP	O	Ghalie	_	0	SENT_783	[p34l129t17r306b75],
2	,	,	O	,	_	0	SENT_783	[p34l129t17r306b75],
3	R.G.	NNP	PERSON	R.G.	nn	4	SENT_783	[p34l323t19r419b67],
4	etal	NNP	O	etal	appos	1	SENT_783	[p34l433t17r548b67],
5	.	.	O	.	_	0	SENT_783	[p34l433t17r548b67],

1	A	DT	O	a	det	2	SENT_784	[p34l561t20r598b66],
2	study	NN	O	study	nsubj	8	SENT_784	[p34l612t17r757b81],
3	of	IN	O	of	_	0	SENT_784	[p34l769t17r824b67],
4	therapy	NN	O	therapy	nn	7	SENT_784	[p34l832t17r1238b81],
5	—	CD	NUMBER	—	num	7	SENT_784	[p34l832t17r1238b81],
6	re	NN	O	re	nn	7	SENT_784	[p34l832t17r1238b81],
7	|	NN	O	|	prep_of	2	SENT_784	[p34l832t17r1238b81],
8	ated	VBD	O	ate	_	0	SENT_784	[p34l832t17r1238b81],
9	acute	JJ	O	acute	amod	10	SENT_784	[p34l1254t25r1397b67],
10	leukaemia	NN	O	leukaemia	dobj	8	SENT_784	[p34l1414t17r1680b67],
11	after	IN	O	after	_	0	SENT_784	[p34l1696t17r1817b67],
12	mitoxantrone	NN	O	mitoxantrone	nn	13	SENT_784	[p34l133t98r488b145],
13	therapy	NN	O	therapy	prep_after	8	SENT_784	[p34l502t95r706b159],
14	for	IN	O	for	_	0	SENT_784	[p34l717t95r790b145],
15	multiple	JJ	O	multiple	amod	16	SENT_784	[p34l804t95r1021b158],
16	sclerosis	NN	O	sclerosis	prep_for	8	SENT_784	[p34l1035t95r1264b145],
17	.	.	O	.	_	0	SENT_784	[p34l1035t95r1264b145],

1	Mult	NNP	O	Mult	_	0	SENT_785	[p34l1277t95r1403b145],
2	.	.	O	.	_	0	SENT_785	[p34l1277t95r1403b145],

1	Scler	NNP	O	Scler	_	0	SENT_786	[p34l1417t95r1548b145],
2	.	.	O	.	_	0	SENT_786	[p34l1417t95r1548b145],

1	8	CD	NUMBER	8	_	0	SENT_787	[p34l1562t98r1607b153],
2	,	,	O	,	_	0	SENT_787	[p34l1562t98r1607b153],
3	441	CD	NUMBER	441	number	4	SENT_787	[p34l1620t99r1705b144],
4	-445	CD	NUMBER	-445	appos	1	SENT_787	[p34l1719t99r1844b145],
5	(	CD	NUMBER	(	num	7	SENT_787	[p34l1861t96r2036b153],
6	2002	CD	DATE	2002	num	7	SENT_787	[p34l1861t96r2036b153],
7	)	NN	O	)	dep	4	SENT_787	[p34l1861t96r2036b153],
8	.	.	O	.	_	0	SENT_787	[p34l1861t96r2036b153],

1	Linker	NN	PERSON	linker	_	0	SENT_788	[p34l132t173r298b231],
2	,	,	O	,	_	0	SENT_788	[p34l132t173r298b231],
3	R.A.	NNP	O	R.A.	appos	1	SENT_788	[p34l314t175r408b223],
4	et	FW	O	et	nn	5	SENT_788	[p34l422t181r471b223],
5	al.	FW	O	al.	dep	3	SENT_788	[p34l480t173r536b223],
6	.	.	O	.	_	0	SENT_788	[p34l480t173r536b223],

1	Fumaric	JJ	MISC	fumaric	amod	3	SENT_789	[p34l554t176r760b223],
2	acid	NN	O	acid	nn	3	SENT_789	[p34l774t173r878b223],
3	esters	NNS	O	ester	nsubj	4	SENT_789	[p34l894t181r1046b223],
4	exert	VBP	O	exert	_	0	SENT_789	[p34l1060t181r1193b223],
5	neuroprotective	JJ	O	neuroprotective	amod	6	SENT_789	[p34l1208t176r1631b236],
6	effects	NNS	O	effect	dobj	4	SENT_789	[p34l1645t173r1817b223],
7	in	IN	O	in	_	0	SENT_789	[p34l1833t176r1875b222],
8	neuroinﬂammation	NN	O	neuroinﬂammation	prep_in	4	SENT_789	[p34l133t251r640b301],
9	via	IN	O	via	_	0	SENT_789	[p34l655t254r727b301],
10	activation	NN	O	activation	prep_via	8	SENT_789	[p34l742t254r999b301],
11	of	IN	O	of	_	0	SENT_789	[p34l1016t251r1070b301],
12	the	DT	O	the	det	15	SENT_789	[p34l1079t251r1164b301],
13	Nrf2	NN	O	nrf2	nn	15	SENT_789	[p34l1181t251r1291b300],
14	antioxidant	NN	O	antioxidant	nn	15	SENT_789	[p34l1306t251r1605b301],
15	pathway	NN	O	pathway	prep_of	10	SENT_789	[p34l1621t251r1855b315],
16	.	.	O	.	_	0	SENT_789	[p34l1621t251r1855b315],

1	Brain	NN	O	brain	_	0	SENT_790	[p34l1869t253r1998b301],
2	134	CD	NUMBER	134	num	1	SENT_790	[p34l2017t254r2129b309],
3	,	,	O	,	_	0	SENT_790	[p34l2017t254r2129b309],
4	678-692	CD	NUMBER	678-692	num	5	SENT_790	[p34l131t331r354b377],
5	(	NN	O	(	appos	1	SENT_790	[p34l371t329r471b385],
6	201	CD	NUMBER	201	number	7	SENT_790	[p34l371t329r471b385],
7	1	CD	NUMBER	1	num	8	SENT_790	[p34l490t329r545b385],
8	)	NN	O	)	dep	5	SENT_790	[p34l490t329r545b385],
9	.	.	O	.	_	0	SENT_790	[p34l490t329r545b385],

1	Kappos	NNP	PERSON	Kappos	_	0	SENT_791	[p34l132t409r336b469],
2	,	,	O	,	_	0	SENT_791	[p34l132t409r336b469],
3	L.	NNP	O	L.	nn	4	SENT_791	[p34l354t409r390b456],
4	etal	NNP	O	etal	appos	1	SENT_791	[p34l404t406r519b456],
5	.	.	O	.	_	0	SENT_791	[p34l404t406r519b456],

1	Effect	NN	O	effect	_	0	SENT_792	[p34l536t406r680b456],
2	of	IN	O	of	_	0	SENT_792	[p34l694t406r749b456],
3	BG	NNP	ORGANIZATION	BG	prep_of	1	SENT_792	[p34l761t408r872b456],
4	—	CD	NUMBER	—	num	3	SENT_792	[p34l761t408r872b456],
5	1	CD	NUMBER	1	number	6	SENT_792	[p34l761t408r872b456],
6	2	CD	NUMBER	2	nsubj	10	SENT_792	[p34l886t410r914b455],
7	on	IN	O	on	_	0	SENT_792	[p34l930t421r994b456],
8	contrast	NN	O	contrast	nn	9	SENT_792	[p34l1010t406r1506b456],
9	—	NN	O	—	prep_on	6	SENT_792	[p34l1010t406r1506b456],
10	enhanced	VBD	O	enhance	rcmod	1	SENT_792	[p34l1010t406r1506b456],
11	lesions	NNS	O	lesion	dobj	10	SENT_792	[p34l1525t406r1701b456],
12	in	IN	O	in	_	0	SENT_792	[p34l1717t409r1759b455],
13	patients	NNS	O	patient	prep_in	10	SENT_792	[p34l1778t409r1988b469],
14	with	IN	O	with	_	0	SENT_792	[p34l2001t406r2114b456],
15	relapsing-remitting	JJ	O	relapsing-remitting	amod	17	SENT_792	[p34l133t484r649b547],
16	multiple	JJ	O	multiple	amod	17	SENT_792	[p34l667t484r884b547],
17	sclerosis	NN	O	sclerosis	prep_with	10	SENT_792	[p34l899t484r1128b534],
18	:	:	O	:	_	0	SENT_792	[p34l899t484r1128b534],
19	subgroup	NN	O	subgroup	nn	20	SENT_792	[p34l1142t484r1397b547],
20	analyses	NNS	O	analysis	dep	1	SENT_792	[p34l1411t484r1630b548],
21	from	IN	O	from	_	0	SENT_792	[p34l1644t484r1766b534],
22	the	DT	O	the	det	25	SENT_792	[p34l1782t484r1867b534],
23	phase	NN	O	phase	nn	25	SENT_792	[p34l1884t484r2037b547],
24	2b	NN	O	2b	nn	25	SENT_792	[p34l2052t484r2117b534],
25	study	NN	O	study	prep_from	20	SENT_792	[p34l131t562r284b626],
26	.	.	O	.	_	0	SENT_792	[p34l131t562r284b626],

1	Mult	NNP	O	Mult	_	0	SENT_793	[p34l298t562r424b612],
2	.	.	O	.	_	0	SENT_793	[p34l298t562r424b612],

1	Scler	NNP	O	Scler	_	0	SENT_794	[p34l438t562r569b612],
2	.	.	O	.	_	0	SENT_794	[p34l438t562r569b612],

1	18	CD	NUMBER	18	_	0	SENT_795	[p34l586t565r663b620],
2	,	,	O	,	_	0	SENT_795	[p34l586t565r663b620],
3	314-321	CD	NUMBER	314-321	number	4	SENT_795	[p34l678t565r892b612],
4	(	CD	NUMBER	(	appos	1	SENT_795	[p34l917t563r1092b620],
5	2012	CD	DATE	2012	num	6	SENT_795	[p34l917t563r1092b620],
6	)	NN	O	)	dep	4	SENT_795	[p34l917t563r1092b620],
7	.	.	O	.	_	0	SENT_795	[p34l917t563r1092b620],

1	MacManus	NNP	PERSON	MacManus	nn	3	SENT_796	[p34l131t643r427b698],
2	,	,	O	,	_	0	SENT_796	[p34l131t643r427b698],
3	D.G.	NNP	O	D.G.	_	0	SENT_796	[p34l444t642r545b690],
4	et	FW	O	et	nn	5	SENT_796	[p34l559t648r608b690],
5	al.	FW	O	al.	dep	3	SENT_796	[p34l617t640r674b690],
6	.	.	O	.	_	0	SENT_796	[p34l617t640r674b690],

1	BG	NNP	ORGANIZATION	BG	nsubj	5	SENT_797	[p34l691t642r802b690],
2	—	CD	NUMBER	—	num	1	SENT_797	[p34l691t642r802b690],
3	1	CD	NUMBER	1	number	4	SENT_797	[p34l691t642r802b690],
4	2	CD	NUMBER	2	amod	1	SENT_797	[p34l817t644r844b689],
5	reduces	VBZ	O	reduce	_	0	SENT_797	[p34l862t640r1064b690],
6	evolution	NN	O	evolution	dobj	5	SENT_797	[p34l1079t640r1325b690],
7	of	IN	O	of	_	0	SENT_797	[p34l1342t640r1396b690],
8	new	JJ	O	new	prep_of	6	SENT_797	[p34l1408t655r1518b690],
9	enhancing	VBG	O	enhance	partmod	8	SENT_797	[p34l1531t640r1808b703],
10	lesions	NNS	O	lesion	dobj	9	SENT_797	[p34l1827t640r2003b690],
11	to	TO	O	to	_	0	SENT_797	[p34l130t726r182b768],
12	T1	NN	O	t1	nn	15	SENT_797	[p34l192t721r245b767],
13	—	NN	O	—	nn	15	SENT_797	[p34l258t718r605b782],
14	hypointense	NN	O	hypointense	nn	15	SENT_797	[p34l258t718r605b782],
15	lesions	NNS	O	lesion	prep_to	9	SENT_797	[p34l621t718r797b768],
16	in	IN	O	in	_	0	SENT_797	[p34l813t721r856b767],
17	patients	NNS	O	patient	prep_in	9	SENT_797	[p34l875t721r1084b781],
18	with	IN	O	with	_	0	SENT_797	[p34l1098t718r1211b768],
19	multiple	JJ	O	multiple	amod	20	SENT_797	[p34l1230t718r1446b781],
20	sclerosis	NN	O	sclerosis	prep_with	17	SENT_797	[p34l1461t718r1689b768],
21	.	.	O	.	_	0	SENT_797	[p34l1461t718r1689b768],

1	J.	NNP	PERSON	J.	nn	2	SENT_798	[p34l1700t721r1734b768],
2	Neurol	NNP	PERSON	Neurol	_	0	SENT_798	[p34l1749t718r1928b768],
3	.	.	O	.	_	0	SENT_798	[p34l1749t718r1928b768],

1	258	CD	NUMBER	258	_	0	SENT_799	[p34l1943t721r2058b776],
2	,	,	O	,	_	0	SENT_799	[p34l1943t721r2058b776],
3	449-456	CD	NUMBER	449-456	num	4	SENT_799	[p34l129t799r355b845],
4	(	NN	O	(	appos	1	SENT_799	[p34l371t796r471b852],
5	201	CD	NUMBER	201	number	6	SENT_799	[p34l371t796r471b852],
6	1	CD	NUMBER	1	num	7	SENT_799	[p34l490t796r545b852],
7	)	NN	O	)	dep	4	SENT_799	[p34l490t796r545b852],
8	.	.	O	.	_	0	SENT_799	[p34l490t796r545b852],

1	Brousil	NNP	PERSON	Brousil	_	0	SENT_800	[p34l132t873r317b931],
2	,	,	O	,	_	0	SENT_800	[p34l132t873r317b931],
3	J.A.	NNP	PERSON	J.A.	conj_and	1	SENT_800	[p34l330t876r428b931],
4	,	,	O	,	_	0	SENT_800	[p34l330t876r428b931],
5	Roberts	NNP	PERSON	Roberts	conj_and	1	SENT_800	[p34l445t873r657b931],
6	,	,	O	,	_	0	SENT_800	[p34l445t873r657b931],
7	R.J.	NNP	ORGANIZATION	R.J.	conj_and	1	SENT_800	[p34l674t875r751b923],
8	&	CC	ORGANIZATION	&	_	0	SENT_800	[p34l765t875r802b923],
9	Schlein	NNP	ORGANIZATION	Schlein	conj_and	1	SENT_800	[p34l815t873r1017b931],
10	,	,	O	,	_	0	SENT_800	[p34l815t873r1017b931],
11	A.L.	NNP	O	A.L.	nn	12	SENT_800	[p34l1030t876r1122b923],
12	Cladribinez	NNP	O	Cladribinez	appos	1	SENT_800	[p34l1136t873r1418b923],
13	an	DT	O	a	det	16	SENT_800	[p34l1432t888r1493b923],
14	investigational	JJ	O	investigational	amod	16	SENT_800	[p34l1511t873r1893b937],
15	immunomodulatory	JJ	O	immunomodulatory	amod	16	SENT_800	[p34l132t951r668b1015],
16	agent	NN	O	agent	dep	12	SENT_800	[p34l681t959r832b1015],
17	for	IN	O	for	_	0	SENT_800	[p34l844t951r917b1001],
18	multiple	JJ	O	multiple	amod	21	SENT_800	[p34l932t951r1148b1014],
19	sc	NN	O	sc	nn	21	SENT_800	[p34l1163t951r1518b1001],
20	|	NN	O	|	nn	21	SENT_800	[p34l1163t951r1518b1001],
21	erosis	NN	O	erosis	prep_for	16	SENT_800	[p34l1163t951r1518b1001],
22	.	.	O	.	_	0	SENT_800	[p34l1163t951r1518b1001],

1	Ann	NNP	PERSON	Ann	_	0	SENT_801	[p34l1163t951r1518b1001],
2	.	.	O	.	_	0	SENT_801	[p34l1163t951r1518b1001],

1	Pharmacother	NNP	O	Pharmacother	_	0	SENT_802	[p34l1532t951r1909b1001],
2	.	.	O	.	_	0	SENT_802	[p34l1532t951r1909b1001],

1	40	CD	NUMBER	40	_	0	SENT_803	[p34l1922t955r2003b1009],
2	,	,	O	,	_	0	SENT_803	[p34l1922t955r2003b1009],
3	1814-1821	CD	DATE	1814-1821	number	4	SENT_803	[p34l135t1032r410b1078],
4	(	CD	NUMBER	(	appos	1	SENT_803	[p34l436t1029r610b1085],
5	2006	CD	DATE	2006	num	6	SENT_803	[p34l436t1029r610b1085],
6	)	NN	O	)	dep	4	SENT_803	[p34l436t1029r610b1085],
7	.	.	O	.	_	0	SENT_803	[p34l436t1029r610b1085],

1	Yang	NNP	PERSON	Yang	nsubj	33	SENT_804	[p34l128t1109r269b1170],
2	,	,	O	,	_	0	SENT_804	[p34l128t1109r269b1170],
3	J.S.	NNP	LOCATION	J.S.	nsubj	33	SENT_804	[p34l282t1108r373b1164],
4	,	,	O	,	_	0	SENT_804	[p34l282t1108r373b1164],
5	Xu	NNP	O	Xu	nsubj	33	SENT_804	[p34l387t1109r467b1164],
6	,	,	O	,	_	0	SENT_804	[p34l387t1109r467b1164],
7	L.Y.	NNP	LOCATION	L.Y.	nsubj	33	SENT_804	[p34l484t1109r575b1164],
8	,	,	O	,	_	0	SENT_804	[p34l484t1109r575b1164],
9	Xiao	NNP	PERSON	Xiao	nsubj	33	SENT_804	[p34l589t1109r714b1164],
10	,	,	O	,	_	0	SENT_804	[p34l589t1109r714b1164],
11	B.G.	NNP	LOCATION	B.G.	nsubj	33	SENT_804	[p34l731t1108r838b1164],
12	,	,	O	,	_	0	SENT_804	[p34l731t1108r838b1164],
13	Hedlund	NNP	PERSON	Hedlund	nsubj	33	SENT_804	[p34l855t1106r1092b1164],
14	,	,	O	,	_	0	SENT_804	[p34l855t1106r1092b1164],
15	G.	NNP	O	G.	nsubj	33	SENT_804	[p34l1106t1108r1157b1156],
16	&	CC	O	&	_	0	SENT_804	[p34l1171t1108r1208b1156],
17	Link	NNP	O	Link	nsubj	33	SENT_804	[p34l1223t1106r1341b1164],
18	,	,	O	,	_	0	SENT_804	[p34l1223t1106r1341b1164],
19	H.	NNP	PERSON	H.	nn	24	SENT_804	[p34l1357t1109r1406b1156],
20	Laquinimod	NNP	PERSON	Laquinimod	nn	24	SENT_804	[p34l1423t1106r1735b1169],
21	(	CD	NUMBER	(	num	24	SENT_804	[p34l1754t1107r1893b1164, p34l131t1188r182b1234],
22	ABR21	NN	O	abr21	nn	24	SENT_804	[p34l1754t1107r1893b1164, p34l131t1188r182b1234],
23	5062	CD	NUMBER	5062	num	24	SENT_804	[p34l196t1185r339b1242],
24	)	NN	O	)	nsubj	25	SENT_804	[p34l196t1185r339b1242],
25	suppresses	VBZ	O	suppress	dep	1	SENT_804	[p34l356t1199r644b1247],
26	the	DT	O	the	det	27	SENT_804	[p34l657t1184r743b1234],
27	development	NN	O	development	dobj	25	SENT_804	[p34l757t1184r1111b1247],
28	of	IN	O	of	_	0	SENT_804	[p34l1125t1184r1179b1234],
29	experimental	JJ	O	experimental	amod	31	SENT_804	[p34l1189t1184r1534b1247],
30	autoimmune	JJ	O	autoimmune	amod	31	SENT_804	[p34l1552t1187r1893b1234],
31	encephalomyelitis	NN	O	encephalomyelitis	prep_of	27	SENT_804	[p34l131t1262r623b1326],
32	,	,	O	,	_	0	SENT_804	[p34l131t1262r623b1326],
33	modulates	VBZ	O	modulate	_	0	SENT_804	[p34l639t1262r916b1312],
34	theTh1/Th2	NN	O	theth1/th2	nn	35	SENT_804	[p34l929t1262r1242b1314],
35	balance	NN	O	balance	dobj	33	SENT_804	[p34l1259t1262r1461b1312],
36	and	CC	O	and	_	0	SENT_804	[p34l1476t1262r1572b1312],
37	induces	VBZ	O	induce	conj_and	33	SENT_804	[p34l1590t1262r1791b1312],
38	theTh3	NN	O	theth3	nn	41	SENT_804	[p34l1804t1262r1995b1312],
39	cytokineTGF	NN	O	cytokinetgf	nn	41	SENT_804	[p34l131t1340r603b1404],
40	—	NN	O	—	nn	41	SENT_804	[p34l131t1340r603b1404],
41	beta	NN	O	beta	dobj	37	SENT_804	[p34l131t1340r603b1404],
42	in	IN	O	in	_	0	SENT_804	[p34l621t1343r663b1389],
43	Lewis	NNP	PERSON	Lewis	nn	44	SENT_804	[p34l682t1343r823b1390],
44	rats	NNS	O	rat	prep_in	37	SENT_804	[p34l840t1348r944b1390],
45	.	.	O	.	_	0	SENT_804	[p34l840t1348r944b1390],

1	J.	NNP	PERSON	J.	nn	2	SENT_805	[p34l954t1343r988b1390],
2	Neuroimmunol	NNP	PERSON	Neuroimmunol	_	0	SENT_805	[p34l1003t1340r1401b1390],
3	.	.	O	.	_	0	SENT_805	[p34l1003t1340r1401b1390],

1	156	CD	NUMBER	156	_	0	SENT_806	[p34l1418t1344r1530b1398],
2	,	,	O	,	_	0	SENT_806	[p34l1418t1344r1530b1398],
3	3-9	CD	NUMBER	3-9	number	4	SENT_806	[p34l1545t1344r1638b1390],
4	(	CD	NUMBER	(	appos	1	SENT_806	[p34l1655t1341r1828b1398],
5	2004	CD	DATE	2004	num	6	SENT_806	[p34l1655t1341r1828b1398],
6	)	NN	O	)	dep	4	SENT_806	[p34l1655t1341r1828b1398],
7	.	.	O	.	_	0	SENT_806	[p34l1655t1341r1828b1398],

1	Comi	NNP	O	Comi	nn	4	SENT_807	[p34l129t1420r278b1476],
2	,	,	O	,	_	0	SENT_807	[p34l129t1420r278b1476],
3	G.	NNP	O	G.	appos	4	SENT_807	[p34l292t1420r343b1468],
4	etal.	NNP	O	etal.	_	0	SENT_807	[p34l357t1418r485b1476],
5	;	:	O	;	_	0	SENT_807	[p34l357t1418r485b1476],
6	ALLEGRO	NNP	O	ALLEGRO	nn	8	SENT_807	[p34l498t1420r745b1468],
7	Study	NNP	O	Study	nn	8	SENT_807	[p34l760t1418r911b1482],
8	Group	NNP	O	Group	dep	4	SENT_807	[p34l924t1420r1099b1481],
9	.	.	O	.	_	0	SENT_807	[p34l924t1420r1099b1481],

1	P	NN	O	p	nn	4	SENT_808	[p34l1116t1418r1611b1468],
2	|	CD	NUMBER	|	num	4	SENT_808	[p34l1116t1418r1611b1468],
3	acebo	NN	O	acebo	nn	4	SENT_808	[p34l1116t1418r1611b1468],
4	—	NN	O	—	nsubj	8	SENT_808	[p34l1116t1418r1611b1468],
5	contro	NN	O	contro	nn	7	SENT_808	[p34l1116t1418r1611b1468],
6	|	CD	NUMBER	|	num	7	SENT_808	[p34l1116t1418r1611b1468],
7	|	NN	O	|	dep	4	SENT_808	[p34l1116t1418r1611b1468],
8	ed	VBD	O	ed	_	0	SENT_808	[p34l1116t1418r1611b1468],
9	trial	NN	O	trial	dobj	8	SENT_808	[p34l1627t1418r1724b1468],
10	of	IN	O	of	_	0	SENT_808	[p34l1740t1418r1795b1468],
11	oral	JJ	O	oral	amod	12	SENT_808	[p34l1805t1418r1899b1468],
12	laquinimod	NN	O	laquinimod	prep_of	9	SENT_808	[p34l133t1496r430b1559],
13	for	IN	O	for	_	0	SENT_808	[p34l445t1496r518b1546],
14	multiple	JJ	O	multiple	amod	15	SENT_808	[p34l533t1496r749b1559],
15	sclerosis	NN	O	sclerosis	prep_for	8	SENT_808	[p34l764t1496r993b1546],
16	.	.	O	.	_	0	SENT_808	[p34l764t1496r993b1546],

1	N.	NNP	O	N.	nn	2	SENT_809	[p34l1007t1499r1054b1546],
2	Engl	NNP	O	Engl	_	0	SENT_809	[p34l1069t1496r1188b1560],
3	.	.	O	.	_	0	SENT_809	[p34l1069t1496r1188b1560],

1	J.	NNP	O	J.	nn	2	SENT_810	[p34l1199t1499r1233b1546],
2	Med	NNP	O	Med	_	0	SENT_810	[p34l1247t1496r1369b1546],
3	.	.	O	.	_	0	SENT_810	[p34l1247t1496r1369b1546],

1	366	CD	NUMBER	366	_	0	SENT_811	[p34l1384t1500r1499b1554],
2	,	,	O	,	_	0	SENT_811	[p34l1384t1500r1499b1554],
3	1000-1009	CD	DATE	1000-1009	number	4	SENT_811	[p34l1518t1500r1803b1546],
4	(	CD	NUMBER	(	appos	1	SENT_811	[p34l1819t1497r1993b1554],
5	2012	CD	DATE	2012	num	6	SENT_811	[p34l1819t1497r1993b1554],
6	)	NN	O	)	dep	4	SENT_811	[p34l1819t1497r1993b1554],
7	.	.	O	.	_	0	SENT_811	[p34l1819t1497r1993b1554],

1	Bielekova	NNP	PERSON	Bielekova	nn	3	SENT_812	[p34l132t1574r392b1632],
2	,	,	O	,	_	0	SENT_812	[p34l132t1574r392b1632],
3	B.	NNP	O	B.	_	0	SENT_812	[p34l408t1576r449b1624],
4	et	FW	O	et	nn	5	SENT_812	[p34l463t1582r512b1624],
5	al.	FW	O	al.	dep	3	SENT_812	[p34l521t1574r578b1624],
6	.	.	O	.	_	0	SENT_812	[p34l521t1574r578b1624],

1	Humanized	VBN	O	humanize	_	0	SENT_813	[p34l595t1574r892b1624],
2	anti	JJ	O	anti	acomp	1	SENT_813	[p34l908t1576r1170b1624],
3	.	.	O	.	_	0	SENT_813	[p34l908t1576r1170b1624],

1	—	NN	O	—	_	0	SENT_814	[p34l908t1576r1170b1624],
2	.	.	O	.	_	0	SENT_814	[p34l908t1576r1170b1624],

1	CD25	NN	O	cd25	nsubj	5	SENT_815	[p34l908t1576r1170b1624],
2	(	CD	NUMBER	(	num	4	SENT_815	[p34l1187t1574r1523b1632],
3	daclizumab	NN	O	daclizumab	nn	4	SENT_815	[p34l1187t1574r1523b1632],
4	)	NN	O	)	dep	1	SENT_815	[p34l1187t1574r1523b1632],
5	inhibits	VBZ	O	inhibit	_	0	SENT_815	[p34l1541t1574r1733b1624],
6	disease	NN	O	disease	nn	7	SENT_815	[p34l1748t1574r1939b1624],
7	activity	NN	O	activity	dobj	5	SENT_815	[p34l1954t1577r2144b1638],
8	in	IN	O	in	_	0	SENT_815	[p34l132t1655r175b1701],
9	multiple	JJ	O	multiple	amod	11	SENT_815	[p34l193t1652r409b1715],
10	sclerosis	NN	O	sclerosis	nn	11	SENT_815	[p34l424t1652r641b1702],
11	patients	NNS	O	patient	prep_in	5	SENT_815	[p34l657t1655r867b1715],
12	failing	VBG	O	fail	partmod	11	SENT_815	[p34l880t1652r1040b1716],
13	to	TO	O	to	aux	14	SENT_815	[p34l1055t1660r1108b1702],
14	respond	VB	O	respond	xcomp	12	SENT_815	[p34l1125t1652r1336b1715],
15	to	TO	O	to	_	0	SENT_815	[p34l1352t1660r1405b1702],
16	interferon	NN	O	interferon	nn	17	SENT_815	[p34l1421t1652r1678b1702],
17	beta	NN	O	beta	prep_to	14	SENT_815	[p34l1697t1652r1824b1702],
18	.	.	O	.	_	0	SENT_815	[p34l1697t1652r1824b1702],

1	Proc	NNP	O	Proc	_	0	SENT_816	[p34l1838t1654r1956b1702],
2	.	.	O	.	_	0	SENT_816	[p34l1838t1654r1956b1702],

1	Natl.	NNP	O	Natl.	nn	2	SENT_817	[p34l1971t1652r2086b1702],
2	Acad	NNP	O	Acad	_	0	SENT_817	[p34l127t1729r265b1779],
3	.	.	O	.	_	0	SENT_817	[p34l127t1729r265b1779],

1	Sci	NNP	O	Sci	_	0	SENT_818	[p34l279t1731r359b1779],
2	.	.	O	.	_	0	SENT_818	[p34l279t1731r359b1779],

1	U.S.A.	NNP	O	U.S.A.	_	0	SENT_819	[p34l376t1731r516b1779],
2	101	CD	NUMBER	101	num	1	SENT_819	[p34l534t1733r646b1786],
3	,	,	O	,	_	0	SENT_819	[p34l534t1733r646b1786],
4	8705-8708	CD	DURATION	8705-8708	num	1	SENT_819	[p34l660t1733r950b1779],
5	(	CD	NUMBER	(	num	7	SENT_819	[p34l966t1730r1140b1786],
6	2004	CD	DATE	2004	num	7	SENT_819	[p34l966t1730r1140b1786],
7	)	NN	O	)	dep	1	SENT_819	[p34l966t1730r1140b1786],
8	.	.	O	.	_	0	SENT_819	[p34l966t1730r1140b1786],

1	Paolillo	NNP	PERSON	Paolillo	_	0	SENT_820	[p34l132t1807r329b1865],
2	,	,	O	,	_	0	SENT_820	[p34l132t1807r329b1865],
3	A.	NNP	O	A.	nn	4	SENT_820	[p34l343t1810r392b1857],
4	etal	NNP	O	etal	appos	1	SENT_820	[p34l406t1807r521b1857],
5	.	.	O	.	_	0	SENT_820	[p34l406t1807r521b1857],

1	Quantitative	JJ	O	quantitative	amod	2	SENT_821	[p34l535t1809r861b1863],
2	MRI	NNP	O	MRI	nsubj	9	SENT_821	[p34l877t1810r970b1856],
3	in	IN	O	in	_	0	SENT_821	[p34l988t1810r1031b1856],
4	patients	NNS	O	patient	prep_in	2	SENT_821	[p34l1050t1810r1259b1870],
5	with	IN	O	with	_	0	SENT_821	[p34l1273t1807r1386b1857],
6	secondary	JJ	O	secondary	amod	8	SENT_821	[p34l1403t1807r1675b1871],
7	progressive	JJ	O	progressive	amod	8	SENT_821	[p34l1689t1810r1989b1871],
8	MS	NN	O	m	prep_with	4	SENT_821	[p34l132t1887r209b1935],
9	treated	VBN	O	treat	_	0	SENT_821	[p34l223t1885r410b1935],
10	with	IN	O	with	_	0	SENT_821	[p34l426t1885r538b1935],
11	monoclonal	JJ	O	monoclonal	amod	13	SENT_821	[p34l557t1885r867b1935],
12	antibody	NN	O	antibody	nn	13	SENT_821	[p34l884t1885r1120b1949],
13	Campath	NN	O	campath	prep_with	9	SENT_821	[p34l1133t1885r1371b1948],
14	1	CD	NUMBER	1	num	16	SENT_821	[p34l1391t1889r1406b1934],
15	H.	NNP	ORGANIZATION	H.	nn	16	SENT_821	[p34l1422t1888r1471b1935],
16	Neurology	NNP	ORGANIZATION	Neurology	dep	13	SENT_821	[p34l1485t1885r1750b1949],
17	53	CD	NUMBER	53	num	16	SENT_821	[p34l1761t1889r1841b1943],
18	,	,	O	,	_	0	SENT_821	[p34l1761t1889r1841b1943],
19	751-757	CD	NUMBER	751-757	num	20	SENT_821	[p34l1856t1889r2078b1935],
20	(	NN	O	(	appos	13	SENT_821	[p34l132t1963r167b2019],
21	1	CD	NUMBER	1	num	23	SENT_821	[p34l132t1963r167b2019],
22	999	CD	NUMBER	999	num	23	SENT_821	[p34l182t1963r306b2019],
23	)	NN	O	)	dep	20	SENT_821	[p34l182t1963r306b2019],
24	.	.	O	.	_	0	SENT_821	[p34l182t1963r306b2019],

1	Coles	NNP	PERSON	Coles	_	0	SENT_822	[p34l129t2040r281b2098],
2	,	,	O	,	_	0	SENT_822	[p34l129t2040r281b2098],
3	A.J.	NNP	PERSON	A.J.	nn	4	SENT_822	[p34l294t2043r379b2090],
4	etal	NNP	O	etal	appos	1	SENT_822	[p34l393t2040r508b2090],
5	.	.	O	.	_	0	SENT_822	[p34l393t2040r508b2090],

1	Alemtuzumab	NNP	O	Alemtuzumab	nsubj	11	SENT_823	[p34l522t2040r896b2090],
2	more	RBR	O	more	advmod	3	SENT_823	[p34l912t2055r1047b2090],
3	effective	JJ	O	effective	dep	1	SENT_823	[p34l1061t2040r1284b2090],
4	than	IN	O	than	_	0	SENT_823	[p34l1298t2040r1416b2090],
5	interferon	NN	O	interferon	prep_than	3	SENT_823	[p34l1434t2040r1691b2090],
6	(	CD	NUMBER	(	num	5	SENT_823	[p34l1710t2040r1781b2090],
7	3-1	CD	NUMBER	3-1	npadvmod	3	SENT_823	[p34l1710t2040r1781b2090],
8	a	DT	O	a	dep	7	SENT_823	[p34l1795t2055r1820b2090],
9	at	IN	O	at	_	0	SENT_823	[p34l1836t2048r1884b2090],
10	5-year	JJ	DURATION	5-year	prep_at	3	SENT_823	[p34l1899t2044r2060b2104],
11	follow	VBP	O	follow	_	0	SENT_823	[p34l129t2118r381b2181],
12	—	CD	NUMBER	—	npadvmod	13	SENT_823	[p34l129t2118r381b2181],
13	up	IN	O	up	advmod	11	SENT_823	[p34l129t2118r381b2181],
14	of	IN	O	of	_	0	SENT_823	[p34l396t2118r450b2168],
15	CAMMS223	NN	O	camms223	nn	17	SENT_823	[p34l460t2120r762b2168],
16	clinical	JJ	O	clinical	amod	17	SENT_823	[p34l779t2118r955b2168],
17	trial	NN	O	trial	prep_of	11	SENT_823	[p34l970t2118r1082b2168],
18	.	.	O	.	_	0	SENT_823	[p34l970t2118r1082b2168],

1	Neurology	NN	O	neurology	_	0	SENT_824	[p34l1097t2118r1362b2182],
2	78	CD	NUMBER	78	num	1	SENT_824	[p34l1373t2122r1452b2176],
3	,	,	O	,	_	0	SENT_824	[p34l1373t2122r1452b2176],
4	1069-1078	CD	DATE	1069-1078	number	5	SENT_824	[p34l1471t2122r1756b2168],
5	(	CD	NUMBER	(	appos	1	SENT_824	[p34l1772t2119r1946b2176],
6	2012	CD	DATE	2012	num	7	SENT_824	[p34l1772t2119r1946b2176],
7	)	NN	O	)	dep	5	SENT_824	[p34l1772t2119r1946b2176],
8	.	.	O	.	_	0	SENT_824	[p34l1772t2119r1946b2176],

1	Jones	NNP	PERSON	Jones	nn	3	SENT_825	[p34l127t2199r288b2254],
2	,	,	O	,	_	0	SENT_825	[p34l127t2199r288b2254],
3	J.L.	NNP	O	J.L.	_	0	SENT_825	[p34l301t2199r378b2246],
4	et	FW	O	et	nn	5	SENT_825	[p34l392t2204r441b2246],
5	al.	FW	O	al.	dep	3	SENT_825	[p34l450t2196r507b2246],
6	.	.	O	.	_	0	SENT_825	[p34l450t2196r507b2246],

1	Improvement	NN	O	improvement	nsubjpass	11	SENT_826	[p34l524t2199r881b2259],
2	in	IN	O	in	_	0	SENT_826	[p34l896t2199r939b2245],
3	disability	NN	O	disability	prep_in	1	SENT_826	[p34l956t2196r1192b2260],
4	after	IN	O	after	_	0	SENT_826	[p34l1205t2196r1326b2246],
5	alemtuzumab	JJ	O	alemtuzumab	amod	6	SENT_826	[p34l1338t2196r1704b2246],
6	treatment	NN	O	treatment	prep_after	3	SENT_826	[p34l1717t2204r1981b2246],
7	of	IN	O	of	_	0	SENT_826	[p34l1995t2196r2049b2246],
8	multiple	JJ	O	multiple	amod	9	SENT_826	[p34l133t2274r349b2337],
9	sclerosis	NN	O	sclerosis	prep_of	6	SENT_826	[p34l364t2274r580b2324],
10	is	VBZ	O	be	auxpass	11	SENT_826	[p34l596t2277r630b2324],
11	associated	VBN	O	associate	_	0	SENT_826	[p34l645t2274r917b2324],
12	with	IN	O	with	_	0	SENT_826	[p34l933t2274r1046b2324],
13	neuroprotective	JJ	O	neuroprotective	amod	14	SENT_826	[p34l1064t2277r1487b2337],
14	autoimmunity	NN	O	autoimmunity	prep_with	11	SENT_826	[p34l1501t2277r1887b2338],
15	.	.	O	.	_	0	SENT_826	[p34l1501t2277r1887b2338],

1	Brain	NN	O	brain	_	0	SENT_827	[p34l1902t2276r2031b2324],
2	133	CD	NUMBER	133	num	1	SENT_827	[p34l134t2355r246b2408],
3	,	,	O	,	_	0	SENT_827	[p34l134t2355r246b2408],
4	2232-2247	CD	DATE	2232-2247	number	5	SENT_827	[p34l261t2355r549b2401],
5	(	CD	NUMBER	(	appos	1	SENT_827	[p34l566t2353r740b2408],
6	2010	CD	DATE	2010	num	7	SENT_827	[p34l566t2353r740b2408],
7	)	NN	O	)	dep	5	SENT_827	[p34l566t2353r740b2408],
8	.	.	O	.	_	0	SENT_827	[p34l566t2353r740b2408],

1	Cossburn	NNP	MISC	Cossburn	_	0	SENT_828	[p34l129t2429r387b2485],
2	,	,	O	,	_	0	SENT_828	[p34l129t2429r387b2485],
3	M.	NNP	O	M.	nn	4	SENT_828	[p34l404t2431r462b2478],
4	etal	NNP	O	etal	appos	1	SENT_828	[p34l477t2429r592b2478],
5	.	.	O	.	_	0	SENT_828	[p34l477t2429r592b2478],

1	Autoimmune	NN	O	autoimmune	nn	2	SENT_829	[p34l606t2431r955b2478],
2	disease	NN	O	disease	_	0	SENT_829	[p34l969t2429r1161b2478],
3	after	IN	O	after	_	0	SENT_829	[p34l1175t2428r1296b2478],
4	alemtuzumab	JJ	O	alemtuzumab	amod	5	SENT_829	[p34l1309t2429r1675b2478],
5	treatment	NN	O	treatment	prep_after	2	SENT_829	[p34l1688t2436r1951b2478],
6	for	IN	O	for	_	0	SENT_829	[p34l1964t2428r2036b2478],
7	multiple	JJ	O	multiple	amod	8	SENT_829	[p34l133t2507r349b2569],
8	sclerosis	NN	O	sclerosis	prep_for	2	SENT_829	[p34l363t2507r580b2556],
9	in	IN	O	in	_	0	SENT_829	[p34l596t2509r638b2555],
10	a	DT	O	a	det	12	SENT_829	[p34l655t2521r680b2556],
11	multicenter	JJ	O	multicenter	amod	12	SENT_829	[p34l698t2507r1001b2556],
12	cohort	NN	O	cohort	prep_in	2	SENT_829	[p34l1014t2507r1200b2556],
13	.	.	O	.	_	0	SENT_829	[p34l1014t2507r1200b2556],

1	Neurology	NN	O	neurology	_	0	SENT_830	[p34l1214t2507r1479b2570],
2	77	CD	NUMBER	77	num	1	SENT_830	[p34l1490t2511r1570b2564],
3	,	,	O	,	_	0	SENT_830	[p34l1490t2511r1570b2564],
4	573-579	CD	NUMBER	573-579	num	5	SENT_830	[p34l1585t2510r1808b2556],
5	(	NN	O	(	appos	1	SENT_830	[p34l1825t2508r1925b2564],
6	201	CD	NUMBER	201	number	7	SENT_830	[p34l1825t2508r1925b2564],
7	1	CD	NUMBER	1	num	8	SENT_830	[p34l1943t2508r1998b2564],
8	)	NN	O	)	dep	5	SENT_830	[p34l1943t2508r1998b2564],
9	.	.	O	.	_	0	SENT_830	[p34l1943t2508r1998b2564],

1	Cuker	NNP	PERSON	Cuker	_	0	SENT_831	[p34l129t2585r289b2642],
2	,	,	O	,	_	0	SENT_831	[p34l129t2585r289b2642],
3	A.	NNP	O	A.	nn	4	SENT_831	[p34l303t2587r351b2634],
4	etal	NNP	O	etal	appos	1	SENT_831	[p34l365t2585r480b2634],
5	.	.	O	.	_	0	SENT_831	[p34l365t2585r480b2634],

1	A	DT	O	a	det	3	SENT_832	[p34l494t2587r530b2634],
2	distinctive	JJ	O	distinctive	amod	3	SENT_832	[p34l544t2585r814b2634],
3	form	NN	O	form	_	0	SENT_832	[p34l827t2584r950b2634],
4	of	IN	O	of	_	0	SENT_832	[p34l966t2584r1021b2634],
5	immune	JJ	O	immune	amod	6	SENT_832	[p34l1032t2587r1250b2634],
6	thrombocytopenia	NN	O	thrombocytopenia	prep_of	3	SENT_832	[p34l1263t2585r1759b2648],
7	in	IN	O	in	_	0	SENT_832	[p34l1778t2587r1820b2634],
8	a	DT	O	a	det	11	SENT_832	[p34l1836t2599r1862b2634],
9	phase	NN	O	phase	nn	11	SENT_832	[p34l1880t2585r2033b2647],
10	2	CD	NUMBER	2	num	11	SENT_832	[p34l131t2666r158b2712],
11	study	NN	O	study	prep_in	3	SENT_832	[p34l174t2663r319b2726],
12	of	IN	O	of	_	0	SENT_832	[p34l332t2662r386b2712],
13	alemtuzumab	NN	O	alemtuzumab	prep_of	11	SENT_832	[p34l395t2663r761b2712],
14	for	IN	O	for	_	0	SENT_832	[p34l774t2662r847b2712],
15	the	DT	O	the	det	16	SENT_832	[p34l858t2663r944b2712],
16	treatment	NN	O	treatment	prep_for	3	SENT_832	[p34l957t2670r1221b2712],
17	of	IN	O	of	_	0	SENT_832	[p34l1235t2662r1289b2712],
18	relapsing-remitting	JJ	O	relapsing-remitting	amod	20	SENT_832	[p34l1301t2663r1804b2726],
19	multiple	JJ	O	multiple	amod	20	SENT_832	[p34l1823t2663r2040b2725],
20	sclerosis	NN	O	sclerosis	prep_of	16	SENT_832	[p34l131t2740r359b2789],
21	.	.	O	.	_	0	SENT_832	[p34l131t2740r359b2789],

1	BIood1	NN	O	biood1	_	0	SENT_833	[p34l374t2740r555b2789],
2	18	CD	NUMBER	18	num	1	SENT_833	[p34l571t2743r648b2796],
3	,	,	O	,	_	0	SENT_833	[p34l571t2743r648b2796],
4	6299-6305	CD	DURATION	6299-6305	num	5	SENT_833	[p34l662t2743r950b2789],
5	(	NN	O	(	appos	1	SENT_833	[p34l968t2741r1068b2796],
6	201	CD	NUMBER	201	number	7	SENT_833	[p34l968t2741r1068b2796],
7	1	CD	NUMBER	1	num	8	SENT_833	[p34l1086t2741r1142b2796],
8	)	NN	O	)	dep	5	SENT_833	[p34l1086t2741r1142b2796],
9	.	.	O	.	_	0	SENT_833	[p34l1086t2741r1142b2796],

1	Calabrese	NNP	PERSON	Calabrese	_	0	SENT_834	[p34l129t2818r396b2875],
2	,	,	O	,	_	0	SENT_834	[p34l129t2818r396b2875],
3	L.H.	NNP	LOCATION	L.H.	conj_and	1	SENT_834	[p34l412t2820r517b2875],
4	,	,	O	,	_	0	SENT_834	[p34l412t2820r517b2875],
5	Molloy	NNP	PERSON	Molloy	conj_and	1	SENT_834	[p34l533t2818r719b2881],
6	,	,	O	,	_	0	SENT_834	[p34l533t2818r719b2881],
7	E.S.	NNP	LOCATION	E.S.	conj_and	1	SENT_834	[p34l736t2819r831b2875],
8	,	,	O	,	_	0	SENT_834	[p34l736t2819r831b2875],
9	Huang	NNP	PERSON	Huang	conj_and	1	SENT_834	[p34l848t2820r1032b2881],
10	,	,	O	,	_	0	SENT_834	[p34l848t2820r1032b2881],
11	D.	NNP	ORGANIZATION	D.	conj_and	1	SENT_834	[p34l1049t2820r1096b2867],
12	&	CC	ORGANIZATION	&	_	0	SENT_834	[p34l1110t2819r1147b2867],
13	Ransohoff	NNP	ORGANIZATION	Ransohoff	conj_and	1	SENT_834	[p34l1162t2817r1436b2875],
14	,	,	O	,	_	0	SENT_834	[p34l1162t2817r1436b2875],
15	R.M.	NNP	O	R.M.	nn	18	SENT_834	[p34l1452t2820r1558b2867],
16	Progressive	NNP	O	Progressive	nn	18	SENT_834	[p34l1575t2820r1871b2881],
17	multifocal	JJ	O	multifocal	amod	18	SENT_834	[p34l1887t2817r2144b2867],
18	leukoencephalopathy	NN	O	leukoencephalopathy	appos	1	SENT_834	[p34l133t2896r707b2959],
19	in	IN	O	in	_	0	SENT_834	[p34l721t2898r764b2945],
20	rheumatic	JJ	O	rheumatic	amod	21	SENT_834	[p34l782t2896r1048b2945],
21	diseases	NNS	O	disease	prep_in	18	SENT_834	[p34l1062t2896r1292b2945],
22	:	:	O	:	_	0	SENT_834	[p34l1062t2896r1292b2945],
23	evolving	VBG	O	evolve	dep	21	SENT_834	[p34l1307t2896r1529b2959],
24	clinical	JJ	O	clinical	amod	27	SENT_834	[p34l1545t2896r1721b2945],
25	and	CC	O	and	_	0	SENT_834	[p34l1738t2896r1834b2945],
26	pathologic	JJ	O	pathologic	conj_and	24	SENT_834	[p34l1853t2896r2134b2959],
27	patterns	NNS	O	pattern	dobj	23	SENT_834	[p34l133t2981r348b3036],
28	of	IN	O	of	_	0	SENT_834	[p34l363t2973r417b3023],
29	disease	NN	O	disease	prep_of	27	SENT_834	[p34l427t2974r847b3023],
30	.	.	O	.	_	0	SENT_834	[p34l427t2974r847b3023],

1	Arthritis	NNP	MISC	Arthritis	nn	2	SENT_835	[p34l427t2974r847b3023],
2	Rheum	NNP	MISC	Rheum	_	0	SENT_835	[p34l859t2974r1050b3023],
3	.	.	O	.	_	0	SENT_835	[p34l859t2974r1050b3023],

1	56	CD	NUMBER	56	_	0	SENT_836	[p34l1065t2977r1144b3031],
2	,	,	O	,	_	0	SENT_836	[p34l1065t2977r1144b3031],
3	21	CD	NUMBER	21	number	4	SENT_836	[p34l1159t2977r1210b3023],
4	16-2128	CD	NUMBER	16-2128	appos	1	SENT_836	[p34l1229t2977r1448b3023],
5	(	CD	NUMBER	(	num	7	SENT_836	[p34l1464t2975r1638b3031],
6	2007	CD	DATE	2007	num	7	SENT_836	[p34l1464t2975r1638b3031],
7	)	NN	O	)	dep	4	SENT_836	[p34l1464t2975r1638b3031],
8	.	.	O	.	_	0	SENT_836	[p34l1464t2975r1638b3031],

1	Barun	NNP	PERSON	Barun	_	0	SENT_837	[p34l131t3054r295b3109],
2	,	,	O	,	_	0	SENT_837	[p34l131t3054r295b3109],
3	B.	NNP	O	B.	conj_and	1	SENT_837	[p34l312t3054r352b3101],
4	&	CC	O	&	_	0	SENT_837	[p34l366t3053r403b3101],
5	Bar-Or	NNP	O	Bar-Or	conj_and	1	SENT_837	[p34l418t3053r592b3109],
6	,	,	O	,	_	0	SENT_837	[p34l418t3053r592b3109],
7	A.	NNP	O	A.	nn	8	SENT_837	[p34l606t3054r654b3101],
8	Treatment	NNP	O	Treatment	appos	1	SENT_837	[p34l664t3054r937b3101],
9	of	IN	O	of	_	0	SENT_837	[p34l951t3051r1005b3101],
10	multiple	JJ	O	multiple	amod	11	SENT_837	[p34l1017t3052r1233b3114],
11	sclerosis	NN	O	sclerosis	prep_of	8	SENT_837	[p34l1248t3052r1464b3101],
12	with	IN	O	with	_	0	SENT_837	[p34l1478t3052r1591b3101],
13	anti-CD20	JJ	O	anti-cd20	amod	14	SENT_837	[p34l1607t3053r1870b3102],
14	antibodies	NNS	O	antibody	prep_with	11	SENT_837	[p34l131t3129r420b3178],
15	.	.	O	.	_	0	SENT_837	[p34l131t3129r420b3178],

1	Clin	NNP	O	Clin	_	0	SENT_838	[p34l435t3129r539b3178],
2	.	.	O	.	_	0	SENT_838	[p34l435t3129r539b3178],

1	Immunol	NNP	O	Immunol	_	0	SENT_839	[p34l554t3129r797b3178],
2	.	.	O	.	_	0	SENT_839	[p34l554t3129r797b3178],

1	142	CD	NUMBER	142	_	0	SENT_840	[p34l814t3132r926b3185],
2	,	,	O	,	_	0	SENT_840	[p34l814t3132r926b3185],
3	31	CD	NUMBER	31	num	4	SENT_840	[p34l941t3132r992b3178],
4	-37	CD	NUMBER	-37	appos	1	SENT_840	[p34l1006t3132r1099b3178],
5	(	CD	NUMBER	(	num	7	SENT_840	[p34l1115t3130r1290b3185],
6	2012	CD	DATE	2012	num	7	SENT_840	[p34l1115t3130r1290b3185],
7	)	NN	O	)	dep	4	SENT_840	[p34l1115t3130r1290b3185],
8	.	.	O	.	_	0	SENT_840	[p34l1115t3130r1290b3185],

1	Kremenchutzky	NNP	PERSON	Kremenchutzky	_	0	SENT_841	[p34l131t3207r551b3270],
2	,	,	O	,	_	0	SENT_841	[p34l131t3207r551b3270],
3	M.	NNP	O	M.	conj_and	1	SENT_841	[p34l567t3209r640b3264],
4	,	,	O	,	_	0	SENT_841	[p34l567t3209r640b3264],
5	Rice	NNP	PERSON	Rice	conj_and	1	SENT_841	[p34l656t3209r772b3264],
6	,	,	O	,	_	0	SENT_841	[p34l656t3209r772b3264],
7	G.P.	NNP	LOCATION	G.P.	conj_and	1	SENT_841	[p34l786t3209r888b3264],
8	,	,	O	,	_	0	SENT_841	[p34l786t3209r888b3264],
9	Baskerville	NNP	PERSON	Baskerville	conj_and	1	SENT_841	[p34l904t3207r1192b3264],
10	,	,	O	,	_	0	SENT_841	[p34l904t3207r1192b3264],
11	J.	NNP	O	J.	conj_and	1	SENT_841	[p34l1204t3207r1593b3270],
12	,	,	O	,	_	0	SENT_841	[p34l1204t3207r1593b3270],
13	Wingerchuk	NNP	LOCATION	Wingerchuk	conj_and	1	SENT_841	[p34l1204t3207r1593b3270],
14	,	,	O	,	_	0	SENT_841	[p34l1204t3207r1593b3270],
15	D.M.	NNP	ORGANIZATION	D.M.	conj_and	1	SENT_841	[p34l1610t3209r1721b3256],
16	&	CC	ORGANIZATION	&	_	0	SENT_841	[p34l1735t3208r1772b3256],
17	Ebers	NNP	ORGANIZATION	Ebers	conj_and	1	SENT_841	[p34l1787t3207r1939b3264],
18	,	,	O	,	_	0	SENT_841	[p34l1787t3207r1939b3264],
19	G.C.	NNP	PERSON	G.C.	appos	1	SENT_841	[p34l1953t3208r2053b3256],
20	.	.	O	.	_	0	SENT_841	[p34l1953t3208r2053b3256],

1	The	DT	O	the	det	3	SENT_842	[p34l128t3285r225b3334],
2	natural	JJ	O	natural	amod	3	SENT_842	[p34l242t3285r421b3334],
3	history	NN	O	history	_	0	SENT_842	[p34l440t3285r619b3348],
4	of	IN	O	of	_	0	SENT_842	[p34l632t3284r686b3334],
5	multiple	JJ	O	multiple	amod	6	SENT_842	[p34l698t3285r914b3347],
6	sclerosis	NN	O	sclerosis	prep_of	3	SENT_842	[p34l929t3285r1158b3334],
7	:	:	O	:	_	0	SENT_842	[p34l929t3285r1158b3334],
8	a	DT	O	a	det	11	SENT_842	[p34l1173t3299r1198b3334],
9	geographically	RB	O	geographically	advmod	10	SENT_842	[p34l1214t3285r1606b3348],
10	based	VBN	O	base	amod	11	SENT_842	[p34l1621t3285r1773b3334],
11	study	NN	O	study	dep	3	SENT_842	[p34l1790t3285r1934b3348],
12	9	CD	NUMBER	9	amod	11	SENT_842	[p34l1948t3288r1989b3334],
13	:	:	O	:	_	0	SENT_842	[p34l1948t3288r1989b3334],
14	observations	NNS	O	observation	dep	11	SENT_842	[p34l131t3363r469b3412],
15	on	IN	O	on	_	0	SENT_842	[p34l484t3377r548b3412],
16	the	DT	O	the	det	18	SENT_842	[p34l563t3363r649b3412],
17	progressive	JJ	O	progressive	amod	18	SENT_842	[p34l666t3365r966b3426],
18	phase	NN	O	phase	prep_on	14	SENT_842	[p34l982t3363r1135b3425],
19	of	IN	O	of	_	0	SENT_842	[p34l1150t3362r1204b3412],
20	the	DT	O	the	det	21	SENT_842	[p34l1213t3363r1298b3412],
21	disease	NN	O	disease	prep_of	18	SENT_842	[p34l1313t3363r1517b3412],
22	.	.	O	.	_	0	SENT_842	[p34l1313t3363r1517b3412],

1	Brain	NN	O	brain	_	0	SENT_843	[p34l1531t3365r1660b3412],
2	129	CD	NUMBER	129	num	1	SENT_843	[p34l1679t3366r1791b3420],
3	,	,	O	,	_	0	SENT_843	[p34l1679t3366r1791b3420],
4	584-594	CD	NUMBER	584-594	number	5	SENT_843	[p34l1806t3366r2030b3412],
5	(	CD	NUMBER	(	appos	1	SENT_843	[p34l132t3441r306b3496],
6	2006	CD	DATE	2006	num	7	SENT_843	[p34l132t3441r306b3496],
7	)	NN	O	)	dep	5	SENT_843	[p34l132t3441r306b3496],
8	.	.	O	.	_	0	SENT_843	[p34l132t3441r306b3496],

1	96	CD	NUMBER	96	_	0	SENT_844	[p35l8t21r82b67],
2	.	.	O	.	_	0	SENT_844	[p35l8t21r82b67],

1	Kappos	NNP	PERSON	Kappos	_	0	SENT_845	[p35l131t20r336b80],
2	,	,	O	,	_	0	SENT_845	[p35l131t20r336b80],
3	L.	NNP	O	L.	nn	4	SENT_845	[p35l353t20r390b67],
4	etaI.	NNP	O	etaI.	appos	1	SENT_845	[p35l404t18r532b75],
5	;	:	O	;	_	0	SENT_845	[p35l404t18r532b75],
6	European	JJ	LOCATION	european	amod	8	SENT_845	[p35l549t20r796b80],
7	(	JJ	O	(	amod	8	SENT_845	[p35l814t19r1082b75],
8	EU-SPMS	NN	O	eu-spm	dep	1	SENT_845	[p35l814t19r1082b75],
9	)	CD	NUMBER	)	num	12	SENT_845	[p35l814t19r1082b75],
10	Interferon	NN	O	interferon	nn	12	SENT_845	[p35l1101t17r1358b67],
11	beta-1	NN	O	beta-1	nn	12	SENT_845	[p35l1377t18r1533b67],
12	b	NN	O	b	dep	8	SENT_845	[p35l1549t18r1579b67],
13	in	IN	O	in	_	0	SENT_845	[p35l1595t20r1638b67],
14	Secondary	JJ	O	secondary	prep_in	12	SENT_845	[p35l1655t18r1933b81],

1	Progressive	JJ	ORGANIZATION	progressive	amod	6	SENT_846	[p35l133t98r429b159],
2	Multiple	JJ	ORGANIZATION	multiple	amod	6	SENT_846	[p35l444t96r660b158],
3	Sclerosis	NN	ORGANIZATION	sclerosis	nn	6	SENT_846	[p35l675t96r897b145],
4	Trial	NNP	ORGANIZATION	Trial	nn	6	SENT_846	[p35l907t96r1013b145],
5	Steering	NNP	ORGANIZATION	Steering	nn	6	SENT_846	[p35l1030t97r1246b159],
6	Committee	NNP	ORGANIZATION	Committee	_	0	SENT_846	[p35l1263t97r1557b145],
7	and	CC	ORGANIZATION	and	_	0	SENT_846	[p35l1572t96r1668b145],
8	Independent	NNP	ORGANIZATION	Independent	nn	10	SENT_846	[p35l1686t96r2027b158],
9	Advisory	NNP	ORGANIZATION	Advisory	nn	10	SENT_846	[p35l130t174r360b237],
10	Board	NNP	ORGANIZATION	Board	conj_and	6	SENT_846	[p35l376t174r539b231],
11	;	:	O	;	_	0	SENT_846	[p35l376t174r539b231],
12	North	NNP	LOCATION	North	nn	19	SENT_846	[p35l556t174r703b223],
13	American	NNP	LOCATION	American	nn	19	SENT_846	[p35l719t176r968b223],
14	(	NNP	O	(	nn	19	SENT_846	[p35l986t175r1262b231],
15	NA-SPMS	NNP	O	NA-SPMS	nn	19	SENT_846	[p35l986t175r1262b231],
16	)	NNP	O	)	nn	19	SENT_846	[p35l986t175r1262b231],
17	Interferon	NN	O	interferon	nn	19	SENT_846	[p35l1281t173r1539b223],
18	beta-1	NN	O	beta-1	nn	19	SENT_846	[p35l1557t174r1713b223],
19	b	NN	O	b	dep	6	SENT_846	[p35l1729t174r1759b223],
20	in	IN	O	in	_	0	SENT_846	[p35l1776t176r1818b223],
21	Secondary	JJ	ORGANIZATION	secondary	amod	22	SENT_846	[p35l1835t174r2114b237],
22	Progressive	NNP	ORGANIZATION	Progressive	prep_in	19	SENT_846	[p35l133t254r429b315],
23	Multiple	JJ	ORGANIZATION	multiple	amod	27	SENT_846	[p35l444t252r660b314],
24	Sclerosis	NNP	ORGANIZATION	Sclerosis	nn	27	SENT_846	[p35l675t252r897b301],
25	Trial	NNP	ORGANIZATION	Trial	nn	27	SENT_846	[p35l907t252r1013b301],
26	Steering	NNP	ORGANIZATION	Steering	nn	27	SENT_846	[p35l1030t253r1246b315],
27	Committee	NNP	ORGANIZATION	Committee	dep	19	SENT_846	[p35l1263t253r1557b301],
28	and	CC	O	and	_	0	SENT_846	[p35l1572t252r1668b301],
29	Independent	NNP	ORGANIZATION	Independent	nn	31	SENT_846	[p35l1686t252r2027b314],
30	Advisory	NNP	ORGANIZATION	Advisory	nn	31	SENT_846	[p35l130t330r360b393],
31	Board	NNP	ORGANIZATION	Board	conj_and	27	SENT_846	[p35l376t330r538b379],
32	.	.	O	.	_	0	SENT_846	[p35l376t330r538b379],

1	Interferon	NN	O	interferon	nn	3	SENT_847	[p35l555t329r813b379],
2	beta-1	NN	O	beta-1	nn	3	SENT_847	[p35l831t330r987b379],
3	b	NN	O	b	_	0	SENT_847	[p35l1003t330r1033b379],
4	in	IN	O	in	_	0	SENT_847	[p35l1050t332r1092b379],
5	secondary	JJ	O	secondary	amod	7	SENT_847	[p35l1109t330r1381b393],
6	progressive	JJ	O	progressive	amod	7	SENT_847	[p35l1396t332r1696b393],
7	MS	NN	O	m	prep_in	3	SENT_847	[p35l1711t331r1802b379],
8	:	:	O	:	_	0	SENT_847	[p35l1711t331r1802b379],
9	a	DT	O	a	det	11	SENT_847	[p35l1816t344r1842b379],
10	combined	JJ	O	combined	amod	11	SENT_847	[p35l1858t330r2123b379],
11	analysis	NN	O	analysis	dep	3	SENT_847	[p35l131t408r333b471],
12	of	IN	O	of	_	0	SENT_847	[p35l347t407r402b458],
13	the	DT	O	the	det	15	SENT_847	[p35l410t408r496b457],
14	two	CD	NUMBER	two	num	15	SENT_847	[p35l509t415r609b457],
15	trials	NNS	O	trial	prep_of	11	SENT_847	[p35l622t408r759b457],
16	.	.	O	.	_	0	SENT_847	[p35l622t408r759b457],

1	Neurology	NN	O	neurology	_	0	SENT_848	[p35l774t408r1039b472],
2	63	CD	NUMBER	63	num	1	SENT_848	[p35l1049t411r1129b465],
3	,	,	O	,	_	0	SENT_848	[p35l1049t411r1129b465],
4	1779-1787	CD	DATE	1779-1787	number	5	SENT_848	[p35l1148t411r1433b457],
5	(	CD	NUMBER	(	appos	1	SENT_848	[p35l1450t409r1624b465],
6	2004	CD	DATE	2004	num	7	SENT_848	[p35l1450t409r1624b465],
7	)	NN	O	)	dep	5	SENT_848	[p35l1450t409r1624b465],
8	.	.	O	.	_	0	SENT_848	[p35l1450t409r1624b465],

1	97	CD	NUMBER	97	_	0	SENT_849	[p35l8t489r82b536],
2	.	.	O	.	_	0	SENT_849	[p35l8t489r82b536],

1	Julian	NNP	PERSON	Julian	nn	5	SENT_850	[p35l127t486r293b543],
2	,	,	O	,	_	0	SENT_850	[p35l127t486r293b543],
3	L.	NNP	O	L.	appos	5	SENT_850	[p35l309t488r346b536],
4	et	NNP	O	et	nn	5	SENT_850	[p35l360t493r409b536],
5	aI.	NNP	O	aI.	_	0	SENT_850	[p35l418t486r488b543],
6	;	:	O	;	_	0	SENT_850	[p35l418t486r488b543],
7	Network	NNP	ORGANIZATION	Network	dep	5	SENT_850	[p35l505t486r729b536],
8	of	IN	ORGANIZATION	of	_	0	SENT_850	[p35l741t485r795b536],
9	Pediatric	NNP	ORGANIZATION	Pediatric	nn	10	SENT_850	[p35l807t486r1032b536],
10	MS	NN	ORGANIZATION	m	nn	11	SENT_850	[p35l1047t488r1124b536],
11	Centers	NNPS	ORGANIZATION	Centers	prep_of	7	SENT_850	[p35l1139t488r1337b536],
12	of	IN	ORGANIZATION	of	_	0	SENT_850	[p35l1352t485r1406b536],
13	Excellence	NNP	ORGANIZATION	Excellence	prep_of	11	SENT_850	[p35l1418t486r1701b536],
14	.	.	O	.	_	0	SENT_850	[p35l1418t486r1701b536],

1	Cognitive	JJ	MISC	cognitive	amod	2	SENT_851	[p35l1715t488r1966b549],
2	impairment	NN	O	impairment	nsubj	3	SENT_851	[p35l132t565r440b624],
3	occurs	VBZ	O	occur	_	0	SENT_851	[p35l453t577r622b612],
4	in	IN	O	in	_	0	SENT_851	[p35l638t565r680b611],
5	children	NNS	O	child	prep_in	3	SENT_851	[p35l697t563r908b612],
6	and	CC	O	and	_	0	SENT_851	[p35l924t563r1021b612],
7	adolescents	NNS	O	adolescent	prep_in	3	SENT_851	[p35l1037t563r1348b612],
8	with	IN	O	with	_	0	SENT_851	[p35l1361t563r1475b612],
9	multiple	JJ	O	multiple	amod	10	SENT_851	[p35l1493t563r1710b624],
10	sclerosis	NN	O	sclerosis	prep_with	5	SENT_851	[p35l1725t563r1954b612],
11	:	:	O	:	_	0	SENT_851	[p35l1725t563r1954b612],
12	results	NNS	O	result	dobj	3	SENT_851	[p35l1970t563r2137b612],
13	from	IN	O	from	_	0	SENT_851	[p35l129t639r251b689],
14	a	DT	O	a	det	17	SENT_851	[p35l268t654r293b689],
15	United	NNP	LOCATION	United	nn	17	SENT_851	[p35l312t640r483b689],
16	States	NNPS	LOCATION	States	nn	17	SENT_851	[p35l500t642r656b689],
17	network	NN	O	network	prep_from	12	SENT_851	[p35l673t640r902b689],
18	.	.	O	.	_	0	SENT_851	[p35l673t640r902b689],

1	J.	NNP	O	J.	nn	3	SENT_852	[p35l912t642r946b689],
2	Child	NNP	O	Child	nn	3	SENT_852	[p35l962t640r1093b689],
3	Neurol	NNP	O	Neurol	_	0	SENT_852	[p35l1102t640r1281b689],
4	.	.	O	.	_	0	SENT_852	[p35l1102t640r1281b689],

1	28	CD	NUMBER	28	_	0	SENT_853	[p35l1296t643r1376b696],
2	,	,	O	,	_	0	SENT_853	[p35l1296t643r1376b696],
3	102-107	CD	NUMBER	102-107	number	4	SENT_853	[p35l1395t643r1614b689],
4	(	CD	NUMBER	(	appos	1	SENT_853	[p35l1630t641r1804b696],
5	2013	CD	DATE	2013	num	6	SENT_853	[p35l1630t641r1804b696],
6	)	NN	O	)	dep	4	SENT_853	[p35l1630t641r1804b696],
7	.	.	O	.	_	0	SENT_853	[p35l1630t641r1804b696],

1	Chabas	NNP	O	Chabas	nn	4	SENT_854	[p35l129t718r333b775],
2	,	,	O	,	_	0	SENT_854	[p35l129t718r333b775],
3	D.	NNP	O	D.	appos	4	SENT_854	[p35l350t720r397b768],
4	etaI.	NNP	O	etaI.	_	0	SENT_854	[p35l411t718r539b775],
5	;	:	O	;	_	0	SENT_854	[p35l411t718r539b775],
6	US	NNP	ORGANIZATION	US	nn	7	SENT_854	[p35l555t720r621b768],
7	Network	NNP	ORGANIZATION	Network	dep	4	SENT_854	[p35l639t718r862b768],
8	of	IN	ORGANIZATION	of	_	0	SENT_854	[p35l875t717r929b768],
9	Pediatric	NNP	ORGANIZATION	Pediatric	nn	10	SENT_854	[p35l941t718r1166b768],
10	MS	NN	ORGANIZATION	m	nn	11	SENT_854	[p35l1181t720r1258b768],
11	Centers	NNPS	ORGANIZATION	Centers	prep_of	7	SENT_854	[p35l1273t719r1471b768],
12	of	IN	ORGANIZATION	of	_	0	SENT_854	[p35l1485t717r1540b768],
13	Excellence	NNP	ORGANIZATION	Excellence	prep_of	11	SENT_854	[p35l1552t718r1835b768],
14	.	.	O	.	_	0	SENT_854	[p35l1552t718r1835b768],

1	Younger	JJ	O	younger	amod	2	SENT_855	[p35l1845t720r2067b781],
2	children	NNS	O	child	nsubj	5	SENT_855	[p35l131t796r342b846],
3	with	IN	O	with	_	0	SENT_855	[p35l357t796r470b845],
4	MS	NN	O	m	prep_with	2	SENT_855	[p35l488t798r565b845],
5	have	VBP	O	have	_	0	SENT_855	[p35l582t796r704b845],
6	a	DT	O	a	det	10	SENT_855	[p35l718t811r743b845],
7	distinct	JJ	O	distinct	amod	10	SENT_855	[p35l759t796r953b846],
8	CSF	NN	O	csf	nn	10	SENT_855	[p35l967t797r1062b845],
9	inﬂammatory	JJ	O	inﬂammatory	amod	10	SENT_855	[p35l1079t795r1434b860],
10	proﬁle	NN	O	proﬁle	dobj	5	SENT_855	[p35l1449t795r1615b858],
11	at	IN	O	at	_	0	SENT_855	[p35l1629t803r1677b845],
12	disease	NN	O	disease	nn	13	SENT_855	[p35l1691t796r1882b846],
13	onset	NN	O	onset	prep_at	5	SENT_855	[p35l1897t803r2054b845],
14	.	.	O	.	_	0	SENT_855	[p35l1897t803r2054b845],

1	Neurology	NN	O	neurology	_	0	SENT_856	[p35l130t874r396b938],
2	74	CD	NUMBER	74	num	1	SENT_856	[p35l407t878r486b931],
3	,	,	O	,	_	0	SENT_856	[p35l407t878r486b931],
4	399-405	CD	NUMBER	399-405	number	5	SENT_856	[p35l501t877r723b923],
5	(	CD	NUMBER	(	appos	1	SENT_856	[p35l741t875r915b931],
6	2010	CD	DATE	2010	num	7	SENT_856	[p35l741t875r915b931],
7	)	NN	O	)	dep	5	SENT_856	[p35l741t875r915b931],
8	.	.	O	.	_	0	SENT_856	[p35l741t875r915b931],

1	VOLUME	NN	O	volume	nn	3	SENT_857	[p35l543t1098r768b1140],
2	95	CD	NUMBER	95	num	3	SENT_857	[p35l785t1099r842b1140],
3	NUMBER	NN	O	number	_	0	SENT_857	[p35l863t1098r1087b1140],
4	1	CD	NUMBER	1	number	5	SENT_857	[p35l1109t1100r1122b1140],
5	|	CD	NUMBER	|	dep	3	SENT_857	[p35l1151t1094r1156b1155],
6	JANUARY	NNP	DATE	JANUARY	dep	5	SENT_857	[p35l1175t1098r1420b1140],
7	2014	CD	DATE	2014	num	6	SENT_857	[p35l1437t1099r1558b1140],
8	|	CD	NUMBER	|	num	9	SENT_857	[p35l1577t1094r1581b1155],
9	www.nature.com/cpt	NN	O	www.nature.com/cpt	dep	3	SENT_857	[p35l1600t1098r2152b1151],

